STOCK TITAN

Forge Nano registers up to 43,553,075 shares for resale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
S-1

Rhea-AI Filing Summary

Forge Nano Holdings, Inc. (NANO) is registering up to 11,499,995 shares of Common Stock for issuance upon exercise of SPAC Warrants. The registration also covers selling securityholder resales of up to 43,553,075 Common Stock shares, 41,435,272 shares issuable upon warrant exercise, and 23,525 SPAC Warrants. These securities may not be sold until the registration statement is effective. Forge Nano will not receive proceeds from selling securityholders’ resales, but may receive cash if warrants are exercised for cash; it expects to use any net exercise proceeds for general corporate purposes.

Forge Nano states that sales or the perception of sales could significantly reduce the Common Stock market price. The company completed its business combination on October 22, 2026, and acquired HzO on November 4, 2026. It issued 5,772,645 shares to HzO’s former equityholders, with up to 1,533,795 additional shares issuable after a 12-month holdback, subject to adjustment.

Filing Explained

Forge Nano’s estimated cash from warrant exercises is conditional, not committed: about $307.2 million if all warrants are exercised for cash with exercise prices reset to the $5 floor and the maximum Reset PIPE Warrants issued and exercised, versus about $357.2 million under the no-reset, no-Reset-Warrant scenario.

Primary shares issuable upon SPAC Warrant exercise Up to 11,499,995 shares Primary offering
Common Stock shares registered for resale Up to 43,553,075 shares Secondary offering by selling securityholders
Shares issuable upon warrant exercise registered for resale 41,435,272 shares Secondary offering by selling securityholders
SPAC Warrants registered for resale 23,525 warrants Held by affiliates of the Sponsor
Potential cash proceeds from warrant exercises Approximately $307.2 million Assumes all Warrants are exercised for cash, specified warrant prices reset to the $5.00 floor, and up to 10,000,000 Reset PIPE Warrants are issued and exercised at a $5.00 PIPE Reset Price
Potential cash proceeds from warrant exercises Approximately $357.2 million Assumes all Warrants are exercised for cash, no such reset occurs, Additional PIPE Warrants are exercised at $10.00 per share, and no Reset PIPE Warrants are issued
Common Stock closing price $3.12 per share November 19, 2026
SPAC Warrant closing price $0.46 per warrant November 19, 2026
atomic layer deposition technical
"nanocoating and atomic layer deposition (“ALD”) technologies"
Atomic layer deposition (ALD) is a precise manufacturing process that deposits materials one atomic layer at a time using repeated, controlled chemical steps, producing ultra-thin, highly uniform coatings even on complex shapes. It matters to investors because ALD enables smaller, faster, more power-efficient chips and more reliable sensors, batteries and optical parts, so companies with ALD capability can improve product performance and yield—like painting a detailed sculpture layer by layer for perfect, even coverage.
Pre-Funded Warrants financial
"7,031,175 Pre-Funded Warrants at a price of $10.00 per Pre-Funded Warrant"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
PIPE Warrants financial
"15,000,000 PIPE Warrants, each exercisable for one share"
Pipe warrants are option-like securities issued together with a private investment in a publicly traded company that give the holder the right to buy a set number of shares at a fixed price for a limited time. They matter to investors because if holders exercise them the company receives new cash but the total number of shares increases, which can reduce each existing shareholder’s ownership and earnings per share and potentially pressure the stock price—like redeeming coupons that create more pieces of the same pie.
PIPE Reset Price financial
"PIPE Reset Price (which will not be less than $5.00 per share)"
VWAP financial
"the VWAP of our Common Stock is less than the Exercise Price"
VWAP, or Volume-Weighted Average Price, is a way to find the average price of a stock throughout the trading day, giving more importance to times when more shares are traded. It helps traders see the typical price and decide whether a stock is expensive or cheap compared to its average, similar to finding the average speed during a trip by giving more weight to times when you traveled faster or slower.
Earn-Out Shares financial
"up to 12,041,118 Earn-Out Shares issuable to our affiliates"
Earn-out shares are company shares promised to sellers or managers only if the business meets agreed future targets after a merger or acquisition, functioning like a performance-based payout instead of immediate cash. They matter to investors because they can dilute existing ownership, change future earnings prospects and reveal how confident buyers are about growth — like a conditional bonus that shifts payment and risk into the future.
Offering Type mixed primary and resale/secondary
Securities Offered Common Stock issuable upon exercise of SPAC Warrants; Common Stock and SPAC Warrants offered for resale
Offering Amount Primary: up to 11,499,995 shares of Common Stock. Secondary: up to 43,553,075 shares of Common Stock, 41,435,272 shares of Common Stock issuable upon exercise of Warrants, and 23,525 SPAC Warrants.
Use of Proceeds Forge Nano will not receive proceeds from selling securityholders’ sales. It may receive cash proceeds if Warrants are exercised for cash and expects to use net proceeds for general corporate purposes.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NANO shares are registered for issuance and resale?

Forge Nano’s offering includes up to 11,499,995 shares of Common Stock for primary issuance upon exercise of SPAC Warrants. Selling securityholders may resell up to 43,553,075 Common Stock shares and 41,435,272 shares issuable upon exercise of Warrants, plus 23,525 SPAC Warrants.

How much cash could Forge Nano (NANO) receive from warrant exercises?

Forge Nano estimates approximately $307.2 million or approximately $357.2 million if all Warrants are exercised for cash. The $307.2 million case assumes the PIPE and Additional PIPE Warrant exercise prices reset to the $5.00 floor and up to 10,000,000 Reset PIPE Warrants are issued and exercised at a $5.00 PIPE Reset Price; the $357.2 million case assumes no such reset, Additional PIPE Warrants exercised at $10.00 per share, and no Reset PIPE Warrants issued.

When can selling securityholders sell NANO shares covered by the registration?

The securities may not be sold until the registration statement is effective. Selling securityholders may sell any, all or none of their securities from time to time, at varying prices, using methods described in the Plan of Distribution.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false0002101833http://fasb.org/us-gaap/2026#RelatedPartyMemberhttp://archimedesspac.com/20260930#InterestExpenseNonoperatingChangesInFairValueOfLiabilityAmortizationOfDebtDiscounthttp://fasb.org/us-gaap/2026#OtherPostretirementBenefitPlansDefinedBenefitMemberhttp://fasb.org/us-gaap/2026#OtherPostretirementBenefitPlansDefinedBenefitMemberhttp://xbrl.sec.gov/country/2026#US687179687179http://fasb.org/us-gaap/2026#RelatedPartyMemberhttp://fasb.org/us-gaap/2026#RelatedPartyMemberhttp://fasb.org/us-gaap/2026#RelatedPartyMember11111128014564020280145640204482495344824953http://fasb.org/us-gaap/2026#OtherNonoperatingIncomeExpense0.50.5P10D0.50.00330.00330.00330.50.5P6M0.50.00330.00330.00330.50.5P10D0.50.5P6Mhttp://fasb.org/us-gaap/2026#RelatedPartyMemberP42Dhttp://fasb.org/us-gaap/2026#RelatedPartyMemberhttp://archimedesspac.com/20260930#InterestExpenseNonoperatingChangesInFairValueOfLiabilityAmortizationOfDebtDiscount0.33330.33330.33332306000P1YP42D0.2200http://xbrl.sec.gov/country/2026#UShttp://fasb.org/us-gaap/2026#RelatedPartyMember1001001001000.520P24M0.003330.003330.00333http://fasb.org/us-gaap/2026#UnrealizedGainLossOnDerivativeshttp://fasb.org/us-gaap/2026#UnrealizedGainLossOnDerivatives0.520P24M0.003330.003330.00333100http://archimedesspac.com/20260930#ChangeInFairValueOfEmbeddedDerivativeAndWarrantLiabilityhttp://fasb.org/us-gaap/2026#MeasurementInputDiscountRateMemberhttp://archimedesspac.com/20260930#ChangeInFairValueOfEmbeddedDerivativeAndWarrantLiability551000.000490.000698018154http://fasb.org/us-gaap/2026#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMemberP2MP2Mhttp://fasb.org/us-gaap/2026#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2026#MeasurementInputDiscountRateMember0.000690.00049111http://archimedesspac.com/20260930#HzoInc.AndSubsidiariesMember0002101833none:ForgeNanoIncMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-09-300002101833none:ForgeNanoIncMemberus-gaap:MeasurementInputPriceVolatilityMember2026-09-300002101833none:ForgeNanoIncMemberus-gaap:MeasurementInputExpectedTermMember2026-09-300002101833none:ForgeNanoIncMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:MeasurementInputPriceVolatilityMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:MeasurementInputExpectedTermMember2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PublicWarrantsMemberus-gaap:MeasurementInputSharePriceMember2025-02-120002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PublicWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2025-02-120002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PublicWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2025-02-120002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PublicWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2025-02-120002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PublicWarrantsMemberus-gaap:MeasurementInputExercisePriceMember2025-02-120002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PublicWarrantsMembernone:ProbabilityOfDeSPACAndMarketAdjustmentMember2025-02-120002101833none:ForgeNanoIncMemberus-gaap:SeriesDPreferredStockMember2024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:IPOMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:IPOMember2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:IPOMember2026-01-012026-09-3000021018332024-01-012024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:PreferredStockMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:CommonStockMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:PreferredStockMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:CommonStockMember2025-01-012025-09-300002101833none:ForgeNanoIncMembernone:ArchimedesTechSpacPartnersIiCo.Member2026-10-222026-10-220002101833us-gaap:ReceivablesFromStockholderMember2025-12-042025-12-310002101833us-gaap:AdditionalPaidInCapitalMember2025-12-042025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2PreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2APreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2PreferredStockMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2APreferredStockMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2PreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:Series2APreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:Series2PreferredStockMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:Series2APreferredStockMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Member2025-02-142025-02-140002101833none:HzoInc.AndSubsidiariesMembernone:Series2CPreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2BPreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2CPreferredStockMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2BPreferredStockMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2CPreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:Series2BPreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:Series2CPreferredStockMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:Series2BPreferredStockMember2025-01-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2026-07-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2026-04-012026-06-300002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2025-07-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2026-01-012026-03-310002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2025-01-012025-12-310002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2025-01-012025-03-310002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMembernone:PrivateInvestmentInPublicEquityInvestorsMemberus-gaap:SubsequentEventMember2026-10-222026-10-220002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMembernone:OrdinaryShareholdersOfArchimedesTechSpacPartnersIiCo.Memberus-gaap:SubsequentEventMember2026-10-222026-10-220002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMembernone:FormerShareholdersMemberus-gaap:SubsequentEventMember2026-10-222026-10-220002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMembernone:EscrowAgentMemberus-gaap:SubsequentEventMember2026-10-222026-10-220002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMembernone:FormerShareholdersMemberus-gaap:SubsequentEventMember2026-10-202026-10-200002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PipeInvestorsMemberus-gaap:SubsequentEventMember2026-10-202026-10-200002101833none:ArchimedesTechSpacPartnersIiCoMembernone:HoldersOfAtiiOrdinarySharesMemberus-gaap:SubsequentEventMember2026-10-202026-10-200002101833none:ArchimedesTechSpacPartnersIiCoMembernone:FormerStockholdersOfForgeNanoMemberus-gaap:SubsequentEventMember2026-10-202026-10-200002101833none:PipeInvestorsMemberus-gaap:SubsequentEventMember2026-10-202026-10-200002101833none:HoldersOfAtiiOrdinarySharesMemberus-gaap:SubsequentEventMember2026-10-202026-10-200002101833none:FormerStockholdersOfForgeNanoMemberus-gaap:SubsequentEventMember2026-10-202026-10-200002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:SubsequentEventMember2026-10-132026-10-130002101833us-gaap:CommonStockMember2025-12-042025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2PreferredStockMember2025-02-142025-05-270002101833none:HzoInc.AndSubsidiariesMembernone:Series2aPreferredStockMember2025-02-142025-05-270002101833none:HzoInc.AndSubsidiariesMembernone:Series2PreferredStockMemberus-gaap:PreferredStockMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2APreferredStockMemberus-gaap:PreferredStockMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2PreferredStockMemberus-gaap:PreferredStockMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:Series2APreferredStockMemberus-gaap:PreferredStockMember2025-01-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:CommonStockMember2025-01-012025-03-310002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Membernone:Series2CPreferredStockMember2025-02-142025-05-270002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Membernone:Series2BPreferredStockMember2025-02-142025-05-270002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Membernone:Series2CPreferredStockMember2025-02-142025-02-140002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Membernone:Series2cpreferredstockMember2025-02-142025-02-140002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Membernone:Series2BPreferredStockMember2025-02-142025-02-140002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Membernone:Series2bpreferredstockMember2025-02-142025-02-140002101833none:HzoInc.AndSubsidiariesMembernone:Series2CPreferredStockMemberus-gaap:PreferredStockMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2BPreferredStockMemberus-gaap:PreferredStockMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2CPreferredStockMemberus-gaap:PreferredStockMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:Series2BPreferredStockMemberus-gaap:PreferredStockMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:RetainedEarningsMember2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AdditionalPaidInCapitalMember2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2026-09-300002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2026-09-300002101833us-gaap:RetainedEarningsMember2026-09-300002101833us-gaap:ReceivablesFromStockholderMember2026-09-300002101833us-gaap:AdditionalPaidInCapitalMember2026-09-300002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2026-06-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2026-06-300002101833us-gaap:RetainedEarningsMember2026-06-300002101833us-gaap:ReceivablesFromStockholderMember2026-06-300002101833us-gaap:AdditionalPaidInCapitalMember2026-06-300002101833none:ForgeNanoIncMember2026-06-300002101833none:ArchimedesTechSpacPartnersIiCoMember2026-06-300002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2026-03-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2026-03-310002101833us-gaap:RetainedEarningsMember2026-03-310002101833us-gaap:ReceivablesFromStockholderMember2026-03-310002101833us-gaap:AdditionalPaidInCapitalMember2026-03-310002101833none:ForgeNanoIncMember2026-03-310002101833none:ArchimedesTechSpacPartnersIiCoMember2026-03-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:RetainedEarningsMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AdditionalPaidInCapitalMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:AdditionalPaidInCapitalMember2025-12-310002101833us-gaap:RetainedEarningsMember2025-12-310002101833us-gaap:ReceivablesFromStockholderMember2025-12-310002101833us-gaap:AdditionalPaidInCapitalMember2025-12-310002101833us-gaap:RetainedEarningsMember2025-12-030002101833us-gaap:ReceivablesFromStockholderMember2025-12-030002101833us-gaap:AdditionalPaidInCapitalMember2025-12-030002101833none:HzoInc.AndSubsidiariesMemberus-gaap:RetainedEarningsMember2025-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AdditionalPaidInCapitalMember2025-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2025-09-300002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2025-06-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2025-06-300002101833none:ForgeNanoIncMember2025-06-300002101833none:ArchimedesTechSpacPartnersIiCoMember2025-06-300002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2025-03-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2025-03-310002101833none:ArchimedesTechSpacPartnersIiCoMember2025-03-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:RetainedEarningsMember2024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AdditionalPaidInCapitalMember2024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:AdditionalPaidInCapitalMember2024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2024-06-060002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:AdditionalPaidInCapitalMember2024-06-060002101833none:ArchimedesTechSpacPartnersIiCoMember2024-06-060002101833none:HzoInc.AndSubsidiariesMemberus-gaap:RetainedEarningsMember2023-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AdditionalPaidInCapitalMember2023-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2023-12-310002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2023-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:CommonStockMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:CommonStockMember2026-06-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:CommonStockMember2026-03-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:CommonStockMember2025-12-310002101833us-gaap:CommonStockMember2025-12-030002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:CommonStockMember2025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:CommonStockMember2025-06-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:CommonStockMember2025-03-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:CommonStockMember2024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:CommonStockMember2024-06-060002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMembernone:OtherInvestorsMember2026-10-220002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMembernone:InitialInvestorMember2026-10-220002101833none:ArchimedesTechSpacPartnersIiCoMembernone:AdditionalPrivateInvestmentInPublicEquityWarrantsMember2026-04-210002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Membernone:Series2CPreferredStockMember2025-05-270002101833none:HzoInc.AndSubsidiariesMembernone:Series2PreferredStockMember2025-05-270002101833none:HzoInc.AndSubsidiariesMembernone:Series2aPreferredStockMember2025-05-270002101833none:HzoInc.AndSubsidiariesMemberus-gaap:PreferredStockMember2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:CommonStockMember2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:PreferredStockMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:CommonStockMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:PreferredStockMember2025-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:CommonStockMember2025-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:PreferredStockMember2024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:CommonStockMember2024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:PreferredStockMember2023-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:CommonStockMember2023-12-310002101833none:ForgeNanoIncMember2023-01-012023-12-310002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMemberus-gaap:PerformanceSharesMemberus-gaap:SubsequentEventMember2026-10-222026-10-220002101833none:ForgeNanoIncMember2022-08-082022-08-080002101833none:ForgeNanoIncMembersrt:DirectorMember2026-01-012026-09-300002101833none:ForgeNanoIncMembernone:EmployeesMember2026-01-012026-09-300002101833none:ForgeNanoIncMembersrt:DirectorMember2025-01-012025-12-310002101833none:ForgeNanoIncMembernone:EmployeesMember2025-01-012025-12-310002101833none:ForgeNanoIncMembersrt:DirectorMember2025-01-012025-09-300002101833none:ForgeNanoIncMembernone:EmployeesMember2025-01-012025-09-300002101833none:ForgeNanoIncMembersrt:DirectorMember2024-01-012024-12-310002101833none:ForgeNanoIncMembernone:EmployeesMember2024-01-012024-12-310002101833none:ForgeNanoIncMemberus-gaap:EMEAMember2026-07-012026-09-300002101833none:ForgeNanoIncMemberstpr:CA2026-07-012026-09-300002101833none:ForgeNanoIncMembersrt:AsiaPacificMember2026-07-012026-09-300002101833none:ForgeNanoIncMembercountry:US2026-07-012026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:EquipmentSalesMember2026-01-012026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:CoatingServicesMember2026-01-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:EMEAMember2026-01-012026-09-300002101833none:ForgeNanoIncMemberstpr:CA2026-01-012026-09-300002101833none:ForgeNanoIncMembersrt:AsiaPacificMember2026-01-012026-09-300002101833none:ForgeNanoIncMembercountry:US2026-01-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:EMEAMember2025-07-012025-09-300002101833none:ForgeNanoIncMemberstpr:CA2025-07-012025-09-300002101833none:ForgeNanoIncMembersrt:AsiaPacificMember2025-07-012025-09-300002101833none:ForgeNanoIncMembercountry:US2025-07-012025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:EquipmentSalesMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:CoatingServicesMember2025-01-012025-12-310002101833none:ForgeNanoIncMemberus-gaap:EMEAMember2025-01-012025-12-310002101833none:ForgeNanoIncMemberstpr:CA2025-01-012025-12-310002101833none:ForgeNanoIncMembersrt:AsiaPacificMember2025-01-012025-12-310002101833none:ForgeNanoIncMembercountry:US2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:EquipmentSalesMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:CoatingServicesMember2025-01-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:EMEAMember2025-01-012025-09-300002101833none:ForgeNanoIncMemberstpr:CA2025-01-012025-09-300002101833none:ForgeNanoIncMembersrt:AsiaPacificMember2025-01-012025-09-300002101833none:ForgeNanoIncMembercountry:US2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:EquipmentSalesMember2024-01-012024-12-310002101833none:HzoInc.AndSubsidiariesMembernone:CoatingServicesMember2024-01-012024-12-310002101833none:ForgeNanoIncMemberus-gaap:EMEAMember2024-01-012024-12-310002101833none:ForgeNanoIncMemberstpr:CA2024-01-012024-12-310002101833none:ForgeNanoIncMembersrt:AsiaPacificMember2024-01-012024-12-310002101833none:ForgeNanoIncMembercountry:US2024-01-012024-12-310002101833none:ForgeNanoIncMember2026-01-012026-01-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PromissoryNoteMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2025-12-122025-12-120002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PromissoryNoteMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2025-02-122025-02-120002101833none:ArchimedesTechSpacPartnersIiCoMembernone:OfficeSpaceAdministrativeAndSupportServicesMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2026-07-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:OfficeSpaceAdministrativeAndSupportServicesMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2026-01-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:OfficeSpaceAdministrativeAndSupportServicesMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2025-07-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:OfficeSpaceAdministrativeAndSupportServicesMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2025-02-102025-02-100002101833none:ArchimedesTechSpacPartnersIiCoMembernone:OfficeSpaceAdministrativeAndSupportServicesMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMembersrt:MinimumMemberus-gaap:MachineryAndEquipmentMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembersrt:MinimumMemberus-gaap:FurnitureAndFixturesMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembersrt:MinimumMembernone:ElectronicEquipmentMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembersrt:MaximumMemberus-gaap:MachineryAndEquipmentMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembersrt:MaximumMemberus-gaap:LeaseholdImprovementsMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembersrt:MaximumMemberus-gaap:FurnitureAndFixturesMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembersrt:MaximumMembernone:ElectronicEquipmentMember2025-12-310002101833none:ForgeNanoIncMembersrt:MinimumMemberus-gaap:MachineryAndEquipmentMember2025-12-310002101833none:ForgeNanoIncMembersrt:MinimumMemberus-gaap:LeaseholdImprovementsMember2025-12-310002101833none:ForgeNanoIncMembersrt:MinimumMemberus-gaap:FurnitureAndFixturesMember2025-12-310002101833none:ForgeNanoIncMembersrt:MinimumMembernone:ComputerEquipmentAndSoftwareMember2025-12-310002101833none:ForgeNanoIncMembersrt:MaximumMemberus-gaap:MachineryAndEquipmentMember2025-12-310002101833none:ForgeNanoIncMembersrt:MaximumMemberus-gaap:LeaseholdImprovementsMember2025-12-310002101833none:ForgeNanoIncMembersrt:MaximumMemberus-gaap:FurnitureAndFixturesMember2025-12-310002101833none:ForgeNanoIncMembersrt:MaximumMembernone:ComputerEquipmentAndSoftwareMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:ConstructionInProgressMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:ConstructionInProgressMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:ConstructionInProgressMember2026-01-012026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:MachineryAndEquipmentMember2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:LeaseholdImprovementsMember2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FurnitureAndFixturesMember2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:ConstructionInProgressMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:OtherTangibleAssetsMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:ElectronicEquipmentMember2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:MachineryAndEquipmentMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:LeaseholdImprovementsMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FurnitureAndFixturesMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:ConstructionInProgressMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:OtherTangibleAssetsMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:ElectronicEquipmentMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:MachineryAndEquipmentMember2024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:LeaseholdImprovementsMember2024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FurnitureAndFixturesMember2024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:ConstructionInProgressMember2024-12-310002101833none:HzoInc.AndSubsidiariesMembernone:OtherTangibleAssetsMember2024-12-310002101833none:HzoInc.AndSubsidiariesMembernone:ElectronicEquipmentMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:MachineryAndEquipmentMember2026-01-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:LeaseholdImprovementsMember2026-01-012026-09-300002101833none:ForgeNanoIncMembernone:ComputerEquipmentAndSoftwareMember2026-01-012026-09-300002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMembernone:OtherInvestorsMember2026-10-222026-10-220002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMembernone:InitialInvestorMember2026-10-222026-10-220002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMember2026-10-222026-10-220002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMemberus-gaap:SubsequentEventMember2026-10-012026-10-310002101833none:ForgeNanoIncMemberus-gaap:SeriesDPreferredStockMember2025-03-012025-03-310002101833none:HzoInc.AndSubsidiariesMember2025-02-142025-05-270002101833none:ForgeNanoIncMemberus-gaap:SeriesCPreferredStockMember2024-02-012024-02-290002101833none:ForgeNanoIncMembernone:OrionInfrastructureCapitalMemberus-gaap:SeriesCPreferredStockMember2023-05-012023-05-310002101833none:ForgeNanoIncMembernone:HanwhaCorporationAndHanwhaAerospaceMemberus-gaap:SeriesCPreferredStockMember2023-05-012023-05-3100021018332025-12-292025-12-290002101833none:ForgeNanoIncMember2026-08-012026-08-310002101833none:ForgeNanoIncMembernone:AtLastAnniversaryMembernone:SundewAldAssetsFromSundewTechnologiesLlcMember2025-08-012025-08-310002101833none:ForgeNanoIncMembernone:AtSecondAnniversaryMembernone:SundewAldAssetsFromSundewTechnologiesLlcMember2024-08-012024-08-310002101833none:ForgeNanoIncMembernone:AtTimeOfClosingMembernone:SundewAldAssetsFromSundewTechnologiesLlcMember2023-08-092023-08-090002101833none:ForgeNanoIncMembernone:AtTimeOfClosingMember2023-08-092023-08-090002101833none:ForgeNanoIncMembernone:AtSecondAnniversaryMember2023-08-092023-08-090002101833none:ForgeNanoIncMembernone:AtLastAnniversaryMember2023-08-092023-08-090002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2026RecordedAsDerivativeLiabilityMember2026-03-122026-03-310002101833us-gaap:SubsequentEventMember2026-10-162026-10-160002101833none:ArchimedesTechSpacPartnersIiCoMembernone:InitialPublicOfferingAndPrivatePlacementMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:StateAndLocalJurisdictionMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:ForeignCountryMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:DomesticCountryMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:StateAndLocalJurisdictionMember2024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:ForeignCountryMember2024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:DomesticCountryMember2024-12-310002101833none:ForgeNanoIncMember2026-05-080002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RelatedPartyMember2024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PromissoryNoteMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PromissoryNoteMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2026-07-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2026-07-012026-09-300002101833us-gaap:RetainedEarningsMember2026-07-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2026-04-012026-06-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2026-04-012026-06-300002101833us-gaap:RetainedEarningsMember2026-04-012026-06-300002101833none:ArchimedesTechSpacPartnersIiCoMember2026-04-012026-06-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:RetainedEarningsMember2026-01-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2026-01-012026-03-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2026-01-012026-03-310002101833us-gaap:RetainedEarningsMember2026-01-012026-03-310002101833none:ArchimedesTechSpacPartnersIiCoMember2026-01-012026-03-3100021018332026-01-012026-03-310002101833us-gaap:RetainedEarningsMember2025-12-042025-12-310002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2025-07-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2025-07-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2025-04-012025-06-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2025-04-012025-06-300002101833none:ArchimedesTechSpacPartnersIiCoMember2025-04-012025-06-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:RetainedEarningsMember2025-01-012025-12-310002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:RetainedEarningsMember2025-01-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2025-01-012025-03-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2025-01-012025-03-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2024-06-072024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:CommonStockMember2024-06-072024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:AdditionalPaidInCapitalMember2024-06-072024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:RetainedEarningsMember2024-01-012024-12-310002101833none:ForgeNanoIncMemberus-gaap:RetainedEarningsMember2024-01-012024-12-310002101833none:HzoInc.AndSubsidiariesMembersrt:MinimumMembernone:EquipmentFinancingMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembersrt:MaximumMembernone:EquipmentFinancingMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:WorkingCapitalLoansMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:WorkingCapitalLoansMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:WorkingCapitalLoansMemberus-gaap:RelatedPartyMember2024-12-3100021018332024-12-310002101833none:HzoInc.AndSubsidiariesMembersrt:MinimumMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembersrt:MaximumMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembersrt:MinimumMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembersrt:MaximumMember2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMembernone:CashInBankAccountMembernone:SingleReportableSegmentMember2026-07-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMembernone:CashHeldInTrustAccountMembernone:SingleReportableSegmentMember2026-07-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:CashInBankAccountMember2026-07-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:CashHeldInTrustAccountMember2026-07-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMembernone:CashInBankAccountMembernone:SingleReportableSegmentMember2026-01-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMembernone:CashHeldInTrustAccountMembernone:SingleReportableSegmentMember2026-01-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:CashInBankAccountMember2026-01-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:CashHeldInTrustAccountMember2026-01-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMembernone:CashInBankAccountMembernone:SingleReportableSegmentMember2025-07-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMembernone:CashHeldInTrustAccountMembernone:SingleReportableSegmentMember2025-07-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:CashInBankAccountMember2025-07-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:CashHeldInTrustAccountMember2025-07-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMembernone:CashInBankAccountMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMembernone:CashHeldInTrustAccountMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:CashInBankAccountMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:CashHeldInTrustAccountMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMembernone:CashInBankAccountMembernone:SingleReportableSegmentMember2025-01-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMembernone:CashHeldInTrustAccountMembernone:SingleReportableSegmentMember2025-01-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:CashInBankAccountMember2025-01-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:CashHeldInTrustAccountMember2025-01-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:CashInBankAccountMember2024-06-072024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:CashHeldInTrustAccountMember2024-06-072024-12-310002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2026RecordedAsWarrantLiabilityMember2026-01-012026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2026Member2026-01-012026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2026Member2025-01-012025-09-300002101833none:ForgeNanoIncMembernone:SeriesDConvertibleNoteMember2024-01-012024-12-310002101833none:ForgeNanoIncMembernone:ToolManufacturingAndRelatedServicesMember2026-09-300002101833none:ForgeNanoIncMembernone:CoatingServicesMember2026-09-300002101833none:ForgeNanoIncMembernone:BatteryManufacturingReportingUnitMember2026-09-300002101833none:ForgeNanoIncMembernone:ToolManufacturingRelatedServicesReportingUnitMember2025-12-310002101833none:ForgeNanoIncMembernone:CoatingServicesReportingUnitMember2025-12-310002101833none:ForgeNanoIncMembernone:BatteryManufacturingReportingUnitMember2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMembernone:SingleReportableSegmentMember2026-07-012026-09-300002101833none:SingleReportableSegmentMember2026-07-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMember2026-07-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMembernone:SingleReportableSegmentMember2026-01-012026-09-300002101833none:SingleReportableSegmentMember2025-12-042025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMembernone:SingleReportableSegmentMember2025-07-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMember2025-07-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMembernone:SingleReportableSegmentMember2025-01-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OperatingSegmentsMember2024-06-072024-12-310002101833none:HzoInc.AndSubsidiariesMember2025-02-142025-02-140002101833none:ForgeNanoIncMembernone:WarrantsAndDerivativesMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2026-06-3000021018332026-06-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2026-04-2000021018332026-03-310002101833none:ForgeNanoIncMembernone:WarrantsAndDerivativesMember2025-12-310002101833none:ForgeNanoIncMembernone:WarrantsAndDerivativesMember2024-12-310002101833none:ForgeNanoIncMembernone:WarrantsAndDerivativesMember2023-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2026-04-202026-04-200002101833none:ForgeNanoIncMembernone:WarrantsAndDerivativesMember2026-01-012026-09-300002101833none:ForgeNanoIncMembernone:WarrantsAndDerivativesMember2025-01-012025-12-310002101833none:ForgeNanoIncMembernone:WarrantsAndDerivativesMember2024-01-012024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2026-07-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2026-04-212026-06-3000021018332026-04-012026-06-300002101833none:HzoInc.AndSubsidiariesMembernone:WarrantLiabilityMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:EmbeddedDerivativeLiabilityMember2026-09-300002101833none:ForgeNanoIncMembernone:ContingentConsiderationLiabilityMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:WarrantLiabilityMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:EmbeddedDerivativeLiabilityMember2025-12-310002101833none:ForgeNanoIncMembernone:ContingentConsiderationLiabilityMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:WarrantLiabilityMember2024-12-310002101833none:ForgeNanoIncMembernone:ContingentConsiderationLiabilityMember2024-12-310002101833none:HzoInc.AndSubsidiariesMembernone:WarrantLiabilityMember2023-12-310002101833none:HzoInc.AndSubsidiariesMembernone:WarrantLiabilityMember2026-01-012026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:EmbeddedDerivativeLiabilityMember2026-01-012026-09-300002101833none:ForgeNanoIncMembernone:ContingentConsiderationLiabilityMember2026-01-012026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:WarrantLiabilityMember2025-01-012025-12-310002101833none:ForgeNanoIncMembernone:ContingentConsiderationLiabilityMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:WarrantLiabilityMember2024-01-012024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2026-01-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PublicWarrantsMember2026-01-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:MeasurementInputPriceVolatilityMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:MeasurementInputExpectedTermMember2024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueMeasurementsRecurringMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2026RecordedAsDerivativeLiabilityMember2026-03-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Member2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Member2024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:MeasurementInputPriceVolatilityMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:MeasurementInputExpectedTermMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ProbabilityOfDeSPACAndMarketAdjustmentMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:MeasurementInputRedemptionTriggerPriceMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:MeasurementInputFloorPriceMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-04-200002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:MeasurementInputPriceVolatilityMember2026-04-200002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:MeasurementInputExpectedTermMember2026-04-200002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ProbabilityOfDeSPACAndMarketAdjustmentMember2026-04-200002101833none:ArchimedesTechSpacPartnersIiCoMembernone:MeasurementInputRedemptionTriggerPriceMember2026-04-200002101833none:ArchimedesTechSpacPartnersIiCoMembernone:MeasurementInputFloorPriceMember2026-04-200002101833none:ArchimedesTechSpacPartnersIiCoMember2026-04-200002101833none:HzoInc.AndSubsidiariesMembercountry:HK2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:ForeignTaxJurisdictionOtherMember2025-01-012025-12-310002101833none:ForgeNanoIncMember2025-07-042025-07-040002101833none:HzoInc.AndSubsidiariesMemberus-gaap:DomesticCountryMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:SubsequentEventMember2026-01-012026-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:RedeemableOrdinarySharesMember2026-07-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:NonredeemableOrdinarySharesMember2026-07-012026-09-3000021018332026-07-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:RedeemableOrdinarySharesMember2026-01-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:NonredeemableOrdinarySharesMember2026-01-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:RedeemableOrdinarySharesMember2025-07-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:NonredeemableOrdinarySharesMember2025-07-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:RedeemableOrdinarySharesMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:NonredeemableOrdinarySharesMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:RedeemableOrdinarySharesMember2025-01-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:NonredeemableOrdinarySharesMember2025-01-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:RedeemableOrdinarySharesMember2024-06-072024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:NonredeemableOrdinarySharesMember2024-06-072024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:NonredeemableOrdinarySharesMember2024-01-012024-12-310002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2025Memberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberus-gaap:SubsequentEventMember2026-03-132026-03-130002101833none:HzoInc.AndSubsidiariesMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberus-gaap:SubsequentEventMember2026-02-240002101833us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMember2026-09-300002101833us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-09-300002101833us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMember2026-09-300002101833us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMember2026-09-300002101833us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExercisePriceMember2026-09-300002101833us-gaap:FairValueInputsLevel3Membernone:MeasurementInputProbabilityOfDeSpacAndMarketAdjustmentMember2026-09-300002101833us-gaap:FairValueInputsLevel3Membernone:MeasurementInputExpectedTermToDeSpacTransactionMember2026-09-300002101833us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputSharePriceMember2026-04-300002101833us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-04-300002101833us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMember2026-04-300002101833us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMember2026-04-300002101833us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExercisePriceMember2026-04-300002101833us-gaap:FairValueInputsLevel3Membernone:MeasurementInputProbabilityOfDeSpacAndMarketAdjustmentMember2026-04-300002101833us-gaap:FairValueInputsLevel3Membernone:MeasurementInputExpectedTermToDeSpacTransactionMember2026-04-3000021018332026-04-200002101833none:ForgeNanoIncMemberus-gaap:NondesignatedMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2026-09-300002101833none:ForgeNanoIncMemberus-gaap:NondesignatedMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:NondesignatedMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:CostOfRevenue2026-07-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:CostOfRevenue2026-01-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:CostOfRevenue2025-07-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:CostOfRevenue2025-01-012025-12-310002101833none:ForgeNanoIncMemberus-gaap:CostOfRevenue2025-01-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:CostOfRevenue2024-01-012024-12-310002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2026RecordedAsDerivativeLiabilityMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2025Member2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2026Member2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2025Member2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2025Member2025-12-220002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Member2025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Member2025-01-100002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2025Memberus-gaap:SubsequentEventMember2026-03-310002101833none:ForgeNanoIncMembersrt:MaximumMembernone:SeriesDConvertibleNoteMember2024-12-310002101833none:ForgeNanoIncMembernone:SeriesDConvertibleNoteMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Membernone:Series2BPreferredStockMember2025-05-270002101833none:ForgeNanoIncMembernone:SeriesDConvertibleNoteMember2025-03-310002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Membernone:Series2cpreferredstockMember2025-02-140002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Membernone:Series2BPreferredStockMember2025-02-140002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Member2025-02-140002101833none:HzoInc.AndSubsidiariesMember2025-02-140002101833none:ForgeNanoIncMemberus-gaap:SecuredDebtMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:SecuredDebtMember2024-12-310002101833none:ForgeNanoIncMembernone:SeriesDConvertibleNoteMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMembernone:ToolManufacturingAndRelatedServicesMember2026-07-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMembernone:CoatingServicesMember2026-07-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMembernone:BatteryManufacturingMember2026-07-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300002101833none:ForgeNanoIncMembernone:ToolManufacturingAndRelatedServicesMember2026-07-012026-09-300002101833none:ForgeNanoIncMembernone:CoatingServicesMember2026-07-012026-09-300002101833none:ForgeNanoIncMembernone:BatteryManufacturingMember2026-07-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMembernone:ToolManufacturingAndRelatedServicesMember2026-01-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMembernone:CoatingServicesMember2026-01-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMembernone:BatteryManufacturingMember2026-01-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300002101833none:ForgeNanoIncMembernone:ToolManufacturingAndRelatedServicesMember2026-01-012026-09-300002101833none:ForgeNanoIncMembernone:CoatingServicesMember2026-01-012026-09-300002101833none:ForgeNanoIncMembernone:BatteryManufacturingMember2026-01-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMembernone:ToolManufacturingAndRelatedServicesMember2025-07-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMembernone:CoatingServicesMember2025-07-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMembernone:BatteryManufacturingMember2025-07-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300002101833none:ForgeNanoIncMembernone:ToolManufacturingAndRelatedServicesMember2025-07-012025-09-300002101833none:ForgeNanoIncMembernone:CoatingServicesMember2025-07-012025-09-300002101833none:ForgeNanoIncMembernone:BatteryManufacturingMember2025-07-012025-09-300002101833none:ForgeNanoIncMembernone:ToolManufacturingAndRelatedServicesMember2025-01-012025-12-310002101833none:ForgeNanoIncMembernone:ToolManufacturingAndRelatedServicesMember2025-01-012025-12-310002101833none:ForgeNanoIncMembernone:CoatingServicesMember2025-01-012025-12-310002101833none:ForgeNanoIncMembernone:CoatingServicesMember2025-01-012025-12-310002101833none:ForgeNanoIncMembernone:BatteryManufacturingMember2025-01-012025-12-310002101833none:ForgeNanoIncMembernone:BatteryManufacturingMember2025-01-012025-12-310002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMembernone:ToolManufacturingAndRelatedServicesMember2025-01-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMembernone:CoatingServicesMember2025-01-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMembernone:BatteryManufacturingMember2025-01-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300002101833none:ForgeNanoIncMembernone:ToolManufacturingAndRelatedServicesMember2025-01-012025-09-300002101833none:ForgeNanoIncMembernone:CoatingServicesMember2025-01-012025-09-300002101833none:ForgeNanoIncMembernone:BatteryManufacturingMember2025-01-012025-09-300002101833none:ForgeNanoIncMembernone:ToolManufacturingAndRelatedServicesMember2024-01-012024-12-310002101833none:ForgeNanoIncMembernone:ToolManufacturingAndRelatedServicesMember2024-01-012024-12-310002101833none:ForgeNanoIncMembernone:CoatingServicesMember2024-01-012024-12-310002101833none:ForgeNanoIncMembernone:CoatingServicesMember2024-01-012024-12-310002101833none:ForgeNanoIncMembernone:BatteryManufacturingMember2024-01-012024-12-310002101833none:ForgeNanoIncMembernone:BatteryManufacturingMember2024-01-012024-12-310002101833none:ForgeNanoIncMembernone:OneCustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2026-07-012026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:ThreeCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:FourCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:TwoCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-06-300002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2026-09-300002101833us-gaap:CommonStockMember2026-09-300002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2026-06-300002101833us-gaap:CommonStockMember2026-06-300002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2026-03-310002101833us-gaap:CommonStockMember2026-03-310002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2025-12-310002101833us-gaap:CommonStockMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2025-09-300002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2025-06-300002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2025-03-310002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2023-12-310002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMemberus-gaap:SubsequentEventMember2026-10-220002101833none:ForgeNanoIncMemberus-gaap:WarrantMember2026-09-300002101833none:ForgeNanoIncMemberus-gaap:WarrantMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PublicWarrantsMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PrivatePlacementWarrantsMember2026-09-300002101833none:ForgeNanoIncMemberus-gaap:WarrantMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:WarrantMember2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PublicWarrantsMember2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PrivatePlacementWarrantsMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:WarrantMember2024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PreFundedWarrantsMemberus-gaap:SubsequentEventMember2026-10-200002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PipeWarrantsMemberus-gaap:SubsequentEventMember2026-10-200002101833none:PreFundedWarrantsMemberus-gaap:SubsequentEventMember2026-10-200002101833none:PipeWarrantsMemberus-gaap:SubsequentEventMember2026-10-200002101833none:VolumeWeightedAveragePriceOfCommonStockIsLessThanExercisePriceMembernone:PipeWarrantsMember2026-04-200002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ResetPipeWarrantsMember2026-04-200002101833none:ArchimedesTechSpacPartnersIiCoMembernone:AdditionalPrivateInvestmentInPublicEquityWarrantsMember2026-04-200002101833none:AdditionalPipeWarrantsMember2026-04-200002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PubcoRightMemberus-gaap:SubsequentEventMember2026-10-210002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMemberus-gaap:WarrantMemberus-gaap:SubsequentEventMember2026-10-220002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMembernone:PreFundedWarrantsMemberus-gaap:SubsequentEventMember2026-10-220002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMembernone:InitialInvestorMembernone:WarrantssMember2026-10-220002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PubcoSpacWarrantMemberus-gaap:SubsequentEventMember2026-10-210002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ArchimedesTechSpacPartnersIiCoWarrantsMemberus-gaap:SubsequentEventMember2026-10-210002101833us-gaap:SubsequentEventMember2026-10-210002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PreFundedWarrantsMemberus-gaap:SubsequentEventMember2026-10-130002101833none:HzoInc.AndSubsidiariesMembernone:WarrantsIssuedOnSeptember2017Member2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:WarrantsIssuedOnNovember2023Member2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:WarrantsIssuedOnMay2019Member2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:WarrantsIssuedOnMarch2026Member2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:WarrantsIssuedOnMarch2018TwoMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:WarrantsIssuedOnMarch2018OneMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:WarrantsIssuedOnJuly2023Member2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:WarrantsIssuedOnDecember2017Member2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2026RecordedAsWarrantLiabilityMember2026-09-300002101833none:ForgeNanoIncMembernone:PennyWarrantsMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PrivateInvestmentInPublicEquityWarrantsMember2026-04-200002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PreFundedWarrantsMember2026-04-200002101833none:PreFundedWarrantsMember2026-04-200002101833none:PipeWarrantsMember2026-04-200002101833none:HzoInc.AndSubsidiariesMembernone:WarrantsIssuedOnSeptember2017Member2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:WarrantsIssuedOnNovember2023Member2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:WarrantsIssuedOnMay2019Member2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:WarrantsIssuedOnMarch2018TwoMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:WarrantsIssuedOnMarch2018OneMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:WarrantsIssuedOnJuly2023Member2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:WarrantsIssuedOnDecember2017Member2025-12-310002101833none:ForgeNanoIncMembernone:PennyWarrantsMember2025-12-310002101833none:ForgeNanoIncMembernone:PennyWarrantsMember2025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PrivatePlacementWarrantsMember2025-02-120002101833none:ForgeNanoIncMembernone:PennyWarrantsMember2024-12-310002101833none:ForgeNanoIncMembernone:OicLlcMembernone:WarrantsWithExercisePriceOf76.42Member2023-12-310002101833none:ForgeNanoIncMembernone:OicLlcMembernone:WarrantsWithExercisePriceOf0.01Member2023-12-3100021018332025-12-030002101833none:HzoInc.AndSubsidiariesMember2025-09-300002101833none:HzoInc.AndSubsidiariesMember2023-12-310002101833none:ForgeNanoIncMembernone:SundewAldAssetsFromSundewTechnologiesLlcMember2025-12-310002101833none:ForgeNanoIncMembernone:SundewAldAssetsFromSundewTechnologiesLlcMember2024-12-310002101833none:ForgeNanoIncMembernone:SundewAldAssetsFromSundewTechnologiesLlcMember2023-08-090002101833none:ForgeNanoIncMember2023-08-090002101833none:HzoInc.AndSubsidiariesMembernone:ForgeNanoHoldingsIncMembernone:HzoInc.AndSubsidiariesMemberus-gaap:SubsequentEventMember2026-11-042026-11-040002101833none:HzoInc.AndSubsidiariesMembernone:ForgeNanoHoldingsIncMembernone:HzoInc.AndSubsidiariesMember2026-02-242026-02-240002101833none:HzoInc.AndSubsidiariesMembernone:ForgeNanoHoldingsIncMembernone:HzoInc.AndSubsidiariesMemberus-gaap:SubsequentEventMember2026-11-040002101833none:HzoInc.AndSubsidiariesMembernone:ForgeNanoHoldingsIncMembernone:HzoInc.AndSubsidiariesMember2026-02-2400021018332025-12-042025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:SingleReportableSegmentMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:SingleReportableSegmentMember2025-12-310002101833none:ForgeNanoIncMember2025-11-300002101833none:ForgeNanoIncMemberus-gaap:WarrantMember2026-07-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:RestrictedStockMember2026-07-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:EmployeeStockOptionMember2026-07-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:WarrantMember2026-01-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:RestrictedStockMember2026-01-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:EmployeeStockOptionMember2026-01-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:WarrantMember2025-07-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:RestrictedStockMember2025-07-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:EmployeeStockOptionMember2025-07-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:WarrantMember2025-01-012025-12-310002101833none:ForgeNanoIncMemberus-gaap:RestrictedStockMember2025-01-012025-12-310002101833none:ForgeNanoIncMemberus-gaap:EmployeeStockOptionMember2025-01-012025-12-310002101833none:ForgeNanoIncMemberus-gaap:WarrantMember2025-01-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:RestrictedStockMember2025-01-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:EmployeeStockOptionMember2025-01-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:WarrantMember2024-01-012024-12-310002101833none:ForgeNanoIncMemberus-gaap:RestrictedStockMember2024-01-012024-12-310002101833none:ForgeNanoIncMemberus-gaap:EmployeeStockOptionMember2024-01-012024-12-310002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2026RecordedAsDerivativeLiabilityMember2026-01-012026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2025Member2026-01-012026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2025Member2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:InitialPublicOfferingAndPrivatePlacementMember2026-01-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:UnderwritersMemberus-gaap:IPOMember2025-02-122025-02-120002101833none:ArchimedesTechSpacPartnersIiCoMembernone:OtherOfferingCostsMemberus-gaap:IPOMember2025-02-122025-02-120002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RetainedEarningsMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:IPOMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:CommonStockMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310002101833none:ArchimedesTechSpacPartnersIiCoMember2025-01-012025-03-310002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-12-310002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:AdditionalPaidInCapitalMember2024-01-012024-12-310002101833none:ForgeNanoIncMemberus-gaap:MachineryAndEquipmentMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:LeaseholdImprovementsMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:FurnitureAndFixturesMember2025-12-310002101833none:ForgeNanoIncMembernone:ComputerEquipmentAndSoftwareMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:MachineryAndEquipmentMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:LeaseholdImprovementsMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:FurnitureAndFixturesMember2024-12-310002101833none:ForgeNanoIncMembernone:ComputerEquipmentAndSoftwareMember2024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RelatedPartyMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RelatedPartyMember2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:InitialPublicOfferingAndPrivatePlacementMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:InitialPublicOfferingAndPrivatePlacementMember2025-12-3100021018332026-09-300002101833none:ForgeNanoIncMembernone:PennyWarrantsMember2026-01-012026-09-300002101833none:ForgeNanoIncMembernone:PennyWarrantsMember2025-01-012025-12-310002101833none:ForgeNanoIncMembernone:PennyWarrantsMember2025-01-012025-09-300002101833none:ForgeNanoIncMembernone:PennyWarrantsMember2024-01-012024-12-310002101833none:ForgeNanoIncMembernone:OicLlcMember2024-01-012024-12-310002101833none:ForgeNanoIncMembernone:OicLlcMember2023-01-012023-12-310002101833none:ArchimedesTechSpacPartnersIiCoMember2025-12-022025-12-020002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PublicWarrantsMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PrivateInvestmentInPublicEquityWarrantsMember2026-04-202026-04-200002101833none:VolumeWeightedAveragePriceOfCommonStockIsLessThanExercisePriceMembernone:PipeWarrantsMember2026-04-202026-04-200002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ResetPipeWarrantsMember2026-04-202026-04-200002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:SubsequentEventMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2026-10-202026-10-200002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:SubsequentEventMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2026-10-202026-10-200002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:SubsequentEventMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2026-10-202026-10-200002101833us-gaap:SubsequentEventMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2026-10-202026-10-200002101833us-gaap:SubsequentEventMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2026-10-202026-10-200002101833us-gaap:SubsequentEventMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2026-10-202026-10-200002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:SubsequentEventMember2026-10-210002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:PrivatePlacementMember2025-02-120002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:IPOMember2025-02-120002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:PrivatePlacementMember2025-02-122025-02-120002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:IPOMember2025-02-122025-02-120002101833none:ForgeNanoIncMember2026-04-012026-06-300002101833none:ForgeNanoIncMember2026-01-012026-03-310002101833none:ForgeNanoIncMemberus-gaap:SeriesCPreferredStockMember2024-09-012024-09-300002101833none:ForgeNanoIncMember2025-04-012025-06-300002101833none:ForgeNanoIncMember2025-01-012025-03-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:SubsequentEventMember2026-10-162026-10-160002101833none:ForgeNanoIncMemberus-gaap:SeriesCPreferredStockMember2024-09-300002101833none:ForgeNanoIncMemberus-gaap:SeriesCPreferredStockMember2024-02-290002101833none:ForgeNanoIncMemberus-gaap:SeriesCPreferredStockMember2023-05-310002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-300002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-300002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310002101833none:ForgeNanoIncMemberus-gaap:SeriesDPreferredStockMember2026-09-300002101833none:ForgeNanoIncMemberus-gaap:SeriesCPreferredStockMember2026-09-300002101833none:ForgeNanoIncMemberus-gaap:SeriesBPreferredStockMember2026-09-300002101833none:ForgeNanoIncMemberus-gaap:SeriesAPreferredStockMember2026-09-300002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2026-09-300002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2026-06-300002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2026-03-310002101833none:ForgeNanoIncMemberus-gaap:SeriesDPreferredStockMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:SeriesCPreferredStockMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:SeriesBPreferredStockMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:SeriesAPreferredStockMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2025-09-300002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2025-06-300002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2025-03-310002101833none:ForgeNanoIncMemberus-gaap:SeriesCPreferredStockMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:SeriesBPreferredStockMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:SeriesAPreferredStockMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:AdditionalPaidInCapitalMember2024-01-012024-12-310002101833none:ForgeNanoIncMemberus-gaap:CommonStockMember2024-01-012024-12-310002101833none:SingleReportableSegmentMember2026-01-012026-09-300002101833none:ForgeNanoIncMember2025-11-012025-11-300002101833none:OdysseyTransferAndTrustCompanyMemberus-gaap:SubsequentEventMember2026-10-222026-10-220002101833none:ForgeNanoIncMember2025-09-300002101833none:ForgeNanoIncMember2023-12-310002101833none:ForgeNanoIncMember2022-08-080002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMemberus-gaap:PerformanceSharesMemberus-gaap:SubsequentEventMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2026-10-222026-10-220002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMemberus-gaap:PerformanceSharesMemberus-gaap:SubsequentEventMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2026-10-222026-10-220002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMemberus-gaap:PerformanceSharesMemberus-gaap:SubsequentEventMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2026-10-222026-10-220002101833none:ForgeNanoIncMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2026-01-012026-09-300002101833none:ForgeNanoIncMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2025-01-012025-12-310002101833none:ForgeNanoIncMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2025-01-012025-09-300002101833none:ForgeNanoIncMemberus-gaap:SubsequentEventMember2026-11-042026-11-040002101833none:HzoInc.AndSubsidiariesMembernone:ProfessionalServicesMembersrt:MinimumMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:ProfessionalServicesMembersrt:MaximumMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:EquipmentSalesMembersrt:MinimumMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:EquipmentSalesMembersrt:MaximumMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembersrt:MinimumMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembersrt:MaximumMember2025-01-012025-12-310002101833none:ForgeNanoIncMembernone:ArchimedesTechSpacPartnersIiCo.Member2026-10-220002101833us-gaap:SubsequentEventMember2026-10-160002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:SubsequentEventMember2026-10-160002101833none:ForgeNanoIncMembernone:HzoInvestorsGroupMemberus-gaap:SubsequentEventMember2026-03-012026-03-310002101833none:ForgeNanoIncMembernone:EdSmithGroupMember2025-10-012025-12-310002101833none:ForgeNanoIncMember2025-04-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2026Member2026-03-122026-03-310002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2025Member2025-11-282025-12-220002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Member2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Member2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Member2024-08-262025-01-100002101833none:HzoInc.AndSubsidiariesMembernone:ConvertiblePromissoryNotes2024Member2024-01-012024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:AdditionalPrivateInvestmentInPublicEquityWarrantsMember2026-04-202026-04-200002101833none:PreFundedWarrantsMember2026-04-202026-04-2000021018332026-04-212026-04-210002101833none:ArchimedesTechSpacPartnersIiCoMembernone:AdditionalPrivateInvestmentInPublicEquityWarrantsMember2026-04-212026-04-210002101833none:ForgeNanoIncMembercountry:US2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMember2024-06-072024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:SubsequentEventMember2026-10-202026-10-200002101833us-gaap:SubsequentEventMember2026-10-202026-10-2000021018332025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:SubsequentEventMember2026-10-130002101833none:ArchimedesTechSpacPartnersIiCoMembernone:SponsorMemberus-gaap:SubsequentEventMember2026-10-202026-10-200002101833none:SponsorMemberus-gaap:SubsequentEventMember2026-10-202026-10-200002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:SubsequentEventMember2026-10-200002101833none:ForgeNanoIncMembernone:ThreeCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2026-07-012026-09-300002101833none:ForgeNanoIncMembernone:OneCustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-300002101833none:ForgeNanoIncMembernone:FourCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-300002101833none:ForgeNanoIncMembernone:TwoCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2025-07-012025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:TwoCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:TwoCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-12-310002101833none:ForgeNanoIncMembernone:TwoCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-12-310002101833none:ForgeNanoIncMembernone:ThreeCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-12-310002101833none:ForgeNanoIncMembernone:OneCustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMembernone:TwoCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310002101833none:HzoInc.AndSubsidiariesMembernone:FourCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310002101833none:ForgeNanoIncMembernone:TwoCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310002101833none:ForgeNanoIncMembernone:FiveCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310002101833none:ForgeNanoIncMember2026-08-310002101833none:ForgeNanoIncMember2026-07-310002101833none:ForgeNanoIncMember2026-03-130002101833none:HzoInc.AndSubsidiariesMemberus-gaap:UnsecuredDebtMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:EquipmentFinancingMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:EquipmentFinancingMember2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:OfficeSpaceAdministrativeAndSupportServicesMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2025-02-100002101833none:HzoInc.AndSubsidiariesMembernone:Series2PreferredStockMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:Series2CPreferredStockMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:Series2BPreferredStockMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:Series2aPreferredStockMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:Series1PreferredStockMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:Series1aPreferredStockMember2026-09-300002101833none:HzoInc.AndSubsidiariesMembernone:Series2PreferredStockMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2CPreferredStockMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2BPreferredStockMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series2aPreferredStockMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series1PreferredStockMember2025-12-310002101833none:HzoInc.AndSubsidiariesMembernone:Series1aPreferredStockMember2025-12-310002101833none:HzoInc.AndSubsidiariesMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OverAllotmentOptionMember2026-01-012026-09-300002101833none:ForgeNanoIncMember2026-05-082026-05-080002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:NonrelatedPartyMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:NonrelatedPartyMember2024-06-072024-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RelatedPartyMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:RelatedPartyMember2024-06-072024-12-310002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMembernone:ToolManufacturingAndRelatedServicesMember2025-01-012025-12-310002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMembernone:CoatingServicesMember2025-01-012025-12-310002101833none:ForgeNanoIncMemberus-gaap:OperatingSegmentsMembernone:BatteryManufacturingMember2025-01-012025-12-310002101833none:ForgeNanoIncMemberus-gaap:CorporateNonSegmentMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2024-06-070002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2024-06-072024-06-070002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputExpectedDividendRateMember2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputDiscountRateMember2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:MeasurementInputPriceVolatilityMember2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:MeasurementInputExpectedTermMember2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:MeasurementInputExpectedDividendRateMember2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputPriceVolatilityMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputExpectedTermMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputExpectedDividendRateMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:MeasurementInputPriceVolatilityMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:MeasurementInputExpectedTermMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:MeasurementInputExpectedDividendRateMember2025-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputPriceVolatilityMember2024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputExpectedTermMember2024-12-310002101833none:HzoInc.AndSubsidiariesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputExpectedDividendRateMember2024-12-310002101833none:ForgeNanoIncMember2026-07-012026-09-300002101833none:ForgeNanoIncMember2025-07-012025-09-300002101833none:ForgeNanoIncMember2025-01-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ForgeNanoInc.Memberus-gaap:SubsequentEventMember2026-10-220002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ForgeNanoInc.Member2026-09-300002101833none:HzoInc.AndSubsidiariesMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberus-gaap:SubsequentEventMember2026-03-132026-03-130002101833none:HzoInc.AndSubsidiariesMembernone:ForgeNanoHoldingsIncMembernone:HzoInc.AndSubsidiariesMember2026-03-132026-03-130002101833none:HzoInc.AndSubsidiariesMembernone:ForgeNanoHoldingsIncMembernone:HzoInc.AndSubsidiariesMember2026-08-060002101833none:HzoInc.AndSubsidiariesMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberus-gaap:SubsequentEventMember2026-03-130002101833none:HzoInc.AndSubsidiariesMembernone:ForgeNanoHoldingsIncMembernone:HzoInc.AndSubsidiariesMember2026-03-130002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OverAllotmentOptionMember2025-12-022025-12-020002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OverAllotmentOptionMember2025-12-020002101833none:ArchimedesTechSpacPartnersIiCoMembernone:UnderwritersMemberus-gaap:IPOMember2025-12-022025-12-020002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OverAllotmentOptionMember2025-02-122025-02-120002101833none:ArchimedesTechSpacPartnersIiCoMember2026-01-012026-09-300002101833none:HzoInc.AndSubsidiariesMembercountry:VN2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMembercountry:CN2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ForgeNanoHoldingsIncMembernone:ScenarioTwoMember2026-10-222026-10-220002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ForgeNanoHoldingsIncMemberus-gaap:SubsequentEventMember2026-10-222026-10-220002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ForgeNanoHoldingsIncMembernone:ScenarioOneMember2026-10-222026-10-220002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ForgeNanoHoldingsIncMembernone:ScenarioTwoMemberus-gaap:SubsequentEventMember2026-10-222026-10-220002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ForgeNanoHoldingsIncMembernone:ScenarioThreeMemberus-gaap:SubsequentEventMember2026-10-222026-10-220002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ForgeNanoHoldingsIncMembernone:ScenarioOneMemberus-gaap:SubsequentEventMember2026-10-222026-10-220002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ForgeNanoHoldingsIncMembernone:ScenarioThreeMember2026-10-222026-10-220002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ForgeNanoHoldingsIncMembernone:ScenarioTwoMember2026-01-012026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:ForgeNanoHoldingsIncMembernone:ScenarioOneMember2026-01-012026-09-300002101833none:Vwap25OrRevenue800MillionMilestoneMemberus-gaap:SubsequentEventMember2026-10-220002101833none:Vwap20OrRevenue600MillionMilestoneMemberus-gaap:SubsequentEventMember2026-10-220002101833none:Vwap15OrRevenue400MillionMilestoneMemberus-gaap:SubsequentEventMember2026-10-220002101833us-gaap:SubsequentEventMember2026-10-222026-10-220002101833none:HzoInc.AndSubsidiariesMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberus-gaap:SubsequentEventMember2026-02-242026-02-240002101833none:ArchimedesTechSpacPartnersIiCoMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMember2025-01-012025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OverAllotmentOptionMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:OverAllotmentOptionMember2025-02-120002101833none:HzoInc.AndSubsidiariesMember2025-12-310002101833none:HzoInc.AndSubsidiariesMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:SubsequentEventMember2026-10-202026-10-200002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:LoansPayableMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMemberus-gaap:LoansPayableMember2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:WorkingCapitalLoansMemberus-gaap:RelatedPartyMember2026-09-300002101833none:ArchimedesTechSpacPartnersIiCoMembernone:WorkingCapitalLoansMemberus-gaap:RelatedPartyMember2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PromissoryNoteMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2024-06-070002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PromissoryNoteMembernone:ArchimedesTechSpacSponsorsIiLlcTheSponsorMember2024-06-070002101833none:ForgeNanoIncMembernone:OicLlcMember2024-12-310002101833none:ForgeNanoIncMembernone:OicLlcMemberus-gaap:WarrantMember2023-12-310002101833none:ForgeNanoIncMembernone:SeriesDConvertibleNoteMember2025-12-310002101833none:ForgeNanoIncMembernone:SeriesDConvertibleNoteMember2025-03-012025-03-310002101833none:ForgeNanoIncMemberus-gaap:SubsequentEventMember2026-03-012026-03-310002101833none:ForgeNanoIncMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2026-09-300002101833none:ForgeNanoIncMemberus-gaap:FairValueMeasurementsRecurringMember2026-09-300002101833none:ForgeNanoIncMembersrt:ScenarioPreviouslyReportedMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-310002101833none:ForgeNanoIncMembersrt:ScenarioPreviouslyReportedMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310002101833none:ForgeNanoIncMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310002101833none:ForgeNanoIncMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-3100021018332025-12-310002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMemberus-gaap:SubsequentEventMember2026-10-222026-10-220002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PublicWarrantsMember2025-12-020002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PublicWarrantsMember2025-02-120002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMembernone:InitialInvestorMembernone:PreFundedWarrantsMember2026-10-220002101833none:ForgeNanoIncMembernone:OicLlcMember2023-12-310002101833none:ForgeNanoIncMemberus-gaap:WarrantMember2026-01-012026-09-300002101833none:ForgeNanoIncMembernone:OicLlcMemberus-gaap:WarrantMember2025-03-312025-03-310002101833none:ForgeNanoIncMembernone:OicLlcMember2025-03-312025-03-310002101833none:ForgeNanoIncMemberus-gaap:WarrantMember2025-01-012025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PublicWarrantsMember2025-12-022025-12-020002101833none:ArchimedesTechSpacPartnersIiCoMembernone:PublicWarrantsMember2025-02-122025-02-120002101833none:ArchimedesTechSpacPartnersIiCoMembernone:BeneficialOwnershipLimitation9.9Membernone:PreFundedWarrantsMemberus-gaap:SubsequentEventMember2026-10-130002101833none:ArchimedesTechSpacPartnersIiCoMembernone:BeneficialOwnershipLimitation4.9Membernone:PreFundedWarrantsMemberus-gaap:SubsequentEventMember2026-10-130002101833none:ArchimedesTechSpacPartnersIiCoMembernone:BeneficialOwnershipLimitation19.9Membernone:PreFundedWarrantsMemberus-gaap:SubsequentEventMember2026-10-130002101833none:HzoInc.AndSubsidiariesMember2025-01-012025-12-310002101833none:HzoInc.AndSubsidiariesMember2024-01-012024-12-310002101833none:HzoInc.AndSubsidiariesMember2025-01-012025-09-300002101833none:HzoInc.AndSubsidiariesMember2026-01-012026-09-300002101833none:ForgeNanoIncMember2026-09-300002101833none:ForgeNanoIncMember2025-12-310002101833us-gaap:SubsequentEventMember2026-10-212026-10-210002101833none:ForgeNanoIncMembersrt:MinimumMembernone:SundewAldAssetsFromSundewTechnologiesLlcMember2023-08-092023-08-090002101833none:ForgeNanoIncMembersrt:MaximumMembernone:SundewAldAssetsFromSundewTechnologiesLlcMember2023-08-092023-08-090002101833none:ForgeNanoIncMembersrt:MinimumMember2023-08-092023-08-090002101833none:ForgeNanoIncMembersrt:MaximumMember2023-08-092023-08-090002101833none:HzoIncMemberus-gaap:SubsequentEventMember2026-11-042026-11-040002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMembernone:HzOIncMemberus-gaap:SubsequentEventMember2026-11-042026-11-040002101833none:ForgeNanoIncMembernone:ForgeNanoHoldingsIncMembernone:HzOIncMemberus-gaap:SubsequentEventMember2026-11-040002101833none:ArchimedesTechSpacPartnersIiCoMember2025-09-300002101833none:ArchimedesTechSpacPartnersIiCoMember2025-02-122025-02-120002101833none:ForgeNanoIncMembernone:SundewAldAssetsFromSundewTechnologiesLlcMember2023-08-092023-08-090002101833none:ForgeNanoIncMember2023-08-092023-08-0900021018332026-04-202026-04-200002101833none:ArchimedesTechSpacPartnersIiCoMember2025-02-120002101833none:ForgeNanoIncMember2025-03-310002101833none:ForgeNanoIncMemberus-gaap:SeriesDPreferredStockMember2026-01-012026-06-300002101833none:ForgeNanoIncMemberus-gaap:SubsequentEventMember2026-01-012026-03-310002101833none:ForgeNanoIncMember2025-03-312025-03-310002101833none:ForgeNanoIncMember2025-03-012025-03-310002101833none:ForgeNanoIncMemberus-gaap:SeriesDPreferredStockMember2025-01-012025-12-310002101833none:ForgeNanoIncMember2026-03-132026-03-130002101833none:PipeWarrantsMember2026-04-202026-04-200002101833none:ArchimedesTechSpacPartnersIiCoMember2026-04-202026-04-200002101833none:ArchimedesTechSpacPartnersIiCoMember2025-12-310002101833none:ArchimedesTechSpacPartnersIiCoMember2024-12-310002101833none:ForgeNanoIncMember2026-01-012026-09-300002101833none:ForgeNanoIncMember2024-12-310002101833none:ForgeNanoIncMember2024-01-012024-12-310002101833none:ForgeNanoIncMember2025-01-012025-12-3100021018332026-01-012026-09-30none:customernone:itemnone:Optionsnone:segmentxbrli:pureiso4217:USDutr:sqftiso4217:USDxbrli:sharesxbrli:sharesnone:paymentnone:Votenone:Dnone:Y
Table of Contents

​

As filed with the Securities and Exchange Commission on November 20, 2026.

Registration No. 333-        

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

Forge Nano Holdings, Inc.

(Exact name of Registrant as Specified in its Charter)

​

​

​

​

​

​

Delaware
(State or other jurisdiction of
incorporation or organization)

  ​ ​ ​

3559
(Primary Standard Industrial
Classification Code Number)

  ​ ​ ​

41-2980280
(I.R.S. Employer
Identification Number)

​

12300 Grant Street, Suite 100

Thornton, CO 80241

(720) 259-8579

(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)

Paul Lichty

Chief Executive Officer

12300 Grant Street, Suite 100

Thornton, CO 80241

(720) 259-8579

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Copies to:

​

Curtis Zimmermann
Chief Legal Counsel
Forge Nano Holdings, Inc.
12300 Grant Street, Suite 100
Thornton, CO 80241
(720) 259-8579

  ​ ​ ​

Benjamin M. Goodchild
Timothy Cruickshank
Christodoulos Kaoutzanis
Paul, Weiss, Rifkind, Wharton &
Garrison LLP
1285 Avenue of the Americas
New York, NY 10019-6064
(212) 373-3000

​

Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

​

​

​

​

​

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☒

Smaller reporting company

☒

​

​

Emerging growth company

☒

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

​

​

​

​

Table of Contents

The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities, nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

​

Subject to Completion, dated November 20, 2026

Primary Offering of

11,499,995 Shares of Common Stock Issuable Upon Exercise of Warrants

Secondary Offering of

43,553,075 Shares of Common Stock,

41,435,272 Shares of Common Stock Issuable Upon Exercise of Warrants and

23,525 Warrants

FORGE NANO HOLDINGS, INC.

This prospectus relates to the issuance by us from time to time of up to 11,499,995 shares of common stock, par value $0.0001 per share (“Common Stock”), of Forge Nano Holdings, Inc. (formerly known as ATII Holdings Inc.) (“Forge Nano”) issuable on the exercise of certain warrants of Forge Nano. In addition, this prospectus relates to the offer and resale from time to time by the selling securityholders named in this prospectus (or their permitted transferees) (the “Selling Securityholders”) of up to 43,553,075 shares of Common Stock, 41,435,272 shares of Common Stock issuable upon exercise of certain warrants of Forge Nano and 23,525 SPAC Warrants (as defined herein) of Forge Nano, in each case that (1) were issued in a private placement or (2) are held by our affiliates or affiliates of the Sponsor (as defined herein).

The Selling Securityholders may sell any, all or none of the securities, and we do not know when or in what amount the Selling Securityholders may sell their securities hereunder following the date of this prospectus. The Selling Securityholders may sell the securities described in this prospectus in a number of different ways and at varying prices. We provide more information about how the Selling Securityholders may sell their securities in the section titled “Plan of Distribution” appearing elsewhere in this prospectus.

We will not receive any of the proceeds from the sale of the securities by the Selling Securityholders. We will receive the exercise price of any warrants that are exercised for cash. The sale of the shares registered hereby, or the perception that such sales may occur, could cause the market price of our Common Stock to decline significantly. We will pay the expenses associated with registering the sales by the Selling Securityholders other than any underwriting discounts and commissions, as described in more detail in the section titled “Use of Proceeds” appearing elsewhere in this prospectus.

Our Common Stock and SPAC Warrants are listed on The Nasdaq Stock Market LLC under the symbols “NANO” and “NANOW,” respectively. On November 19, 2026, the closing price of our Common Stock was $3.12 per share and the closing price of our SPAC Warrants was $0.46 per warrant.

We are an “emerging growth company” and a “smaller reporting company” as defined under the federal securities laws and, as such, have elected to comply with certain reduced public company reporting requirements for this prospectus and may elect to do so in future filings.

Investing in our securities involves a high degree of risk. Before buying any securities, you should carefully read the discussion of the risks of investing in our securities in “Risk Factors” beginning on page 7 of this prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

​

​

​

Prospectus dated           , 2026.

​

​

​

Table of Contents

​

TABLE OF CONTENTS

​

​

Page

FREQUENTLY USED TERMS

iv

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

x

PROSPECTUS SUMMARY

1

RISK FACTORS

7

USE OF PROCEEDS

31

DIVIDEND POLICY

32

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

33

BUSINESS

47

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

61

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

77

MANAGEMENT

78

EXECUTIVE COMPENSATION

84

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

94

SELLING SECURITYHOLDERS

95

DESCRIPTION OF SECURITIES

101

MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES

116

PLAN OF DISTRIBUTION

123

LEGAL MATTERS

125

EXPERTS

125

WHERE YOU CAN FIND ADDITIONAL INFORMATION

125

INDEX TO FINANCIAL STATEMENTS

F-1

​

​

​

i

Table of Contents

​

EXPLANATORY NOTE

Neither we nor the Selling Securityholders have authorized any person to provide you any information or to make any representations other than those contained in this prospectus or any applicable prospectus supplement or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. Neither we nor the Selling Securityholders take responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. Neither we nor the Selling Securityholders are making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted.

This prospectus is part of a registration statement on Form S-1 that we filed with the SEC and relates to the issuance by us of up to 11,499,995 shares of Common Stock that are issuable upon exercise of SPAC Warrants.

In addition, this prospectus relates to the offer and resale from time to time by the Selling Securityholders of (i) up to 43,553,075 shares of Common Stock that (1) were issued in a private placement or (2) are held by our affiliates or affiliates of the Sponsor, which consist of (a) 2,968,825 shares of Common Stock issued to the Initial PIPE Investor; (b) 2,300,000 shares of Common Stock issued to the Additional PIPE Investors; (c) 5,772,645 shares of Common Stock issued in the HzO Merger; (d) 18,816,341 shares of Common Stock issued or issuable to certain of our affiliates; (e) 1,654,146 shares of Common Stock held by affiliates of the Sponsor; and (f) up to 12,041,118 Earn-Out Shares issuable to certain of our affiliates; (ii) up to 41,435,272 shares of Common Stock that are issuable upon exercise of our Warrants, which consist of (a) 420,000 shares of Common Stock issuable upon exercise of SPAC Warrants; (b) 7,031,175 shares of Common Stock issuable upon exercise of the Pre-Funded Warrants; (c) 15,000,000 shares of Common Stock issuable upon exercise of the PIPE Warrants; (d) 5,000,000 shares of Common Stock issuable upon exercise of the Additional PIPE Warrants; (e) 10,000,000 shares of Common Stock issuable upon exercise of the Reset PIPE Warrants; (f) 3,562,305 shares of Common Stock issuable upon exercise of the Ascent Warrants; and (g) 421,792 shares of Common Stock issuable upon exercise of the Forge Nano Warrants; and (iii) 23,525 SPAC Warrants held by affiliates of the Sponsor.

The Selling Securityholders may use this prospectus to sell such shares of Common Stock and SPAC Warrants from time to time through any means described in the section entitled “Plan of Distribution.” We will not receive any proceeds from the sale by such Selling Securityholders of the securities offered by them described in this prospectus. We may receive cash from the exercise of Warrants, assuming such Warrants are exercised for cash, but we will not receive any proceeds from the sale of shares of Common Stock issuable upon such exercise. We expect to use the net proceeds from the exercise of such warrants for cash, if any, for general corporate purposes. See the section titled “Use of Proceeds.”

We may also provide a prospectus supplement or post-effective amendment to the registration statement to add information to, or update or change information contained in, this prospectus. Before purchasing any securities, you should read both this prospectus and any applicable prospectus supplement or post-effective amendment to the registration statement together with the additional information to which we refer you in the section of this prospectus titled “Where You Can Find Additional Information.”

​

ii

Table of Contents

​

MARKET AND INDUSTRY DATA

Certain industry data and market data contained in this prospectus were obtained from independent third-party surveys, market research, publicly available information, reports of governmental agencies and industry publications and surveys. All of Forge Nano’s management’s estimates presented herein concerning the market and the industry in which Forge Nano competes, including its market position, general expectations of market opportunity, size and growth rates, are based upon review of independent third-party surveys and industry publications prepared by a number of sources and other publicly available information. Third-party industry publications and forecasts generally state that the information contained therein has been obtained from sources generally believed to be reliable. All the industry data, market data and related estimates used in this prospectus involve a number of assumptions and limitations, and you are cautioned not to give undue weight to such data and estimates. Although we have no reason to believe that the information from these industry publications and surveys included in this prospectus is not reliable, we have not independently verified this information and cannot guarantee its accuracy or completeness. In addition, we believe that industry data, market data and related estimates provide general guidance but are inherently imprecise. The industry in which Forge Nano operates is subject to a high degree of uncertainty and risk due to a variety of factors, including those described in “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors — Risks Related to Forge Nano’s Business” and elsewhere in this prospectus. These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties and by us.

TRADEMARKS

This document contains references to trademarks, trade names and service marks belonging to other entities. Solely for convenience, trademarks, trade names and service marks referred to in this prospectus may appear without the ®, TM or SM symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. Forge Nano does not intend that use or display of other companies’ trade names, trademarks, or service marks to imply a relationship with, or endorsement or sponsorship of us, by any other companies.

​

iii

Table of Contents

​

FREQUENTLY USED TERMS

Unless otherwise stated or unless the context otherwise requires, the terms “we,” “us,” “our,” “Forge Nano” and the “Company” refer to Forge Nano Holdings, Inc. (formerly known as ATII Holdings Inc.), a Delaware corporation, and its consolidated subsidiaries following the consummation of the Business Combination and Forge Nano, Inc., a Delaware corporation, prior to the consummation of the Business Combination.

In this document:

“2026 Equity Plan” means the Forge Nano Holdings, Inc. 2026 Omnibus Incentive Compensation Plan, adopted in connection with the Business Combination.

“A&R Registration Rights Agreement” means the Amended and Restated Registration Rights Agreement, dated as of October 22, 2026, by and among Forge Nano Holdings, the Sponsor and certain individuals party thereto.

“Additional PIPE Warrants” means additional warrants to purchase 5,000,000 shares of Common Stock at an exercise price of $10.00 per share (subject to a one-time downward reset to a floor of $5.00 per share), to be issued to the Initial PIPE Investor if, on the 24-month anniversary of the Closing, the Initial PIPE Investor certifies in writing that it beneficially owns 5,000,000 shares of Common Stock.

“Additional PIPE Subscription Agreements” means the subscription agreements that Forge Nano Holdings, ATII and Forge Nano, Inc. entered into with certain accredited investors (the “Additional PIPE Investors”), pursuant to which Forge Nano Holdings, substantially concurrently with the Closing, sold an aggregate of 2,300,000 shares of Common Stock (the “Additional Subscribed Shares”) to the Additional PIPE Investors at a subscription price of $10.00 per share, for an aggregate commitment of $23,000,000 (the “Additional PIPE Financing”).

“Additional Subscribed Shares” means the 2,300,000 shares of Common Stock issued to the Additional PIPE Investors in connection with the Additional PIPE Financing pursuant to the Additional PIPE Subscription Agreements.

“Ascent Warrant Agreement” means each warrant agreement, dated as of October 22, 2026, between Forge Nano Holdings and the holder party thereto, which governs the Ascent Warrants, and “Ascent Warrant Agreements” means all such warrant agreements, collectively.

“Ascent Warrants” means the warrants issued to Ascent Funds International Management LLC or its affiliates pursuant to the Merger Agreement and the other agreements contemplated therein.

“ATII” means Archimedes Tech SPAC Partners II Co. (which prior to the Domestication Merger Effective Time, was an exempted company incorporated under the laws of the Cayman Islands and, pursuant to the Domestication Merger, merged with and into Forge Nano Holdings, following which the separate corporate existence of ATII ceased and Forge Nano Holdings continued as the surviving corporation incorporated under the laws of the State of Delaware pursuant to the Companies Act and the DGCL).

“ATII Ordinary Shares” means the ordinary shares of ATII, par value $0.0001 per share.

“ATII Private Shares” means the ATII Ordinary Shares included in the ATII Private Units.

“ATII Private Units” means 840,000 private placement units of ATII sold in a private placement concurrently with the IPO, each unit consisting of one ATII Ordinary Share and one-half of one ATII Private Warrant. Of those 840,000 ATII Private Units, the Sponsor purchased 530,000 ATII Private Units and BTIG purchased 310,000 ATII Private Units.

“ATII Private Warrants” means the ATII Warrants issued as part of the ATII Private Units.

“ATII Public Shares” means the ATII Ordinary Shares sold in the IPO (whether they were purchased in the IPO as part of the ATII Public Units or thereafter in the open market).

iv

Table of Contents

​

“ATII Public Units” means the units issued by ATII in the IPO (including pursuant to the overallotment option), each unit consisting of one ATII Ordinary Share and one-half of one ATII Warrant.

“ATII Public Warrants” means the ATII Warrants issued as part of the ATII Public Units.

“ATII Units” means, collectively, the ATII Public Units and the ATII Private Units.

“ATII Warrant Agreement” means the warrant agreement, dated as of February 10, 2025, (as assumed by the Company pursuant to the Assumption of Warrant Agreement dated as of October 21, 2026), by and between ATII and Odyssey Transfer and Trust Company, as warrant agent.

“ATII Warrants” means, collectively, the redeemable warrants issued as part of the ATII Units exercisable for one ATII Ordinary Share at an exercise price of $11.50 per share, subject to adjustment, pursuant to the terms of the ATII Warrant Agreement.

“Board” means the board of directors of Forge Nano Holdings.

“BTIG” means BTIG, LLC.

“Business Combination” means the Mergers and the other transactions contemplated by the Merger Agreement and the other agreements contemplated therein.

“Bylaws” means the amended and restated bylaws of Forge Nano Holdings.

“Charter” means the amended and restated certificate of incorporation of Forge Nano Holdings.

“Closing” means the closing of the Business Combination.

“Closing Date” means the date of the Closing.

“Code” means the U.S. Internal Revenue Code of 1986, as amended.

“Common Stock” means the common stock of Forge Nano Holdings, par value $0.0001 per share.

“Companies Act” refers to the Companies Act (as revised) of the Cayman Islands.

“DGCL” means the Delaware General Corporation Law, as amended.

“Domestication Merger” means the statutory merger of ATII with and into Forge Nano Holdings pursuant to the terms of the Merger Agreement.

“Domestication Merger Effective Time” means such time when the Plan of Merger is registered by the Registrar of Companies in the Cayman Islands (the “Cayman Registrar”) and when the certificate of merger is filed with the Secretary of State of the State of Delaware, or such later time as may be specified in the Plan of Merger and certificate of merger.

“Earn-Out Shares” means an aggregate amount of 90,000,000 shares of Common Stock, being the shares payable pursuant to Section 1.18(b) of the Merger Agreement.

“Escrow Agent” means Odyssey Transfer and Trust Company.

“Escrow Agreement” means the Earnout Escrow Agreement, dated as of October 21, 2026, by and between Forge Nano Holdings and the Escrow Agent.

“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended.

v

Table of Contents

​

“Excise Tax” means the 1% U.S. federal excise tax on certain repurchases (including redemptions) of stock by a publicly traded U.S. corporation.

“Exempt Issuance” means, with respect to the PIPE Subscription Agreement and PIPE Warrant Certificate, issuances of securities (i) to employees, directors and officers, and other agents of Forge Nano Holdings pursuant to certain share or option plans, (ii) pursuant to the Merger Agreement, (iii) to certain specified investors prior to the Closing in an aggregate amount up to $60,000,000, (iv) with respect to the shares underlying the PIPE Warrants or (v) pursuant to any merger, acquisition or strategic transaction, subject to certain limitations.

“First Company Merger” means the statutory merger of Merger Sub I with and into Forge Nano, Inc. pursuant to the terms of the Merger Agreement, upon which the separate existence of Merger Sub I ceased and Forge Nano, Inc. continued as the “Initial Surviving Corporation” and a wholly-owned subsidiary of Forge Nano Holdings.

“First Effective Time” means the effective time of the First Company Merger.

“Forge Nano” means Forge Nano Holdings, Inc. (formerly known as ATII Holdings Inc.), a Delaware corporation, and its consolidated subsidiaries following the consummation of the Business Combination and Forge Nano, Inc., a Delaware corporation, and, if the context requires, Forge Nano, Inc. together with its subsidiaries, prior to the consummation of the Business Combination.

“Forge Nano 2017 Equity Incentive Plan” or “2017 Equity Plan” means the 2017 Equity Incentive Plan of Forge Nano, as amended from time to time.

“Forge Nano Board” means the board of directors of Forge Nano as of immediately prior to the Closing.

“Forge Nano Common Stock” means the shares of common stock, $0.0001 par value per share, of Forge Nano.

“Forge Nano Holdings” means Forge Nano Holdings, Inc. (formerly known as ATII Holdings Inc.), a Delaware corporation.

“Forge Nano Lock-Up Holders” means, collectively, such stockholders of Forge Nano whose names appear on the signature pages to the Lock-Up Agreement.

“Forge Nano Preferred Stock” means, collectively, the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock, par value $0.0001 per share, of Forge Nano.

“Forge Nano Stock” means any shares of the Forge Nano Common Stock and the Forge Nano Preferred Stock.

“Forge Nano Warrants” means, collectively, the following warrants to purchase shares of Common Stock that were assumed by Forge Nano Holdings in the First Company Merger: (1) the initial warrant to purchase shares of Common Stock issued to Silicon Valley Bank (the “Initial SVB Warrant”), (2) the additional warrant to purchase shares of Common Stock issued to Silicon Valley Bank (the “Additional SVB Warrant”) and (3) the warrant to purchase shares of Common Stock issued to Saoradh Energy Partners LLC (the “SEP Warrant”).

“Founder Shares” means the 5,750,000 ATII Ordinary Shares purchased by the Sponsor in June 2024.

“GAAP” means U.S. generally accepted accounting principles.

“HzO” means HzO, Inc.

“HzO Merger” means the merger of FN Merger Sub, Inc., a wholly owned subsidiary of the Company, with and into HzO, with HzO surviving as a wholly owned subsidiary of the Company, pursuant to the HzO Merger Agreement.

“HzO Merger Agreement” means the Agreement and Plan of Merger, dated as of November 4, 2026, by and among the Company, FN Merger Sub, Inc., HzO and Fortis Advisors LLC, as the stockholders’ representative.

“Initial PIPE Investor” means Alyeska Master Fund, L.P.

vi

Table of Contents

​

“Initial Surviving Corporation” means the surviving corporation pursuant to the First Company Merger.

“Insider Letter” means ATII’s letter agreement with certain insiders of ATII, dated February 10, 2025.

“Investment Company Act” means the Investment Company Act of 1940, as amended.

“IPO” means ATII’s initial public offering of the ATII Public Units (consisting of ATII Ordinary Shares and ATII Warrants) pursuant to registration statements on Form S-1 declared effective by the SEC on February 10, 2025 (SEC File No. 333-282885), which was completed on February 12, 2025.

“IRS” means the U.S. Internal Revenue Service.

“JOBS Act” means the Jumpstart Our Business Startups Act of 2012, as amended.

“Lock-Up Agreement” means each lock-up agreement entered into, on or prior to the Closing Date, by and among Forge Nano Holdings, Forge Nano, Inc. and the applicable Forge Nano Lock-Up Holder.

“Merger Agreement” means the agreement and plan of merger, dated as of April 20, 2026, by and among ATII, Forge Nano Holdings, Merger Sub I, Merger Sub II and Forge Nano, Inc., and as it may be further amended and/or restated from time to time.

“Mergers” means, collectively, the Domestication Merger, the First Company Merger and the Second Company Merger.

“Merger Sub I” means ATII Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of ATII.

“Merger Sub II” means ATII Merger Sub II, LLC, a Delaware limited liability company and a wholly-owned subsidiary of ATII.

“Nasdaq” means The Nasdaq Stock Market LLC.

“Options” means outstanding options to purchase shares of Common Stock.

“Organizational Documents” means, collectively, the Charter and the Bylaws.

“PCAOB” means the U.S. Public Company Accounting Oversight Board.

“Person” means any individual, firm, corporation, partnership, limited liability company, association, trust, joint venture, joint stock company, governmental authority or instrumentality or other entity or organization of any other kind.

“PIPE Closing” means the closing of the PIPE Financing.

“PIPE Financing” means the financing transaction pursuant to which Forge Nano Holdings, substantially concurrently with the Closing and pursuant to the PIPE Subscription Agreement, issued and sold to the Initial PIPE Investor, for an aggregate purchase price of $100,000,000, 2,968,825 shares of Common Stock at a subscription price of $10.00 per share and 7,031,175 Pre-Funded Warrants at a subscription price of $10.00 per Pre-Funded Warrant, together with the PIPE Warrants to purchase an aggregate of 15,000,000 shares of Common Stock, each at an initial exercise price of $10.00 per share. Pursuant to the Purchaser Support Agreement, the Sponsor transferred 3,000,000 Sponsor Contribution Shares to the Initial PIPE Investor at the Closing. In the event that on the 21st trading day following the six-month anniversary of Closing, the VWAP (as defined in the PIPE Warrant Certificate) of our Common Stock is less than the Exercise Price (as defined in the PIPE Warrant Certificate), Forge Nano will issue to the Initial PIPE Investor the Reset PIPE Warrants entitling the Initial PIPE Investor to purchase up to 10,000,000 shares of Common Stock, in an amount equal to (i) the product of (x) 10,000,000, multiplied by (y) the Exercise Price then in effect divided by the PIPE Reset Price minus (ii) 10,000,000. In addition, if, on the 24-month anniversary of the Closing Date, the Initial PIPE Investor certifies in writing that the Initial PIPE Investor beneficially owns at least an aggregate of 5,000,000 shares of Common Stock (including shares underlying any Pre-Funded Warrants that have not yet been exercised), Forge Nano will issue to the Initial PIPE Investor the Additional PIPE Warrants entitling the Initial PIPE Investor to purchase 5,000,000 shares of Common Stock at an exercise price of $10.00 per share, subject to a one-time downward reset to a floor of $5.00.

vii

Table of Contents

​

“PIPE Investors” means, collectively, the Initial PIPE Investor and the Additional PIPE Investors.

“PIPE Reset Price” means the greater of (x) the VWAP (as defined in the PIPE Warrant Certificate) of the shares of Common Stock for the twenty trading day period commencing on the date that is six months after the Closing Date and (y) $5.00.

“PIPE Subscribed Shares” means the 2,968,825 shares of Common Stock issued to the Initial PIPE Investor in connection with the PIPE Financing pursuant to the PIPE Subscription Agreement.

“PIPE Subscription Agreement” means the subscription agreement, dated April 20, 2026 (as amended and restated on October 13, 2026), to purchase the PIPE Subscribed Shares by and among ATII, Forge Nano Holdings, Forge Nano, Inc. and the Initial PIPE Investor.

“PIPE Subscription Agreements” means the PIPE Subscription Agreement and the Additional PIPE Subscription Agreements.

“PIPE Warrant Certificate” means the warrant certificate representing the PIPE Warrants.

“PIPE Warrants” means the warrants to purchase shares of Common Stock issued to the Initial PIPE Investor, each with an exercise price of $10.00 (subject to adjustments as described herein).

“Plan of Merger” means the plan of merger in the form required under the Companies Act in respect of the Domestication Merger.

“Pre-Funded Warrants” means the 7,031,175 pre-funded warrants issued to the Initial PIPE Investor pursuant to the PIPE Subscription Agreement, each exercisable immediately for one share of Common Stock at an exercise price of $0.0001 per share.

“Private Warrants” means the SPAC Warrants into which the ATII Private Warrants originally issued as part of the ATII Private Units converted in the Domestication Merger.

“Purchaser Support Agreement” means the purchaser support agreement, dated as of April 20, 2026, entered into by and among ATII, Forge Nano and the Sponsor.

“Redemption” means the redemption of ATII Public Shares by ATII for the Redemption Price in connection with its initial business combination.

“Reset PIPE Warrants” means warrants to purchase shares of Common Stock to be issued to the Initial PIPE Investor in the event that on the 21st trading day following the six-month anniversary of Closing, the VWAP (as defined in the PIPE Warrant Certificate) of our Common Stock is less than the Exercise Price (as defined in the PIPE Warrant Certificate), in an amount equal to (i) the product of (x) 10,000,000, multiplied by (y) the Exercise Price then in effect divided by the PIPE Reset Price minus (ii) 10,000,000.

“Sarbanes-Oxley Act” means the Sarbanes-Oxley Act of 2002.

“SEC” means the U.S. Securities and Exchange Commission.

“Second Company Merger” means the statutory merger of the Initial Surviving Corporation with and into Merger Sub II, upon which the separate corporate existence of the Initial Surviving Corporation ceased and Merger Sub II continued as the surviving entity and a wholly-owned subsidiary of Forge Nano Holdings.

“Securities Act” means the U.S. Securities Act of 1933, as amended.

“Selling Securityholders” means the selling securityholders named in this prospectus (or their permitted transferees).

“SPAC Warrants” means the warrants exercisable for shares of Common Stock into which the ATII Warrants converted in the Domestication Merger pursuant to the ATII Warrant Agreement.

viii

Table of Contents

​

“Sponsor” means Archimedes Tech SPAC Sponsors II LLC, a Delaware limited liability company.

“Sponsor Contribution Shares” means up to 3,300,000 of the Founder Shares which are subject to transfer pursuant to the Purchaser Support Agreement.

“Surviving Company” means the surviving company pursuant to the Second Company Merger.

“Transfer Agent” means Odyssey Transfer and Trust Company.

“Warrants” means, collectively, (i) the SPAC Warrants, (ii) the Forge Nano Warrants, (iii) the Ascent Warrants, (iv) the PIPE Warrants, (v) the Pre-Funded Warrants, (vi) the Additional PIPE Warrants, if issued, and (vii) the Reset PIPE Warrants, if issued.

​

ix

Table of Contents

​

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This prospectus contains “forward-looking statements” that involve substantial risks and uncertainties, including information about, among other topics, expectations for future financial performance and business strategies or expectations for our business following the Business Combination. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Such statements can be identified by the fact that they are not historical statements of fact and are statements regarding, but not limited to, our expectations, hopes, beliefs, intentions or strategies regarding the future. When used in this prospectus, words such as “anticipate”, “believe”, “can”, “continue”, “could”, “estimate”, “expect”, “forecast”, “intend”, “may”, “might”, “plan”, “possible”, “potential”, “predict”, “project”, “seek”, “should”, “strive”, “target”, “will”, “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to significant risks and uncertainties. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and we assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

Forward-looking statements in this prospectus may include information about, among other topics, the following that could cause actual results to differ materially from those expressed or implied by such statements:

●our future financial performance following the Business Combination;
●changes in the market for Forge Nano’s products and services; and
●expansion plans and opportunities.

Risks and uncertainties include, among other things:

●risks related to the ability to realize the anticipated benefits of the Business Combination, including the possibility that the expected benefits from the Business Combination will not be realized within the expected time period;
●risks relating to the uncertainty of the projected financial information with respect to Forge Nano;
●risk of litigation and/or regulatory actions related to the Business Combination that may be instituted against us;
●our ability to maintain the listing of our Common Stock and SPAC Warrants on Nasdaq;
●risks related to Forge Nano’s public securities’ liquidity and trading;
●the risk that the Business Combination disrupts current plans and operations;
●the projected financial information, anticipated growth rate, profitability and market opportunity of Forge Nano may not be an indication of the actual results of the Business Combination or Forge Nano’s future results;
●significant transaction costs related to the Business Combination;
●Forge Nano’s ability to obtain sufficient additional capital needed to operate and grow its business;
●the impact of our indebtedness outstanding, which may reduce funds available for other business purposes and reduce our operational flexibility;
●changes in the market in which Forge Nano competes, including with respect to its competitive landscape, technology evolution or changes in applicable laws or regulations;
●the impact of macroeconomic events, such as inflation, recessions or depressions and war or fears of war;

x

Table of Contents

​

●changes in the vertical markets that Forge Nano targets or consolidation among Forge Nano’s distributors and customers or the loss of any key customer;
●the impact of current or future government regulation and oversight, including by U.S. federal, state and local authorities;
●the ability to launch new Forge Nano services and products or to profitably expand into new markets;
●the ability to develop and maintain effective internal controls and procedures, or correct or remediate any material weaknesses;
●future litigation or legal disputes, which could lead us to incur significant liabilities and costly litigation or reputational damage;
●a material failure, inadequacy or interruption of our information technology systems;
●other risks and uncertainties indicated in this prospectus, including those set forth under “Risk Factors” of this prospectus.

You should carefully consider the foregoing factors and the other risks and uncertainties that affect our business described in the section titled “Risk Factors” of this prospectus and in other documents filed by us from time to time with the SEC, all of which are available at www.sec.gov. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and we do not assume any obligation to, and do not intend to, update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law. We cannot give any assurance that we will achieve our expectations.

​

​

xi

Table of Contents

​

PROSPECTUS SUMMARY

The following summary highlights information contained elsewhere in this prospectus. It does not contain all the information you should consider before investing in our Common Stock. You should read this entire prospectus carefully, including the sections titled “Risk Factors,” “Our Business,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Where You Can Find Additional Information,” “Unaudited Pro Forma Condensed Combined Financial Information,” and our consolidated financial statements and related notes included elsewhere in this prospectus, before making an investment decision.

Forge Nano

Forge Nano is a leading technology company pioneering domestic battery and semiconductor innovations. Forge Nano develops and commercializes nanocoating and atomic layer deposition (“ALD”) technologies, a process that provides perfectly conformal, atom-thin coatings on surfaces, wafers and powders for battery cells, semiconductor devices and other advanced hardware applications.

Forge Nano was incorporated in Delaware on July 14, 2017. Forge Nano’s principal executive office is located at 12300 Grant Street, Suite 100, Thornton, CO 80241 and its telephone number is (720) 259-8579. Forge Nano’s corporate website address is www.forgenano.com. Forge Nano’s website and the information contained on, or that can be accessed through, the website is not deemed to be incorporated by reference in, and is not considered part of, this prospectus. Our Common Stock and SPAC Warrants began trading on Nasdaq under the symbols “NANO” and “NANOW,” respectively, on October 22, 2026.

The Business Combination and the Merger Agreement

On April 20, 2026, ATII entered into an Agreement and Plan of Merger (as amended, the “Merger Agreement”) with ATII Holdings Inc. (now Forge Nano Holdings, Inc., “Forge Nano Holdings”), ATII Merger Sub Inc., a Delaware corporation and wholly-owned subsidiary of ATII (“Merger Sub I”), ATII Merger Sub II, LLC, a Delaware limited liability company and wholly-owned subsidiary of ATII (“Merger Sub II”), and Forge Nano, Inc. Pursuant to the Merger Agreement, (i) on October 21, 2026, ATII merged with and into Forge Nano Holdings, with Forge Nano Holdings as the surviving corporation (the “Domestication Merger”), (ii) on October 22, 2026, Merger Sub I merged with and into Forge Nano, Inc., with Forge Nano, Inc. as the surviving corporation (the “First Company Merger”), and (iii) immediately following the First Company Merger, the surviving corporation of the First Company Merger merged with and into Merger Sub II, with Merger Sub II as the surviving company (the “Second Company Merger,” and together with the Domestication Merger and the First Company Merger, the “Mergers,” and together with the other transactions related thereto, the “Business Combination”). In connection with the Domestication Merger, Forge Nano Holdings changed its name from “ATII Holdings Inc.” to “Forge Nano Holdings, Inc.” The Business Combination was consummated on October 22, 2026.

PIPE Financing

In connection with the execution of the Merger Agreement, ATII, Forge Nano Holdings and Forge Nano, Inc. entered into the PIPE Subscription Agreement with the Initial PIPE Investor, pursuant to which, substantially concurrently with the Closing, Forge Nano Holdings issued and sold to the Initial PIPE Investor 2,968,825 shares of Common Stock (the “PIPE Subscribed Shares”) at a subscription price of $10.00 per share and 7,031,175 Pre-Funded Warrants at a price of $10.00 per Pre-Funded Warrant, together with warrants to purchase an aggregate of 15,000,000 shares of Common Stock (the “PIPE Warrants”), for an aggregate purchase price of $100,000,000. Additionally, ATII, Forge Nano Holdings and Forge Nano, Inc. entered into the Additional PIPE Subscription Agreements with the Additional PIPE Investors, pursuant to which, substantially concurrently with the Closing, Forge Nano Holdings issued and sold to the Additional PIPE Investors an aggregate of 2,300,000 shares of Common Stock (the “Additional Subscribed Shares”) at a subscription price of $10.00 per share, for an aggregate purchase price of $23,000,000.

HzO Merger

On November 4, 2026, we completed our acquisition of HzO, a provider of parylene-based thin-film coating solutions that protect electronic components from moisture, corrosion and other environmental damage, pursuant to the HzO Merger Agreement. In connection with the HzO Merger, we issued 5,772,645 shares of Common Stock to the former equityholders of HzO, and an additional 1,533,795 shares of Common Stock are issuable to such equityholders following the expiration of a twelve-month holdback period, subject to adjustment, for an aggregate of up to 7,306,440 shares of Common Stock.

1

Table of Contents

​

Risk Factors Summary

There may be events in the future that we are not able to predict accurately or over which we have no control. The section in this prospectus entitled “Risk Factors” and the other cautionary language discussed in this prospectus provide examples of certain risks, uncertainties and events that may cause actual results to differ materially from the expectations described by us in such forward-looking statements. Set forth below is only a summary of certain principal risks associated with an investment in our securities. You should carefully consider the following discussion of risks, as well as the discussion of risks included elsewhere in this prospectus, including those described under “Risk Factors.”

●If Forge Nano does not successfully develop and deploy new technologies to address the needs of its customers, its business, financial condition and results of operations could be materially and adversely affected.
●Forge Nano operates in highly competitive and rapidly evolving markets, and may be unable to compete effectively.
●The semiconductor tool and battery markets are cyclical and variable, which may cause significant fluctuations in Forge Nano’s results.
●Forge Nano is an early-stage company with a history of losses and expects to incur losses for the foreseeable future.
●If Forge Nano fails to manage growth and scale its operations effectively, Forge Nano’s business could be adversely affected.
●The proliferation of artificial intelligence presents competitive, legal, regulatory and other risks.
●Forge Nano is exposed to risks associated with a highly concentrated customer base.
●Cancellations, non-renewals or renegotiations of customer arrangements could adversely affect Forge Nano’s business and results of operations.
●If Forge Nano cannot meet the specifications and requirements of our customers or adequately provide them with effective support and services, customer satisfaction and retention may be affected, and it could materially and adversely impact Forge Nano’s business.
●Disruptions to Forge Nano’s supply chain and providers could impact Forge Nano’s ability to meet demand, increase Forge Nano’s costs, and adversely impact Forge Nano’s revenue and operating results.
●Product defects or safety issues could result in recalls, liability and reputational harm.
●Forge Nano may be unable to control input costs and achieve cost advantages as Forge Nano scales.
●Forge Nano is subject to risks of doing business internationally, including international sales and management of global operations.
●Forge Nano is exposed to foreign currency exchange rate fluctuations.
●Disruptions in Forge Nano’s information technology systems (or those of Forge Nano’s key suppliers, contract manufacturers, distributors, sales agents and other partners) or other cybersecurity incidents could adversely affect Forge Nano’s business operations and result in the loss or misappropriation of, and unauthorized access to, sensitive information.
●The availability and cost of raw materials that Forge Nano requires may fluctuate, which could adversely affect Forge Nano and Forge Nano’s customers.
●Forge Nano has outstanding indebtedness and may incur additional debt from time to time to finance working capital, capital expenditures, investments or acquisitions, or for other corporate purposes.

2

Table of Contents

​

●Forge Nano may require additional capital, which may not be available on acceptable terms or at all.
●We recently acquired HzO and may pursue additional acquisitions, which could divert management’s attention, cause us to incur unanticipated costs and liabilities, and fail to achieve the anticipated benefits, any of which could adversely affect our business, financial condition and results of operations.
●If Forge Nano is unable to protect or enforce Forge Nano’s intellectual property, Forge Nano’s business and competitive position would be harmed.
●Forge Nano is subject to environmental, health and safety regulations that could increase costs and affect Forge Nano’s operations.
●Forge Nano is subject to various risks related to new, different, inconsistent, or even conflicting laws, rules, and regulations that may be enacted by legislative or executive bodies and/or regulatory agencies in the countries in which Forge Nano operates.
●Changes in trade policy, tariffs and export controls could limit Forge Nano’s sales and increase costs.
●Natural disasters, public health crises and other catastrophic events could disrupt Forge Nano’s operations.
●The requirements of being a public company may strain Forge Nano’s resources and distract Forge Nano’s management and Forge Nano will incur substantial costs as a result of being a public company.
●Sales of a substantial amount of our Common Stock in the public market, particularly sales by Forge Nano’s executive officers, directors and significant stockholders, or the perception that these sales could occur, could cause the market price of our Common Stock to decline.
●A decline in the price of our Common Stock could affect Forge Nano’s ability to raise working capital and adversely impact Forge Nano’s ability to continue operations.
●Forge Nano does not intend to pay any cash dividends in the foreseeable future and, therefore, any return on your investment in our Common Stock must come from increases in the fair market value and trading price of our Common Stock.
●If the benefits of the Business Combination do not meet the expectations of investors or securities analysts, the market price of our securities may decline.
●Forge Nano may be controlled or substantially influenced by certain individuals who were employees of Forge Nano prior to the Business Combination, whose interests may conflict with other stockholders.
●The Initial PIPE Investor subscribed for 2,968,825 shares of Common Stock and 7,031,175 Pre-Funded Warrants at a subscription price of $10.00 per share, and was transferred an aggregate of 3,000,000 shares of Common Stock at the Closing by the Sponsor pursuant to the Purchaser Support Agreement. The effective purchase price per share for the Initial PIPE Investor, taking into account this transfer from the Sponsor, was approximately $7.69.
●Sales of a substantial amount of shares of Common Stock in the public market, particularly sales by our executive officers, directors and significant stockholders, or the perception that these sales could occur, could cause the market price of shares of our Common Stock to decline.
●The SPAC Warrants may never be in the money, and they may expire worthless. The terms of the SPAC Warrants may be amended in a manner adverse to a holder if holders of at least a majority of the then outstanding SPAC Warrants approve of such amendment.
●Forge Nano may redeem your unexpired SPAC Warrants prior to their exercise at a time that is disadvantageous to you, thereby making such SPAC Warrants worthless.

3

Table of Contents

​

●Forge Nano is a “smaller reporting company” and “emerging growth company” under the U.S. federal securities laws, and the reduced reporting requirements applicable to “smaller reporting companies” and “emerging growth companies” could make the shares of Common Stock less attractive to investors.
●The historical financial results of Forge Nano and unaudited condensed combined pro forma financial information included elsewhere in this prospectus may not be indicative of what Forge Nano’s actual financial position or results of operations would have been had Forge Nano been a public company.

Implications of Being an Emerging Growth Company

We are an “emerging growth company” as defined in the JOBS Act. As an “emerging growth company,” we may (and intend to) take advantage of specified reduced reporting and other requirements that are otherwise applicable to public companies. These provisions include, among other things:

●exemption from the auditor attestation requirement under Section 404(b) of the Sarbanes-Oxley Act in the assessment of the effectiveness of our internal control over financial reporting;
●exemption from new or revised financial accounting standards applicable to public companies until such standards are also applicable to private companies;
●exemption from compliance with certain types of new requirements adopted by the PCAOB;
●exemption from the requirement to seek non-binding stockholder advisory votes on executive compensation and golden parachute arrangements;
●reduced disclosure about executive compensation arrangements; and
●the ability to present only two (2) years of audited financial statements and only two (2) years of related “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in ATII’s and/or Forge Nano’s periodic reports and registration statements filed with the SEC, including in this prospectus.

We may choose to take advantage of some, but not all, of these reduced burdens. For example, we have (i) taken advantage of the reduced reporting requirement with respect to disclosure regarding executive compensation arrangements and (ii) presented only two (2) years of audited financial statements in this prospectus. In addition, we may take advantage of the exemption from the auditor attestation requirement in the assessment on the effectiveness of our internal control over financial reporting. In addition, while we have elected to avail ourselves of the exemption to adopt new or revised accounting standards until those standards apply to private companies, we are permitted and may elect to early adopt certain new or revised accounting standards for which the respective standard allows for early adoption. We have elected to use this extended transition period for complying with certain new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that we (i) are no longer an “emerging growth company” as defined in the JOBS Act or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. For as long as we take advantage of these reduced reporting obligations, the information that we provide to holders of shares of Common Stock may be different from information provided by other similarly situated public companies.

We will remain an “emerging growth company” until the earlier of (1) the last day of the fiscal year (a) following February 12, 2030, (b) in which we have total annual gross revenue of at least $1.235 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common equity that is held by non-affiliates exceeds $700 million as of the end of the prior fiscal year’s second fiscal quarter and (2) the date on which we have issued more than $1.00 billion in non-convertible debt securities during the prior three-year period.

​

​

4

Table of Contents

​

THE OFFERING

​

​

Issuer

Forge Nano Holdings, Inc. (formerly known as ATII Holdings Inc.).

Primary Offering: Common Stock issuable upon exercise of warrants

Up to 11,499,995 shares of Common Stock issuable upon exercise of SPAC Warrants.

Secondary Offering: Securities offered by Selling Securityholders

(i) 43,553,075 shares of Common Stock that (1) were issued in a private placement or (2) are held by our affiliates or affiliates of the Sponsor, which consist of (a) 2,968,825 shares of Common Stock issued to the Initial PIPE Investor; (b) 2,300,000 shares of Common Stock issued to the Additional PIPE Investors; (c) 5,772,645 shares of Common Stock issued in the HzO Merger; (d) 18,816,341 shares of Common Stock issued or issuable to our affiliates; (e) 1,654,146 shares of Common Stock held by affiliates of the Sponsor; and (f) up to 12,041,118 Earn-Out Shares issuable to our affiliates;

(ii) 41,435,272 shares of Common Stock issuable upon exercise of our Warrants, which consist of (a) 420,000 shares of Common Stock issuable upon exercise of SPAC Warrants; (b) 7,031,175 shares of Common Stock issuable upon exercise of the Pre-Funded Warrants; (c) 15,000,000 shares of Common Stock issuable upon exercise of the PIPE Warrants; (d) 5,000,000 shares of Common Stock issuable upon exercise of the Additional PIPE Warrants; (e) 10,000,000 shares of Common Stock issuable upon exercise of the Reset PIPE Warrants; (f) 3,562,305 shares of Common Stock issuable upon exercise of the Ascent Warrants; and (g) 421,792 shares of Common Stock issuable upon exercise of the Forge Nano Warrants; and

(iii) 23,525 SPAC Warrants held by affiliates of the Sponsor.

Common Stock outstanding

224,428,230 shares of Common Stock

SPAC Warrants outstanding

11,919,995 SPAC Warrants

Use of Proceeds

We will not receive any proceeds from the sale of our Common Stock offered by the Selling Securityholders under this prospectus.

Assuming all of our Warrants are exercised for cash, we would receive approximately $307.2 million, assuming that the exercise price of the PIPE Warrants and the Additional PIPE Warrants is reset to the $5.00 floor and that the maximum of 10,000,000 Reset PIPE Warrants are issued and exercised at a PIPE Reset Price of $5.00 (or approximately $357.2 million if no such reset occurs, the Additional PIPE Warrants are exercised at the current exercise price of $10.00 per share and no Reset PIPE Warrants are issued), but we will not receive any proceeds from the sale of shares of Common Stock issuable upon such exercise. We expect to use the net proceeds from the exercise of such warrants for cash, if any, for general corporate purposes. See the section titled “Use of Proceeds” appearing elsewhere in this prospectus for more information.

52,935,267 shares of Common Stock registered under this prospectus are issuable upon exercise of our Warrants, which consist of the following:

·

11,919,995 SPAC Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share;

5

Table of Contents

​

·

7,031,175 Pre-Funded Warrants, each exercisable for one share of Common Stock at an exercise price of $0.0001 per share;

·

15,000,000 PIPE Warrants, each exercisable for one share of Common Stock at an exercise price of $10.00 per share, subject to a one-time downward reset to a floor of $5.00 per share;

·

up to 5,000,000 Additional PIPE Warrants, if issued, each exercisable for one share of Common Stock at an exercise price equal to the exercise price of the PIPE Warrants then in effect;

·

up to 10,000,000 Reset PIPE Warrants, if issued, each exercisable for one share of Common Stock at an exercise price equal to the PIPE Reset Price (which will not be less than $5.00 per share);

·

Ascent Warrants exercisable for an aggregate of 3,562,305 shares of Common Stock, of which 2,351,238 have an exercise price of $3.40 per share (subject to increase) and 1,211,067 have an exercise price of $9.83 per share; and

·

Forge Nano Warrants exercisable for an aggregate of 421,792 shares of Common Stock, consisting of the Initial SVB Warrant (75,656 shares at an exercise price of $0.33 per share), the Additional SVB Warrant (88,279 shares at an exercise price of $0.56 per share) and the SEP Warrant (257,857 shares at an exercise price of $0.56 per share).

Dividend Policy

We have not paid any cash dividends on our Common Stock to date, and we do not intend to pay cash dividends in the foreseeable future. The payment of cash dividends in the future will be at the discretion of our Board and will depend on our revenues and earnings, if any, capital requirements and general financial condition. In addition, our debt agreements may restrict our ability to pay dividends.

Risk Factors

See the section titled “Risk Factors” beginning on page 7 of this prospectus and other information included in this prospectus for a discussion of factors that you should consider carefully before deciding to invest in our Common Stock.

Market for our Common Stock

Our Common Stock and SPAC Warrants are listed on The Nasdaq Stock Market LLC under the symbols “NANO” and “NANOW,” respectively.

​

​

​

​

6

Table of Contents

​

RISK FACTORS

Investing in our securities involves a high degree of risk. Before making an investment decision, you should consider carefully the risks and uncertainties described below. Our business, operating results, financial condition or prospects could also be harmed by risks and uncertainties not currently known to us or that we currently do not believe are material. If any of the risks actually occur, our business, operating results, financial condition and prospects could be adversely affected. In that event, the market price of our Common Stock and SPAC Warrants could decline, and you could lose part or all of your investment. The risks discussed below may not prove to be exhaustive and are based on certain assumptions that later may prove to be incorrect or incomplete. Forge Nano may face additional risks and uncertainties that are not presently known to such entity, or that are currently deemed immaterial, which may also impair our business or financial condition.

Unless the context requires otherwise, references to “Forge Nano”, “we”, “us”, “our” and “the company” in this section are to the business and operations of Forge Nano, Inc. prior to the Business Combination and to Forge Nano Holdings, Inc. and its consolidated subsidiaries, including Forge Nano, LLC, following the Business Combination.

Risks Related to This Offering

A sale of a substantial amount of shares of our Common Stock may cause the price of our Common Stock to decline.

We are registering for resale up to 43,553,075 shares of our Common Stock, 41,435,272 shares of Common Stock issuable upon exercise of Warrants and 23,525 SPAC Warrants held by the Selling Securityholders and the issuance of up to 11,499,995 shares of our Common Stock upon the exercise of SPAC Warrants, which together represent a significant number of shares compared to the current number of total shares of Common Stock issued and outstanding. We cannot predict if and when the Selling Securityholders may sell such shares, or whether the holders of such warrants will exercise them and sell the underlying shares, and what effect, if any, sales of our shares in the public market or the availability of shares for sale will have on the market price of our Common Stock. However, future sales of substantial amounts of our Common Stock in the public market, or the perception that such sales may occur, could adversely affect the market price of our Common Stock. In addition, to raise capital, we may sell Common Stock, convertible securities or other equity-linked securities in one or more transactions at prices and in a manner we determine from time to time. To the extent that additional capital is raised through the sale and issuance of shares of our Common Stock or other securities convertible into shares of our Common Stock, our stockholders will be diluted. These sales, or the perception in the market that the holders of a large number of shares of our Common Stock intend to sell shares, could reduce the market price of our Common Stock.

Risks Related to Forge Nano’s Business, Industry, and Operations

If Forge Nano does not successfully develop and deploy new technologies to address the needs of its customers, its business, financial condition and results of operations could be materially and adversely affected.

We devote significant resources to research and development, but there is no assurance that enhancements to our products or new features, capabilities or offerings will be accepted by the market, adequately differentiated, or priced competitively to gain adoption. If our research and development investments do not accurately anticipate customer demand or if we fail to develop our platforms in a manner that satisfies customer preferences in a timely and cost-effective manner, we may fail to retain our existing customers or increase demand for our platforms.

The introduction of new products and services by competitors or the development of entirely new technologies to replace existing offerings could make our products obsolete or adversely affect our business, financial condition, and results of operations. We may experience development, design or commercialization challenges that delay or prevent the introduction of new products, features or capabilities. In the past, we have experienced delays in internally planned release dates and there can be no assurance that future releases will occur on expected timelines or meet performance specifications. Any delays could result in adverse publicity, loss of revenue or market acceptance, or claims by customers brought against us, any of which could harm our business. Moreover, the design and development of new products or new features and capabilities to our existing platforms may require substantial investment, and we have no assurance that such investments will be successful. If customers do not widely adopt our new platforms, experiences, features, and capabilities, we may not be able to realize a return on our investment and our business, financial condition, and results of operations may be adversely affected.

7

Table of Contents

​

Our new and existing platforms, or changes to such platforms, may fail to achieve market acceptance for many reasons, including:

●our failure to predict market demand accurately in terms of product functionality and to supply offerings that meet this demand in a timely fashion;
●product defects, errors, or failures or our inability to satisfy customer service level requirements;
●negative publicity or negative private statements about the performance, or effectiveness of our products or product enhancements;
●delays in releasing to the market our new offerings or enhancements to our existing offerings;
●introduction or anticipated introduction of competing products or functionalities by our competitors;
●inability of our products or product enhancements to scale and perform to meet customer demands;
●receiving qualified or adverse opinions in connection with performance, certifications or audits, such as those related to device controls, performance standards, frameworks or compliance; and
●poor business conditions for our customers, causing them to delay purchases.

If we fail to anticipate customer needs or to timely develop, license or acquire features and capabilities that achieve market acceptance, our ability to retain customers, drive expansion and achieve anticipated revenue growth could be adversely affected. Because we derive, and expect to continue to derive, substantially all of our revenue from customers purchasing our products, market acceptance of these products and any enhancements or changes thereto, is critical to our success.

We operate in highly competitive and rapidly evolving markets, and we may be unable to compete effectively.

The semiconductor and battery markets are intensely competitive and subject to rapid technological change, and we may not be successful in competing in these industries. Our ability to compete depends on technology leadership, product performance, tool reliability and productivity, service and support, speed of innovation, time-to-market, manufacturing and supply chain efficiency, and total cost of ownership. Many competitors are large and well-capitalized, with significant installed bases and longstanding customer relationships, and may introduce new products more rapidly or engage in aggressive pricing or bundling that pressures our margins and commercial terms.

Our competitive position can also be affected by government industrial policies and export controls that favor domestic suppliers or restrict access to key markets, components, or technologies. In certain regions, including parts of Asia, state support and localization requirements may enable competitors to offer lower prices or more favorable terms, expand capacity more quickly, or sustain losses longer, which can lengthen sales cycles and impede our ability to win or retain business. Changes in U.S. or foreign export controls and sanctions could further limit our ability to sell, service, or obtain components in certain geographies, potentially ceding advantage to competitors not subject to comparable restrictions.

Customer qualification dynamics further intensify competition. Once a customer selects a supplier’s tool for a given process step, integration complexity, process stability, and the cost and time required to requalify alternatives often make incumbents difficult to displace. Our ability to win business or expand market share typically requires meeting stringent specifications through lengthy evaluations and demonstrating superior throughput, yield, uptime, defectivity, and cost of ownership. If we are unable to compete effectively on technology, performance, service, or price, our revenues, gross margins, market share, and business could be materially and adversely affected.

8

Table of Contents

​

The semiconductor tool and battery markets are cyclical and variable, which may cause significant fluctuations in our results.

The semiconductor tool and battery markets are subject to variability and periods of rapid growth or decline, and the businesses of many of our customers are subject to significant fluctuations as a result of the cyclical nature of their industries and their sensitivity to general economic conditions, which could adversely affect their demand for our products and reduce our sales and profitability. Changes in demand can occur quickly and materially affect the timing and amount of our customers’ investments, complicating our forecasting and strategic resource allocation. During industry downturns, customers may reduce, delay or cancel orders, often with limited or no penalties, which can result in lower revenues, unfavorable product and customer mix, increased inventory and related reserves, and reduced factory and field utilization. In addition, customers’ weaker financial condition in down cycles may impair our ability to recognize revenue or collect receivables, each of which may adversely affect cash flows and operating results.

The timing, length and severity of industry cycles are inherently uncertain and can be influenced by factors outside our control, such as export controls, tariffs and other trade restrictions, shifts in national or regional industrial policies, inflation and interest rate movements, and geopolitical events. Cycles can be further amplified by customer consolidation and purchasing behavior, including long qualification cycles, limited penalties for rescheduling or cancellation, and tool reuse strategies that reduce new tool purchases in certain environments. If we fail to accurately forecast demand and align resources, inventory, and supply commitments accordingly, our revenues, gross margins, earnings and cash flows could be materially and adversely affected.

We are an early-stage company with a history of losses and expect to incur losses for the foreseeable future.

We are in the early stages of commercialization, have incurred net losses to date, and expect to continue incurring significant expenses and losses for the foreseeable future as we invest in technology development, production capacity, customer qualifications, and go-to-market activities. Early-stage semiconductor and battery companies typically experience sustained losses until they achieve meaningful production scale or licensing revenues, and the rate of loss may increase as we expand research and development, add manufacturing capability, build inventory, and scale public company infrastructure.

Our path to profitability depends on timely progress in product performance, yield and throughput improvements, cost reductions, supply-chain scaling, and customer adoption, each of which involves significant technical, operational, and market risk. Meeting target specifications and passing customer qualification can take years and may require iterative design and process changes; delays, failures to meet milestones, or lower-than-expected demand could postpone or prevent revenue generation at planned margins. If costs to develop, manufacture, or support our products exceed expectations, or if unit volumes, pricing, or mix are less favorable than planned, our losses could increase and our ability to achieve profitability could be further delayed or not realized at all. Our business plan has yet to be tested at scale, and we may not succeed in executing on our strategic plans.

If we fail to manage growth and scale our operations effectively, our business could be adversely affected.

Semiconductor tool and battery manufacturing are subject to complex manufacturing processes, and achieving volume production involves a significant degree of risk and uncertainty in terms of operational performance such as yield and costs. Both business lines are sensitive to disruptions to our supply chain and outsource providers, which could impact our ability to meet demand, increase our costs, and adversely impact our revenue and operating results. Our growth places significant demands on our corporate culture, operational infrastructure and management. Periods of increasing demand require us to add manufacturing capacity, broaden our supply chain, scale field service and customer support, strengthen internal controls, and implement or upgrade enterprise systems, often on compressed timelines. If we do not anticipate and allocate resources appropriately, we could experience bottlenecks, under-absorption of fixed costs, and variability in revenue recognition and margins. Managing global operations adds complexity, including differing legal regimes, labor markets, cultural alignment, and the need to maintain consistent operating standards and controls across regions, any of which can strain management attention and impair execution.

Effective scaling also depends on our ability to recruit, train and retain qualified personnel in engineering, manufacturing, quality, software, and field service, and to preserve a culture that supports collaboration, safety, and compliance as the organization grows. Turnover, rapid hiring, or restructuring can lead to loss of institutional knowledge, uneven processes, and inefficiencies during transition periods, which may divert management focus from operating and growing the business. In addition, as we scale, we may rely more heavily on third parties for manufacturing, logistics, and other services; if these partners do not perform, or if we do not effectively manage outsourcing and supplier relationships, we could face quality issues, delays, higher costs, inventory imbalances, and challenges protecting our intellectual property.

9

Table of Contents

​

Failure to manage growth and organizational change effectively, including forecasting demand, aligning capacity and supply commitments, and retaining personnel, could adversely affect our ability to execute on strategic priorities, which in turn could materially and adversely impact our business, financial condition and results of operations.

The proliferation of artificial intelligence presents competitive, legal, regulatory and other risks.

We are increasingly incorporating artificial intelligence capabilities into our business operations. Artificial intelligence (“AI”) technology is complex and rapidly evolving and presents risks and challenges that may impact our business, including subjecting us to significant competitive, legal, regulatory, operational and other risks. The implementation of AI can be costly and there is no guarantee that our use of AI will enhance our technologies, benefit our business operations or produce products and services that are preferred by our customers. Additionally, AI algorithms or training methodologies may be flawed, and datasets may contain irrelevant, insufficient, biased or proprietary information, including the intellectual property of others, which can result in output errors and inadvertent infringement of others’ intellectual property rights, and may give rise to legal liability and materially harm our business. Our competitors may also be more successful in their artificial intelligence strategy and develop competitive products with the aid of artificial intelligence technology. As a result, any issues in the development and use of artificial intelligence by us or our suppliers, partners and competitors, combined with an uncertain regulatory environment, may result in reputational harm, liability, or other adverse consequences to our business operations.

We are exposed to risks associated with a highly concentrated customer base.

We derive a significant portion of our revenue from a limited number of existing customers, and our growth strategy depends in part on expanding opportunities with those customers by increasing the number, size, and scope of semiconductor tool placements and selling additional battery volumes, while also developing new accounts. Customer spending patterns can shift quickly with technology roadmaps, capacity utilization, macroeconomic conditions, and export controls, and large customers have significant purchasing leverage. As a result, even if we execute our growth strategy, we may not achieve the expected pace or scale of expansion with existing customers. Wins among new customers can be delayed by lengthy qualification processes and integration requirements, which can constrain growth and revenue visibility. For the nine-month period ended September 30, 2026, one customer represented approximately 23% and one customer represented approximately 18% of total net revenue, respectively. The loss of one or more of these significant customers or a reduction in the amount of revenue we derive from any such customers could significantly and adversely affect our business, financial condition and results of operations.

Cancellations, non-renewals or renegotiations of customer arrangements could adversely affect our business and results of operations.

In tool sales, engagements are typically for single pieces of equipment with associated service and maintenance. Customer orders are often subject to change, delay or cancellation with limited penalties, which can result in non-recoverable costs, excess or obsolete inventory, and manufacturing inefficiencies. We may recover certain build costs upon cancellation but could forgo expected service revenue and margin. Battery sales can be one-time or recurring, and loss or termination of any multi-year arrangements could negatively impact our results.

If one or more of our customers (i) terminate their contracts with us, whether for convenience, for default in the event of a breach by us, or for other reasons specified in our contracts, as applicable, (ii) elect not to renew their contracts with us, (iii) renew their contractual arrangements with us for shorter contract lengths or for a reduced scope, or (iv) otherwise seek to renegotiate terms of their existing agreements on terms less favorable to us, our business and results of operations could be adversely affected. This adverse impact would be even more pronounced for customers that represent a material portion of our revenue or business operations.

Our ability to renew or expand customer relationships may vary due to product performance and reliability, implementation quality, pricing, competitive alternatives, macroeconomic conditions and customers’ spending levels. If our customers do not renew or expand their agreements with us or if they renew their contracts on other terms less favorable to us, our revenue may grow more slowly than expected or decline, and our business could suffer. Our business, financial condition, and results of operations would also be adversely affected if we face difficulty collecting our accounts receivable from our customers.

10

Table of Contents

​

Achieving renewal or expansion of deployments may require us to increasingly engage in sophisticated and costly sales efforts that may not result in additional sales. In addition, our customers’ decisions to purchase more tools or battery cells depend on several factors, including general economic conditions, the performance of our products, the ability of our forward-deployed service engineers to maintain our tools and keep them at top productive capacity and our customers’ satisfaction with all our services. If our efforts to expand within our existing customer base are not successful, our business may suffer.

If we cannot meet the specifications and requirements of our customers or adequately provide them with effective support and services, customer satisfaction and retention may be affected, and it could materially and adversely impact our business.

Once our platforms are deployed and integrated into customers’ processes or systems, our customers may depend on our support and maintenance services to resolve issues relating to our products. In the future, our products may be deployed in large-scale, complex environments, and we believe our future success will depend on our ability to increase sales of our products for use in such deployments. Further, our ability to provide effective ongoing services, or to provide such services in a timely, efficient, or scalable manner, may depend in part on our customers’ environments and their participation in our centralized platform for service management.

In addition, our ability to provide effective services is largely dependent on our ability to attract, train, and retain qualified personnel with experience in supporting customers with products such as ours. We may be unable to respond quickly enough to accommodate short-term increases in customer demand for our services. We also may be unable to modify the future scope and delivery of our services to compete with changes in the services provided by our competitors. Increased customer demand for support, without corresponding revenue, could increase costs and negatively affect our business and results of operations.

In the future our customers may need training in the proper use of and the variety of benefits that can be derived from our products. If we do not effectively deploy, update, or upgrade our products, succeed in helping our customers quickly resolve post-deployment issues, and provide effective ongoing services, our ability to sell additional products and services to existing customers could be adversely affected, we may face negative publicity and our reputation with potential customers could be damaged. As a result, our failure to maintain high quality services may have a material adverse effect on our business, financial condition, results of operations and growth prospects.

Disruptions to our supply chain and providers could impact our ability to meet demand, increase our costs, and adversely impact our revenue and operating results.

Managing manufacturing operations exposes us to risks such as supply chain disruptions, production delays, cost overruns, equipment failures, and scaling challenges, which may hinder our ability to meet demand or maintain competitive pricing. We depend on third party providers, suppliers and licensors to supply some of the hardware and support necessary to provide some of our products and services. We obtain these materials from a limited number of vendors which may not be able to continue to supply the equipment, supplies, and services we desire. Shortages, longer lead times, quality issues, or logistics interruptions can delay production, constrain output, and increase costs, which may also affect shipment timing, customer acceptances, and revenue recognition, pressuring gross margins and results of operations. These risks can be amplified by difficulties or delays in obtaining import/export approvals, transportation capacity constraints, geopolitical trade actions, and export controls, any of which can disrupt our supply chain or restrict our ability to deliver and install products or procure inputs on favorable terms.

We have a limited number of manufacturing facilities, and damage to those facilities, or to critical pieces of equipment in these facilities, could interrupt our operations, increase our costs of doing business, and impair our ability to deliver our products on a timely basis. If supply chain disruptions or facility interruptions occur, it could interrupt our operations, increase our costs of doing business and impair our ability to deliver our products on a timely basis.

11

Table of Contents

​

Product defects or safety issues could result in recalls, liability and reputational harm.

Our operations present inherent safety risks. Complex, large-scale equipment and processes can experience malfunctions, fires or other incidents that may result in personal injury, facility damage, production downtime, environmental impacts, administrative fines, higher insurance costs, litigation, and reputational harm, any of which could materially affect our business and financial condition. Even with precautionary measures and training, handling hazardous materials and operating high-voltage, high-current systems poses risks we may not fully prevent, and changes in environmental or safety regulations (including restrictions on certain chemicals or materials) could increase costs or constrain supply alternatives, which could restrict our ability to meet demand, maintain quality and delivery performance, and achieve expected financial results.

Similarly, unexpected product performance issues among our semiconductor tools could result in significant costs and damages, including increased service and warranty expenses, the need to provide product replacements or modifications, reimbursement for damages caused by our products, product recalls, related litigation, product write-offs, and disposal costs. Battery technologies can also exhibit unexpected failures once deployed at scale, and early-generation products may require repairs, redesigns or replacement. Safety incidents could trigger customer delays or terminations, injunctions, warranty and service obligations greater than expected, and product liability claims seeking significant damages, any of which could materially affect our business, prospects and financial results. Insurance coverage may be unavailable or insufficient to cover such claims, and certain customer contracts may obligate us to fund recall or replacement costs, further increasing exposure.

Our tools and related offerings are complex and highly integrated, and unexpected product performance issues can lead to substantial costs, including increased warranty and service expense, replacements or modifications, reimbursement obligations, litigation, recalls, product write-offs or disposal costs. Such issues can also disrupt shipment timing, customer acceptance and revenue recognition, and cause reputational harm that reduces demand for our products and services. In addition, contractual indemnities to customers or other counterparties can expand our potential defense and settlement costs, which may be difficult to predict and could adversely affect results even if claims lack merit.

Even with testing and safeguards, new or existing products may have reliability, quality, design, or safety problems, and our performance may be impacted by reduced orders, higher manufacturing costs, delays in acceptance of and payment for new products, and additional service and warranty expenses. Any of these outcomes could materially and adversely affect our business, financial condition and results of operations.

We may be unable to control input costs and achieve cost advantages as we scale.

Our semiconductor tool and battery businesses are exposed to fluctuating input costs which can have substantial impact on our ability to produce products profitably. We may be unable to adequately control the costs associated with our operations and the components necessary to develop and commercialize our batteries, and, if we are unable to control these costs and achieve cost advantages, our business will be adversely affected.

As we continue to scale our operations, we expect to continue to incur significant expenses, including those relating to raw material procurement, leases, sales, and distribution. Input cost inflation or volatility can arise from a range of factors outside our control. Export controls and trade restrictions affecting strategic materials could further increase costs, reduce availability of materials, necessitate design changes, lengthen qualification timelines, or disrupt our supply chain. Even where alternatives are available, requalification can be time-consuming and costly and may not fully mitigate the impact on our cost structure or delivery schedules. Our ability to offset cost increases through pricing, redesign, productivity gains, or supply chain initiatives may be limited by competitive dynamics, contractual terms, and customer budget constraints. In periods of elevated demand, we may incur additional charges and other premiums to secure or expedite delivery of components; in weaker markets, we may be unable to recover committed costs or minimum purchase obligations. Our ability to become profitable in the future will depend, in part, on our ability to successfully control these costs.

12

Table of Contents

​

We are subject to risks of doing business internationally, including international sales and management of global operations.

Operating globally exposes us to a wide range of risks, including varying economic conditions, political and regulatory changes, trade restrictions and tariffs, supply chain challenges, and currency fluctuations. Our ability to sell across multiple jurisdictions depends on navigating diverse political and regulatory regimes. Changes in these regimes, including localization mandates, government procurement preferences, and content or certification requirements, may increase costs, delay shipments and installations, restrict market access, or require modifications to our products or commercial terms. In certain countries, weak intellectual property enforcement, differing standards, or the need to engage local partners may elevate intellectual property, contractual, and operational risks.

International operations also heighten supply chain and logistics complexity. We rely on global suppliers and transportation networks for critical components and materials; disruptions due to port congestion, carrier constraints, public health events, natural disasters, labor actions, geopolitical tensions, or armed conflict can lengthen lead times, increase freight and expediting costs, and delay customer acceptances, adversely affecting revenue recognition and margins. Export controls, retaliatory tariffs, and restrictions on critical minerals can further constrain sourcing options and raise input costs. Establishing and scaling operations in new countries, whether through subsidiaries, contractors, or third-party service providers, requires significant investment in systems, internal controls, and compliance oversight and may expose us to additional tax liabilities, permanent establishment risks, restrictions on cash repatriation, and complexities in transfer pricing and indirect taxes.

We are exposed to foreign currency exchange rate fluctuations.

Although our global operations are conducted primarily in U.S. dollars, we incur expenses in other currencies which exposes us to foreign exchange risk such as adverse fluctuations in foreign currency exchange rates through third-party remeasurement of foreign currency-denominated assets and liabilities. Adverse currency movements can affect our pricing competitiveness in local markets, increase the U.S. dollar cost of non-U.S. expenses, and create remeasurement gains and losses on foreign-currency-denominated receivables, payables, leases, and intercompany balances. These effects can introduce volatility into our reported revenues, gross margins, operating results, and cash flows, particularly when exchange rates move rapidly or are highly correlated with changes in demand or input costs.

To date, we have not engaged in any formal hedging program to mitigate these risks. Even if we adopt hedging strategies in the future, such measures may be inadequate, costly, or only partially effective. Additionally, changes in monetary policy, interest rate differentials, and geopolitical developments can increase foreign exchange volatility and impact the value of cash and investments held in non-U.S. jurisdictions. If we are unable to effectively manage foreign currency exposure through natural hedging, pricing, sourcing, or financial instruments, our reported results, liquidity, and financial condition could be materially and adversely affected.

Disruptions in our information technology systems (or those of our key suppliers, contract manufacturers, distributors, sales agents and other partners) or other cybersecurity incidents could adversely affect our business operations and result in the loss or misappropriation of, and unauthorized access to, sensitive information.

We depend on key information systems to transact our business accurately and efficiently. These systems and services are vulnerable to interruptions or other failures resulting from, among other things, pandemics, epidemics, natural disasters, terrorist attacks, software or equipment failures, processing errors, computer viruses, other security issues or supplier defaults. Security, backup and disaster recovery measures may not be adequate or implemented properly to avoid such disruptions or failures. Any disruption or failure of these systems or services (or those of our key suppliers, contract manufacturers, distributors, sales agents and other partners) could cause substantial errors, processing inefficiencies, security breaches, inability to use the systems or process transactions, loss of customers or other business disruptions, all of which could negatively affect our business and financial performance and result in the loss or misappropriation of, and unauthorized access to, sensitive information.

All information systems are subject to breach and disruption, and our information systems could be penetrated or compromised by internal and external parties intent on extracting confidential information, disrupting business processes or corrupting information. These risks could arise from external parties or from acts or omissions of internal or service provider personnel. Potential vulnerabilities can be exploited from inadvertent or intentional actions of our employees, third-party vendors, business partners, or by malicious third parties. Attacks of this nature are increasing in their frequency, levels of persistence, sophistication, and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of expertise and motives (including industrial espionage), including organized criminal groups, nation states, and others. Such unauthorized access could disrupt our

13

Table of Contents

​

business and could result in the loss of assets, litigation, remediation costs, damage to our reputation and failure to retain or attract customers following such an event, which could adversely affect our business. Insurance may not cover all losses, and compliance with expanding privacy, cybersecurity, and disclosure regimes (including new SEC incident reporting rules and emerging cross-border data restrictions) increases costs and complexity without eliminating risk.

The availability and cost of raw materials that we require may fluctuate, which could adversely affect us and our customers.

Our semiconductor tool and battery businesses depend on raw materials that are subject to price volatility and competing demand. Critical inputs may be available only from limited or single sources, have long lead times, or incorporate suppliers’ intellectual property, which can constrain our ability to qualify substitutes on acceptable schedules or terms. Supply constraints, price increases, business interruptions of suppliers, reduced availability of labor, transit disruptions, consolidation in the supply chain, export controls, sanctions, trade restrictions, tariffs, geopolitical tensions, economic circumstances, conflict, political conditions, or quality issues can delay production, increase expediting and material costs, and adversely affect shipment timing of the raw materials we rely on.

Regulatory and geopolitical developments may further impact availability and cost. Export restrictions or licensing regimes affecting the materials we use, as well as evolving environmental and product-safety rules, could reduce the pool of qualified materials, necessitate design changes, lengthen timelines, and increase compliance and sourcing costs. Even where alternatives exist, substituting materials or suppliers can require engineering modifications, process validation and customer approval, which may not be achieved on expected timelines.

Our ability to offset cost inflation through pricing, productivity, redesign or hedging may be limited by competitive dynamics, customer budget constraints and contractual commitments. In addition, higher input costs or material shortages at our customers and their supply chains can reduce downstream demand for our products and services, increase order cancellations or pushouts, and elevate the risk of excess or obsolete inventory. If we are unable to secure required materials on acceptable terms and timelines, or effectively manage cost volatility, our production, margins, cash flows and customer relationships could be materially and adversely affected.

Our future success depends, in part, on our ability to attract and retain key personnel.

Our future success depends, in part, on attracting, retaining and motivating highly skilled personnel. The loss of the services of any of our key personnel, the inability to attract or retain qualified personnel, or delays in hiring required personnel, particularly in engineering and sales, may seriously and adversely affect our business, financial condition and results of operations. Although we have entered into employment or consulting agreements with our personnel, their employment is generally for no specific duration.

Our future performance also depends on the continued services and continuing contributions of our senior management team to execute on our business plan and to identify and pursue new opportunities and product innovations. The loss of services of our senior management team, particularly our Chief Executive Officer or Chief Technology Officer, could significantly delay or prevent the achievement of our development and strategic objectives, which could adversely affect our business, financial condition and results of operations.

Risks Related to Forge Nano’s Financing and Liquidity

We have outstanding indebtedness and may incur additional debt from time to time to finance working capital, capital expenditures, investments or acquisitions, or for other corporate purposes.

Our leverage and debt service obligations could increase our vulnerability to adverse economic and industry conditions, require us to devote a substantial portion of our cash flows for interest and principal payments, and limit our flexibility to invest in capacity or other strategic initiatives. We cannot make any assurances that we will be able to refinance or replace existing debt on acceptable terms, or at all.

Our current and future debt agreements may contain restrictive covenants, financial or performance metrics, collateral or guaranty requirements, and other provisions that limit our ability to incur additional indebtedness or liens, make investments or acquisitions, pay dividends or repurchase shares, dispose of assets, or engage in certain transactions. Some instruments may include cross-default or cross-acceleration provisions, change-of-control or fundamental change put rights, and requirements to repay or repurchase outstanding notes for cash upon specified events, including the cash settlement of any conversion obligations. These restrictions could

14

Table of Contents

​

limit our ability to raise the funds necessary to meet our working capital needs, pursue our strategy, or respond to business and competitive developments on a timely basis.

A breach of covenants, the occurrence of specified events of default, or a failure to maintain required financial ratios could result in some or all of our indebtedness being declared immediately due and payable and, in secured facilities, could permit lenders to foreclose on collateral. Meeting our debt service and covenant obligations may require us to generate sufficient cash from operations, reduce or delay investments, raise additional capital, or dispose of assets, any of which may not be achievable when needed or on favorable terms. If we are unable to service, refinance, or repay our indebtedness as it comes due, or if we are required to repurchase or settle obligations in cash, our liquidity, financial condition, and results of operations could be materially and adversely affected.

We may require additional capital, which may not be available on acceptable terms or at all.

We may require additional capital to support business growth, and such financing may not be available on acceptable terms or at all, particularly during periods of market volatility or if our stock price declines. If capital markets tighten or investor sentiment weakens, our access to financing could diminish, and any required refinancing or new issuance could be delayed, costly, or unavailable. Failure to secure in a timely fashion additional funding could require us to slow development, defer capacity additions, reduce spending, or alter our strategy, which could materially and adversely affect our business and prospects.

Volatility in the equity and credit markets, including periods of rising interest rates, inflation, banking stress, and reduced liquidity, can negatively impact our ability to raise capital on favorable terms and can reduce the value and liquidity of our securities. A sustained decline in our stock price or increased market volatility could further constrain our financing alternatives, increase dilution in any equity raise, or render capital raises impracticable at the times and in the amounts we require. If we cannot obtain sufficient additional capital from operations or external sources when required, we may be unable to fund our operating plan or meet our obligations, which could materially and adversely affect our business, financial condition, and results of operations.

Risks Related to Forge Nano’s Intellectual Property

If we are unable to protect or enforce our intellectual property, our business and competitive position would be harmed.

We rely heavily on our intellectual property portfolio, and if we are unable to protect or assert our intellectual property, our business and competitive position would be harmed. Protecting against the unauthorized use of our intellectual property, products and other proprietary rights is expensive and can be difficult, particularly with respect to international jurisdictions. Unauthorized parties may attempt to copy or reverse engineer our products or certain aspects of our products that are considered proprietary. Litigation may be necessary in the future to enforce or defend our intellectual property rights, prevent unauthorized parties from copying or reverse engineering our products, determine the validity and scope of the proprietary rights of others or block the importation of infringing products into the United States. Any such litigation, regardless of merit, could be costly, divert the attention of management and may not ultimately be resolved in our favor.

Effective patent, trademark, service mark, copyright and trade secret protection may not be available or applied for in every country in which our products are available, and competitors based in other countries may sell infringing products in one or more markets. An inability to adequately protect and enforce our intellectual property and other proprietary rights or an inability to prevent unauthorized parties from copying or reverse engineering our products or certain aspects of our products that we consider proprietary could adversely affect our business, operating results, financial condition and prospects.

Our patent applications may not result in issued patents or our patent rights may be contested, circumvented, invalidated or limited in scope, any of which could have a material adverse effect on our ability to prevent others from interfering with our commercialization of our products.

We may need to defend ourselves against intellectual property infringement claims, which may be time-consuming and cause us to incur substantial costs.

Our competitors protect their proprietary rights by means of patents, trade secrets, copyrights, trademarks and other intellectual property. If we are determined to have infringed on any such rights, we could be required to cease sales or uses, pay substantial damages, obtain costly licenses that may not be available on acceptable terms (or at all), or redesign products or processes, any of which could delay our products, increase costs, or restrict our business in affected markets.

15

Table of Contents

​

We may receive letters from third parties alleging, or inquiring about, possible infringement, misappropriation or violation of their intellectual property rights. Any party asserting that we have infringed, misappropriated or violated their proprietary rights may force us to defend ourselves, and potentially our customers, against the alleged claim. These claims and any resulting lawsuit, if successful, could subject us to significant liability for damages and/or invalidation of our proprietary rights or interruption or cessation of our operations. Any such claims or lawsuits could:

●be time-consuming and expensive to defend regardless of the degree of merit;
●require us to stop providing products or services that use the technology that allegedly infringes the other party’s intellectual property;
●divert the attention of our technical and managerial resources;
●require us to enter into royalty or licensing agreements with third parties, which may not be available on terms that we deem acceptable;
●prevent us from operating all or a portion of our business or force us to redesign our products, services or technology platforms, which could be difficult and expensive and may make the performance or value of our product or service offerings less attractive;
●subject us to significant liability for damages or result in significant settlement payments; or
●require us to indemnify our customers.

Any such event could materially and adversely affect our business, financial condition, and results of operations.

Risks Related to Forge Nano’s Legal and Regulatory Environment

We are subject to environmental, health and safety regulations that could increase costs and affect our operations.

We are subject to extensive and evolving environmental, health and safety laws and regulations governing, among other things, the design, manufacture, sale, shipment and use of our products, the handling, storage, emissions and disposal of hazardous materials, and the operation of our facilities. Compliance can require significant capital and operating expenditures, process changes, new equipment and additional personnel and controls. Changes in environmental laws and regulations (including any relating to climate change and GHG emissions) could require us, or others in our value chain, to install additional equipment, alter operations to incorporate new technologies or processes, or revise process inputs, among other things, which may cause us to incur significant costs or otherwise adversely impact our business performance. Failure to comply could result in fines, penalties, remediation obligations, restrictions on product sales or facility operations, or other sanctions that could materially affect our business, financial condition and results of operations.

Regulatory requirements are also expanding with respect to climate and sustainability disclosures and related operational expectations. New and emerging rules may require additional data collection, reporting systems, third-party assurance, and adjustments to operations or product designs, and could increase scrutiny of our greenhouse gas targets and performance. Any failure to meet these requirements in a timely fashion or meet stakeholder expectations could result in reputational harm, regulatory inquiries, higher compliance costs, or reduced demand for our products.

We are subject to various risks related to new, different, inconsistent, or even conflicting laws, rules, and regulations that may be enacted by legislative or executive bodies and/or regulatory agencies in the countries in which we operate.

As a company operating across multiple jurisdictions, we face an expanding and sometimes inconsistent set of laws, regulations and standards. Additionally, these laws, regulations and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to invest resources to comply with evolving laws, regulations and

16

Table of Contents

​

standards, and this investment may result in increased general and administrative expenses and a diversion of management’s time and attention from revenue-generating activities to compliance activities. If our efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be adversely affected.

Tax increases and changes in tax laws may adversely affect our financial results.

As a company conducting business on a global basis with material operations throughout the United States, we are exposed, both directly and indirectly, to the effects of changes in U.S., state, local, and foreign tax laws. Taxes for financial reporting purposes and cash tax liabilities in the future may be adversely affected by changes in such tax laws. Such changes may put us at a competitive disadvantage compared to some of our major competitors, to the extent we are unable to pass the tax costs through to our customers. Consistent with the international nature of our business, we conduct certain manufacturing, supply chain and other operations in Asia, bringing these activities closer to customers and reducing operating costs. In some foreign jurisdictions, we must meet certain requirements to continue to qualify for tax incentives. There is no assurance we will be able to meet such requirements in the future to fully realize benefits from these incentives. Furthermore, the proposed plans to implement global minimum tax regimes could reduce or eliminate the benefits of our tax incentives.

We are subject to examination by the U.S. Internal Revenue Service and other tax authorities, and from time to time amend previously filed tax returns. We regularly assess the likelihood of favorable or unfavorable outcomes resulting from these examinations and amendments to determine the adequacy of our provision for income taxes, which requires estimates and judgments. Although we believe our tax estimates are reasonable, there can be no assurance the tax authorities will agree with such estimates. We may have to engage in litigation to achieve the results reflected in the estimates, which may be time-consuming and expensive. There can be no assurance that we will be successful or that any final determination will not be materially different from the treatment reflected in our historical income tax provisions and effective tax rates.

General Forge Nano Risk Factors

Adverse macroeconomic and geopolitical conditions could negatively affect our business.

Macroeconomic and geopolitical conditions, including inflation, interest rate volatility, recessions, supply chain disruptions, pandemics, armed conflicts, and trade tensions (particularly those involving China), can rapidly reduce customer spending, impede access to components, and increase our costs. When economic or industry conditions weaken, customers often push out, cancel, or refrain from purchasing equipment and services, which can lower demand and increase inventory, negatively impacting our revenues and margins. Our inability to offset price inflation in our materials, components, shipping, or labor through increased prices to customers with long-term fixed contracts and formula-based or long-term fixed price contracts with suppliers could adversely affect our business, financial condition and results of operations. Global supply chain and labor market challenges could also negatively affect our performance as well as the performance of our suppliers. Interest rate increases have also created financial market volatility and could further negatively impact financial markets, lead to an economic downturn or recession or have an adverse effect on our operating results. Any of these factors can lead to lower demand, reduced revenue visibility, and variability in cash flows. If adverse macroeconomic or geopolitical conditions persist or deteriorate, our business, financial condition, and results of operations could be materially and adversely affected.

Changes in trade policy, tariffs and export controls could limit our sales and increase costs.

Tariffs, sanctions and evolving export controls can increase our costs, restrict access to markets, and limit our ability to sell, install or service products in certain jurisdictions. In particular, U.S. and foreign export license requirements, especially for shipments to China, have limited, and could further limit, our addressable market, delay or prevent shipments, and disrupt revenue recognition. Certain of our international sales depend on our ability to obtain export licenses from the U.S. or foreign governments, and our inability to obtain such licenses, or an expansion of the number or kinds of sales for which export licenses are required, may in the future further limit the market for our products and adversely impact our revenues. Obtaining licenses can be difficult and time-consuming, with no assurance of approval or favorable terms. Failure to obtain required licenses may necessitate canceling or deferring deliveries, returning customer deposits, and could cede advantages to foreign or state-supported competitors not subject to comparable restrictions.

17

Table of Contents

​

Retaliatory measures and related policy actions, such as reciprocal tariffs, localization mandates, and restrictions on the export of critical minerals, can further increase manufacturing and logistics costs, complicate supply chains, and impair our competitiveness. Ongoing changes in rules, enforcement priorities, and country or end-user designations also create uncertainty for order intake, installation, and service activities, and additional restrictions, new prohibited entity list designations by the U.S. government, or broader licensing requirements could further limit sales, disrupt backlog conversion, and increase the risk of refunds and contract disputes.

Our technology is subject to substantial regulation under international, federal, state, and local laws, including export control laws and other trade regulations, and we incur significant costs in complying with these regulations as we develop and work to commercialize our technology. The U.S. government has made and continues to make significant changes in U.S. trade policy, and if we are unable to navigate these trade and regulatory dynamics, our market access, revenue visibility, and operating results could be materially and adversely affected.

Natural disasters, public health crises and other catastrophic events could disrupt our operations.

Our facilities or operations could be adversely affected by events outside of our control, including natural disasters, wars or other armed conflicts, health epidemics, pandemics or other outbreaks, extreme weather (such as earthquakes, wildfires, hurricanes, flooding and heatwaves) and other calamities. These events can damage facilities and equipment, interrupt utilities, restrict site access, disrupt manufacturing and installation schedules, and impair our ability to ship, install or service products, resulting in delays, increased costs, lost revenue opportunities, and adverse effects on margins and cash flows. Our exposure is heightened by our reliance on a limited number of manufacturing sites and critical tools, as well as single- or limited-source suppliers that may be concentrated in higher-risk regions. Public health crises and government responses (including travel restrictions, quarantine orders, export/import controls, health and safety protocols, and remote-work mandates) can disrupt our workforce availability, lengthen customer qualification and acceptance timelines, and impede onsite service and installations. These conditions can have significant macroeconomic impacts, including, but not limited to, significant disruption of global financial markets, supply chains, increases in levels of unemployment, and economic uncertainty. They can also strain global supply chains and transportation networks, reduce customer spending or ability to pay, and cause order pushouts, cancellations, or changes in product mix, increasing volatility in our results and working capital needs.

Although we maintain business continuity, disaster recovery and insurance coverages, these measures may be insufficient, may not cover all types of losses or costs (including lost profits, reputational harm, contractual penalties or recall expenses), and may not be available on acceptable terms in the future. If catastrophic events occur at our sites, at key supplier or logistics hubs, or at major customer locations, our operations, financial condition and results of operations could be materially and adversely affected.

Risks Related to Ownership of Our Securities

The market price of shares of Common Stock may be volatile.

The market price of shares of Common Stock is likely to be highly volatile and could fluctuate widely in price in response to various factors, many of which are beyond our control, including the following:

●the concentration of the ownership of our shares by a limited number of affiliated stockholders may limit interest in our securities;
●additions or departures of key personnel;
●loss of one or more strategic relationships;
●variations in operating results from the expectations of securities analysts or investors;
●announcements of new products or services by us or our competitors;
●reductions in the market share of our products;

18

Table of Contents

​

●announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments;
●investor perception of our industry or prospects;
●insider selling or buying;
●investors entering into short sale contracts;
●regulatory developments affecting our industry;
●changes in our industry;
●competitive pricing pressures;
●our ability to obtain working capital financing;
●sales of shares of Common Stock;
●our ability to execute our business plan;
●operating results that fall below expectations;
●revisions in securities analysts’ estimates or reductions in security analysts’ coverage; and
●economic and other external factors.

The sale or issuance of our Common Stock in the public market, or the perception that such sales or issuances could occur, could harm the prevailing market price of our Common Stock and cause dilution to our stockholders. These sales or issuances, or the possibility that these sales or issuances may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. As described elsewhere in this prospectus, in connection with the Business Combination, we entered into Lock-Up Agreements with each of the Forge Nano Lock-Up Holders, who collectively owned approximately 61.4% of the outstanding Common Stock immediately following the Closing. Pursuant to the Lock-Up Agreement, each Forge Nano Lock-Up Holder agreed to restrictions on transfer, subject to certain exceptions, ending on the earlier of (a) April 22, 2027 and (b) the date the last reported sale price of our Common Stock equals or exceeds $12.00 per share (subject to adjustment) for any twenty trading days within any thirty-trading day period. In connection with the HzO Merger, each former HzO stockholder agreed to a lock-up of the shares of Common Stock received until the earlier of (x) May 4, 2027 and (y) the date on which the last reported sale price of the Common Stock equals or exceeds $12.00 per share for any 20 trading days within a 30-trading-day period, subject to customary permitted transfers.

Additionally, pursuant to the Purchaser Support Agreement, and subject to the terms and conditions set forth therein, the Sponsor agreed to contribute up to 3,300,000 Founder Shares, together with all shares of Common Stock issued upon conversion thereof in the Domestication Merger, including 3,000,000 Founder Shares that were transferred to the Initial PIPE Investor at the Closing to secure the Financing Transaction (as defined in the Purchaser Support Agreement), and the remaining 300,000 Founder Shares that were transferred at the Closing to another investor to secure other Financing Transactions.

Pursuant to the Insider Letter, the Sponsor and certain insiders of ATII agreed to restrictions on transfer with respect to 2,450,000 shares of Common Stock, subject to certain exceptions, ending on the earlier of (a) April 22, 2027 and (b) the date the last reported sale price of our Common Stock equals or exceeds $12.00 per share (subject to adjustment) for any twenty trading days within any thirty-trading day period. On October 13, 2026, ATII and the Sponsor, with the consent of BTIG, waived these transfer restrictions with respect to the 3,000,000 Founder Shares transferred by the Sponsor to the Initial PIPE Investor at the Closing.

The sale of the shares of Common Stock subject to lock-up upon release, or the possibility that these sales may occur, could have an adverse effect on the market price of our Common Stock.

19

Table of Contents

​

Shares of Common Stock reserved for future issuance under our equity incentive plans will become eligible for sale in the public market once those shares are issued, subject to provisions relating to various vesting agreements, lock-up agreements and, in some cases, limitations on volume and manner of sale applicable to affiliates under Rule 144, as applicable. The Compensation Committee of our Board may determine the exact number of shares to be reserved for future issuance under Forge Nano’s equity incentive plans at its discretion. Forge Nano expects to file registration statements on Form S-8 under the Securities Act to register shares of Common Stock or securities convertible into or exchangeable for shares of Common Stock issued pursuant to its equity incentive plans. Any such Form S-8 registration statement will automatically become effective upon filing. Accordingly, shares registered under such registration statements will be available for sale in the open market.

In the future, Forge Nano may also issue its securities in connection with investments or acquisitions. The number of shares of Common Stock issued in connection with an investment or acquisition could constitute a material portion of the then-outstanding shares of Common Stock. Any issuance of additional securities in connection with investments or acquisitions may result in additional dilution to holders of our Common Stock.

Regardless of our operating performance, the market price of the shares of Common Stock could be subject to wide fluctuations in response to, among other things, the risk factors described in this prospectus, and other factors beyond our control, such as fluctuations in the valuation of companies perceived by investors to be comparable to us. We cannot make any predictions or projections as to what the prevailing market price for the shares of Common Stock will be at any time, including as to whether the shares of Common Stock will sustain current market prices, or as to what effect the sale of shares or the availability of the shares of Common Stock for sale at any time will have on the prevailing market price.

In addition, the securities markets have from time-to-time experienced significant price and volume fluctuations that are unrelated to the operating performance of particular companies. These market and industry fluctuations, as well as general economic, political, and market conditions, such as the occurrence of natural disasters, pandemics, geopolitical tensions (particularly those relating to the People’s Republic of China), military conflicts, trade conflicts, recessions, inflation, interest rate changes or international currency fluctuations, may negatively affect the market price of our Common Stock. In the past, many companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert our management’s attention from other business concerns, which could seriously harm our business.

We issued shares to the Initial PIPE Investor in connection with the Business Combination at a price which may be less than the prevailing market price of our shares.

In connection with the Closing, we issued shares to the Initial PIPE Investor in the PIPE Financing. Pursuant to the PIPE Subscription Agreement, the Initial PIPE Investor purchased 2,968,825 shares of Common Stock and Pre-Funded Warrants to purchase 7,031,175 shares of Common Stock, in each case at a subscription price equal to $10.00 per share or Pre-Funded Warrant. In addition, at the Closing, the Sponsor transferred 3,300,000 shares of Common Stock issued in exchange for Founder Shares in the Domestication Merger under the Purchaser Support Agreement, consisting of 3,000,000 shares transferred to the Initial PIPE Investor and 300,000 shares transferred to another investor. The effective purchase price per share paid by the Initial PIPE Investor in the PIPE Financing was approximately $7.69, taking into account the transfer of 3,000,000 of such shares to the Initial PIPE Investor. Such price may be less than the market price for our shares of Common Stock. This may dilute the interests of our other stockholders in a manner that would not ordinarily occur in a traditional public offering and could result in both a reduction in the trading price of our shares and fluctuations in the net tangible book value per share of Common Stock.

If the benefits of the Business Combination do not meet the expectations of investors or securities analysts, the market price of our securities may decline.

Fluctuations in the price of shares of Common Stock could contribute to the loss of all or part of your investment. The trading price of shares of Common Stock could be volatile and subject to wide fluctuations in response to various factors, some of which are beyond our control. Additionally, adverse market and economic forces as well as any of the risk factors discussed in this prospectus could have a material adverse effect on your investment and shares of Common Stock may trade at prices significantly below the price you paid for them. In such circumstances, the trading price of shares of Common Stock may not recover and may experience a further decline.

20

Table of Contents

​

Broad market and industry factors may materially harm the market price of shares of Common Stock irrespective of Forge Nano’s operating performance. The stock market in general, and shares listed on Nasdaq specifically, have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. As a result of this volatility, you may not be able to sell your securities at or above the price at which they were acquired. A loss of investor confidence in the market for the stocks of other companies which investors perceive to be similar to Forge Nano could depress the market price of shares of Common Stock regardless of Forge Nano’s business, prospects, financial condition or results of operations. A decline in the market price of our securities also could adversely affect Forge Nano’s ability to issue additional securities and Forge Nano’s ability to obtain additional financing in the future.

Forge Nano’s executive officers and directors exercise significant control over the company, which will limit your ability to influence corporate matters and could delay or prevent a change in corporate control.

As of November 9, 2026, Paul Lichty, Forge Nano’s Co-Founder and our Chief Executive Officer, beneficially owned approximately 7.3% of the outstanding shares of Common Stock, and our executive officers and directors as a group beneficially owned approximately 8.0% of the outstanding shares of Common Stock. As a result, these stockholders, and Mr. Lichty in particular, are able to influence our management and affairs and the outcome of matters submitted to our stockholders for approval, including the election of directors and any sale, merger, consolidation, or sale of all or substantially all of our assets.

This stockholder may have interests, with respect to his shares of Common Stock, which are different from those of the public investors and the concentration of voting power among this stockholder may have an adverse effect on the market price of the shares of Common Stock.

In addition, this concentration of ownership might adversely affect the market price of the shares of Common Stock by: (1) delaying, deferring or preventing a change of control; (2) impeding a merger, consolidation, takeover or other Business Combination involving us; or (3) discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of us.

The requirements of being a public company, including reporting obligations under the U.S. securities laws and the requirements of Section 404 of the Sarbanes-Oxley Act, may strain Forge Nano’s resources and distract management and we will incur substantial costs as a result of being a public company.

As a result of the Business Combination, we are subject to the requirements of the Exchange Act, the Sarbanes-Oxley Act, the Securities Act and Nasdaq. These rules, regulations and requirements are extensive. We incur significant costs associated with our public company corporate governance and reporting requirements. The Exchange Act requires, among other things, that we file annual, quarterly and current reports with respect to our business and operating results. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. In order to maintain and, if required, improve our disclosure controls and procedures and internal control over financial reporting to meet this standard, significant resources and management oversight may be required. If management is unable to conclude that we have effective internal control over financial reporting, or to certify the effectiveness of such controls, and our independent registered public accounting firm cannot render an unqualified opinion on management’s assessment and the effectiveness of our internal control over financial reporting at such time as it is required to do so, and material weaknesses in our internal control over financial reporting are identified, we could be subject to regulatory scrutiny, a loss of public and investor confidence, and to litigation from investors and stockholders, which could have a material adverse effect on our business and our stock price. In addition, if we do not maintain adequate financial and management personnel, processes and controls, we may not be able to manage our business effectively or accurately report our financial performance on a timely basis, which could cause a decline in our common stock price and adversely affect our business, financial condition and results of operations. If we fail to timely meet our reporting obligations under the Exchange Act, the Sarbanes-Oxley Act and other applicable securities rules and regulations in their entirety, we could be subject to penalties under federal securities laws and regulations of Nasdaq and face lawsuits, and may not be able to obtain independent accountant certifications required for public companies under the Sarbanes-Oxley Act.

The requirements described above may divert management’s attention from other business concerns, which could adversely affect our business and operating results. We may need to hire more corporate employees to comply with these requirements or engage outside consultants, which would increase our costs and expenses. This may divert management’s attention from other business concerns, which could have a material adverse effect on our business, financial condition and results of operations. These applicable rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability insurance and we

21

Table of Contents

​

may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be more difficult for us to attract and retain qualified individuals to serve on our Board or as executive officers.

In addition, changing laws, regulations and standards relating to corporate governance and public disclosure are creating uncertainty for public companies, increasing legal and financial compliance costs and making some activities more time-consuming. These laws, regulations and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to invest resources to comply with evolving laws, regulations and standards, and this investment may result in increased general and administrative expenses and a diversion of management’s time and attention from revenue-generating activities to compliance activities. If our efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be adversely affected.

As a result of disclosure of information in this prospectus and in the filings that we are required to make as a public company, our business, operating results and financial condition have become more visible, which may result in threatened or actual litigation, including by competitors and other third parties. If any such claims are successful, our business, operating results and financial condition could be adversely affected, and even if the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to resolve them, could divert the resources of our management and adversely affect our business, operating results and financial condition.

There can be no assurance that Forge Nano will be able to comply with the continued listing rules of Nasdaq.

Our Common Stock and SPAC Warrants are listed on Nasdaq under the symbols “NANO” and “NANOW,” respectively. We cannot assure you that our securities will continue to be listed on Nasdaq in the future. Nasdaq listing standards are quantitative and qualitative, and Nasdaq has broad discretion in applying and interpreting these standards. If we fail to satisfy applicable listing standards or Nasdaq determines that we do not meet the requirements for continued listing, Nasdaq may delist our securities. In order to continue listing our securities on Nasdaq, we must continue to satisfy Nasdaq’s continued listing requirements, including (among other things) maintaining a minimum bid price and meeting applicable distribution and financial standards. For example, companies listed on the Nasdaq Global Market must maintain, among other requirements, a $1.00 minimum bid price and at least 400 total holders, and must satisfy at least one ongoing financial standard (e.g., $10 million stockholders’ equity, $50 million market value of listed securities, or $50 million of each of total assets and total revenue, in each case together with the applicable publicly held shares, market value of publicly held shares and market maker requirements).

Additionally, there can be no assurance that Forge Nano will be able to comply with the continued listing standards of Nasdaq, including as a result of insufficient public “float”, insufficient distribution, an insufficient trading price, or our inability to satisfy the applicable financial standards.

If Nasdaq delists the shares of Common Stock or the SPAC Warrants from trading on its exchange for failure to meet its listing rules, Forge Nano and the holders of shares of Common Stock or SPAC Warrants, as applicable, could face significant material adverse consequences including:

●a limited availability of market quotations for shares of Common Stock or the SPAC Warrants;
●reduced liquidity for shares of Common Stock or the SPAC Warrants;
●a determination that the shares of Common Stock are a “penny stock” which will require brokers trading in shares of Common Stock to adhere to more stringent rules under applicable law and possibly result in a reduced level of trading activity in the secondary trading market for shares of Common Stock or the SPAC Warrants;
●a limited amount of news and analyst coverage; and
●a decreased ability to issue additional securities or obtain additional financing in the future.

22

Table of Contents

​

The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” The shares of Common Stock and the SPAC Warrants are covered securities because they are listed on Nasdaq. Although the states are preempted from regulating the sale of our securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. Further, if shares of Common Stock or the SPAC Warrants were no longer listed on Nasdaq, such securities would not qualify as covered securities and Forge Nano would be subject to regulation in each state in which it offers its securities.

Sales of a substantial amount of shares of Common Stock in the public market, particularly sales by our executive officers, directors and significant stockholders, or the perception that these sales could occur, could cause the market price of shares of Common Stock to decline.

In connection with the Business Combination, the Forge Nano Lock-Up Holders entered into the Lock-Up Agreement. Pursuant to the Lock-Up Agreement, the Forge Nano Lock-Up Holders agreed to restrictions on offering for sale, selling, contracting to sell, granting any option for the sale of, transferring or otherwise disposing of any shares of Common Stock and of any securities convertible into or exercisable for our Common Stock, subject to certain exceptions, for up to the earlier of (1) April 22, 2027 and (2) the date the last reported sale price of shares of Common Stock equals or exceeds $12.00 per share (subject to adjustment) for any twenty trading days within any thirty-trading day period. In connection with the HzO Merger, each former HzO stockholder agreed to a lock-up of the shares of Common Stock received until the earlier of (x) May 4, 2027 and (y) the date on which the last reported sale price of the Common Stock equals or exceeds $12.00 per share for any 20 trading days within a 30-trading-day period, subject to customary permitted transfers.

Additionally, the Sponsor and certain insiders of ATII have agreed to restrictions on transfer with respect to their shares of Common Stock, subject to certain exceptions, ending on the earlier of (a) April 22, 2027 and (b) the date the last reported sale price of shares of Common Stock equals or exceeds $12.00 per share (subject to adjustment) for any twenty trading days within any thirty-trading day period.

On October 13, 2026, ATII and the Sponsor, with the consent of BTIG, waived the transfer restrictions under the Insider Letter applicable to the 3,000,000 Founder Shares transferred by the Sponsor to the Initial PIPE Investor at the Closing pursuant to the Purchaser Support Agreement. Accordingly, the shares of Common Stock received by the Initial PIPE Investor in respect of such Founder Shares are not subject to the lock-up described above. In addition, each holder who received shares of Common Stock in the HzO Merger is subject to a six-month lock-up pursuant to the letter of transmittal delivered in connection with the HzO Merger, on terms no less favorable to such holders than the lock-up terms applicable to the Forge Nano Lock-Up Holders.

When the applicable lock-up periods expire, holders of shares of Common Stock subject to the lock-up provisions will be able to sell shares of Common Stock in the public market. Sales of a substantial number of such shares of Common Stock upon expiration of the lock-up provisions, the perception that such sales may occur or early release of these provisions could cause our market price to fall or make it more difficult for you to sell your shares of Common Stock at a time and price that you deem appropriate.

In addition, we will file a registration statement to register shares of Common Stock reserved for future issuance under our equity incentive plans. Subject to the satisfaction of applicable vesting requirements and expiration of the lock-up provisions referred to above, the shares of Common Stock issued upon exercise or conversion of outstanding equity awards under our equity incentive plans would be available for immediate resale in the open market.

A decline in the price of shares of Common Stock could affect our ability to raise working capital and adversely impact our ability to continue operations.

A prolonged decline in the market price of shares of Common Stock could result in a reduction in the liquidity of the shares of Common Stock and a reduction in our ability to raise equity capital, which could be especially detrimental to our liquidity, operations and strategic plans. Such reductions may force us to reallocate funds from other planned uses and may have a significant negative effect on our business plan and operations, including our ability to develop new products and services and continue current operations. We can offer no assurance that we will be able to raise additional equity capital or generate funds from operations sufficient to meet our obligations if the market price for the shares of Common Stock declines. If we are unable to raise sufficient equity capital in the future, we may not be able to have the resources to continue our normal operations.

23

Table of Contents

​

Forge Nano does not intend to pay any cash dividends in the foreseeable future and, therefore, any return on your investment in the shares of Common Stock may come from increases in the fair market value and trading price of the shares of Common Stock.

Forge Nano does not intend to pay any cash dividends on the shares of Common Stock in the foreseeable future. Forge Nano intends to retain future earnings, if any, for reinvestment in the development and expansion of our business. Additionally, our debt agreements may restrict our ability to pay dividends. Whether we pay cash dividends in the future will be at the discretion of our Board and will be dependent upon our financial condition, results of operations, capital requirements and any other factors that our Board decides is relevant. Therefore, any return on your investment in shares of Common Stock may come from increases in the fair market value and trading price of the shares of Common Stock.

Our outstanding warrants are exercisable for shares of Common Stock, which would increase the number of shares of Common Stock eligible for future resale in the public market and result in dilution to our stockholders.

As of November 9, 2026, 11,919,995 SPAC Warrants were outstanding and exercisable to purchase an aggregate of 11,919,995 shares of Common Stock at an exercise price of $11.50 per share in accordance with the ATII Warrant Agreement.

As of the Closing, Warrants to purchase an aggregate of 37,935,267 shares of Common Stock were outstanding, consisting of:

●the 11,919,995 SPAC Warrants with an exercise price of $11.50 per share issued in exchange for ATII Warrants in the Domestication Merger;
●the Forge Nano Warrants to purchase an aggregate of 421,792 shares of Common Stock, consisting of (i) the Initial SVB Warrant to purchase 75,656 shares of Common Stock at an exercise price of $0.33 per share, (ii) the Additional SVB Warrant to purchase 88,279 shares of Common Stock at an exercise price of $0.56 per share and (iii) the SEP Warrant to purchase 257,857 shares of Common Stock at an exercise price of $0.56 per share;
●the 3,562,305 shares of Common Stock underlying the Ascent Warrants, of which 2,351,238 have an exercise price of $3.40 per share and expire on December 31, 2028, subject to extension to December 31, 2029 at the holder’s election, in which case the exercise price applicable to any exercise occurring between January 1, 2029 and December 31, 2029 will increase by 25%, and 1,211,067 of which have an exercise price of $9.83 per share and expire on December 31, 2029;
●the 15,000,000 shares of Common Stock underlying the PIPE Warrants issued to the Initial PIPE Investor pursuant to the PIPE Subscription Agreement, each with an initial exercise price of $10.00 per share, subject to a one-time downward reset based on the trading price of our Common Stock, with a floor of $5.00 per share; and
●the 7,031,175 shares of Common Stock underlying the Pre-Funded Warrants issued to the Initial PIPE Investor pursuant to the PIPE Subscription Agreement, each with an exercise price of $0.0001 per share.

In addition, up to 5,000,000 shares of Common Stock may become issuable upon exercise of the Additional PIPE Warrants and up to 10,000,000 shares of Common Stock may become issuable upon exercise of the Reset PIPE Warrants, in each case if issued. The Additional PIPE Warrants, if issued, would have an initial exercise price equal to the exercise price of the PIPE Warrants then in effect, and the Reset PIPE Warrants, if issued, would have an exercise price equal to the PIPE Reset Price (which would not be less than $5.00 per share).

To the extent the Warrants are exercised, additional shares of Common Stock will be issued, which will result in dilution to the holders of shares of Common Stock and may increase the number of shares of Common Stock eligible for resale in the public market. We cannot predict the value of the SPAC Warrants. Sales of substantial numbers of shares of Common Stock issued upon the exercise of SPAC Warrants in the public market or the potential that such SPAC Warrants may be exercised could also adversely affect the market price of the shares of Common Stock.

24

Table of Contents

​

The SPAC Warrants may never be in the money, and they may expire worthless. The terms of the SPAC Warrants may be amended in a manner adverse to a holder if holders of at least a majority of the then outstanding SPAC Warrants approve of such amendment.

The exercise price for the SPAC Warrants will be $11.50 per share of Common Stock, subject to adjustment in accordance with the ATII Warrant Agreement. There can be no assurance that the SPAC Warrants will be “in the money” following the time they become exercisable and prior to their expiration and, as such, the SPAC Warrants may expire worthless. The SPAC Warrants will expire five (5) years after the completion of the Business Combination, at 5:00 p.m. Eastern Time, or earlier upon redemption.

The SPAC Warrants were issued in registered form under the ATII Warrant Agreement. The ATII Warrant Agreement provides that the terms of the SPAC Warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision or in a manner adverse to a holder with the approval of the holders of at least a majority of the aggregate then outstanding SPAC Warrants. The terms of the SPAC Warrants may be amended as described above to, among other things, increase the exercise price of such SPAC Warrants, shorten the exercise period or decrease the number of securities purchasable upon exercise of such SPAC Warrants.

Forge Nano may redeem your unexpired SPAC Warrants prior to their exercise at a time that is disadvantageous to you, thereby making such SPAC Warrants worthless.

We will have the ability to redeem issued and outstanding SPAC Warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per SPAC Warrant, in accordance with the terms of the ATII Warrant Agreement, provided that the last reported sale price of the shares of Common Stock equals or exceeds $18.00 per share (as adjusted for share subdivisions, share consolidations, share capitalizations, rights issuances, reorganizations, recapitalizations and the like) for any twenty (20) trading days within a thirty- (30-) trading day period ending on the third (3rd) trading day prior to the date we send the notice of redemption to the holders of SPAC Warrants and provided certain other conditions are met. We will not redeem the SPAC Warrants unless an effective registration statement under the Securities Act covering the shares of Common Stock issuable is effective and a current prospectus relating to those shares of Common Stock is available throughout the thirty- (30-) day redemption period, except if we elect to require the SPAC Warrants to be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If and when such SPAC Warrants become redeemable by us, we may not exercise our redemption right if the issuance of shares upon exercise of such SPAC Warrants is not exempt from registration or qualification under applicable state blue sky laws or we are unable to effect such registration or qualification. Redemption of the issued and outstanding and unexpired SPAC Warrants could force you (i) to exercise such SPAC Warrants and pay the exercise price therefor at a time when it may be disadvantageous for you to do so, (ii) to sell such SPAC Warrants at the then-current market price when you might otherwise wish to hold your SPAC Warrants or (iii) to accept the nominal redemption price which, at the time the issued and outstanding and unexpired SPAC Warrants are called for redemption, is likely to be substantially less than the market value of such SPAC Warrants.

Our ability to require holders of the SPAC Warrants to exercise such SPAC Warrants on a cashless basis will cause holders to receive fewer shares of Common Stock upon their exercise of the SPAC Warrants than they would have received had they been able to exercise their SPAC Warrants for cash.

If we call the SPAC Warrants for redemption after the redemption criteria described elsewhere in this prospectus have been satisfied, we will have the option to require any holder that wishes to exercise such SPAC Warrants to do so on a “cashless basis.” If we choose to require holders to exercise such SPAC Warrants on a cashless basis, the number of shares of Common Stock received by a holder upon exercise will be fewer than it would have been had such holder exercised such SPAC Warrant for cash. This will have the effect of reducing the potential “upside” of the holder’s investment.

If a holder elects to exercise such SPAC Warrants on a “cashless basis” as described above, such holder would pay the exercise price by surrendering the SPAC Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product obtained by multiplying (i) the number of shares of Common Stock underlying the SPAC Warrants by (ii) the difference between the exercise price of the SPAC Warrants and the “fair market value” (defined below) by (y) the “fair market value.” The “fair market value” shall mean the average reported closing price of the shares of Common Stock for the five (5) trading days ending on the third (3rd) trading day prior to the date the notice of exercise is received by the warrant agent; if we require cashless exercise in connection with a redemption, the “fair market value” is the average reported closing price for the five (5) trading days ending on the third (3rd) trading day prior to the date on which the notice of redemption is sent to holders of SPAC Warrants.

25

Table of Contents

​

The ATII Warrant Agreement designates the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of the SPAC Warrants, which could limit the ability of holders of SPAC Warrants to obtain a favorable judicial forum for disputes.

The ATII Warrant Agreement provides that, subject to applicable law, (i) any action, proceeding or claim against us arising out of or relating in any way to the ATII Warrant Agreement will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and (ii) that we irrevocably submit to such jurisdiction, which jurisdiction shall be the exclusive forum for any such action, proceeding or claim. We will waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum.

Notwithstanding the foregoing, these provisions of the ATII Warrant Agreement will not apply to suits brought to enforce any liability or duty created by the Securities Act or the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum. We note that there is uncertainty as to whether a court would enforce such provisions, and that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. The Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.

Any person or entity purchasing or otherwise acquiring any interest in any SPAC Warrants shall be deemed to have notice of and to have consented to the forum provisions in the ATII Warrant Agreement. If any action, the subject matter of which is within the scope of the forum provisions of the ATII Warrant Agreement, is filed in a court other than a court of the State of New York or the United States District Court for the Southern District of New York (a “foreign action”) in the name of any holder of such SPAC Warrants, such holder shall be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located in the State of New York in connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service of process made upon such holder of such SPAC Warrants in any such enforcement action by service upon such holder of such SPAC Warrants’ counsel in the foreign action as agent for such holder of such SPAC Warrants.

This choice-of-forum provision may limit the ability of a holder of SPAC Warrants to bring a claim in a judicial forum that it finds favorable for disputes, which may discourage such lawsuits and result in increased costs to holders of such SPAC Warrants to bring a lawsuit. Alternatively, if a court were to find these provisions of the ATII Warrant Agreement inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could materially and adversely affect our business, financial condition and results of operations and result in a diversion of the time and resources of our management team.

Forge Nano is a “smaller reporting company” and “emerging growth company” under the U.S. federal securities laws, and the reduced reporting requirements applicable to “smaller reporting companies” and “emerging growth companies” could make the shares of Common Stock less attractive to investors.

We are a “smaller reporting company” and an “emerging growth company” under U.S. federal securities laws. For as long as we continue to be a “smaller reporting company,” we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not “smaller reporting companies,” including reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements filed with the SEC. Furthermore, as an “emerging growth company,” we intend to take advantage of exemptions from certain reporting requirements, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act and exemptions from the requirements of holding a non-binding advisory vote on executive compensation. Investors may not find shares of Common Stock attractive because we may rely on these exemptions and reduced disclosures. If some investors find shares of Common Stock less attractive as a result, there may be a less active trading market for shares of Common Stock and the market price for shares of Common Stock may be more volatile.

We will remain a “smaller reporting company” for so long as either (1) the market value of the shares of Common Stock held by non-affiliates is less than $250 million as of the last business day of our most recently completed second fiscal quarter or (2) our annual revenues are less than $100 million during the most recently completed fiscal year and the market value of the shares of Common Stock held by non-affiliates is less than $700 million as of the last business day of our most recently completed second fiscal quarter.

26

Table of Contents

​

Further, Section 102(b)(1) of the JOBS Act exempts “emerging growth companies” from being required to comply with new or revised financial accounting standards until private companies are required to comply with them. We have elected not to opt out of this extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, we can adopt the new or revised standard at the time private companies adopt it. This may make comparison of our financial statements with those of another public company difficult or impossible because of the potential differences in accounting standards used. Once we lose our “emerging growth company” and “smaller reporting company” status, we will no longer be able to take advantage of these exemptions, we will be required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, and we will incur additional expenses and management time in connection with such compliance.

We will remain an “emerging growth company” until the earlier of: (1) the last day of the fiscal year (a) following February 12, 2030, (b) in which we have total annual gross revenue of at least $1.235 billion, or (c) in which we are deemed to be a “large accelerated filer,” which means the market value of shares of Common Stock held by non-affiliates exceeds $700 million as of the end of the prior fiscal year’s second fiscal quarter; and (2) the date on which we have issued more than $1.00 billion in non-convertible debt securities during the prior three-year period.

The historical financial results of Forge Nano and unaudited condensed combined pro forma financial information included elsewhere in this prospectus may not be indicative of what Forge Nano’s actual financial position or results of operations would have been had Forge Nano been a public company.

The historical financial results of Forge Nano included in this prospectus do not reflect the financial condition, results of operations or cash flows Forge Nano would have achieved as a standalone public company during the periods presented or those Forge Nano will achieve in the future. This is primarily the result of the following factors: (i) Forge Nano will incur additional ongoing costs as a result of the Business Combination, including costs related to public company reporting, investor relations and compliance with the Sarbanes-Oxley Act; and (ii) Forge Nano’s capital structure after the Business Combination is different from that reflected in Forge Nano’s historical financial statements. Forge Nano’s financial condition and future results of operations could be materially different from amounts reflected in its historical financial statements included elsewhere in this prospectus, so it may be difficult for investors to compare Forge Nano’s future results to historical results or to evaluate its relative performance or trends in its business.

Similarly, the unaudited condensed combined pro forma financial information in this prospectus is presented for illustrative purposes only and has been prepared based on a number of assumptions including, but not limited to, ATII being treated as the “acquired” company for financial reporting purposes in the Business Combination. Accordingly, such unaudited condensed combined pro forma financial information may not be indicative of Forge Nano’s future operating or financial performance and Forge Nano’s actual financial condition and results of operations may vary materially from our pro forma results of operations and balance sheet contained elsewhere in this prospectus, including as a result of such assumptions not being accurate. See “Unaudited Pro Forma Condensed Combined Financial Information.”

We are a holding company and our only significant assets are our ownership interests in our subsidiaries, and such ownership may not be sufficient to pay dividends or make distributions or loans to enable us to pay any dividends on shares of Common Stock or satisfy our other financial obligations.

We have no direct operations and no significant assets other than our ownership of our subsidiaries. We depend on such subsidiaries for distributions, loans and other payments to generate the funds necessary to meet our financial obligations, including our expenses as a publicly traded company and to pay any dividends with respect to shares of Common Stock. The financial condition and operating requirements of our subsidiaries may limit our ability to obtain cash from them. The earnings from, or other available assets of, our subsidiaries may not be sufficient to pay dividends or make distributions or loans to enable us to pay any dividends on shares of Common Stock or satisfy our other financial obligations.

We may be subject to the Excise Tax included in the Inflation Reduction Act of 2022 in connection with redemptions of ATII Public Shares after December 31, 2022.

The Code imposes a 1% U.S. federal excise tax on certain repurchases (including redemptions) of stock by publicly traded U.S. corporations (the “Excise Tax”), subject to certain exceptions. If applicable, the amount of the Excise Tax is generally 1% of the aggregate fair market value of any stock repurchased by the corporation during a taxable year, net of the aggregate fair market value of certain new stock issuances by the repurchasing corporation during the same taxable year.

27

Table of Contents

​

Because we became a Delaware corporation as a result of the Domestication Merger, we expect to be a “covered corporation” for purposes of the Excise Tax. While not free from doubt, absent any further guidance from the U.S. Department of the Treasury (the “Treasury”), the Excise Tax may apply to redemptions of ATII Public Shares, including redemptions in connection with the Business Combination, unless an exemption is available. Generally, issuances of securities in connection with an initial business combination transaction (including any PIPE transaction at the time of an initial business combination), as well as any other issuances of securities not in connection with an initial business combination, would be expected to reduce the amount of the Excise Tax in connection with redemptions occurring in the same calendar year, but the number of securities redeemed may exceed the number of securities issued.

Although the final Treasury Regulations clarify certain aspects of the Excise Tax, the interpretation and operation of certain other aspects of the Excise Tax remain unclear. Moreover, because these regulations are subject to varying interpretations, their application in practice may evolve over time as new guidance becomes available. The application of the Excise Tax to our particular circumstances is complex and may be subject to uncertainty, and there cannot be any assurance that the Excise Tax will not apply to redemptions of our ATII Public Shares in connection with the Business Combination.

We recently acquired HzO and may pursue additional acquisitions, which could divert management’s attention, cause us to incur unanticipated costs and liabilities, and fail to achieve the anticipated benefits, any of which could adversely affect our business, financial condition and results of operations.

As part of our growth strategy, we acquired HzO on November 4, 2026, and we may from time to time acquire or invest in other businesses, products or technologies. The success of this strategy depends, in part, on selecting strategic acquisition candidates at attractive prices and effectively integrating their businesses into our own, including with respect to financial reporting and regulatory matters. Forge Nano cannot assure you that it will be able to identify attractive acquisition candidates or complete the acquisition of any identified candidates at favorable prices and upon advantageous terms and conditions, including financing alternatives.

Forge Nano may not have sufficient management, financial and other resources to integrate and consolidate any future acquisition targets, including HzO. Any significant diversion of management’s attention or any major difficulties encountered in the integration of the businesses Forge Nano may acquire, including HzO, could have a material adverse effect on the acquired company’s business, financial condition or results of operations, which could decrease its profitability and make it more difficult for Forge Nano to grow its business. Among other things, these integration risks could include:

●the loss of key employees;
●the disruption of operations and business;
●the retention or transition of customers and vendors;
●the integration of corporate cultures and maintenance of employee morale;
●inability to maintain and increase competitive presence;
●customer loss and revenue loss;
●possible inconsistencies in standards, control procedures and policies;
●problems with the assimilation of new operations, sites or personnel, which could divert resources from Forge Nano’s regular operations;
●integration of financial reporting and regulatory reporting functions; and/or
●other potential unknown liabilities.

In addition, general economic conditions or unfavorable capital and credit markets could affect the timing and extent to which we can successfully acquire or integrate new businesses, which could limit our revenues and profitability.

28

Table of Contents

​

Risks Related to Our Organizational Documents and Delaware Law

Delaware law and the Organizational Documents contain certain provisions, including anti-takeover provisions that limit the ability of holders of shares of Common Stock to take certain actions and could delay or discourage takeover attempts that holders of shares of Common Stock may consider favorable.

The Organizational Documents and the DGCL contain provisions that could have the effect of rendering more difficult, delaying, or preventing an acquisition that holders of shares of Common Stock may consider favorable, including transactions in which holders of shares of Common Stock might otherwise receive a premium for such shares. These provisions could also limit the price that investors might be willing to pay in the future for shares of Common Stock, and therefore depress the trading price of shares of Common Stock. These provisions could also make it difficult for holders of shares of Common Stock to take certain actions, including electing directors to our Board who are not nominated by our Board or taking other corporate actions, including effecting changes in our management. Among other things, the Organizational Documents include provisions regarding:

●the ability of our Board to issue shares of preferred stock of Forge Nano, including “blank-check” preferred stock, and to determine the price and other terms of those preferred shares, including with respect to preferences and voting rights, without approval of the holders of shares of Common Stock, which could be used to significantly dilute the ownership of a hostile acquirer;
●the Organizational Documents prohibit cumulative voting in the election of directors to our Board, which limits the ability of minority stockholders to elect director candidates to our Board;
●the limitation of the liability of, and the indemnification of, Forge Nano’s directors and officers;
●the ability of our Board to unilaterally amend the Bylaws, which may allow our Board to take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquirer to amend the Bylaws to facilitate an unsolicited takeover attempt; and
●advance notice procedures with which holders of shares of Common Stock must comply to nominate director candidates for our Board or to propose matters to be acted upon at a stockholders’ meeting, which could preclude stockholders from bringing matters before annual or special meetings of stockholders and delay changes in our Board and also may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of Forge Nano.

These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our Board or management.

The provisions of the Charter requiring exclusive forum in the Court of Chancery of the State of Delaware and the federal district courts of the United States for certain types of lawsuits may have the effect of discouraging lawsuits against Forge Nano’s directors and officers.

The Charter provides that, to the fullest extent permitted by law, and unless Forge Nano consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, in the event that the Chancery Court does not have jurisdiction, the federal district court for the District of Delaware or other state courts of the State of Delaware) will be the sole and exclusive forum for (i) any derivative action, suit or proceeding brought on Forge Nano’s behalf, (ii) any action, suit or proceeding asserting a claim of breach of a fiduciary duty owed by any director, officer or stockholder of Forge Nano to Forge Nano or holders of shares of Common Stock, (iii) any action, suit or proceeding arising pursuant to any provision of the DGCL or the Organizational Documents (as each may be amended from time to time), or (iv) any action, suit or proceeding asserting a claim against Forge Nano governed by the internal affairs doctrine.

29

Table of Contents

​

Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. Accordingly, both state and federal courts have jurisdiction to entertain such Securities Act claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, the Charter also provides that, unless Forge Nano consents in writing to the selection of an alternative forum, to the fullest extent permitted by applicable law, the federal district courts of the United States of America will be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act; provided, however, that there is uncertainty as to whether a court would enforce such provision, and investors cannot waive compliance with federal securities laws and the rules and regulations thereunder. Notwithstanding the foregoing, the Charter provides that the federal forum provision will not apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the federal courts of the United States have exclusive jurisdiction. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder.

These provisions may have the effect of discouraging lawsuits against Forge Nano’s directors and officers. The enforceability of similar choice of forum provisions in other companies’ certificates of incorporation has been challenged in legal proceedings, and it is possible that, in connection with any applicable action brought against Forge Nano, a court could find the choice of forum provisions contained in the Charter to be inapplicable or unenforceable in such action.

Our board of directors has adopted resolutions renouncing our interest and expectancy in certain corporate opportunities.

On October 22, 2026, our board of directors adopted resolutions waiving the application of the doctrine of corporate opportunity, or any other analogous doctrine, with respect to the Company, any non-employee directors, any non-employee stockholders or any of their respective affiliates. In addition, pursuant to such resolutions, the Company renounced, to the fullest extent permitted by law, any interest or expectancy of the Company, its stockholders and any of their respective affiliates in, or in being notified of or offered an opportunity to participate in any matter, transaction or interest that is presented to, or acquired, created or developed by, or which otherwise comes into the possession of (i) any director of the Company who is not an employee of the Company or any of its subsidiaries, or (ii) any such director’s affiliates, partners, or other representatives (each of the foregoing, an “Exempt Person” and each such contemplated opportunity, an “Excluded Opportunity”), unless such matter, transaction or interest is expressly offered to such director solely in his or her capacity as a director of the Company. The foregoing renunciation and waiver does not apply to, and shall not result in the renunciation by the Company or any of its subsidiaries of any interest or expectancy in a business opportunity with respect to, an Exempt Person who first identified the applicable opportunity solely through the disclosure of the Company’s or any of its subsidiaries’ confidential information in circumstances in which the Company had a reasonable expectation that such information would be held in confidence. In addition, no Exempt Person shall have any duty to communicate or offer an Excluded Opportunity to the Company or any of its affiliates or stockholders, and no Exempt Person shall have any liability to the Company, any of its affiliates or stockholders for breach of any duty, as a director or otherwise, by reason of the fact that such Exempt Person pursues or acquires an Excluded Opportunity, directs an Excluded Opportunity to another person or fails to present an Excluded Opportunity, or information regarding an Excluded Opportunity, to the Company or any of its affiliates or stockholders.

For example, the Exempt Persons may pursue acquisition opportunities that may be complementary to our business, and, as a result, those acquisition opportunities may not be available to us. In addition, the Exempt Persons may have an interest in our pursuing acquisitions, divestitures, and other transactions that, in their judgment, could enhance their investment, even though such transactions might involve risks to us and our stockholders. These potential conflicts of interest could have a material adverse effect on our business, financial condition, results of operations or prospects if attractive corporate opportunities are allocated elsewhere by Exempt Persons instead of to us.

​

30

Table of Contents

​

USE OF PROCEEDS

All of the securities offered by the Selling Securityholders pursuant to this prospectus will be sold by the Selling Securityholders for their respective accounts. We will not receive any of the proceeds from these sales.

Assuming all of our Warrants are exercised for cash, we would receive approximately $307.2 million, assuming that the exercise price of the PIPE Warrants and the Additional PIPE Warrants is reset to the $5.00 floor and that the maximum of 10,000,000 Reset PIPE Warrants are issued and exercised at a PIPE Reset Price of $5.00 (or approximately $357.2 million if no such reset occurs, the Additional PIPE Warrants are exercised at the current exercise price of $10.00 per share and no Reset PIPE Warrants are issued), but we will not receive any proceeds from the sale of shares of Common Stock issuable upon such exercise. We expect to use the net proceeds from the exercise of such warrants, if any, for general corporate purposes. We will have broad discretion over the use of any proceeds from the exercise of such warrants. There is no assurance that the holders of such warrants will elect to exercise for cash any or all of such warrants. To the extent that any such warrants are exercised on a “cashless basis”, we would not receive any proceeds from the exercise of such warrants.

The Selling Securityholders will pay any underwriting discounts and commissions and expenses incurred by them for brokerage, accounting, tax or legal services or any other expenses incurred in disposing of the securities. We will bear the costs, fees and expenses incurred in effecting the registration of the securities covered by this prospectus, including all registration and filing fees, Nasdaq listing fees and fees and expenses of our counsel and our independent registered public accounting firm.

​

31

Table of Contents

​

DIVIDEND POLICY

We have not paid any cash dividends on our Common Stock to date, and we do not intend to pay cash dividends in the foreseeable future. The payment of cash dividends in the future will be at the discretion of our Board and will depend on our revenues and earnings, if any, capital requirements and general financial condition. In addition, our debt agreements may restrict our ability to pay dividends.

​

32

Table of Contents

​

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

Introduction

The following unaudited pro forma condensed combined financial information presents the combination of the historical financial information of Forge Nano, ATII and HzO, adjusted to give effect to (i) the Business Combination and (ii) the HzO Merger (collectively, the “Transactions”). References in this section to the “Company” are to Forge Nano Holdings, Inc. (formerly known as ATII Holdings Inc.).

The unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X as amended by the final rule, Release No. 33-10786 “Amendments to Financial Disclosures about Acquired and Disposed Businesses” to depict the accounting for the transactions (“Transaction Accounting Adjustments”) and present the reasonably estimable synergies and other transaction effects that have occurred or are reasonably expected to occur (“Management’s Adjustments”). Forge Nano has elected not to present Management’s Adjustments and will only be presenting Transaction Accounting Adjustments in the unaudited pro forma condensed combined financial information.

The following unaudited pro forma condensed combined balance sheet as of September 30, 2026, assumes that the Transactions occurred on September 30, 2026. The unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2026 and for the year ended December 31, 2025, assumes that the Transactions occurred on January 1, 2025, the beginning of the earliest periods presented. This information is presented for illustrative purposes only and is not necessarily indicative of the financial position or results of operations that would have been achieved had the Transactions occurred on the dates indicated, or of future results. It should be read together with the historical financial statements of Forge Nano, ATII and HzO and the related notes included elsewhere in this prospectus.

Description of the Business Combination

On October 22, 2026, the Company completed the Business Combination pursuant to the Merger Agreement dated April 20, 2026. In connection with the closing, ATII re-domesticated as a Delaware corporation and merged into the Company, and Forge Nano became a wholly owned subsidiary of the Company.

Each outstanding share of Forge Nano capital stock was converted into shares of Common Stock at an exchange ratio of approximately 28.4957, and outstanding Forge Nano warrants and options were assumed or converted into corresponding Company securities. Concurrently, the Company received aggregate PIPE proceeds of $123.0 million. Former Forge Nano stockholders are also eligible to receive up to 90,000,000 Earn-Out Shares in three equal tranches, subject to stock price or revenue milestones.

Ownership of the Company Following the Business Combination

The following table sets out share ownership of the Company immediately following the Business Combination, excluding the dilutive effect of SPAC Warrants, Forge Nano Warrants, Ascent Warrants, Options, PIPE Warrants, Reset PIPE Warrants, Additional PIPE Warrants and Earn-Out Shares:

​

​

​

​

​

​

​

  ​ ​ ​

Shares

  ​ ​ ​

%

  ​

ATII Public Shareholders

 

780,932

 

0.6

%

Initial Shareholders(1)

 

3,290,000

 

2.6

%

Forge Nano Stockholders(2)

 

116,015,828

 

90.2

%

PIPE Investors(3)

 

8,568,825

 

6.6

%

Total

 

128,655,585

 

100.0

%

(1)Consists of (i) the 2,450,000 shares of Common Stock issued to the Sponsor and the Initial Shareholders in exchange for 2,450,000 Founder Shares (3,300,000 shares of Common Stock issued in exchange for 3,300,000 Founder Shares were transferred by the Sponsor to the PIPE Investors upon the Closing pursuant to the Purchaser Support Agreement), (ii) the 530,000 ATII Private Shares held by the Sponsor and (iii) the 310,000 ATII Private Shares held by BTIG.

33

Table of Contents

​

(2)Consists of the 116,015,828 shares of Common Stock issuable in respect of 4,071,346 shares of Forge Nano Common Stock (including shares of Forge Nano Common Stock issued upon conversion of Forge Nano Preferred Stock immediately prior to the First Effective Time) based on the exchange ratio of approximately 28.4957.
(3)Consists of (i) the 2,968,825 PIPE Subscribed Shares acquired by the Initial PIPE Investor pursuant to the PIPE Subscription Agreement, (ii) the 3,300,000 Founder Shares transferred by the Sponsor to the PIPE Investors in connection with the PIPE Financing for no additional cash consideration pursuant to the Purchaser Support Agreement, and (iii) the 2,300,000 shares of Common Stock acquired by the Additional PIPE Investors pursuant to the Additional PIPE Subscription Agreements at a subscription price of $10.00 per share.

Accounting Treatment of the Business Combination

The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP, with Forge Nano treated as the accounting acquirer and ATII treated as the acquired company for financial reporting purposes. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Forge Nano issuing equity for the net assets of ATII, accompanied by a recapitalization. The net assets of ATII were stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination are those of Forge Nano.

Forge Nano was determined to be the accounting acquirer based on, among other factors, the relative voting interests in the Company following the Business Combination, the ability of the former Forge Nano stockholders to influence the election and removal of directors and officers of the Company, Forge Nano comprising the ongoing operations of the Company, and Forge Nano’s existing senior management comprising the senior management of the Company.

Description of the HzO Merger

On November 4, 2026, the Company completed its acquisition of HzO, a provider of parylene-based thin-film coating solutions that protect electronic components from moisture, corrosion and other environmental damage, pursuant to an Agreement and Plan of Merger dated November 4, 2026. Under the HzO Merger Agreement, a wholly owned subsidiary of the Company merged with and into HzO, with HzO surviving as a wholly owned subsidiary of the Company.

As consideration, HzO’s equityholders became entitled to receive an aggregate of 7,306,440 shares of Common Stock. The number of shares was based on a purchase price of $55.0 million plus the value of the Common Stock held by HzO immediately before closing. The purchase price was then adjusted for HzO’s closing cash, working capital, indebtedness and unpaid transaction expenses. It was also reduced by the settlement of a $3.0 million loan previously made by Forge Nano to HzO and by the value of restricted stock units granted to participants in HzO’s Transaction Incentive Plan. The resulting amount was converted into shares at $10.00 per share. Of the total shares, 5,772,645 were issued at closing. This includes 2,168,979 shares issued in exchange for the Common Stock HzO held before closing. The remaining 1,533,795 shares (the “Holdback Shares”) will be held back for twelve months to secure certain post-closing adjustments and indemnification obligations. In addition, outstanding HzO stock options, restricted stock units, warrants and convertible notes were cancelled, converted or settled under the terms of the HzO Merger Agreement.

Accounting Treatment of the HzO Merger

The HzO Merger has been accounted for as a business combination using the acquisition method of accounting in accordance with ASC 805, Business Combinations, with the Company identified as the accounting acquirer. Under the acquisition method of accounting, the consideration transferred is allocated to the identifiable assets acquired and liabilities assumed based on their estimated acquisition-date fair values, with any excess of the consideration transferred over the fair value of the identifiable net assets acquired recognized as goodwill.

Accordingly, the purchase consideration of approximately $21.6 million, measured at fair value as of the closing date, was allocated to the assets acquired and liabilities assumed based on their estimated fair values, with any excess recorded as goodwill. The purchase price allocation is preliminary and subject to change during the measurement period, including for post-closing purchase price adjustments, as additional information becomes available and valuations are finalized.

​

34

Table of Contents

​

UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET

SEPTEMBER 30, 2026(1)

(in thousands, except share and per share data)

​

​

​

​

​

​

​

​

De-Spac

​

​

​

​

​

​

HzO

​

​

​

​

​

​

​

Forge

​

​

​

​

Transaction

​

​

​

​

​

​

Transaction

​

​

​

Pro

​

​

Nano

​

ATII

​

Accounting

​

​

​

​

HzO

​

Accounting

​

​

​

Forma

​

  ​ ​ ​

(Historical)

  ​ ​ ​

(Historical)

  ​ ​ ​

Adjustments

  ​ ​ ​

​

  ​ ​ ​

​

(Historical)

  ​ ​ ​

Adjustments

  ​ ​ ​

​

  ​ ​ ​

Combined

Assets

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Current assets

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cash and cash equivalents

​

$

15,723

​

$

130

​

$

100,000

 

A

​

$

1,730

 

​

(305)

 

B1

​

$

143,429

​

​

​

​

​

​

​

​

 

23,000

 

B

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

8,379

 

E

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

(5,228)

 

F

​

​

​

​

​

​

​

​

​

​

​

Restricted cash and cash equivalents

​

 

1,033

​

 

—

​

 

—

 

​

​

 

—

 

​

—

 

​

​

 

1,033

Accounts receivable – net of allowance for credit losses of $37

​

 

1,837

​

 

—

​

 

—

 

​

​

 

1,662

 

​

(283)

 

B1

​

 

3,216

Contract assets – unbilled accounts receivable

​

 

6,925

​

 

—

​

 

—

 

​

​

 

—

 

​

—

 

​

​

 

6,925

Inventory

​

 

6,691

​

 

—

​

 

—

 

​

​

 

971

 

​

(235)

 

B1

​

 

7,427

Notes receivable

​

 

1,000

​

 

—

​

 

—

 

​

​

 

—

 

​

—

 

​

​

 

1,000

Prepaid expenses and other current assets

​

 

2,647

​

 

59

​

 

2,033

 

G

​

 

547

 

​

145

 

B1

​

 

5,431

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Total current assets

​

 

35,856

​

 

189

​

 

128,184

 

​

​

 

4,910

 

​

(678)

 

​

​

 

168,461

Cash held in trust account

​

 

—

​

 

246,395

​

 

(238,404)

 

C

​

 

—

 

​

—

 

​

​

 

—

​

​

​

​

​

​

​

​

 

388

 

D

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

(8,379)

 

E

​

​

​

​

​

​

​

​

​

​

​

Property and equipment – net

​

 

13,673

​

 

—

​

 

—

 

​

​

 

2,449

 

​

4,616

 

B1

​

 

20,738

Goodwill

​

 

3,124

​

 

—

​

 

—

 

​

​

 

8,079

 

​

(6,623)

 

B1

​

 

4,580

Intangible assets – net

​

 

1,436

​

 

—

​

 

—

 

​

​

 

866

 

​

12,434

 

B1

​

 

14,736

Restricted cash and cash equivalents

​

 

56

​

 

—

​

 

—

 

​

​

 

—

 

​

—

 

​

​

 

56

Right-of-use operating lease assets

​

 

64,486

​

 

—

​

 

—

 

​

​

 

2,159

 

​

(42)

 

B1

​

 

66,603

Deposits

​

 

12,982

​

 

—

​

 

—

 

​

​

 

—

 

​

—

 

​

​

 

12,982

Non-marketable equity securities

​

 

—

​

 

—

​

 

—

 

​

​

 

15,000

 

​

(15,000)

 

A1

​

 

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Total assets

​

$

131,613

​

$

246,584

​

$

(118,211)

 

​

​

$

33,463

​

$

(5,293)

 

​

​

$

288,156

Liabilities, ordinary shares subject to possible redemption, and shareholders’ deficit

​

 

  ​

​

 

  ​

​

 

  ​

 

​

​

 

  ​

​

 

  ​

 

​

​

 

  ​

Current Liabilities

​

 

  ​

​

 

  ​

​

 

  ​

 

​

​

 

  ​

​

 

  ​

 

​

​

 

  ​

Accounts payable

​

$

4,300

​

$

—

​

$

—

 

​

​

$

1,550

​

$

200

 

C1

​

$

5,702

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

(348)

 

B1

​

​

​

Current portion of operating lease liabilities

​

 

1,781

​

 

—

​

 

—

 

​

​

 

983

​

 

(3)

 

B1

​

 

2,761

Contract liabilities – deferred revenue

​

 

3,579

​

 

—

​

 

—

 

​

​

 

—

​

 

—

 

​

​

 

3,579

Provision for loss on contract

​

 

151

​

 

—

​

 

—

 

​

​

 

—

​

 

—

 

​

​

 

151

Accrued and other current liabilities

​

 

6,211

​

 

795

​

 

19,095

 

G

​

 

2,198

​

 

771

 

B1

​

 

29,070

PIPE subscription derivative liability

​

 

—

​

 

100,420

​

 

(100,420)

 

A

​

 

—

​

 

—

 

​

​

 

—

Current portion of debt – net of discount

​

 

10,488

​

 

—

​

 

—

 

​

​

 

—

​

 

—

 

​

​

 

10,488

Unfavorable leasehold interest

​

 

—

​

 

—

​

 

—

 

​

​

 

—

​

 

63

 

B1

​

 

63

Current portion of notes payable

​

 

—

​

 

—

​

 

—

 

​

​

 

23

​

 

(23)

 

B1

​

 

—

Embedded derivative liability

​

 

—

​

 

—

​

 

—

 

​

​

 

62,057

​

 

(62,057)

 

A1

​

 

—

Convertible promissory notes, net of discount

​

 

—

​

 

—

​

 

—

 

​

​

 

17,687

​

 

(17,687)

 

A1

​

 

—

Warrant liability

​

 

—

​

 

—

​

 

—

 

​

​

 

2,784

​

 

(2,784)

 

A1

​

 

—

Total current liabilities

​

 

26,510

​

 

101,215

​

 

(81,325)

 

​

​

 

87,282

​

 

(81,868)

 

​

​

 

51,814

Deferred underwriting fee payable

​

 

—

​

 

8,050

​

 

(8,050)

 

F

​

 

—

​

 

—

 

​

​

 

—

Operating lease liabilities

​

 

64,372

​

 

—

​

 

—

 

​

​

 

1,369

​

 

(42)

 

B1

​

 

65,699

Due to Sundew Technologies, LLC

​

 

2,769

​

 

—

​

 

—

 

​

​

 

—

​

 

—

 

​

​

 

2,769

Warrant liabilities

​

 

14,917

​

 

—

​

 

133,260

 

A

​

 

—

​

 

—

 

​

​

 

148,177

Earnout shares liability

​

 

—

​

 

—

​

 

725,802

 

L

​

 

—

​

 

—

 

​

​

 

725,802

Other liabilities

​

 

—

​

 

—

​

 

—

 

​

​

 

73

​

 

(5)

 

B1

​

 

68

Long-term notes payable, net of current portion (HzO)

​

 

—

​

 

—

​

 

—

 

​

​

 

3,010

​

 

(3,010)

 

B1

​

 

—

Total liabilities

​

 

108,568

​

 

109,265

​

 

769,687

 

​

​

 

91,734

​

 

(84,925)

 

​

​

 

994,329

35

Table of Contents

​

​

​

​

​

​

​

​

​

De-Spac

​

​

​

​

​

​

HzO

​

​

​

​

​

​

​

Forge

​

​

​

​

Transaction

​

​

​

​

​

​

Transaction

​

​

​

Pro

​

​

Nano

​

ATII

​

Accounting

​

​

​

​

HzO

​

Accounting

​

​

​

Forma

​

  ​ ​ ​

(Historical)

  ​ ​ ​

(Historical)

  ​ ​ ​

Adjustments

  ​ ​ ​

​

  ​ ​ ​

​

(Historical)

  ​ ​ ​

Adjustments

  ​ ​ ​

​

  ​ ​ ​

Combined

Commitments and contingencies

​

 

  ​

​

 

  ​

​

 

  ​

 

​

​

 

  ​

​

 

  ​

 

​

​

 

  ​

Mezzanine equity

​

 

  ​

​

 

  ​

​

 

  ​

 

​

​

 

  ​

​

 

  ​

 

​

​

 

  ​

Additional paid-in capital

​

 

185,265

​

 

—

​

 

(185,265)

 

H

​

 

—

​

 

—

 

​

​

 

—

Ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of $10.71 per share

​

 

—

​

 

246,395

​

 

388

 

D

​

 

—

​

 

—

 

​

​

 

—

​

​

​

​

​

​

​

​

 

(238,404)

 

C

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

(8,379)

 

J

​

​

​

​

​

​

​

​

​

​

​

Stockholders’ equity (deficit)

​

 

  ​

​

 

  ​

​

 

  ​

 

​

​

 

  ​

​

 

  ​

 

​

​

 

  ​

Ordinary shares, $0.0001 par value; 400,000,000 shares authorized; 6,590,000 shares issued and outstanding (excluding 23,000,000 shares subject to possible redemption)

​

 

—

​

 

1

​

 

—

 

J

​

 

—

​

 

—

 

​

​

 

—

​

​

​

​

​

​

​

​

 

(1)

 

K

​

​

​

​

​

​

​

​

​

​

​

Common stock – $0.0001 par value; 4,850,000 shares authorized and 1,642,597 shares issued and outstanding

​

 

—

​

 

—

​

 

—

 

H

​

 

—

​

 

—

 

—

​

 

—

Convertible preferred stock, $0.001 par value, 49,086,791,753 shares authorized; 28,014,564,020 shares issued and outstanding (HzO)

​

 

—

​

 

—

​

 

—

 

​

​

 

28,015

​

 

(28,015)

 

B1

​

 

—

Common stock, $0.001 par value, 33,588,600,000 shares authorized; 44,824,953 shares issued and outstanding (HzO)

​

 

—

​

 

—

​

 

—

 

​

​

 

45

​

 

(45)

 

B1

​

 

—

Common Stock

​

 

—

​

 

—

​

 

—

 

A

​

 

—

​

 

—

 

​

​

 

13

​

​

​

​

​

​

​

​

 

—

 

B

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

12

 

H

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

1

 

K

​

​

​

​

​

​

​

​

​

​

​

Additional paid-in capital

​

 

11,372

​

 

—

​

 

67,160

 

A

​

 

291,375

​

 

67,528

 

A1

​

 

21,561

​

​

​

​

​

​

​

​

 

23,000

 

B

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

2,822

 

F

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

(11,054)

 

G

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

185,253

 

H

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

(115,085)

 

I

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

8,379

 

J

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

(725,802)

 

L

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

553,955

 

M

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

(337,342)

 

B1

​

​

​

Accumulated deficit

​

 

(173,592)

​

 

(109,077)

​

 

(6,008)

 

G

​

 

(377,987)

​

 

377,987

 

B1

​

 

(727,747)

​

​

​

​

​

​

​

​

 

115,085

 

I

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

(553,955)

 

M

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

(200)

 

C1

​

​

​

Other comprehensive income (HzO)

​

 

—

​

 

—

​

 

—

 

​

​

 

281

​

 

(281)

 

B1

​

 

—

Total stockholders’ equity (deficit)

​

 

(162,220)

​

 

(109,076)

​

 

(456,238)

 

​

​

 

(58,271)

​

 

79,632

 

​

​

 

(706,173)

Total liabilities and stockholders’ equity (deficit)

​

$

131,613

​

$

246,584

​

$

(118,211)

 

​

​

$

33,463

​

$

(5,293)

 

​

​

$

288,156

(1)The Company was incorporated for the sole purpose of effectuating the Business Combination. It does not meet the definition of a business. It has no activities other than transaction costs which are included in the transaction accounting adjustments.

​

36

Table of Contents

​

Adjustments to Unaudited Pro Forma Condensed Combined Balance Sheets

The following Transaction Accounting Adjustments give effect to the Business Combination and the HzO Merger as if each Transaction had occurred on September 30, 2026:

(1)Derived from the unaudited condensed consolidated balance sheet of Forge Nano as of September 30, 2026.
(2)Derived from the unaudited balance sheet of ATII as of September 30, 2026.
(3)Derived from the unaudited balance sheet of HzO as of September 30, 2026.
(A)Reflects the receipt of $100.0 million proceeds from the PIPE Financing. Pursuant to the PIPE Subscription Agreements, the Company sold 2,968,825 shares of Common Stock, Pre-Funded Warrants to purchase an aggregate of 7,031,175 shares of Common Stock, and PIPE Warrants to purchase an aggregate of 15,000,000 shares of Common Stock to the Initial PIPE Investor for an aggregate price of $100,000,000. If, on the 24-month anniversary of the Closing Date, the Initial PIPE Investor certifies in writing that the Initial PIPE Investor beneficially owns 5,000,000 shares of Common Stock, the Company will issue to the Initial PIPE Investor the Additional PIPE Warrants entitling the Initial PIPE Investor to purchase 5,000,000 shares of Common Stock. In the event that on the 21st trading day following the six-month anniversary of the Closing, the VWAP (as defined in the PIPE Warrant Certificate) of the Common Stock is less than the exercise price of the PIPE Warrants then in effect, the Initial PIPE Investor shall receive up to 10,000,000 Reset PIPE Warrants. The Pre-Funded Warrants, PIPE Warrants, Additional PIPE Warrants and Reset PIPE Warrants are precluded from equity classification under ASC 815-40, and management determined it to be classified as a liability, initially measured at fair value and subsequently remeasured through earnings until settlement. The fair value of the warrants is estimated to be $133.3 million.

The warrants were valued using a Monte Carlo simulation. Below are the significant assumptions used in the simulation:

​

​

​

​

​

Equity volatility:

  ​ ​ ​

​

45.0

%

Risk-free rate:

 

​

5.03

%

Term:

 

​

5.0

​

Stock price:

​

$

10.00

​

​

Changes in those assumptions could result in different fair value measurement and therefore could have affected the amounts presented in the pro forma financial information. Because the warrants are accounted for as a liability and remeasured at fair value at each reporting date, changes in assumptions used in the valuation model may result in significant non-cash gains or losses in future periods, which could materially affect the future combined results of operations.

(B)Reflects the receipt of $23.0 million proceeds from the Additional PIPE Financing. Pursuant to the Additional PIPE Subscription Agreements, the Company issued and sold an aggregate of 2,300,000 shares of Common Stock to the Additional PIPE Investors.
(C)Reflects the redemption of 22,219,068 ATII Public Shares for aggregate redemption payments of $238.4 million at a redemption price of approximately $10.73 per share.
(D)Reflects the interest income earned on the cash held in Trust Account subsequent to September 30, 2026.
(E)Reflects the transfer of cash held in the Trust Account to cash.
(F)Reflects the settlement of the deferred underwriting fee payable by cash upon the Closing of the Business Combination.
(G)Represents transaction costs incurred by Forge Nano and ATII of approximately $12.7 million and $8.9 million, respectively. These costs are accounted for as a reduction in the combined cash account with a corresponding reduction in additional paid-in capital or accumulated deficit consistent with the treatment described in SEC Staff Accounting Bulletin Topic 5.A. These transaction costs will not recur in the Company’s income beyond 12 months after the transaction.

37

Table of Contents

​

For the Forge Nano transaction costs, $11.3 million have been accrued. Of this amount, $2.0 million related to the D&O insurance is reflected as an adjustment to prepaid expenses, and the remaining $9.3 million is included as an adjustment to additional paid-in capital.

For the ATII transaction costs, $7.8 million have been accrued. The amount of $1.8 million related to placement fee is reflected as an adjustment to additional paid-in capital. The remaining amount of $6.0 million is reflected as an adjustment to accumulated losses. The ATII estimated transaction costs exclude the deferred underwriting fee included in (F) above.

(H)Represents the issuance of 116,015,828 shares of Common Stock to the existing stockholders of Forge Nano.
(I)Reflects the elimination of ATII’s historical accumulated deficit after recording the transaction costs as described in (G) above.
(J)Reflects the reclassification of 780,932 ordinary shares subject to possible redemption to permanent equity.
(K)Represents the conversion of 7,370,932 ATII Ordinary Shares, par value of $0.0001 per share, into the same number of Common Stock, par value of $0.0001 per share.
(L)Represents the recognition of the Earn-Out Shares liability upon the Closing. The Earn-Out Shares are precluded from equity classification under ASC 815-40, and management determined it to be classified as a liability, initially measured at fair value and subsequently remeasured through earnings until settlement. The fair value of the Earn-Out Shares is estimated to be $725.8 million.

The Earn-Out Shares were valued using a Monte Carlo simulation. Below are the significant assumptions used in the simulation:

​

​

​

​

​

Equity volatility:

  ​ ​ ​

​

45.0

%

Risk-free rate:

 

​

5.03

%

Term:

 

​

5.0

​

Stock price:

​

$

10.00

​

​

Changes in those assumptions could result in different fair value measurement and therefore could have affected the amounts presented in the pro forma financial information. Because the Earn-Out Shares are accounted for as a liability and remeasured at fair value at each reporting date, changes in assumptions used in the valuation model may result in significant non-cash gains or losses in future periods, which could materially affect the future combined results of operations.

(M)Represents the reclassification among equity to avoid negative additional paid-in capital.

(A1) Non-marketable equity security represents shares of Forge Nano which will be converted into shares of Common Stock at the closing of the Business Combination. These shares will be received into treasury and are expected to be cancelled upon the consummation of the HzO acquisition. The convertible notes, along with their associated warrants, will be converted prior to the closing of the transaction and exchanged for Common Stock. Accordingly, these assets and liabilities were excluded from the preliminary analysis.

(B1) Represents the preliminary purchase price allocation for the HzO Merger.

(C1) Represents the accrual for estimated additional non-recurring transaction related costs of $0.2 million, primarily consisting of professional fees, not reflected in the historical financial information and estimated to be incurred subsequent to September 30, 2026.

​

38

Table of Contents

​

UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026(1)

(in thousands, except share and per share data)

​

​

​

​

​

​

​

​

De-Spac

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Transaction

​

​

​

​

​

​

HzO Transaction

​

​

​

​

​

​

​

Forge Nano

​

ATII

​

Accounting

​

​

​

HzO

​

Accounting

​

​

​

Pro Forma

​

​

(Historical)

​

(Historical)

​

Adjustments

​

​

​

(Historical)

​

Adjustments

​

​

​

Combined

Net Sales

  ​ ​ ​

​

  ​

  ​ ​ ​

​

  ​

  ​ ​ ​

​

  ​

  ​ ​ ​

  ​

  ​ ​ ​

​

  ​

  ​ ​ ​

​

  ​

  ​ ​ ​

  ​

  ​ ​ ​

​

  ​

Tool manufacturing and related services

​

$

4,180

​

$

—

​

$

—

 

  ​

​

$

—

​

$

—

 

  ​

​

$

4,180

Coating services

​

 

972

​

 

—

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

972

Battery manufacturing

​

 

915

​

 

—

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

915

Revenue – HZO

​

 

—

​

 

—

​

 

—

 

  ​

​

 

6,812

​

 

—

 

  ​

​

 

6,812

Total Net Sales

​

 

6,067

​

 

—

​

 

—

 

  ​

​

 

6,812

​

 

—

 

  ​

​

 

12,879

Cost of Sales

​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

Tool manufacturing and related services

​

 

6,688

​

 

—

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

6,688

Coating services

​

 

3,921

​

 

—

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

3,921

Battery manufacturing

​

 

494

​

 

—

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

494

Cost of revenue – HzO

​

 

—

​

 

—

​

 

—

 

  ​

​

 

5,992

​

 

—

 

  ​

​

 

5,992

Total Cost of Sales

​

 

11,103

​

 

—

​

 

—

 

  ​

​

 

5,992

​

 

—

 

  ​

​

 

17,095

Gross Profit/Loss

​

 

(5,036)

​

 

—

​

 

—

 

  ​

​

 

820

​

 

—

 

  ​

​

 

(4,216)

Operating Expenses

​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

General and administrative expenses

​

 

31,582

​

 

1,975

​

 

(90)

 

BB

​

 

6,461

​

 

683

 

AA1

​

 

41,658

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

1,047

 

BB1

​

​

​

Sales and marketing

​

 

—

​

 

—

​

 

—

 

  ​

​

 

1,099

​

 

—

 

  ​

​

 

1,099

Research and development

​

 

—

​

 

—

​

 

—

 

  ​

​

 

627

​

 

—

 

  ​

​

 

627

Total Operating Expenses

​

 

31,582

​

 

1,975

​

 

(90)

 

  ​

​

 

8,187

​

 

1,730

 

  ​

​

 

43,384

Operating Loss

​

 

(36,618)

​

 

(1,975)

​

 

90

 

  ​

​

 

(7,367)

​

 

(1,730)

 

  ​

​

 

(47,600)

Other income (expense):

​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

Interest earned on cash in bank account

​

 

—

​

 

22

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

22

Interest earned on cash held in Trust Account

​

 

—

​

 

6,534

​

 

(6,534)

 

AA

​

 

—

​

 

—

 

  ​

​

 

—

PIPE subscription expense

​

 

—

​

 

(100,000)

​

 

100,000

 

CC

​

 

—

​

 

—

 

  ​

​

 

—

Change in fair value of PIPE subscription derivative liability

​

 

—

​

 

(420)

​

 

420

 

CC

​

 

—

​

 

—

 

  ​

​

 

—

Interest income

​

 

401

​

 

—

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

401

Grant income

​

 

2,715

​

 

—

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

2,715

Other income/loss

​

 

208

​

 

—

​

 

—

 

  ​

​

 

(574)

​

 

—

 

  ​

​

 

(366)

Interest expense, change in fair value, and amortization of debt discount

​

 

(11,182)

​

 

—

​

 

—

 

  ​

​

 

(7,862)

​

 

—

 

  ​

​

 

(19,044)

Foreign currency gain

​

 

—

​

 

—

​

 

—

 

  ​

​

 

1,152

​

 

—

 

  ​

​

 

1,152

Embedded derivative loss

​

 

—

​

 

—

​

 

—

 

  ​

​

 

(55,318)

​

 

55,318

 

DD1

​

 

​

Other expense

​

 

(28)

​

 

—

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

(28)

Total other (expense) income, net

​

 

(7,886)

​

 

(93,864)

​

 

93,886

 

  ​

​

 

(62,602)

​

 

55,318

 

  ​

​

 

(15,148)

Loss before provision for income taxes

​

 

(44,504)

​

 

(95,839)

​

 

93,976

 

  ​

​

 

(69,969)

​

 

53,588

 

  ​

​

 

(62,748)

Provision for income taxes

​

 

—

​

 

—

​

 

—

 

  ​

​

 

87

​

 

(87)

 

CC1

​

 

—

Net (loss) income

​

$

(44,504)

​

$

(95,839)

​

$

93,976

 

  ​

​

$

(70,056)

​

$

53,675

 

  ​

​

$

(62,748)

Net Loss Per Share, Basic and Diluted

​

$

(27.85)

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

Basic and diluted net income per share, redeemable ordinary shares

​

 

  ​

​

$

(3.24)

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

Basic net income per share, non-redeemable ordinary shares

​

 

  ​

​

$

(3.24)

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

Diluted net income per share, non-redeemable ordinary shares

​

 

  ​

​

$

(3.24)

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

Pro forma weighted average number of shares outstanding – basic

​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

132,259,251

Pro forma net loss per share – basic

​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

$

(0.47)

Pro forma weighted average number of shares outstanding – diluted

​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

132,259,251

Pro forma net loss per share – diluted

​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

$

(0.47)

(1)The Company was incorporated for the sole purpose of effectuating the Business Combination. It does not meet the definition of a business. It has no activities other than transaction costs which are included in the transaction accounting adjustments.

​

39

Table of Contents

​

Adjustments to Unaudited Pro Forma Condensed Combined Statements of Operations

(1)

Derived from the unaudited condensed consolidated statement of operations of Forge Nano for the nine months ended September 30, 2026.

(2)Derived from the unaudited statement of operations of ATII for the nine months ended September 30, 2026.
(3)Derived from the unaudited statement of operations of HzO for the nine months ended September 30, 2026.

(AA)

Represents an adjustment to eliminate interest earned on cash held in the Trust Account after giving effect to the Business Combination as if it had occurred on January 1, 2025.

(BB)Represents an adjustment to eliminate administrative service fees that will cease at the Business Combination.

(CC)

Represents the elimination of PIPE subscription expense and change in fair value of PIPE subscription derivative liability after giving effect to the Business Combination as if it had occurred on January 1, 2025.

(AA1)

Represents a net increase in depreciation expense on a straight-line basis based on the preliminary step-up in fair value of the property and equipment and the respective assigned estimated useful lives.

(BB1)

Represents the pro forma adjustment to record amortization expense based on the preliminary fair value of identified intangible assets.

(CC1)Reflects an adjustment to eliminate historical income tax expense related to HzO.

(DD1)

Reflects an adjustment to eliminate historical embedded derivative loss related to HzO.

​

40

Table of Contents

​

UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

FOR THE YEAR ENDED DECEMBER 31, 2025(1)

(in thousands, except share and per share data)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

De-Spac

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Transaction

​

​

​

​

​

​

HzO Transaction

​

​

​

​

​

​

​

Forge Nano

​

ATII

​

Accounting

​

​

​

HzO

​

Accounting

​

​

​

Pro Forma

​

  ​ ​ ​

(Historical)

  ​ ​ ​

(Historical)

  ​ ​ ​

Adjustments

  ​ ​ ​

​

  ​ ​ ​

(Historical)

  ​ ​ ​

Adjustments

  ​ ​ ​

​

  ​ ​ ​

Combined

Net Sales

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Tool manufacturing and related services

​

$

4,625

​

$

—

​

$

—

 

  ​

​

$

—

​

$

—

 

  ​

​

$

4,625

Coating services

​

 

1,429

​

 

—

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

1,429

Battery manufacturing

​

 

1,334

​

 

—

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

1,334

Revenue – HzO

​

 

—

​

 

—

​

 

—

 

  ​

​

 

4,842

​

 

—

 

  ​

​

 

4,842

Total Net Sales

​

 

7,388

​

 

—

​

 

—

 

  ​

​

 

4,842

​

 

—

 

  ​

​

 

12,230

Cost of Sales

​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

Tool manufacturing and related services

​

 

6,239

​

 

—

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

6,239

Coating services

​

 

3,921

​

 

—

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

3,921

Battery manufacturing

​

 

1,085

​

 

—

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

1,085

Cost of revenue – HzO

​

 

—

​

 

—

​

 

—

 

  ​

​

 

6,379

​

 

—

 

  ​

​

 

6,379

Total Cost of Sales

​

 

11,245

​

 

—

​

 

—

 

  ​

​

 

6,379

​

 

—

 

  ​

​

 

17,624

Gross Loss

​

 

(3,857)

​

 

—

​

 

—

 

  ​

​

 

(1,537)

​

 

—

 

  ​

​

 

(5,394)

Operating Expenses

​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

General and administrative expenses

​

 

40,788

​

 

786

​

 

6,008

 

CC

​

 

8,706

​

 

152

 

AA1

​

 

57,928

​

​

​

​

​

​

​

​

 

(107)

 

BB

​

​

​

​

 

1,395

 

BB1

​

 

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

200

 

DD1

​

 

—

Sales and marketing

​

 

—

​

 

—

​

 

—

 

  ​

​

 

2,023

​

 

—

 

  ​

​

 

2,023

Research and development

​

 

—

​

 

—

​

 

—

 

  ​

​

 

1,007

​

 

—

 

  ​

​

 

1,007

Total Operating Expenses

​

 

40,788

​

 

786

​

 

5,901

 

  ​

​

 

11,736

​

 

1,747

 

  ​

​

 

60,958

Operating Loss

​

 

(44,645)

​

 

(786)

​

 

(5,901)

 

  ​

​

 

(13,273)

​

 

(1,747)

 

  ​

​

 

(66,352)

Other income (expense):

​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

Interest earned on cash in bank account

​

 

—

​

 

62

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

62

Interest earned on cash held in Trust Account

​

 

—

​

 

8,711

​

 

(8,711)

 

AA

​

 

—

​

 

—

 

  ​

​

 

—

Interest income

​

 

637

​

 

—

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

637

Grant income

​

 

7,062

​

 

—

​

 

—

 

  ​

​

 

—

​

 

—

 

  ​

​

 

7,062

Other income (expense)

​

 

865

​

 

—

​

 

—

 

  ​

​

 

(3,502)

​

 

—

 

  ​

​

 

(2,637)

Interest expense, change in fair value, and amortization of debt discount

​

 

(6,515)

​

 

—

​

 

—

 

  ​

​

 

(438)

​

 

—

 

  ​

​

 

(6,953)

Foreign currency gain

​

 

—

​

 

—

​

 

—

 

  ​

​

 

1,344

​

 

—

 

  ​

​

 

1,344

Other expense

​

 

(578)

​

 

—

​

 

—

 

  ​

​

 

  ​

​

 

—

 

  ​

​

 

(578)

Total other (expense) income, net

​

 

1,471

​

 

8,773

​

 

(8,711)

 

  ​

​

 

(2,596)

​

 

—

 

  ​

​

 

(1,063)

Loss before provision for income taxes

​

 

(43,174)

​

 

7,987

​

 

(14,612)

 

  ​

​

 

(15,869)

​

 

(1,747)

 

  ​

​

 

(67,415)

Provision for income taxes

​

 

—

​

 

—

​

 

—

 

  ​

​

 

(240)

​

 

240

 

CC1

​

 

—

​

​

 

—

​

 

—

​

 

—

​

​

​

 

—

​

 

—

​

​

​

 

—

Net (loss) income

​

$

(43,174)

​

$

7,987

​

$

(14,612)

 

  ​

​

$

(15,629)

​

$

(1,987)

 

  ​

​

$

(67,415)

Net Loss Per Share, Basic and Diluted

​

$

(27.94)

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

Basic and diluted net income per share, redeemable ordinary shares

​

 

  ​

​

$

0.30

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

Basic net income per share, non-redeemable ordinary shares

​

 

  ​

​

$

0.30

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

Diluted net income per share, non-redeemable ordinary shares

​

 

  ​

​

$

0.30

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

Pro forma weighted average number of shares outstanding – basic

​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

132,259,251

Pro forma net loss per share – basic

​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

$

(0.51)

Pro forma weighted average number of shares outstanding – diluted

​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

132,259,251

Pro forma net loss per share – diluted

​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

 

  ​

​

 

  ​

 

  ​

​

$

(0.51)

(1)The Company was incorporated for the sole purpose of effectuating the Business Combination. It does not meet the definition of a business. It has no activities other than transaction costs which are included in the transaction accounting adjustments.

​

41

Table of Contents

​

Adjustments to Unaudited Pro Forma Condensed Combined Statements of Operations

(1)Derived from the audited consolidated statement of operations of Forge Nano for the year ended December 31, 2025.
(2)Derived from the audited statement of operations of ATII for the year ended December 31, 2025.
(3)Derived from the audited statement of operations of HzO for the year ended December 31, 2025.

(AA)

Represents an adjustment to eliminate interest earned on cash held in the Trust Account after giving effect to the Business Combination as if it had occurred on January 1, 2025.

(BB)

Represents an adjustment to eliminate administrative service fees that will cease at the Business Combination.

(CC)

Represents the effect of the pro forma balance sheet adjustment presented in (G) above in the aggregate amount of $6.0 million for the direct, incremental costs of the Business Combination incurred by ATII. As these costs are directly related to the Business Combination, they are not expected to recur in the income of the Company beyond 12 months after the Business Combination.

(AA1)

Represents a net increase in depreciation expense on a straight-line basis based on the preliminary step-up in fair value of the property and equipment and the respective assigned estimated useful lives.

(BB1)

Represents the pro forma adjustment to record amortization expense based on the preliminary fair value of identified intangible assets.

(CC1)

Reflects an adjustment to eliminate historical income tax expense related to HzO.

(DD1)

Represents the accrual for estimated additional non-recurring transaction related costs of $0.2 million, primarily consisting of professional fees, not reflected in the historical financial information and estimated to be incurred subsequent to September 30, 2026.

(EE1)

Reflects an adjustment to eliminate historical embedded derivative loss related to HzO.

​

​

42

Table of Contents

​

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

Note 1.    Description of the Transactions

The Business Combination and the HzO Merger are described under “Description of the Business Combination” and “Description of the HzO Merger” above. Those descriptions are incorporated into this note by reference. The Transaction Accounting Adjustments related to the Business Combination and the HzO Merger are presented separately in Notes 3 and 4, respectively.

Note 2.    Basis of Presentation

The unaudited pro forma condensed combined balance sheet as of September 30, 2026 gives effect to the Business Combination and the HzO Merger as if each transaction had occurred on September 30, 2026. The unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2026 and the year ended December 31, 2025 give effect to the Transactions as if each transaction had occurred on January 1, 2025.

The unaudited pro forma condensed combined financial information has been prepared using, and should be read together with, the following historical financial statements of Forge Nano, ATII and HzO and related notes:

●the unaudited financial statements as of and for the nine months ended September 30, 2026; and
●audited financial statements for the year ended December 31, 2025.

The historical financial information has been adjusted to give effect to Transaction Accounting Adjustments that reflect the accounting for the Transactions in accordance with U.S. GAAP, including adjustments that are not expected to have a continuing impact. The Transaction Accounting Adjustments related to the Business Combination and the HzO Merger are presented separately in the accompanying unaudited pro forma condensed combined financial information to provide readers with visibility into the effects of each Transaction.

The Transaction Accounting Adjustments are based on currently available information and assumptions that management believes are reasonable under the circumstances. The adjustments related to the HzO Merger are preliminary and may be revised as additional information becomes available, including upon completion of the related valuation analyses and purchase price allocation. Accordingly, the final amounts recorded in connection with the HzO Merger may differ materially from the amounts reflected in the unaudited pro forma condensed combined financial information.

Following the Business Combination, management completed a comprehensive review of the accounting policies of Forge Nano and ATII and a preliminary review of HzO’s accounting policies to determine whether adjustments are necessary to conform ATII and HzO’s accounting policies to those of the Company. Based on the information currently available, management has not identified any material differences in accounting policies requiring pro forma adjustment.

Forge Nano and ATII did not have any historical relationship prior to the Business Combination; accordingly, no pro forma adjustments were required to eliminate transactions between them. The preexisting relationship between Forge Nano and HzO arising from Forge Nano’s loan to HzO is addressed in Note 3.

The unaudited pro forma condensed combined financial information is for illustrative purposes only. It does not necessarily indicate what the Company’s financial position or results of operations would have been had the Transactions occurred on the dates indicated. It also does not project the Company’s future financial position or results of operations. The Company has elected not to present Management’s Adjustments and is presenting only Transaction Accounting Adjustments. Accordingly, the unaudited pro forma condensed combined financial information does not reflect anticipated synergies, operating efficiencies, revenue enhancements, cost savings or related costs to achieve such benefits, except to the extent such amounts qualify as Transaction Accounting Adjustments under Article 11 of Regulation S-X.

43

Table of Contents

​

Note 3.    Purchase Price Consideration and Purchase Price Allocation for the HzO Merger

Purchase Price Consideration

The estimated preliminary purchase price consideration transferred or estimated to be transferred for the HzO Merger is approximately $21.6 million. The following table summarizes the components of the preliminary purchase price consideration reflected in the unaudited pro forma condensed combined financial information (HzO Merger):

​

​

​

​

(in thousands)

  ​ ​ ​

​

  ​

Purchase Price Consideration

 

​

  ​

Base purchase price

​

$

55,000

Plus: closing cash

​

 

1,033

Plus: working capital overage

​

 

1,846

Less: closing debt

​

 

(228)

Less: seller acquisition costs

​

 

(664)

Less: deemed loan payoff amount

​

 

(3,008)

Less: TIP consideration adjustment amount

​

 

(2,454)

Less: Stockholders representative expense

​

 

(150)

​

​

 

51,375

Plus: preexisting relationship related to Forge Nano debt

​

 

3,000

Plus: paid seller expenses

​

 

73

Total contractual consideration at $10.00 per share

​

$

54,448

Less: fair value adjustment to measure Common Stock at approximately $3.96 per share

​

 

(32,887)

Total fair value of purchase consideration

​

$

21,561

​

The table above begins with the contractual consideration of $54.4 million, which is based on a price of $10.00 per share, and adjusts it to the fair value of the Common Stock issued, measured at approximately $3.96 per share.

Preliminary Allocation of Purchase Price Consideration to Assets Acquired and Liabilities Assumed

The fair values of the assets and liabilities in the unaudited pro forma condensed combined financial information (HzO Merger) are based upon a preliminary assessment of fair value and may change when the final valuation of assets acquired, and liabilities assumed has been prepared, as well as working capital settlements are made. Valuation assessments of specifically identifiable tangible and intangible assets, including the determination of their economic useful lives, have been performed based on currently available information and assumptions as of the closing date; however, these assessments remain preliminary and subject to change during the measurement period.

Forge Nano expects to finalize the purchase price allocation as soon as practicable, but no later than one year from the closing date. As such, the purchase price allocation may change. There can be no assurance that such revisions will not result in material changes.

44

Table of Contents

​

The preliminary allocation of the purchase price consideration is as follows:

​

​

​

​

(in thousands)

  ​ ​ ​

​

  ​

Cash and cash equivalents

​

$

1,425

Accounts receivable – net of allowance for credit losses

​

 

1,379

Inventory

​

 

736

Prepaid expenses and other current assets

​

 

692

Total current assets

​

 

4,232

Property and equipment

​

 

7,065

Intangible assets

​

 

13,300

Right-of-use operating lease assets

​

 

2,117

Total assets acquired

​

$

26,714

Accounts payable

​

$

1,202

Current portion of operating lease liabilities

​

 

980

Accrued and other current liabilities

​

 

2,969

Unfavorable leasehold interest

​

 

63

Total current liabilities

​

 

5,214

Operating lease liabilities

​

 

1,327

Other liabilities

​

 

68

Total liabilities assumed

​

$

6,609

Net identifiable assets acquired

​

$

20,105

Goodwill

​

 

1,456

Total consideration to be transferred

​

$

21,561

​

​

Note 4.    Income Taxes and Net Loss per Share

The unaudited pro forma combined statements of operations do not reflect a provision for income taxes or any amounts that would have resulted had the Company filed consolidated income tax returns during the periods presented. The unaudited pro forma condensed combined balance sheet does not reflect the deferred taxes of the Company as a result of the Business Combination. Since it is likely that the Company will record a valuation allowance against the total U.S. and state deferred tax assets given the net operating losses as the recoverability of the tax assets is uncertain, the tax provision is zero. HzO’s historical income tax expense has been eliminated (see adjustment (CC1)).

45

Table of Contents

​

The pro forma basic and diluted net loss per share amounts presented in the unaudited pro forma condensed combined statements of operations are based upon the number of shares of the Company’s and HzO’s Common Stock outstanding, assuming the Business Combination occurred on January 1, 2025.

​

​

​

​

​

  ​ ​ ​

As of September 30,

(in thousands, except share and per share data)

​

2026

Net loss

​

$

(62,748)

Stockholders’ deficit

​

 

(706,173)

Weighted average shares outstanding of common stock(1)

​

 

132,259,251

Net loss per common share, basic and diluted

​

$

(0.47)

Book deficit per share

​

$

(5.34)

The weighted average shares outstanding of Common Stock consists of the 128,655,585 shares outstanding immediately following the Business Combination, plus the 5,772,645 shares issued at the closing of the HzO Merger, less the 2,168,979 shares of Common Stock held by HzO before closing that are expected to be cancelled. 1,533,795 Holdback Shares are excluded from the weighted average shares.

(1)For the purposes of calculating diluted earnings per share, all (i) the 11,500,000 shares of Common Stock underlying the SPAC Warrants that were originally issued as ATII Public Warrants as part of the ATII Public Units in the IPO, (ii) the 420,000 shares of Common Stock underlying the SPAC Warrants that were originally issued as ATII Private Warrants as part of the ATII Private Units issued in a private placement that closed simultaneously with the closing of the IPO, (iii) the 7,031,175 shares of Common Stock underlying the Pre-Funded Warrants, (iv) the 15,000,000 shares of Common Stock underlying the PIPE Warrants, (v) the 10,000,000 shares of Common Stock underlying the Reset PIPE Warrants, (vi) the 5,000,000 shares of Common Stock underlying the Additional PIPE Warrants, (vii) the 421,792 shares of Common Stock underlying the Forge Nano Warrants, (viii) the 3,562,305 shares of Common Stock underlying the Ascent Warrants, (ix) the 11,959,924 shares of Common Stock underlying the Options, (x) the 8,744,864 shares of Common Stock underlying the PSUs, or (xi) the 90,000,000 Earn-Out Shares, should have been assumed to have been exercised or issued. However, since this results in anti-dilution, the effect of such exercise or issuance was not included in calculation of diluted earnings per share.

​

46

Table of Contents

​

BUSINESS

Our Mission

Forge Nano’s mission is to apply its unique atomic layer deposition (“ALD”) solutions to advanced materials to foster more efficient, better performing and safer products. Our scalable, adaptable technology platforms Atomic Armor for powders and ALDx for semiconductor manufacturing, strengthen the systems powering modern life, from energy and defense to advanced technologies and advanced materials.

Company Overview

Founded in 2011, Forge Nano is a leading innovator in ALD, a process that provides perfectly conformal, atom-thin coatings on surfaces, wafers and powders. Invented in the 1960s, ALD is a well-understood coating solution. However, attempts to apply ALD to commercial products have largely failed, as the process has historically been too slow and inefficient to be of general utility outside of the semiconductor manufacturing industry. Despite these shortcomings, ALD continues to be employed in semiconductor manufacturing as chip sizes have diminished to the atomic scale.

In the semiconductor space, with our unique wafer tools, Forge Nano applies our ALDx technology to solve scale, speed and efficiency problems, making it a superior coating solution compared to chemical vapor deposition (“CVD”), physical vapor deposition (“PVD”) or any other thin-film coating technology used in semiconductor manufacturing. Our tools produce passivation layers for 3D devices, high-K dielectrics, and conformal films for emerging sensors and power devices, helping to improve efficiency and overcome limitations in traditional manufacturing. Forge Nano’s tools, which, according to our calculations and available data, run at approximately 10 times the speed yet consume a fraction of the costly precursor use of our competitors’ ALD tools, can improve manufacturing yields by delivering higher fidelity of coatings, thus lowering manufacturing costs. Products sold in the semiconductor space include both our commercial research-scale wafer tools, Tephra, and research-scale Theia tools. Our clients include secured defense contractors and commercial and university labs, and we have a rapidly expanding pipeline.

In the battery cell industry, we believe we have also developed the world’s fastest and most efficient approach to creating ALD coatings on powders on a commercial scale with our Atomic Armor technology. While we have applied Atomic Armor ALD coatings to products as varied as pharmaceuticals, three-dimensional (“3D”) printing material and rocket fuel, Forge Nano has been focused on lithium-ion (“Li-ion”) batteries for nearly 15 years. These conformal, ultra-thin coatings fundamentally change a material’s surface properties without altering its core structure, unlocking enhanced performance and novel functionalities for a wide range of applications. We have fully commercialized our research-scale tools, Pandora and Prometheus, and our commercial-scale tools, Lithos and Circe.

By applying our patented ALD coatings to battery anode and cathode powders (the main components of every Li-ion battery), we mitigate the degradation usually encountered in the charging and discharging process while reducing or eliminating the side reactions within the batteries that can produce a thermal runaway. Our Atomic Armor protective coating delivers superior performance by allowing higher operating voltages, which can increase the battery’s overall capacity and energy density by as much as 20% while extending cycle life and reducing gas generation. Applying ALD coatings can significantly reduce or even eliminate the need for costly electrolyte additives, helping reduce the overall manufacturing cost of the battery cell itself. Forge Nano manufactures and sells ALD-enhanced battery cells for a wide array of clients in aerospace, defense, mobility and other non-EV applications.

Forge Nano’s headquarters and manufacturing facility is in Thornton, CO. This 70,605 square foot leased facility is home to our prototype manufacturing battery line, a 4,000 square foot dry room launched in 2025 with capacity for one MWh of batteries annually. It also houses our 2,000 square foot cleanroom where our commercial semiconductor tools are manufactured and tested before deployment. The site also features 25,000 square feet of floor space hosting a wide array of research and commercial-scale equipment we use to conduct coating services for clients and for internal development. We believe it is the world’s largest ALD-focused facility in terms of material coating capacity.

Forge Nano formed its Forge Battery subsidiary in 2023. In August 2026, Forge Battery broke ground on a manufacturing facility in Morrisville, NC featuring ALD-coated 21700 cells, suitable for use in the production of mission-ready battery packs. Forge Battery is developing what we believe will be the first fully U.S.-sourced and manufactured battery available at gigawatt scale, for aerospace, defense, specialty mobility, unmanned airborne vehicles (“UAVs”), data centers and other applications. We anticipate Forge Battery ramping up for commercial offtake in the next few years.

47

Table of Contents

​

Through selling tools and ALD-coating services, Forge Nano has developed strategic relationships among and received substantial investment from auto-, material-, manufacturing-, mining- and defense-focused companies.

Our technology is backed by investments in intellectual property (“IP”), with over 200 owned or in-licensed patents and pending or to-be-filed patent applications spanning multiple aspects of ALD application from Li-ion and solid-state batteries to work in additive manufacturing, passive components, pharmaceutical and energetic (explosive/propellant) materials. Our patent estate has been strategically designed to cover materials, processes and equipment, devices (batteries) and application levels, making it difficult for a competitor to do large-scale ALD coating on battery and other critical particles without licensing or designing around Forge Nano intellectual property.

On November 4, 2026, we completed the HzO Merger. In connection with the HzO Acquisition, we issued 5,772,645 shares of Common Stock with an additional 1,533,795 Holdback Shares to be held back for twelve months to secure post closing adjustment and indemnification obligations. Upon completion of the HzO Merger assuming the full issuance of the Holdback Shares, HzO stockholders would own 7,306,440 shares of Common Stock.

Market Opportunity

Semiconductor Tools

Semiconductor fabricators plan to invest more than $1 trillion in new facilities by 2030 according to McKinsey, by which time the chip market size is expected to be more than $330 billion per year and growing. Much of this growth is expected to be driven by the market for chips to be used in Artificial Intelligence (“AI”) data centers.

We believe Forge Nano’s revolutionary Tephra semiconductor tool not only performs better than the ALD products of its competitors, but is also able to unlock 3D chip manufacturing with its ability to produce conformal coatings at aspect ratios of 1,000:1 in through-silicon and through-glass vias where we believe its competitors can only reach 10:1. These chips are expected to reduce energy consumption and corresponding heat generation by up to 50x. Forge Nano currently has internal tools that we believe work at scales appropriate for realizing this opportunity.

We believe our current tools can supplant existing ALD tools in existing and new semiconductor fabrications, and their speed and efficiency make them ideal to displace the relatively fast but inefficient CVD and PVD tools, which expands their addressable market.

Battery Cells

Forge Nano’s battery opportunity lies in its ability to produce batteries featuring ALD-enhanced superior performance domestically and with a U.S.-supply chain, making them of particular interest to defense contractors and other customers that require enhanced performance. Recently issued restrictions on purchases of foreign batteries for military applications are expected to remain in place for the near future. Many non-defense customers have a similar interest in securing battery supply from non-foreign entities of concern (“FEOCs”). We believe Forge Battery will be the sole manufacturer qualifying as a fully Department of Defense / War (“DOD” or “DOW”)-suitable producer at the time its facility is operational.

As part of Forge Battery’s efforts to reduce execution risk, it has signed agreements with Samsung SDI to purchase Samsung SDI’s equipment for a 3 GWh production line, to secure their expertise to install and commission that equipment to operate at 90% overall equipment effectiveness, and to receive substantial investment and take-or-pay offtake agreements. The agreements also give Forge Battery the opportunity to purchase primary materials at Samsung SDI’s scale pricing, helping to bring down bill-of-materials costs.

In addition to the above advantages, Forge Nano’s commercial-scale ALD coatings for powder materials do not substantially increase the cost of a battery and can leverage any existing supply chain. To the contrary, some aspects of the standard battery manufacturing process may become much more efficient with coated materials, potentially dropping the cost.

48

Table of Contents

​

Other

Beyond semiconductor tools and Li-ion batteries, we seek to exploit coating formulations we have already developed for time-release pharmaceuticals, additive manufacturing of metal alloys, magnetics, and other high-value advanced material markets where Forge Nano’s unique ability to coat powders can unlock superior products.

Strategy

Semiconductor — Current

While ALD tools have been used in semiconductor manufacturing processes for decades, use of ALD tools has historically resulted in inefficient manufacturing bottlenecks. Legacy ALD tools traditionally achieve precision through operating slowly and using a great deal of expensive precursor material to produce the conformal coatings required by increasingly small chips. Forge Nano’s solution to this (see “Technology”) addresses these problems with what we believe to be the world’s fastest and most efficient tools, which we believe can coat at aspect ratios far beyond its competitors through its use of its unique turbulent-flow technology.

Entering this market requires taking on well-established, well-capitalized competitors with extensive experience serving equally established customers. Forge Nano is simply too new to the market to approach the largest manufacturers of the traditional semiconductor market with this disruptive tool, regardless of its efficiency.

The first phase of Forge Nano’s commercial development for its semiconductor tool business is in progress with its focus on its 200mm wafer commercial semiconductor manufacturing tool “Tephra,” firmly directed at the edge AI/more-than-Moore applications (sensing, power management, connectivity and related activities). This market segment produces chips used for micro-electro-mechanical systems, power, RF (radio frequency for devices designed to generate, amplify, process, transmit or receive high-frequency electrical signals used in wireless systems), photonics, image sensors and more. These newer, high-growth segments offer fewer barriers to entry and more opportunities to establish defensible beachheads. In contrast to the 300mm market for memory and logic chips, it features a greater number of potential clients seeking efficiencies in production and improvements in yield.

This market segment also includes defense contractors, that are reshoring their manufacturing capabilities and require U.S.-made equipment and materials. Forge Nano’s prior-generation tools have been operating in the field for more than 10 years with some of these clients, but demand for our Tephra tool indicates substantial opportunities.

Along with our effort to deploy more tools into the 200mm space, we are expanding service teams to maintain these tools in the field. This will fulfill two requirements of our next phase: earning a reputation for quality tools and superior support and gathering the data required to harden these and the next iterations of these tools to a variety of field conditions and applications.

Semiconductor — Future

In its next phase of commercial development, Forge Nano expects to develop the facilities necessary to expand past the Thornton, CO cleanroom where it can build a maximum of approximately $30 million in tools per year. Since tool manufacturing is largely a function of commercially available components and applied Forge Nano intellectual property, capital required for expansion is largely used to build or acquire cleanroom space, purchase inventory and train technicians. Ideally, we will expand capacity at a rate slightly higher than our addressable sales pipeline.

The final phase in commercial development will be to develop 300mm tools to approach the designers and fabs behind memory and logic. We expect that this process can begin once appropriate resources are allocated to design, development and testing, which we do not expect to cost more than $5 to $10 million given the work Forge Nano has already invested in development.

With a viable and hardened 300mm tool, we will be better positioned to address the more consolidated market of mass-scale chip manufacturers both in the United States and internationally. As AI competition increases, we believe that differentiation in hardware will have a much greater impact for the leading companies than the software going into its AI development. Developing large language models (“LLMs”) no longer presents large barriers to entry for the AI market, as demonstrated by DeepSeek’s use of open source software resulting in training costs estimated to be less than $10 million (relative to OpenAI’s ChatGPT-4 in 2023 costs of approximately $100 million). In contrast to the falling cost of software, the challenge is to deploy hardware that can use increasingly expensive power more efficiently than what is currently available. According to a recent Goldman Sachs analyst report, “As AI

49

Table of Contents

​

demands massive power, reliable and ample power supply is likely to be a key factor shaping the AI race, especially because power infrastructure bottlenecks can be slow to solve.” Forge Nano’s ALDx solution unlocks the ability to make much more efficient chips and can be included in an increasing number of manufacturing steps, which is expected to capture substantial demand.

Battery Cell Production — Current

Forge Nano decided to apply its commercial-scale powder ALD technology first to Li-ion batteries because we felt electrification is an inevitable shift in global power systems. We also believe that the strategic imperative to bring energy storage manufacturing back to the West — especially to the United States — has never been more acute. U.S. defense experts agree with this assessment, but competing directly with China has proven difficult for many industries including batteries.

Equally difficult is making inroads to existing battery manufacturing operations with innovative technology, even if it produces vastly superior products. Once a battery factory at gigawatt scale is operational, a difficult and expensive achievement, manufacturers are extremely reluctant to disrupt workflows and formulations to incorporate new technologies. This is true even for battery manufacturers who are investors in Forge Nano.

Our approach to these difficulties is to focus on the most salient aspects of our batteries, high performance and national origin, in markets that require both aspects to be successful among clients that are willing to pay a higher price for a premium product.

We concluded that our target markets should first be those outside electric vehicle (“EV”) applications and large-scale energy-storage systems (“ESS”). Factories producing batteries for EV applications and large-scale ESS require substantial scale, are capital-intensive, are able to capture substantial economies of scale to meet cost requirements and can withstand several years of losses as their products are tested and certified for deployment. These requirements are beyond the capabilities of emerging companies. Recent experience suggests meeting these requirements successfully can be a difficult task for well-funded large-scale producers as well, as demonstrated by the Northvolt AB bankruptcy filing in March 2025.

This leaves a substantial domestic market of demand from specialty vehicles, aerospace, DOD, Department of Energy (“DOE”), small-scale ESS, clean-energy storage and other potential customers. The DOD spent approximately $250 million on batteries in fiscal year 2024. The United States also moved to ban battery purchases from China for U.S. military applications in the 2024 National Defense Authorization Act (“NDAA”), a ban that extends to suppliers of other military products in 2028.

Forge Nano encountered difficulties convincing battery manufacturers to incorporate Forge Nano’s coating technology into existing battery plants. Once they bring factories to an operational status, battery manufacturers are reluctant to halt production and potentially jeopardize revenue generation by incorporating technology they have not seen implemented successfully elsewhere. Therefore, we concluded manufacturing our own batteries was the most expedient method to prove the technology is viable at scale and can be profitable. We are thus pursuing three avenues: small-scale prototype manufacturing at our Thornton facility, third-party manufacturing and the construction of our Forge Battery 3 GWh facility in Morrisville, NC.

Having developed partnerships with five small-scale manufacturers (producing 1 to 5 million cells annually), Forge has already produced cells for deployment on a series of low-earth satellites and other applications. With our current partners now fully conditioned to produce 21700 and 18650 products (formats in wide use both inside and outside of defense and aerospace), we expect to be able to serve more offtake in future years.

In addition to serving current offtake, these partnerships allow us to place samples of Forge Nano batteries in the hands of those who require high-performance, U.S.-made batteries. This enhances the work being done at our own 1 MWh prototype battery manufacturing line in Thornton, CO to also provide samples to prospective clients.

50

Table of Contents

​

Battery Cell Production — Future

Under development since 2023, Forge Battery’s estimated $300 to $330 million (including contingency) factory has garnered the support of the DOE in the form of a $100 million grant for construction and equipment, which will be paired with an estimated $200 to $230 million of equity and debt financing. The financing remains subject to market and other customary conditions. These estimates are inherently uncertain, depend on numerous assumptions and contract terms that may not be finalized, and actual costs could be materially higher due to, among other things, design changes, schedule delays, supply chain constraints, weather, regulatory requirements, contract performance and decisions to increase the scale, capacity or capabilities of the facility beyond current plans. This grant was upheld in the 2025 review process placed upon all DOE grant recipients under the BIL, and we are using funds received under this grant as cost reimbursements for the development of our new site.

The plant is expected to focus on producing a single 21700 form factor utilizing ALD-coated battery materials to produce between 140 million to 150 million cells annually once fully operational. We expect production to begin in 2028. We have partnered with a leading Korean equipment manufacturer and integrator.

As the market examines how Forge Nano batteries perform at scale, and begins to appreciate how coating battery components can enhance performance regardless of specific chemistries or formats, we expect to shift the focus of our battery efforts away from highly capital-intensive factories and toward our capabilities in producing coatings for materials at commercial-scale. Our approach to the battery market will accrue to our wider efforts in advanced materials, where Forge Nano has potential to become the definitive source of ALD-coating suitable to batteries and other advanced products.

Pursue Strategic Acquisitions

Forge Nano has successfully completed two acquisitions in the past six years and, on November 4, 2026, we completed our acquisition of HzO, a services provider specializing in parylene coatings applied to electronic components with operations in the United States, Mexico and Asia. Forge Nano expects to accelerate its business acquisition strategy following the Business Combination in three primary areas of focus: production capacity, technology enhancement and territorial expansion.

Technology

Semiconductor Background

The semiconductor manufacturing process consists of a series of interdependent fabrication stages, including front-end transistor formation, middle-of-line contact construction, back-end interconnect build-out, advanced memory fabrication, lithographic patterning, and final packaging and assembly. Across these stages, semiconductor manufacturers employ several thin-film deposition technologies — most notably ALD, CVD, and PVD — each of which provides distinct technical attributes and is applied according to the performance, geometry and material requirements of specific process steps.

●Front-end transistor formation:    In front-end processing, where transistor structures and other active components are defined, ALD is traditionally used for applications that require highly controlled and conformal ultra-thin films. These applications include the deposition of high-K gate dielectric materials, work-function metals and spacer layers used in advanced transistor geometries. CVD is extensively used for forming bulk dielectric layers, including silicon dioxide and silicon nitride, as well as for epitaxial silicon growth. PVD remains in use for certain metal layers within the gate stack where directional deposition is feasible and conformality is not a primary requirement.
●Middle-of-line contact construction:    During middle-of-line processing, which establishes the electrical interface between the transistor and the initial interconnect layer, ALD is commonly employed to deposit conformal barrier and liner materials in increasingly narrow contact features. CVD processes are used primarily for large-volume metal deposition, such as tungsten or cobalt fill operations. PVD is used for selected metal layers where step coverage limitations are acceptable due to feature geometry.

51

Table of Contents

​

●Back-end of interconnect build-out:    Back-end of line processing creates the multi-layer interconnect networks necessary for power distribution and signal routing. In this phase, manufacturers use all three deposition technologies depending on the requirements of each layer. ALD is increasingly relied upon for ultra-thin diffusion barriers and nucleation layers for copper, cobalt or ruthenium metallization, particularly in high-aspect-ratio structures. CVD remains the predominant method for interlayer dielectric deposition, including low-K materials, and for forming etch-stop and hardmask films. PVD is widely applied for metal seed and liner layers and for certain hardmask materials where conformal deposition is not required.
●Advanced memory fabrication:    In memory manufacturing, including both 3D NAND flash memory architecture and dynamic random access memory (“DRAM”), ALD is used extensively due to its ability to produce uniform coatings in deep, narrow or otherwise high-aspect-ratio features. ALD is the principal method for the deposition of high-K dielectric materials in DRAM capacitors and for oxide and nitride layers integral to 3D NAND structures. CVD is used for certain oxide and nitride films in memory stacks, while PVD has a more limited role due to conformality constraints.
●Lithographic patterning:    Advanced lithography and patterning technologies require precise thin-film deposition for spacer formation, hardmask layers and protective coatings. ALD is a critical element of spacer-based patterning approaches used for line-width and pitch control at advanced technology nodes. CVD is widely applied for antireflective coatings and hardmask films, whereas PVD is used in selected lithography tool components and mask structures where directional metal deposition is required.
●Final packaging and assembly:    In packaging, assembly and heterogeneous integration processes, ALD, CVD and PVD each support various metallization, barrier and dielectric requirements. ALD is applied where conformal barrier layers are necessary, CVD is used for bulk dielectric layers, and PVD is used for redistribution lines, metal pads and other features that do not require conformal coverage.

Across the manufacturing lifecycle, ALD is utilized where precise thickness control and conformal coating are essential and where high aspect ratio and non-line of sight applications are required. CVD is employed where higher-volume dielectric or bulk material deposition is required, and PVD is used where metallic films can be deposited directionally without compromising electrical or structural performance. These deposition techniques collectively support the fabrication of advanced semiconductor devices and enable the continued scaling of integrated circuit architectures.

Semiconductor — Forge Nano ALD

Forge Nano’s breakthrough thermal atomic layer deposition ALD solution for metal barrier/seed applications on high aspect ratio (“HAR”) vias enables unprecedented conformal coating in structures with aspect ratios exceeding 1,000:1. Our tool solutions, which we refer to as ALDx, overcome ALD’s traditional limitations: slow deposition rates, poor precursor efficiency, and reliance on plasma enhancement to enable reaction chemistries at lower temperatures and speed up processes (which also limits aspect ratio capability). ALDx features fast-dosing valves with 1ms actuation times, unique chamber designs for rapid purging and all-thermal catalyzed process for very high aspect ratio capability.

Forge Nano also relies on a turbulent-flow regime to achieve many of its improvements on traditional ALD. ALDx architecture employs a controlled turbulent-flow regime that differs materially from the laminar-flow approach used in most conventional semiconductor ALD tools. In our systems, gas flow is intentionally driven into a highly mixed state within the reaction zone, which enhances gas exchange, reduces boundary-layer thickness at the wafer surface and improves mass transport kinetics. This design, however, is combined with rapid-response precursor valving and synchronized pressure modulation intended to maintain temporal separation of ALD precursor doses while operating at higher mixing intensities which both speed up ALD processes and increase precursor utilization efficiency.

In semiconductor wafer processing, this approach is designed to address several structural limitations of our competitors’ laminar-flow ALD reactors:

●Throughput Constraints:   Traditional laminar-flow reactors rely on diffusion-limited purging, which can extend cycle times for advanced process stacks. Forge Nano’s use of controlled turbulent flow is intended to accelerate chamber refresh between precursor steps, thereby enabling shorter cycle times while maintaining self-limiting ALD behavior.

52

Table of Contents

​

●Precursor Utilization:    Laminar-flow systems often experience precursor waste due to slow gas exchange and boundary-layer effects. By promoting rapid mixing and residence control, Forge Nano’s platform is designed to improve precursor utilization efficiency, which can reduce chemical consumption in production environments.
●Advanced Device Integration:    As semiconductor architectures adopt higher aspect-ratio structures, three-dimensional geometries and complex topographies, uniform precursor penetration becomes increasingly challenging. Forge Nano’s turbulent-flow regime is intended to improve precursor access to recessed or high-surface-area features, supporting more uniform film growth across advanced device structures.
●Process Window Expansion:    The combined use of turbulent flow dynamics, dynamically modulated pressure and fast-switching delivery hardware is designed to provide a wider operating window relative to conventional laminar systems, particularly for chemistries requiring higher precursor pressures or rapid purge transitions.

This differentiated flow architecture delivers advantages in semiconductor applications where throughput, precursor utilization and conformality are critical performance drivers. Adoption of our approach has met with overwhelmingly positive customer qualification, integration into existing semiconductor manufacturing workflows, and demonstration of process stability across targeted device generations.

Battery Background

Li-ion batteries utilize an electrochemical architecture consisting of four primary components: the anode, the cathode, the electrolyte and the separator. These components function together as an integrated system that enables reversible storage and release of electrical energy. The performance, safety and reliability of Li-ion cells depend on precise material selection, manufacturing controls and operating conditions:

●Anode:    The anode, typically composed of graphite, other carbonaceous materials or silicon, serves as the host structure for lithium ions during the charging process. The anode’s porosity, particle morphology and binder system influence its capacity, rate capability and long-term cycling stability. During charge, lithium ions migrate from the cathode and intercalate into the anode’s layered structure. During discharge, these ions de-intercalate and travel back toward the cathode, providing the electron flow that powers external devices. Structural degradation of the anode or formation of excessive surface films may reduce performance and create safety risks.
●Cathode:    The cathode is commonly produced from lithium-containing metal oxides such as lithium nickel-manganese-cobalt oxide (“NMC”) and lithium nickel-cobalt-aluminum oxide (“NCA”), or other materials such as lithium iron phosphate. The cathode determines the cell’s operating voltage, energy density, and thermal characteristics. During charge, lithium ions leave the cathode framework, while electrons move through the external circuit toward the anode. During discharge, the cathode reabsorbs lithium ions and electrons, completing the electrochemical cycle. Instability in cathode chemistry — particularly at high states of charge or elevated temperature — can accelerate degradation or contribute to thermal runaway events.
●Electrolyte:    The electrolyte consists of a lithium salt dissolved in organic carbonate solvents and facilitates ion transport between the electrodes. It is electrically insulating yet ionically conductive. The electrolyte plays a central role in forming the solid-electrolyte interphase (“SEI”), a protective passivation layer that develops on the anode during initial charging. Proper SEI formation is critical to limiting side reactions, preserving cycle life and maintaining safety. Variations in electrolyte composition, moisture content or impurity levels may impair SEI stability and increase internal resistance.
●Separator:    The separator is a porous polymeric membrane positioned between the anode and cathode to prevent physical contact while allowing lithium ions to move freely. Separator integrity is essential to safe operation; breaches (dendrites that form on the anode surface that can breach the separator) or shrinkage under high temperature may result in short circuits. Many separators incorporate shutdown features that reduce ionic conductivity at elevated temperatures in an effort to mitigate damage from abnormal operating conditions.

53

Table of Contents

​

Battery manufacturing operations consist of a multi-stage, vertically integrated process designed to convert raw materials into high-performance rechargeable battery cells. The process is capital-intensive, technologically complex, and subject to ongoing innovation and regulatory oversight. The following description summarizes the primary production steps and associated considerations:

●Raw Materials and Electrode Preparation:    Li-ion battery cells are manufactured using active materials usually sourced from third-party suppliers, including lithium compounds, nickel-rich cathode materials, graphite, silicon, conductive additives and polymeric binders. These materials are blended and dispersed using industrial mixers to produce cathode and anode “slurries” with tightly controlled viscosity profiles. Slurries are coated onto metal foils — aluminum for cathodes and copper for anodes, i.e., current collectors — using precision coating lines. Following coating, the electrodes are dried, calendered or pressed to achieve specified porosity and density parameters, and slit into narrow rolls for downstream use. Variability in the quality or availability of raw materials may adversely affect production yields and cost structure.
●Cell Assembly:    Electrodes are transferred to automated winding or stacking equipment where they are combined with microporous polymer separators to form a cell “stack.” The assembly process is conducted in controlled environments to reduce contaminants that may impair electrochemical performance or safety. Assembled cells are enclosed in cylindrical, prismatic or pouch formats depending on customer requirements. Forge Nano’s ability to maintain consistent assembly precision is critical to achieving targeted energy density, cycle life, and safety characteristics.
●Electrolyte Filling and Formation:    Cells are vacuum-filled with a proprietary electrolyte formulation consisting of lithium salts dissolved in organic solvents. After sealing, the cells undergo a “formation” process in which they are charged and discharged under strictly defined profiles to establish the SEI layer. Formation is one of the most time- and equipment-intensive stages of Li-ion battery production. Errors in electrolyte composition, formation protocols or temperature control may reduce cell durability, increase internal resistance or create safety risks, which could lead to increased scrap rates or warranty obligations.
●Aging, Testing and Grading:    Following formation, cells enter an aging period during which electrochemical stabilization occurs. Cells then undergo diagnostic testing — capacity, impedance, self-discharge and safety metrics — to ensure compliance with customer specifications, internal standards and applicable regulatory requirements. Cells are graded based on performance characteristics and allocated to appropriate product classes. Lower-grade cells are typically sold into less demanding markets, and the metals in the lowest grade cells are typically recycled if cells fail to meet minimum performance thresholds.
●Module and Pack Integration:    Qualified cells are assembled into modules and packs with associated thermal-management hardware, structural components, busbars and battery-management system electronics. Pack integration requires compliance with numerous safety, transportation and performance standards, including those imposed by industry bodies, regulators and original equipment manufacturer customers. Forge Nano’s pack-level designs incorporate firmware and diagnostic algorithms intended to improve cycle efficiency and mitigate thermal-runaway risks.

Battery — Forge Nano ALD

Forge Nano achieves superior battery performance by applying ALD coatings, referred to as Atomic Armor, to the raw materials that comprise the anode and cathode slurries. The entire manufacture of the battery thereafter is as described above. In this way, we believe Forge Nano can produce batteries without disrupting the existing supply chain and manufacturing methodologies.

We believe Forge Nano is uniquely positioned to produce these coatings at commercial scale, with our Lithos and Circe tools that can coat industrial-scale amounts of materials to support gigafactories.

54

Table of Contents

​

These coatings produce a multitude of benefits for cathode materials to enhance their performance:

●Surface Passivation and Reduced Side Reactions:    For high-energy cathode materials (such as NMC or NCA), direct contact between the cathode surface and liquid electrolyte leads to electrolyte oxidation at high voltages, hydrofluoric acid (“HF”) attack, transition-metal dissolution and gas evolution and surface reconstruction. Our ALD coatings (commonly Al₂O₃ or similar oxides) form a conformal passivation layer on each cathode particle. This layer is engineered to be electronically insulating to suppress parasitic electron-driven side reactions and Li-ion permeability to allow lithium transport with minimal added impedance when properly optimized. White papers and program reports involving Forge Nano’s Atomic Armor show that such coatings reduce cathode — electrolyte reactivity, lowering metal dissolution and electrolyte decomposition while improving cycle life and storage stability.
●Structural Stabilization at High Voltage and Temperature:    High-energy cathode materials can suffer from oxygen release, surface reconstruction, and particle cracking at elevated voltage and temperature, which can trigger impedance growth and safety concerns. Studies of particle ALD coatings on NMC-type cathodes indicate that a properly engineered surface layer can stabilize the cathode surface structure, suppress oxygen release, which leads to cell gassing, reduce microcracking, and reduce impedance growth over long cycling, particularly at high cutoff voltages. By moderating the cathode — electrolyte interface, Forge Nano’s Atomic Armor is intended to extend cathode life and enable more aggressive operating windows (higher voltage, higher temperature) than uncoated material, subject to appropriate cell design and validation.
●Graphite Anodes — Controlled SEI and Reduced Degradation:    In conventional graphite anodes, initial charging leads to formation of SEI as the electrolyte decomposes on the graphite surface. Excessive or unstable SEI formation consumes lithium and electrolyte, generates gas and contributes to impedance growth. Nano-engineered oxide coatings applied via ALD create an artificial interphase that moderates the initial electrolyte decomposition, resulting in a thinner, more uniform SEI, limiting ongoing side reactions during cycling and reducing gas evolution and swelling.
●Silicon-Based Anodes — Mechanical and Chemical Protection:    Silicon-based anodes offer high capacity but undergo large volume changes during cycling, causing particle cracking and pulverization, continuous SEI rupture and reformation, rapid capacity fade and gas generation. In this context, powder ALD coatings act as a mechanically robust, chemically stable shell around each silicon-containing particle, functioning as a pre-formed, flexible SEI that buffers volume changes and slows particle pulverization, reduces direct contact between fresh silicon surface and electrolyte and decreases continuous SEI reformation and associated loss of lithium inventory. These mechanisms collectively support improved cycle life and coulombic efficiency for silicon-containing anodes relative to uncoated materials, under comparable testing conditions.

By coating both anode and cathode powders, Forge Nano’s Atomic Armor technology seeks to harmonize the entire electrochemical system, not just stabilize individual components. The process reduces cross-talk, which is to say the lower transition-metal dissolution from the cathode results in less metal deposition on the anode, mitigating impedance growth and gas formation.

Coating both materials also improves high-temperature and high-voltage stability. Stabilization of interfacial reactions can enable extended operation at elevated temperatures and higher cutoff voltages, subject to validation and safety constraints.

Finally, the process enhances fast-charge capability. By reducing parasitic reactions and moderating SEI formation, coated materials may tolerate more aggressive charge protocols with less degradation, depending on cell design and use conditions.

Research and Development

Forge Nano was born from research that the founders conducted while at the University of Colorado Boulder. Throughout its commercial existence, Forge Nano has conducted research funded by grants from federal partners and universities as well as joint development agreements and proof-of-concept work with corporate strategic partners. Our development of ALD commercial applications, which we refer to as verticals, related to pharmaceuticals, 3D printing materials, rocket fuels and other applications exemplifies the research we have conducted successfully and from which we have gleaned substantial commercial benefits from coating services, tool sales, royalties and more.

55

Table of Contents

​

This work is expected to continue to the extent that it does not distract from our primary commercial applications in semiconductor tools and batteries. When resources are available, our research capabilities will be brought to bear in the verticals mentioned above and beyond.

Access to Raw Materials

Semiconductor Tools

Forge Nano is supplied by U.S. distributors with global supply chains that source their tool components from around the world. Although these components are widely available internationally, supply chain disruptions have occurred in the past, for example, during the COVID pandemic. Forge Nano modifies many of these components before assembly with readily available tools, parts and methods. We are working to ensure we have a minimum of two sources for all critical components.

Battery Cell Production

Much of the raw material for battery manufacturing is sourced abroad, with China remaining the dominant supplier of anode, cathode, and other critical inputs. Forge Nano is building a domestic supply chain to counter this strategic threat to its supply, working with leading innovators for U.S.-based cathode active material, synthetic graphite, silicon-carbon anodes, and electrolytes. While Asia continues to lead in cathode materials, particularly China’s CATL, Forge Nano does not procure from CATL. However, Forge Nano will source from international suppliers, including South Korean suppliers of advanced cathode materials. European suppliers also play a role in supplementing our supply chain.

Sales and Marketing

Forge Nano has traditionally taken a demand-driven approach to its operations in both semiconductor tools and battery cells, ready to focus resources on paying engagements once an end-use, scale and sales have been positively identified. Sales and marketing efforts have been designed to identify this demand, with personnel on three continents engaged with prospective clients in both commercial and academic settings.

These engagements commence with small-scale or prototype commercial engagements, effectively folding our Research and Development (“R&D”) and operations groups into the sales and marketing process at our Thornton, CO facility, which we believe is one of the largest research-scale ALD tool centers in the world. As an example, we have had such engagements with producers of graphite materials who want to see how ALD coating enhances the performance of their materials as they assess their options with Forge Nano’s ALD technology. When these engagements involving a few kilograms of material prove successful, larger commercial engagements become possible.

Our success in capturing customers among military contractors is another example of our demand-driven approach. In semiconductor applications, we have been successful among clients interested both in the superior performance of our tools and the fact they are manufactured domestically in the United States. Similarly with battery cell sales, our products have attracted the attention of military and aerospace clients through their performance. We have maintained that interest through testing and prototype phases with the domestic origin of our batteries and semiconductor tools.

Our semiconductor sales group focuses on the sales of semiconductor tools in North America, Asia and Europe. With substantial ALDx capabilities in the Thornton facility, which allows us to demonstrate the operation of the Tephra (commercial-scale) and Theia (research-scale) tools, our sales group has grown the pipeline from 22 marketing-qualified leads in July 2025 to 155 by December 2025. We expect that the expansion of the sales team and its infrastructure will play a critical role in the next phase of our evolution. The expansion of a robust support team is also critical to provide clients with the assurance that tools will perform as advertised once deployed, as well as return critical operational data back to Forge Nano that will enable us to further improve our tools in the future.

56

Table of Contents

​

Producing batteries through third parties and our own prototype line, our battery sales group has a substantial pipeline of prospective sales several multiples larger than our current estimated capacity to produce approximately $13 million in cells. The sales team is, by necessity, dedicated to moving cells through our clients’ pre-sale testing, a process that can take several months as cells are charged, discharged and subjected to safety tests in a variety of conditions. This group works with our R&D and battery groups to continue qualifying third-party manufacturers and ramp-up manufacturing capacity, which can be a time-consuming and expensive endeavor. Our decision to pursue our own gigafactory through Forge Battery was based on the development of a substantial demand profile for our 21700 cells and our experience selling our third-party manufactured cells.

Key Strategic Partners

Forge Nano sees strategic partnerships as the foundation of our ongoing growth and success. Our deep collaboration with leading companies across industries has allowed our technology to reach customers and markets that would not have been possible without such collaborations. Many but not all of our partnerships have involved direct investment into Forge Nano through successive equity raise rounds.

Some of the partners with whom we have developed products, processes and procedures include:

●Volkswagen
●Hanwha Aerospace
●General Motors
●LG Chem
●Air Liquide
●Mitsui Kinzoku

Forge Nano is party to a range of customer and material commercial agreements across its tool manufacturing, coating services and battery operations in the form of equipment purchase orders, coating and service agreements, and grant agreements.

Forge Battery is party to a Battery Supply Agreement with Samsung SDI, consisting of an equipment purchase agreement and a battery offtake agreement in furtherance of the development of Forge Battery’s 3 GWh production facility in Morrisville, North Carolina. Forge Battery broke ground on the expansion of the facility on August 19, 2026, and Forge Nano expects structural completion by year-end. Forge Nano expects full construction to be complete and equipment to begin to arrive by the third quarter of 2027. Commissioning of that equipment is expected by the end of the first quarter of 2028, with production beginning by the middle of 2028. These expectations have been carefully formulated among Forge Battery and its partners, but are dependent on funding, equipment deliveries and the timely performance obligations of construction vendors.

Intellectual Property

Our business performance and technology leadership are underpinned by proprietary innovations. We protect these technologies through a mix of U.S. and international patents, trademarks, and trade secrets, supplemented by license agreements and other contractual measures to secure, preserve, and enforce our rights. Our intellectual property portfolio includes over 200 owned, in-licensed and to-be-filed patents and patent applications, along with numerous invention disclosures on which we anticipate filing additional patents. While no single patent is material to our business, our patent portfolio — together with the products protected by it — constitutes an important component of our overall operations.

57

Table of Contents

​

We pursue patent protection for innovations arising from our product development and manufacturing efforts, including new offerings and enhancements, as a routine component of our R&D activities and safeguard our intellectual property and our proprietary rights therein through confidentiality and invention assignment agreements with employees and consultants, as well as nondisclosure arrangements with business partners and other external parties. Consistent with our broader intellectual property strategy, we also may undertake legal measures to stop unauthorized use, misappropriation, or other improper access to our technology, trade secrets or specialized know-how by third parties.

In addition to the intellectual property rights in our proprietary technology, we pursue trademark protection of key marks to strengthen and protect the valuable brand recognition we have built around our company and products. Our current trademark portfolio covers our core brands: FORGE NANO (registered in the U.S.) and ATOMIC ARMOR (registered or pending in multiple jurisdictions). Additionally, we hold the E.U. registration for our OPERIO equipment and pending applications for our semiconductor equipment brand TEPHRA in multiple jurisdictions.

Employees and Company Culture

As of November 17, 2026, Forge Nano has a team of 372 members. The majority are in North America, with teams in Asia and Europe largely focused on sales efforts. We have a robust intern program through local high schools and have taken on paid interns from local universities.

Our commitment to innovation begins with the commitment to creating an environment in which our employees can do their best work. Our ability to create differentiated value in the marketplace is driven by the capability of our people to anticipate technology inflections and integrate customer requirements. To achieve this level of value creation, we believe we must continue to attract, hire, develop and retain a world-class workforce. We invest in our employees by providing quality training and learning opportunities, a compelling career path, building a connected and highly engaged culture, and upholding a high standard of ethics and respect for human rights.

We seek team members who are motivated to help solve significant problems and positively impact the world. Our hiring and advancement practices are designed to be fair and consistent, with a focus on measurable progress in representation over time. We provide competitive cash compensation and meaningful equity awards to attract, motivate, and retain individuals who can drive outsized results. In setting compensation, we consider market benchmarks, the strategic importance of the role, and each individual’s performance and impact.

We seek to create growth and development opportunities to support an engaged and connected workforce. Also, to help expand professional breadth, we provide technical and job-specific training, while general professional, management, and leadership training is provided at the corporate level.

We value great talent and having employees with a broad mix of perspectives, skills and experiences. We therefore strive to provide fair and equal opportunity for career development and advancement to all our employees and to build a connected and highly engaged culture where all of our employees feel they belong.

Facilities

Our headquarters is located in Thornton, Colorado in a 165,700 square foot facility that we share roughly equally with Ascent Solar. The facility contains our equipment build bays, our cleanroom for semiconductor tool production and testing, and our 1 MWh prototype battery cell line with a cleanroom facility. The facility is leased with a term that ends June 2029. We have also leased office space in Taiwan for our local team and visiting members in December 2025.

58

Table of Contents

​

Forge Battery has leased a 100,000 square foot, single-floor facility in Morrisville, North Carolina which is to be the home to our 3 GWh line. The development of the site began in August 2026 and the facility has a 15-year lease term with renewable options of five years. The facility is currently constructed to core-and-shell, comprising approximately 100,000 square feet, and has been designed to accommodate a second floor and other additions to the existing facility, permitting expansion to a manufacturing campus of approximately 315,000 square feet. Forge Battery has entered into agreements with its primary equipment vendor and production partner and has made initial deposits thereunder, and has completed the core-and-shell design and facility layout. Forge Battery broke ground on the expansion of the facility on August 19, 2026, and Forge Nano expects structural completion by year-end. Forge Nano expects full construction to be complete and equipment to begin to arrive by the third quarter of 2027. Commissioning of that equipment is expected by the end of the first quarter of 2028, with production beginning by the middle of 2028. These expectations have been carefully formulated among Forge Battery and its partners, but are dependent on funding, equipment deliveries and the timely performance obligations of construction vendors.

Competition

The semiconductor and battery markets are highly competitive and continue to evolve, and we may not be successful in competing in this industry. Our competitors may be able to develop products comparable or superior to those we offer or may adapt more quickly to new technologies or evolving customer requirements. While we believe we have compelling products we can offer at a substantial value to our customers, we could face state-sponsored competition from overseas and may not be able to compete in the market on the basis of price.

Several development-stage companies are pursuing enhancements to conventional Li-ion batteries and exploring next-generation solid-state and lithium-metal architectures. New market entrants are also working on innovations across the battery stack, including cathodes, anodes, electrolytes, and additive chemistries. Some of these participants have formed collaborations with automotive OEMs and are progressing through different phases of development. We expect our competitive position against Li-ion battery makers and other solid-state battery developers to hinge on a range of factors, including cost, safety, energy density, charging speed, and cycle life, as well as non-technical considerations such as brand strength, existing customer relationships, and the depth of our financial and manufacturing capabilities.

The semiconductor capital equipment industry is highly competitive and characterized by rapid change. Semiconductor manufacturers evaluate capital equipment providers across a broad set of criteria, including process performance, productivity, defect control, customer service and support, and total cost of ownership. These considerations are influenced by factors such as equipment design, reliability and uptime, software capabilities, and other technical attributes. We face competition from a number of emerging and established companies in the industry, including ASM International and Wonik IPS. Our ability to succeed in the marketplace depends upon producing and delivering products according to customer timelines, sustaining existing offerings, and introducing timely enhancements and new products that meet customer specifications.

Government Regulations

We are subject to various laws, regulations and permitting requirements of federal, state and local authorities, related to health and safety, anti-corruption and export controls. The foregoing may include the U.S. Foreign Corrupt Practices Act of 1977, the U.S. Export Administration Regulations, Money Laundering Control Act of 1986 and any other equivalent or comparable laws of other countries. We are also regulated under various international laws regarding the purchase and sale of goods and related items, including but not limited to those related to trade policies and export regulations, and limitations on transfer of intellectual property. We believe that we are in material compliance with all such laws, regulations and permitting requirements.

Additionally, both the Forge Nano HQ and the Forge Battery sites will be subject to standard local, state and federal environmental regulations concerning battery manufacturing.

These laws, regulations and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices.

59

Table of Contents

​

We intend to invest resources to comply with evolving laws, regulations and standards, and this investment may result in increased general and administrative expenses and a diversion of management’s time and attention from revenue-generating activities to compliance activities.

If our efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be adversely affected.

Legal Proceedings

From time to time, we may become involved in actions, claims, suits and other legal proceedings arising in the ordinary course of our business, including assertions by third parties relating to personal injuries sustained using our products and services, intellectual property infringement, breaches of contract or warranties or employment-related matters. We are not currently a party to any actions, claims, suits or other legal proceedings the outcome of which, if determined adversely to us, would individually or in the aggregate have a material adverse effect on our business, financial condition and results of operations.

Available Information

Our website can be found at www.forgenano.com. Any information available on or accessible through our website is not included in, incorporated by reference into, or otherwise part of this prospectus or any other filings we make with the SEC.

​

60

Table of Contents

​

MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Unless the context otherwise requires, all references in this section to the “Company,” “we,” “us,” “our” or “Forge Nano” refer to the business of Forge Nano, Inc. and its subsidiaries prior to the consummation of the Business Combination.

You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our historical audited annual consolidated financial statements as of and for the years ended December 31, 2025 and 2024 and our unaudited condensed consolidated financial statements as of September 30, 2026 and for the nine months ended September 30, 2026 and 2025 and the related notes to those financial statements appearing elsewhere in this prospectus. This discussion contains forward-looking statements that involve risk, assumptions and uncertainties, such as statements of our plans, objectives, expectations, intentions and forecasts. Our actual results and the timing of selected events could differ materially from those discussed in these forward-looking statements as a result of several factors, including those set forth under the section of this prospectus titled “Risk Factors” and elsewhere in this prospectus. You should carefully read the “Risk Factors” to gain an understanding of the important factors that could cause actual results to differ materially from our forward-looking statements. Please also see the section of this prospectus titled “Cautionary Note Regarding Forward-Looking Statements.”

Unless otherwise specified, all dollar amounts presented in tables in this section are in thousands.

Overview

Founded in 2011, Forge Nano is a leading innovator in Atomic Layer Deposition (“ALD”), a process that provides perfectly conformal, atom-thin coatings on surfaces, wafers and powders. Invented in the 1960s, ALD is a well-understood coating solution. However, attempts to apply ALD to commercial products have largely failed, as the process has historically been too slow and inefficient to be of general utility outside of the semiconductor manufacturing industry. Despite these shortcomings, ALD continues to be employed in semiconductor manufacturing as chip sizes have diminished to the atomic scale.

In the semiconductor space, with our unique wafer tools, Forge Nano applies our ALDx technology to solve scale, speed and efficiency problems, making it a superior coating solution compared to chemical vapor deposition (“CVD”), physical vapor deposition (“PVD”) or any other thin-film coating technology used in semiconductor manufacturing. Our tools produce passivation layers for 3D devices, high-K dielectrics, and conformal films for emerging sensors and power devices, helping to improve efficiency and overcome limitations in traditional manufacturing. Forge Nano’s tools, which, according to our calculations and available data, run at approximately 10 times the speed yet consume a fraction of the costly precursor use of our competitors’ ALD tools, can improve manufacturing yields by delivering higher fidelity of coatings, thus lowering manufacturing costs. Products sold in the semiconductor space include both our commercial research-scale wafer tools, Tephra, and research-scale Theia tools. Our clients include secured defense contractors and commercial and university labs, and we have a rapidly expanding pipeline.

In the battery cell industry, we believe we have also developed the world’s fastest and most efficient approach to creating ALD coatings on powders on a commercial scale with our Atomic Armor technology. While we have applied Atomic Armor ALD coatings to products as varied as pharmaceuticals, three-dimensional (“3D”) printing material and rocket fuel, Forge Nano has been focused on lithium-ion (“Li-ion”) batteries for nearly 15 years. These conformal, ultra-thin coatings fundamentally change a material’s surface properties without altering its core structure, unlocking enhanced performance and novel functionalities for a wide range of applications. We have fully commercialized our research-scale tools, Pandora and Prometheus, and our commercial-scale tools, Lithos and Circe.

By applying our patented ALD coatings to battery anode and cathode powders (the main components of every Li-ion battery), we mitigate the degradation usually encountered in the charging and discharging process while reducing or eliminating the side reactions within the batteries that can produce a thermal runaway. Our Atomic Armor protective coating delivers superior performance by allowing higher operating voltages, which can increase the battery’s overall capacity and energy density by as much as 20% while extending cycle life and reducing gas generation. Applying ALD coatings can significantly reduce or even eliminate the need for costly electrolyte additives, helping reduce the overall manufacturing cost of the battery cell itself. Forge Nano manufactures and sells ALD-enhanced battery cells for a wide array of clients in aerospace, defense, mobility and other non-EV applications.

61

Table of Contents

​

Forge Nano’s headquarters and manufacturing facility is in Thornton, CO. This 70,605 square foot leased facility is home to our prototype manufacturing battery line, a 4,000 square foot dry room launched in 2025 with capacity for one MWh of batteries annually. It also houses our 2,000 square foot cleanroom where our commercial semiconductor tools are manufactured and tested before deployment. The site also features 25,000 square feet of floor space hosting a wide array of research and commercial-scale equipment we use to conduct coating services for clients and for internal development.

Forge Nano formed its Forge Battery subsidiary in 2023. In August 2026, Forge Battery broke ground on a manufacturing facility in Morrisville, NC featuring ALD-coated 21700 cells, suitable for use in the production of mission-ready battery packs. Forge Battery is developing the first fully U.S.-sourced and manufactured battery available at gigawatt scale, for aerospace, defense, specialty mobility, unmanned airborne vehicles (“UAVs”), data centers and other applications. We anticipate Forge Battery ramping up for commercial offtake in the next few years.

Through selling tools and ALD-coating services, Forge Nano has developed strategic relationships among and received substantial investment from auto-, material-, manufacturing-, mining- and defense-focused companies.

Our technology is backed by investments in intellectual property (“IP”), with over 200 owned or in-licensed patents and pending or to-be-filed patent applications spanning multiple aspects of ALD application from Li-ion and solid-state batteries to work in additive manufacturing, passive components, pharmaceutical and energetic (explosive/propellant) materials. Our patent estate has been strategically designed to cover materials, processes and equipment, devices (batteries) and application levels, making it difficult for a competitor to do large-scale ALD coating on battery and other critical particles without licensing or designing around Forge Nano intellectual property.

Recent Developments

Acquisition of HzO

On November 4, 2026, we completed the HzO Merger. In connection with the HzO Merger, we issued 5,772,645 shares of Forge Nano common stock with an additional 1,533,795 shares of Forge Nano common stock to be held back for twelve months to secure post closing adjustment and indemnification obligations (the “Holdback Shares”). Upon completion of the HzO Merger assuming the full issuance of the Holdback Shares, HzO stockholders would own 7,306,440 shares of Forge Nano common stock.

Key Factors Affecting our Results of Operations

We are a growing commercial-stage company that generates income through sales of tools and service contracts, batteries, coating services and related development services to a wide range of advanced material-related companies. We also participate in grant programs with national labs and the Department of Energy to develop applications for ALD and prove efficacy of our coatings in various applications.

Our revenues can be variable due to several factors, principally demand for our semiconductor tools and batteries. The semiconductor industry typically experiences volatility as end-user demand fluctuates and as supply can be subject to external forces in addition to the challenging task of building chips. While generally we believe the demand for semiconductors will grow over time, we recognize that a slowing of the global economy can dampen demand and by extension demand for our tools, as has occurred in recent downturns. By the same measure, supply chain interruptions can drive a scarcity of chips that drives higher pricing but gives rise to the potential for production overcompensation. This can lead to product gluts and ultimately, price depression. Forge Nano believes that it can weather such market turbulence by providing ALD tools that feature rapid throughput and minimal use of expensive precursors while unlocking the ability to produce chips in 3D stacking configurations, which fill a growing need for energy-efficient AI data centers.

62

Table of Contents

​

The market for Li-ion batteries is similarly subject to variation driven by general demand, especially from electric vehicles (“EV”s). While the market is expected to grow and energy storage expected to become a critical measure of infrastructure and mobility, market demand is subject to government incentives for end-use products (like EVs) and world-wide supply. The current administration in the United States has eliminated many incentives to purchase EVs and has led to a drop in pricing for batteries. Supply in the battery market is dominated by Chinese suppliers, who have weathered a downturn in global EV demand by dumping their products in the United States and several other markets. Forge Battery has the advantage of serving primarily aerospace, alternative vehicles and Department of Defense contractors, all of whom prefer premium-performance batteries and a local supply chain.

Demand for tool maintenance and repair services depends deeply on tools in the field and tools being installed. The more tools sold, the more this revenue can grow. The same is true for parts. Our coating services are driven largely by corporations’ willingness to pay for product improvements through making changes to their primary inputs. This means that during downturns, corporations are potentially less eager to spend available cash on this work. The unique nature of our powder ALD work is such that we expect companies that continue to strive for improvements in performance or manufacturing economics to continue turning to us for solutions to their advanced material problems.

Our material inputs are subject to many of the same factors. Our tools are assembled with individual components sourced largely from domestic vendors but not exclusively, and those domestic vendors frequently rely on international supply. Disruptions in such supply can include logistical and financial hindrances (in the case of export restrictions or tariffs) which have an impact on the profitability and delivery dates of the final products, which could harm both the results of operations and future bookings.

Volume of business is key to maintaining low input costs for tools, batteries and related services. High throughput opens the capacity for scale pricing for primary materials and efficient use of labor.

Selling, general and administrative (“SG&A”) expenses consist mainly of personnel-related expenses such as salaries, employee benefits and stock-based compensation expense of our executive and administrative employees, as well as fees for professional and advisory services such as legal, accounting and audit. Selling, general and administrative expenses also include corporate insurance expense, including directors’ and officers’ insurance costs, and allocation of overhead costs, which include utilities, rent, depreciation expense and other facilities-related costs. We expect that our selling, general and administrative expenses will increase for the foreseeable future primarily due to costs for compliance-related requirements resulting from being a public company and investment in additional SG&A personnel to support the growth of our business.

Key Components of Consolidated Statement of Operations

The following presents an explanation of key components of our consolidated statements of operations.

Revenues and direct costs for tools are recognized over time on the basis of labor hours incurred in relation to total expected labor hours, as this is the pattern in which control transfers to the customer. With sufficient volumes we expect customization to evolve to configuration (as opposed to actual production), and sales volumes to force an evolution to mass-production, at which point we will be able to migrate to a more standard recognition of revenues and direct costs for tools upon transfer of ownership of each tool. Services for tools are either recognized on a periodic basis for contracted services or on an as-delivered basis for services provided on an ad-hoc basis. Parts revenues are recognized as they are shipped. Direct costs in each category are recognized as revenues are.

Revenues from sales of batteries are recognized as deliveries are made to customers, which includes batteries manufactured for client testing purposes. Coating services, whose engagements can vary from very short and low-resource requirement jobs to very large and resource-intense jobs, are recognized on a percent-complete basis.

The Company receives government grants under cost-sharing arrangements in connection with certain research, development, and infrastructure projects. Grant income is recognized when there is reasonable assurance that the Company has complied with the applicable conditions and the grant will be received. Grant proceeds are presented on a gross basis within non-operating income in the unaudited condensed consolidated statements of operations. Related costs incurred under these arrangements are recorded within the applicable operating expense categories and are not netted against grant income.

63

Table of Contents

​

Many of the Company’s grant arrangements are structured as cost-share programs, under which the Company is reimbursed for a portion of costs incurred. For a majority of these programs, reimbursements approximate the Company’s eligible expenditures. For example, certain grant arrangements provide for reimbursement that is approximately commensurate with the Company’s level of qualifying spend.

Certain grants provide for reimbursement at levels below the Company’s total project costs. For example, under the Bipartisan Infrastructure Law (“BIL”) grant to support development of the Company’s Morrisville battery facility, the Company expects reimbursement of approximately 42% of eligible costs incurred under the program.

Management believes that presenting grant income on a gross basis provides greater transparency into both the level of grant funding received and the underlying operating costs associated with these programs.

Consolidated Results of Operations

We discuss our historical results of operations, and the key components of those results, below. Our results of operations set forth below and elsewhere in this prospectus may not necessarily be indicative of future results.

The Company operates in three reportable segments based on the nature of its products and services:

●Tool Manufacturing & Related Services
●Coating Services
●Battery Manufacturing

These segments reflect the manner in which the Company’s Chief Operating Decision Maker (“CODM”) evaluates financial performance.

The CODM reviews operating results at the segment level, including revenue and gross profit (loss).

The CODM does not review asset information at the reportable segment level and does not use such information in allocating resources or assessing performance.

Operating expenses, including general and administrative and research and development expenses, are managed and evaluated on a consolidated basis.

64

Table of Contents

​

Nine Months Ended September 30, 2026 Compared to the Nine Months Ended September 30, 2025

The following table sets forth our historical results for the periods indicated, and the changes between periods (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Nine months ended
September 30,

​

​

​

​

​

 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

Variance

  ​ ​ ​

%

 

Net Sales

​

​

​

​

​

​

​

​

​

​

​

​

Tool manufacturing and related services

​

$

4,180

​

$

3,107

 

​

1,073

 

35

%

Coating services

​

 

972

​

 

1,067

 

​

(95)

 

(9)

%

Battery manufacturing

​

 

915

​

 

1,153

 

​

(238)

 

(21)

%

Total Net Sales

​

 

6,067

​

 

5,327

 

​

740

 

14

%

Cost of Sales

​

 

​

​

 

​

 

​

​

 

  ​

​

Tool manufacturing and related services

​

 

6,688

​

 

3,699

 

​

2,989

 

81

%

Coating services

​

 

3,921

​

 

2,838

 

​

1,083

 

38

%

Battery manufacturing

​

 

494

​

 

1,040

 

​

(546)

 

(53)

%

Total Cost of Sales

​

 

11,103

​

 

7,577

 

​

3,526

 

47

%

Gross Loss

​

 

(5,036)

​

 

(2,250)

 

​

(2,786)

 

124

%

Operating Expenses

​

 

​

​

 

​

 

​

​

 

  ​

​

General and administrative

​

 

31,582

​

 

30,409

 

​

1,173

 

4

%

Total Operating Expenses

​

 

31,582

​

 

30,409

 

​

1,173

 

4

%

Operating Loss

​

 

(36,618)

​

 

(32,659)

 

​

(3,959)

 

12

%

Nonoperating Income (Expense)

​

 

​

​

 

​

 

​

​

 

  ​

​

Interest income

​

 

401

​

 

548

 

​

(147)

 

(27)

%

Grant income

​

 

2,715

​

 

6,153

 

​

(3,438)

 

(56)

%

Other income

​

 

208

​

 

703

 

​

(495)

 

(70)

%

Interest expense, change in fair value, and amortization of debt discount

​

 

(11,182)

​

 

(8,385)

 

​

(2,797)

 

33

%

Other expense

​

 

(28)

​

 

(29)

 

​

1

 

(3)

%

Total Nonoperating Income (Expense)

​

 

(7,886)

​

 

(1,010)

 

​

(6,876)

 

681

%

Net Loss

​

$

(44,504)

​

$

(33,669)

​

$

(10,835)

 

32

%

​

Net Sales

Total net sales increased by approximately $0.7 million, or 14%, for the nine months ended September 30, 2026 as compared to the nine months ended September 30, 2025. The increase was primarily driven by higher sales of our Tephra semiconductor tool platform. This increase was partially offset by lower coating services revenue and a modest decrease in battery manufacturing revenue during the period.

Tool manufacturing and related services

Revenue from tool manufacturing and related services increased by approximately $1.1 million, or 35%, for the nine months ended September 30, 2026 as compared to the nine months ended September 30, 2025. The increase was primarily driven by the Company’s continued focus on expanding its Tephra semiconductor tool platform. Revenue from Tephra projects increased by approximately $1.4 million as work commenced on two new commercial-scale Tephra projects during 2026. Tephra projects represent higher-value commercial equipment projects and contributed significantly to the year-over-year increase. This increase was partially offset by a decline of approximately $0.4 million in revenue from the Prometheus product line as the Company continued to shift its focus toward Tephra offerings.

Coating services

Coating services revenue decreased by approximately $95.0 thousand, or 9%, for the nine months ended September 30, 2026 as compared to the nine months ended September 30, 2025. The decrease was primarily attributable to the timing of customer orders and shipments at month-end, partially offset by revenue recognized from Phase 3 activities under a collaboration agreement entered into in connection with the Series D financing during the current-year period.

65

Table of Contents

​

Battery manufacturing

Battery manufacturing revenue decreased by approximately $0.2 million, or 21%, for the nine months ended September 30, 2026 as compared to the nine months ended September 30, 2025. The decrease was primarily driven by a $0.5 million reduction in revenue from low-volume, high-value Forge Nano-produced cell, pack, and analysis projects, for which revenue fluctuates based on the completion of milestone deliverables. This decrease was partially offset by revenue from the distribution of Samsung SDI-produced cells, which commenced in June 2026. The Company continues to develop its pipeline for Forge Nano-produced cells and battery packs. The timing and amount of revenue recognized from ongoing projects will depend on the completion of the applicable project deliverables. The Company also expects its expanded Samsung SDI battery portfolio to support higher-volume sales opportunities.

Cost of sales

Total cost of sales increased by approximately $3.5 million, or 47%, for the nine months ended September 30, 2026 as compared to the nine months ended September 30, 2025. The increase was primarily attributable to higher Tephra production costs, expansion of the Company’s semiconductor equipment and coating operations, and increased personnel, facility and travel-related expenses. These increases were partially offset by lower battery manufacturing cost of sales following the completion of the Cesium Astro battery project and the application of estimated contract losses accrued in prior periods against losses incurred on the project during the current-year period.

Tool manufacturing and related services

Cost of sales for tool manufacturing and related services increased by approximately $3.0 million, or 81%, for the nine months ended September 30, 2026 as compared to the nine months ended September 30, 2025. The increase was primarily attributable to increased Tephra production activity as the Company continued to focus on expanding its commercial-scale Tephra product line, which has higher bill of materials costs and labor requirements to produce, resulting in increase in direct materials and direct labor costs by approximately $1.0 million and $0.1 million, respectively. The increase also reflects the Company’s expansion of operations in Taiwan and growth of its Operations and Service teams in both Thornton and Taiwan to support its semiconductor equipment business, resulting in approximately $0.7 million of additional personnel costs and a $0.3 million increase in materials and supplies expense. In addition, travel costs increased by approximately $0.5 million as employees were deployed to support Hyperlight Tephra installation activities and the onboarding of newly hired personnel in Taiwan.

Coating services

Coating services cost of sales increased by approximately $1.1 million, or 38%, for the nine months ended September 30, 2026 as compared to the nine months ended September 30, 2025. The increase was primarily attributable to the expansion of the Company’s Thornton facility capabilities through investments in new equipment, cleanrooms, dry rooms and other manufacturing infrastructure, which resulted in increases of approximately $0.4 million in personal property tax expense and $0.1 million in utility costs. The increase also reflected higher direct material and labor costs associated with a strategic JDA coating project with Toyota that commenced in the third quarter of 2026, as the project required greater material and labor resources than the Company’s typical proof-of-concept and other JDA projects.

Battery manufacturing

Battery manufacturing cost of sales decreased by approximately $0.5 million, or 53%, for the nine months ended September 30, 2026 as compared to the nine months ended September 30, 2025. The decrease was primarily attributable to the completion of the Company’s Cesium Astro battery project in August 2026. Upon completion of the final project deliverable, approximately $0.6 million of estimated contract losses accrued in prior periods was applied against losses incurred on the project during the current-year period, reducing battery manufacturing cost of sales. This reduction was partially offset by costs associated with other battery manufacturing activities during the current-year period.

66

Table of Contents

​

General and administrative

General and administrative expenses increased by approximately $1.2 million, or 4%, for the nine months ended September 30, 2026 as compared to the nine months ended September 30, 2025. The increase was primarily attributable to a $2.7 million increase in facilities expenses, including $2.4 million of rent expense associated with the Morrisville battery manufacturing facility and the impact of a first amendment to the Morrisville Lease executed in May 2026; a $2.5 million increase in personnel costs, reflecting additional personnel for the prototype line, sales and executive functions, including a $0.5 million increase in stock-based compensation; a $1.9 million increase in professional services expenses, primarily accounting and consulting fees related to the Business Combination, due diligence activities and public company readiness initiatives; and a net $1.5 million increase in other general and administrative expenses, including travel, IT systems, laboratory, marketing and recruiting expenses. These increases were partially offset by a $7.5 million decrease in grant-related expenses, consisting of a $4.0 million decrease in equipment costs, as no comparable expenditures were submitted in 2026 compared with Siemens switchgear-related expenditures submitted under the BIL grant during the third quarter of 2025, and a $3.5 million decrease in other grant-related costs, primarily contractual and materials costs following the completion of certain longstanding grant projects.

Interest income

Interest income decreased by approximately $0.1 million, or 27%, for the nine months ended September 30, 2026 as compared to the nine months ended September 30, 2025. The decrease was primarily attributable to lower average cash balances held in money market accounts during the current-year period. Money market account balances decreased from approximately $7.9 million at September 30, 2025 to approximately $3.8 million at September 30, 2026. The decrease in cash balances was primarily attributable to the utilization of proceeds from the Series D financing raised in 2025 to fund the Company’s working capital requirements.

Grant income

Grant income decreased by approximately $3.4 million, or 56%, for the nine months ended September 30, 2026 as compared to the nine months ended September 30, 2025. The decrease was primarily attributable to lower reimbursable activity under the Company’s BIL grant and other grant programs. During the prior-year period, the Company submitted approximately $3.8 million of Siemens switchgear-related expenditures, resulting in approximately $1.6 million of grant income. The decrease in grant income during 2026 was generally consistent with the lower level of grant-related expenditures during the period. Grant income may fluctuate between periods based on the timing and amount of eligible expenditures and related reimbursement submissions under the BIL grant.

Other Income

Other income decreased by approximately $0.5 million, or 70%, for the nine months ended September 30, 2026 as compared to the nine months ended September 30, 2025. The decrease was primarily attributable to a change in the classification of fair-value gains related to warrants and other financial instruments. During the prior-year period, such gains were recorded within other income. During 2026, such gains were recorded within the fair-value adjustment account and presented within interest expense, change in fair value, and amortization of debt discount, where the gains offset related losses.

Interest expense, change in fair value, and amortization of debt discount

Interest expense, changes in fair value and amortization of debt discount increased by approximately $2.8 million for the nine months ended September 30, 2026 as compared to the nine months ended September 30, 2025. The increase was primarily attributable to a $9.3 million fair-value loss resulting from an increase in the fair value of warrant liabilities during the current-year period, compared to a $0.7 million fair-value gain in the prior-year period. During the second quarter of 2026, the Company increased the estimated probability of exercise of certain paid-in warrants to 90%, reflecting the increased probability of completing the Business Combination and the anticipated trading liquidity following such transaction. This change in estimate resulted in a significant increase in the fair value of the related warrant liabilities. The Company also recorded a $1.0 million fair-value loss on the contingent consideration liability for the Sundew ALD acquisition, compared to a $0.8 million loss in the prior-year period. The increase was partially offset by the absence in the current-year period of a $3.9 million loss on extinguishment of debt recognized in the prior-year period in connection with the 2025 Series D financing transactions, a decrease in amortization of debt issuance costs and debt discount to $0.1 million from $2.3 million in the prior-year period, and lower interest expense of $0.8 million, compared to $1.4 million in the prior-year period, following the $8.0 million principal repayment in November 2025.

67

Table of Contents

​

Year Ended December 31, 2025 Compared to the Year Ended December 31, 2024

The following table sets forth our historical results for the periods indicated, and the changes between periods (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Years ended December 31,

​

​

​

​

​

 

​

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

Variance

  ​ ​ ​

%

 

Net Sales

​

​

​

​

​

​

​

​

​

​

​

​

Tool manufacturing and related services

​

$

4,625

​

$

6,852

 

​

(2,227)

 

(33)

%

Coating services

​

 

1,429

​

 

1,332

 

​

97

 

7

%

Battery manufacturing

​

 

1,334

​

 

115

 

​

1,219

 

1,060

%

Total net sales

​

 

7,388

​

 

8,299

 

​

(911)

 

(11)

%

Cost of Sales

​

 

  ​

​

 

  ​

 

​

  ​

 

  ​

​

Tool manufacturing and related services

​

 

6,239

​

 

5,441

 

​

798

 

15

%

Coating services

​

 

3,921

​

 

2,486

 

​

1,435

 

58

%

Battery manufacturing

​

 

1,085

​

 

40

 

​

1,045

 

2,613

%

Total Cost of Sales

​

 

11,245

​

 

7,967

 

​

3,278

 

41

%

Gross (Loss) Profit

​

 

(3,857)

​

 

332

 

​

(4,189)

 

(1,262)

%

Operating Expenses

​

 

  ​

​

 

  ​

 

​

  ​

 

  ​

​

General and administrative

​

 

40,788

​

 

27,474

 

​

13,314

 

48

%

Total operating expenses

​

 

40,788

​

 

27,474

 

​

13,314

 

48

%

Operating Loss

​

 

(44,645)

​

 

(27,142)

 

​

(17,503)

 

64

%

Nonoperating Income (Expense)

​

 

  ​

​

 

  ​

 

​

  ​

 

  ​

​

Interest income

​

 

637

​

 

1,053

 

​

(416)

 

(40)

%

Grant income

​

 

7,062

​

 

2,306

 

​

4,756

 

206

%

Other income

​

 

865

​

 

263

 

​

602

 

229

%

Interest expense, change in fair value, and amortization of debt discount

​

 

(6,515)

​

 

(3,439)

 

​

(3,076)

 

89

%

Other expense

​

 

(578)

​

 

(25)

 

​

(553)

 

2,212

%

Total nonoperating expense

​

 

1,471

​

 

158

 

​

1,313

 

831

%

Net Loss

​

$

(43,174)

​

$

(26,984)

​

$

(16,190)

 

60

%

​

Net Sales

Total net sales decreased by $0.9 million, or 11%, for the year ended December 31, 2025 as compared to the year ended December 31, 2024. This decrease was primarily attributable to a continued strategic shift away from powder tools toward semiconductor-focused products and services. This strategic shift required time to develop the related sales pipeline and resulted in increased use of discounts to incentivize sales of semiconductor equipment. The decrease was partially offset by increased battery manufacturing revenue.

Tool manufacturing and related services

Revenue from tool manufacturing and related services decreased by $2.2 million, or 33%, for the year ended December 31, 2025 as compared to the year ended December 31, 2024. The decrease was attributable to lower booking activity and increased discounts, which rose to 22% from 9% as incentives were provided to commercial semiconductor tool buyers, increasing semiconductor tool revenue by $2.1 million. These increases were offset by a $2.6 million decline in powder tool revenue as commercial powder tools were de-prioritized, as well as a $1.1 million decline in research semiconductor tool revenue.

Coating services

Coating services revenue increased by $0.1 million, or 7%, for the year ended December 31, 2025 as compared to the year ended December 31, 2024. The increase was primarily attributable to a shift toward larger, longer-term proof-of-concept projects with fewer discounts. Although gross revenue and total project volume declined, average discounts decreased from 45% to 34%, resulting in higher net revenue.

68

Table of Contents

​

Battery manufacturing

Battery manufacturing revenue increased by $1.2 million for the year ended December 31, 2025 as compared to the year ended December 31, 2024. The increase was driven by the ramp-up of commercial battery manufacturing activity, supported by new third-party manufacturing partnerships and the Forge Nano prototype battery line.

Cost of sales

Total cost of sales increased by $3.3 million, or 41%, for the year ended December 31, 2025 as compared to the year ended December 31, 2024. The increase was primarily driven by lower gross margins on equipment sales due to a higher proportion of semiconductor alpha and custom tool builds, increased direct labor and material costs and expanded battery manufacturing activity, which currently carries lower margins as the business scales.

Tool manufacturing and related services

Cost of sales for tool manufacturing and related services increased by $0.8 million, or 15%, for the year ended December 31, 2025 as compared to the year ended December 31, 2024. The increase was driven by higher labor and material inputs required for alpha and custom semiconductor tool builds, partially offset by lower overall production volumes.

Coating services

Coating services cost of sales increased by $1.4 million, or 58%, for the year ended December 31, 2025 as compared to the year ended December 31, 2024. The increase was primarily attributable to higher depreciation expense related to cleanroom and coating equipment capitalized and placed into service toward the end of 2024, along with increased facility-related costs.

Battery manufacturing

Battery manufacturing cost of sales increased by $1.0 million for the year ended December 31, 2025 as compared to the year ended December 31, 2024. The increase reflects higher production volumes as battery manufacturing activity expanded in 2025. These services currently operate at lower margins as the Company continues to scale operations with its third-party manufacturers and optimize processes on its own prototype line. Lower-margin jobs were also undertaken to penetrate new markets, including satellite applications.

General and administrative

General and administrative expenses increased by $13.3 million, or 48%, for the year ended December 31, 2025 as compared to the year ended December 31, 2024. The increase was primarily attributable to the launch of the Department of Energy grant for the Morrisville battery facility in 2025, which incurred $10.4 million of general and administrative expenses. In addition, $4.1 million of non-cash rent expense associated with the Forge Battery Morrisville, North Carolina facility also commenced in 2025.

Interest income

Interest income decreased by $0.4 million, or 40%, for the year ended December 31, 2025 as compared to the year ended December 31, 2024. The decrease was primarily due to lower average cash balances held in interest-bearing money market accounts during 2025.

Grant income

Grant income increased by $4.8 million for the year ended December 31, 2025 as compared to the year ended December 31, 2024, driven by the commencement of the Department of Energy BIL grant under which the Company submitted $5.5 million in reimbursements.

69

Table of Contents

​

Interest expense, change in fair value, and amortization of debt discount

Interest expense, change in fair value, and amortization of debt discount increased by $3.1 million, or 89%, for the year ended December 31, 2025 as compared to the year ended December 31, 2024. The increase was primarily driven by losses attributable to the fair market value of warrants, which were subject to a lender’s exercise of $2.6 million of its paid-in warrants.

Other expense

Other expense increased by $0.6 million for the year ended December 31, 2025 as compared to the year ended December 31, 2024. The increase was primarily attributable to early payment penalties associated with the repayment of the Orion Infrastructure Capital note.

Non-GAAP Financial Measures of our Performance

We present Adjusted EBITDA, Adjusted EBITDA Margin and Free Cash Flow because we believe these measures provide investors with additional insight into our operating performance and liquidity. Management uses these measures internally to evaluate performance, allocate resources, and assess our ability to service indebtedness. These measures are not prepared in accordance with U.S. GAAP and should not be considered in isolation or as substitutes for GAAP results. Other companies may define these measures differently.

Adjusted EBITDA is defined as net income (loss) before interest expense, income taxes, depreciation and amortization, amortization of right-of-use assets, amortization of intangible assets, stock-based compensation, non-cash interest expense, changes in fair value of derivative liabilities and contingent consideration, and other nonrecurring items. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by total net sales. Free Cash Flow is defined as net cash provided by (used in) operating activities less purchases of property and equipment and deposits paid for property and equipment.

The following table reconciles Adjusted EBITDA and Adjusted EBITDA Margin to net loss and net loss margin, the most directly comparable financial measure calculated and presented in accordance with GAAP for the three and nine months ended September 30:

​

​

​

​

​

​

​

​

​

​

Nine months ended

 

​

​

September 30,

 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

 

Net loss

​

$

(44,504)

​

$

(33,669)

​

Net loss margin

​

 

(734)

%  

 

(632)

%

Add back:

​

 

  ​

​

 

  ​

​

Depreciation and amortization

​

 

2,096

​

 

2,101

​

Amortization of right-of-use operating lease asset

​

 

2,275

​

 

1,410

​

Amortization of intangible assets

​

 

153

​

 

152

​

Stock-based compensation

​

 

1,262

​

 

765

​

Board of directors stock-based compensation

​

 

77

​

 

74

​

(Gain) loss on reversal of provision for loss on contract

​

 

(353)

​

 

15

​

Amortization of convertible debt discount

​

 

122

​

 

2,336

​

Loss on extinguishment of debt

​

 

—

​

 

3,891

​

Change in fair value of contingent consideration for Sundew ALD acquisition

​

 

958

​

 

765

​

Change in fair value of warrant liabilities

​

 

9,293

​

 

(711)

​

Other nonoperating income

​

 

(2,487)

​

 

(5,271)

​

Adjusted EBITDA

​

$

(31,108)

​

$

(28,142)

​

Adjusted EBITDA margin

​

 

(513)

%  

 

(528)

%

​

70

Table of Contents

​

The following table reconciles net cash provided by operating activities in the Consolidated Statements of Cash Flows to Free Cash Flow for the nine months ended September 30:

​

​

​

​

​

​

​

​

​

Nine months ended

​

​

September 30,

​

​

2026

​

2025

Net cash, cash equivalents, and restricted cash used in operating activities

  ​ ​ ​

$

(29,326)

  ​ ​ ​

$

(26,648)

Purchase of property and equipment

​

 

(1,117)

​

 

(363)

Free cash flow

​

$

(30,443)

​

$

(27,011)

​

The following table reconciles Adjusted EBITDA and Adjusted EBITDA Margin to net loss and net loss margin, the most directly comparable financial measure calculated and presented in accordance with GAAP for the years ended December 31, 2025 and 2024:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Years ended December 31,

 

​

  ​ ​ ​

2025

  ​ ​ ​

2024

 

Net loss

​

$

(43,174)

​

$

(26,984)

 

Net loss margin

​

​

(584)

%  

​

(325)

%

Add back:

​

​

  ​

 

​

  ​

​

Depreciation and amortization

​

​

2,822

 

​

1,354

​

Amortization of righ-of-use operating lease asset

​

​

2,315

 

​

429

​

Amortization of intangible assets

​

​

203

 

​

253

​

Stock-based compensation

​

​

851

 

​

620

​

Board of directors stock-based compensation

​

​

572

 

​

400

​

Gain on reversal of provision for loss on contract

​

​

504

 

​

(2)

​

Amortization of convertible debt discount

​

​

2,859

 

​

2,963

​

Loss on extinguishment of debt

​

​

3,841

 

​

—

​

Change in fair value of derivative liability

​

​

—

 

​

—

​

Change in fair value of contingent consideration for Sundew ALD acquisition

​

​

748

 

​

811

​

Non-cash interest expense

​

​

—

 

​

17

​

Change in fair value of warrant liabilities

​

​

(640)

 

​

366

​

Other nonoperating income

​

​

(8,279)

 

​

(4,315)

​

Adjusted EBITDA

​

$

(37,378)

​

$

(24,088)

​

Adjusted EBITDA margin

​

 

(506)

%  

 

(290)

%

​

The following table reconciles net cash provided by operating activities in the Consolidated Statements of Cash Flows to Free Cash Flow for the years ended December 31, 2025 and 2024:

​

​

​

​

​

​

​

​

​

Years ended December 31,

​

​

2025

​

2024

Net cash, cash equivalents, and restricted cash used in operating

  ​ ​ ​

$

(34,346)

  ​ ​ ​

$

(23,772)

Purchase of property and equipment

​

 

(882)

​

 

(12,553)

Free cash flow

​

$

(35,228)

​

$

(36,325)

​

These metrics are not constructed in accordance with U.S. GAAP, and our use of these terms varies from others in our industry. These metrics should not be considered as alternatives to net income, cash flow from operations or any other performance measure derived in accordance with U.S. GAAP as measures of operating performance. These metrics have important limitations as an analytical tool and should not be considered in isolation or as substitutes for analysis of our results as reported under U.S. GAAP. Because of the limitations, we rely primarily on our U.S. GAAP results and use these metrics only as supplemental measures.

71

Table of Contents

​

Liquidity, Going Concern and Capital Resources

During the three months ended September 30, 2026 and 2025, the Company incurred net losses in the amount of $12.0 million and $11.7 million, respectively. During the nine months ended September 30, 2026 and 2025, the Company incurred net losses in the amount of $44.5 million and $33.7 million, respectively, and generated negative cash flows from operations in the amounts of $29.3 million and $26.6 million, respectively. Additionally, as of September 30, 2026, the Company had an accumulated deficit in the amount of $173.6 million and cash and cash equivalents of $15.7 million.

Based on current liquidity, historical operating losses, negative operating cash flows, and forecasted expenditures as of September 30, 2026, the Company’s current forecast of operating results and cash flows, combined with the effect of the financing transactions related to the Business Combination, management determined that there is substantial doubt about the Company’s ability to continue as a going concern over the twelve months following the date of these financial statements.

Subsequent to September 30, 2026, the Company completed the Business Combination and PIPE Financing. Management believes that these proceeds are adequate to fund the Company’s operations and planned capital expenditures.

As of September 30, 2026, the Company’s unaudited consolidated balance sheet reflects a working capital ratio of approximately 1.4, indicating that current assets are sufficient to meet short-term obligations. Based on the Company’s current cash burn rate, management estimates that existing cash resources provide approximately nine months of liquidity, exclusive of other commitments.

The Company’s cash balance at September 30, 2026 reflects the proceeds received from the final closing of its Series D convertible preferred equity financing.

The initial Series D financing round was undertaken during a period of constrained capital market activity, characterized by increased market uncertainty associated with U.S. trade policy developments and a broader decline in investor confidence in global equity markets. Notwithstanding these conditions, the Company completed the Series D financing as planned.

Management has prepared an interim cash flow forecast covering the period from October 1, 2026 through September 30, 2027 based on the Company’s current operating plan, revenue outlook, historical spending patterns. The forecast assumes no additional equity or project financing proceeds, including any proceeds that may result from the Business Combination and associated $123.0 million of committed PIPE financing or its efforts to secure approximately $275.0 million of financing for the Morrisville facility through the Office of Strategic Capital. As a result, the forecast assumes a reduced pace of capital deployment for the Morrisville facility until additional financing is obtained. The forecast further assumes continued funding under the Department of Energy’s $100.0 million Bipartisan Infrastructure Law grant program, forecasted commercial bookings for Forge Nano products and services, gradual improvement in direct gross margins to approximately 27.5% by the third quarter of 2027, and limited investment in Forge Nano and the acquisition of HzO during the forecast period.

Based on this forecast, management expects the Company’s cash balance to remain positive throughout the forecast period, including under a sensitivity in which revenues reach only 75% of forecasted revenues. The forecast is based on estimates and assumptions that are subject to uncertainty, including the timing and amount of bookings and the Company’s ability to achieve forecasted margins, and actual results could differ materially.

The Company’s capital structure includes preferred shares that do not carry mandatory dividend requirements. The Company maintains flexibility in its financing strategy, including potential equity raises and refinancing options to address outstanding debt obligations.

The Forge Battery project represents a significant future capital commitment. Project financing will only be pursued once key risks have been mitigated, including secured off-take agreements, finalized construction and equipment budgets, and engagement of an experienced Engineering, Procurement and Construction (“EPC”) contractor. Forge Battery will bear the obligations and collateral associated with project financing and lease commitments, insulating Forge Nano from direct exposure. While failure to complete the Forge Battery facility could negatively impact the Company’s reputation and future capital-raising efforts, it is not expected to materially affect cash flows within the next 12 months.

72

Table of Contents

​

Cash Flows

Nine Months Ended September 30, 2026 Compared to the Nine Months Ended September 30, 2025

The following table presents a summary of our net cash (used in) provided by operating, investing and financing activities for the historical periods:

​

​

​

​

​

​

​

​

​

Nine months ended

​

​

September 30,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Cash flows (used in) provided by:

​

  ​

​

​

  ​

​

Operating activities

​

$

(29,326)

​

$

(26,648)

Investing activities

​

 

(12,117)

​

 

(363)

Financing activities

​

 

48,826

​

 

33,714

Net increase in cash, cash equivalents, and restricted cash

​

$

7,383

​

$

6,703

​

Net cash used in operating activities

During the nine months ended September 30, 2026, net cash used in operating activities was $29.3 million, consisting primarily of a net loss of $44.5 million and $0.7 million of cash used by changes in operating assets and liabilities, partially offset by $15.9 million of non-cash adjustments. Non-cash items include change in fair value of warrant liabilities of $9.3 million, amortization of non-cash lease expense and intangible assets of $2.4 million, depreciation and amortization expense of $2.1 million, a change in fair value of contingent consideration for Sundew ALD acquisition of $1.0 million, stock-based compensation including Board of Directors of $1.3 million, gain on reversal of provision for loss on contract of $0.4 million and amortization of debt discount of $0.1 million. Cash used by changes in operating assets and liabilities was primarily attributable to increases in inventory of $3.0 million, deposits of $0.1 million, prepaid expenses and other current assets of $1.0 million and contract assets — unbilled accounts receivable of $0.3 million. These uses were partially offset by increases in accrued and other current liabilities of $3.2 million and contract liabilities-deferred revenue of $0.5 million, and decrease in accounts receivable of $0.1 million.

During the nine months ended September 30, 2025, net cash used in operating activities was $26.6 million, consisting primarily of a net loss of $33.7 million and $3.8 million of cash used by changes in operating assets and liabilities, partially offset by $10.8 million of non-cash adjustments. Non-cash items include amortization of non-cash lease expense and intangible assets of $1.6 million, amortization of debt discount of $2.3 million, depreciation and amortization expense of $2.1 million, a change in fair value of contingent consideration for Sundew ALD acquisition of $0.8 million, change in fair value of warrant liabilities of $(0.7) million, loss on extinguishment of debt of $3.9 million and stock-based compensation of $0.8 million. Changes in working capital were primarily driven by increase in deposits of $0.8 million, contract assets — unbilled accounts receivable of $2.0 million, inventory of $0.9 million, prepaid expenses and other current assets of $0.4 million, partially offset by decreases in accounts payable of $2.2 million, contract liabilities-deferred revenue of $0.3 million and accrued and other current liabilities of $0.5 million, partially offset by decrease in the accounts receivable of $0.6 million and an increase in operating lease liabilities of $2.8 million.

Net cash used in investing activities

During the nine months ended September 30, 2026, we used $12.1 million of cash in investing activities, primarily for the purchases of property and equipment of $1.1 million, deposits paid for property and equipment of $10.0 million and issuance of $1.0 million advance to HzO under a credit agreement.

During the nine months ended September 30, 2025, we used $0.4 million of cash in investing activities, primarily for the purchases of property and equipment.

Net cash provided by financing activities

Cash provided by financing activities during the nine months ended September 30, 2026 was $48.8 million, primarily as a result of net proceeds from issuance of Series D preferred stock of $50.3 million, net of issuance costs of $1.6 million.

73

Table of Contents

​

Cash provided by financing activities during the nine months ended September 30, 2025 was $33.7 million, primarily as a result of net proceeds from issuance of Series D preferred stock of $33.6 million, and Series D convertible note of $1.2 million, partially offset by issuance costs of $0.7 million and a $0.4 million payment of contingent consideration for the Sundew ALD acquisition.

Year Ended December 31, 2025 Compared to the Year Ended December 31, 2024

The following table presents a summary of our net cash (used in) provided by operating, investing and financing activities for the historical periods:

​

​

​

​

​

​

​

​

​

Years ended December 31,

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Cash flows (used in) provided by:

​

​

​

​

​

​

Operating activities

​

$

(34,346)

​

$

(23,772)

Investing activities

​

 

(882)

​

 

(12,553)

Financing activities

​

 

32,419

​

 

7,087

Net decrease in cash, cash equivalents, and restricted cash

​

$

(2,809)

​

$

(29,238)

​

Net cash used in operating activities

During the year ended December 31, 2025, net cash used in operating activities of $34.3 million resulted primarily from adjusted non-cash items of $14.1 million, changes in our operating assets and liabilities of $5.2 million, offset by our net loss of $43.2 million. Non-cash items include loss on extinguishment of debt of $3.8 million, amortization of debt discount of $2.9 million, depreciation and amortization expense of $2.8 million, amortization of non-cash lease expense and intangible assets of $2.5 million, stock-based compensation including Board of Directors of $1.4 million, a change in fair value of contingent consideration for our acquisition of Sundew of $0.7 million and change in fair value of warrant liabilities of $0.6 million. Changes in working capital were primarily driven by increases in deposits of $3.4 million, contract assets — unbilled accounts receivable of $2.9 million, inventory of $1.1 million, prepaid expenses and other current assets of $0.5 million, account receivable of $0.3 million, partially offset by increase in operating lease liabilities of $2.6 million, increases in accounts payable of $0.4 million, contract liabilities-deferred revenue of $0.1 million and decreases in accrued and other current liabilities of less than $0.1 million.

During the year ended December 31, 2024, net cash used in operating activities of $23.8 million resulted primarily from adjusted non-cash items of $7.2 million, changes in our operating assets and liabilities of $4.0 million, offset by our net loss of $27.0 million. Non-cash items include amortization of debt discount of $3.0 million, depreciation and amortization expense of $1.4 million, amortization of non-cash lease expense and intangible assets of $0.7 million, stock-based compensation including Board of Directors of $1.0 million, change in fair value of warrant liabilities of $0.4 million and a change in fair value of contingent consideration for Sundew ALD acquisition of $0.8 million. Changes in working capital were primarily driven by increases in contract assets — unbilled accounts receivable of $2.6 million, deposits of $3.0 million, inventory of $0.2 million, prepaid expenses and other current assets of $0.2 million and decreases in accrued and other current liabilities of $0.2 million, and operating lease liabilities of $0.4 million, partially offset by decreases in account receivable of $0.9 million, and increases in accounts payable of $1.2 million, and contract liabilities-deferred revenue of $0.4 million.

Net cash used in investing activities

During the year ended December 31, 2025, we used $0.9 million of cash in investing activities, primarily for the purchases of property and equipment.

During the year ended December 31, 2024, we used $12.6 million of cash in investing activities, primarily for the purchases of property and equipment.

Net cash provided by financing activities

Cash provided by financing activities during the year ended December 31, 2025 was $32.4 million, primarily as a result of net proceeds from issuance of Series D preferred stock of $40.3 million, net of issuance costs of $0.8 million, partially offset by cash paid for the principle payment of debt of $7.5 million and cash paid for acquisition of Sundew ALD assets of $0.4 million.

74

Table of Contents

​

Cash provided by financing activities during the year ended December 31, 2024 was $7.1 million, primarily as a result of net proceeds from the issuance of Series C preferred stock of $5.3 million, proceeds from the issuance of Series D convertible note of $1.9 million, proceeds from warrants exercised of $0.2 million, partially offset by cash paid for the acquisition of Sundew ALD assets of $0.4 million.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, a material current or future effect on our financial condition, changes in financial condition, revenues, expenses, results of operations, liquidity, capital expenditures or capital resources.

Critical Accounting Estimates and Significant Judgments and Estimates

Our audited consolidated financial statements have been prepared in accordance with GAAP. The preparation of these audited consolidated financial statements in accordance with GAAP requires management to make certain estimates, assumptions and judgments that affect the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenue and expenses during the reporting period. Although we believe our estimates, assumptions and judgments are reasonable, actual results may differ from our estimates under different assumptions, judgments or conditions.

Our significant accounting policies, which are detailed in Note 2 to our audited consolidated financial statements included elsewhere in this prospectus, describe the significant accounting policies and methods used in the preparation of our consolidated financial statements. Of our significant accounting policies, we consider the following policies to be critical as they involve a higher degree of subjective or complex judgments and assumptions, often as a result of the need to make estimates about the effect of inherently uncertain matters.

Revenue Recognition

Revenue is recognized over time for most contracts using an input method based on labor hours incurred relative to total estimated labor hours. This requires significant judgment in estimating total contract costs and progress toward completion. Changes in these estimates can materially affect the timing and amount of revenue recognized. For the three months ended September 30, 2026 and 2025, three customers represented approximately 33% and two customers represented approximately 35% of total net revenue, respectively. For the nine months ended September 30, 2026 and 2025, one customer represented approximately 23% and one customer represented approximately 18% of total net revenue, respectively. Variable consideration, primarily related to change orders and cost overages, is included in the transaction price when it is probable that a significant reversal will not occur. While historical adjustments have not been material, future changes in estimates could significantly impact reported results.

Accounts Receivable

The Company estimates an allowance for credit losses on accounts receivable based on historical collection experience, current conditions, and benchmarking against comparable public companies. This estimate involves judgment and is subject to change based on customer credit risk and economic factors. The allowance is generally calculated as approximately 2% of total accounts receivable, with additional adjustments made for specific accounts as needed. Changes in these estimates could materially affect reported results. As of September 30, 2026 and December 31, 2025, the allowance for credit losses was $37 and $40, respectively, and any significant changes in assumptions could impact future periods’ financial condition and results of operations.

Recent Accounting Pronouncements Not Yet Adopted

See Note 2 to our unaudited condensed consolidated financial statements included elsewhere in this prospectus for more information about recent accounting pronouncements, the timing of their adoption, and our assessment, to the extent we have made one yet, of their potential impact on our financial condition or results of operations.

75

Table of Contents

​

Quantitative and Qualitative Disclosures about Market Risk

We are exposed to certain market risks as part of our ongoing business operations, including risks from changes in interest rates on debt obligations and foreign currency exchange rates that could impact our financial condition, results of operations and cash flows. We manage our exposure to these and other market risks through regular operating and financing activities.

Interest Rate Risk

Our exposure to interest rate risk primarily relates to our outstanding indebtedness and any future borrowings. As of September 30, 2026, we had an outstanding note payable to OIC with a remaining balance of approximately $10.5 million, which bore interest at a fixed rate and was repaid in full on October 20, 2026. Because this obligation was fixed-rate debt, we are not currently exposed to fluctuations in market interest rates with respect to this note. However, if we seek to refinance this debt or obtain additional financing, changes in prevailing interest rates could increase our cost of capital and adversely affect our financial condition.

Additionally, if we pursue project financing for the Forge Battery initiative, such financing may include variable-rate components, which would expose us to interest rate volatility. A hypothetical 100 basis point increase in interest rates on a $50 million variable-rate borrowing would result in an incremental annual interest expense of approximately $.55 million. We currently do not utilize derivative instruments to manage interest rate risk.

Commodity Risk

Our operations involve the development and commercialization of advanced materials and technologies, which require certain raw materials and components. While we do not currently engage in large-scale commodity purchases, our costs may be indirectly affected by fluctuations in commodity prices, particularly metals and chemicals used in powder and semiconductor applications. Significant increases in the prices of these inputs could raise our production costs and negatively impact margins.

We do not currently hedge commodity price risk through futures contracts or other derivative instruments. However, as our commercial volumes increase, we may consider implementing risk management strategies to mitigate exposure to commodity price volatility.

JOBS Act Accounting Election

The JOBS Act contains provisions that, among other things, reduce certain reporting requirements for an “emerging growth company.” We have elected to use this extended transition period for complying with certain new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our audited financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. Refer to Note 2 to our audited consolidated financial statements included elsewhere in this prospectus for additional information regarding new or revised accounting pronouncements.

We have chosen to rely on the other exemptions and reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, as an “emerging growth company” we are not required to, among other things, (i) provide an auditor’s attestation report on our system of internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act; (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies; (iii) comply with certain types of new requirements adopted by the PCAOB; and (iv) disclose certain executive compensation-related items, such as the correlation between executive compensation and performance and comparisons of the chief executive officer’s compensation to median employee compensation. We may remain an “emerging growth company” until the last day of the fiscal year following the February 12, 2030. However, if certain events occur prior to such date, including if we become a “large accelerated filer,” our annual gross revenue equals or exceeds $1.235 billion or we issue more than $1.0 billion of non-convertible debt in any three-year period, we will cease to be an “emerging growth company” prior to such date.

​

76

Table of Contents

​

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

Founder Shares

In June 2024, ATII issued an aggregate of 5,750,000 Founder Shares to the Sponsor for an aggregate purchase price of $25,000.

Pursuant to the Insider Letter, the Sponsor and certain insiders of ATII agreed, subject to limited exceptions, to restrictions on transfer with respect to their shares of Common Stock, ending on the earlier of (A) April 22, 2027 and (B) the date the last reported sale price of our Common Stock equals or exceeds $12.00 per share (subject to adjustment) for any twenty trading days within any thirty-trading day period.

In connection with the Business Combination, ATII, Forge Nano and the Sponsor entered into the Purchaser Support Agreement.

Registration Rights Agreement

On October 22, 2026, certain holders of our Common Stock entered into the A&R Registration Rights Agreement, pursuant to which, among other things, we agreed to file a shelf registration statement with the SEC as soon as practicable but no later than 30 calendar days following the Closing to register the resale of certain of our securities, and to use commercially reasonable efforts to have such registration statement declared effective as soon as practicable after the filing thereof, but no later than the earlier of (i) 60 calendar days (or 90 calendar days if the SEC notifies us that it will “review” such registration statement) following the date of the A&R Registration Rights Agreement and (ii) five business days after we are notified by the SEC that such registration statement will not be “reviewed” or will not be subject to further review. The A&R Registration Rights Agreement also provides certain holders with demand, underwritten shelf takedown and “piggy-back” registration rights, subject to certain requirements and customary conditions. All expenses of registration under the A&R Registration Rights Agreement, including the legal fees of one firm of counsel chosen by stockholders participating in a registration (subject to a cap), will be paid by the Company.

Consulting Agreement

On August 8, 2022, Forge Nano entered into a consulting agreement (the “Ascent Consulting Agreement”) with Ascent Funds International Management LLC (“Ascent”), as amended by the amended and restated consulting agreement, by and between Forge Nano and Ascent Funds International Management LLC, dated as of September 1, 2025, pursuant to which Ascent agreed to provide consulting services to Forge Nano relating to among other things, marketing, financial modeling and fundraising activities in exchange for options to purchase shares of Forge Nano common stock. Such options converted into Ascent Warrants in connection with the Business Combination, as described herein.

Officer Loan

On March 23, 2018, Paul Lichty issued a promissory note to Forge Nano for a principal amount of $504,003.72. The promissory note was settled in full on January 28, 2026.

Acquisition of HzO

On November 4, 2026, we completed our acquisition of HzO, a provider of parylene-based thin-film coating solutions that protect electronic components from moisture, corrosion and other environmental damage with operations in the United States, Mexico and Asia, in exchange for up to 7,306,440 shares of Common Stock. HzO’s coating capabilities are complementary to Forge Nano’s ALD platform and are expected to expand the combined company’s environmental barrier protection offerings.

On March 13, 2026, HzO funded an investment in Forge Nano consisting of (i) $13,000,000 in cash and (ii) a deemed unsecured loan of $2,000,000 from Forge Nano to HzO, evidenced by a credit agreement, dated as of March 13, 2026, between Forge Nano and HzO (the “HzO Loan Agreement”), in each case in exchange for 76,116 shares of Forge Nano Series D Preferred Stock, which shares were exchanged for shares of Common Stock in connection with the Business Combination. Pursuant to the HzO Merger Agreement, at the closing of the HzO Merger, the outstanding principal amount of, and all accrued and unpaid interest on, the HzO Loan Agreement was deemed satisfied in full, with the amount so satisfied deducted from the HzO Merger consideration.

Kamal Bherwani, one of our directors, resigned from his positions as Executive Chairman, Lead Director and a member of the board of HzO in connection with the HzO Merger.

​

77

Table of Contents

​

MANAGEMENT

Executive Officers and Directors

The following persons serve as our directors and executive officers as of the date of this prospectus.

Directors

​

​

​

​

​

Name

  ​ ​ ​

Age

  ​ ​ ​

Position

Paul Lichty

​

42

​

Chair of the Board, Director

Michael Danner

​

64

​

Director

David Goggins

​

60

​

Director

Millicent Pitts-DiCicco

​

72

​

Director

Jimmy Smith

​

60

​

Director

Kamal Bherwani

​

57

​

Director

Ben Landen

​

39

​

Director

​

Background and Business Experience

Paul Lichty is a co-founder of Forge Nano, has served as a Forge Nano director since July 2017, and has served as Chief Executive Officer of Forge Nano since 2011. Prior to founding Forge Nano, Mr. Lichty was Research Engineer at Sundrop Fuels Inc. from 2012 to 2014, Engineering Consultant at Lichty Engineering from 2007 to 2010, and Research Engineer at Copernican Energy from 2006 to 2007. Mr. Lichty holds a Ph.D. in Chemical and Biological Engineering and a B.S. in Mechanical Engineering from the University of Colorado, Boulder. Mr. Lichty has been published in various scientific journals and holds numerous U.S. public patents. We believe Mr. Lichty is qualified to serve on our Board given his leadership experience and expertise.

Michael Danner has served as a director of Forge Nano since 2018. Mr. Danner is currently a partner at Invent Development Partners, a real estate development firm specializing in modern construction techniques, a position he has held since 2013. Prior to this, Mr. Danner founded and operated a manufacturing company specializing in magnetics, motors, pumps and electronics in 1996, where he partnered with others to develop commercial size wind farms before ultimately selling the company to General Electric in 2008. Mr. Danner began his career as a computer-aided design engineer for the high voltage switch gear division of Boeing Commercial Aircraft and Siemens in Germany. Mr. Danner graduated from Northeastern University with a degree in Mechanical Engineering. We believe Mr. Danner is qualified to serve on our Board due to his extensive technical and leadership experience.

David Goggins has served as a director of Forge Nano since 2024. Mr. Goggins currently manages his own consulting company, which he founded in 2023, providing executive consulting with a focus on strategy development, program management, risk/opportunity strategy and industrial base strategy development. Prior to his retirement, Mr. Goggins served in the U.S. Navy for over 34 years and achieved the rank of Rear Admiral. In 2022, Mr. Goggins was assigned as the special assistant to the Assistant Secretary of the Navy for Research, Development and Acquisition for the Australian-United Kingdom-United States Partnership, a position he held until 2023. From 2021 to 2022, Mr. Goggins served as Program Executive Officer, Attack Submarines and from 2018 to 2021, he served as Program Executive Officer, Submarines. Mr. Goggins served as major program manager of the Virginia Class Program and the Columbia Class Program from 2012 to 2015 and 2015 to 2018, respectively, where he led the design, construction and sustainment of nuclear-powered submarines for the U.S. Navy. Prior to these roles, Mr. Goggins held various roles within the U.S. Navy. Mr. Goggins attended the University of California, Berkeley and graduated in 1989 with a B.S. in Nuclear Engineering and Material Science Engineering. His graduate education includes an M.S. degree in Operations Research from the Naval Postgraduate School and two M.S. degrees from the Massachusetts Institute of Technology in Mechanical Engineering and in Naval Architecture and Marine Engineering. We believe Mr. Goggins is qualified to serve on our Board given his extensive leadership and advisory experience.

78

Table of Contents

​

Millicent Pitts-DiCicco has served as a director of Forge Nano since 2023. Ms. Pitts-DiCicco is a seasoned executive with over 30 years of experience in the chemicals and materials industry, having worked for companies such as BASF/Engelhard, Mayan Pigments, Ferro Corp, Rohm & Haas and Arco Chemical. Ms. Pitts-DiCicco currently serves as the Chief Executive Officer of the Ocean Exchange, a non-profit that awards seed funding to industrial and social start-ups, a position she has held since 2013. Ms. Pitts-DiCicco was a board member and officer of the Landings Association from 2011 to 2013, an 8,700-resident coastal community with a $10 million operating budget. Ms. Pitts-DiCicco also serves as a steering committee member of OceanVisions.org, a non-profit organization aimed at advancing responsible and effective ocean-based climate solutions. She is currently an associate at Creative Destruction Labs in Atlantic Canada and is an awardee of a four-year NOAA program for the Ocean Enterprises. She previously served as a registered civil mediator and has frequently served as a judge, mentor or advisor in clean-tech and marine-energy programs. Ms. Pitts-DiCicco holds an M.B.A. from the Wharton School of the University of Pennsylvania and a B.A. in Accounting, with a minor in Economics, from Stephen F. Austin State University. We believe Ms. Pitts-DiCicco is qualified to serve on our Board due to her extensive management and entrepreneurship experience.

Jimmy Smith has served as a director of Forge Nano since 2024. Mr. Smith is currently the Vice President for Commercial Strategy and Contract Performance for Government Programs at Hornbeck Offshore, a global marine logistics company headquartered in Covington, Louisiana. Prior to that role, he served as the Chief Executive Officer of Pacific Engineering Incorporated, a composite material design and manufacturing company with headquarters in Nebraska, a position he has held since 2023. He is also the owner of “Smith Advisory Consulting,” a consulting firm he founded in 2023. Prior to this, Mr. Smith served as the Small Business Director for the Department of the Navy Senior Executive Service from 2019 to 2023. In fiscal year 2022, Mr. Smith served as the Chairman of the Federal Office of Small Disadvantaged Business Utilization Directors Interagency Council, where he worked closely with Congress, the Small Business Administration and the Office of Management and Budget to ensure that the barriers to small businesses doing business with the Federal government were eliminated through more inclusive policies and the adoption of best practices. In 2019, Mr. Smith served as the Small Business Director for the Department of the Navy, where he was charged with overseeing small business acquisition policy. In 2017, Mr. Smith served as the Deputy Assistant Secretary of the Navy for Expeditionary Programs & Logistics Management delivering upon urgent warfighter needs and overseeing acquisition logistics policy for the entire U.S. Navy and U.S. Marine Corps team. In 2013, Mr. Smith served as the Director for Integrated Nuclear Weapons Safety and Security within the U.S. Navy’s Strategic Systems Programs, where he was charged with safekeeping nuclear arsenal. Mr. Smith’s other notable positions include working as an Executive Director for Undersea Technology; Deputy Program Manager for the Ohio Class Guided Missile Submarine (SSGN) Program; and Construction Manager, Test & Evaluation Manager and Environmental Manager for the Virginia (SSN 774) Class Submarine Program. Currently, Mr. Smith also serves on the Board of Directors for Dobbs Defense Solutions, 11th Hour Services, JRC Integrated Systems and Acquisition NexGen.

Mr. Smith received a B.S. in mechanical engineering, in 1990, from Tuskegee University. He completed graduate-level studies in Environmental Engineering, Marine Engineering and Business Management. He also possesses four executive leadership certificates from the Cornell University School of Industrial and Labor Relations and two executive business certificates from the University of North Carolina at Chapel Hill, Kenan-Flagler Business School. We believe Mr. Smith is qualified to serve on our Board given his extensive technical, leadership and advisory experience.

Kamal Bherwani has served as a director of Forge Nano since 2026. Mr. Bherwani has more than 30 years of global technology and operating experience with multibillion-dollar enterprises across both the public and private sectors. He served as Chairman, Lead Director and a director of HzO, Inc., a provider of advanced nanocoating and materials-protection technologies, from 2014, and as its Executive Chairman from early 2024, until our acquisition of HzO in November 2026, at which time he resigned from all positions with HzO. In addition, Mr. Bherwani serves as Chairman and Chief Executive Officer of PreClivity and Innovation Advisory Services, Inc., and as Chairman of Magine and Leyra in Stockholm, Sweden. Since January 2026, he has also served as Interim Chief Executive Officer and a director of RadiusAI, Inc. in Tempe, Arizona. Mr. Bherwani previously served as Chief Executive Officer of Voyatek (formerly GCOM Software, Inc.) from 2019 to 2023. Mr. Bherwani has spent a significant portion of his career in various New York City administrations, including as the first Chief Information Officer of the City’s Health and Human Services domain, comprised of several agencies focusing on social services, criminal justice, and health. We believe Mr. Bherwani is qualified to serve on our Board due to his background in advanced materials and nanocoating technologies and his extensive governance and management experience across multiple technology and media companies.

79

Table of Contents

​

Ben Landen has served as a Special Advisor to Archimedes Tech SPAC Partners II Co. since February 2025. Mr. Landen has been Chief Executive Officer of Archimedes Tech SPAC Partners III Co. since April 2026 and its Chief Technology Officer since December 2025; Mr. Landen was previously the Chief Executive Officer of Archimedes Tech SPAC Partners III Co. and a director from August 2025 to December 2025. From 2021 to 2022, Mr. Landen served as a Special Advisor to Archimedes Tech SPAC Partners Co. In 2020, Mr. Landen co-founded Superposition Venture Partners, a technology-focused early-stage and pre-IPO investment firm and serves as its Managing Director. From 2021 to October 2025, Mr. Landen served as the Vice President of Business Development for the autonomous vehicle solutions developer, Cyngn Inc., after serving as the Senior Director of Product and Partnership for Cyngn Inc. from 2019. From 2017 to 2019, Mr. Landen served as the Head of Product & Business Development at DeepScale, a venture-backed startup that developed AI perception solutions for autonomous vehicles (acquired by Tesla in 2019). Mr. Landen began his career as one of the first automotive business managers of Maxim Integrated, where he spearheaded the fledgling automotive business unit’s growth and ultimately managed a $100 million automotive semiconductor product line. We believe Mr. Landen is qualified to serve on our Board due to his extensive investing and leadership experience.

Executive Officers

Name

  ​ ​ ​

Age

  ​ ​ ​

Position

Paul Lichty

​

42

​

Chief Executive Officer

Michael Kleinberg

​

56

​

Chief Financial Officer

Curtis Zimmermann

​

64

​

Chief Legal Counsel

Shane Smith

​

59

​

President of Forge Battery

​

Background and Business Experience

See above for the background and experience of Paul Lichty.

Michael Kleinberg has served as Chief Financial Officer of Forge Nano since 2020. Prior to this role, Mr. Kleinberg worked as Chief Financial and Administrative Officer at RS2 Software, Inc. from 2018 to 2020, Principal at CBIZ CMF from 2017 to 2018 and Chief Financial Officer at Accucode, Inc. from 2015 to 2017. Mr. Kleinberg also served as Chief Financial Officer / Operations at Solera Salon, Inc. and Needham Roof Systems, Inc. from 2008 to 2015. Earlier in his career, Mr. Kleinberg held various finance and investment roles at Aaron, Bell International, KNN Public Finance, La Mancha Associates, LLC, and Daniels and Associates (RBC Capital Markets). Mr. Kleinberg holds an M.B.A. in Finance from Rotman School of Management, University of Toronto, and a B.A. in English and History from Trinity College, University of Toronto.

Curtis Zimmermann has served as Chief Legal Counsel of Forge Nano since 2021. Prior to joining Forge Nano, Mr. Zimmermann held various positions at BASF Corporation, a chemical manufacturing company, including Manager, Government Liaison from 2012 to 2021. Before this, Mr. Zimmermann’s positions at BASF Corporation included Manager, Inorganic Pigments and Materials from 2010 to 2012; Manager, Science Relations in 2010; Senior Manager, New Technologies & Effect Materials from 2009 to 2010; and Manager, New Technologies & Effect Materials from 2006 to 2009. Prior to these roles, Mr. Zimmermann was involved in various technical managerial positions in materials science with an emphasis on pearlescence, optical thin film materials, fine particle science, and colloid chemistry, including as a Senior Scientist at Geo-Centers, Inc., where he focused on powder technology & military obscuration. Mr. Zimmermann holds a J.D. from Pace Law School and is a member of the New York Bar. He obtained his Ph.D. in physical chemistry from Clarkson University, New York, and his B.S. in chemistry from Millersville University, Pennsylvania.

Shane Smith has served as the President of Forge Battery since 2026. Mr. Smith worked at Microvast as Chief Operating Officer from 2019 to 2023, and at Transacore as Senior Vice-President of Product Marketing from 2013 to 2019. Prior to these roles, Mr. Smith also served at Triquint Semiconductor (which became Qorvo) from 2004 to 2013 and Sawtek from 2000-2004. Mr. Smith holds an MS Business from Johns Hopkins University, a Certified Naval Nuclear Engineer designation from the US Department of Energy and a BS in Engineering from the US Naval Academy.

80

Table of Contents

​

Board Composition

Our Board consists of seven members, with a classified board of directors divided into three classes serving staggered three-year terms as follows:

●Class I directors consist of Jimmy Smith and Ben Landen and their term will expire at the first annual meeting of stockholders following the Closing.
●Class II directors consist of David Goggins and Kamal Bherwani and their term will expire at the second annual meeting of stockholders following the Closing.
●Class III directors consist of Michael Danner, Paul Lichty and Millicent Pitts-DiCicco and their term will expire at the third annual meeting of stockholders following the Closing.

Any additional directorships resulting from an increase in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third of the directors on our Board. This classification of our Board may have the effect of delaying or preventing changes in control. At each annual meeting, holders of shares of Common Stock will elect the successors to one class of the directors on our Board.

Director Independence

Nasdaq rules generally require that independent directors (as defined under the rules of Nasdaq) must comprise a majority of a listed company’s board of directors. Based upon information requested from and provided by each director concerning his or her background, employment and affiliations, including family relationships, our board of directors has determined that David Goggins, Ben Landen, Millicent Pitts-DiCicco and Jimmy Smith, representing four of our seven directors, are “independent” as that term is defined under the applicable rules and regulations of the SEC and the listing requirements and rules of Nasdaq. In making such determinations, our board of directors considered the relationships that each such non-employee director has with us and all other facts and circumstances our board of directors deemed relevant in determining independence, including the beneficial ownership of our capital stock by each non-employee director and any institutional stockholder with which he or she is affiliated.

Role of our Board in Risk Oversight

Our Board has extensive involvement in the oversight of risk management related to Forge Nano and its business and accomplishes this oversight through the regular reporting to our Board by the audit committee. The audit committee represents our Board by periodically reviewing Forge Nano’s accounting, reporting and financial practices, including the integrity of its financial statements, the surveillance of administrative and financial controls and its compliance with legal and regulatory requirements. Through its regular meetings with management, including the finance, legal, internal audit and information technology functions, the audit committee reviews and discusses all significant areas of Forge Nano business and summarizes for our Board all areas of risk and the appropriate mitigating factors. In addition, our Board receives periodic detailed operating performance reviews from management.

Board Committees

The committees of our Board include an audit committee, a compensation committee and a nominating and corporate governance committee, each as described below. From time to time, our Board may establish other committees to facilitate the management of Forge Nano’s business.

Forge Nano’s chief executive officer and other executive officers will regularly report to the non-executive directors and the audit, compensation and nominating and corporate governance committees to ensure effective and efficient oversight of Forge Nano’s activities and to assist in proper risk management and the ongoing evaluation of management controls. Forge Nano believes that the leadership structure of our Board will provide appropriate risk oversight of Forge Nano’s activities.

81

Table of Contents

​

Audit Committee

Our audit committee consists of Millicent Pitts-DiCicco (chair), Ben Landen and David Goggins. Each member of the audit committee qualifies as an independent director under Nasdaq corporate governance standards and the independence requirements of Rule 10A-3 under the Exchange Act. Our Board has determined that Millicent Pitts-DiCicco qualifies as an “audit committee financial expert” as such term is defined in Item 407(d)(5) of Regulation S-K and possesses financial sophistication, as defined under the rules of Nasdaq.

The principal duties and responsibilities of the audit committee are as follows:

●to prepare the audit committee report required by the SEC to be included in Forge Nano’s annual proxy statement;
●to oversee and monitor our financial reporting process;
●to oversee and monitor the integrity of our financial statements and internal control system;
●to oversee and monitor the independence, retention, performance and compensation of our independent registered public accounting firm;
●to oversee and monitor the performance, appointment and retention of our internal audit function;
●to discuss, oversee and monitor policies with respect to risk assessment and risk management;
●to oversee and monitor our compliance with legal and regulatory matters;
●to oversee and monitor our cybersecurity, information and technology security and data privacy strategies and policies; and
●to provide regular reports to our Board.

Our Board has adopted a written charter for the audit committee, which is available on Forge Nano’s website.

Compensation Committee

Our compensation committee consists of Ben Landen (chair) and Millicent Pitts-DiCicco.

The principal duties and responsibilities of the Compensation Committee are as follows:

●to review and make recommendations to the full board of directors regarding our compensation policies and programs;
●to review and approve the compensation of our chief executive officer and other officers, including all material benefits, option or stock award grants and perquisites and all material employment agreements;
●to review and make recommendations to our Board with respect to our incentive compensation plans, pension plans and equity-based compensation plans;
●to administer incentive compensation, pension plans and equity-based compensation plans;
●to review and make recommendations to our Board with respect to the financial and other performance targets that must be met;
●to oversee our human capital management policies, including policies related to talent development;
●to review and make recommendations to the full board of directors regarding compensation of non-executive directors;

82

Table of Contents

​

●to prepare an annual compensation committee report; and
●to take such other actions as are necessary and consistent with the governing law and our organizational documents.

Our Board has adopted a written charter for the compensation committee, which is available on Forge Nano’s website.

Nominating and Corporate Governance Committee

Our nominating and corporate governance committee consists of David Goggins (chair) and Jimmy Smith. The principal duties and responsibilities of the nominating and corporate governance committee are as follows:

●to identify candidates qualified to become directors of Forge Nano, consistent with criteria approved by our Board;
●to review and recommend to our Board a succession plan for the chief executive officer and other executive officers;
●to recommend to our board of directors nominees for election as directors at the next annual meeting of stockholders or a special meeting of stockholders at which directors are to be elected, as well as to recommend directors to serve on the committees of the board;
●to recommend to our board of directors candidates to fill vacancies and newly created directorships on the board of directors;
●to identify best practices and recommend corporate governance principles, including giving proper attention and making effective responses to stockholder concerns regarding corporate governance;
●to set and review the compensation of the non-executive members of the board of directors;
●to develop and recommend to our board of directors guidelines setting forth corporate governance principles applicable to the Company; and
●to oversee the evaluation of our board of directors.

Our Board has adopted a written charter for the nominating and corporate governance committee, which is available on Forge Nano’s website.

Code of Business Conduct and Ethics

In connection with the completion of the Business Combination, Forge Nano adopted a code of business conduct and ethics that applies to all of its directors, officers and employees, including its principal executive officer, principal financial officer and principal accounting officer. The code of business conduct and ethics contains general guidelines for conducting our business consistent with the highest standards of business ethics. We intend to disclose future amendments to certain provisions of our code of business conduct and ethics, or waivers of such provisions applicable to any principal executive officer, principal financial officer, principal accounting officer and controller or persons performing similar functions, and our directors, on our website. The code of business conduct and ethics is available on Forge Nano’s website.

Compensation Committee Interlocks and Insider Participation

No member of Forge Nano’s compensation committee has at any time been one of Forge Nano’s officers or employees. None of Forge Nano’s executive officers serves, or has served during the last completed fiscal year, on the compensation committee or board of directors of any other entity, one of whose executive officers served as a member of our Board or compensation committee.

​

83

Table of Contents

​

EXECUTIVE COMPENSATION

All share counts in this section are shown on a pre-Business Combination basis.

Throughout this section, unless otherwise noted, “we,” “us,” “our,” the “Company,” “our board of directors” and similar terms refer to Forge Nano, Inc. prior to the consummation of the Business Combination, and to Forge Nano Holdings, Inc. and its consolidated subsidiaries (including Forge Nano, LLC) after the consummation of the Business Combination.

The following discussion contains forward-looking statements that are based on our current plans, considerations, expectations and determinations regarding the Company’s future compensation programs. The actual amount and form of compensation and the compensation policies and practices that we adopt in the future may differ materially and adversely from currently planned programs as summarized in this discussion.

As an emerging growth company, we have opted to comply with the executive compensation disclosure rules applicable to “smaller reporting companies,” as such term is defined in the rules promulgated under the Securities Act. The compensation provided to our named executive officers (“NEOs”) for the fiscal year ended December 31, 2025, is detailed in the Summary Compensation Table and accompanying footnotes and narrative that follow. The Company’s named executive officers for the fiscal year ended December 31, 2025, are:

●Paul Lichty, Chief Executive Officer
●Michael Kleinberg, Chief Financial Officer
●Curtis Zimmermann, Chief Legal Counsel

To achieve our compensation objectives, we historically have provided our executives with a compensation package consisting of the following elements:

Compensation Element

  ​ ​

Compensation Purpose

Base Salary

​

Recognize scope and impact of job responsibilities and attract and retain our executives with superior talent, expertise, and experience

Annual Cash Bonus

​

Incentivize and reward our executives for annual contributions to Forge Nano performance by tying to both Forge Nano and individual performance

Long-Term Incentive Compensation

​

Promote an ownership culture and the maximization of long-term stockholder value by aligning the interests of our executives and stockholders

​

84

Table of Contents

​

Named Executive Officers Summary Compensation Table

The following table sets forth information concerning the compensation of our named executive officers for the fiscal year ended December 31, 2025.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Nonqualified

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

​

  ​ ​ ​

​

  ​ ​ ​

​

  ​ ​ ​

​

  ​ ​ ​

Nonequity

  ​ ​ ​

Deferred

  ​ ​ ​

​

  ​ ​ ​

​

​

​

​

​

​

​

​

​

Stock

​

Option

​

Incentive Plan

​

Compensation

​

All Other

​

​

​

​

​

​

Salary

​

Bonus

​

Awards

​

Awards

​

Compensation

​

Earnings

​

Compensation

​

Total

Name and Principal Position

​

Year

​

($)

​

($)(1)

​

($)

​

($)(2)

​

($)

​

($)

​

($)(3)

​

($)

Paul Lichty
Chief Executive Officer

 

2025

 

348,075

 

40,000

 

0

 

50,850

 

0

 

0

 

23,283

 

462,208

Michael Kleinberg
Chief Financial Officer

 

2025

 

275,000

 

40,000

 

0

 

33,620

 

0

 

0

 

29,567

 

378,187

Curtis Zimmermann
Chief Legal Counsel

 

2025

 

296,489

 

40,000

 

0

 

24,801

 

0

 

0

 

40,399

 

401,689

(1)The amounts in this column represent discretionary bonuses paid to the Company’s executives in 2025.
(2)The amounts in this column represent the aggregate grant-date fair value of option awards granted to each NEO, computed in accordance with FASB ASC Topic 718. For more information on these option awards, please see the Outstanding Equity Awards at Fiscal 2025 table.
(3)The amounts in this column are comprised of health, life and other benefits for each named executive officer.

Narrative Disclosure to 2025 Summary Compensation Table

For 2025, the compensation program for our NEOs consisted of base salary and an annual cash bonus opportunity as well as an annual equity award consisting of options to purchase shares of common stock. In addition, our NEOs were eligible to participate in any employee benefit programs generally available to all employees.

Base Salary

Base salary is set at a level that reflects the remit, scope, and impact of the role and is commensurate with the NEO’s contributions, prior experience, and sustained performance. Initial base salaries of our NEOs are established through arm’s-length negotiation at the time the individual NEO is hired, taking into consideration any relevant factors as well as experience and comparable market data. Thereafter, Forge Nano’s Board has generally reviewed, and adjusted as necessary, base salaries for each of our NEOs periodically and whenever there is a change in the scope of the NEO’s role. In setting base salary levels for 2025, Forge Nano’s Board considered a range of factors, including:

●the individual’s anticipated responsibilities and experience;
●the collective experience and knowledge in compensating similarly situated individuals at other companies; and
●the value of the NEO’s existing equity awards.

Annual Cash Bonus

Annual cash bonuses provided to NEOs are discretionary and any such bonuses are determined by Mr. Lichty and the compensation committee of the Board (except for Mr. Lichty, whose cash bonus is determined solely by the compensation committee), although NEOs have bonus targets set as a percentage of such NEO’s base salary. Annual cash bonuses can be awarded in the form of both cash and equity (options or restricted stock).

85

Table of Contents

​

Long-Term Incentive Compensation

The Forge Nano compensation committee has discretion to grant equity awards as part of the compensation packages of our NEOs and granted equity awards to Messrs. Lichty, Kleinberg, and Zimmermann in 2025. Additionally, 100% of our NEOs’ unvested equity compensation is in the form of options to purchase shares of common stock which were granted under the 2017 Equity Plan. Stock options granted under the 2017 Equity Plan generally vest over four years with a one-year cliff, subject to the NEO’s continued service. Please see the “Outstanding Equity Awards at Fiscal 2025” table and below for a description of the vesting, termination and change in control treatment of the Options.

Outstanding Equity Awards at Fiscal 2025

The following table presents information regarding outstanding equity awards held by our NEOs as of December 31, 2025:

​

​

​

​

​

​

​

​

​

​

​

​

Number of

​

Number of

​

​

​

​

​

​

​

Securities

​

Securities

​

​

​

​

​

​

​

Underlying

​

Underlying

​

​

​

​

​

​

​

Unexercised

​

Unexercised

​

​

Option

​

​

​

​

Options

​

Options

​

​

Exercise

​

Option

​

​

Exercisabl

​

Unexercisable

​

​

Price

​

Expiration

Name/Grant Date

  ​ ​ ​

 (#)

  ​ ​ ​

(#)

  ​ ​ ​

​

($)

  ​ ​ ​

Date

Paul Lichty Chief

 

  ​

 

  ​

 

​

  ​

 

  ​

Executive Officer

​

​

​

​

​

​

​

​

​

04/11/2022(1)

 

30,039

 

2,731

​

$

0.62

 

04/11/2027

12/26/2023(2)

 

323,498

 

323,497

​

$

1.13

 

12/25/2028

04/01/2024(3)

 

10,092

 

14,129

​

$

1.13

 

03/31/2029

12/12/2024(4)

 

51,549

 

154,645

​

$

1.46

 

12/11/2029

10/01/2025(5)

 

242,612

 

0

​

$

3.24

 

09/30/2030

10/24/2025(6)

 

0

 

27,070

​

$

2.94

 

10/23/2035

Michael Kleinberg

 

  ​

 

  ​

​

 

  ​

 

  ​

Chief Financial Officer

​

​

​

​

​

​

​

​

​

02/08/2021(7)

 

370,444

 

0

​

$

0.37

 

02/07/2031

04/11/2022(8)

 

24,162

 

2,196

​

$

0.56

 

04/10/2032

04/01/2024(9)

 

10,448

 

14,628

​

$

1.03

 

03/31/2034

12/12/2024(10)

 

110,399

 

331,198

​

$

1.33

 

12/11/2034

10/24/2025(11)

 

0

 

17,382

​

$

2.94

 

10/23/2035

Curtis Zimmermann

 

  ​

 

  ​

​

 

  ​

 

  ​

Chief Legal Counsel

​

​

​

​

​

​

​

​

​

01/11/2022(12)

 

302,179

 

6,429

​

$

0.56

 

01/11/2032

04/25/2022(13)

 

24,162

 

2,196

​

$

0.56

 

04/25/2032

04/01/2024(14)

 

8,311

 

11,635

​

$

1.03

 

03/31/2034

12/12/2024(15)

 

42,651

 

127,952

​

$

1.33

 

12/11/2034

10/24/2025(16)

 

0

 

12,823

​

$

2.94

 

10/23/2035

(1)On April 11, 2022, Mr. Lichty was granted incentive stock options exercisable for 32,770 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $0.62 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options vest over four years, with 25% of the options cliff vesting after one year and the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued employment with the Company through each applicable vesting date.
(2)On December 26, 2023, Mr. Lichty was granted incentive stock options exercisable for 646,995 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $1.13 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options vest over four years, with 25% of the options cliff vesting after one year and the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued employment with the Company through each applicable vesting date.

86

Table of Contents

​

(3)On April 1, 2024, Mr. Lichty was granted incentive stock options exercisable for 24,221 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $1.13 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options vest over four years, with 25% of the options cliff vesting after one year and the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued employment with the Company through each applicable vesting date.
(4)On December 12, 2024, Mr. Lichty was granted incentive stock options exercisable for 206,194 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $1.46 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options vest over four years, with 25% of the options cliff vesting after one year and the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued employment with the Company through each applicable vesting date.
(5)On October 1, 2025, Mr. Lichty was granted incentive stock options exercisable for 242,612 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $3.24 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options were fully vested upon grant.
(6)On October 24, 2025, Mr. Lichty was granted incentive stock options exercisable for 27,070 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $2.94 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options vest over four years, with 25% of the options cliff vesting after one year and the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued employment with the Company through each applicable vesting date.
(7)On February 8, 2021, Mr. Kleinberg was granted incentive stock options exercisable for 370,444 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $0.37 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options vested over four years, with 25% of the options cliff vesting after one year and the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued employment with the Company through each applicable vesting date.
(8)On April 11, 2022, Mr. Kleinberg was granted incentive stock options exercisable for 26,358 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $0.56 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options vested over four years, with 25% of the options cliff vesting after one year and the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued employment with the Company through each applicable vesting date.
(9)On April 1, 2024, Mr. Kleinberg was granted incentive stock options exercisable for 25,076 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $1.03 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options vest over four years, with 25% of the options cliff vesting after one year and the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued employment with the Company through each applicable vesting date.
(10)On December 12, 2024, Mr. Kleinberg was granted incentive stock options exercisable for 441,597 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $1.33 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options vest over four years, with 25% of the options cliff vesting after one year and the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued employment with the Company through each applicable vesting date.
(11)On October 24, 2025, Mr. Kleinberg was granted incentive stock options exercisable for 17,382 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $2.94 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options vest over four years, with 25% of the options cliff vesting after one year and the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued employment with the Company through each applicable vesting date.

87

Table of Contents

​

(12)On January 11, 2022, Mr. Zimmermann was granted incentive stock options exercisable for 308,608 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $0.56 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options vest over four years, with 25% of the options cliff vesting after one year and the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued employment with the Company through each applicable vesting date.
(13)On April 25, 2022, Mr. Zimmermann was granted incentive stock options exercisable for 26,358 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $0.56 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options vest over four years, with 25% of the options cliff vesting after one year and the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued employment with the Company through each applicable vesting date.
(14)On April 1, 2024, Mr. Zimmermann was granted incentive stock options exercisable for 19,946 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $1.03 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options vest over four years, with 25% of the options cliff vesting after one year and the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued employment with the Company through each applicable vesting date.
(15)On December 12, 2024, Mr. Zimmermann was granted stock options exercisable for 170,603 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $1.33 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options vest over four years, with 25% of the options cliff vesting after one year and the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued employment with the Company through each applicable vesting date.
(16)On October 24, 2025, Mr. Zimmermann was granted incentive stock options exercisable for 12,823 shares of our common stock (as adjusted to reflect the business combination) with an exercise price of $2.94 per share. The grant was made pursuant to the terms and conditions of the 2017 Equity Plan. The options vest over four years, with 25% of the options cliff vesting after one year and the remaining 75% vesting in equal monthly installments over the following 36 months, subject to continued employment with the Company through each applicable vesting date.

Section 401(k) Plan

Forge Nano sponsors a tax-qualified Section 401(k) profit-sharing plan (the “401(k) Plan”) for all employees, including our NEOs. Full-time employees of Forge Nano are eligible to participate in the 401(k) Plan and may contribute up to a specified percentage of their base salary to the 401(k) Plan, and Forge Nano makes matching contributions equal to 3% of the participating employee’s eligible earnings.

Pension Benefits

None of our NEOs participated in any defined benefit pension plans in 2025.

Nonqualified Deferred Compensation

None of our NEOs participated in any non-qualified deferred compensation plans, supplemental executive retirement plans, or any other unfunded retirement arrangements in 2025.

Other Benefits and Perquisites

Forge Nano offers benefits to our NEOs on the same basis as provided to all of its employees, including health, dental and vision insurance; life insurance; accidental death and dismemberment insurance; short- and long-term disability insurance; a health savings account and flexible spending accounts.

88

Table of Contents

​

Employment Agreements

We have entered into employment agreements with Messrs. Lichty and Kleinberg and an offer letter with Mr. Zimmermann that generally set forth the terms and conditions of employment, including base salary, target bonus opportunities and standard employee benefit plan participation. In addition, Messrs. Lichty’s and Kleinberg’s employment agreements also contain provisions for certain payments and benefits in connection with certain terminations of employment, as described further in “Potential Payments upon Termination or Change in Control” below. However, in connection with the Business Combination, the Company intends to further develop its executive compensation program to align compensation with the Company’s business objectives and the creation of stockholder value, while enabling the Company to attract, motivate and retain individuals who contribute to the long-term success of the Company, and expects that it will amend and restate each of the employment agreements detailed below.

Paul Lichty

Mr. Lichty entered into an employment agreement which provides his base salary, bonus eligibility and eligibility to participate in Company-sponsored benefit programs. In addition, Mr. Lichty is subject to the following restrictive covenants: one-year post-termination non-compete, two-year post-termination customer, supplier and employee non-solicit, two-year no-hire of Forge Nano employees, perpetual non-disparage and perpetual confidentiality. Further, Mr. Lichty’s employment agreement provides for the rights and responsibilities of the parties in the event of certain terminations of employment, as further described in “Potential Payments upon Termination or Change in Control” below. Furthermore, Mr. Lichty entered into a letter agreement on March 31, 2026 that supplements his employment agreement with us, which, amongst other things, sets forth his current base salary and provides that he will be eligible for certain performance-based incentives based on Company performance following the Business Combination.

Michael Kleinberg

Mr. Kleinberg entered into an employment agreement which provides his base salary, bonus eligibility and eligibility to participate in Company-sponsored benefit programs. In addition, Mr. Kleinberg is subject to the following restrictive covenants: one-year post-termination non-compete, two-year post-termination customer, supplier and employee non-solicit, two-year no-hire of Forge Nano employees, perpetual non-disparage and perpetual confidentiality. Further, Mr. Kleinberg’s employment agreement provides for the rights and responsibilities of the parties in the event of certain terminations of employment, as further described in “Potential Payments upon Termination or Change in Control” below.

Curtis Zimmermann

Mr. Zimmermann entered into an offer letter with the Company, which provides for base salary, bonus eligibility and eligibility to participate in Company-sponsored benefit programs. In addition, Mr. Zimmermann entered into the Company’s standard Confidential Information and Invention Agreement.

Potential Payments Upon Termination or Change in Control

Each NEO employment agreement (but not the offer letter entered into with Mr. Zimmermann) provides for severance payments and benefits upon certain terminations of employment with Forge Nano and its affiliates, as described further below. Each NEO’s rights with respect to his or her equity awards with Forge Nano or its affiliates are governed by the applicable equity plan and award agreement and the NEO’s rights with respect to employee benefits are governed by the applicable benefit plans.

As provided in Messrs. Lichty’s and Kleinberg’s employment agreements, upon a termination of employment by Forge Nano for “cause” or due to a resignation without “good reason” (as each such term is defined in the employment agreement), Messrs. Lichty and Kleinberg would be entitled to receive their base salary through the date of termination, and reimbursement for any unreimbursed business expenses that have been properly incurred prior to the termination date (the “Accrued Rights”).

In the event that Messrs. Lichty or Kleinberg is terminated by Forge Nano without “cause” or the NEO resigns for “good reason” (as each such term is defined in their respective employment agreements), such executive will be entitled to receive, in addition to the Accrued Rights, and subject to their execution and non-revocation of a release of claims in a form acceptable to Forge Nano and continued compliance with restrictive covenants set forth in their employment agreements:

●12 months of base salary, payable in installments in accordance with Forge Nano’s regular payroll practices; and

89

Table of Contents

​

●If the applicable NEO is eligible and elects continuation coverage under Section 4980B of the Code or other similar applicable law (“COBRA”), Forge Nano will reimburse the applicable NEO for each month that such COBRA coverage is in effect (up to 12 months) an amount equal to the excess of the premium charged for such COBRA coverage over the premium that would be paid by Forge Nano executives generally for comparable coverage, which will be discontinued if the applicable NEO becomes eligible for similar benefits from a successor employer (the “Continued Health Benefits”).

Potential Payments upon Termination or Change in Control Table

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

​

  ​ ​ ​

Pension/ 

  ​ ​ ​

Perquisites/ 

  ​ ​ ​

Tax 

  ​ ​ ​

​

  ​ ​ ​

​

​

​

Cash

​

Equity

​

NDQC

​

benefits

​

Reimbursement 

​

Other

​

Total

Name

​

($)

​

($)

​

($)

​

($)

​

($)

​

($)

​

($)

Paul Lichty

 

348,075

 

2,936,859

 

0

 

23,283

 

0

 

0

 

3,308,217

Chief Executive Officer

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Michael Kleinberg

 

275,000

 

2,163,165

 

0

 

28,194

 

0

 

0

 

2,466,359

Chief Financial Officer

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Curtis Zimmermann

 

0

 

908,954

 

0

 

40,399

 

0

 

0

 

949,353

Chief Legal Counsel

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

2017 Equity Plan

The 2017 Equity Plan was adopted on July 19, 2017, as amended from time to time (including most recently on May 14, 2019). The 2017 Equity Plan permits the grant of incentive stock options, non-qualified stock options, stock bonuses, stock purchases, stock units, stock appreciation rights, and other stock based awards (each, a “Stock Award”) to eligible employees, directors, and consultants of Forge Nano. If the 2017 Equity Plan is terminated, it will continue to govern the terms and conditions of any outstanding Stock Awards previously granted thereunder.

The 2017 Equity Plan is administered by the Board, or any committee designated by the Board to administer the 2017 Equity Plan in accordance with its terms (the “Administrator”). Subject to the provisions of the 2017 Equity Plan, the Administrator has the authority in its discretion to make all decisions it deems necessary or expedient to promote the best interests of Forge Nano which are not in conflict with the provisions of the 2017 Equity Plan. The Administrator’s powers are specified in the 2017 Equity Plan. The Administrator has all authority and discretion necessary to administer the 2017 Equity Plan and to control its operation, including the authority to construe and interpret the terms of the 2017 Equity Plan and the Stock Awards granted under the 2017 Equity Plan. The Administrator’s decisions are final and binding on all participants.

Subject to any change in the capitalization of the 2017 Equity Plan or other corporate transaction described in the 2017 Equity Plan, the aggregate number of shares of Forge Nano Common Stock which may be issued under the 2017 Equity Plan is 551,586. As of December 31, 2025, stock options covering 373,039 shares of Forge Nano Common Stock were outstanding under the 2017 Equity Plan and 178,547 shares of Forge Nano Common Stock remained to be issued.

Subject to the provisions of the 2017 Equity Plan, the Administrator will select the individuals to whom a Stock Award may be granted, determine the term of the Stock Award, determine the number of shares of Forge Nano Common Stock subject to the Stock Award and determine the other terms and conditions of the Stock Award as provided in the 2017 Equity Plan.

The 2017 Equity Plan may be amended or otherwise modified, suspended or terminated at any time by the Administrator. Except in certain specified situations, neither the amendment, suspension nor termination of the 2017 Equity Plan will, without the consent of the holder of the Stock Award, materially and adversely alter or impair any rights or obligations under any Stock Award theretofore granted.

90

Table of Contents

​

2026 Equity Plan

In connection with the Business Combination, Forge Nano adopted the 2026 Equity Plan. Following the adoption of the 2026 Equity Plan, we do not expect to issue additional awards under the 2017 Equity Plan. Key terms of the 2026 Equity Plan include:

●Administration.    The compensation committee of our board of directors (the “Compensation Committee”) will administer the 2026 Equity Plan. The Compensation Committee will have the authority to determine the terms and conditions of any agreements evidencing any awards granted under the 2026 Equity Plan and to adopt, alter and repeal rules, guidelines and practices relating to the 2026 Equity Plan. The Compensation Committee will have full discretion to administer and interpret the 2026 Equity Plan and to adopt such rules, regulations and procedures as it deems necessary or advisable and to determine, among other things, the time or times at which the awards may be exercised and whether and under what circumstances an award may be exercised.
●Eligibility.    Any current or prospective employees, directors, officers, consultants or advisors of the Company or its affiliates who are selected by the Compensation Committee will be eligible for awards under the 2026 Equity Plan. Except as otherwise required by applicable law or regulation or stock exchange rules, the Compensation Committee will have the sole and complete authority to determine who will be granted an award under the 2026 Equity Plan.
●Number of Shares Authorized. The initial aggregate number of shares of our common stock available for issuance under the 2026 Equity Plan is 12,865,558, which number will automatically increase on January 1 of each year, commencing on January 1, 2027, by an amount equal to 5% of the total number of shares of our common stock outstanding as of the immediately preceding December 31, or a lesser number of shares determined by the Compensation Committee. No more than 12,865,558 shares of our common stock may be issued with respect to incentive stock options under the 2026 Equity Plan. The maximum grant date fair value of cash and equity awards that may be awarded to a non-employee director under the 2026 Equity Plan during any one fiscal year, taken together with any cash fees paid to such non-employee director during such fiscal year, will be (i) $1,500,000 for the chairman of the Board or (ii) $750,000 for any other non-employee director, provided that the foregoing limitation will not apply to any awards issued to a non-employee director in respect of any one-time initial equity grant upon the appointment to the board of directors.
●Change in Capitalization.    If there is a change in our capitalization in the event of a stock or extraordinary cash dividend, recapitalization, stock split, reverse stock split, split-up or spin-off such that the Compensation Committee determines that an adjustment to the terms of the 2026 Equity Plan (or awards thereunder) is necessary or appropriate, then the Compensation Committee will be authorized to make adjustments in a manner that it deems equitable. Such adjustments may be to the number of shares reserved for issuance under the 2026 Equity Plan, the number of shares covered by awards then outstanding under the 2026 Equity Plan, the limitations on awards under the 2026 Equity Plan, the exercise price of outstanding options, or any applicable vesting conditions (including performance goals).
●Awards Available for Grant.    The Compensation Committee will be authorized to grant awards of non-qualified stock options, incentive (qualified) stock options, stock appreciation rights (“SARs”), restricted stock awards, restricted stock units, other stock-based awards, other cash-based awards or any combination of the foregoing. Awards may be granted under the 2026 Equity Plan in assumption of, or in substitution for, outstanding awards previously granted by an entity acquired by the Company or with which the Company combines, which are referred to herein as “Substitute Awards.” All awards granted under the 2026 Equity Plan will vest and become exercisable in such manner and on such date or dates or upon such event or events as determined by the Compensation Committee.

91

Table of Contents

​

●Stock Options.    The Compensation Committee will be authorized to grant options to purchase shares of our common stock that are either “qualified,” meaning they are intended to satisfy the requirements of Section 422 of the Code for incentive stock options, or “non-qualified,” meaning they are not intended to satisfy the requirements of Section 422 of the Code. All options granted under the 2026 Equity Plan shall be non-qualified unless the applicable award agreement expressly states that the option is intended to be an incentive stock option. Options granted under the 2026 Equity Plan will be subject to the terms and conditions established by the Compensation Committee. Under the terms of the 2026 Equity Plan, the exercise price of the options will not be less than the fair market value of our common stock at the time of grant (except with respect to Substitute Awards). Options granted under the 2026 Equity Plan will be subject to such terms, including the exercise price and the conditions and timing of exercise, as may be determined by the Compensation Committee and specified in the applicable award agreement. The maximum term of an option granted under the 2026 Equity Plan will be ten years from the date of grant. Payment in respect of the exercise of an option may be made in cash, by check, by cash equivalent and/or shares of our common stock valued at the fair market value at the time the option is exercised.
●Stock Appreciation Rights.    The Compensation Committee will be authorized to award SARs under the 2026 Equity Plan. SARs will be subject to the terms and conditions established by the Compensation Committee. A SAR is a contractual right that allows a participant to receive, in the form of either cash, shares or any combination of cash and shares, the appreciation, if any, in the value of a share over a certain period of time. The strike price per share of our common stock underlying each SAR shall not be less than 100% of the fair market value of such share, determined as of the date of grant and the maximum term of a SAR granted under the 2026 Equity Plan will be ten years from the date of grant.
●Restricted Stock.    The Compensation Committee will be authorized to grant restricted stock under the 2026 Equity Plan, which will be subject to the terms and conditions established by the Compensation Committee. Restricted stock is common stock that is generally non-transferable and is subject to other restrictions determined by the Compensation Committee for a specified period.
●Restricted Stock Unit Awards.    The Compensation Committee will be authorized to grant restricted stock unit awards, which will be subject to the terms and conditions established by the Compensation Committee. A restricted stock unit award, once vested, may be settled in a number of shares of our common stock equal to the number of units earned, in cash equal to the fair market value of the number of shares of our common stock earned in respect of such restricted stock unit award or in a combination of the foregoing, at the election of the Compensation Committee.
●Effect of a Change of Control.    In the event of a Change of Control (as defined in the 2026 Equity Plan), the Compensation Committee may in its discretion, cause any outstanding awards to be continued, substituted or assumed by the surviving corporation, accelerate the vesting of outstanding awards, and/or cancel any outstanding options or SARs and pay the holders in cash or other consideration for the value of such awards based upon the price per share of the Company’s common stock received or to be received by other stockholders of the Company in connection with the transaction (it being understood that any option or SAR having a per-share exercise price or strike price equal to, or in excess of, the fair market value (as of the date specified by the Compensation Committee) of a share of the Company’s common stock subject thereto may be canceled and terminated without payment or consideration therefor). Notwithstanding the above, the Compensation Committee shall exercise such discretion over the timing of settlement of any award subject to Section 409A of the Code at the time such award is granted.
●Nontransferability.    Each award may be exercised during the participant’s lifetime by the participant or, if permissible under applicable law, by the participant’s guardian or legal representative. No award may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by a participant other than by will or by the laws of descent and distribution.
●Amendment.    The 2026 Equity Plan will have a term of ten years. Our board of directors may amend, suspend or terminate the 2026 Equity Plan at any time, subject to stockholder approval if necessary to comply with any tax, exchange rules, or other applicable regulatory requirement. No amendment, suspension or termination will materially and adversely affect the rights of any participant or recipient of any award without the consent of the participant or recipient.

92

Table of Contents

​

●Our board of directors may, to the extent consistent with the terms of any applicable award agreement, waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate, any award theretofore granted or the associated award agreement, prospectively or retroactively; provided that any such waiver, amendment, alteration, suspension, discontinuance, cancellation or termination that would materially and adversely affect the rights of any participant or any holder or beneficiary with respect to any award theretofore granted will not to that extent be effective without the consent of the affected participant, holder or beneficiary; and provided further that, without stockholder approval, (i) no amendment or modification may reduce the exercise price of any option or the strike price of any SAR, (ii) the Compensation Committee may not cancel any outstanding option and replace it with a new option (with a lower exercise price) or cancel any SAR and replace it with a new SAR (with a lower strike price) or, in each case, with another award or cash in a manner that would be treated as a repricing (for compensation disclosure or accounting purposes), and (iii) the Compensation Committee may not take any other action considered a repricing for purposes of the stockholder approval rules of the applicable securities exchange on which our common shares are listed. However, stockholder approval is not required with respect to clauses (i), (ii) and (iii) above with respect to certain adjustments on changes in capitalization.
●Clawback/Forfeiture.    Awards may be subject to clawback or forfeiture to the extent required by applicable law (including, without limitation, Section 304 of the Sarbanes-Oxley Act and Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act) and/or the rules and regulations of the Nasdaq or other applicable securities exchange, or if so required pursuant to a written policy adopted by the Company or the provisions of an award agreement.

Director Compensation

The Forge Nano Board sets non-employee director compensation which is designed to provide competitive compensation necessary to attract and retain high quality non-employee directors and to encourage ownership of Forge Nano stock to further align their interests with those of our stockholders. Each non-employee director of Forge Nano is eligible to receive the following compensation:

●A $20,000 annual cash retainer paid quarterly;
●A stock option award with a value of $100,000 (based on the Forge Nano fair-market value on the date of grant), upon such director’s election to office, subject to vest over three years in equal quarterly installments beginning on the date of grant; and
●An annual stock option award with a value of $50,000 (based on the Forge Nano fair-market value on the date of grant), for service on the board of directors subject to vest over one year in equal quarterly installments beginning on the date of grant.

Forge Nano also pays reasonable travel and accommodation expenses of the non-employee directors in connection with their participation in meetings of the Forge Nano Board.

The following table sets forth compensation for non-employee directors of Forge Nano for the year ended December 31, 2025.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Fees Earned or

​

​

​

  ​ ​ ​

​

  ​ ​ ​

Option Awards

  ​ ​ ​

Paid in Cash

  ​ ​ ​

Total

Name

​

Year

​

($)

​

($)

​

($)

Millicent Pitts-DiCicco

 

2025

 

103,357

 

20,000

 

123,357

Michael Danner

 

2025

 

103,357

 

20,000

 

123,357

Jimmy Smith

 

2025

 

103,357

 

20,000

 

123,357

David Goggins

 

2025

 

103,357

 

20,000

 

123,357

​

​

​

​

93

Table of Contents

​

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth information regarding the beneficial ownership of shares of Common Stock as of November 9, 2026 by:

●each person who is known to be the beneficial owner of more than 5% of shares of Common Stock;
●each of our named executive officers and directors; and
●all of our executive officers and directors as a group.

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including shares of common stock underlying any security that is currently exercisable or exercisable within 60 days. In computing the number of shares beneficially owned by a person or entity and the percentage ownership of that person or entity in the table below, all shares subject to securities held by such person or entity were deemed outstanding if such securities are currently exercisable, or exercisable within 60 days of November 9, 2026. These shares were not deemed outstanding, however, for the purpose of computing the percentage ownership of any other person or entity.

The beneficial ownership of shares of Common Stock is based on 224,428,230 shares of Common Stock issued and outstanding as of November 9, 2026.

​

​

​

​

​

​

​

  ​ ​ ​

Common Stock Beneficially Owned

 

​

​

Number of

  ​ ​ ​

% of

​

​

​

Shares of

​

Outstanding

 

​

​

Common

​

Common

 

Name and Address of Beneficial Owner(1)

​

Stock

​

Stock

 

Directors and Executive Officers

​

​

​

​

 

Paul Lichty(2)

 

16,532,751

 

7.3

%

Michael Danner

 

—

 

—

​

David Goggins(3)

 

130,282

 

*

​

Millicent Pitts-DiCicco(4)

 

130,282

 

*

​

Jimmy Smith(5)

 

130,282

 

*

​

Ben Landen(6)

 

93,237

 

*

​

Kamal Bherwani

 

—

 

—

​

Michael Kleinberg(7)

 

659,046

 

*

​

Curtis Zimmermann(8)

 

428,801

 

*

​

All directors and executive officers as a group (9 individuals)

 

18,104,681

 

8.0

%

*

Less than 1%.

(1)Unless otherwise noted, the business address of each of the directors and executive officers of the Company is c/o Forge Nano Holdings, Inc., 12300 Grant Street, Suite 100, Thornton, CO 80241.
(2)Includes 888,493 shares of Common Stock issuable upon the exercise of Options that are exercisable within 60 days. Does not include 11,733,193 Earn-Out Shares that may be issuable to Mr. Lichty or 1,035,356 performance stock units (“PSUs”) held by Mr. Lichty.
(3)Does not include 97,712 Earn-Out Shares that may be issuable to Mr. Goggins.
(4)Does not include 97,712 Earn-Out Shares that may be issuable to Ms. Pitts-DiCicco.
(5)Does not include 97,712 Earn-Out Shares that may be issuable to Mr. Smith.
(6)Includes 1,250 shares of Common Stock issuable upon exercise of SPAC Warrants.
(7)Includes 639,327 shares of Common Stock issuable upon the exercise of Options that are exercisable within 60 days. Does not include 14,789 Earn-Out Shares that may be issuable to Mr. Kleinberg or 686,291 PSUs held by Mr. Kleinberg.
(8)Consists of 428,801 shares of Common Stock issuable upon the exercise of Options that are exercisable within 60 days. Does not include 422,777 PSUs held by Mr. Zimmermann.

94

Table of Contents

​

SELLING SECURITYHOLDERS

This prospectus relates to the resale by the Selling Securityholders named in this prospectus of up to 43,553,075 shares of Common Stock, 41,435,272 shares of Common Stock issuable upon exercise of Warrants and 23,525 SPAC Warrants. The Selling Securityholders may from time to time offer and sell any or all of the shares of Common Stock set forth below pursuant to this prospectus and any accompanying prospectus supplement. When we refer to the “Selling Securityholders” in this prospectus, we mean the persons listed in the table below, and the pledgees, donees, transferees, assignees, successors, designees and others who later come to hold any of the Selling Securityholders’ interest in our Common Stock or warrants other than through a public sale.

We cannot advise you as to whether the Selling Securityholders will in fact sell any or all of such securities. In particular, the Selling Securityholders identified in the tables below may have sold, transferred or otherwise disposed of all or a portion of their securities after the date on which they provided us with information regarding their securities. Any changed or new information given to us by the Selling Securityholders, including regarding the identity of, and the securities held by, each Selling Securityholder, will be set forth in a prospectus supplement or amendments to the registration statement of which this prospectus is a part, if and when necessary.

Please see the section entitled “Plan of Distribution” for further information regarding the Selling Securityholders’ method of distributing these securities.

We have determined beneficial ownership in accordance with the rules and regulations of the SEC and the information is not necessarily indicative of beneficial ownership for any other purpose. Under the SEC rules, beneficial ownership includes any shares of Common Stock as to which a person has sole or shared voting power or investment power and any shares of Common Stock that the person has the right to acquire within 60 days through the exercise of any option, warrant or right, through conversion of any security or pursuant to the automatic termination of a power of attorney or revocation of a trust, discretionary account or similar arrangement. Except as otherwise set forth herein, each Selling Securityholder is not a broker-dealer or an affiliate of a broker-dealer. Except as indicated by the footnotes below, we believe, based on information furnished to us, that the persons and entities named in the table below have sole voting and sole investment power with respect to all shares that they beneficially own, subject to applicable community property laws.

95

Table of Contents

​

Shares of Common Stock

The following table sets forth, as of November 9, 2026, based on information provided to us by each Selling Securityholder the names of the Selling Securityholders, the aggregate number of shares of Common Stock held by each Selling Securityholder immediately prior to any sale of such shares in this offering, the number of shares of Common Stock that may be sold by each Selling Securityholder under this prospectus, and the aggregate number of shares of Common Stock that each Selling Securityholder will beneficially own after this offering. For purposes of the table below, we have assumed that the Selling Securityholders will sell all of the securities offered hereby and will not acquire beneficial ownership of any additional securities prior to or during the offering. Percentage ownership is based on 224,428,230 shares of Common Stock outstanding as of November 9, 2026.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Common Stock

​

​

​

Common Stock

 

​

​

Beneficially Owned

​

Common

​

Beneficially Owned

 

​

​

Prior to the Offering

 

Stock Being

​

After This Offering

​

​

​

Number

​

Percent

 

Offered

​

Number

​

Percent

​

Name of Selling Securityholder(1)

  ​ ​ ​

  ​

  ​ ​ ​

  ​

  ​ ​ ​

  ​

  ​ ​ ​

  ​

  ​ ​ ​

  ​

​

Alyeska Master Fund, L.P.(2)

 

11,260,913

 

4.9

%  

40,000,000

 

3,105,258

 

1.4

%

Samsung SDI Co., Ltd.(3)

 

2,445,986

 

1.1

%  

1,000,000

 

1,445,986

 

*

​

Beusa Investments TEC, LLC(4)

 

1,310,063

 

*

 

1,310,063

 

—

 

—

​

OIC Growth Funds(5)

 

9,842,747

 

4.4

%  

500,000

 

9,342,747

 

4.2

%

Mahler International Limited(6)

 

249,054

 

*

 

249,054

 

—

 

—

​

Barton Investors Ltd.(7)

 

2,330,512

 

1.0

%  

2,330,512

 

—

 

—

​

Clyde Smith McGregor & LeAnn Pedersen Pope Revocable Trust U/A/D 10/22/16(8)

 

30,674

 

*

 

30,674

 

—

 

—

​

Dunhams Wood Limited(9)

 

396,193

 

*

 

396,193

 

—

 

—

​

Iron Gate HzO LLC(10)

 

914,490

 

*

 

914,490

 

—

 

—

​

Puccini Investments Holdings Limited(11)

 

795,022

 

*

 

795,022

 

—

 

—

​

Robert Neil Palmer Brown(12)

 

307

 

*

 

307

 

—

 

—

​

Ascent Funds(13)

 

10,097,880

 

4.4

%  

3,562,305

 

6,535,575

 

2.9

%

SFTrust Holdings, LLC(14)

 

163,935

 

*

 

163,935

 

—

 

—

​

Saoradh Energy Partners LLC(15)

 

361,744

 

*

 

257,857

 

103,887

 

*

​

Paul Lichty(16)

 

16,532,751

 

7.3

%  

28,657,816

 

—

 

—

​

Michael Kleinberg(17)

 

659,046

 

*

 

787,562

 

—

 

—

​

Curtis Zimmermann(18)

 

428,801

 

*

 

489,126

 

—

 

—

​

Shane Smith(19)

 

—

 

—

 

106,858

 

—

 

—

​

David Goggins(20)

 

130,282

 

*

 

227,994

 

—

 

—

​

Millicent Pitts-DiCicco(21)

 

130,282

 

*

 

227,994

 

—

 

—

​

Jimmy Smith(22)

 

130,282

 

*

 

227,994

 

—

 

—

​

The Ball Axline Living Trust dated 7/22/2014(23)

 

312,941

 

*

 

312,941

 

—

 

—

​

Daniel L. Sheehan(24)

 

321,291

 

*

 

321,291

 

—

 

—

​

Long Long(25)

 

600,332

 

*

 

600,332

 

—

 

—

​

Stephen N. Cannon

 

101,451

 

*

 

101,451

 

—

 

—

​

Jack G. Crawford Jr. and Karen Crawford Family Trust

​

55,391

​

*

​

55,391

​

—

​

—

​

Kai Ming Chan

 

114,203

 

*

 

114,203

 

—

 

—

​

Christy Albeck

 

10,652

 

*

 

10,652

 

—

 

—

​

Jennifer Calabrese

​

7,457

​

*

​

7,457

​

—

​

—

​

Harley L. Rollins, III

​

1,598

​

*

​

1,598

​

—

​

—

​

Ben Landen(26)

 

93,237

 

*

 

93,237

 

—

 

—

​

Vishwesh Pai(27)

 

59,118

 

*

 

59,118

 

—

 

—

​

BTIG, LLC(28)

 

465,000

 

*

 

155,000

 

310,000

 

*

​

Other Selling Securityholders(29)

 

919,920

 

*

 

919,920

 

—

 

—

​

*

Represents beneficial ownership or voting power of less than one percent.

(1)Unless otherwise noted, the business address of each of those listed in the table above is c/o 12300 Grant Street, Suite 100, Thornton, CO 80241.

96

Table of Contents

​

(2)Consists of 5,874,583 shares of Common Stock, 199,500 shares of Common Stock issuable upon exercise of SPAC Warrants and 5,186,830 shares of Common Stock issuable upon exercise of the Pre-Funded Warrants, of which 2,968,825 shares of Common Stock are being offered hereby. The shares being offered also include 7,031,175 shares of Common Stock issuable upon exercise of the Pre-Funded Warrants, 15,000,000 shares of Common Stock issuable upon exercise of the PIPE Warrants, up to 5,000,000 shares of Common Stock issuable upon exercise of the Additional PIPE Warrants, if issued, and up to 10,000,000 shares of Common Stock issuable upon exercise of the Reset PIPE Warrants, if issued. Alyeska Master Fund, L.P. currently owns 2,905,758 shares of Common Stock and 199,500 SPAC Warrants that are not being offered hereby. Alyeska Master Fund, L.P. has elected to be subject to a beneficial ownership limitation under the Pre-Funded Warrants and the PIPE Warrants, such that they may not be exercised to the extent that, after giving effect to such exercise, the holder would beneficially own more than 4.9% of the outstanding shares of Common Stock. The 2,032,256 shares of Common Stock issuable upon exercise of the Pre-Funded Warrants included above represent the maximum number that may be acquired under such limitation. Alyeska Investment Group, L.P., the investment manager of Alyeska Master Fund, L.P., has voting and investment control of the shares held by Alyeska Master Fund, L.P. Anand Parekh is the Chief Executive Officer of Alyeska Investment Group, L.P. and may be deemed to be the beneficial owner of such shares. Mr. Parekh, however, disclaims any beneficial ownership of the shares held by Alyeska Master Fund, L.P. The registered address of Alyeska Master Fund, L.P. is at c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, South Church Street George Town, Grand Cayman, KY1-1104, Cayman Islands. Alyeska Investment Group, L.P. is located at 77 W. Wacker, Suite 700, Chicago IL 60601.
(3)Consists of 2,445,986 shares of Common Stock, of which 1,445,986 shares are not being offered hereby. Does not include 1,084,490 Earn-Out Shares that may be issuable to Samsung SDI Co., Ltd. Samsung SDI Co., Ltd. is the direct beneficial owner of the shares of Common Stock. The business address of Samsung SDI Co., Ltd. is 150-20 Gongse-ro, Giheung-gu, Yongin-si, Gyeonggi-do 17084, Republic of Korea.
(4)Does not include 215,234 Holdback Shares that may be issuable to Beusa Investments TEC, LLC. Beusa Investments Tec, LLC is wholly owned by Beusa Company Investments, LLC, which is wholly owned by Beusa Company Holdings, LLC, which is wholly owned by Beusa Holdings, Inc., which is wholly owned by Associated Petroleum Investors, Ltd. (“APIL”). APIL is owned 50% by the A-1 Trust and 50% by the A-2 Trust. Each entity and trust in the chain disclaims beneficial ownership except to the extent of its pecuniary interest therein. Jeffrey Morris is the manager of Beusa Investments TEC, LLC. The business address of Beusa Investments TEC, LLC is 1780 Hughes Landing Blvd, Suite 100, The Woodlands, TX 77380.
(5)Consists of an aggregate of 9,886,839 shares of Common Stock held by OIC Growth Fund I, L.P., OIC Growth Fund I PV, L.P., OIC Growth Fund I GPFA, L.P., OIC Growth Fund I AUS, L.P. and OIC Growth Fund I GP, L.P. (collectively, the “OIC Growth Funds”), of which 9,386,839 shares are not being offered hereby. Does not include an aggregate of 7,040,132 Earn-Out Shares that may be issuable to the OIC Growth Funds. The general partner of the OIC Growth Funds is OIC Growth Fund GP, and the general partner of OIC Growth Fund GP is OIC Growth Fund Upper GP, LLC (“OIC Growth Fund Upper GP”). OIC Growth Fund Upper GP is owned and controlled by Nazar Massouh and Gerrit Nicholas and, as such, Messrs. Massouh and Nicholas may be deemed to have voting and dispositive control of the securities held by the OIC Growth Funds and OIC Growth Fund GP. Each of OIC Growth Fund Upper GP and Messrs. Massouh and Nicholas disclaims beneficial ownership of any securities held of record by the OIC Growth Funds or OIC Growth Fund GP, in each case except to the extent of any pecuniary interest therein. The business address of each of the OIC Growth Funds is 292 Madison Ave, Suite 2500, New York, NY 10017.
(6)Does not include 13,034 Holdback Shares that may be issuable to Mahler International Limited. Chau Hoi Shuen Solina Holly is the ultimate beneficial owner of Mahler International Limited. The business address of Mahler International Limited is c/o Suites PT.2909 & 2910, Harbour Centre, 25 Harbour Road, Wanchai, Hong Kong.
(7)Does not include 592,648 Holdback Shares that may be issuable to Barton Investors Ltd. The business address of Barton Investors Ltd. is Palm Grove House, P.O. Box 438, Road Town, Tortola, British Virgin Islands.
(8)Does not include 8,150 Holdback Shares that may be issuable to Clyde Smith McGregor & LeAnn Pedersen Pope Revocable Trust U/A/D 10/22/16. The beneficial owner of such shares of Common Stock is the Clyde Smith McGregor & LeAnn Pedersen Pope Revocable Trust U/A/D 10/22/16.

97

Table of Contents

​

(9)Does not include 105,269 Holdback Shares that may be issuable to Dunhams Wood Limited. Dunhams Wood (“Dunhams”) is managed by a board of directors consisting of five individuals. Any action by Dunhams with respect to the shares of Common Stock held by Dunhams, including voting and dispositive decisions, requires a majority vote of the members of the board of directors of Dunhams. Under the so-called “rule of three,” because voting and dispositive decisions are made by a majority of Dunham’s directors, none of the directors of Dunhams is deemed to be a beneficial owner of the shares of Common Stock held by Dunhams, even those in which any director holds a pecuniary interest. Each of the directors of Dunhams expressly disclaims beneficial ownership of the shares of Common Stock held by Dunhams, except to the extent of any direct or indirect pecuniary intertest he or she might have therein. The business address of Dunhams is Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG, 1110, British Virgin Islands.
(10)Does not include 242,981 Holdback Shares that may be issuable to Iron Gate HzO LLC. Iron Gate Management is the manager of Iron Gate HZO LLC. The members of Iron Gate Management are Ryan Pollock, Douglas Fahoury, Robert Cohen, Stephen McConahey and Andrew Dye. The business address of Iron Gate HZO LLC is 357 McCaslin Blvd, Suite 200, CO 80027.
(11)Does not include 211,237 Holdback Shares that may be issuable to Puccini Investments Holdings Limited. Chau Hoi Shuen Solina Holly is the ultimate beneficial owner of Puccini Investments Holdings Limited. The business address of Puccini Investments Holdings Limited is co/suites PT.2909 & 2910, Harbour Centre, 25 Harbour Road, Wanchai Hong Kong.
(12)Does not include 82 Holdback Shares that may be issuable to Robert Neil Palmer Brown.
(13)Consists of 6,535,575 shares of Common Stock and 3,562,305 shares of Common Stock issuable upon exercise of the Ascent Warrants, of which the 3,562,305 shares of Common Stock issuable upon exercise of the Ascent Warrants are being offered hereby. Does not include 7,573,411 Earn-Out Shares that may be issuable to the Ascent Funds. Reflects securities held by Ascent Energy Innovation SPV I LP, Ascent Funds International SPV I LP, Ascent Funds International SPV II LP, Ascent Funds International SPV III LP and Ascent Funds International Management LLC (collectively, the “Ascent Funds”). Mark Gordon is the Managing Partner of each of Ascent Energy Innovation Management LLC and Ascent Funds International Management LLC and may be deemed to be the beneficial owner of the securities held by the Ascent Funds. Mr. Gordon disclaims any beneficial ownership of such securities. The business address of each of the Ascent Funds is 788 NE 23rd Street, 5401, Miami, FL 33137.
(14)Consists of 163,935 shares of Common Stock issuable upon exercise of the Initial SVB Warrant and the Additional SVB Warrant. The business address for SFTrust Holdings, LLC is c/o SVB Financial Trust, 9110 Alcosta Blvd Ste H #3113, San Ramon, CA 94583.
(15)Consists of 103,887 shares of Common Stock and 257,857 shares of Common Stock issuable upon exercise of the SEP Warrant, of which the 257,857 shares of Common Stock issuable upon exercise of the SEP Warrant are being offered hereby. The beneficial owner of the securities held by Saoradh Energy Partners LLC is Paul Nelson. The business address for Saoradh Energy Partners LLC is 4410 Arapahoe Avenue, Suite 200, Boulder, Colorado, 80303.
(16)Consists of 15,644,258 shares of Common Stock and 888,493 shares of Common Stock issuable upon the exercise of Options. The shares being offered consist of such 15,644,258 shares of Common Stock, 1,280,365 shares of Common Stock issuable upon the exercise of Options and 11,733,193 Earn-Out Shares that may be issuable to Mr. Lichty. The Earn-Out Shares are not deemed beneficially owned until released from escrow and are therefore excluded from the shares beneficially owned prior to this offering. Does not include any shares underlying PSUs held by Mr. Lichty.
(17)Consists of 19,719 shares of Common Stock and 639,327 shares of Common Stock issuable upon the exercise of Options. The shares being offered consist of such 19,719 shares of Common Stock, 753,054 shares of Common Stock issuable upon the exercise of Options and 14,789 Earn-Out Shares that may be issuable to Mr. Kleinberg. The Earn-Out Shares are not deemed beneficially owned until released from escrow and are therefore excluded from the shares beneficially owned prior to this offering. Does not include any shares underlying PSUs held by Mr. Kleinberg.
(18)Consists of 428,801 shares of Common Stock issuable upon the exercise of Options. The shares being offered consist of 489,126 shares of Common Stock issuable upon the exercise of Options. Does not include any shares underlying PSUs held by Mr. Zimmermann.
(19)Consists of 106,858 shares of Common Stock issuable upon the exercise of Options.

98

Table of Contents

​

(20)Consists of 130,282 shares of Common Stock and 97,712 Earn-Out Shares that may be issuable to Mr. Goggins. The Earn-Out Shares are not deemed beneficially owned until released from escrow and are therefore excluded from the shares beneficially owned prior to this offering.
(21)Consists of 130,282 shares of Common Stock and 97,712 Earn-Out Shares that may be issuable to Ms. Pitts-DiCicco. The Earn-Out Shares are not deemed beneficially owned until released from escrow and are therefore excluded from the shares beneficially owned prior to this offering.
(22)Consists of 130,282 shares of Common Stock and 97,712 Earn-Out Shares that may be issuable to Mr. Smith. The Earn-Out Shares are not deemed beneficially owned until released from escrow and are therefore excluded from the shares beneficially owned prior to this offering.
(23)Consists of 307,441 shares of Common Stock and 5,500 shares of Common Stock issuable upon exercise of SPAC Warrants, which SPAC Warrants are also being offered hereby. Eric Ball and Sheryl Axline are the trustees of The Ball Axline Living Trust dated 7/22/2014.
(24)Consists of 314,016 shares of Common Stock and 7,275 shares of Common Stock issuable upon exercise of SPAC Warrants, which SPAC Warrants are also being offered hereby.
(25)Consists of 593,332 shares of Common Stock and 7,000 shares of Common Stock issuable upon exercise of SPAC Warrants, which SPAC Warrants are also being offered hereby.
(26)Consists of 91,987 shares of Common Stock and 1,250 shares of Common Stock issuable upon exercise of SPAC Warrants, which SPAC Warrants are also being offered hereby.
(27)Consists of 56,618 shares of Common Stock and 2,500 shares of Common Stock issuable upon exercise of SPAC Warrants, which SPAC Warrants are also being offered hereby.
(28)Consists of 310,000 shares of Common Stock and 155,000 shares of Common Stock issuable upon exercise of Private Warrants, of which the 155,000 shares of Common Stock issuable upon exercise of the Private Warrants are being offered hereby.
(29)Consists of selling stockholders not otherwise listed in this table who collectively beneficially own less than 1% of the outstanding shares of Common Stock. Includes 241,475 shares of Common Stock issuable upon exercise of Private Warrants. Does not include an aggregate of 145,160 Holdback Shares that may be issuable to certain of such Selling Securityholders.

SPAC Warrants

The following table sets forth, based on information provided to us by each Selling Securityholder, as of November 9, 2026, the names of the Selling Securityholders that may sell SPAC Warrants pursuant to this prospectus, the number of SPAC Warrants held by each such Selling Securityholder immediately prior to any sale of such SPAC Warrants in this offering, the number of SPAC Warrants that may be sold by each such Selling Securityholder under this prospectus, and the number of SPAC Warrants that each such Selling Securityholder will beneficially own after this offering. For purposes of the table below, we have assumed that the Selling Securityholders will sell all of the SPAC Warrants offered hereby. Percentage ownership is based on 11,919,995 SPAC Warrants outstanding as of November 9, 2026. The shares of Common Stock issuable upon exercise of these SPAC Warrants are included in the table above.

​

​

​

​

​

​

​

​

​

​

​

​

​

Warrants Beneficially

​

​

​

Warrants Beneficially

​

  ​ ​ ​

Owned Prior to the

  ​ ​ ​

Warrants

  ​ ​ ​

Owned After This

​

​

Offering

 

Being

​

Offering

​

​

Number

  ​ ​ ​

Percent

 

Offered

​

Number

  ​ ​ ​

Percent

Name of Selling Securityholder(1)

​

​

​

​

​

​

​

​

​

​

The Ball Axline Living Trust dated 7/22/2014

 

5,500

 

*

 

5,500

 

—

 

—

Daniel L. Sheehan

 

7,275

 

*

 

7,275

 

—

 

—

Long Long

 

7,000

 

*

 

7,000

 

—

 

—

Ben Landen

 

1,250

 

*

 

1,250

 

—

 

—

99

Table of Contents

​

Vishwesh Pai

 

2,500

 

*

 

2,500

 

—

 

—

(1)Unless otherwise noted, the business address of each of those listed in the table above is 12300 Grant Street, Suite 100, Thornton, CO 80241. For additional information regarding these Selling Securityholders, see the footnotes to the first table in this section.

Registration Rights

On October 22, 2026, certain holders of our Common Stock entered into the A&R Registration Rights Agreement, pursuant to which, among other things, we agreed to file a shelf registration statement with the SEC as soon as practicable but no later than 30 calendar days following the Closing to register the resale of certain of our securities, and to use commercially reasonable efforts to have such registration statement declared effective as soon as practicable after the filing thereof, but no later than the earlier of (i) 60 calendar days (or 90 calendar days if the SEC notifies us that it will “review” such registration statement) following the date of the A&R Registration Rights Agreement and (ii) five business days after we are notified by the SEC that such registration statement will not be “reviewed” or will not be subject to further review. The A&R Registration Rights Agreement also provides certain holders with demand, underwritten shelf takedown and “piggy-back” registration rights, subject to certain requirements and customary conditions.

PIPE Subscription Agreements. Pursuant to the PIPE Subscription Agreement and the Additional PIPE Subscription Agreements, we agreed to file with the SEC, no later than 30 calendar days after the Closing Date, a registration statement registering the resale of the Registrable Securities (as defined in the applicable subscription agreement), and to use commercially reasonable efforts to have such registration statement declared effective as soon as practicable after the filing thereof, but no later than the earlier of (i) 60 calendar days (or 90 calendar days if the SEC notifies us that it will “review” such registration statement) after its filing, in the case of the PIPE Subscription Agreement, or after the Closing Date, in the case of the Additional PIPE Subscription Agreements, and (ii) five business days after we are notified by the SEC that such registration statement will not be “reviewed” or will not be subject to further review. Under the PIPE Subscription Agreement, we are subject to liquidated damages if we fail to file such registration statement by the filing deadline. We also agreed to keep such registration statement effective until the earliest of (i) the second anniversary of its effectiveness (or, in the case of the Additional PIPE Subscription Agreements, the third anniversary of the Closing Date), (ii) the date on which the applicable investor ceases to hold any Registrable Securities and (iii) the first date on which the applicable investor is able to sell all of its Registrable Securities under Rule 144 under the Securities Act without volume or manner of sale limitations.

Ascent Warrant Agreements. Pursuant to the Ascent Warrant Agreements, we agreed to use our best efforts to file with the SEC, no later than 20 business days after the Closing, a registration statement covering the shares of Common Stock issuable upon exercise of the Ascent Warrants, and to use our best efforts to cause such registration statement to become effective and to maintain its effectiveness, and a current prospectus relating to such shares of Common Stock, until the Ascent Warrants expire. If such registration statement is not effective by the 60th business day after the Closing, holders may exercise the Ascent Warrants on a cashless basis.

HzO Merger Agreement. Pursuant to the HzO Merger Agreement, we agreed to grant the former HzO stockholders customary “piggy-back” registration rights with respect to the shares of Common Stock issued in the HzO Merger in connection with the filing of the registration statement of which this prospectus forms a part. In connection with the HzO Merger, each former HzO stockholder agreed to a lock-up of the shares of Common Stock received until the earlier of (x) May 4, 2027 and (y) the date on which the last reported sale price of the Common Stock equals or exceeds $12.00 per share for any 20 trading days within a 30-trading-day period, subject to customary permitted transfers.

We have filed the registration statement of which this prospectus forms a part in part to satisfy our obligations under the foregoing agreements.

Material Relationships with Selling Securityholders

Certain of the Selling Securityholders have, or within the past three years have had, positions, offices or other material relationships with us or our predecessors or affiliates. Certain of the Selling Securityholders, including the OIC Growth Funds and Samsung SDI Co., Ltd., are or have been party to certain contractual arrangements with Forge Nano. Certain of the Selling Securityholders are directors or executive officers of Forge Nano, and certain of the Selling Securityholders received their shares of Common Stock in connection with the HzO Merger. In addition, certain of the Selling Securityholders acquired their securities in connection with the PIPE Financing or the Business Combination, including affiliates of the Sponsor. For additional information, see the footnotes to the tables above and the sections titled “Management” and “Certain Relationships and Related Party Transactions.”

​

100

Table of Contents

​

DESCRIPTION OF SECURITIES

The following summary sets forth the material terms of our securities. The following summary is not intended to be a complete summary of the rights and preferences of such securities and is qualified by reference to the Charter, a copy of which is filed as Exhibit 3.1 to the registration statement of which this prospectus forms a part, and the Bylaws, a copy of which is filed as Exhibit 3.2 to such registration statement. We urge you to read the Charter and Bylaws in their entirety for a complete description of the rights and preferences of our securities.

Authorized and Outstanding Stock

The Charter authorizes the issuance of 505,000,000 shares, consisting of:

●500,000,000 shares of Common Stock; and
●5,000,000 shares of preferred stock, par value $0.0001 per share (“Preferred Stock”).

Common Stock

As of November 9, 2026, there were 224,428,230 shares of Common Stock outstanding. All shares of Common Stock are fully paid and non-assessable.

Voting rights.    Each holder of shares of Common Stock is entitled to one vote for each share of Common Stock held of record by such holder on all matters on which stockholders generally are entitled to vote. The holders of shares of Common Stock do not have cumulative voting rights in the election of directors. Except as otherwise provided by the Charter, the Bylaws, applicable stock exchange rules or applicable law, directors will be elected by a plurality of the votes cast, and each other matter presented to stockholders at a duly called or convened meeting at which a quorum is present will be decided by the affirmative vote of the holders of a majority in voting power of the votes cast, excluding abstentions and broker non-votes, on such matter.

Dividend Rights.    Subject to preferences that may be applicable to any outstanding Preferred Stock, the holders of shares of Common Stock are entitled to receive ratably such dividends, if any, as may be declared from time to time by our Board out of funds legally available for such purposes.

Liquidation Rights.     In the event of any voluntary or involuntary liquidation, dissolution or winding up of Forge Nano’s affairs, the holders of shares of Common Stock are entitled to share ratably in all assets remaining after payment of Forge Nano’s debts and other liabilities, subject to prior distribution rights of any Preferred Stock or any class or series of stock having a preference over our Common Stock, then outstanding, if any.

Other rights.    The holders of shares of Common Stock have no pre-emptive or conversion rights or other subscription rights. There are no redemption or sinking fund provisions applicable to the shares of Common Stock. The rights, preferences and privileges of holders of shares of Common Stock will be subject to those of the holders of any shares of the Preferred Stock that Forge Nano may issue in the future.

Preferred Stock

No shares of Preferred Stock are currently issued or outstanding. The Charter authorizes our Board to establish one or more series of Preferred Stock. Unless required by law or any stock exchange, the authorized shares of Preferred Stock are available for issuance without further action by the holders of shares of Common Stock. Our Board has the discretion to determine the powers, preferences and relative, participating, optional and other special rights, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of Preferred Stock. The issuance of Preferred Stock may have the effect of delaying, deferring or preventing a change in control of Forge Nano without further action by the stockholders. Additionally, the issuance of Preferred Stock may adversely affect the holders of shares of Common Stock by restricting dividends on the shares of Common Stock, diluting the voting power of the shares of Common Stock or subordinating the liquidation rights of the shares of Common Stock. As a result of these or other factors, the issuance of Preferred Stock could have an adverse impact on the market price of the shares of Common Stock, restricting dividends on shares of Common Stock, diluting the voting power of shares of Common Stock, impairing the liquidation rights of Forge Nano’s capital stock, or delaying or preventing a change in control of Forge Nano. At present, there are no plans to issue any Preferred Stock.

101

Table of Contents

​

Warrants

SPAC Warrants

Each whole SPAC Warrant entitles the registered holder to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment as discussed below. Pursuant to the ATII Warrant Agreement, a holder of SPAC Warrants may exercise its SPAC Warrants only for a whole number of shares of Common Stock. This means that only a whole SPAC Warrant may be exercised at any given time by a holder of SPAC Warrants. The SPAC Warrants will expire on the 5-year anniversary of the completion of the Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

Forge Nano will not be obligated to deliver any shares of Common Stock pursuant to the exercise of a SPAC Warrant and will have no obligation to settle such exercise unless a registration statement under the Securities Act with respect to the shares of Common Stock underlying the SPAC Warrant is then effective and a prospectus relating thereto is current, subject to Forge Nano’s satisfaction of its obligations described below with respect to registration under the Securities Act. No SPAC Warrant will be exercisable for cash or on a cashless basis, and Forge Nano will not be obligated to issue any shares of Common Stock to holders seeking to exercise their SPAC Warrants, unless the issuance of the shares of Common Stock upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a SPAC Warrant, the holder of such SPAC Warrant will not be entitled to exercise such SPAC Warrant and such SPAC Warrant may have no value and expire worthless. In the event that a registration statement under the Securities Act is not then effective for the exercised SPAC Warrants, the purchaser of a unit containing such SPAC Warrant will have paid the full purchase price for the unit solely for the share of Common Stock underlying such unit.

Forge Nano agreed that as soon as practicable, but in no event later than twenty (20) business days, after the Closing, Forge Nano would use its best efforts to file with the SEC a registration statement under the Securities Act covering the shares of Common Stock issuable upon exercise of the SPAC Warrants. Forge Nano will use its best efforts to cause such registration statement to become effective within sixty (60) business days following the Closing and to maintain a current prospectus relating to those shares of Common Stock until the SPAC Warrants expire or are redeemed, as specified in the ATII Warrant Agreement. If such a registration statement covering the shares of Common Stock issuable upon exercise of the SPAC Warrant is not effective by the sixtieth (60th) business day following the Closing or any time thereafter, holders of SPAC Warrants may, until such time as there is an effective registration statement under the Securities Act and during any period when Forge Nano will have failed to maintain an effective registration statement, exercise SPAC Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. In the case of a cashless exercise, each holder of SPAC Warrants would pay the exercise price by surrendering the SPAC Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (1) the product obtained by multiplying (x) the number of shares of Common Stock underlying the SPAC Warrants by (y) the difference between the exercise price of the SPAC Warrants and the “fair market value” (as defined below) by (2) the fair market value. The “fair market value” as used in this paragraph shall mean the average reported closing price of the shares of Common Stock for the five (5) trading days ending on the third (3rd) trading day prior to the date of exercise. We have filed the registration statement on Form S-1 of which this prospectus forms a part pursuant to our obligations under the A&R Registration Rights Agreement.

Redemption of SPAC Warrants

Once the SPAC Warrants become exercisable, Forge Nano may redeem the outstanding SPAC Warrants:

●in whole and not in part;
●at a price of $0.01 per such SPAC Warrant;
●upon not less than thirty days’ prior written notice of redemption (the “30-day redemption period”) to each holder of such SPAC Warrants; and
●if, and only if, the reported last sale price of the shares of Common Stock equals or exceeds $18.00 per share (as adjusted for share subdivisions, share consolidations, share capitalizations, rights issuances, reorganizations, recapitalizations and the like) for any twenty (20) trading days within a thirty (30)-trading day period ending on the third (3rd) trading day prior to the date Forge Nano sends the notice of redemption to the holders of SPAC Warrants.

102

Table of Contents

​

If and when the SPAC Warrants become redeemable by Forge Nano, Forge Nano may not exercise its redemption right if the issuance of shares of Common Stock upon exercise of such SPAC Warrants is not exempt from registration under the Securities Act or qualification under applicable state blue sky laws or Forge Nano is unable to effect such registration or qualification. Forge Nano will use its best efforts to register or qualify such shares under the applicable state blue sky laws.

Forge Nano has established the last of the redemption criteria discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the exercise price of the SPAC Warrants. If the foregoing conditions are satisfied and Forge Nano issues a notice of redemption of such SPAC Warrants, each holder of such SPAC Warrants will be entitled to exercise such SPAC Warrant prior to the scheduled redemption date. However, the price of the shares of Common Stock may fall below the $18.00 redemption trigger price as well as the $11.50 exercise price of the SPAC Warrants after the redemption notice is issued.

If Forge Nano calls the SPAC Warrants for redemption as described above, Forge Nano’s management will have the option to require any holder of such SPAC Warrants that wishes to exercise such SPAC Warrant to do so on a “cashless basis.” In determining whether to require all holders of SPAC Warrants to exercise their SPAC Warrants on a “cashless basis,” Forge Nano’s management will consider, among other factors, its cash position, the number of such SPAC Warrants that are issued and outstanding and the dilutive effect on the holders of shares of Common Stock of issuing the maximum number of shares of Common Stock issuable upon the exercise of such SPAC Warrants. If Forge Nano’s management takes advantage of this option, all holders of SPAC Warrants would pay the exercise price by surrendering their respective SPAC Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (1) the product obtained by multiplying (x) the number of shares of Common Stock underlying the SPAC Warrants by (y) the difference between the exercise price of such SPAC Warrants and the “fair market value” (defined below) by (2) the fair market value. The “fair market value” shall mean the average reported closing price of the shares of Common Stock for the five (5) trading days ending on the third (3rd) trading day prior to the date on which the notice of redemption is sent to the holders of SPAC Warrants. If Forge Nano’s management takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of shares of Common Stock to be received upon exercise of such SPAC Warrants, including the “fair market value” in such case. Requiring a cashless exercise in this manner will reduce the number of shares of Common Stock to be issued and thereby lessen the dilutive effect of a redemption of a SPAC Warrant.

A holder of such SPAC Warrants may notify Forge Nano in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such SPAC Warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates) or any “group” of which the holder or its affiliates is a member would beneficially own in excess of 4.9% or 9.8% (or such other amount as the holder may specify) of the shares of Common Stock issued and outstanding immediately after giving effect to such exercise.

Anti-Dilution Adjustments

If the number of issued and outstanding shares of Common Stock is increased by a capitalization payable in shares of Common Stock, or by a sub-division of shares of Common Stock or other similar event, then, on the effective date of such capitalization, sub-division or similar event, the number of shares of Common Stock issuable on exercise of each SPAC Warrant will be increased in proportion to such increase in the issued and outstanding shares of Common Stock. A rights offering to holders of shares of Common Stock entitling holders to purchase shares of Common Stock at a price less than the fair market value will be deemed a capitalization of a number of shares of Common Stock equal to the product obtained by multiplying (1) the number of shares of Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for shares of Common Stock) by (2) one minus the quotient obtained by dividing (x) the price per share of Common Stock paid in such rights offering by (y) the “fair market value.” For these purposes (i) if the rights offering is for securities convertible into or exercisable for shares of Common Stock, in determining the price payable for shares of Common Stock, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “fair market value” means the volume weighted average price of shares of Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the shares of Common Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

103

Table of Contents

​

In addition, if Forge Nano, at any time while the SPAC Warrants are issued and outstanding and unexpired, pays a dividend or makes a distribution in cash, securities or other assets to the holders of shares of Common Stock on account of such shares of Common Stock (or other shares of Common Stock into which the SPAC Warrants are convertible), other than (a) as described above, or (b) certain ordinary cash dividends of not greater than $0.10 per share per annum (subject to adjustment), then the SPAC Warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each share of Common Stock in respect of such event.

If the number of issued and outstanding shares of Common Stock is decreased by a consolidation, combination or reclassification of shares of Common Stock or other similar event, then, on the effective date of such consolidation, combination, reclassification or similar event, the number of shares of Common Stock issuable on exercise of each SPAC Warrant then outstanding and unexercised will be decreased in proportion to such decrease in issued and outstanding shares of Common Stock.

Whenever the number of shares of Common Stock purchasable upon the exercise of the SPAC Warrants is adjusted, as described above, the SPAC Warrant exercise price will be adjusted by multiplying (i) the SPAC Warrant exercise price as in effect immediately prior to such adjustment by (ii) a fraction (x) the numerator of which will be the number of shares of Common Stock purchasable upon the exercise of the SPAC Warrant immediately prior to such adjustment, and (y) the denominator of which will be the number of shares of Common Stock so purchasable immediately thereafter.

In case of any reclassification or reorganization of the issued and outstanding shares of Common Stock (other than those described above or that solely affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of Forge Nano with or into another entity in which any “person” or “group” (as such terms are used in Section 13(d) and 14(d) of the Exchange Act) acquires more than 50% of the voting power of the securities, or in the case of any sale or conveyance to another corporation or entity of the assets or other property of Forge Nano as an entirety or substantially as an entirety, the holders of the SPAC Warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the SPAC Warrants and in lieu of Forge Nano’s shares of Common Stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the SPAC Warrants would have received if such holder had exercised their SPAC Warrant immediately prior to such event.

The SPAC Warrants were issued in registered form under the ATII Warrant Agreement. The ATII Warrant Agreement provides that the terms of the SPAC Warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, or correct any mistake, including to conform the provisions of the warrant agreement to the description of the terms of the SPAC Warrants and the warrant agreement set forth in this prospectus, but with respect to any change that adversely affects the interests of the registered holders of SPAC Warrants, requires the approval by the holders of at least a majority of the then outstanding SPAC Warrants.

The SPAC Warrants may be exercised upon surrender of the SPAC Warrant certificate on or prior to the expiration date at the offices of the Transfer Agent, as warrant agent, with the exercise form on the reverse side of the SPAC Warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless basis, if applicable), by good certified check payable to the order of the Transfer Agent, as the warrant agent, or by wire transfer, for the number of SPAC Warrants being exercised. The holders of SPAC Warrants do not have the rights or privileges of holders of shares of Common Stock nor any voting rights until they exercise their SPAC Warrants and receive shares of Common Stock. After the issuance of shares of Common Stock upon exercise of the SPAC Warrants, each holder will be entitled to one vote for each share of Common Stock held of record on all matters to be voted on by holders of shares of Common Stock.

SPAC Warrants may be exercised only for a whole number of shares of Common Stock. No fractional shares of Common Stock will be issued upon exercise of the SPAC Warrants. If, upon exercise of the SPAC Warrants, a holder would be entitled to receive a fractional interest in a share of Common Stock, Forge Nano will, upon exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to the holder of such SPAC Warrants. If by reason of any adjustment described above, the holder of SPAC Warrants would be entitled to receive a fractional interest in a share of Common Stock, Forge Nano will, upon exercise, round up to the nearest whole the number of shares of Common Stock to be issued to the holder of SPAC Warrants.

104

Table of Contents

​

Forge Nano has agreed that, subject to applicable law, any action, proceeding or claim against Forge Nano arising out of or relating in any way to the warrant agreement will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and Forge Nano irrevocably submits to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. Notwithstanding the foregoing, this provision does not apply to suits brought to enforce any liability or duty created by the Securities Act or the Exchange Act or any other claim for which the federal district courts of the U.S. are the sole and exclusive forum. Forge Nano notes that there is uncertainty as to whether a court would enforce such provision, and that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. The Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.

Ascent Warrants

Each Ascent Warrant entitles the registered holder to purchase one share of Common Stock at a price of $3.40 per share (in the case of Ascent Warrants exercisable for 2,351,238 shares) or $9.83 per share (in the case of Ascent Warrants exercisable for 1,211,067 shares), subject to adjustment as discussed below (the “Ascent Warrant Price”). Ascent Warrants exercisable for 1,211,067 shares will expire on December 31, 2029. Additionally, Ascent Warrants exercisable for 2,351,238 shares will expire on December 31, 2028, unless extended to December 31, 2029 at the sole option of the holder in exchange for increasing the Ascent Warrant Price by 25% if such Ascent Warrant is exercised between January 1, 2029 and December 31, 2029.

Forge Nano will not be obligated to deliver any shares of Common Stock pursuant to the exercise of a Ascent Warrant and will have no obligation to settle such Ascent Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Common Stock underlying the Ascent Warrants is then effective and a prospectus relating thereto is current, subject to Forge Nano’s satisfaction of its obligations described below with respect to registration under the Securities Act. No Ascent Warrant will be exercisable for cash or on a cashless basis, and Forge Nano will not be obligated to issue any shares to holders seeking to exercise their Ascent Warrants, unless the issuance of the shares of Common Stock upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Ascent Warrant, the holder of such Ascent Warrant will not be entitled to exercise such Ascent Warrant and such Ascent Warrant may have no value and expire worthless.

Upon exercise of any Ascent Warrant, the holder of such Ascent Warrant will be allocated a number of Earn-Out Shares by the Escrow Agent as if the shares of Common Stock issued upon exercise of such Ascent Warrant had been issued on the Closing Date; provided, that solely for purposes of this calculation, one share of Common Stock shall be deemed to be issued upon the exercise of each Ascent Warrant and no effect shall be given to the anti-dilution adjustments described below. Any Earn-Out Shares will thereafter be disbursed in accordance with the terms, and subject to the conditions, of the Merger Agreement (or disbursed promptly after the exercise of such Ascent Warrant to the extent any of the applicable milestones described in the Merger Agreement have been met prior to or concurrently with such exercise).

Registration Rights

Forge Nano has agreed to, as soon as practicable, but in no event later than twenty (20) business days after the Closing, use its best efforts to file with the SEC a registration statement covering the shares of Common Stock issuable upon exercise of the Ascent Warrants. Forge Nano will use its best efforts to cause such registration statement to become effective within sixty (60) business days after the Closing and to maintain a current prospectus relating to those shares of Common Stock issuable upon exercise of the Ascent Warrants until the Ascent Warrants expire or are redeemed, as specified in the Ascent Warrant Agreement. If a registration statement covering the shares of Common Stock issuable upon exercise of the Ascent Warrants is not effective by the 60th business day after the closing of the Business Combination or any time thereafter, holders of Ascent Warrants may, during the period beginning on the 91st day after the date of the execution of the Ascent Warrant Agreement and ending upon the date such registration statement is declared effective by the SEC, and during any other period when Forge Nano shall fail to have maintained an effective registration statement covering the shares of Common Stock issuable upon exercise of the Ascent Warrants, exercise such Ascent Warrants on a “cashless basis” as determined in accordance with Section 3.3.1(c) therein. In the case of a cashless exercise, each holder would pay the exercise price by surrendering the Ascent Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (1) the product obtained by multiplying (x) the number of shares of Common Stock underlying the Ascent Warrants by (y) the difference between the exercise price of the Ascent Warrants and the “fair market value” (as defined below) by (2) the fair market value. The “fair market value” as used in this paragraph shall mean the average reported closing price for the five trading days ending

105

Table of Contents

​

on the third trading day prior to the date of exercise. We have filed the registration statement on Form S-1 of which this prospectus forms a part pursuant to our obligations under the Ascent Warrants Agreements.

Anti-Dilution Adjustments

If the number of issued and outstanding shares of Common Stock is increased by a capitalization payable in shares of Common Stock, or by a sub-division of shares of Common Stock or other similar event, then, on the effective date of such capitalization, sub-division or similar event, the number of shares of Common Stock issuable on exercise of each Ascent Warrant will be increased in proportion to such increase in the issued and outstanding shares of Common Stock. A rights offering to holders of shares of Common Stock entitling holders to purchase shares of Common Stock at a price less than the fair market value will be deemed a capitalization of a number of shares of Common Stock equal to the product obtained by multiplying (1) the number of shares of Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for shares of Common Stock) by (2) one minus the quotient obtained by dividing (x) the price per share of Common Stock paid in such rights offering by (y) the fair market value. For these purposes (i) if the rights offering is for securities convertible into or exercisable for shares of Common Stock, in determining the price payable for shares of Common Stock, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “fair market value” means the VWAP of shares of Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the shares of Common Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

In addition, if Forge Nano, at any time while the Ascent Warrants are issued and outstanding and unexpired, pays a dividend or makes a distribution in cash, securities or other assets to the holders of shares of Common Stock on account of such shares of Common Stock (or other shares of Common Stock into which the Ascent Warrants are convertible), other than (i) as described above, or (ii) certain ordinary cash dividends of not greater than $0.50 per share per annum (subject to adjustment), then the applicable Ascent Warrant Price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each share of Common Stock in respect of such event.

If the number of issued and outstanding shares of Common Stock is decreased by a consolidation, combination or reclassification of shares of Common Stock or other similar event, then, on the effective date of such consolidation, combination, reclassification or similar event, the number of shares of Common Stock issuable on exercise of each Ascent Warrant will be decreased in proportion to such decrease in issued and outstanding shares of Common Stock.

Whenever the number of shares of Common Stock purchasable upon the exercise of the Ascent Warrants is adjusted, as described above, the applicable Ascent Warrant Price will be adjusted by multiplying (i) the Ascent Warrant Price immediately prior to such adjustment by (ii) a fraction (x) the numerator of which will be the number of shares of Common Stock purchasable upon the exercise of the Ascent Warrants immediately prior to such adjustment and (y) the denominator of which will be the number of shares of Common Stock so purchasable immediately thereafter.

In case of any reclassification or reorganization of the issued and outstanding shares of Common Stock (other than those described above or that solely affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of Forge Nano with or into another company (other than a consolidation or merger in which Forge Nano is the continuing company and that does not result in any reclassification or reorganization of the outstanding shares of Common Stock), or in the case of any sale or conveyance to another company, corporation or entity of the assets or other property of Forge Nano as an entirety or substantially as an entirety in connection with which Forge Nano is dissolved, the holders of the Ascent Warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Ascent Warrants and in lieu of shares of Common Stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Ascent Warrants would have received if such holder had exercised their Ascent Warrants immediately prior to such event (the “Alternative Issuance”); provided, however, that if the holders of the shares of Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets constituting the Alternative Issuance for which each Ascent Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of the shares of Common Stock in such consolidation or merger that affirmatively make such election; provided, further, that if less than seventy percent (70%) of the consideration receivable by the holders of the shares of Common Stock in the applicable event is payable in the form of shares in the successor entity that is listed for trading on a national

106

Table of Contents

​

securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the holder properly exercises the Ascent Warrant within thirty (30) days following the public disclosure of the consummation of such applicable event by Forge Nano pursuant to a current report on Form 8-K filed with the SEC, the applicable Ascent Warrant Price shall be reduced by an amount (in dollars) equal to the difference of (i) the applicable Ascent Warrant Price in effect prior to such reduction minus (ii) (A) the per share consideration (but in no event less than zero) minus (B) the Black-Scholes Warrant Value (as defined in the Ascent Warrant Agreements).

Other Terms

The Ascent Warrants were issued in registered form under the Ascent Warrant Agreements, each dated as of October 22, 2026, between Forge Nano and Ascent Funds International Management LLC. The Ascent Warrant Agreements provide that the terms of the Ascent Warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, or correct any mistake, but with respect to any change that adversely affects the interests of the registered holders of Ascent Warrants, requires the written consent or vote of the registered holders of a majority of the then outstanding Ascent Warrants.

The Ascent Warrants may be exercised upon surrender of the warrant certificate to Forge Nano on or prior to the expiration date, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless basis, if applicable), by wire transfer, for the number of Ascent Warrants being exercised. The holders of Ascent Warrants do not have the rights or privileges of holders of shares of Common Stock and any voting rights until they exercise their Ascent Warrants and receive shares of Common Stock. After the issuance of shares of Common Stock upon exercise of the Ascent Warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by shareholders.

Ascent Warrants may be exercised only for a whole number of shares of Common Stock. No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the Ascent Warrants, a holder would be entitled to receive a fractional interest in a share, Forge Nano will, upon exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to the holder of Ascent Warrants.

Forge Nano has agreed that, subject to applicable law, any action, proceeding or claim against Forge Nano arising out of or relating in any way to the Ascent Warrant Agreement will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and Forge Nano irrevocably submits to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. Notwithstanding the foregoing, this provision does not apply to suits brought to enforce any liability or duty created by the Securities Act or the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum. Forge Nano notes that there is uncertainty as to whether a court would enforce such provision, and that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. The Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.

Forge Nano Warrants

General

The Forge Nano Warrants consist of (1) the Initial SVB Warrant, issued to Silicon Valley Bank on February 10, 2021, (2) the Additional SVB Warrant, issued to Silicon Valley Bank on May 24, 2022, and (3) the SEP Warrant, issued to Saoradh Energy Partners LLC.

107

Table of Contents

​

Initial SVB Warrant

The Initial SVB Warrant entitles the registered holder to purchase 75,656 shares of Common Stock at a price of $0.33 per share, subject to adjustment as discussed below (the “Initial SVB Warrant Price”). The Initial SVB Warrant expires on February 10, 2031. The Initial SVB Warrant may be exercised by the holder thereof in whole or in part at any time and from time to time prior to the expiration or earlier termination of the Initial SVB Warrant by delivering, among other things, the payment of the aggregate Initial SVB Warrant Price with respect to the number of shares being purchased. In lieu of payment of the Initial SVB Warrant Price, the holder of the Initial SVB Warrant may elect for “cashless exercise” to receive, instead of paying the Initial SVB Warrant Price in cash, fully paid and non-assessable shares of Common Stock based on the difference between the Initial SVB Warrant Price and the “fair market value” of our Common Stock, as described in the Initial SVB Warrant. For purposes of the Initial SVB Warrant, “fair market value” means, so long as our Common Stock is traded on a nationally recognized securities exchange, inter-dealer quotation system, or over-the-counter market, the closing price or last sale price per share reported for the business day immediately before the date the holder delivers a notice of exercise.

If Forge Nano declares or pays a dividend or distribution on the outstanding Common Stock payable in securities or property (other than cash), then upon exercise of the Initial SVB Warrant, for each share acquired, the holder shall receive, without additional cost to the holder, the total number and kind of securities and property which the holder would have received had such holder owned the shares of record as of the date the dividend or distribution occurred. If Forge Nano subdivides the outstanding shares by reclassification or otherwise into a greater number of shares, the number of shares purchasable hereunder shall be proportionately increased and the Initial SVB Warrant Price proportionately decreased. If the outstanding shares are combined or consolidated into a lesser number of shares, the Initial SVB Warrant Price shall be proportionately increased and the number of shares proportionately decreased.

Upon any event whereby all of the outstanding shares are reclassified, exchanged, combined, substituted, or replaced for, into, with or by Forge Nano securities of a different class and/or series, the Initial SVB Warrant will thereafter be exercisable for the number, class and series of Forge Nano securities that the holder would have received had the shares been outstanding as of the consummation of such event, subject to further adjustment thereafter, with the same treatment applying to successive such events. The Initial SVB Warrant shall be governed by and construed in accordance with the laws of the State of California, without giving effect to its principles regarding conflicts of law. Forge Nano and the holder each irrevocably and unconditionally submit to the exclusive jurisdiction of the State and Federal courts in Santa Clara County, California; provided, however, that nothing in the Warrant shall be deemed to operate to preclude the holder from bringing suit or taking other legal action in any other jurisdiction to enforce a judgment or other court order in favor of such holder.

Additional SVB Warrant

The Additional SVB Warrant entitles the registered holder to purchase 88,279 shares of Common Stock at a price of $0.56 per share, subject to adjustment as discussed below (the “Additional SVB Warrant Price”). The Additional SVB Warrant expires on May 24, 2034.

The Additional SVB Warrant may be exercised by the holder thereof in whole or in part at any time and from time to time prior to the expiration or earlier termination of the Additional SVB Warrant by delivering, among other things, payment of the Additional SVB Warrant Price with respect to the number of shares of Common Stock being purchased. In lieu of payment of the Additional SVB Warrant Price, the holder of the Additional SVB Warrant may elect for “cashless exercise” and surrender to Forge Nano shares of Common Stock having an aggregate value equal to the aggregate Additional SVB Warrant Price for the number of shares of Common Stock being purchased. If the holder elects for “cashless exercise,” then upon surrender of the Additional SVB Warrant and shares of Common Stock as described above, Forge Nano shall issue to the holder fully paid and non-assessable shares of Common Stock based on the difference between the Additional SVB Warrant Price and the “fair market value” of our Common Stock, as described in the Additional SVB Warrant. For purposes of the Additional SVB Warrant, “fair market value” means, so long as the shares of Common Stock are traded on a nationally recognized securities exchange, the closing price or last sale price per share on the business day immediately before the date of exercise.

108

Table of Contents

​

If Forge Nano declares or pays a dividend or distribution on the outstanding shares of Common Stock of the class payable in additional shares of the class (including fractional shares) or other securities or property (other than cash), then upon exercise of the Additional SVB Warrant, for each share of Common Stock acquired, the holder shall receive, without additional cost to the holder, the total number and kind of securities and property which the holder would have received had such holder owned the shares of Common Stock of record as of the date the dividend or distribution occurred. If Forge Nano subdivides the outstanding shares of the class by reclassification or otherwise into a greater number of shares, the number of shares of Common Stock purchasable hereunder shall be proportionately increased, even if such number would include fractional shares, and the exercise price thereof shall be proportionately decreased. If the outstanding shares of the class are combined or consolidated, by reclassification or otherwise, into a lesser number of shares, the exercise price shall be proportionately increased and the number of shares of Common Stock shall be proportionately decreased, even if such number would include fractional shares.

Upon any event whereby all of the outstanding shares of the class are reclassified, exchanged, combined, substituted, or replaced for, into, with or by Forge Nano securities of a different class and/or series, then from and after the consummation of such event, “class” shall mean such securities and the Additional SVB Warrant will be exercisable for the number of such securities that the holder would have received had the shares of Common Stock been outstanding on and as of the effective time of such event, at an aggregate exercise price equal to the aggregate exercise price in effect as of immediately prior to the effective time of such event, all subject to further adjustment thereafter from time to time in accordance with the provisions of the Additional SVB Warrant. For the avoidance of doubt, the foregoing shall similarly apply to successive reclassifications, exchanges, combinations, substitutions, replacements or other similar events.

In the event that Forge Nano, at any time or from time to time prior to the exercise in full of the Additional SVB Warrant, pays any cash dividend on the outstanding shares of the class or makes any cash distribution on or in respect of all outstanding shares of the class (other than a distribution of cash proceeds received by Forge Nano in certain limited contexts), then on and as of the date of each such dividend payment and/or distribution, the exercise price shall be reduced by an amount equal to the amount paid or distributed upon or in respect of each outstanding share of the class; provided, that in no event shall the exercise price of the Additional SVB Warrant be reduced below the then-par value, if any, of a share of the class.

The holder of the Additional SVB Warrant receives certain information and notice rights with respect to Forge Nano, as described in the Additional SVB Warrant.

The Additional SVB Warrant shall be governed by and construed in accordance with the laws of the State of California, without giving effect to its principles regarding conflicts of law. Forge Nano and the holder of the Additional SVB Warrant each irrevocably and unconditionally submit to the exclusive jurisdiction of the State and Federal courts in Santa Clara County, California; provided, however, that nothing in the Additional SVB Warrant shall be deemed to operate to preclude the holder from bringing suit or taking other legal action in any other jurisdiction to enforce a judgment or other court order in favor of such holder.

SEP Warrant

The SEP Warrant entitles the registered holder to purchase 257,857 shares of Common Stock at a price of $0.56 per share, subject to adjustment as discussed below (the “SEP Warrant Price”). The SEP Warrant will expire upon the earliest to occur of (i) February 3, 2027, (ii)(a) the acquisition of Forge Nano by another entity by means of any transaction or series of transactions to which Forge Nano is a party, other than a transaction or series of related transactions in which the holders of the voting securities in Forge Nano immediately prior to such acquisition retain at least a majority of the total voting power immediately following such acquisition or (b) a sale, lease or other disposition of all or substantially all of the assets of Forge Nano and its subsidiaries (except to a wholly-owned subsidiary of Forge Nano) and (iii) the closing of a firm commitment underwritten initial public offering pursuant to an effective registration statement filed under the Securities Act covering the offering and sale of Forge Nano’s Common Stock.

The purchase right represented by the SEP Warrant may be exercised by the holder thereof, in whole or in part and from time to time, by surrender of the SEP Warrant to Forge Nano and by payment to Forge Nano of an amount equal to the product obtained by multiplying (i) the then-applicable SEP Warrant Price by (ii) the number of shares of Common Stock being purchased pursuant to such exercise. Forge Nano shall issue to the holder a new SEP Warrant representing the remaining portion of shares of Common Stock, if any.

109

Table of Contents

​

If at any time while the SEP Warrant remains outstanding and unexpired Forge Nano (i) subdivides or combines the outstanding shares of Common Stock, (ii) pays a dividend with respect to shares of Common Stock payable in shares of Common Stock; or (iii) makes any other distribution with respect to the shares of Common Stock (except any distribution specifically provided for in the foregoing subparagraphs), the number of shares of Common Stock purchasable pursuant to the SEP Warrant and the SEP Warrant Price shall be proportionately adjusted to give effect to such subdivision, combination or distribution.

The SEP Warrant shall be construed and enforced in accordance with, and the rights of the parties shall be governed by, the laws of the State of Colorado.

PIPE Warrants

The PIPE Warrants are exercisable for our Common Stock at any time after the date of their issuance and expire five years after the date of their issuance. The exercise price per PIPE Warrant is $10.00, subject to adjustment as set forth in the PIPE Warrant Certificate and described below. The PIPE Warrants may be exercised on a cashless “net issuance” basis.

The PIPE Warrants are subject to a beneficial ownership limitation, at the election of the holder. If the election is made, Forge Nano will not effect any exercise of the PIPE Warrants, and a holder will not have the right to exercise any portion of the PIPE Warrants, to the extent that after giving effect to such issuance after exercise the holder (together with the holder’s affiliates, and anyone acting as a group together with the holder or any of the holder’s affiliates) would beneficially own in excess of 4.9%, 9.9% or 19.9% (or such other amount as the holder may specify) of our Common Stock.

The exercise price of the PIPE Warrants is subject to adjustment if Forge Nano (i) subdivides or combines (including by way of a reverse share split) the outstanding Common Stock, (ii) issues by reclassification of our Common Stock into any capital shares of Forge Nano, (iii) issues any Common Stock credited as fully paid to shareholders by way of capitalization of profits or reserves, (iv) issues or sells pro rata to the record holders of our Common Stock any rights, options or warrants entitling them to subscribe for or purchase Common Stock, or (v) declares or makes any dividend or other distribution of its assets (or rights to acquire its assets) to holders of our Common Stock, by way of return of capital or otherwise.

The exercise price of the PIPE Warrants also is subject to a one-time adjustment based on the subsequent market price. If, on the 21st trading day following the six-month anniversary of the Closing Date, the Measurement Price (as defined in the PIPE Warrant Certificate) is less than the exercise price then in effect, then the exercise price then in effect shall be reduced to an amount equal to the greater of (i) the Measurement Price and (ii) $5.00.

In addition, the exercise price of the PIPE Warrants is subject to adjustment for subsequent equity issuances. If and whenever during the period commencing on the date of the PIPE Subscription Agreement and ending on the expiration date of the PIPE Warrants, Forge Nano issues or sells, or is deemed to have issued or sold, any Common Stock (subject to certain exceptions) for proceeds per share of Common Stock less than the exercise price then in effect (where the aggregate amount of proceeds received by Forge Nano, together with all prior issuances and sales (excluding any Exempt Issuance) conducted for the purpose of raising capital by Forge Nano on or after the date of the PIPE Subscription Agreement, exceeds $500,000), then immediately after such issuance, the exercise price then in effect shall be reduced to the amount of such proceeds per share of Common Stock. If there is any adjustment to the exercise price of the PIPE Warrants, the number of shares of Common Stock that may be purchased upon exercise of the PIPE Warrant shall also be increased or decreased proportionately so that after such adjustment the aggregate exercise price payable for the adjusted number of shares of Common Stock shall be the same as the aggregate exercise price in effect immediately prior to such adjustment.

At any time commencing on the two-year anniversary of the Closing Date, all but not less than all of the PIPE Warrants may be redeemed at Forge Nano’s option at the price of $0.01 per PIPE Warrant, provided that the closing price of our Common Stock equals or exceeds $35.00 per share (subject to adjustment in accordance with Section 3(a) of the PIPE Warrant Certificate), on each of twenty (20) trading days within any thirty (30) trading day period.

110

Table of Contents

​

If a Fundamental Transaction (as defined in the PIPE Warrant Certificate) occurs, then, upon any subsequent exercise of a PIPE Warrant, the Initial PIPE Investor will have the right to receive, for each share of Common Stock that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Initial PIPE Investor (without regard to the beneficial ownership limitation), the number of shares of the successor or acquiring corporation or of Forge Nano, if it is the surviving corporation, and any additional consideration receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which such PIPE Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to the beneficial ownership limitation).

In connection with a Fundamental Transaction in which less than 70% of the consideration is payable in publicly listed common equity, the Initial PIPE Investor has the option to require Forge Nano (or any successor entity) to repurchase its warrants for their Black Scholes Value (as defined in the PIPE Warrant Certificate) in cash.

Pre-Funded Warrants

The Pre-Funded Warrants are exercisable for our Common Stock on or after the date of their issuance and have no expiration date. The exercise price per Pre-Funded Warrant is $0.0001, subject to adjustment as set forth in the Pre-Funded Warrant certificate. The Pre-Funded Warrants may be exercised on a “net-issuance” basis. The Pre-Funded Warrants are subject to a beneficial ownership limitation, at the election of the holder. If the election is made, Forge Nano will not effect any exercise of the Pre-Funded Warrants, and a holder will not have the right to exercise any portion of the Pre-Funded Warrants, to the extent that after giving effect to such exercise the holder (together with the holder’s affiliates, and anyone acting as a group together with the holder or any of the holder’s affiliates) would beneficially own in excess of 4.9%, 9.9% or 19.9% (or such other amount as the holder may specify) of the outstanding shares of Common Stock. The holder may increase or decrease such limitation by written notice, provided that any increase will not be effective until the 61st day after such notice is delivered to Forge Nano.

Dividends

Forge Nano has not paid any cash dividends on its Common Stock to date and does not intend to pay cash dividends in the foreseeable future. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition. The payment of any cash dividends will be within the discretion of our Board at such time. If we incur any indebtedness, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith.

Our Transfer Agent and Warrant Agent

The transfer agent for the shares of Common Stock and warrant agent for the SPAC Warrants is Odyssey Transfer and Trust Company. We have agreed to indemnify the Transfer Agent in its roles as transfer agent and warrant agent, its agents and each of its shareholders, directors, officers and employees against all claims and losses that may arise out of acts performed or omitted for its activities in that capacity, except for any liability due to any gross negligence or intentional misconduct of the indemnified person or entity.

Certain Anti-Takeover Provisions of the Charter, the Bylaws and Certain Provisions of the DGCL

The Organizational Documents and the DGCL contain provisions, summarized in the following paragraphs, which are intended to enhance the likelihood of continuity and stability in the composition of our Board and to discourage certain types of transactions that may involve an actual or threatened acquisition of Forge Nano. These provisions are intended to avoid costly takeover battles, reduce Forge Nano’s vulnerability to a hostile change of control or other unsolicited acquisition proposal, and enhance the ability of our Board to maximize stockholder value in connection with any unsolicited offer to acquire Forge Nano. However, these provisions may have the effect of delaying, deterring or preventing a merger or acquisition of Forge Nano by means of a tender offer, a proxy contest or other takeover attempt that a holder of shares of Common Stock might consider in its best interest, including attempts that might result in a premium over the prevailing market price for the shares of Common Stock. The Charter provides that any action required or permitted to be taken by the holders of shares of Common Stock must be effected at a duly called annual or special meeting of holders of shares of Common Stock and may not be effected by any consent in writing by such holders, except that any action required or permitted to be taken by holders of any series of Preferred Stock (if any), voting separately as a series or separately as a class with one or more other such series, may be taken without a meeting, without prior notice and without a vote, to the extent expressly permitted to do so by the certificate of designation relating to one or more series of Preferred Stock, if a consent or consents, setting forth the

111

Table of Contents

​

action so taken, are signed by the holders of outstanding shares of the relevant class or series having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted and are delivered to Forge Nano in accordance with the applicable provisions of the DGCL. See also “Risk Factors — Risks Related to Our Organizational Documents and Delaware Law — Delaware law and the Organizational Documents contain certain provisions, including anti-takeover provisions that limit the ability of holders of shares of Common Stock to take certain actions and could delay or discourage takeover attempts that holders of shares of Common Stock may consider favorable.”

Authorized but Unissued Capital Stock

The DGCL does not require stockholder approval for any issuance of authorized shares. However, the listing requirements of Nasdaq, which would apply if and so long as the shares of Common Stock remain listed on Nasdaq, require stockholder approval of certain issuances equal to or exceeding 20% of the then outstanding voting power or then outstanding number of shares of Common Stock. Additional shares of Common Stock that may be issued in the future may be used for a variety of corporate purposes, including future public offerings, to raise additional capital or to facilitate acquisitions. One of the effects of the existence of unissued and unreserved Forge Nano capital stock may be to enable our Board to issue capital stock to persons friendly to current management, which issuance could render more difficult or discourage an attempt to obtain control of Forge Nano by means of a merger, tender offer, proxy contest or otherwise and thereby protect the continuity of management and possibly deprive holders of shares of Common Stock of opportunities to sell their shares of Common Stock at prices higher than prevailing market prices.

Election of Directors and Vacancies

The Charter provides that the number of directors constituting our Board is fixed exclusively by resolution of our Board. Our Board is classified into three classes of directors, designated Class I, Class II and Class III. The initial Class I, Class II and Class III directors serve for terms expiring at the first, second and third annual meetings of stockholders, respectively, following the date of Closing, and, thereafter, at each annual meeting, the successors of the class of directors whose term expires at that meeting will be elected for a term expiring at the annual meeting held in the third year following the year of their election. There is no limit on the number of terms a director may serve on our Board.

In addition, the Charter provides that any vacancy on our Board, including a vacancy that results from an increase in the number of directors or a vacancy that results from the removal of a director with cause, may be filled only by a majority of the directors then in office, subject to any rights of the holders of Preferred Stock.

Quorum

The Bylaws provide that at any meeting of our Board, a majority of the total number of directors then in office constitutes a quorum for the transaction of business.

No Cumulative Voting

Under the DGCL, the right to vote cumulatively does not exist unless the certificate of incorporation expressly authorizes cumulative voting. The Charter does not authorize cumulative voting.

Special Meetings of Holders of Shares of Common Stock

The Charter provides that special meetings of the holders of shares of Common Stock may be called only by or at the direction of our Board, the Chair of our Board, the Chief Executive Officer or, in the absence of a Chief Executive Officer, the President, in each case, in accordance with the Bylaws.

Requirements for Advance Notification of Meetings of Holders of Shares of Common Stock, Nominations and Proposals

The Bylaws establish advance notice procedures with respect to proposals by holders of shares of Common Stock and the nomination of candidates for election as directors, other than nominations made by or at the direction of our Board or a committee of our Board. For any matter to be “properly brought” before a meeting, a holder of shares of Common Stock will have to comply with advance notice requirements and provide Forge Nano with certain information. Generally, to be timely, such notice must be received at Forge Nano’s principal executive offices not less than ninety (90) days nor more than one hundred twenty (120) days prior to the

112

Table of Contents

​

first anniversary of the immediately preceding annual meeting of holders of shares of Common Stock (for the purposes of the first annual meeting of the holders of shares of Common Stock following the adoption of the Bylaws, the date of the preceding annual meeting will be deemed to be June 1, 2026). The Bylaws allow our Board to adopt rules and regulations for the conduct of a meeting of the holders of shares of Common Stock as it deems appropriate, which may have the effect of precluding the conduct of certain business at a meeting if the rules and regulations are not followed. These provisions may also defer, delay or discourage a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to influence or obtain control of Forge Nano.

Supermajority Provisions

The Organizational Documents provide that our Board is expressly authorized to adopt, amend or repeal, in whole or in part, the Bylaws without a vote of the holders of shares of Common Stock in any manner not inconsistent with the DGCL or the Charter. The holders of shares of voting stock of Forge Nano also will have the power to adopt, amend or repeal the Bylaws by the affirmative vote of the holders of at least two-thirds of the voting power of all of the then outstanding shares of voting stock of Forge Nano with the power to vote generally in an election of directors, voting together as a single class, subject to any vote of the holders of any class or series of capital stock of Forge Nano required by applicable law or by the Charter (including any certificate of designation in respect of any series of Preferred Stock, if any) or the Bylaws.

The DGCL provides generally that the affirmative vote of a majority of the outstanding shares entitled to vote thereon, voting together as a single class, is required to amend a corporation’s certificate of incorporation, unless the certificate of incorporation requires a greater percentage. The Charter provides that the following provisions therein may be amended, altered, repealed or rescinded only by the affirmative vote of the holders of at least two-thirds in voting power of all the then outstanding shares of stock of Forge Nano entitled to vote thereon, voting together as a single class:

●the provision regarding our Board being authorized to establish one or more series of Preferred Stock with such powers, preferences and relative, participating, optional and other special rights, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences as our Board may determine;
●the provisions regarding removal of directors;
●the provisions regarding filling vacancies on our Board and newly created directorships;
●the provision regarding our Board being authorized to amend the Bylaws without a vote of the holders of shares of Common Stock;
●the provisions regarding action by written consent of the holders of shares of Common Stock;
●the provisions regarding calling special meetings of the holders of shares of Common Stock;
●the provisions regarding nominations by holders of shares of Common Stock for the election of directors and of other business proposed to be brought by holders before any meeting of the holders of shares of Common Stock;
●the provisions regarding limitation on liability and indemnification of Forge Nano’s directors and officers;
●the provisions adopting Delaware as the exclusive forum for certain stockholder litigation and adopting the federal district courts of the United States as the exclusive forum for resolving complaints asserting a cause of action under the Securities Act; and
●the amendment provision requiring that the above provisions be amended only with a two-thirds supermajority vote.

113

Table of Contents

​

These provisions may have the effect of deterring hostile takeovers or delaying or preventing changes in control of Forge Nano or its management, such as a merger, reorganization or tender offer. These provisions are intended to enhance the likelihood of continued stability in the composition of our Board and its policies and to discourage certain types of transactions that may involve an actual or threatened acquisition of Forge Nano. These provisions are designed to reduce Forge Nano’s vulnerability to an unsolicited acquisition proposal. The provisions are also intended to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for shares of Common Stock and, as a consequence, may inhibit fluctuations in the market price of shares of Common Stock that could result from actual or rumored takeover attempts. Such provisions may also have the effect of preventing changes in management.

On October 22, 2026, our Board adopted resolutions waiving the application of the doctrine of corporate opportunity, or any other analogous doctrine, with respect to Forge Nano, any non-employee directors, any non-employee stockholders or any of their respective affiliates. In addition, pursuant to such resolutions, Forge Nano renounced, to the fullest extent permitted by law, any interest or expectancy of Forge Nano, its stockholders and any of their respective affiliates in, or in being notified of or offered an opportunity to participate in any matter, transaction or interest that is presented to, or acquired, created or developed by, or which otherwise comes into the possession of (i) any director of Forge Nano who is not an employee of Forge Nano or any of its subsidiaries or (ii) any such director’s affiliates, partners, or other representatives (each of the foregoing, an “Exempt Person” and each such contemplated opportunity, an “Excluded Opportunity”), unless such matter, transaction or interest is expressly offered to such director solely in his or her capacity as a director of Forge Nano. The foregoing renunciation and waiver does not apply to, and shall not result in the renunciation by Forge Nano or any of its subsidiaries of any interest or expectancy in a business opportunity with respect to, an Exempt Person who first identified the applicable opportunity solely through the disclosure of Forge Nano’s or any of its subsidiaries’ confidential information in circumstances in which Forge Nano had a reasonable expectation that such information would be held in confidence. In addition, no Exempt Person shall have any duty to communicate or offer an Excluded Opportunity to Forge Nano or any of its affiliates or stockholders, and no Exempt Person shall have any liability to Forge Nano, any of its affiliates or stockholders for breach of any duty, as a director or otherwise, by reason of the fact that such Exempt Person pursues or acquires an Excluded Opportunity, directs an Excluded Opportunity to another person or fails to present an Excluded Opportunity, or information regarding an Excluded Opportunity, to Forge Nano or any of its affiliates or stockholders.

Exclusive Forum

The Charter provides that, unless Forge Nano consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, in the event that the Court of Chancery does not have jurisdiction, the federal district court for the District of Delaware or other state courts of the State of Delaware) shall, to the fullest extent permitted by law, be the sole and exclusive forum for the following claims or causes of action under the Delaware statutory or common law: (i) any derivative action, suit or proceeding brought on behalf of Forge Nano, (ii) any action, suit or proceeding asserting a claim of breach of a fiduciary duty owed by any director, officer or stockholder of Forge Nano to Forge Nano or Forge Nano’s stockholders, (iii) any action, suit or proceeding arising pursuant to any provision of the DGCL or the Organizational Documents (as each may be amended from time to time), or (iv) any action, suit or proceeding asserting a claim against Forge Nano governed by the internal affairs doctrine, in all cases to the fullest extent permitted by law and subject to the court having personal jurisdiction over the indispensable parties named as defendants. To the fullest extent permitted by law, any person or entity purchasing or otherwise acquiring or holding any interest in shares of capital stock of Forge Nano will be deemed to have notice of and consented to the forum provisions in the Charter. The Charter further provides that unless Forge Nano consents in writing to the selection of an alternative forum, to the fullest extent permitted by law, the federal district courts of the United States will be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. This provision in the Charter will not apply to any claim or action arising under the Exchange Act or any other claim for which the federal courts of the United States have exclusive jurisdiction; however, Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. However, it is possible that a court could find Forge Nano’s forum selection provisions to be inapplicable or unenforceable. Although our Board believes this provision will benefit Forge Nano by providing increased consistency in the application of Delaware law in the types of lawsuits to which it applies, the provision may have the effect of discouraging lawsuits against Forge Nano’s directors and officers.

Limitations on Liability and Indemnification of Officers and Directors

The DGCL authorizes corporations to limit or eliminate the personal liability of directors to corporations and their stockholders for monetary damages for breaches of directors’ fiduciary duties, subject to certain exceptions.

114

Table of Contents

​

The Charter includes a provision that eliminates the personal liability of directors and officers for monetary damages for any breach of fiduciary duty as a director or officer, except to the extent such exemption from liability or limitation thereof is not permitted under the DGCL. The effect of these provisions is to eliminate the rights of Forge Nano and the holders of shares of Common Stock, through stockholders’ derivative suits on Forge Nano’s behalf, to recover monetary damages from a director or officer for breach of fiduciary duty as a director or officer, including breaches resulting from grossly negligent behavior. However, exculpation does not apply to any director or officer if the director or officer has acted in bad faith, knowingly or intentionally violated the law, authorized illegal dividends or redemptions or derived an improper benefit from his or her actions as a director or officer.

The limitation of liability provision in the Organizational Documents may discourage stockholders from bringing a lawsuit against directors or officers for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful, might otherwise benefit Forge Nano and the holders of shares of Common Stock. In addition, your investment may be adversely affected to the extent Forge Nano pays the costs of settlement and damage awards against directors and officers pursuant to indemnification agreements. We believe that this provision, liability insurance and the indemnification agreements are necessary to attract and retain talented and experienced directors and officers.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to Forge Nano’s directors, officers and controlling persons pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.

There is currently no pending material litigation or proceeding involving any of our directors, officers or employees for which indemnification is sought.

Holders

As of November 9, 2026, there were approximately 235 holders of record of our Common Stock and approximately 110 holders of record of our SPAC Warrants. The actual number of holders is greater than these numbers of record holders and includes holders whose shares or warrants are held in “street name” by brokers and other nominees.

Transfer Agent and Registrar

The transfer agent and registrar for shares of our Common Stock and SPAC Warrants is Continental Stock Transfer & Trust Company.

Listing of Securities

Our Common Stock and SPAC Warrants are listed on Nasdaq under the symbols “NANO” and “NANOW,” respectively.

​

115

Table of Contents

​

MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES

The following summary is a discussion of certain material U.S. federal income tax considerations relating to the ownership and disposition of shares of Common Stock (including shares of Common Stock issuable upon exercise of Warrants) and Warrants acquired pursuant to this prospectus, which we refer to collectively as our “securities.” This section applies only to holders that hold their securities as capital assets for U.S. federal income tax purposes (generally, property held for investment) and does not address the Sponsor or its affiliates, representatives, employees or other stakeholders.

This section is general in nature and does not discuss all aspects of U.S. federal income taxation that might be relevant to a particular holder in light of such holder’s circumstances or status, nor does it address tax considerations applicable to a holder subject to special rules, including:

●financial institutions or financial services entities;
●broker-dealers;
●governments or agencies or instrumentalities thereof;
●insurance companies;
●taxpayers subject to a mark-to-market method of tax accounting with respect to our securities;
●persons holding our securities as part of a “straddle,” hedge, integrated transaction or similar transaction, or persons deemed to sell our securities under constructive sale provisions of the Code;
●taxpayers whose functional currency is not the U.S. dollar;
●partnerships (including any entity or arrangement that is treated as a partnership) for U.S. federal income tax purposes or beneficial owners in such partnerships;
●holders who are controlled foreign corporations or passive foreign investment companies;
●regulated investment companies;
●real estate investment trusts;
●grantor trusts;
●subchapter S corporations, or beneficial owners of such entities;
●cooperatives;
●personal holding companies;
●persons who acquired our securities through the exercise or cancellation of employee stock options or otherwise as compensation for their services;
●persons owning (directly, indirectly, or constructively) 5% or more of the total combined voting power of all classes of stock entitled to vote of, or 5% or more of the total value of all classes of shares of, Forge Nano, except to the extent otherwise discussed herein;
●taxpayers that hold their securities through a non-U.S. broker or other non-U.S. intermediary;

116

Table of Contents

​

●U.S. expatriates or former long-term residents of the United States;
●persons that are subject to “applicable financial statement rules” under Section 451(b) of the Code;
●individual retirement or other tax-deferred accounts; or
●tax-exempt entities.

If a partnership (including any entity or arrangement that is treated as a partnership) for U.S. federal income tax purposes holds our securities, the tax treatment of such partnership and a person treated as a partner of such partnership will generally depend on the status of the partner and the activities of the partnership. Partnerships holding our securities and persons that are treated as partners of such partnerships should consult their tax advisors as to the particular U.S. federal income tax consequences to them of the ownership and disposition of our securities.

This discussion is based on the Code, and administrative pronouncements, judicial decisions and final, temporary and proposed Treasury Regulations all as of the date hereof, changes to any of which subsequent to the date of this prospectus may affect the tax consequences described herein (possibly with retroactive effect).

This discussion does not take into account proposed changes in such tax laws and does not address any aspect of state, local or foreign taxation, or any U.S. federal taxes other than income taxes (such as estate or gift tax consequences, the alternative minimum tax or the Medicare tax on investment income). Each of the foregoing is subject to change, possibly with retroactive effect. You should consult your tax advisors with respect to the application of U.S. federal tax laws to your particular situation, as well as any tax consequences arising under the laws of any state, local or foreign jurisdiction.

We have not sought and do not intend to seek any rulings from the IRS regarding the matters discussed in this prospectus. There can be no assurance that the IRS will not take positions concerning the tax consequences of the ownership and disposition of our securities that are inconsistent with the considerations discussed below or that any such positions would not be sustained by a court of competent jurisdiction.

THE FOLLOWING IS FOR INFORMATIONAL PURPOSES ONLY. ALL HOLDERS OF OUR SECURITIES SHOULD CONSULT THEIR TAX ADVISORS REGARDING THE TAX CONSEQUENCES OF THE OWNERSHIP AND DISPOSITION OF OUR SECURITIES, INCLUDING THE EFFECTS OF U.S. FEDERAL, STATE, LOCAL AND FOREIGN TAX LAWS.

The term “U.S. holder” means a beneficial owner of our securities that is, for U.S. federal income tax purposes:

●an individual who is a citizen or resident of the United States;
●a corporation (or other entity treated as a corporation) that is created or organized (or treated as created or organized) under the laws of the United States, any state thereof or the District of Columbia;
●an estate the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source; or
●a trust, if (i) a court within the United States is able to exercise primary supervision over the administration of such trust and one or more “United States persons” (within the meaning of the Code) have the authority to control all substantial decisions of the trust, or (ii) the trust has validly elected to be treated as a United States person.

Treatment of Pre-Funded Warrants

Although the characterization of the Pre-Funded Warrants for U.S. federal income tax purposes is not entirely clear, because the exercise price of the Pre-Funded Warrants is nominal, Forge Nano expects to treat the Pre-Funded Warrants as shares of Common Stock for U.S. federal income tax purposes, and a holder of Pre-Funded Warrants generally should be taxed in the same manner as a holder of Common Stock, as described below. Accordingly, no gain or loss should be recognized upon the exercise of a Pre-Funded Warrant, and, upon exercise, the holding period of the share of Common Stock received should include the holding period of the Pre-

117

Table of Contents

​

Funded Warrant. Similarly, the tax basis of a share of Common Stock received upon exercise of a Pre-Funded Warrant should include the tax basis of the Pre-Funded Warrant, increased by the exercise price of $0.0001 per share. The balance of this discussion generally assumes that the characterization described above is respected for U.S. federal income tax purposes and, accordingly, except as otherwise noted, the discussion below of Warrants does not apply to the Pre-Funded Warrants.

Forge Nano’s position with respect to the characterization of the Pre-Funded Warrants is not binding on the IRS, and the IRS may treat the Pre-Funded Warrants as warrants to acquire Common Stock, in which case the amount, timing and character of a holder’s income, gain or loss with respect to an investment in the Pre-Funded Warrants could change. In addition, the U.S. federal income tax treatment of a cashless exercise of Pre-Funded Warrants is unclear, and the tax consequences of a cashless exercise could differ from the consequences of the exercise of a Pre-Funded Warrant described in the preceding paragraph. Holders should consult their tax advisors regarding the characterization of the Pre-Funded Warrants for U.S. federal income tax purposes and the consequences to them of an investment in the Pre-Funded Warrants based on their particular facts and circumstances.

U.S. Holders

U.S. Federal Income Tax Consequences of Ownership and Disposition of our Common Stock and Warrants

Taxation of Distributions on our Common Stock

In general, distributions of cash or other property to U.S. holders of our Common Stock (other than certain distributions of Forge Nano stock or rights to acquire Forge Nano stock) generally will constitute dividends for U.S. federal income tax purposes to the extent paid from Forge Nano’s current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Distributions in excess of current and accumulated earnings and profits will constitute a return of capital that will be applied against and reduce (but not below zero) the U.S. holder’s adjusted tax basis in its Common Stock. Any remaining excess will be treated as gain realized on the sale or other disposition of our Common Stock and will be treated as described below under the section entitled “— Gain or Loss on Sale, Exchange or Other Taxable Disposition of our Common Stock”.

Dividends paid to a U.S. holder that is treated as a taxable corporation for U.S. federal income tax purposes generally will qualify for the dividends received deduction if the requisite holding period is satisfied. With certain exceptions (including, but not limited to, dividends treated as investment income for purposes of investment interest deduction limitations), and provided certain holding period requirements are met, dividends paid to a non-corporate U.S. holder may constitute “qualified dividend income” that will be subject to tax at reduced rates accorded to long-term capital gains.

A U.S. holder of a Pre-Funded Warrant is expected to receive any distributions paid with respect to our Common Stock prior to the exercise of the Pre-Funded Warrant and, in such case, would be taxed in the same manner as a U.S. holder of Common Stock that receives such a distribution. However, under certain circumstances, cash may be held in abeyance for the U.S. holder until the Pre-Funded Warrant is exercised or the applicable beneficial ownership limitations would not be exceeded, at which time the U.S. holder would be entitled to receive such distributions. It is possible that such entitlement to distributions could cause the declaration of a distribution on our Common Stock to be currently taxable to U.S. holders of Pre-Funded Warrants, including under the principles of Section 305 of the Code, even though such holders will not receive such distributions until a future date. In addition, it is possible that other adjustments to the terms of the Pre-Funded Warrants may be treated as constructive distributions under Section 305 of the Code and taxable as described above. U.S. holders of Pre-Funded Warrants should consult their tax advisors regarding the tax treatment of any distribution with respect to a Pre-Funded Warrant that is held in abeyance in connection with any applicable limitation on the holder’s beneficial ownership of our Common Stock.

Gain or Loss on Sale, Exchange or Other Taxable Disposition of our Common Stock

Upon a sale or other taxable disposition of our Common Stock, a U.S. holder generally will recognize capital gain or loss in an amount equal to the difference between (i) the sum of the amount of cash and the fair market value of any property received in such disposition and (ii) the U.S. holder’s adjusted tax basis in our Common Stock so disposed of. A U.S. holder’s adjusted tax basis in its Common Stock generally will equal its acquisition cost for such Common Stock (or, in the case of Common Stock received upon exercise of a Warrant, its initial tax basis in such Common Stock, determined as described below under “— Exercise, Lapse or Redemption of a Warrant”), less any prior distributions treated as a return of capital. Any such capital gain or loss generally will be long-term capital gain or loss if the U.S. holder’s holding period for our Common Stock so disposed of exceeds one year. Long-term capital gains recognized by non-corporate U.S. holders may be eligible to be taxed at reduced rates. The deductibility of capital losses is subject to limitations.

118

Table of Contents

​

Exercise, Lapse or Redemption of a Warrant

Except as discussed below with respect to the cashless exercise of a Warrant, a U.S. holder generally will not recognize taxable gain or loss upon the exercise of a Warrant for cash. A U.S. holder’s initial tax basis in a share of Common Stock received upon the exercise of a Warrant generally will equal the sum of the U.S. holder’s acquisition cost for the Warrant (or, in the case of a PIPE Warrant acquired in the PIPE Financing, the portion of the purchase price allocated to the PIPE Warrant, as described above under “— PIPE Financing”) and the exercise price paid. It is unclear whether a U.S. holder’s holding period for Common Stock received upon the exercise of a Warrant will commence on the date of exercise or on the day following the date of exercise; in either case, the holding period will not include the period during which the U.S. holder held the Warrant.

The U.S. federal income tax consequences of a cashless exercise of a Warrant are not clear under current law. A cashless exercise may be nontaxable, either because the exercise is not a realization event or because the exercise is treated as a recapitalization for U.S. federal income tax purposes. In either situation, a U.S. holder’s initial tax basis in the Common Stock received generally would equal the U.S. holder’s adjusted tax basis in the Warrants exercised. If the cashless exercise were not a realization event, it is unclear whether a U.S. holder’s holding period for the Common Stock would commence on the date of exercise or on the day following the date of exercise; in either case, the holding period would not include the period during which the U.S. holder held the Warrant. If, instead, the cashless exercise were treated as a recapitalization, the holding period of the Common Stock generally would include the holding period of the Warrant.

It is also possible that a cashless exercise could be treated in part as a taxable exchange in which gain or loss would be recognized. In that event, a U.S. holder could be deemed to have surrendered a portion of the Warrants being exercised, having a value equal to the exercise price of such Warrants, in satisfaction of the exercise price. The U.S. holder generally should recognize capital gain or loss in an amount equal to the difference between the fair market value of the Warrants deemed surrendered to satisfy the exercise price and the U.S. holder’s adjusted tax basis in such Warrants. In this case, a U.S. holder’s initial tax basis in the Common Stock received would equal the sum of the exercise price and the U.S. holder’s adjusted tax basis in the Warrants exercised, and it is unclear whether the U.S. holder’s holding period for the Common Stock would commence on the date of exercise or on the day following the date of exercise; in either case, the holding period would not include the period during which the U.S. holder held the Warrant. Because of the absence of authority on the U.S. federal income tax treatment of a cashless exercise, including when a U.S. holder’s holding period would commence with respect to the Common Stock received, there can be no assurance as to which, if any, of the alternative tax consequences and holding periods described above would be adopted by the IRS or a court. Accordingly, U.S. holders should consult their tax advisors regarding the tax consequences of a cashless exercise.

Upon a sale, exchange (other than by exercise), redemption (other than a redemption for Common Stock) or expiration of a Warrant, a U.S. holder will recognize taxable gain or loss in an amount equal to the difference between (i) the amount realized upon such disposition or expiration and (ii) the U.S. holder’s adjusted tax basis in the Warrant. Such gain or loss generally will be treated as long-term capital gain or loss if the Warrant is held by the U.S. holder for more than one year at the time of such disposition or expiration. A U.S. holder’s adjusted tax basis in its Warrants generally will equal the U.S. holder’s acquisition cost (or, in the case of PIPE Warrants acquired in the PIPE Financing, the portion of the purchase price allocated to the PIPE Warrants, as described above under “— PIPE Financing”), increased by the amount of any constructive distributions included in income by the U.S. holder (as described below under “— Possible Constructive Distributions”). If a Warrant is allowed to lapse unexercised, a U.S. holder generally will recognize a capital loss equal to the U.S. holder’s adjusted tax basis in the Warrant. The deductibility of capital losses is subject to certain limitations.

Possible Constructive Distributions

The terms of each Warrant provide for an adjustment to the number of shares of Common Stock for which the Warrant may be exercised or to the exercise price of the Warrant in certain events, as discussed under the section entitled “Description of Securities — Warrants.” An adjustment that has the effect of preventing dilution generally should not be a taxable event. Nevertheless, a U.S. holder of Warrants would be treated as receiving a constructive distribution from Forge Nano if, for example, the adjustment increases the holder’s proportionate interest in Forge Nano’s assets or earnings and profits (e.g., through an increase in the number of shares of Common Stock that would be obtained upon exercise) as a result of a distribution of cash to the holders of shares of our Common Stock that is taxable to such holders as a distribution. Such constructive distribution would be subject to tax as described above under “— Taxation of Distributions on our Common Stock” in the same manner as if the U.S. holder received a cash distribution from Forge Nano on Common Stock equal to the fair market value of such increased interest resulting from the adjustment.

119

Table of Contents

​

Non-U.S. Holders

A “non-U.S. holder” is a beneficial owner of our securities that is, for U.S. federal income tax purposes:

●a non-resident alien individual;
●a foreign corporation; or
●an estate or trust that is not a U.S. holder.

Such term, however, generally does not include an individual who is present in the United States for 183 days or more in the taxable year of disposition. If you are such an individual, you are urged to consult your tax advisor regarding the U.S. federal income tax consequences of the sale or other disposition of our securities.

U.S. Federal Income Tax Consequences of Ownership and Disposition of our Common Stock and Warrants

Taxation of Distributions on our Common Stock

Any distribution of cash or property (or a constructive distribution) Forge Nano makes to a non-U.S. holder of shares of Common Stock, to the extent paid out of Forge Nano’s current or accumulated earnings and profits (as determined under U.S. federal income tax principles), generally will constitute a dividend for U.S. federal income tax purposes. Any such dividends paid or deemed paid to a non-U.S. holder in respect of shares of Common Stock that are not effectively connected with the non-U.S. holder’s conduct of a trade or business within the United States, as described below, generally will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the dividend, unless such non-U.S. holder is eligible for a reduced rate of withholding tax under an applicable income tax treaty and provides proper certification of its eligibility for such reduced rate (usually on an IRS Form W-8BEN or W-8BEN-E, as applicable). Any such distribution not constituting a dividend generally will be treated, for U.S. federal income tax purposes, first as reducing the non-U.S. holder’s adjusted tax basis in such shares of Common Stock (but not below zero) and, to the extent such distribution exceeds the non-U.S. holder’s adjusted tax basis, as gain from the sale or other taxable disposition of such shares of Common Stock, which will be treated as described under “— Gain or Loss on Sale, Exchange or Other Taxable Disposition of our Common Stock and Warrants” below.

Dividends (including constructive dividends) Forge Nano pays to a non-U.S. holder that are effectively connected with such non-U.S. holder’s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, are attributable to a U.S. permanent establishment or fixed base of the non-U.S. holder) generally will not be subject to the foregoing U.S. federal withholding tax, provided such non-U.S. holder complies with certain certification and disclosure requirements (usually by providing an IRS Form W-8ECI). Instead, unless an applicable income tax treaty provides otherwise, such dividends generally will be subject to U.S. federal income tax, net of certain deductions, at the same regular U.S. federal income tax rates applicable to a comparable U.S. holder. In addition, if the non-U.S. holder is a corporation, such holder’s effectively connected earnings and profits (subject to adjustments) may be subject to a U.S. federal “branch profits tax” at a rate of 30% (or such lower rate as may be specified by an applicable income tax treaty).

A non-U.S. holder of a Pre-Funded Warrant is expected to receive any distributions paid with respect to our Common Stock prior to the exercise of the Pre-Funded Warrant and, in such case, would be taxed in the same manner as a non-U.S. holder of Common Stock that receives such a distribution. However, under certain circumstances, cash may be held in abeyance for the non-U.S. holder until the Pre-Funded Warrant is exercised or the applicable beneficial ownership limitations would not be exceeded, at which time the non-U.S. holder would be entitled to receive such distributions. It is possible that such entitlement to distributions could cause the declaration of a distribution on our Common Stock to be currently taxable to non-U.S. holders of Pre-Funded Warrants, including under the principles of Section 305 of the Code, even though such holders will not receive such distributions until a future date. In addition, it is possible that other adjustments to the terms of the Pre-Funded Warrants may be treated as constructive distributions under Section 305 of the Code and taxable as described above. Non-U.S. holders of Pre-Funded Warrants should consult their tax advisors regarding the tax treatment of any distribution with respect to a Pre-Funded Warrant that is held in abeyance in connection with any applicable limitation on the holder’s beneficial ownership of our Common Stock.

120

Table of Contents

​

Gain or Loss on Sale, Exchange or Other Taxable Disposition of our Common Stock and Warrants

A non-U.S. holder generally will not be subject to U.S. federal income tax in respect of gain recognized on a sale, exchange or other disposition of our securities unless:

●the gain is effectively connected with the conduct of a trade or business by the non-U.S. holder within the United States (and, if required by an applicable income tax treaty, is attributable to a U.S. permanent establishment or fixed base of the non-U.S. holder);
●the non-U.S. holder is an individual who is present in the United States for 183 days or more in the taxable year of disposition and certain other conditions are met; or
●Forge Nano is or has been a “United States real property holding corporation” (“USRPHC”) for U.S. federal income tax purposes at any time during the shorter of the five-year period ending on the date of disposition or the non-U.S. holder’s holding period, and either (i) shares of Common Stock are not regularly traded on an established securities market or (ii) the non-U.S. holder has owned or is deemed to have owned under constructive ownership rules, at any time during the shorter of the five-year period preceding the disposition or the non-U.S. holder’s holding period, more than 5% of the outstanding shares of Common Stock.

Unless an applicable tax treaty provides otherwise, any gain described in the first bullet point above generally will be subject to U.S. federal income tax, net of certain deductions, at the same regular U.S. federal income tax rates applicable to a comparable U.S. holder and, in addition, a non-U.S. holder described in the first bullet point that is a foreign corporation will be subject to U.S. federal “branch profits tax” at a 30% rate (or a lower applicable tax treaty rate) on such non-U.S. holder’s effectively connected earnings and profits (subject to adjustments).

Any gain of a non-U.S. holder described in the second bullet point above (which may be offset by U.S. source capital losses during the taxable year of the disposition) generally will be subject to a flat 30% U.S. federal income tax rate (or a lower applicable tax treaty rate).

Unless an applicable tax treaty provides otherwise, any gain described in the third bullet point above that is recognized by such non-U.S. holder on the sale, exchange or other disposition of our securities generally will be subject to tax at generally applicable U.S. federal income tax rates. In addition, a buyer of such securities from a non-U.S. holder may be required to withhold U.S. federal income tax at a rate of 15% of the amount realized upon such disposition if such securities are not treated as “regularly traded on an established securities market.” Forge Nano will generally be classified as a USRPHC if the fair market value of its “United States real property interests” equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests and its other assets used or held for use in a trade or business, as determined for U.S. federal income tax purposes. Forge Nano does not expect to be classified as a USRPHC. However, such determination is factual in nature and subject to change, and no assurance can be provided as to whether Forge Nano is or will be a USRPHC with respect to a non-U.S. holder at any future time.

Exercise, Lapse or Redemption of a Warrant

The U.S. federal income tax treatment of a non-U.S. holder’s exercise of a Warrant, or the lapse of a Warrant held by a non-U.S. holder, generally will correspond to the U.S. federal income tax treatment of the exercise, lapse or redemption of a Warrant by a U.S. holder, as described above under “— U.S. Holders — Exercise, Lapse or Redemption of a Warrant,” although to the extent a cashless exercise results in a taxable exchange, the consequences would be similar to those described above under “— Gain or Loss on Sale, Exchange or Other Taxable Disposition of our Common Stock and Warrants.”

Possible Constructive Distributions

The terms of each Warrant provide for an adjustment to the number of shares of Common Stock for which the Warrant may be exercised or to the exercise price of the Warrant in certain events, as discussed under the section entitled “Description of Securities — Warrants.” An adjustment that has the effect of preventing dilution generally should not be a taxable event. Nevertheless, a non-U.S. holder of Warrants would be treated as receiving a constructive distribution from Forge Nano if, for example, the adjustment increases the holder’s proportionate interest in Forge Nano’s assets or earnings and profits (e.g., through an increase in the number of shares of Common Stock that would be obtained upon exercise) as a result of a distribution of cash to the holders of shares of our Common Stock that is taxable to such holders as a distribution. A non-U.S. holder would be subject to U.S. federal withholding tax as described above under “— Taxation of Distributions on our Common Stock” in the same manner as if the non-U.S. holder received a cash

121

Table of Contents

​

distribution from Forge Nano on Common Stock equal to the fair market value of such increased interest resulting from the adjustment.

ALL NON-U.S. HOLDERS ARE URGED TO CONSULT THEIR TAX ADVISORS REGARDING THE U.S. FEDERAL, STATE, LOCAL AND FOREIGN TAX CONSEQUENCES OF THE OWNERSHIP AND DISPOSITION OF OUR SECURITIES.

Information Reporting and Backup Withholding

Dividend payments with respect to shares of Common Stock and proceeds from the sale, exchange or redemption of our securities may be subject to information reporting to the IRS and possible U.S. backup withholding. Backup withholding will not apply, however, to a U.S. holder who furnishes a correct taxpayer identification number on an IRS Form W-9 and makes other required certifications, or who is otherwise exempt from backup withholding and establishes such exempt status.

A Non-U.S. holder generally will eliminate the requirement for information reporting (other than with respect to dividends) and backup withholding by providing certification of its non-U.S. status on a duly executed applicable IRS Form W-8 or by otherwise establishing an exemption.

Backup withholding is not an additional tax. Any amounts withheld as backup withholding may be credited against a holder’s U.S. federal income tax liability, if any, and a holder generally may obtain a refund of any excess amounts withheld under the backup withholding rules by timely filing the appropriate claim for refund with the IRS and furnishing any required information.

Foreign Account Tax Compliance Act

Pursuant to the Foreign Account Tax Compliance Act, set forth in Sections 1471 through 1474 of the Code and the Treasury Regulations and administrative guidance promulgated thereunder (commonly referred to as “FATCA”), foreign financial institutions (which include hedge funds, private equity funds, mutual funds and any other investment vehicles regardless of their size) must comply with information reporting rules with respect to their U.S. account holders and investors or bear a withholding tax on certain payments made to them (including such payments made to them in their capacity as intermediaries). Generally, if a foreign financial institution or certain other foreign entity does not comply with these reporting requirements, “withholdable payments” to the noncomplying entity will be subject to a 30% withholding tax. For this purpose, withholdable payments include U.S.-source payments otherwise subject to nonresident withholding tax and, subject to the discussion of the proposed Treasury Regulations below, the entire gross proceeds from the sale of certain equity or debt instruments of U.S. issuers. This withholding tax will apply to a non-compliant foreign financial institution regardless of whether the payment would otherwise be exempt from U.S. nonresident withholding tax.

Withholding under FATCA will generally apply to payments of dividends on our securities to foreign financial institutions that are not in compliance with FATCA. The U.S. Department of the Treasury has released proposed regulations which, if finalized in their present form, would eliminate the U.S. federal withholding tax for U.S. federal income tax purposes of 30% applicable to the gross proceeds of a sale or disposition of equity interests. In its preamble to the proposed regulations, the U.S. Department of the Treasury stated that taxpayers may generally rely on the proposed regulations until final regulations are issued.

Similar withholding requirements to the foregoing apply to dividends on and, subject to the proposed regulations, gross proceeds from the sale of, our securities held by an investor that is a non-financial foreign entity unless such entity provides certain information regarding the entity’s “substantial United States owners,” which the applicable withholding agent will in turn be required to provide to the Secretary of the Treasury.

If a dividend payment is both subject to withholding under FATCA and subject to the withholding tax discussed above, the withholding under FATCA may be credited against, and therefore reduce, such other withholding tax. Each non-U.S. holder is urged to consult its tax advisor regarding these rules and whether they may be relevant to such non-U.S. holder’s ownership and disposition of our securities.

FOREIGN ENTITIES LOCATED IN JURISDICTIONS THAT HAVE ENTERED INTO INTERGOVERNMENTAL AGREEMENTS WITH THE UNITED STATES IN CONNECTION WITH FATCA MAY BE SUBJECT TO DIFFERENT RULES. ALL HOLDERS ARE URGED TO CONSULT WITH THEIR TAX ADVISORS REGARDING THE POSSIBLE IMPLICATIONS OF THE ABOVE RULES UNDER, OR RELATED TO, FATCA ON THEIR INVESTMENT IN OUR SECURITIES.

​

122

Table of Contents

​

PLAN OF DISTRIBUTION

We are registering the issuance by us of up to 11,499,995 shares of Common Stock issuable upon the exercise of the SPAC Warrants. We are also registering the resale by the Selling Securityholders or their permitted transferees of up to 43,553,075 shares of Common Stock, 41,435,272 shares of Common Stock issuable upon the exercise of the SPAC Warrants, the Pre-Funded Warrants, the PIPE Warrants, the Additional PIPE Warrants, the Reset PIPE Warrants, the Ascent Warrants and the Forge Nano Warrants and 23,525 SPAC Warrants, as described under “Selling Securityholders” (collectively, the “Securities”).

We will not receive any of the proceeds from the sale of the securities offered by the Selling Securityholders pursuant to this prospectus. Assuming all of our Warrants are exercised for cash, we would receive approximately $307.2 million, assuming that the exercise price of the PIPE Warrants and the Additional PIPE Warrants is reset to the $5.00 floor and that the maximum of 10,000,000 Reset PIPE Warrants are issued and exercised at a PIPE Reset Price of $5.00 (or approximately $357.2 million if no such reset occurs, the Additional PIPE Warrants are exercised at the current exercise price of $10.00 per share and no Reset PIPE Warrants are issued), but we will not receive any proceeds from the sale of shares of Common Stock issuable upon such exercise. We intend to use those proceeds, if any, for general corporate purposes. The aggregate proceeds to the Selling Securityholders from the sale of the securities will be the purchase price of the securities less any discounts and commissions. We will not pay any brokers’ or underwriters’ discounts and commissions in connection with the registration and sale of the securities covered by this prospectus. The Selling Securityholders reserve the right to accept and, together with their respective agents, to reject, any proposed purchases of securities to be made directly or through agents.

The Selling Securityholders, which includes donees, pledgees, transferees or other successors-in-interest selling Securities received after the date of this prospectus from a Selling Securityholder as a gift, pledge, partnership distribution or other transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of their Securities on any stock exchange, market or trading facility on which the shares are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices.

The Selling Securityholders may use any one or more of the following methods when disposing of shares:

●distributions to members, partners, stockholders or other equityholders of the Selling Securityholders;
●to or through underwriters, brokers or dealers;
●ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
●block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block as principal to facilitate the transaction;
●purchases by a broker-dealer as principal and resale by the broker-dealer for its account;
●an exchange distribution in accordance with the rules of the applicable exchange;
●privately negotiated transactions;
●short sales and settlement of short sales;
●through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;
●broker-dealers may agree with the Selling Securityholders to sell a specified number of such shares at a stipulated price per share;
●through agents on a best-efforts basis;
●trading plans entered into by the Selling Securityholders pursuant to Rule 10b5-1 under the Exchange Act that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their Securities on the basis of parameters described in such trading plans;
●a combination of any such methods of sale; and

123

Table of Contents

​

●any other method permitted pursuant to applicable law.

The Selling Securityholders may, from time to time, pledge or grant a security interest in some or all of the Securities owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the Securities, from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act, amending the list of Selling Securityholders to include the pledgee, transferee or other successors in interest as Selling Securityholders under this prospectus. The Selling Securityholders also may transfer the Securities in other circumstances, in which case the transferees, pledgees or other successors in interest will be the Selling Securityholders for purposes of this prospectus.

In connection with the sale of the Securities, the Selling Securityholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the Securities in the course of hedging the positions they assume. The Selling Securityholders may also sell Securities short and deliver these securities to close out their short positions, or loan or pledge the Securities to broker-dealers that in turn may sell these securities. The Selling Securityholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).

The aggregate proceeds to the Selling Securityholders from the sale of the Securities offered by them will be the purchase price of the Securities less discounts or commissions, if any. Each of the Selling Securityholders reserves the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of Securities to be made directly or through agents. We will not receive any of the proceeds from this offering.

The Selling Securityholders also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities Act, provided that they meet the criteria and conform to the requirements of that rule, or another available exemption from the registration requirements under the Securities Act. Because we were formerly a shell company, Rule 144 will not be available for the resale of our securities until October 27, 2027, or one year after we filed current Form 10 information with the SEC reflecting that we are no longer a shell company.

The Selling Securityholders and any underwriters, broker-dealers or agents that participate in the sale of the Securities or interests therein may be “underwriters” within the meaning of Section 2(a)(11) of the Securities Act (it being understood that the Selling Securityholders shall not be deemed to be underwriters solely as a result of their participation in this offering). Any discounts, commissions, concessions or profit they earn on any resale of the shares may be underwriting discounts and commissions under the Securities Act. Selling Securityholders who are “underwriters” within the meaning of Section 2(a)(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities Act.

To the extent required, the Securities to be sold, the names of the Selling Securityholders, the respective purchase prices and public offering prices, the names of any agent, dealer or underwriter, and any applicable commissions or discounts with respect to a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus.

In order to comply with the securities laws of some states, if applicable, the Securities may be sold in these jurisdictions only through registered or licensed brokers or dealers. In addition, in some states the Securities may not be sold unless it has been registered or qualified for sale or an exemption from registration or qualification requirements is available and is complied with.

We have advised the Selling Securityholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares in the market and to the activities of the Selling Securityholders and their affiliates. In addition, to the extent applicable, we will make copies of this prospectus (as it may be supplemented or amended from time to time) available to the Selling Securityholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The Selling Securityholders may indemnify any broker-dealer that participates in transactions involving the sale of the shares against certain liabilities, including liabilities arising under the Securities Act.

We have agreed to indemnify the Selling Securityholders against liabilities, including liabilities under the Securities Act and state securities laws, relating to the registration of the shares offered by this prospectus.

​

124

Table of Contents

​

LEGAL MATTERS

The validity of the shares of Common Stock offered by this prospectus will be passed upon for us by Paul, Weiss, Rifkind, Wharton & Garrison LLP.

EXPERTS

The financial statements of ATII Holdings Inc. as of December 31, 2025 and for the period from December 4, 2025 (inception) through December 31, 2025 have been audited by WithumSmith+Brown, PC, independent registered public accounting firm, as set forth in their report thereon (which contains an explanatory paragraph relating to substantial doubt about the ability of ATII Holdings Inc. to continue as a going concern as discussed in Note 1 to the financial statements), appearing elsewhere in this prospectus and in the registration statement, and are included in reliance on the report of such firm given on the authority of such firm as experts in accounting and auditing.

The financial statements of Archimedes Tech SPAC Partners II Co. as of December 31, 2025 and 2024, for the year ended December 31, 2025 and for the period from June 7, 2024 (inception) through December 31, 2024 have been audited by WithumSmith+Brown, PC, independent registered public accounting firm, as set forth in their report thereon (which contains an explanatory paragraph relating to substantial doubt about the ability of Archimedes Tech SPAC Partners II Co. to continue as a going concern as discussed in Note 1 to the financial statements), appearing elsewhere in this prospectus and in the registration statement, and are included in reliance on the report of such firm given on the authority of such firm as experts in accounting and auditing.

The consolidated financial statements of Forge Nano, Inc. as of December 31, 2025 and 2024 and for the years then ended included in this prospectus, have been audited by Baker Tilly US, LLP, an independent registered public accounting firm, as stated in their report (which report expresses an unqualified opinion and includes an explanatory paragraph relating to a going concern uncertainty), which is included herein. Such consolidated financial statements are included in reliance upon the report of such firm given on the authority of such firm as experts in accounting and auditing.

The consolidated financial statements of HzO, Inc. as of December 31, 2025 and 2024 and for the years then ended included in this prospectus have been audited by EisnerAmper LLP, independent auditors, as stated in their report, which is included herein. Such report includes an explanatory paragraph about the existence of substantial doubt concerning HzO’s ability to continue as a going concern. Such consolidated financial statements are included in reliance upon the report of such firm given on the authority of such firm as experts in accounting and auditing.

WHERE YOU CAN FIND ADDITIONAL INFORMATION

We have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the securities offered by this prospectus. This prospectus constitutes only a part of the registration statement. Some items are contained in exhibits to the registration statement as permitted by the rules and regulations of the SEC. For further information with respect to us and our securities, we refer you to the registration statement, including the exhibits filed as a part of the registration statement. Statements contained in this prospectus concerning the contents of any contract or document referred to are not necessarily complete. If a contract or document has been filed as an exhibit to the registration statement, please see the copy of the contract or document that has been filed. Each statement in this prospectus relating to a contract or document filed as an exhibit is qualified in all respects by the filed exhibit.

We file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains an Internet website at www.sec.gov that contains reports, proxy and information statements and other information about issuers, like us, that file electronically with the SEC. We also maintain a website at www.forgenano.com. We make available, free of charge on our website, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to these reports as soon as reasonably practicable after electronically filing or furnishing those reports to the SEC. Information contained on our website is not a part of or incorporated by reference into this prospectus and the inclusion of our website and investor relations website addresses in this prospectus is an inactive textual reference only.

​

​

125

Table of Contents

​

INDEX TO FINANCIAL STATEMENTS

​

​

​

Page

Archimedes Tech SPAC Partners II Co.

​

Condensed Consolidated Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025

F-2

Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and 2025 (Unaudited)

F-3

Condensed Consolidated Statements of Changes in Shareholders’ Deficit for the three and nine months ended September 30, 2026 and 2025 (Unaudited)

F-4

Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 2025 (Unaudited)

F-5

Notes to Condensed Consolidated Financial Statements (Unaudited)

F-6

Report of Independent Registered Public Accounting Firm (PCAOB ID 100)

F-27

Consolidated Balance Sheets as of December 31, 2025 and 2024

F-28

Consolidated Statements of Operations for the year ended December 31, 2025 and for the period from June 7, 2024 (inception) through December 31, 2024

F-29

Consolidated Statements of Changes in Shareholders’ Deficit for the year ended December 31, 2025 and for the period from June 7, 2024 (inception) through December 31, 2024

F-30

Consolidated Statements of Cash Flows for the year ended December 31, 2025 and for the period from June 7, 2024 (inception) through December 31, 2024

F-31

Notes to Financial Statements

F-32

​

Forge Nano, Inc.

​

Unaudited Condensed Consolidated Balance Sheets as of September 30, 2026 and December 31, 2025

F-45

Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2026 and 2025

F-46

Unaudited Condensed Consolidated Statements of Mezzanine Equity and Stockholders’ Deficit for the Three and Nine Months Ended September 30, 2026 and 2025

F-47

Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025

F-49

Notes to Unaudited Condensed Consolidated Financial Statements

F-50

Report of Independent Registered Public Accounting Firm (PCAOB ID Number 23)

F-71

Consolidated Balance Sheets as of December 31, 2025 and 2024

F-72

Consolidated Statements of Operations for the Years Ended December 31, 2025 and 2024

F-73

Consolidated Statements of Mezzanine Equity and Stockholders’ Deficit for the Years Ended December 31, 2025 and 2024

F-74

Consolidated Statements of Cash Flows for the Years Ended December 31, 2025 and 2024

F-75

Notes to Consolidated Financial Statements

F-76

Forge Nano Holdings, Inc. (formerly known as ATII Holdings Inc.)

​

Condensed Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025

F-103

Condensed Statements of Operations for the three and nine months ended September 30, 2026 (Unaudited)

F-104

Condensed Statements of Changes in Stockholder’s Deficit for the three and nine months ended September 30, 2026 (Unaudited)

F-105

Condensed Statement of Cash Flows for the nine months ended September 30, 2026 (Unaudited)

F-106

Notes to Condensed Financial Statements (Unaudited)

F-107

Report of Independent Registered Public Accounting Firm (PCAOB ID 100)

F-118

Balance Sheet as of December 31, 2025

F-119

Statement of Operations for the Period from December 4, 2025 (Inception) Through December 31, 2025

F-120

Statement of Changes in Shareholders’ Deficit for the Period from December 4, 2025 (Inception) Through December 31, 2025

F-121

Statement of Cash Flows for the Period from December 4, 2025 (Inception) Through December 31, 2025

F-122

Notes to Financial Statements

F-123

​

HzO, Inc. and Subsidiaries

​

Unaudited Condensed Consolidated Balance Sheets

F-128

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss

F-129

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity

F-130

Unaudited Condensed Consolidated Statements of Cash Flows

F-131

Notes to Unaudited Condensed Consolidated Financial Statements

F-132

Report of Independent Auditors

F-150

Consolidated Balance Sheets

F-152

Consolidated Statements of Operations and Comprehensive Loss

F-153

Consolidated Statements of Changes in Stockholders’ Equity

F-154

Consolidated Statements of Cash Flows

F-155

Notes to Consolidated Financial Statements

F-156

​

​

​

F-1

Table of Contents

​

ARCHIMEDES TECH SPAC PARTNERS II CO.

CONDENSED CONSOLIDATED BALANCE SHEETS

​

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30, 2026

  ​ ​ ​

December 31, 2025

​

​

(Unaudited)

​

​

​

ASSETS

 

​

  ​

 

​

  ​

Current assets

 

​

  ​

 

​

  ​

Cash

​

$

130,359

​

$

1,362,766

Prepaid expenses

​

 

58,821

​

 

111,403

Total current assets

​

 

189,180

​

 

1,474,169

Prepaid insurance

​

 

—

​

 

9,896

Demand deposit held in Trust Account

​

 

246,395,327

​

 

239,860,969

TOTAL ASSETS

​

$

246,584,507

​

$

241,345,034

​

​

​

​

​

​

​

LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT

​

 

  ​

​

 

  ​

Current liabilities

​

 

  ​

​

 

  ​

Accrued expenses

​

$

795,522

​

$

61,277

Accrued offering costs

​

 

—

​

 

75,000

Due to related party

​

 

—

​

 

1,239

PIPE subscription derivative liability

​

 

100,420,000

​

 

—

Total current liabilities

​

 

101,215,522

​

 

137,516

Deferred underwriting fee payable

​

 

8,050,000

​

 

8,050,000

TOTAL LIABILITIES

​

 

109,265,522

​

 

8,187,516

​

​

​

​

​

​

​

Commitments and Contingencies (Note 6)

​

 

  ​

​

 

  ​

​

​

​

​

​

​

​

Ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of $10.71 and $10.43 per share as of September 30, 2026 and December 31, 2025, respectively

​

 

246,395,327

​

 

239,860,969

​

​

​

​

​

​

​

SHAREHOLDERS’ DEFICIT

​

 

  ​

​

 

  ​

Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding

​

 

—

​

 

—

Ordinary shares, $0.0001 par value; 400,000,000 shares authorized; 6,590,000 shares issued and outstanding (excluding 23,000,000 shares subject to possible redemption) as of September 30, 2026 and December 31, 2025

​

 

659

​

 

659

Additional paid-in capital

​

 

—

​

 

—

Accumulated deficit

​

 

(109,077,001)

​

 

(6,704,110)

TOTAL SHAREHOLDERS’ DEFICIT

​

 

(109,076,342)

​

 

(6,703,451)

TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT

​

$

246,584,507

​

$

241,345,034

​

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

​

F-2

Table of Contents

​

ARCHIMEDES TECH SPAC PARTNERS II CO.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

For the Three Months Ended September 30,

  ​ ​ ​

For The Nine Months Ended September 30,

​

​

2026

  ​ ​ ​

2025

​

2026

  ​ ​ ​

2025

General and administrative expenses

​

$

548,632

​

$

159,842

​

$

1,974,919

​

$

467,299

Loss from operations

​

 

(548,632)

​

 

(159,842)

​

 

(1,974,919)

​

 

(467,299)

​

​

​

​

​

​

​

​

​

​

​

​

​

Other income (expense):

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

Interest earned on cash in bank account

​

 

2,959

​

 

17,165

​

 

22,028

​

 

47,602

Interest earned on demand deposit held in Trust Account

​

 

2,233,259

​

 

2,546,478

​

 

6,534,358

​

 

6,341,299

PIPE subscription expense

​

 

―

​

 

—

​

 

(100,000,000)

​

 

—

Change in fair value of PIPE subscription derivative liability

​

 

37,522,000

​

 

—

​

 

(420,000)

​

 

—

Total other income (expense)

​

$

39,758,218

​

$

2,563,643

​

 

(93,863,614)

​

 

6,388,901

​

​

​

​

​

​

​

​

​

​

​

​

​

Net income (loss)

​

$

39,209,586

​

$

2,403,801

​

$

(95,838,533)

​

$

5,921,602

​

​

​

​

​

​

​

​

​

​

​

​

​

Basic and diluted weighted average shares outstanding, redeemable ordinary shares

​

 

23,000,000

​

 

23,000,000

​

 

23,000,000

​

 

19,377,289

Basic and diluted net income (loss) per share, redeemable ordinary shares

​

$

1.33

​

$

0.08

​

$

(3.24)

​

$

0.23

Basic weighted average shares outstanding, non-redeemable ordinary shares

​

 

6,590,000

​

 

6,590,000

​

 

6,590,000

​

 

6,339,560

Basic net income (loss) per share, non-redeemable ordinary shares

​

$

1.33

​

$

0.08

​

$

(3.24)

​

$

0.23

Diluted weighted average shares outstanding, non-redeemable ordinary shares

​

 

6,590,000

​

 

6,590,000

​

 

6,590,000

​

 

6,454,945

Diluted net income (loss) per share, non-redeemable ordinary shares

​

$

1.33

​

$

0.08

​

$

(3.24)

​

$

0.23

​

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

​

F-3

Table of Contents

​

ARCHIMEDES TECH SPAC PARTNERS II CO.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

(UNAUDITED)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

​

​

  ​ ​ ​

Additional

  ​ ​ ​

  ​ ​ ​

​

  ​ ​ ​

Total

​

​

Ordinary Shares

​

Paid-in

​

Accumulated

​

Shareholders’

​

​

Shares

​

Amount

​

Capital

​

Deficit

​

Deficit

Balance — January 1, 2026

 

6,590,000

​

$

659

​

$

—

​

$

(6,704,110)

​

$

(6,703,451)

Accretion of ordinary shares subject to possible redemption to redemption value

 

—

​

 

—

​

 

—

​

 

(2,141,962)

​

 

(2,141,962)

Net income

 

—

​

 

—

​

 

—

​

 

1,704,803

​

 

1,704,803

Balance – March 31, 2026 (unaudited)

 

6,590,000

​

 

659

​

 

—

​

 

(7,141,269)

​

 

(7,140,610)

Accretion of ordinary shares subject to possible redemption to redemption value

 

—

​

 

—

​

 

—

​

 

(2,159,137)

​

 

(2,159,137)

Net loss

 

—

​

 

—

​

 

—

​

 

(136,752,922)

​

 

(136,752,922)

Balance – June 30, 2026 (unaudited)

 

6,590,000

​

 

659

​

 

—

​

 

(146,053,328)

​

 

(146,052,669)

Accretion of ordinary shares subject to possible redemption to redemption value

 

—

​

 

—

​

 

—

​

 

(2,233,259)

​

 

(2,233,259)

Net income

 

—

​

 

—

​

 

—

​

 

39,209,586

​

 

39,209,586

Balance – September 30, 2026 (unaudited)

 

6,590,000

​

$

659

​

$

—

​

$

(109,077,001)

​

$

(109,076,342)

​

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

​

​

​

  ​ ​ ​

Additional

  ​ ​ ​

  ​ ​ ​

​

  ​ ​ ​

Total

​

​

Ordinary Shares(1)

​

Paid-in

​

Accumulated

​

Shareholders’

​

​

Shares

  ​ ​ ​

Amount

​

Capital

​

Deficit

​

Deficit

Balance — January 1, 2025

 

5,750,000

​

$

575

​

$

24,425

​

$

(78,700)

​

$

(53,700)

Sale of 840,000 private placement units

 

840,000

​

 

84

​

 

8,399,916

​

 

—

​

 

8,400,000

Fair value of Public Warrants at issuance

 

—

​

 

—

​

 

1,725,000

​

 

—

​

 

1,725,000

Allocated value of transaction costs to warrants and private placement units

 

—

​

 

—

​

 

(117,194)

​

 

—

​

 

(117,194)

Accretion of ordinary shares subject to possible redemption to redemption value

 

—

​

 

—

​

 

(10,032,147)

​

 

(7,207,063)

​

 

(17,239,210)

Net income

 

—

​

 

—

​

 

—

​

 

1,159,223

​

 

1,159,223

Balance – March 31, 2025 (unaudited)

 

6,590,000

​

 

659

​

 

—

​

 

(6,126,540)

​

 

(6,125,881)

Accretion of ordinary shares subject to possible redemption to redemption value

 

—

​

 

—

​

 

—

​

 

(2,488,937)

​

 

(2,488,937)

Net income

 

—

​

 

—

​

 

—

​

 

2,358,578

​

 

2,358,578

Balance – June 30, 2025 (unaudited)

 

6,590,000

​

 

659

​

 

—

​

 

(6,256,899)

​

 

(6,256,240)

Accretion of ordinary shares subject to possible redemption to redemption value

 

—

​

 

—

​

 

—

​

 

(2,546,478)

​

 

(2,546,478)

Net income

 

—

​

 

—

​

 

—

​

 

2,403,801

​

 

2,403,801

Balance – September 30, 2025 (unaudited)

 

6,590,000

​

$

659

​

$

—

​

$

(6,399,576)

​

$

(6,398,917)

​

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

​

F-4

Table of Contents

​

ARCHIMEDES TECH SPAC PARTNERS II CO.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

​

​

​

​

​

​

​

​

​

  ​ ​ ​

For the Nine

  ​ ​ ​

For the Nine

​

​

Months Ended

​

Months Ended

​

​

September 30,

​

September 30,

​

​

2026

​

2025

Cash Flows from Operating Activities:

 

​

  ​

 

​

  ​

Net (loss) income

​

$

(95,838,533)

​

$

5,921,602

Adjustments to reconcile net (loss) income to net cash used in operating activities:

​

 

  ​

​

 

  ​

Interest earned on demand deposit held in Trust Account

​

 

(6,534,358)

​

 

(6,341,299)

PIPE subscription expense - initial recognition

​

 

100,000,000

​

 

—

Change in fair value of PIPE subscription derivative liability

​

 

420,000

​

 

—

General and administrative expenses paid by related parties

​

 

—

​

 

15,363

General and administrative expenses paid through promissory note – related party

​

 

—

​

 

51,600

Changes in operating assets and liabilities:

​

 

  ​

​

 

  ​

Prepaid expenses

​

 

52,582

​

 

(338,765)

Accrued expenses

​

 

734,245

​

 

29,292

Prepaid insurance

​

 

9,896

​

 

(31,771)

Net cash used in operating activities

​

 

(1,156,168)

​

 

(693,978)

​

​

​

​

​

​

​

Cash Flows from Investing Activities:

​

 

  ​

​

 

  ​

Investment of cash into the Trust Account

​

 

—

​

 

(231,150,000)

Net cash used in investing activities

​

 

—

​

 

(231,150,000)

​

​

​

​

​

​

​

Cash Flows from Financing Activities:

​

 

  ​

​

 

  ​

Proceeds from sale of Units, net of underwriting discounts paid

​

 

—

​

 

225,400,000

Proceeds from sale of Private Placement Units

​

 

—

​

 

8,400,000

Repayment of due to related party

​

 

(1,239)

​

 

(14,086)

Proceeds from promissory note - related party

​

 

—

​

 

40,927

Repayment of promissory note – related party

​

 

—

​

 

(290,000)

Payment of offering costs

​

 

(75,000)

​

 

(283,747)

Net cash (used in) provided by financing activities

​

 

(76,239)

​

 

233,253,094

​

​

​

​

​

​

​

Net Change in Cash

​

 

(1,232,407)

​

 

1,409,116

Cash – Beginning of period

​

 

1,362,766

​

 

—

Cash – End of period

​

$

130,359

​

$

1,409,116

​

​

​

​

​

​

​

Non-cash investing and financing activities:

​

 

  ​

​

 

  ​

Offering costs included in accrued offering costs

​

$

—

​

$

75,000

Offering costs paid through promissory note – related party

​

$

—

​

$

5,440

Deferred underwriting fee payable

​

$

—

​

$

8,050,000

​

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

​

​

F-5

Table of Contents

​

ARCHIMEDES TECH SPAC PARTNERS II CO.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(UNAUDITED)

NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Archimedes Tech SPAC Partners II Co. (the “Company” or “ATII”) is a blank check company newly incorporated in the Cayman Islands on June 7, 2024. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. Although the Company may acquire a business in any industry, it intends to focus on companies engaged in the technology industry. The Company is an early stage and emerging growth company, and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of September 30, 2026, the Company has three subsidiaries, ATII Merger Sub Inc. (“Merger Sub I”), a Delaware corporation and a direct, wholly owned subsidiary of the Company incorporated on December 4, 2025, ATII Merger Sub II, LLC (“Merger Sub II”), a Delaware limited liability company and a direct, wholly owned subsidiary of the Company formed on December 11, 2025, and ATII Holdings Inc. (“Pubco”), a Delaware corporation and a direct, wholly owned subsidiary of the Company incorporated on December 4, 2025. Merger Sub I, Merger Sub II and Pubco were formed for the purpose of facilitating the Business Combination (as defined below). As of September 30, 2026, Merger Sub I, Merger Sub II and Pubco are inactive and have not commenced operations, and have no material assets, liabilities, revenues, or expenses attributable to these subsidiaries during the period.

As of September 30, 2026, the Company had not commenced any operations. All activity for the period from June 7, 2024 (inception) through September 30, 2026 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company and negotiating for an initial business combination. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.

The registration statement for the Company’s Initial Public Offering was declared effective on February 10, 2025. On February 12, 2025, the Company consummated the Initial Public Offering of 23,000,000 units (the “Units” and, with respect to the ordinary shares included in the Units being offered, the “Public Shares”), which included the full exercise by the underwriters of their over-allotment option in the amount of 3,000,000 Units, at $10.00 per Unit, generating gross proceeds of $230,000,000. Each Unit consists of one ordinary share, par value $0.0001 per share, and one-half of one redeemable warrant (the “Public Warrants”), each whole Public Warrant entitling the holder thereof to purchase one ordinary share at an exercise price of $11.50 per share, subject to adjustment.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 840,000 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to Archimedes Tech SPAC Sponsors II LLC (the “Sponsor”) and BTIG, LLC, the representative of the underwriters in the Initial Public Offering (“BTIG”), generating gross proceeds of $8,400,000. Each Private Placement Unit consists of one ordinary share and one-half of one redeemable warrant (“Private Placement Warrants”), with each whole Private Placement Warrant entitling the holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment.

Transaction costs amounted to $13,175,520, consisting of $4,600,000 of cash underwriting fee, $8,050,000 of deferred underwriting fee and $525,520 of other offering costs.

F-6

Table of Contents

​

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating an initial business combination. There is no assurance that the Company will be able to complete an initial business combination successfully. The Company must complete one or more initial business combinations with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding any deferred underwriting fees and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial business combination. The Company will only complete an initial business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”).

Following the closing of the Initial Public Offering, on February 12, 2025, an amount of $231,150,000 ($10.05 per Unit) from the net proceeds of the sale of the Units and the sale of the Private Placement Units was held in a trust account (“Trust Account”), located in the United States and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations and/or held as cash or cash items (including in demand deposit accounts). The Company will not be permitted to withdraw any of the principal or interest held in the Trust Account except for the withdrawal of interest to pay taxes. The funds held in the Trust Account will not otherwise be released from the Trust Account until the earliest of: (1) the completion of an initial business combination; (2) the redemption of any Public Shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with initial business combination or to redeem 100% of the Public Shares if the Company does not complete the initial business combination within the Completion Window, as defined below, or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial business combination activity; and (3) the redemption of the Public Shares if the Company has not completed an initial business combination within the Completion Window, subject to Cayman Islands laws.

The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of an initial business combination either (i) in connection with a shareholder meeting called to approve the business combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of an initial business combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.05 per Public Share, plus any pro rata interest then in the Trust Account, net of funds withdrawn to pay taxes). There will be no redemption rights upon the completion of an initial business combination with respect to the Company’s warrants. The Public Shares subject to possible redemption were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.”

The Company’s amended and restated memorandum and articles of association does not provide a specified maximum redemption threshold, except that in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than any net tangible asset or cash requirement that may be contained in the agreement relating to the initial business combination. As a result, the Company may be able to complete its initial business combination even though a substantial majority of the public shareholders do not agree with the transaction and have redeemed their shares or, if the Company seeks shareholder approval of the initial business combination and does not conduct redemptions in connection with the initial business combination pursuant to the tender offer rules, have entered into privately negotiated agreements to sell their shares to the initial shareholders, directors, officers, advisors or any of their respective affiliates. In the event the aggregate cash consideration the Company would be required to pay for all public shares that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed business combination exceed the aggregate amount of cash available to the Company, the Company will not complete the business combination or redeem any shares, and all ordinary shares submitted for redemption will be returned to the holders thereof, and the Company instead may search for an alternate business combination.

Notwithstanding the foregoing, if the Company seeks shareholder approval of an initial business combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s amended and restated memorandum and articles of association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange

F-7

Table of Contents

​

Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company.

The initial shareholders and the Company’s officers and directors entered into a letter agreement, pursuant to which they have agreed to waive: (1) their redemption rights with respect to any shares held by them in connection with the completion of the initial business combination; (2) their redemption rights with respect to any shares held by them in connection with a shareholder vote to amend the amended and restated memorandum and articles of association (A) to modify the substance or timing of the obligation to allow redemption in connection with the initial business combination or to redeem 100% of the public shares if the Company does not complete the initial business combination within the Completion Window (as defined below) or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial business combination activity; and (3) their rights to liquidating distributions from the Trust Account with respect to any founder shares and private shares they hold if the Company fails to complete its initial business combination within the Completion Window as a result of a shareholder vote to amend the amended and restated memorandum and articles of association (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial business combination within the Completion Window). If the Company submits its initial business combination to the public shareholders for a vote, the initial shareholders, directors and officers have agreed (and their permitted transferees will agree), pursuant to the terms of a letter agreement entered into with the Company, to vote any shares held by them in favor of the initial business combination.

The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete an initial business combination within the Completion Window and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

The Company will have until 21 months from the closing of the Initial Public Offering, or until such earlier liquidation date as the Company’s board of directors may approve, to complete an initial business combination (the “Completion Window”). If the Company has not completed an initial business combination within the Completion Window, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (net of funds withdrawn to pay taxes and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject, in each case, to obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There is no limitation on the Company’s ability to raise funds privately or through loans in connection with its initial business combination.

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (other than the independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.05 per public share or (2) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

F-8

Table of Contents

​

Merger Agreement

On April 20, 2026, the Company, Pubco, Merger Sub I, Merger Sub II, and Forge Nano, Inc., a Delaware corporation (“Forge Nano”), entered into a merger agreement (the “Merger Agreement”). Pursuant to the Merger Agreement, and subject to the terms and conditions set forth therein, the Company will re-domicile and become a Delaware corporation by merging with Pubco, following which the separate corporate existence of the Company will cease and Pubco will continue as the surviving corporation. At the effective time of the merger, Pubco will adopt Delaware organizational documents, which will provide, among other things, that the name of Pubco will be changed to “Forge Nano Holdings Inc.”

On October 16, 2026, the Company held an extraordinary general meeting (the “Extraordinary General Meeting”) to approve the Business Combination and the transactions contemplated therewith. On the same date, the Company issued a press release announcing the approval of the previously announced Business Combination between the Company and Forge Nano, as well as all other proposals related to the Business Combination considered and voted upon at the Extraordinary General Meeting. In connection with the shareholders’ vote at such meeting, 22,219,068 shares were tendered for redemption and $238,404,289, or approximately $10.73 redemption price per share, was withdrawn from the Trust Account to pay the redeeming shareholders.

As described in more detail below, on October 21, 2026, the Company consummated the Domestication Merger (as defined below) and, on October 22, 2026 (the “Closing Date”), the parties to the Merger Agreement consummated the Company Mergers (as defined below) and the other transactions contemplated by the Merger Agreement (the “Closing”).

Domestication Merger

Pursuant to the Merger Agreement, on October 21, 2026, the Company re-domiciled and became a Delaware corporation by merging with and into Pubco (the “Domestication Merger”), following which the separate corporate existence of the Company ceased and Pubco continued as the surviving corporation. At the effective time of the Domestication Merger (the “Domestication Merger Effective Time”), Pubco adopted Delaware organizational documents (the Charter and the Bylaws), which provide, among other things, that the name of Pubco was changed to Forge Nano Holdings, Inc.

Immediately prior to the Domestication Merger Effective Time, each then issued and outstanding Unit of the Company (an “ATII Unit”) separated and converted automatically into one ordinary share, par value $0.0001 per share, of the Company (an “ATII Ordinary Share”) and one-half of one warrant of the Company, each whole warrant entitling the holder thereof to acquire one ATII Ordinary Share at a purchase price of $11.50 per share (the “ATII Warrants”), and all ATII Units ceased to be outstanding and ceased to exist. At the Domestication Merger Effective Time, each then issued and outstanding ATII Ordinary Share was cancelled in exchange for the right to receive one share of common stock, par value $0.0001 per share, of Pubco (each, a share of “Pubco Common Stock”) and each whole ATII Warrant that was outstanding and unexercised converted automatically into a warrant to acquire one share of Pubco Common Stock at a purchase price of $11.50 per share (each, a “Pubco SPAC Warrant”), pursuant to the terms of the Warrant Agreement, dated as of February 10, 2025 (as assumed by Pubco pursuant to the Assumption of Warrant Agreement dated as of October 21, 2026, the “ATII Warrant Agreement”), by and between the Company and Odyssey Transfer and Trust Company, as warrant agent.

Company Mergers

On the Closing Date, as contemplated by the Merger Agreement, the parties to the Merger Agreement consummated the Company Mergers, whereby:

●Merger Sub I merged with and into Forge Nano (the “First Company Merger”), with Forge Nano surviving the First Company Merger as a wholly-owned subsidiary of Forge Nano Holdings, Inc. (the “Initial Surviving Corporation”);
●at the effective time of the First Company Merger (the “First Effective Time”), (i) each share of each class of preferred stock, par value $0.0001 per share, of Forge Nano (the “Forge Nano Preferred Stock”) issued and outstanding immediately prior to the First Effective Time was converted into shares of common stock, par value $0.0001 per share, of Forge Nano (the “Forge Nano Common Stock”) pursuant to Forge Nano’s organizational documents, and (ii) each share of Forge Nano Common Stock issued and outstanding immediately prior to the First Effective Time (including shares of Forge Nano Common Stock issued upon conversion of the Forge Nano Preferred Stock, but excluding treasury shares, which were cancelled) was cancelled and automatically converted into the right to receive, without interest, the applicable pro rata portion of the Closing

F-9

Table of Contents

​

Payment Shares, based on an exchange ratio calculated as of the First Effective Time of approximately 28.5 to 1 (the “Exchange Ratio”);
●in addition, at the First Effective Time, (i) each option to purchase shares of Forge Nano Common Stock (each, a “Forge Nano Option”) outstanding and unexpired immediately prior to the First Effective Time was converted into an option to purchase shares of Pubco Common Stock (each, a “Pubco Option”) on substantially the same terms and conditions, including with respect to vesting and termination-related provisions, except that the number of shares of Pubco Common Stock subject to each Pubco Option equals the product (rounded down to the nearest whole share) of (a) the number of shares of Forge Nano Common Stock subject to such Forge Nano Option immediately prior to the First Effective Time and (b) the quotient of the Applicable Per Share Merger Consideration divided by the Equity Award Conversion Amount (each as defined in the Merger Agreement), and the per-share exercise price of each Pubco Option equals the exercise price per share of such Forge Nano Option divided by the Equity Award Conversion Amount, rounded up to the nearest whole cent; (ii) each warrant of Forge Nano (each, a “Forge Nano Warrant”) outstanding and unexpired immediately prior to the First Effective Time was assumed and became a corresponding warrant to purchase shares of Pubco Common Stock (each, a “Pubco Forge Nano Warrant”), subject to the same terms and conditions (including vesting and exercisability) as were applicable to the corresponding Forge Nano Warrant immediately prior to the First Effective Time; and (iii) each option to acquire securities of Forge Nano held by Ascent Funds International Management LLC or its affiliates (the “Forge Nano Ascent Options” and, together with the Forge Nano Warrants, the “Forge Nano Convertible Securities”) outstanding and unexpired immediately prior to the First Effective Time was cancelled and converted into a warrant to purchase shares of Pubco Common Stock (each, a “Pubco Ascent Warrant” and, together with the Pubco Forge Nano Warrants, the “Pubco Convertible Securities”) pursuant to the Pubco Ascent Warrant Agreement (as defined below);
●Forge Nano Holdings, Inc. issued an aggregate of 90,000,000 shares of Pubco Common Stock (the “Earn-Out Shares”) to Odyssey Transfer and Trust Company, as escrow agent (the “Escrow Agent”), which will be disbursed to the former shareholders of Forge Nano who received Closing Payment Shares and the holders of Pubco Convertible Securities, in proportional amounts, upon the achievement of the following milestones during the five-year period following the Closing Date: (a) 30,000,000 Earn-Out Shares if the VWAP (as defined in the Merger Agreement) of the Pubco Common Stock equals or exceeds $15.00 per share over any 30-trading-day period or the revenue publicly reported by Forge Nano Holdings, Inc. for the preceding twelve months equals or exceeds $400,000,000; (b) 30,000,000 Earn-Out Shares if such VWAP equals or exceeds $20.00 per share or such revenue equals or exceeds $600,000,000; and (c) 30,000,000 Earn-Out Shares if such VWAP equals or exceeds $25.00 per share or such revenue equals or exceeds $800,000,000. The milestones operate on a cumulative basis, and Earn-Out Shares attributable to holders of Pubco Convertible Securities will only be disbursed upon the exercise, conversion or settlement of such Pubco Convertible Securities in accordance with their terms; and
●immediately following the First Effective Time, the Initial Surviving Corporation merged with and into Merger Sub II (the “Second Company Merger” and, together with the First Company Merger, the “Company Mergers” and, the Company Mergers together with the Domestication Merger and the other transactions contemplated by the Merger Agreement, the “Business Combination”), with Merger Sub II surviving the Second Company Merger as a wholly-owned subsidiary of Forge Nano Holdings, Inc.

PIPE Financing

On April 20, 2026, concurrently with the execution of the Merger Agreement, the Company, Pubco and Forge Nano entered into a subscription agreement (the “PIPE Subscription”, as amended and restated on October 13, 2026, the “A&R PIPE Subscription Agreement”) with a certain accredited investor (the “Initial PIPE Investor”), pursuant to which, substantially concurrently with the Closing, Forge Nano Holdings, Inc. issued and sold to the Initial PIPE Investor for an aggregate purchase price of $100,000,000 (the “PIPE Financing”) (a) 2,968,825 shares of Pubco Common Stock (the “PIPE Subscribed Shares”) at a subscription price of $10.00 per share, (b) pre-funded warrants (the “Pre-Funded Warrants”) to purchase an aggregate of 7,031,175 shares of Pubco Common Stock, each with an exercise price of $0.0001 per share, at a subscription price of $10.00 per Pre-Funded Warrant, and (c) warrants (the “PIPE Warrants”) to purchase an aggregate of 15,000,000 shares of Pubco Common Stock, each with an initial exercise price of $10.00 per share (subject to adjustment as described below).

The PIPE Warrants are exercisable at any time after their issuance and expire five years after the date of issuance. The exercise price of the PIPE Warrants is subject to certain adjustments, including a one-time reset on the 21st trading day following the six-month anniversary of the Closing Date to the greater of (i) the VWAP (as defined in the PIPE Warrant Certificate) of the Pubco

F-10

Table of Contents

​

Common Stock for the twenty trading day period commencing on the date that is six months after the Closing Date and (ii) a floor price of $5.00 per share (the “PIPE Reset Price”). The terms of the PIPE Warrants are described in the section of the Proxy Statement/Prospectus titled “Description of Pubco Securities – Warrants – PIPE Warrants” beginning on page 360, which is incorporated herein by reference.

In the event that on the 21st trading day following the six-month anniversary of the Closing Date, the VWAP (as defined in the PIPE Warrant Certificate) of the Pubco Common Stock is less than the Exercise Price (as defined in the PIPE Warrant Certificate), Forge Nano Holdings, Inc. will issue to the Initial PIPE Investor additional warrants entitling the Initial PIPE Investor to purchase up to 10,000,000 shares of Pubco Common Stock (the “Reset PIPE Warrants”), in an amount equal to (i) the product of (x) 10,000,000, multiplied by (y) the Exercise Price then in effect divided by the PIPE Reset Price minus (ii) 10,000,000. In addition, if, on the 24- month anniversary of the Closing Date, the Initial PIPE Investor certifies in writing that the Initial PIPE Investor beneficially owns 5,000,000 shares of Pubco Common Stock, Forge Nano Holdings, Inc. will issue to the Initial PIPE Investor additional warrants entitling the Initial PIPE Investor to purchase 5,000,000 shares of Pubco Common Stock (the “Additional PIPE Warrants”).

Additionally, subsequent to the execution of the Merger Agreement, the Company, Pubco and Forge Nano entered into subscription agreements (the “Additional PIPE Subscription Agreements”) with certain other accredited investors (collectively, the “Additional PIPE Investors” and together with the Initial PIPE Investor, the “PIPE Investors”), pursuant to which, substantially concurrently with the Closing, Forge Nano Holdings, Inc. issued and sold an aggregate of 2,300,000 shares of Pubco Common Stock (the “Additional PIPE Subscribed Shares”) to the Additional PIPE Investors at a subscription price of $10.00 per share, for an aggregate purchase price of $23,000,000 (the “Additional PIPE Financing”).

Outstanding Securities

In connection with the consummation of the Business Combination and the PIPE Financing, and after giving effect to the redemptions, Forge Nano Holdings, Inc.:

(1)issued an aggregate of 128,655,585 shares of Pubco Common Stock, consisting of:

●7,370,932 shares of Pubco Common Stock issued to the holders of ATII Ordinary Shares in the Domestication Merger (after giving effect to the redemptions);
●116,015,828 shares of Pubco Common Stock issued to the former stockholders of Forge Nano as Closing Payment Shares in the First Company Merger;
●5,268,825 shares of Pubco Common Stock issued to the PIPE Investors in the PIPE Financing and the Additional PIPE Financing;

(2)issued 90,000,000 Earn-Out Shares to the Escrow Agent;

(3)issued 11,919,995 Pubco SPAC Warrants in exchange for ATII Warrants in the Domestication Merger;

(4)

issued PIPE Warrants exercisable for up to 15,000,000 shares of Pubco Common Stock and Pre-Funded Warrants exercisable for up to 7,031,175 shares of Pubco Common Stock in the PIPE Financing;

(5)

issued or assumed Pubco Options, Pubco Forge Nano Warrants and Pubco Ascent Warrants that collectively are exercisable for 15,954,561 shares of Pubco Common Stock; and

(6)

granted an aggregate of 8,744,864 Performance Stock Units (“PSUs”) which will vest as follows: (i) one third of the PSUs will vest if the VWAP of the Pubco Common Stock equals or exceeds $15.00 per share over any 30-trading day period or the revenue of Forge Nano Holdings, Inc. for the preceding twelve months equals or exceeds $400,000,000, (ii) one third of the PSUs will vest if the VWAP of the Pubco Common Stock equals or exceeds $20.00 per share over any 30-trading day period or the revenue of Forge Nano Holdings, Inc. for the preceding twelve months equals or exceeds $600,000,000 and (iii) one third of the PSUs will vest if the VWAP of the Pubco Common Stock equals or exceeds $25.00 per share over any 30-trading day period or the revenue of Forge Nano Holdings, Inc. for the preceding twelve months equals or exceeds $800,000,000.

F-11

Table of Contents

​

In addition, at the Closing, pursuant to the Purchaser Support Agreement, dated as of April 20, 2026 (the “Purchaser Support Agreement”), by and among the Company, Forge Nano and the Sponsor, the Sponsor transferred an aggregate of 3,300,000 shares of Pubco Common Stock (which it received in exchange for Founder Shares in the Domestication Merger) to certain investors at the Closing in connection with the PIPE Financing for no additional cash consideration.

Liquidity and Capital Resources

As of September 30, 2026, the Company had cash of $130,359 and working capital deficit of $101,026,342. The Company intends to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete an initial business combination.

In order to fund working capital deficiencies or finance transaction costs in connection with an initial business combination, the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required. If the Company completes an initial business combination, the Company would repay such loaned amounts. In the event that an initial business combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units, at a price of $10.00 per unit, at the option of the lender. The units would be identical to the Private Placement Units.

In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the Company currently lacks the liquidity it needs to sustain operations for a reasonable period of time, which is considered to be at least one year from the date that the unaudited condensed consolidated financial statements are issued as it expects to continue to incur significant costs in pursuit of its acquisition plans. In addition, if the Company is unable to complete an initial business combination by November 12, 2026, then the Company will cease all operations except for the purpose of liquidating. As of September 30, 2026, the date for mandatory liquidation and subsequent dissolution and liquidity condition raise substantial doubt about the Company’s ability to continue as a going concern. On October 21, 2026, the Company re-domiciled and became a Delaware corporation by merging with and into Forge Nano Holdings, Inc. (previously known as Pubco), following which the separate corporate existence of the Company ceased and Forge Nano Holdings, Inc. continued as the surviving corporation. As a result of the Closing, the mandatory liquidation condition no longer applies, and the Company’s obligations have been assumed by the surviving company, which continues the combined business. The Company’s dissolution through the merger does not constitute a liquidation, as defined in ASC 205-30, and these unaudited condensed consolidated financial statements have been prepared on a going concern basis. Management has concluded that the conditions that raised substantial doubt about the Company’s ability to continue as a going concern have been resolved.

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in unaudited condensed consolidated financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the SEC on March 4, 2026. The interim results for the three and nine months ended September 30, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.

F-12

Table of Contents

​

Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions were eliminated in the unaudited condensed consolidated financial statements.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of other income and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments held outside of Trust Account with an original maturity of three months or less when purchased to be cash equivalents. The Company had $130,359 and $1,362,766 in cash as of September 30, 2026 and December 31, 2025, respectively, and no cash equivalents as of such dates.

Demand Deposit Held in Trust Account

As of September 30, 2026 and December 31, 2025, the assets held in Trust Account, amounting to $246,395,327 and $239,860,969, respectively, were held in demand deposit accounts.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution, which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. Any loss incurred

F-13

Table of Contents

​

or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

Offering Costs

The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “Expenses of Offering”. Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, “Debt with Conversion and Other Options”, addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the warrants and then to the ordinary shares. Offering costs allocated to the Public Shares were charged to temporary equity, and offering costs allocated to the Public Warrants and Private Placement Units were charged to shareholders’ deficit as the warrants associated with units issued in the Initial Public Offering and Private Placement, after management’s evaluation, are accounted for under equity treatment.

Transaction costs amounted to $13,175,520, consisting of $4,600,000 of cash underwriting fee, $8,050,000 of deferred underwriting fee and $525,520 of other offering costs.

Income Taxes

The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2026 and December 31, 2025, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.

Net Income (Loss) per Ordinary Share

The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Accretion associated with the redeemable ordinary shares is excluded from earnings per share as the redemption value approximates fair value.

The calculation of diluted net income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement, since the exercise of the warrants are contingent upon the occurrence of future events. For the three and nine months ended September 30, 2026 and 2025, the warrants are exercisable to purchase 11,920,000 ordinary shares. The weighted average of these shares was excluded from the calculation of diluted net income (loss) per ordinary share since the inclusion of such warrants would be anti-dilutive. The warrants cannot be converted to ordinary shares prior to an initial business combination; therefore, they have been classified as anti-dilutive.

​

F-14

Table of Contents

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

For the Three Months Ended September 30,

  ​ ​ ​

For the Nine Months Ended September 30,

​

​

2026

​

2025

​

2026

​

2025

​

​

​

​

​

Non-

​

​

​

​

Non-

​

​

​

​

Non-

​

​

​

​

Non-

​

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

Basic net income(loss) per share:

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

Numerator:

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

Allocation of net income (loss) Denominator:

​

$

30,477,204

​

$

8,732,382

​

$

1,868,450

​

$

535,351

​

$

(74,494,297)

​

$

(21,344,236)

​

$

4,461,845

​

$

1,459,757

Basic weighted-average shares outstanding

​

 

23,000,000

​

 

6,590,000

​

 

23,000,000

​

 

6,590,000

​

 

23,000,000

​

 

6,590,000

​

 

19,377,289

​

 

6,339,560

Basic net income (loss) per ordinary share

​

$

1.33

​

$

1.33

​

$

0.08

​

$

0.08

​

$

(3.24)

​

$

(3.24)

​

$

0.23

​

$

0.23

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

For the Three Months Ended September 30,

  ​ ​ ​

For the Nine Months Ended September 30,

​

​

2026

​

2025

​

2026

​

2025

​

​

​

​

​

Non-

​

​

​

​

Non-

​

​

​

​

Non-

​

​

​

​

Non-

​

​

Redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

Diluted net income (loss) per share:

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

Numerator:

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

Allocation of net income (loss) Denominator:

​

$

30,477,204

​

$

8,732,382

​

$

1,868,450

​

$

535,351

​

$

(74,494,297)

​

$

(21,344,236)

​

$

4,441,915

​

$

1,479,687

Diluted weighted-average shares outstanding

​

 

23,000,000

​

 

6,590,000

​

 

23,000,000

​

 

6,590,000

​

 

23,000,000

​

 

6,590,000

​

 

19,377,289

​

 

6,454,945

Diluted net income (loss) per ordinary share

​

$

1.33

​

$

1.33

​

$

0.08

​

$

0.08

​

$

(3.24)

​

$

(3.24)

​

$

0.23

​

$

0.23

​

​

F-15

Table of Contents

​

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period in accordance with FASB ASC Topic 480, “Distinguishing Liabilities from Equity”. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The PIPE Subscription is representative of a derivative instrument within the scope of ASC 815.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the condensed consolidated balance sheets, primarily due to their short-term nature.

Fair Value Measurement

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1:    Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2:    Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3:    Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability.

The PIPE Subscription was evaluated under freestanding financial instrument framework and management concluded that the common stock subscribed and the related warrant features together, should be evaluated as a single common stock PIPE freestanding financial instrument.

F-16

Table of Contents

​

On April 20, 2026, the PIPE Subscription was initially recognized at fair value of $100,000,000. As of September 30, 2026, the PIPE Subscription has a fair value of $100,420,000. The fair value of the PIPE Subscription was determined using Monte Carlo Simulation Model. The PIPE Subscription has been classified as current liability within the scope of ASC 815 and will require remeasurement at each reporting period. The following table presents the quantitative information regarding market assumptions used in the Level 3 valuation of the PIPE Subscription:

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

April 20,

  ​ ​ ​

September 30,

 

​

​

2026

​

2026

 

Expected term to De-SPAC (Years)

 

​

0.4

 

​

0.13

​

Warrant term

 

​

5.0

 

​

5.0

​

Probability of De-SPAC and Market Adjustment

 

​

64.0

%  

​

52.0

%

Forward Risk-Free Rate (Continuous

 

​

3.88

%  

​

5.04

%

Volatility

 

​

19.5

%  

​

40.0

%

Redemption trigger price

​

$

35.00

​

$

35.00

​

Floor price

​

$

7.28

​

$

7.28

​

​

The following table provides a summary of the changes in the fair value of PIPE Subscription, a Level 3 financial instrument, that was measured at fair value on a recurring basis:

​

​

​

​

​

Fair value at April 20, 2026

  ​ ​ ​

$

100,000,000

Change in fair value of PIPE Subscription derivative liability

 

​

37,942,000

Fair value at June 30, 2026

 

​

137,942,000

Change in fair value of PIPE Subscription derivative liability

 

​

(37,522,000)

Fair value at September 30, 2026

​

$

100,420,000

​

Warrant Instruments

The Company accounted for the Public and Private Placement Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging”, whereby under that provision, the warrants that do not meet the criteria for equity treatment must be recorded as liability. Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned values.

The fair value of the Public Warrants on the closing of the Initial Public Offering on February 12, 2025, was $1,725,000, or $0.15 per Public Warrant. The fair value of Public Warrants was determined using Monte Carlo Simulation Model. The Public Warrants have been classified within shareholders’ deficit and will not require remeasurement after issuance. The following table presents the quantitative information regarding market assumptions used in the level 3 valuation of the Public Warrants:

​

​

​

​

​

​

​

  ​ ​ ​

February 12,

 

​

​

2025

 

Implied ordinary share price

​

$

9.93

​

Exercise price

​

$

11.50

​

Simulation term (years)

​

 

6.5

​

Risk-free rate (continuous)

​

 

4.49

%

Selected volatility

​

 

3.0

%

Calculated value per warrant

​

$

0.15

​

Probability of de-SPAC and market adjustment

​

 

11.0

%

​

F-17

Table of Contents

​

Ordinary Shares Subject to Possible Redemption

The public shares contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial business combination. In accordance with ASC 480-10-S99, the Company classifies public shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of September 30, 2026 and December 31, 2025, the ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed consolidated balance sheets. As of September 30, 2026 and December 31, 2025, the ordinary shares subject to possible redemption reflected in the condensed consolidated balance sheets are reconciled in the following table:

​

​

​

​

​

Gross proceeds

  ​ ​ ​

$

230,000,000

Less:

 

​

  ​

Proceeds allocated to Public Warrants

 

​

(1,725,000)

Ordinary shares issuance costs

 

​

(13,058,326)

Plus:

 

​

  ​

Accretion of carrying value to redemption value

 

​

24,644,295

Ordinary shares subject to possible redemption, December 31, 2025

​

$

239,860,969

Plus:

​

 

  ​

Accretion of carrying value to redemption value

​

 

6,534,358

Ordinary shares subject to possible redemption, September 30, 2026

​

$

246,395,327

​

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.

​

NOTE 3 — INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering, the Company sold 23,000,000 Units, which included a full exercise by the underwriters of their over-allotment option of 3,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one ordinary share and one-half Public Warrant. Each whole Public Warrant entitles the holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7).

​

NOTE 4 — PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 840,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement to the Sponsor and BTIG, generating gross proceeds of $8,400,000. Each Private Placement Unit consists of one ordinary share and one-half of one redeemable warrant (the “Private Placement Warrants”), with each whole Private Placement Warrant entitling the holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7). The proceeds from the sale of the Private Placement Units are added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete an initial business combination within the Completion Window, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).

​

F-18

Table of Contents

​

NOTE 5 — RELATED PARTIES

Founder Shares

On June 7, 2024, the Sponsor made a capital contribution of $25,000 to cover certain of the Company’s expenses, for which the Company issued 5,750,000 ordinary shares (the “Founder Shares”). The Founder Shares include an aggregate of up to 750,000 shares subject to surrender and forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the number of Founder Shares will equal, on an as-converted basis, approximately 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. As a result of the Initial Public Offering and the full exercise by the underwriters of their over-allotment option, 750,000 shares are no longer subject to surrender and forfeiture.

Pursuant to a letter agreement that the initial shareholders, directors and officers have entered into with the Company, with certain limited exceptions, the Founder Shares are not transferable, assignable or salable (except to directors and officers and other persons or entities affiliated with the initial shareholders, each of whom will be subject to the same transfer restrictions) until the earlier of: (i) six months after the completion of the initial business combination; and (ii) subsequent to the initial business combination, the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, the Founder Shares will be released from the lock-up if (1) the last reported sale price of the Company’s ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period after the initial business combination or (2) if the Company completes a transaction after the initial business combination which results in all of the Company’s shareholders having the right to exchange their shares for cash, securities or other property.

Promissory Note — Related Party

On June 7, 2024, the Sponsor issued an unsecured promissory note to the Company (as amended, the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $290,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) March 31, 2025 or (ii) the consummation of the Initial Public Offering or (iii) the date on which the Company determines to not proceed with the Initial Public Offering. Simultaneously with the closing of the Initial Public Offering on February 12, 2025, the Company repaid the outstanding borrowings under the Promissory Note amounting to $290,000. Borrowings under the note are no longer available.

Due to Related Party

Due to related party represents recurring Company expenses advanced by officers on behalf of the Company. As of September 30, 2026 and December 31, 2025, the Company owed $0 and $1,239 to officers, respectively.

Administrative Support Agreement

Commencing on the effective date, February 10, 2025, the Company agreed to reimburse the Sponsor in an amount equal to $10,000 per month for office space, administrative and support services. Upon completion of the initial business combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the three and nine months ended September 30, 2026, the Company incurred and paid $30,000 and $90,000 in fees for these services, respectively. For the three and nine months ended September 30, 2025, the Company incurred $30,000 and $76,786 in fees for these services, respectively, all of which were paid as of September 30, 2025. These fees were included in general and administrative expenses on the unaudited condensed consolidated statements of operations. As of September 30, 2026 and December 31, 2025, nothing was accrued related to these fees.

​

F-19

Table of Contents

​

Working Capital Loans

In order to finance transaction costs in connection with an initial business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes an initial business combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that an initial business combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of an initial business combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into units of the post-business combination entity at a price of $10.00 per unit. The units would be identical to the Private Placement Units. As of September 30, 2026 and December 31, 2025, no Working Capital Loans were outstanding.

NOTE 6 — COMMITMENTS AND CONTINGENCIES

Risks and Uncertainties

Before the Business Combination closed, the Company’s ability to complete an initial business combination could have been adversely affected by various factors, many of which were beyond the Company’s control. These factors included, among others, changes in laws or regulations, downturns in the financial markets or in economic conditions, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine and the Middle East. As described in Note 9, the Company completed the Business Combination with Forge Nano Holdings Inc. on October 22, 2026. The factors described above did not prevent the Company from completing the Business Combination.

However, these factors, or any other negative impact on the global economy, capital markets or geopolitical conditions resulting from ongoing or future global conflicts and any resulting sanctions or related actions, could adversely affect Forge Nano Holdings Inc., with and into which the Company merged, after the Business Combination. Possible effects include adverse impacts on its business, operations, financial condition, results of operations, liquidity, access to capital, and the market price of its securities. The Company cannot at this time predict the likelihood of any of these events, their duration or magnitude, or the extent to which they may negatively affect Forge Nano Holdings Inc.

Registration Rights

The holders of the Founder Shares, Private Placement Units (and underlying securities) and any units (and underlying securities) that may be issued on conversion of Working Capital Loans are entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain piggyback registration rights with respect to registration statements filed subsequent to the completion of the initial business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

​

F-20

Table of Contents

​

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of Initial Public Offering to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On February 12, 2025, simultaneously with the Initial Public Offering, the underwriters exercised their over-allotment option in full, closing on the 3,000,000 additional Units.

The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $4,600,000 in the aggregate upon the closing of the Initial Public Offering. In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $8,050,000 in the aggregate. In connection with the shareholders’ vote at the Extraordinary General Meeting and the related redemption of Public Shares, the deferred fee was reduced by an aggregate amount of $2,221,907, representing the amount allocated to the Public Shares redeemed. The outstanding deferred fee of $5,828,093 was settled at Closing.

NOTE 7 — SHAREHOLDERS’ DEFICIT

Preference Shares — The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2026 and December 31, 2025, there were no preference shares issued or outstanding.

Ordinary Shares — The Company is authorized to issue 400,000,000 ordinary shares with a par value of $0.0001 per share. Holders of ordinary shares are entitled to one vote for each share. As of September 30, 2026 and December 31, 2025, there were 6,590,000 ordinary shares issued and outstanding, excluding the 23,000,000 ordinary shares subject to possible redemption.

Warrants — As of September 30, 2026 and December 31, 2025, there were approximately 11,920,000 warrants outstanding, including 11,500,000 Public Warrants and 420,000 Private Placement Warrants. Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of an initial business combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of an initial business combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue ordinary shares upon exercise of a warrant unless ordinary shares issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.

The Company has agreed that as soon as practicable, but in no event later than twenty (20) business days after the closing of an initial business combination, it will use its best efforts to file with the SEC a registration statement covering the ordinary share issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of an initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the foregoing, if a registration statement covering the ordinary shares issuable upon exercise of the warrants is not effective within a specified period following the consummation of an initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.

​

F-21

Table of Contents

​

Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants:

●in whole and not in part;
●at a price of $0.01 per Public Warrant;
●upon a minimum of 30 days’ prior written notice of redemption, referred to as the 30-day redemption period; and
●if, and only if, the last sale price of ordinary shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share consolidations, share capitalizations, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

If the Company calls the warrants for redemption, management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” management will consider, among other factors, the Company’s cash position, the number of warrants that are outstanding and the dilutive effect on the Company’s shareholders of issuing the maximum number of ordinary shares issuable upon the exercise of the Company’s warrants. In such event, each holder would pay the exercise price by surrendering the warrants for that number of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” over the exercise price of the warrants by (y) the fair market value. The “fair market value” shall mean the highest closing sale price of the ordinary share for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.

In addition, if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial business combination at a Newly Issued Price of less than $9.20 per ordinary shares (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination on the date of the consummation of the initial business combination (net of redemptions), and (z) the Market Value is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

The Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Initial Public Offering, subject to certain limited exceptions.

NOTE 8 — SEGMENT INFORMATION

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker (“CODM”), or group, in deciding how to allocate resources and assess performance.

The Company’s CODM has been identified as the Chief Executive Officer, who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that there is only one reportable segment.

F-22

Table of Contents

​

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the unaudited condensed consolidated statements of operations as net income or loss. The measure of segment assets is reported on the condensed consolidated balance sheets as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total assets, which include the following:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30,

  ​ ​ ​

December 31,

​

​

2026

​

2025

Cash

​

$

130,359

​

$

1,362,766

Demand deposit held in Trust Account

​

$

246,395,327

​

$

239,860,969

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

For the Three Months

  ​ ​ ​

  ​ ​ ​For the Nine Months

​

​

Ended September 30,

​

Ended September 30,

​

​

2026

​

2025

​

2026

​

2025

General and administrative expenses

​

$

548,632

​

$

159,842

​

$

1,974,919

​

$

467,299

Interest earned on cash in bank account

​

$

2,959

​

$

17,165

​

$

22,028

​

$

47,602

Interest earned on demand deposit held in Trust Account

​

$

2,233,259

​

$

2,546,478

​

$

6,534,358

​

$

6,341,299

​

The CODM is provided with details of cash and liquid resources available with the Company. The CODM reviews the position of total assets available with the Company to assess if the Company has sufficient resources available to discharge its liabilities.

The CODM reviews interest earned on demand deposit held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.

Interest earned on cash in bank account and general and administrative expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete an initial business combination or similar transaction within the Completion Window. The CODM also reviews the interest earned on cash in bank account and general and administrative expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative expenses, as reported on the unaudited condensed consolidated statements of operations, are the significant segment expenses provided to the CODM on a regular basis.

NOTE 9 — SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the condensed consolidated balance sheet date up to the date that the unaudited condensed consolidated financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed consolidated financial statements.

On October 13, 2026, the parties to the original PIPE Subscription entered into an Amended and Restated Subscription Agreement (the “Amended and Restated Subscription Agreement”), which provides that 7,031,175 of the Investor’s 10,000,000 subscribed shares will be issued instead in the form of pre-funded warrants to purchase an equal number of shares of Pubco Common Stock at an exercise price of $0.0001 per share (the “Pre-Funded Warrants”), and otherwise contains substantially the same terms as the original PIPE Subscription. The Pre-Funded Warrants are exercisable for Pubco Common Stock on or after the date of their issuance and have no expiration date. The exercise price per Pre-Funded Warrant is $0.0001, subject to adjustment. The Pre-Funded Warrants may be exercised on a “net-issuance” basis. The Pre-Funded Warrants are subject to a beneficial ownership limitation, at the election of the holder. If the election is made, Pubco will not effect any exercise of the Pre-Funded Warrants, and a holder will not have the right to exercise any portion of the Pre-Funded Warrants, to the extent that after giving effect to such exercise the holder (together with the holder’s affiliates, and anyone acting as a group together with the holder or any of the holder’s affiliates) would beneficially own in excess of 4.9%, 9.9% or 19.9% (or such other amount as the holder may specify) of outstanding shares of Pubco Common Stock. The holder may increase or decrease such limitation by written notice; provided, however, that any such increase will not be effective until the 61st day after such notice is delivered to Pubco. The Pre-Funded Warrants do not entitle the holder to any rights of a stockholder of Pubco, including voting rights, prior to exercise, except as expressly provided in the Pre-Funded Warrant (including the right to participate in certain distributions).

F-23

Table of Contents

​

On October 13, 2026, the Company and the Sponsor, with the consent of BTIG, LLC, waived the transfer restrictions applicable to the 3,000,000 ordinary shares of the Company to be transferred by the Sponsor to the Investor under the Purchaser Support Agreement.

On October 16, 2026, the Company held an extraordinary general meeting (the “Extraordinary General Meeting”) to approve the Business Combination and the transactions contemplated therewith. On the same date, the Company issued a press release announcing the approval of the previously announced Business Combination between the Company and Forge Nano, as well as all other proposals related to the Business Combination considered and voted upon at the Extraordinary General Meeting. In connection with the shareholders’ vote at such meeting, 22,219,068 shares were tendered for redemption and $238,404,289, or approximately $10.73 redemption price per share, was withdrawn from the Trust Account to pay the redeeming shareholders.

Domestication Merger

Pursuant to the Merger Agreement, on October 21, 2026, the Company re-domiciled and became a Delaware corporation by merging with and into Pubco, following which the separate corporate existence of the Company ceased and Pubco continued as the surviving corporation. At the effective time of the Domestication Merger, Pubco adopted Delaware organizational documents (the Charter and the Bylaws), which provide, among other things, that the name of Pubco was changed to Forge Nano Holdings, Inc.

Immediately prior to the Domestication Merger Effective Time, each then issued and outstanding Unit of the Company separated and converted automatically into one ordinary share, par value $0.0001 per share, of the Company and one-half of one warrant of the Company, each whole warrant entitling the holder thereof to acquire one ATII Ordinary Share at a purchase price of $11.50 per share, and all ATII Units ceased to be outstanding and ceased to exist. At the Domestication Merger Effective Time, each then issued and outstanding ATII Ordinary Share was cancelled in exchange for the right to receive one share of common stock, par value $0.0001 per share, of Pubco and each whole ATII Warrant that was outstanding and unexercised converted automatically into a warrant to acquire one share of Pubco Common Stock at a purchase price of $11.50 per share, pursuant to the terms of the ATII Warrant Agreement, by and between the Company and Odyssey Transfer and Trust Company, as warrant agent.

Company Mergers

On the Closing Date, as contemplated by the Merger Agreement, the parties to the Merger Agreement consummated the Company Mergers, whereby:

●Merger Sub I merged with and into Forge Nano, with Forge Nano surviving the First Company Merger as a wholly-owned subsidiary of Forge Nano Holdings, Inc.;
●at the effective time of the First Company Merger, (i) each share of each class of preferred stock, par value $0.0001 per share, of Forge Nano issued and outstanding immediately prior to the First Effective Time was converted into shares of common stock, par value $0.0001 per share, of Forge Nano pursuant to Forge Nano’s organizational documents, and (ii) each share of Forge Nano Common Stock issued and outstanding immediately prior to the First Effective Time (including shares of Forge Nano Common Stock issued upon conversion of the Forge Nano Preferred Stock, but excluding treasury shares, which were cancelled) was cancelled and automatically converted into the right to receive, without interest, the applicable pro rata portion of the Closing Payment Shares, based on an exchange ratio calculated as of the First Effective Time of approximately 28.5 to 1;
●in addition, at the First Effective Time, (i) each option to purchase shares of Forge Nano Common Stock outstanding and unexpired immediately prior to the First Effective Time was converted into an option to purchase shares of Pubco Common Stock on substantially the same terms and conditions, including with respect to vesting and termination-related provisions, except that the number of shares of Pubco Common Stock subject to each Pubco Option equals the product (rounded down to the nearest whole share) of (a) the number of shares of Forge Nano Common Stock subject to such Forge Nano Option immediately prior to the First Effective Time and (b) the quotient of the Applicable Per Share Merger Consideration divided by the Equity Award Conversion Amount (each as defined in the Merger Agreement), and the per-share exercise price of each Pubco Option equals the exercise price per share of such Forge Nano Option divided by the Equity Award Conversion Amount, rounded up to the nearest whole cent; (ii) each warrant of Forge Nano outstanding and unexpired immediately prior to the First Effective Time was assumed and became a corresponding warrant to purchase shares of Pubco Common Stock, subject to the same terms and conditions (including vesting and exercisability) as were applicable to the corresponding Forge

F-24

Table of Contents

​

Nano Warrant immediately prior to the First Effective Time; and (iii) each option to acquire securities of Forge Nano held by Ascent Funds International Management LLC or its affiliates outstanding and unexpired immediately prior to the First Effective Time was cancelled and converted into a warrant to purchase shares of Pubco Common Stock pursuant to the Pubco Ascent Warrant Agreement (as defined below);
●Forge Nano Holdings, Inc. issued an aggregate of 90,000,000 shares of Pubco Common Stock to Odyssey Transfer and Trust Company, as escrow agent (the “Escrow Agent”), which will be disbursed to the former shareholders of Forge Nano who received Closing Payment Shares and the holders of Pubco Convertible Securities, in proportional amounts, upon the achievement of the following milestones during the five-year period following the Closing Date: (a) 30,000,000 Earn-Out Shares if the VWAP (as defined in the Merger Agreement) of the Pubco Common Stock equals or exceeds $15.00 per share over any 30-trading-day period or the revenue publicly reported by Forge Nano Holdings, Inc. for the preceding twelve months equals or exceeds $400,000,000; (b) 30,000,000 Earn-Out Shares if such VWAP equals or exceeds $20.00 per share or such revenue equals or exceeds $600,000,000; and (c) 30,000,000 Earn-Out Shares if such VWAP equals or exceeds $25.00 per share or such revenue equals or exceeds $800,000,000. The milestones operate on a cumulative basis, and Earn-Out Shares attributable to holders of Pubco Convertible Securities will only be disbursed upon the exercise, conversion or settlement of such Pubco Convertible Securities in accordance with their terms; and
●immediately following the First Effective Time, the Initial Surviving Corporation merged with and into Merger Sub II, with Merger Sub II surviving the Second Company Merger as a wholly-owned subsidiary of Forge Nano Holdings, Inc.

PIPE Financing

On April 20, 2026, concurrently with the execution of the Merger Agreement, the Company, Pubco and Forge Nano entered into a subscription agreement with a certain accredited investor, pursuant to which, substantially concurrently with the Closing, Forge Nano Holdings, Inc. issued and sold to the Initial PIPE Investor for an aggregate purchase price of $100,000,000 (the “PIPE Financing”) (a) 2,968,825 shares of Pubco Common Stock at a subscription price of $10.00 per share, (b) pre-funded warrants to purchase an aggregate of 7,031,175 shares of Pubco Common Stock, each with an exercise price of $0.0001 per share, at a subscription price of $10.00 per Pre-Funded Warrant, and (c) warrants to purchase an aggregate of 15,000,000 shares of Pubco Common Stock, each with an initial exercise price of $10.00 per share (subject to adjustment as described below).

The PIPE Warrants are exercisable at any time after their issuance and expire five years after the date of issuance. The exercise price of the PIPE Warrants is subject to certain adjustments, including a one-time reset on the 21st trading day following the six-month anniversary of the Closing Date to the greater of (i) the VWAP (as defined in the PIPE Warrant Certificate) of the Pubco Common Stock for the twenty trading day period commencing on the date that is six months after the Closing Date and (ii) a floor price of $5.00 per share. The terms of the PIPE Warrants are described in the section of the Proxy Statement/Prospectus titled “Description of Pubco Securities – Warrants – PIPE Warrants” beginning on page 360, which is incorporated herein by reference.

In the event that on the 21st trading day following the six-month anniversary of the Closing Date, the VWAP (as defined in the PIPE Warrant Certificate) of the Pubco Common Stock is less than the Exercise Price (as defined in the PIPE Warrant Certificate), Forge Nano Holdings, Inc. will issue to the Initial PIPE Investor additional warrants entitling the Initial PIPE Investor to purchase up to 10,000,000 shares of Pubco Common Stock, in an amount equal to (i) the product of (x) 10,000,000, multiplied by (y) the Exercise Price then in effect divided by the PIPE Reset Price minus (ii) 10,000,000. In addition, if, on the 24-month anniversary of the Closing Date, the Initial PIPE Investor certifies in writing that the Initial PIPE Investor beneficially owns 5,000,000 shares of Pubco Common Stock, Forge Nano Holdings, Inc. will issue to the Initial PIPE Investor additional warrants entitling the Initial PIPE Investor to purchase 5,000,000 shares of Pubco Common Stock.

Additionally, subsequent to the execution of the Merger Agreement, the Company, Pubco and Forge Nano entered into subscription agreements with certain other accredited investors, pursuant to which, substantially concurrently with the Closing, Forge Nano Holdings, Inc. issued and sold an aggregate of 2,300,000 shares of Pubco Common Stock to the Additional PIPE Investors at a subscription price of $10.00 per share, for an aggregate purchase price of $23,000,000.

Outstanding Securities

In connection with the consummation of the Business Combination and the PIPE Financing, and after giving effect to the redemptions, Forge Nano Holdings, Inc.:

F-25

Table of Contents

​

(1)

issued an aggregate of 128,655,585 shares of Pubco Common Stock, consisting of:

●7,370,932 shares of Pubco Common Stock issued to the holders of ATII Ordinary Shares in the Domestication Merger (after giving effect to the redemptions);
●116,015,828 shares of Pubco Common Stock issued to the former stockholders of Forge Nano as Closing Payment Shares in the First Company Merger;
●5,268,825 shares of Pubco Common Stock issued to the PIPE Investors in the PIPE Financing and the Additional PIPE Financing;

(2)

issued 90,000,000 Earn-Out Shares to the Escrow Agent;

(3)

issued 11,919,995 Pubco SPAC Warrants in exchange for ATII Warrants in the Domestication Merger;

(4)

issued PIPE Warrants exercisable for up to 15,000,000 shares of Pubco Common Stock and Pre-Funded Warrants exercisable for up to 7,031,175 shares of Pubco Common Stock in the PIPE Financing;

(5)

issued or assumed Pubco Options, Pubco Forge Nano Warrants and Pubco Ascent Warrants that collectively are exercisable for 15,954,561 shares of Pubco Common Stock; and

(6)

granted an aggregate of 8,744,864 Performance Stock Units which will vest as follows: (i) one third of the PSUs will vest if the VWAP of the Pubco Common Stock equals or exceeds $15.00 per share over any 30-trading day period or the revenue of Forge Nano Holdings, Inc. for the preceding twelve months equals or exceeds $400,000,000, (ii) one third of the PSUs will vest if the VWAP of the Pubco Common Stock equals or exceeds $20.00 per share over any 30-trading day period or the revenue of Forge Nano Holdings, Inc. for the preceding twelve months equals or exceeds $600,000,000 and (iii) one third of the PSUs will vest if the VWAP of the Pubco Common Stock equals or exceeds $25.00 per share over any 30-trading day period or the revenue of Forge Nano Holdings, Inc. for the preceding twelve months equals or exceeds $800,000,000.

In addition, at the Closing, pursuant to the Purchaser Support Agreement, dated as of April 20, 2026, by and among the Company, Forge Nano and the Sponsor, the Sponsor transferred an aggregate of 3,300,000 shares of Pubco Common Stock (which it received in exchange for Founder Shares in the Domestication Merger) to certain investors at the Closing in connection with the PIPE Financing for no additional cash consideration.

​

​

F-26

Table of Contents

​

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and the Board of Directors of

Archimedes Tech SPAC Partners II Co.:

​

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Archimedes Tech SPAC Partners II Co. (the “Company”) as of December 31, 2025 and 2024, the related consolidated statements of operations, changes in shareholders’ deficit and cash flows for the year ended December 31, 2025 and for the period from June 7, 2024 (inception) through December 31, 2024, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for the year ended December 31, 2025 and for the period ended from June 7, 2024 (inception) through December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.

Going Concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, if the Company is unable to complete a business combination by November 12, 2026, then the Company will cease all operations except for the purpose of liquidating. The date for mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management’s plans regarding these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility of the entity’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ WithumSmith+Brown, PC

We have served as the Company’s auditor since 2024.

New York, New York
March 3, 2026
PCAOB ID Number 100

​

​

F-27

Table of Contents

​

ARCHIMEDES TECH SPAC PARTNERS II CO.

CONSOLIDATED BALANCE SHEETS

​

​

​

​

​

​

​

​

​

  ​ ​ ​

December 31,

  ​ ​ ​

December 31,

​

​

2025

​

2024

ASSETS

​

​

​

​

​

​

Current assets

​

​

​

​

​

​

Cash

​

$

1,362,766

​

$

—

Prepaid expenses

​

​

111,403

​

​

—

Total current assets

​

​

1,474,169

​

​

—

Deferred offering costs

​

​

—

​

​

429,691

Prepaid insurance

​

​

9,896

​

​

—

Cash held in Trust Account

​

​

239,860,969

​

​

—

TOTAL ASSETS

​

$

241,345,034

​

$

429,691

LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT

​

 

​

​

​

​

Current liabilities

​

 

​

​

​

​

Accrued expenses

​

$

61,277

​

$

23,000

Accrued offering costs

​

 

75,000

​

​

268,358

Due to related party

​

​

1,239

​

​

—

Promissory note – related party

​

 

—

​

​

192,033

Total current liabilities

​

​

137,516

​

​

483,391

Deferred underwriting fee payable

​

​

8,050,000

​

​

—

TOTAL LIABILITIES

​

 

8,187,516

​

​

483,391

Commitments and Contingencies (Note 6)

​

 

​

​

​

​

Ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of $10.43 per share as of December 31, 2025 and none at December 31, 2024

​

​

239,860,969

​

​

—

SHAREHOLDERS’ DEFICIT

​

 

​

​

​

​

Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding

​

 

—

​

​

—

Ordinary shares, $0.0001 par value; 400,000,000 shares authorized; 6,590,000 and 5,750,000 shares issued and outstanding (excluding 23,000,000 and 0 shares subject to possible redemption) as of December 31, 2025 and 2024, respectively(1)

​

 

659

​

​

575

Additional paid-in capital

​

 

—

​

​

24,425

Accumulated deficit

​

 

(6,704,110)

​

​

(78,700)

TOTAL SHAREHOLDERS’ DEFICIT

​

 

(6,703,451)

​

​

(53,700)

TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT

​

$

241,345,034

​

$

429,691

(1)As of December 31, 2024, included an aggregate of up to 750,000 ordinary shares that were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option was exercised (see Note 5). On February 12, 2025, the Company consummated its Initial Public Offering and sold 23,000,000 Units, including 3,000,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment; as a result, the 750,000 ordinary shares were no longer subject to forfeiture.

The accompanying notes are an integral part of the consolidated financial statements.

​

F-28

Table of Contents

​

ARCHIMEDES TECH SPAC PARTNERS II CO.

CONSOLIDATED STATEMENTS OF OPERATIONS

​

​

​

​

​

​

​

​

​

​

​

​

For the

​

​

​

​

​

Period

​

​

​

​

​

from June 7,

​

​

​

​

​

2024

​

​

For the Year

​

(Inception)

​

​

Ended

​

Through

​

​

December 31,

​

December 31,

​

  ​ ​ ​

2025

  ​ ​ ​

2024

General and administrative expenses

  ​ ​ ​

$

785,975

​

$

78,700

Loss from operations

​

​

(785,975)

​

​

(78,700)

Other income:

​

​

​

​

​

​

Interest earned on cash in bank account

​

​

61,744

​

​

—

Interest earned on cash held in Trust Account

​

​

8,710,969

​

​

—

Total other income

​

​

8,772,713

​

​

—

Net income (loss)

​

$

7,986,738

​

$

(78,700)

Basic and diluted weighted average shares outstanding, redeemable ordinary shares

​

​

20,290,411

​

​

—

Basic and diluted net income per share, redeemable ordinary shares

​

$

0.30

​

​

—

Basic weighted average shares outstanding, non-redeemable ordinary shares(1)

​

 

6,402,685

​

​

5,000,000

Basic net income (loss) per share, non-redeemable ordinary shares

​

$

0.30

​

$

(0.02)

Diluted weighted average shares outstanding, non-redeemable ordinary shares(1)

​

​

6,488,986

​

​

5,000,000

Diluted net income (loss) per share, non-redeemable ordinary shares

​

$

0.30

​

$

(0.02)

(1)Prior to the Company’s Initial Public Offering, the ordinary shares excluded an aggregate of up to 750,000 ordinary shares that were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option was exercised (see Note 5). On February 12, 2025, the Company consummated its Initial Public Offering and sold 23,000,000 Units, including 3,000,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment; as a result, the 750,000 ordinary shares were no longer subject to forfeiture.

The accompanying notes are an integral part of the consolidated financial statements.

​

F-29

Table of Contents

​

ARCHIMEDES TECH SPAC PARTNERS II CO.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

FOR THE YEAR ENDED DECEMBER 31, 2025 AND

FOR THE PERIOD FROM JUNE 7, 2024 (INCEPTION) THROUGH DECEMBER 31, 2024

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

​

​

  ​ ​ ​

Additional

  ​ ​ ​

​

​

  ​ ​ ​

Total

​

​

Ordinary Shares(1)

​

Paid-in

​

Accumulated

​

Shareholders’

​

​

Shares

​

Amount

​

Capital

​

Deficit

​

Deficit

Balance – June 7, 2024 (inception)

 

—

​

$

—

​

$

—

​

$

—

​

$

—

Issuance of Ordinary Shares to Sponsor

 

5,750,000

​

 

575

​

 

24,425

​

 

—

​

 

25,000

Net loss

 

—

​

 

—

​

 

—

​

 

(78,700)

​

 

(78,700)

Balance – December 31, 2024

 

5,750,000

​

​

575

​

​

24,425

​

​

(78,700)

​

​

(53,700)

Sale of 840,0000 private placement units

​

840,000

​

​

84

​

​

8,399,916

​

​

—

​

​

8,400,000

Fair value of Public Warrants at issuance

​

—

​

​

—

​

​

1,725,000

​

​

—

​

​

1,725,000

Allocated value of transaction costs to warrants and private placement units

​

—

​

​

—

​

​

(117,194)

​

​

—

​

​

(117,194)

Accretion of ordinary shares subject to possible redemption to redemption value

​

—

​

​

—

​

​

(10,032,147)

​

​

(14,612,148)

​

​

(24,644,295)

Net income

​

—

​

​

—

​

​

—

​

​

7,986,738

​

​

7,986,738

Balance – December 31, 2025

​

6,590,000

​

$

659

​

$

—

​

$

(6,704,110)

​

$

(6,703,451)

(1)As of December 31, 2024, included an aggregate of up to 750,000 ordinary shares that were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option was exercised (see Note 5). On February 12, 2025, the Company consummated its Initial Public Offering and sold 23,000,000 Units, including 3,000,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment; as a result, the 750,000 ordinary shares were no longer subject to forfeiture.

The accompanying notes are an integral part of the consolidated financial statements.

​

F-30

Table of Contents

​

ARCHIMEDES TECH SPAC PARTNERS II CO.

CONSOLIDATED STATEMENTS OF CASH FLOWS

​

​

​

​

​

​

​

​

​

​

​

​

For the Period

​

​

​

​

​

from

​

​

​

​

​

June 7, 2024

​

​

For the Year

​

(Inception)

​

​

Ended

​

Through

​

​

December 31,

​

December 31,

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Cash Flows from Operating Activities:

  ​ ​ ​

​

  ​

​

​

​

Net income (loss)

​

$

7,986,738

​

$

(78,700)

Adjustments to reconcile net income (loss) to net cash used in operating activities:

​

 

​

​

​

​

General and administrative expenses paid by Sponsor in exchange for issuance of Founder Shares

​

 

—

​

​

3,880

Interest earned on cash held in Trust Account

​

​

(8,710,969)

​

​

—

General and administrative expenses paid by related parties

​

 

16,603

​

​

—

General and administrative expenses paid through promissory note – related party

​

​

51,600

​

​

51,820

Changes in operating assets and liabilities:

​

 

​

​

​

​

Prepaid expenses

​

​

(111,403)

​

​

—

Accrued expenses

​

 

38,277

​

​

23,000

Prepaid insurance

​

​

(9,896)

​

​

—

Net cash used in operating activities

​

 

(739,050)

​

​

—

Cash Flows from Investing Activities:

​

​

​

​

​

​

Investment of cash in Trust Account

​

​

(231,150,000)

​

​

—

Net cash used in investing activities

​

​

(231,150,000)

​

​

—

Cash Flows from Financing Activities:

​

​

​

​

​

​

Proceeds from sale of Units, net of underwriting discounts paid

​

​

225,400,000

​

​

—

Proceeds from sale of Private Placement Units

​

​

8,400,000

​

​

—

Repayment of due to related party

​

​

(15,364)

​

​

—

Proceeds from promissory note – related party

​

​

40,927

​

​

—

Repayment of promissory note – related party

​

​

(290,000)

​

​

—

Payment of offering costs

​

​

(283,747)

​

​

—

Net cash provided by financing activities

​

​

233,251,816

​

​

—

Net Change in Cash

​

 

1,362,766

​

​

—

Cash – Beginning of period

​

 

—

​

​

—

Cash – End of period

​

$

1,362,766

​

$

—

Non-Cash investing and financing activities:

​

 

​

​

​

​

Offering costs included in accrued offering costs

​

$

75,000

​

$

268,358

Offering costs paid by Sponsor in exchange for the issuance of Founder Shares

​

$

—

​

$

21,120

Offering costs paid through promissory note - related party

​

$

5,440

​

$

140,213

Deferred underwriting fee payable

​

$

8,050,000

​

​

—

​

The accompanying notes are an integral part of the consolidated financial statements.

​

​

F-31

Table of Contents

​

NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Archimedes Tech SPAC Partners II Co. (the “Company”) is a blank check company newly incorporated in the Cayman Islands on June 7, 2024. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any Business Combination target.

Although the Company may acquire a business in any industry, it intends to focus on companies engaged in the technology industry. The Company is an early stage and emerging growth company, and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of December 31, 2025, the Company has three subsidiaries, ATII Merger Sub Inc., a Delaware corporation and a direct, wholly owned subsidiary of the Company incorporated on December 4, 2025, ATII Merger Sub II, LLC, a Delaware limited liability company and a direct, wholly owned subsidiary of the Company incorporated on December 11, 2025, and ATII Holdings Inc. (“Holdings”), a Delaware corporation and a direct, wholly owned subsidiary of the Company incorporated on December 4, 2025. Holdings was formed for the purpose of merging with the Company to facilitate the consummation of the Business Combination. As of December 31, 2025, ATII Merger Sub Inc. and ATII Merger Sub II, LLC are inactive and have not commenced operations, and have no material assets, liabilities, revenues, or expenses attributable to these subsidiaries during the period.

As of December 31, 2025, the Company had not commenced any operations. All activity for the period from June 7, 2024 (inception) through December 31, 2025 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.

The registration statement for the Company’s Initial Public Offering was declared effective on February 10, 2025. On February 12, 2025, the Company consummated the Initial Public Offering of 23,000,000 units (the “Units” and, with respect to the ordinary shares included in the Units being offered, the “Public Shares”), which included the full exercise by the underwriters of their over-allotment option in the amount of 3,000,000 Units, at $10.00 per Unit, generating gross proceeds of $230,000,000. Each Unit consists of one ordinary share, par value $0.0001 per share, and one-half of one redeemable warrant (the “Public Warrants”), each whole Public Warrant entitling the holder thereof to purchase one ordinary share at an exercise price of $11.50 per share, subject to adjustment.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 840,000 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to Archimedes Tech SPAC Sponsors II LLC (the “Sponsor”) and BTIG, LLC, the representative of the underwriters in the Initial Public Offering (“BTIG”), generating gross proceeds of $8,400,000. Each Private Placement Unit consists of one ordinary share and one-half of one redeemable warrant (“Private Placement Warrants”), with each whole Private Placement Warrant entitling the holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment.

Transaction costs amounted to $13,175,520, consisting of $4,600,000 of cash underwriting fee, $8,050,000 of deferred underwriting fee and $525,520 of other offering costs.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding any deferred underwriting fees and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial business combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”).

F-32

Table of Contents

​

Following the closing of the Initial Public Offering, on February 12, 2025, an amount of $231,150,000 ($10.05 per Unit) from the net proceeds of the sale of the Units and the sale of the Private Placement Units was held in a trust account (“Trust Account”), located in the United States and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations and/or held as cash or cash items (including in demand deposit accounts). The Company will not be permitted to withdraw any of the principal or interest held in the Trust Account except for the withdrawal of interest to pay taxes. The funds held in the Trust Account will not otherwise be released from the Trust Account until the earliest of: (1) the completion of an initial Business Combination; (2) the redemption of any Public Shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete the initial Business Combination within the completion window, as defined below, or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial business combination activity; and (3) the redemption of the Public Shares if the Company has not completed an initial Business Combination within the completion window, subject to Cayman Islands laws.

The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.05 per Public Share, plus any pro rata interest then in the Trust Account, net of funds withdrawn to pay taxes). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to possible redemption were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.”

The Company’s amended and restated memorandum and articles of association does not provide a specified maximum redemption threshold, except that in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than any net tangible asset or cash requirement that may be contained in the agreement relating to the initial Business Combination. As a result, the Company may be able to complete its initial Business Combination even though a substantial majority of the public shareholders do not agree with the transaction and have redeemed their shares or, if the Company seeks shareholder approval of the initial Business Combination and does not conduct redemptions in connection with the initial Business Combination pursuant to the tender offer rules, have entered into privately negotiated agreements to sell their shares to the initial shareholders, directors, officers, advisors or any of their respective affiliates. In the event the aggregate cash consideration the Company would be required to pay for all public shares that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed Business Combination exceed the aggregate amount of cash available to the Company, the Company will not complete the Business Combination or redeem any shares, and all ordinary shares submitted for redemption will be returned to the holders thereof, and the Company instead may search for an alternate Business Combination.

Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s amended and restated memorandum and articles of association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company.

F-33

Table of Contents

​

The initial shareholders and the Company’s officers and directors entered into a letter agreement, pursuant to which they have agreed to waive: (1) their redemption rights with respect to any shares held by them in connection with the completion of the initial Business Combination; (2) their redemption rights with respect to any shares held by them in connection with a shareholder vote to amend the amended and restated memorandum and articles of association (A) to modify the substance or timing of the obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within the Completion Window (as defined below) or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial business combination activity; and (3) their rights to liquidating distributions from the Trust Account with respect to any founder shares and private shares they hold if the Company fails to complete its initial Business Combination within the Completion Window as a result of a shareholder vote to amend the amended and restated memorandum and articles of association (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Completion Window). If the Company submits its initial Business Combination to the public shareholders for a vote, the initial shareholders, directors and officers have agreed (and their permitted transferees will agree), pursuant to the terms of a letter agreement entered into with the Company, to vote any shares held by them in favor of the initial Business Combination.

The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Completion Window and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

The Company will have until 21 months from the closing of the Initial Public Offering, or until such earlier liquidation date as the Company’s board of directors may approve, to complete a Business Combination (the “Completion Window”). If the Company has not completed a Business Combination within the Completion Window, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (net of funds withdrawn to pay taxes and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject, in each case, to obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There is no limitation on the Company’s ability to raise funds privately or through loans in connection with its initial Business Combination.

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (other than the independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.05 per public share or (2) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Liquidity and Capital Resources

As of December 31, 2025, the Company had cash of $1,362,766. The Company intends to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

F-34

Table of Contents

​

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required. If the Company completes a Business Combination, the Company would repay such loaned amounts. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units, at a price of $10.00 per unit, at the option of the lender. The units would be identical to the Private Placement Units.

In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial Business Combination. Management has determined that the Company has sufficient funds to finance the working capital needs of the Company within one year from the date of issuance of the financial statement. However, if the Company is unable to complete an Initial Business Combination by November 12, 2026, then the Company will cease all operations except for the purpose of liquidating. The date for mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management plans to consummate an Initial Business Combination prior to the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after November 12, 2026.

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying consolidated financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”).

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions were eliminated in the consolidated financial statements.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

F-35

Table of Contents

​

Use of Estimates

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of other income and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,362,766 and $0 in cash as of December 31, 2025 and 2024, respectively, and no cash equivalents as of such dates.

Cash Held in Trust Account

As of December 31, 2025, the assets held in Trust Account, amounting to $239,860,969, were held in demand deposit accounts. As of December 31, 2024, there were no funds deposited in the Trust Account.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution, which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

Offering Costs

The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “Expenses of Offering”. Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, “Debt with Conversion and Other Options”, addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the warrants and then to the ordinary shares. Offering costs allocated to the Public Shares were charged to temporary equity, and offering costs allocated to the Public Warrants and Private Placement Units were charged to shareholders’ deficit as the warrants associated with units issued in the Initial Public Offering and Private Placement, after management’s evaluation, are accounted for under equity treatment.

Transaction costs amounted to $13,175,520, consisting of $4,600,000 of cash underwriting fee, $8,050,000 of deferred underwriting fee and $525,520 of other offering costs.

Income Taxes

The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the consolidated financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

F-36

Table of Contents

​

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of December 31, 2025 and 2024, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.

Net Income (Loss) per Ordinary Share

The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Accretion associated with the redeemable ordinary shares is excluded from earnings per share as the redemption value approximates fair value.

The calculation of diluted net income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement, since the exercise of the warrants are contingent upon the occurrence of future events. For the year ended December 31, 2025 and for the period from June 7, 2024 (inception) through December 31, 2024, the warrants are exercisable to purchase 11,920,000 ordinary shares. The weighted average of these shares was excluded from the calculation of diluted net income (loss) per ordinary share since the inclusion of such warrants would be anti-dilutive. The warrants cannot be converted to ordinary shares prior to an initial Business Combination; therefore, they have been classified as anti-dilutive.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Period from

​

​

​

​

​

​

​

​

June 7,

​

​

​

​

​

​

​

​

2024 (Inception)

​

​

For the Year Ended

​

Through

​

​

December 31,

​

December 31,

​

  ​ ​ ​

2025

  ​ ​ ​

2024

​

​

​

​

  ​ ​ ​

Non-

​

​

​

  ​ ​ ​

Non-

​

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

Basic net income (loss) per share:

​

​

​

​

​

​

​

​

​

​

​

​

Numerator:

​

​

​

​

​

​

​

​

​

​

​

​

Allocation of net income (loss)

​

$

6,071,015

​

$

1,915,723

​

$

—

​

$

(78,700)

Denominator:

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

Basic weighted-average shares outstanding

​

 

20,290,411

​

 

6,402,685

​

 

—

​

 

5,000,000

Basic net income (loss) per ordinary share

​

$

0.30

​

$

0.30

​

$

—

​

$

(0.02)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Period from

​

​

​

​

​

​

​

​

June 7,

​

​

​

​

​

​

​

​

2024 (Inception)

​

​

For the Year Ended

​

Through

​

​

December 31,

​

December 31,

​

 

2025

 

2024

​

​

​

​

​

Non-

​

​

​

​

Non-

​

  ​ ​ ​

Redeemable

  ​ ​ ​

​

Redeemable

  ​ ​ ​

Redeemable

  ​ ​ ​

Redeemable

Diluted net income (loss) per share:

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

Numerator:

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

Allocation of net income (loss)

​

$

6,051,450

​

$

1,935,288

​

$

—

​

$

(78,700)

Denominator:

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

Diluted weighted-average shares outstanding

​

 

20,290,411

​

 

6,488,986

​

 

—

​

 

5,000,000

Diluted net income (loss) per ordinary share

​

$

0.30

​

$

0.30

​

$

—

​

$

(0.02)

​

F-37

Table of Contents

​

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the consolidated balance sheets, primarily due to their short-term nature.

Fair Value Measurement

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1:

Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2:

Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3:

Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability.

Warrant Instruments

The Company accounted for the Public and Private Placement Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging”, whereby under that provision, the warrants that do not meet the criteria for equity treatment must be recorded as liability. Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned values.

The fair value of the Public Warrants on the closing of the Initial Public Offering on February 12, 2025, was $1,725,000, or $0.15 per Public Warrant. The fair value of Public Warrants was determined using Monte Carlo Simulation Model. The Public Warrants have been classified within shareholders’ deficit and will not require remeasurement after issuance. The following table presents the quantitative information regarding market assumptions used in the level 3 valuation of the Public Warrants:

​

​

​

​

​

​

​

  ​ ​ ​

February 12,

 

​

​

2025

 

Implied ordinary share price

​

$

9.93

​

Exercise price

​

$

11.50

​

Simulation term (years)

​

 

6.5

​

Risk-free rate (continuous)

​

 

4.49

%

Selected volatility

​

 

3.0

%

Calculated value per warrant

​

$

0.15

​

Probability of de-SPAC and market adjustment

​

 

11.0

%

​

F-38

Table of Contents

​

Ordinary Shares Subject to Possible Redemption

​

The public shares contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies public shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of December 31, 2025, the ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s consolidated balance sheets. As of December 31, 2025, the ordinary shares subject to possible redemption reflected in the consolidated balance sheets are reconciled in the following table:

​

​

​

​

​

Gross proceeds

  ​ ​ ​

$

230,000,000

Less:

​

​

​

Proceeds allocated to Public Warrants

​

 

(1,725,000)

Ordinary shares issuance costs

​

 

(13,058,326)

Plus:

​

​

​

Accretion of carrying value to redemption value

​

 

24,644,295

Ordinary shares subject to possible redemption, December 31, 2025

​

$

239,860,969

​

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

NOTE 3 — INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering, the Company sold 23,000,000 Units, which included a full exercise by the underwriters of their over-allotment option of 3,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one ordinary share and one-half Public Warrant. Each whole Public Warrant entitles the holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment (Note 7).

NOTE 4 — PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 840,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement to the Sponsor and BTIG, generating gross proceeds of $8,400,000. Each Private Placement Unit consists of one ordinary share and one-half of one redeemable warrant (the “Private Placement Warrants”), with each whole Private Placement Warrant entitling the holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment (Note 7). The proceeds from the sale of the Private Placement Units are added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Completion Window, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).

F-39

Table of Contents

​

NOTE 5 — RELATED PARTIES

Founder Shares

On June 7, 2024, the Sponsor made a capital contribution of $25,000 to cover certain of the Company’s expenses, for which the Company issued 5,750,000 ordinary shares (the “Founder Shares”). The Founder Shares include an aggregate of up to 750,000 shares subject to surrender and forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the number of Founder Shares will equal, on an as-converted basis, approximately 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. As a result of the Initial Public Offering and the full exercise by the underwriters of their over-allotment option, 750,000 shares are no longer subject to surrender and forfeiture.

Pursuant to a letter agreement that the initial shareholders, directors and officers have entered into with the Company, with certain limited exceptions, the Founder Shares are not transferable, assignable or salable (except to directors and officers and other persons or entities affiliated with the initial shareholders, each of whom will be subject to the same transfer restrictions) until the earlier of: (i) six months after the completion of the initial Business Combination; and (ii) subsequent to the initial Business Combination, the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, the Founder Shares will be released from the lock-up if (1) the last reported sale price of the Company’s ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period after the initial Business Combination or (2) if the Company completes a transaction after the initial Business Combination which results in all of the Company’s shareholders having the right to exchange their shares for cash, securities or other property.

Promissory Note — Related Party

On June 7, 2024, the Sponsor issued an unsecured promissory note to the Company (as amended, the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $290,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) March 31, 2025 or (ii) the consummation of the Initial Public Offering or (iii) the date on which the Company determines to not proceed with the Initial Public Offering. Simultaneously with the closing of the Initial Public Offering on February 12, 2025, the Company repaid the outstanding borrowings under the Promissory Note amounting to $290,000. Borrowings under the note are no longer available. As of December 31, 2025 and 2024, the Company had $0 and $192,033 outstanding under the Promissory Note, respectively.

Due to Related Party

Due to related party represents recurring Company expenses advanced by officers on behalf of the Company. As of December 31, 2025 and 2024, the Company owed $1,239 and $0 to officers, respectively.

Administrative Support Agreement

Commencing on the effective date, February 10, 2025, the Company agreed to reimburse the Sponsor in an amount equal to $10,000 per month for office space, administrative and support services. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the year ended December 31, 2025, the Company incurred and paid $106,786 in fees for these services. For the period from June 7, 2024 (inception) through December 31, 2024, the Company did not incur any fees for these services.

F-40

Table of Contents

​

Working Capital Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into units of the post-Business Combination entity at a price of $10.00 per unit. The units would be identical to the Private Placement Units. As of December 31, 2025 and December 31, 2024, no Working Capital Loans were outstanding.

NOTE 6 — COMMITMENTS AND CONTINGENCIES

Risks and Uncertainties

The Company’s ability to complete an initial Business Combination may be adversely affected by various factors, many of which are beyond the Company’s control. The Company’s ability to consummate an initial Business Combination could be impacted by, among other things, changes in laws or regulations, downturns in the financial markets or in economic conditions, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine and the Middle East. The Company cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company’s ability to complete an initial Business Combination.

Any of the above-mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine, the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect the Company’s search for an initial Business Combination and any target business with which the Company may ultimately consummate an initial Business Combination.

Registration Rights

The holders of the Founder Shares, Private Placement Units (and underlying securities) and any units (and underlying securities) that may be issued on conversion of Working Capital Loans are entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain piggyback registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of Initial Public Offering to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On February 12, 2025, simultaneously with the Initial Public Offering, the underwriters exercised their over-allotment option in full, closing on the 3,000,000 additional Units.

The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $4,600,000 in the aggregate upon the closing of the Initial Public Offering. In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $8,050,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

F-41

Table of Contents

​

NOTE 7 — SHAREHOLDERS’ DEFICIT

Preference Shares — The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2025 and 2024, there were no preference shares issued or outstanding.

Ordinary Shares — The Company is authorized to issue 400,000,000 ordinary shares with a par value of $0.0001 per share. Holders of ordinary shares are entitled to one vote for each share. As of December 31, 2025 and 2024, there were 6,590,000 and 5,750,000 ordinary shares issued and outstanding, excluding the 23,000,000 and 0 ordinary shares subject to possible redemption, respectively.

Warrants — As of December 31, 2025, there were 11,920,000 warrants outstanding, including 11,500,000 Public Warrants and 420,000 Private Placement Warrants. There are no warrants issued or outstanding as of December 31, 2024. Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue ordinary shares upon exercise of a warrant unless ordinary shares issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.

The Company has agreed that as soon as practicable, but in no event later than twenty (20) business days after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement covering the ordinary share issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the foregoing, if a registration statement covering the ordinary shares issuable upon exercise of the warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.

Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants:

●in whole and not in part;
●at a price of $0.01 per Public Warrant;
●upon a minimum of 30 days’ prior written notice of redemption, referred to as the 30-day redemption period; and
●if, and only if, the last sale price of ordinary shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share consolidations, share capitalizations, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

F-42

Table of Contents

​

If the Company calls the warrants for redemption, management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” management will consider, among other factors, the Company’s cash position, the number of warrants that are outstanding and the dilutive effect on the Company’s shareholders of issuing the maximum number of ordinary shares issuable upon the exercise of the Company’s warrants. In such event, each holder would pay the exercise price by surrendering the warrants for that number of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” over the exercise price of the warrants by (y) the fair market value. The “fair market value” shall mean the highest closing sale price of the ordinary share for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.

In addition, if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at a Newly Issued Price of less than $9.20 per ordinary shares (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the Market Value is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

The Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Initial Public Offering, subject to certain limited exceptions.

NOTE 8 — SEGMENT INFORMATION

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker (“CODM”), or group, in deciding how to allocate resources and assess performance.

The Company’s CODM has been identified as the Chief Executive Officer, who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that there is only one reportable segment.

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the consolidated statements of operations as net income or loss. The measure of segment assets is reported on the consolidated balance sheets as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total assets, which include the following:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

December 31,

  ​ ​ ​

December 31,

​

​

2025

​

2024

Cash

​

$

1,362,766

​

$

—

Cash held in Trust Account

​

$

239,860,969

​

$

—

​

​

​

​

​

For the Period

​

​

For the Year

​

from June 7, 2024

​

​

Ended

​

(Inception) Through

​

​

December 31,

​

December 31,

​

  ​ ​ ​

2025

  ​ ​ ​

2024

General and administrative expenses

​

$

785,975

​

$

78,700

Interest earned on cash in bank account

​

​

61,744

​

​

—

Interest earned on cash held in Trust Account

​

​

8,710,969

​

​

—

​

F-43

Table of Contents

​

The CODM is provided with details of cash and liquid resources available with the Company. The CODM reviews the position of total assets available with the Company to assess if the Company has sufficient resources available to discharge its liabilities.

The CODM reviews interest earned on cash held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.

Interest earned on cash in bank account and general and administrative expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination or similar transaction within the business combination period. The CODM also reviews the interest earned on cash in bank account and general and administrative expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative expenses, as reported on the consolidated statements of operations, are the significant segment expenses provided to the CODM on a regular basis.

NOTE 9 — SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the consolidated balance sheet date up to the date that the consolidated financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated financial statements.

​

​

F-44

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED BALANCE SHEETS

As of September 30, 2026 and December 31, 2025

(All amounts in thousands, except share, per share and par values)

(Unaudited)

​

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30,

  ​ ​ ​

December 31,

​

​

2026

​

2025

Assets

 

​

  ​

 

​

  ​

Current Assets

 

​

  ​

 

​

  ​

Cash and cash equivalents

​

$

15,723

​

$

9,061

Restricted cash and cash equivalents

​

 

1,033

​

 

313

Accounts receivable - net of allowance for credit losses of $37 and $40 as of September 30, 2026 and December 31, 2025, respectively

​

 

1,837

​

 

1,963

Contract assets - unbilled accounts receivable

​

 

6,925

​

 

6,586

Inventory

​

 

6,691

​

 

3,665

Notes receivable

​

 

1,000

​

 

—

Prepaid expenses and other current assets

​

 

2,647

​

 

1,607

Total current assets

​

 

35,856

​

 

23,195

Property and equipment - net

​

 

13,673

​

 

14,652

Goodwill

​

 

3,124

​

 

3,124

Intangible assets - net

​

 

1,436

​

 

1,589

Restricted cash and cash equivalents

​

 

56

​

 

55

Right-of-use operating lease assets

​

 

64,486

​

 

65,087

Deposits

​

 

12,982

​

 

2,922

Total other assets

​

 

95,757

​

 

87,429

Total Assets

​

$

131,613

​

$

110,624

​

​

​

​

​

​

​

Liabilities, Mezzanine Equity, and Stockholders’ Deficit

​

 

  ​

​

 

  ​

Current Liabilities

​

 

  ​

​

 

  ​

Accounts payable

​

$

4,300

​

$

4,332

Current portion of operating lease liabilities

​

 

1,781

​

 

1,287

Contract liabilities - deferred revenue

​

 

3,579

​

 

3,126

Provision for loss on contract

​

 

151

​

 

504

Accrued and other current liabilities

​

 

6,211

​

 

3,027

Due to Sundew Technologies, LLC - current

​

 

—

​

 

1,811

Current portion of debt – net of discount

​

 

10,488

​

 

10,366

Total Current Liabilities

​

 

26,510

​

 

24,453

Operating lease liabilities

​

 

64,372

​

 

63,163

Due to Sundew Technologies, LLC

​

 

2,769

​

 

—

Warrant liabilities

​

 

14,917

​

 

5,624

Total Liabilities

​

 

108,568

​

 

93,240

Commitments and contingencies (Note 5)

​

 

  ​

​

 

  ​

​

​

​

​

​

​

​

Mezzanine Equity

​

 

  ​

​

 

  ​

Preferred stock - $0.0001 par value; 2,204,216 and 4,663,753 shares authorized and 2,190,939 and 1,925,348 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively.

​

 

—

​

 

—

Additional paid-in capital

​

 

185,265

​

 

136,538

​

​

​

​

​

​

​

Stockholders’ Deficit

​

 

  ​

​

 

  ​

Common stock - $0.0001 par value; 4,850,000 and 4,850,000 shares authorized and 1,642,597 and 1,648,841 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively.

​

 

—

​

 

—

Additional paid-in capital

​

 

11,372

​

 

9,934

Accumulated deficit

​

 

(173,592)

​

 

(129,088)

Total Stockholders’ Deficit

​

 

(162,220)

​

 

(119,154)

Total Liabilities, Mezzanine Equity, and Stockholders’ Deficit

​

$

131,613

​

$

110,624

​

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

​

F-45

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the Three and Nine Months Ended September 30, 2026 and 2025

(All amounts in thousands, except share and per share values)

(Unaudited)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended

​

Nine months ended

​

​

September 30,

​

September 30,

​

​

2026

​

2025

​

2026

​

2025

Net Sales

  ​ ​ ​

​

  ​

  ​ ​ ​

​

  ​

  ​ ​ ​

​

  ​

  ​ ​ ​

​

  ​

Tool manufacturing & related services

​

$

1,044

​

$

944

​

$

4,180

​

$

3,107

Coating services

​

 

358

​

 

296

​

 

972

​

 

1,067

Battery manufacturing

​

 

564

​

 

765

​

 

915

​

 

1,153

Total Net Sales

​

 

1,966

​

 

2,005

​

 

6,067

​

 

5,327

Cost of Sales

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

Tool manufacturing & related services

​

 

2,294

​

 

1,255

​

 

6,688

​

 

3,699

Coating services

​

 

1,255

​

 

957

​

 

3,921

​

 

2,838

Battery manufacturing

​

 

355

​

 

879

​

 

494

​

 

1,040

Total Cost of Sales

​

 

3,904

​

 

3,091

​

 

11,103

​

 

7,577

Gross Loss

​

 

(1,938)

​

 

(1,086)

​

 

(5,036)

​

 

(2,250)

Operating Expenses

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

General and administrative

​

 

11,028

​

 

12,438

​

 

31,582

​

 

30,409

Total Operating Expenses

​

 

11,028

​

 

12,438

​

 

31,582

​

 

30,409

Operating Loss

​

 

(12,966)

​

 

(13,524)

​

 

(36,618)

​

 

(32,659)

Nonoperating Income (Expense)

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

Interest income

​

 

181

​

 

198

​

 

401

​

 

548

Grant income

​

 

896

​

 

2,735

​

 

2,715

​

 

6,153

Other income

​

 

138

​

 

695

​

 

208

​

 

703

Interest expense, change in fair value, and amortization of debt discount

​

 

(194)

​

 

(1,973)

​

 

(11,182)

​

 

(8,385)

Other income (expense)

​

 

(9)

​

 

122

​

 

(28)

​

 

(29)

Total Nonoperating Income (Expense)

​

 

1,012

​

 

1,777

​

 

(7,886)

​

 

(1,010)

Net Loss

​

$

(11,954)

​

$

(11,747)

​

$

(44,504)

​

$

(33,669)

​

​

​

​

​

​

​

​

​

​

​

​

​

Net Loss Per Share, Basic and Diluted

​

$

(7.03)

​

$

(7.60)

​

$

(27.85)

​

$

(21.81)

Weighted-Average Shares Outstanding, Basic and Diluted

​

 

1,701,536

​

 

1,546,401

​

 

1,597,987

​

 

1,543,975

​

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

​

F-46

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT

For the Three and Nine Months Ended September 30, 2026 and 2025

(All amounts in thousands, except share and par values)

(Unaudited)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Nine months ended September 30, 2026

​

​

​

​

​

​

​

Additional

​

​

​

​

​

​

Additional

​

​

​

​

​

​

​

​

​

​

​

​

​

Paid-In

​

​

​

​

​

​

Paid-In

​

Accumulated

​

​

​

​

​

Preferred Stock

​

Capital

​

Common Stock

​

Capital

​

Deficit

​

Total

​

​

Shares

​

Amount

​

​

​

​

Shares

​

Amount

​

​

​

​

​

​

​

Balance - January 1, 2026

  ​ ​ ​

1,925,348

  ​ ​ ​

$

—

  ​ ​ ​

$

136,538

  ​ ​ ​

1,648,841

  ​ ​ ​

$

—

  ​ ​ ​

$

9,934

  ​ ​ ​

$

(129,088)

  ​ ​ ​

$

(119,154)

Stock-based compensation expense

 

—

​

 

—

​

 

—

 

—

​

 

—

​

 

391

​

 

—

​

 

391

Issuance of common stock - board of directors compensation

 

—

​

 

—

​

 

—

 

2,388

​

 

—

​

 

19

​

 

—

​

 

19

Issuance of Series D preferred stock

 

90,325

​

 

—

​

 

15,800

 

—

​

 

—

​

 

—

​

 

—

​

 

—

RSA Redemption

 

—

​

 

—

​

 

—

 

(14,851)

​

 

—

​

 

—

​

 

—

​

 

—

Series D preferred stock issuance costs

 

—

​

 

—

​

 

(561)

 

—

​

 

—

​

 

—

​

 

—

​

 

—

Net loss

 

—

​

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

(11,676)

​

 

(11,676)

Balance - March 31, 2026

 

2,015,673

​

$

—

​

$

151,777

 

1,636,378

​

$

—

​

$

10,344

​

$

(140,764)

​

$

(130,420)

Stock-based compensation expense

 

—

​

 

—

​

 

—

 

—

​

 

—

​

 

447

​

 

—

​

 

447

Issuance of common stock - board of directors compensation

 

—

​

 

—

​

 

—

 

—

​

 

—

​

 

24

​

 

—

​

 

24

Issuance of Series D preferred stock

 

175,266

​

 

—

​

 

34,540

 

—

​

 

—

​

 

—

​

 

—

​

 

—

Series D preferred stock issuance costs

 

—

​

 

—

​

 

(1,052)

 

—

​

 

—

​

 

—

​

 

—

​

 

—

Issuance of common stock for exercise of stock options

 

—

​

 

—

​

 

—

 

540

​

 

—

​

 

5

​

 

—

​

 

5

Net loss

 

—

​

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

(20,874)

​

 

(20,874)

Balance - June 30, 2026

 

2,190,939

​

$

—

​

$

185,265

 

1,636,918

​

$

—

​

$

10,820

​

$

(161,638)

​

$

(150,818)

Stock-based compensation expense

 

—

​

 

—

​

 

—

 

—

​

 

—

​

 

424

​

 

—

​

 

424

Issuance of common stock - board of directors compensation

 

—

​

 

—

​

 

—

 

—

​

 

—

​

 

34

​

 

—

​

 

34

Issuance of common stock for exercise of stock options

 

—

​

 

—

​

 

—

 

5,679

​

 

—

​

 

94

​

 

—

​

 

94

Net loss

 

—

​

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

(11,954)

​

 

(11,954)

Balance - September 30, 2026

 

2,190,939

​

$

—

​

$

185,265

 

1,642,597

​

$

—

​

$

11,372

​

$

(173,592)

​

$

(162,220)

​

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

​

F-47

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND

STOCKHOLDERS’ DEFICIT

For the Three and Nine Months Ended September 30, 2026 and 2025

(All amounts in thousands, except share and par values)

(Unaudited)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Nine months ended September 30, 2025

​

​

​

​

​

​

​

Additional

​

​

​

​

​

​

Additional

​

​

​

​

​

​

​

​

​

​

​

​

​

Paid-In

​

​

​

​

​

​

Paid-In

​

Accumulated

​

​

​

​

​

Preferred Stock

​

Capital

​

Common Stock

​

Capital

​

Deficit

​

Total

​

​

Shares

​

Amount

​

​

​

​

Shares

​

Amount

​

​

​

​

​

​

​

Balance - January 1, 2025

  ​ ​ ​

1,676,528

  ​ ​ ​

$

—

  ​ ​ ​

$

88,347

  ​ ​ ​

1,643,081

  ​ ​ ​

$

—

  ​ ​ ​

$

8,508

  ​ ​ ​

$

(85,914)

  ​ ​ ​

$

(77,406)

Stock-based compensation expense

 

—

​

 

—

​

 

—

 

—

​

 

—

​

 

165

​

 

—

​

 

165

Issuance of common stock - board of directors compensation

 

—

​

 

—

​

 

—

 

5,300

​

 

—

​

 

74

​

 

—

​

 

74

Issuance of Series D preferred stock

 

172,187

​

 

—

​

 

33,933

 

—

​

 

—

​

 

—

​

 

—

​

 

—

Issuance of Series D preferred stock resulting from debt conversion

 

19,814

​

 

—

​

 

3,905

 

—

​

 

—

​

 

—

​

 

—

​

 

—

Series D preferred stock issuance costs

 

—

​

 

—

​

 

(88)

 

—

​

 

—

​

 

—

​

 

—

​

 

—

Net loss

 

—

​

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

(13,983)

​

 

(13,983)

Balance - March 31, 2025

 

1,868,529

​

$

—

​

$

126,097

 

1,648,381

​

$

—

​

$

8,747

​

$

(99,897)

​

$

(91,150)

Stock-based compensation expense

 

—

​

 

—

​

 

—

 

—

​

 

—

​

 

245

​

 

—

​

 

245

Issuance of Series D preferred stock

 

24,370

​

 

—

​

 

4,803

 

—

​

 

—

​

 

—

​

 

—

​

 

—

Issuance of Series D preferred stock resulting from debt conversion

 

254

​

 

—

​

 

50

 

—

​

 

—

​

 

—

​

 

—

​

 

—

Series D preferred stock issuance costs

 

—

​

 

—

​

 

(578)

 

—

​

 

—

​

 

—

​

 

—

​

 

—

Net loss

 

—

​

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

(7,939)

​

 

(7,939)

Balance - June 30, 2025

 

1,893,153

​

$

—

​

$

130,372

 

1,648,381

​

$

—

​

$

8,992

​

$

(107,836)

​

$

(98,844)

Stock-based compensation expense

 

—

​

 

—

​

 

—

 

—

​

 

—

​

 

355

​

 

—

​

 

355

Issuance of common stock for exercise of stock options

 

—

​

 

—

​

 

—

 

360

​

 

—

​

 

2

​

 

—

​

 

2

Net loss

 

—

​

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

(11,747)

​

 

(11,747)

Balance - September 30, 2025

 

1,893,153

​

$

—

​

$

130,372

 

1,648,741

​

$

—

​

$

9,349

​

$

(119,583)

​

$

(110,234)

​

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

​

​

F-48

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Nine Months Ended September 30, 2026 and 2025

(All amounts in thousands)

(Unaudited)

​

​

​

​

​

​

​

​

​

​

Nine months ended September 30

​

​

2026

​

2025

Cash Flows from Operating Activities

  ​ ​ ​

​

  ​

  ​ ​ ​

​

  ​

Net loss

​

$

(44,504)

​

$

(33,669)

Adjustments to reconcile net loss to net cash, cash equivalents, and restricted cash used in operating activities:

​

 

  ​

​

 

  ​

Depreciation

​

 

2,096

​

 

2,101

(Gain) Loss on reversal of provision for loss on contract

​

 

(353)

​

 

15

Amortization of debt and convertible debt discount

​

 

122

​

 

2,336

Loss on extinguishment of debt

​

 

—

​

 

3,891

Change in fair value of warrant liabilities

​

 

9,293

​

 

(711)

Change in fair value of contingent consideration for Sundew ALD acquisition

​

 

958

​

 

765

Amortization of right-of-use operating lease asset

​

 

2,275

​

 

1,410

Amortization of intangible assets

​

 

153

​

 

152

Stock-based compensation

​

 

1,262

​

 

765

Board of directors’ stock-based compensation

​

 

77

​

 

74

Changes in operating assets and liabilities (used in) provided by cash, cash equivalents, and restricted cash:

​

 

  ​

​

 

  ​

Accounts receivable

​

 

126

​

 

627

Contract assets - unbilled accounts receivable

​

 

(339)

​

 

(2,021)

Inventory

​

 

(3,026)

​

 

(938)

Prepaid expenses and other current assets

​

 

(1,040)

​

 

(401)

Deposits

​

 

(60)

​

 

(838)

Accounts payable

​

 

(32)

​

 

(2,239)

Contract liabilities - deferred revenue

​

 

453

​

 

(250)

Accrued and other current liabilities

​

 

3,184

​

 

(543)

Operating lease liabilities

​

 

29

​

 

2,826

Net cash, cash equivalents, and restricted cash used in operating activities

​

 

(29,326)

​

 

(26,648)

Cash Flows from Investing Activities

​

 

  ​

​

 

  ​

Purchase of property and equipment

​

 

(1,117)

​

 

(363)

Deposits for property and equipment

​

 

(10,000)

​

 

—

Issuance of notes receivable

​

 

(1,000)

​

 

—

Net cash, cash equivalents, and restricted cash used in investing activities

​

 

(12,117)

​

 

(363)

Cash Flows from Financing Activities

​

 

  ​

​

 

  ​

Series D funding issuance costs

​

 

(1,613)

​

 

(666)

Proceeds from issuance of Series D preferred stock

​

 

50,340

​

 

33,578

Proceeds from issuance of Series D convertible note

​

 

—

​

 

1,150

Proceeds from options exercised

​

 

99

​

 

2

Contingent consideration payment for Sundew ALD acquisition

​

 

—

​

 

(350)

Net cash, cash equivalents, and restricted cash provided by financing activities

​

 

48,826

​

 

33,714

Net Increase in Cash, Cash Equivalents, and Restricted Cash

​

 

7,383

​

 

6,703

Cash, Cash Equivalents, and Restricted Cash - Beginning of the period

​

 

9,429

​

 

12,238

Cash, Cash Equivalents, and Restricted Cash - End of the period

​

$

16,812

​

$

18,941

​

​

​

​

​

​

​

Supplemental Disclosure of Noncash Operating, Investing and Financing Transactions

​

 

  ​

​

 

  ​

Non-cash portion of warrant exercise

​

$

—

​

$

104

Lease liabilities arising from obtaining right-of-use assets

​

$

1,674

​

$

59,079

Non-cash portion of conversion of convertible debt to Series D preferred stock

​

$

—

​

$

2,755

Fair value of Series D preferred stock in exchange for warrant exercise

​

$

—

​

$

3,158

Fair value of Series D preferred stock in exchange for debt forgiveness

​

$

—

​

$

2,000

​

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

​

​

F-49

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

1.

Nature of Business

Forge Nano, Inc. and Subsidiary (the “Company”) was formed on September 1, 2011 under the name PneumatiCoat Technologies LLC. In 2017, the Company changed its name to Forge Nano, Inc. The Company offers commercially viable surface engineering and precision nano-coating technology for a wide range of materials, applications, and industries.

This engineering process, formally known as atomic layer deposition (ALD), has been employed in the semi conductor space for more than a decade to enhance materials used to manufacture better-performing products. The technology developed by the Company allows the application to surfaces and powders, as well as to the wafers used by the semiconductor industry, in a fast and consistent process at a commercial scale.

Applying ALD to the components required for lithium-ion battery manufacturing produces substantial performance and safety improvements. The Company has focused on this industry for the past decade and has validated independently the performance benefits of batteries produced with ALD-coated components. The Company anticipates becoming a world leader in the provision of ALD equipment and corresponding services for this sector as electrification of economies advances.

​

2.

Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and for interim financial information in accordance with the Securities and Exchange Commission (“SEC”), instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included.

Certain information and footnote disclosures normally included in the annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the years ended December 31, 2025 and 2024, included in the Company’s Registration Statement on Form S-4 (File No. 333-295563), as amended, initially filed with the Securities and Exchange Commission (the “SEC”) on May 5, 2026 and declared effective on September 22, 2026.

The information presented in the accompanying unaudited condensed consolidated balance sheet as of December 31, 2025 has been derived from the Company’s 2025 audited consolidated financial statements.

Use of Estimates

The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Management periodically evaluates estimates used in the preparation of the unaudited condensed consolidated financial statements for continued reasonableness. Appropriate adjustments, if any, to estimates are made prospectively based upon such periodic evaluations. It is reasonably possible that changes may occur in the near term that would affect managements’ estimates with respect to revenue recognition, estimates of cost to complete contracts, allowance for credit losses, share-based payments, accrued expenses, inventory, deferred taxes, property and equipment and valuation of assets acquired in business combinations.

F-50

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

Reclassification of Previously Issued Presentation

Certain amounts from previously issued financial statements have been reclassified to ensure consistency with the current year’s presentation. These reclassifications did not affect the reported results of operations.

Going Concern

During the three months ended September 30, 2026 and 2025, the Company incurred net losses in the amount of $11,954 and $11,747, respectively. During the nine months ended September 30, 2026 and 2025, the Company incurred net losses in the amount of $44,504 and $33,669, respectively, and generated negative cash flows from operations in the amounts of $29,326 and $26,648, respectively. Additionally, as of September 30, 2026, the Company had an accumulated deficit in the amount of $173,592 and cash and cash equivalents of $15,723. The Company’s cash position was primarily the result of proceeds received from the final closing of its Series D convertible preferred stock financing.

Subsequent to September 30, 2026, the Company completed its Business Combination (defined below) on October 22, 2026 and received the proceeds from the private investment in public equity (the “PIPE”) financing in October 2026 (see “Forge Nano de-SPAC” below and Note 20. Subsequent Events). Management believes that these proceeds are adequate to fund the Company’s operations and planned capital expenditures for the twelve months following the issuance of these unaudited condensed consolidated financial statements. Accordingly, management has concluded that substantial doubt about the Company’s ability to continue as a going concern has been alleviated.

In evaluating the Company’s ability to continue as a going concern, management prepared a cash flow forecast for the period from October 1, 2026 through September 30, 2027 based on the Company’s current operating plan, revenue outlook, historical spending patterns and planned capital expenditures. The forecast incorporates the PIPE proceeds and assumes no additional equity or project financing, a reduced pace of capital deployment for the Morrisville facility until additional financing is obtained, continued funding under the Department of Energy’s Bipartisan Infrastructure Law grant program, and limited additional investment in the Company and in HzO, Inc. (see Note 20) during the forecast period. Based on the forecast, the Company’s cash balance is expected to remain positive throughout the forecast period.

Forge Nano de-SPAC

On April 20, 2026, the Company entered into an Agreement and Plan of Merger with Archimedes Tech SPAC Partners II Co.(“ATII”), ATII Holdings Inc. (“Pubco”) and certain merger subsidiaries. ATII’s shareholders approved the business combination on October 16, 2026, and it was completed on October 22, 2026 (the “Business Combination”). Pubco was renamed Forge Nano Holdings, Inc., and its common stock and warrants began trading on Nasdaq on October 22, 2026.

In connection with the Business Combination, Pubco entered into PIPE subscription agreements for gross proceeds of $123,000, consisting of $100,000 from an initial investor and $23,000 from other investors. The securities received by the initial investor are comprised of 2,968,825 shares of common stock at $10.00 per share, pre-funded warrants to purchase 7,031,175 shares at an exercise price of $0.0001 per share, at $10.00 per pre-funded warrant, and warrants to purchase 15,000,000 shares at an initial exercise price of $10.00 per share. The other investors purchased an aggregate of 2,300,000 shares at $10.00 per share.

In connection with the closing, holders of 22,219,068 ATII public shares exercised their right to redeem their shares for approximately $10.73 per share, or approximately $238,400 in the aggregate, leaving approximately $8,400 in ATII’s trust account immediately prior to the closing. As the Business Combination closed after September 30, 2026, it is not reflected in the accompanying unaudited condensed consolidated balance sheet.

F-51

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

Principles of Consolidation

The unaudited condensed consolidated financial statements include the accounts of the Company and all of its wholly owned and majority- owned subsidiaries. All material intercompany accounts and transactions have been eliminated in consolidation.

Cash, Cash Equivalents and Restricted Cash

As of the balance sheet date and periodically throughout the year, the Company maintained balances with a financial institution in excess of the amount insured by the Federal Deposit Insurance Corporation (FDIC). The total amount of bank deposits (checking and savings accounts) that was insured by the FDIC at year end was $250 at each institution.

Restricted cash consists of cash balances that are restricted as to withdrawal or usage and includes cash to collateralize a bank line of credit related primarily to customer deposits for new projects. The Company has two restricted cash accounts with a combined balance of $1,089 and $368 as of September 30, 2026 and December 31, 2025, respectively. Cash, cash equivalents, and restricted cash as of September 30, 2026 and December 31, 2025 were as follows:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30,

  ​ ​ ​

December 31,

​

​

2026

​

2025

Cash and cash equivalents

​

$

15,723

​

$

9,061

Restricted cash

​

 

1,089

​

 

368

Total

​

$

16,812

​

$

9,429

​

Accounts Receivable

Accounts receivable are stated at net invoice amounts. An allowance for credit losses is established for amounts expected to be uncollectible over the contractual life of the receivables. The Company collectively evaluates accounts receivable to determine the allowance for credit losses based on its historical bad debt expense and benchmarking of the allowances of comparable public companies.

Four customers accounted for 84 percent and three customers accounted for 65 percent of net accounts receivable as of September 30, 2026 and December 31, 2025, respectively.

Revenue Concentration

Of the total net revenue, three customers accounted for 33%, and two customer accounted for 35% for the three months ended September 30, 2026 and 2025, respectively. Of the total net revenue, one customer accounted for 23%, and one customer accounted for 18% for the nine months ended September 30, 2026 and 2025, respectively.

Recently Issued Accounting Pronouncements Not Yet Adopted

In October 2023, the FASB issued ASU 2023-06, “Disclosure Improvements”, to clarify or improve disclosure and presentation requirements of a variety of topics and align the requirements in the FASB ASC with the SEC’s regulations. The amendments in ASU 2023-06 will become effective on the date the related disclosures are removed from Regulation S-X or Regulation S-K by the SEC, and will no longer be effective if the SEC has not removed the applicable disclosure requirement by September 30, 2027. Early adoption is prohibited. The Company is currently evaluating the impact of ASU 2023-06 on its interim unaudited condensed consolidated financial statements. Adoption is not expected to have a material impact on the Company’s interim unaudited condensed consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses to expand the disclosure requirements

F-52

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

for certain costs and expenses. In January 2025, FASB issued ASU 2025-01, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03 as periods beginning after December 15, 2026 for annual reporting, and interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2024-03 and ASU 2025-01 on its interim unaudited condensed consolidated financial statements.

In December 2025, the FASB issued ASU 2025-11, “Interim Reporting (Topic 270): Narrow Scope Improvements”. The amendments clarify the applicability of the interim reporting guidance in Topic 270, improve the navigability of the interim reporting requirements, and provide a more comprehensive framework for interim disclosures, including a principle that entities disclose events and changes since the last annual reporting period that have a material effect on the entity. ASU 2025-11 is effective for public business entities for interim reporting periods within annual reporting periods beginning after December 15, 2027, and for all other entities for interim reporting periods within annual reporting periods beginning after December 15, 2028. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2025-11 on its interim unaudited condensed consolidated financial statements and related disclosures.

The Company does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company’s financial statement presentation or disclosures.

​

3.

Inventory

Inventory consists of the following as of September 30, 2026 and December 31, 2025:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30,

  ​ ​ ​

December 31,

​

​

2026

​

2025

Raw materials

​

$

4,079

​

$

2,478

Work in progress

​

 

2,388

​

 

1,187

Finished goods

​

 

224

​

 

—

Total

​

$

6,691

​

$

3,665

​

Inventory increased by $3,026 from $3,665 as of December 31, 2025 to $6,691 as of September 30, 2026. This increase was primarily driven by the procurement of long-lead raw materials and an accumulation of work-in-process inventory to support projected tool manufacturing schedules and commercial distribution commitments.

​

4.

Property and Equipment

Property and equipment as of September 30, 2026 and December 31, 2025 are summarized as follows:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30,

  ​ ​ ​

December 31,

​

​

2026

​

2025

Property and equipment

 

​

24,439

 

​

23,322

Less: accumulated depreciation

 

​

(10,766)

 

​

(8,670)

Net property and equipment

​

$

13,673

​

$

14,652

​

During the nine months ended September 30, 2026, the Company purchased property and equipment of $1,117, consisting primarily of additions to machinery and equipment of $1,420, leasehold improvements of $213 and computer equipment and software of $9, partially offset by a net decrease in construction in progress of $525.

Depreciation and amortization expense for the three months ended September 30, 2026 and 2025 was $691 and $705, respectively, of which $547 and $511 was recorded into cost of sales within the Company’s unaudited condensed consolidated statements of operations.

F-53

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

Depreciation and amortization expense for the nine months ended September 30, 2026 and 2025 was $2,096 and $2,101, respectively, of which $1,615 and $1,535 was recorded into cost of sales within the Company’s unaudited condensed consolidated statements of operations.

5.

Commitments and Contingencies

On August 9, 2023, the Company completed the acquisition of Sundew ALD assets from Sundew Technologies, LLC for consideration composed of three cash payments comprised of $350 at the time of close, $350 cash payment on the second anniversary, August 2024, and the remaining $350 future cash payment due upon the last anniversary, August 2025. The consideration also included contingent cash consideration to be paid to the sellers based on percentages ranging from 2 to 5 percent of net sales through 2032. The Company estimated the fair value of the contingent consideration using a Monte Carlo simulation model, resulting in an initial liability of $311 recognized as part of the purchase consideration at the acquisition date. As of September 30, 2026, the fair value of the contingent consideration was remeasured to $2,769 due to a new projection for tool sales related to the Intellectual Property (IP), which was revised sharply upward. As of December 31, 2025, the fair value of the contingent consideration was remeasured to $1,811. The acquisition was completed to enable the Company to repurpose several patents and product designs for its own line of semiconductor coating equipment.

6.

Acquired Intangible Assets and Goodwill

Intangible assets of the Company as of September 30, 2026 and December 31, 2025 are summarized as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

September 30, 2026

​

December 31, 2025

​

​

Gross

​

​

​

​

​

​

​

Gross

​

​

​

​

​

​

​

​

Carrying

​

Accumulated

​

​

​

​

Carrying

​

Accumulated

​

​

​

​

​

Amount

​

Amortization

​

Net

​

Amount

​

Amortization

​

Net

Amortizable intangible assets - acquired patents

  ​ ​ ​

$

3,212

  ​ ​ ​

$

(1,776)

  ​ ​ ​

$

1,436

  ​ ​ ​

$

3,212

  ​ ​ ​

$

(1,623)

  ​ ​ ​

$

1,589

​

​

$

3,212

​

$

(1,776)

​

$

1,436

​

$

3,212

​

$

(1,623)

​

$

1,589

​

The acquired patents are being amortized over an estimated life of 15 years. Amortization expense for intangible assets totaled $51 and $50 for the three months ended September 30, 2026 and 2025, respectively, and $153 and $152 for the nine months ended September 30, 2026 and 2025, respectively. These amounts are included in general and administrative expenses within the Company’s unaudited condensed consolidated statements of operations.

Estimated amortization expense is as follows:

​

​

​

​

​

Years ending

  ​ ​ ​

Amount

Remainder of 2026

​

$

50

2027

​

 

203

2028

​

 

194

2029

​

 

165

2030

​

 

165

Thereafter

​

 

659

Total

​

$

1,436

​

Goodwill

Goodwill represents the excess of purchase price over the fair value of identifiable net assets acquired in business combinations. Goodwill is not amortized but is tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the carrying amount may not be recoverable.

F-54

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

Reporting Unit

The Company evaluates goodwill for impairment at the reporting unit level in accordance with ASC 350-20. The Company has identified three reporting units, which correspond to its operating and reportable segments: Tool Manufacturing & Related Services, Coating Services, and Battery Manufacturing.

Each reporting unit represents a component of the business for which discrete financial information is available and regularly reviewed by management for purposes of assessing performance and allocating resources.

Allocation of Goodwill

Goodwill is allocated to reporting units expected to benefit from the synergies of the related business combinations. The Company has allocated goodwill based on the business combinations giving rise to the goodwill and the manner in which the acquired assets contribute to current operations.

The following table presents goodwill balances for each of our reportable segments as of September 30, 2026:

​

​

​

​

Reporting Unit

  ​ ​ ​

Goodwill

Tool Manufacturing & Related Services

​

$

900

Coating Services

​

 

2,224

Battery Manufacturing

​

 

—

Total

​

$

3,124

​

The goodwill associated with the ALD Nano Solutions acquisition is allocated to the Coating Services reporting unit, as the acquired reactor assets and related intellectual property are utilized in coating operations and generate revenue within this reporting unit.

The goodwill associated with the Sundew acquisition is allocated to the Tool Manufacturing & Related Services reporting unit, as the acquired intellectual property supports the Company’s equipment platform.

No goodwill is allocated to the Battery Manufacturing reporting unit.

The Company performs its annual goodwill impairment test during the fourth quarter of each fiscal year. The Company first performs a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. The Company recognized no impairment to goodwill during the nine months ended September 30, 2026 and 2025.

​

7.

Leases

On March 31, 2025, the Company entered into an operating lease for a manufacturing facility located at 401 Southport Drive, Morrisville, North Carolina (the “Morrisville Lease”). The leased facility initially consisted of approximately 100,000 square feet of base floor area and was to be modified to include approximately 37,297 square feet of mezzanine area, resulting in an aggregate leased area of approximately 137,297 square feet.

On May 8, 2026, the Company entered into the First Amendment to the Morrisville Lease, which modified the contractual fixed base rent payments through August 2026 while the Company and the landlord continued to finalize the design and layout of the planned expansion space. The amendment also retroactively adjusted the rent due for the period from October 2025 through May 2026, which had previously been accrued as rent payable on the Company’s balance sheet.

Upon execution of the amendment, the Company paid the outstanding rent payable related to the prior periods, net of the discount provided under the amendment. Pursuant to the terms of the amendment, the discount is expected to be applied against the future rent

F-55

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

abatement associated with the expansion space and may be required to be repaid to the landlord to the extent the discount exceeds the available expansion space rent abatement. As the ultimate amount of the discount that will be retained by the Company will not be determined until the expansion space arrangement is finalized, the Company has continued to recognize the discounted portion of $1,743 as a liability on its balance sheet.

The Company accounted for the amendment as a modification of the existing operating lease under ASC 842 and remeasured the operating lease liability using the revised contractual lease payments. The discount rate used in the remeasurement was 9.76%. The resulting remeasurement adjustment was recorded as a corresponding adjustment to the operating lease right-of-use asset.

The Company is obligated under operating leases only for building and office rentals. The leases require the Company to pay taxes, insurance, utilities, and maintenance costs. Total rent expense under these leases are included in cost of sales and general and administrative expenses within the Company’s unaudited condensed consolidated statements of operations.

Expenses recognized under these leases for the three and nine months ended September 30, 2026 and 2025 consist of the following:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended September 30,

​

Nine months ended September 30,

​

​

2026

​

2025

​

2026

​

2025

Lease cost - Operating lease cost

  ​ ​ ​

$

2,410

  ​ ​ ​

$

2,297

  ​ ​ ​

$

7,189

  ​ ​ ​

$

4,775

​

​

​

​

​

​

​

​

​

​

​

​

​

Other information:

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

Cash paid for amounts included in the measurement of lease liabilities - Operating cash flows from operating leases

​

$

1,464

​

$

183

​

$

4,861

​

$

540

Right-of-use assets obtained in exchange for new operating lease liabilities

​

$

—

​

$

—

​

$

1,674

​

$

59,079

​

​

​

8.

Accrued and Other Current Liabilities

The following is the detail of accrued and other current liabilities as of September 30, 2026 and December 31, 2025:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30,

  ​ ​ ​

December 31,

​

​

2026

​

2025

Other accrued liabilities

​

$

4,042

​

$

1,216

Payroll liabilities

​

 

2,146

​

 

1,748

Warranty reserve liability

​

 

23

​

 

63

Total

​

$

6,211

​

$

3,027

​

Other accrued liabilities increased by $2,826 as of September 30, 2026, as compared to December 31, 2025, primarily due to the lease modification recovery liability of $1,743 recorded in connection with the May 2026 amendment to the Morrisville lease (see Note 7), and approximately $1,600 of accrued rent and other facility-related obligations for the Morrisville facility which invoices had not yet been received.

​

9.

Capital Stock

As of September 30, 2026 and December 31, 2025, common stock consists of 4,850,000 and 4,850,000 authorized shares, respectively, of common stock and 2,204,216 and 4,663,753 authorized shares, respectively, of preferred stock, each with a par value of $0.0001. As of September 30, 2026 and December 31, 2025, 1,642,597 and 1,648,841 shares, respectively, of common stock and 2,190,939 and 1,925,348 shares, respectively, of preferred stock were issued and outstanding.

F-56

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

Mezzanine Equity

The Series A, Series B, Series C and Series D shares are recorded as mezzanine equity in accordance with ASC 480, Distinguishing Liabilities from Equity, as the shares are contingently redeemable upon the occurrence of events outside of the Company’s control.

Dividends

The holders of preferred stock shall be entitled to receive annual noncumulative dividends of 7 percent of the original issue price if and when declared by the board of directors. There were no dividends declared as of September 30, 2026 and December 31, 2025.

Capital stock is as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

September 30, 2026

​

December 31, 2025

​

​

Number of shares

​

APIC Amount

​

Number of shares

​

APIC Amount

Forge Nano, Inc. - Preferred stock:

  ​ ​ ​

  ​

  ​ ​ ​

​

  ​

  ​ ​ ​

  ​

  ​ ​ ​

​

  ​

Series A - $0.0001 par value (voting) - Authorized - 858,410 shares

 

858,410

​

$

31,235

 

858,410

​

$

31,235

Series B - $0.0001 par value (voting) - Authorized – 130,939 shares

 

130,939

​

 

7,070

 

130,939

​

 

7,070

Series C - $0.0001 par value (voting) - Authorized - 687,179 shares

 

687,179

​

 

50,042

 

687,179

​

 

50,042

Series D - $0.0001 par value (voting) - Authorized - 527,688 shares

 

514,411

​

 

96,918

 

248,820

​

 

48,191

Total

 

2,190,939

​

$

185,265

 

1,925,348

​

$

136,538

​

Conversion of Series D Convertible Note to Preferred Stock

In March 2025, the first close of the Series D capital raise was completed, which mandated the conversion of the Company’s $3,905 convertible note to preferred stock. The convertible note and related bifurcated derivative liability converted into 19,814 shares of Series D preferred stock with a par value of $0.0001 at a conversion price of $157.66 per share, representing a 20% discount to the Series D fair market value of $197.07. The conversion was accounted for as an extinguishment of the convertible debt liability and subsequently recorded as preferred stock under equity. The impact of the conversion of the convertible loan debt balance to Series D preferred stock was to reduce the outstanding convertible debt balance of $3,905 to $0.

Series D Preferred Stock

The Company initiated its Series D preferred stock financing in connection with the conversion of certain outstanding convertible notes, the exercise of warrants and an initial closing on March 31, 2025. In connection with the initial closing, the Company issued Series D preferred stock for aggregate proceeds of approximately $37,800.

Following the initial closing, the Company continued to raise additional capital through multiple subsequent closings. Total gross proceeds from the Series D financing were approximately: $48,200 cumulatively raised through December 31, 2025, and the Series D round closed on June 30, 2026 with a total $97,386 raised.

10.

Stock-Based Compensation

As of September 30, 2026 and 2025, the Company has one share-based compensation plan the 2017 Equity Incentive Plan (the “Plan”), which is stockholder approved and permits the grant of stock options to its employees for up to 551,686 shares of common stock. The Company believes that such awards better align the interests of its employees with those of its stockholders. Option awards are generally granted with an exercise price equal to the market price of the Company’s stock at the date of grant. Those option awards generally vest over four years, with the first 25 percent vesting after 12 months of continuous service, and options granted have four-year contractual terms. Certain option awards provide for accelerated vesting if there is a change in control (as defined in the Plan).

F-57

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model that uses the weighted-average assumptions noted in the following table. Expected volatilities are based on historical volatility of the Company’s stock price and historical volatility of comparable public companies. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

The compensation cost that has been charged against income for the plan was $424 and $355 for the three months ended September 30, 2026 and 2025, respectively, and $1,262 and $765 for the nine months ended September 30, 2026 and 2025, respectively. These amounts are included in general and administrative expenses within the Company’s unaudited condensed consolidated statements of operations.

When calculating the amount of annual compensation expense, the Company has elected not to estimate forfeitures and instead accounts for forfeitures as they occur.

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30,

  ​ ​ ​

December 31,

 

​

​

2026

​

2025

 

Average expected life (in years)

 

​

5.80

 

​

3.97

​

Risk-free interest rate

 

​

4.05

%  

​

3.74

%

Expected dividend yield

 

​

—

%  

​

—

%

Volatility

 

​

44.48

%  

​

39.06

%

Estimated fair value of options granted

​

$

39.68

​

$

20.78

​

​

A summary of option activity under the Plan as of September 30, 2026 and December 31, 2025 is presented below:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted-

​

​

​

​

​

​

​

​

Weighted-

​

average

​

Weighted

​

​

​

​

Number of

​

average

​

Grant-date

​

Remaining

​

Aggregate

​

​

Options

​

Exercise Price

​

Fair Value

​

Contractual

​

Intrinsic Value

Options

  ​ ​ ​

​

  ​ ​ ​

(Dollars)

  ​ ​ ​

(Dollars)

  ​ ​ ​

Term (in Years)

  ​ ​ ​

(Dollars)

Outstanding at January 1, 2026

 

455,551

 

68.45

 

  ​

 

5.13

 

16,456

Granted

 

196,307

 

99.77

 

19.67

 

  ​

 

  ​

Exercised

 

(6,219)

 

15.99

 

  ​

 

  ​

 

421

Forfeited

 

(6,004)

 

67.49

 

32.21

 

  ​

 

  ​

Expired

 

(94,862)

 

86.81

 

  ​

 

  ​

 

  ​

Outstanding at September 30, 2026

 

544,773

 

77.15

 

  ​

 

5.34

 

15,139

Vested or expected to vest at September 30, 2026

 

544,773

 

77.15

 

  ​

 

5.34

 

15,139

Exercisable at September 30, 2026

 

356,677

 

80.57

 

  ​

 

3.81

 

12,626

​

As of September 30, 2026 and December 31, 2025, there was $5,018 and $2,676 respectively, of total unrecognized compensation cost related to unvested share-based compensation arrangements granted under the Plan. That cost is expected to be recognized over a weighted-average period of 2.43 years and 2.54 years as of September 30, 2026 and December 31, 2025, respectively.

F-58

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

A summary of unvested shares under the Plan for as of September 30, 2026 and December 31, 2025 is presented below:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted-

​

​

​

​

​

​

​

​

Weighted-

​

average

​

Weighted

​

​

​

​

Number of

​

average

​

Grant-date

​

Remaining

​

Aggregate

​

​

Options

​

Exercise Price

​

Fair Value

​

Contractual

​

Intrinsic Value

Unvested Options

  ​ ​ ​

​

  ​ ​ ​

(Dollars)

  ​ ​ ​

(Dollars)

  ​ ​ ​

Term (in Years)

  ​ ​ ​

(Dollars)

Unvested at January 1, 2026

 

132,228

 

51.87

 

22.97

​

​

​

​

Granted

 

196,307

 

99.77

 

19.67

​

​

​

​

Vested

 

(134,435)

 

94.83

 

9.08

 

2.72

 

1,601

Forfeited

 

(6,004)

 

67.49

 

32.21

​

​

​

​

Unvested at September 30, 2026

 

188,096

 

70.66

 

29.54

​

​

​

​

​

Restricted Stock

During the year ended December 31, 2025, the Company granted an additional 5,300 restricted shares. A total of 7,505 shares were vested during the year ended, December 31, 2025, with a weighted-average grant-date fair value of $33.71 per share, and 0 shares were forfeited. As of December 31, 2025, 5,526 restricted shares remained outstanding, with a weighted-average grant-date fair value of $31.23 per share. A total of 3,979 shares were vested during the nine months ended, September 30, 2026, with a weighted-average grant-date fair value of $32.03 per share, and 0 shares were forfeited. As of September 30, 2026, 1,547 restricted shares remained outstanding, with a weighted-average grant-date fair value of $29.18 per share. As of September 30, 2026 and December 31, 2025, the Company had $35 and $112 of unrecognized compensation expense related to unvested restricted stock awards.

In January 2026, certain holders of vested restricted stock awards satisfied outstanding promissory notes and related accrued interest through a net share settlement arrangement. The Company withheld 14,851 shares to satisfy the outstanding note principal and accrued interest and issued 144,636 net shares to the holders. The settlement did not result in incremental compensation cost.

Non plan Stock Options

On August 8, 2022, the Company issued 82,512 common stock options to Ascent Funds International Management as compensation in exchange for consulting services related to the preparation for a potential initial public offering. The options fully vested six weeks after the grant date with an exercise price of $96.95 based on a fixed pre-money valuation of $300,000 and 3,094,378 fully diluted shares at grant date. The options were amended to expire on December 31, 2028 with an option to expire December 31, 2029 with an increase in strike price to $121.19, and may be fully or partially exercised so long as they are fully exercised prior to an initial public offering.

11.

Revenue Recognition

Contract Liabilities

The following table provides information on the changes in the balance of contract liabilities:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

September 30,

  ​ ​ ​

​

December 31,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Balance - Beginning of period

​

$

3,126

​

$

3,012

Cash received

​

 

4,776

​

 

7,007

Less revenue recognized from continuing operations (net of returns, allowances, etc.) from satisfaction of performance obligations in the current period

​

 

(4,323)

​

 

(6,893)

Balance - End of period

​

$

3,579

​

$

3,126

​

Total contract liabilities increased by $453 during the nine months ended September 30, 2026. The increase was primarily due to increased sales deposits received during the year.

F-59

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

Contract Assets

The following table provides information on the changes in the balance of contract assets:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30,

  ​ ​ ​

December 31,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Balance - Beginning of period

​

$

6,586

​

$

3,660

Revenue recognized from continuing operations (net of returns, allowances, etc.) from satisfaction of performance obligations in the current period

​

 

4,457

​

 

10,706

Less contract assets reclassified to receivables

​

 

(4,118)

​

 

(7,780)

Balance - End of period

​

$

6,925

​

$

6,586

​

Total contract assets increased by $339 during the nine months ended September 30, 2026, primarily driven by unbilled revenue related to equipment orders for which revenue was recognized, but the equipment had not yet been shipped to customers.

The Company recognized (gain)/losses on trade receivables and contract assets of $(3) and $24 as of September 30, 2026 and December 31, 2025, respectively.

Performance Obligations

As of September 30, 2026 and December 31, 2025, the Company had remaining performance obligations primarily related to equipment orders. Revenue from these performance obligations is recognized as control of the equipment transfers to customers, which may occur over periods extending beyond twelve months depending on delivery schedules and customer acceptance.

12.

Debt

Debt as of September 30, 2026 and December 31, 2025 is as follows:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30,

  ​ ​ ​

December 31,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Senior secured term loan issued in May 2023 by OIC, LLC, including a weighted-average interest at 10 percent per annum at September 30, 2026 and December 31, 2025. The note is collateralized by the Company’s assets and intellectual property and is due in full on October 20, 2026

​

$

10,488

​

$

10,488

Less: unamortized debt issuance costs and discounts

​

 

—

​

 

(122)

Total debt, less unamortized debt issuance costs and discounts

​

$

10,488

​

$

10,366

​

Interest expense attributable to the debt for three months ended September 30, 2026 and 2025 was $282 and $1,230, respectively, and $931 and $3,733 for the nine months ended September 30, 2026 and 2025, respectively. On October 20, 2026, the Company repaid the loan in full.

13.

Related Party Notes Receivable

On March 13, 2026, the Company entered into a credit agreement as lender with HzO, Inc. (“HzO” or the “Borrower”) pursuant to which the Company agreed to lend the Borrower $2,000 (the “Note”). The Borrower is considered a related party due to their participation as an investor in the Company’s Series D financing. The Note bears interest at 6.00% per annum (computed on a 365-day year), with interest payable monthly beginning one month after issuance and due on the 15th day of each month (or the next business day if the15th is not a business day). The principal balance is payable in full at maturity on March 12, 2028. The Borrower may prepay the Note, in whole or in part, at any time without penalty, with prepayments applied first to accrued interest and then to principal. The Note is unsecured and, in the event of default, the outstanding principal balance bears interest at 12% per annum (or the

F-60

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

maximum rate permitted by law, if lower), and late payments may be subject to a 5% fee if not received within 10 days of the due date. The agreement is governed by the laws of the State of Delaware.

The Note was issued in connection with Borrower’s participation in the Company’s Series D equity financing, pursuant to which Borrower committed to invest $15,000, consisting of $13,000 in cash and $2,000 funded through the Note.

The Company evaluated the accounting for the Note in accordance with ASC 505‑10, SEC Staff Accounting Bulletin Topic 4.E, and ASC 850. Given that the Note was issued by an investor in satisfaction of a portion of its equity commitment and is not independent of the equity financing, the Company determined that the Note represents a subscription receivable from an investor. Accordingly, consistent with SAB Topic 4.E, the $2,000 has been recorded as a reduction of equity (additional paid‑in capital) rather than as a notes receivable on the balance sheet.

As the Note is not recognized as a financial asset, the Company did not record an allowance for expected credit losses under ASC 326.

In August 2026, the Company amended its existing credit agreement with HzO to increase the total principal amount available under the agreement from $2,000 to $3,000. The Company advanced the additional $1,000 to HzO for working capital purposes. The advance bears interest at 6.0% per annum, calculated on a 365-day year, with interest payable monthly. Although the Note and the advance are governed by the same credit agreement, they are accounted for differently based on the purpose of the funds. The Note, which funded a portion of the Borrower’s Series D investment, is presented as a reduction from equity as described above, while the advance, which funded the Borrower’s working capital, is recognized as an asset. Accordingly, the $1,000 advance is presented as notes receivable within the current assets in the unaudited condensed consolidated balance sheet as of September 30, 2026,

For the three and nine months ended September 30, 2026, the Company recognized interest income of approximately $39 and $75, respectively, within interest income in the unaudited condensed consolidated statements of operations. As of September 30, 2026, the Company had accrued interest receivable of approximately $7, included in prepaid expenses and other current assets in the unaudited condensed consolidated balance sheet.

The Company evaluated the note receivable for expected credit losses in accordance with the applicable U.S. GAAP credit loss guidance. Based on the Company’s assessment of the borrower’s creditworthiness and other relevant information available as of September 30, 2026, the Company concluded that an allowance for credit losses was not necessary. Accordingly, no allowance for credit losses was recorded as of September 30, 2026.

On November 4, 2026, Pubco completed its acquisition of HzO (see Note 20). Pursuant to the HzO Merger Agreement, the outstanding loans under the credit agreement, comprising the Note ($2,000) and the advance ($1,000), were settled through a reduction of the consideration payable to the HzO stockholders.

14.

Derivative Financial Instruments

The Company evaluates its convertible instruments, options, warrants, and other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under ASC 815. The result of this accounting treatment is that the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the unaudited condensed consolidated statements of operations as interest income (expense), and reported within the adjustments to reconcile net loss from operating activities as change in fair value of derivative liability within the unaudited condensed consolidated statements of cash flows. Upon conversion or exercise of the Company’s warrant derivative instruments, they are marked to fair value at the conversion date, and their fair value is reclassified to preferred stock. After the closing of the Forge Nano de-SPAC, the conversion fair value of Company warrants will be reclassified to common stock. If equity instruments that are initially classified as equity become subject to reclassification as liabilities under ASC 815, they are measured using the fair value of the instrument as of the reclassification date.

F-61

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

Warrants

In 2023, as part of the loan agreement between OIC and the Company (see Note 12), the Company issued warrants to OIC to purchase common stock, of which 65,430 were issued at an exercise price of $0.01 per share, and 261,722 were issued at an exercise price of $76.42 per share. The warrants may be exercised during the period commencing on the repayment date and ending 30 calendar days following the repayment date. The repayment date is the earlier of (i) the date on which the loan is repaid or (ii) the earlier to occur of (a) November 5, 2025 and (b) the date upon which the entire outstanding principal amount of the loans, together with all unpaid interest, fees, charges and costs, shall be accelerated in accordance with the loan agreement. The number of shares available for purchase by each OIC fund is calculated by dividing $5,000 by the common stock price and then multiplying each OIC fund’s respective percentage. The common stock price is the Series C original issue price. The liability is recorded at fair value at inception and recorded as debt discount at the grant date. The warrants were not exercisable prior to the repayment of the OIC loan on October 20, 2026 (see Note 12). As a result of the repayment, the exercise period ends on November 21, 2026. The fair value is revalued at each reporting date on a recurring basis. On March 31, 2025 OIC leveraged $2,000 of its outstanding note to exercise 26,172 of its warrants to purchase Series D shares at the Series C exercise price.

​

​

​

​

​

​

​

  ​ ​ ​

Warrant Shares

​

​

September 30,

  ​ ​ ​

December 31,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Beginning balance

 

300,980

 

327,152

Granted

 

—

 

—

Exercised

 

—

 

(26,172)

Expired

 

—

 

—

Ending balance

 

300,980

 

300,980

​

In addition to the OIC warrants, as of September 30, 2026 and December 31, 2025, the Company had 14,802 and 12,147 warrants outstanding, respectively, which are equity classified.

As of September 30, 2026 and December 31, 2025 the fair value of derivatives was as follows:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30,

  ​ ​ ​

December 31,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Derivatives not designated as hedging instruments:

 

​

  ​

 

​

  ​

Warrants issued in conjunction with the 2023 issuances of Series C preferred stock and long-term debt

 

​

14,917

 

​

5,624

Total derivatives not designated as hedging instruments

​

$

14,917

​

$

5,624

​

The Company values warrants at fair value using a weighted Black-Scholes calculation. The following inputs and assumptions were used to value the warrants as of September 30, 2026 and December 31, 2025:

​

​

​

​

​

​

​

​

  ​ ​ ​

Warrants

 

​

​

September 30,

  ​ ​ ​

December 31,

 

​

​

2026

​

2025

 

Expected volatility

 

50.00

%  

50.00

%

Risk-free rate

 

5.29

%  

4.17

%

Expiration date

​

November 21, 2026

​

June 4, 2026

​

Term (in years)

​

0.14

​

0.68

​

​

F-62

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

For the three and nine months ended September 30, 2026 and 2025, the amounts of gain or loss recognized attributable to derivative instruments and their corresponding locations in the unaudited condensed statements of operations are as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Amount of Loss (Gain) Recognized in

  ​ ​ ​

Amount of Loss (Gain) Recognized in

  ​ ​ ​

​

​

​

Earnings for Three months ended on

​

Earnings for Nine months ended on

​

Reported in

​

​

September 30,

​

September 30,

​

September 30,

​

September 30,

​

Statement of

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

Operations

Change in fair market value

 

(48)

 

(66)

 

9,293

 

(711)

 

Interest expense

​

​

15.

Fair Value Measurements

In accordance with ASC 820, Fair Value Measurements and Disclosures (ASC 820), the Company measures and accounts for certain assets and liabilities at fair value on a recurring basis. ASC 820 provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the inputs and valuation techniques used to measure fair value.

Fair values determined by Level 1 inputs use quoted prices in active markets for identical liabilities that the Company has the ability to access. Fair values determined by Level 2 inputs use other inputs that are observable, either directly or indirectly. These Level 2 inputs include quoted prices for similar liabilities in active markets and other inputs, such as interest rates and yield curves, that are observable at commonly quoted intervals.

Level 3 inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related liability. These Level 3 fair value measurements are based primarily on management’s own estimates using pricing models, discounted cash flow methodologies, or similar techniques taking into account the characteristics of the liability.

The Company used Level 3 inputs to value its liabilities measured at fair value on a recurring basis as of September 30, 2026 and December 31, 2025, as Level 1 and Level 2 inputs were not available. These liabilities consisted of warrants, derivatives, and contingent consideration See Note 14 for details of the method and inputs used to measure fair value of the derivative liabilities and Note 5 for the contractual terms and fair value measurement of the contingent consideration liability as of September 30, 2026 and December 31, 2025.

In instances where inputs used to measure fair value fall into different levels in the above fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each liability.

F-63

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

The following tables present information about the Company’s liabilities measured at fair value on a recurring basis as of September 30, 2026 and December 31, 2025 and the valuation techniques used by the Company to determine those fair values:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Liabilities Measured at Fair Value on a Recurring Basis at

​

​

September 30, 2026

​

​

Quoted Prices in

​

​

​

​

​

​

​

​

​

​

​

Active Markets

​

Significant Other

​

Significant

​

​

​

​

​

for Identical

​

Observable

​

Unobservable

​

Balance at

​

​

Assets

​

Inputs

​

Inputs

​

September 30,

​

  ​ ​ ​

(Level 1)

  ​ ​ ​

(Level 2)

  ​ ​ ​

(Level 3)

  ​ ​ ​

2026

Liabilities

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

Warrants (Note 14)

​

$

—

​

$

—

​

$

14,917

​

$

14,917

Contingent consideration (Note 5)

​

 

—

​

 

—

​

 

2,769

​

 

2,769

Total liabilities

​

$

—

​

$

—

​

$

17,686

​

$

17,686

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Liabilities Measured at Fair Value on a Recurring Basis at

​

​

December 31, 2025

​

​

Quoted Prices in

​

​

​

​

​

​

​

​

​

​

​

Active Markets

​

Significant Other

​

Significant

​

​

​

​

​

for Identical

​

Observable

​

Unobservable

​

Balance at

​

​

Assets

​

Inputs

​

Inputs

​

December 31,

​

  ​ ​ ​

(Level 1)

  ​ ​ ​

(Level 2)

  ​ ​ ​

(Level 3)

  ​ ​ ​

2025

Liabilities

  ​ ​ ​

​

  ​

  ​ ​ ​

​

  ​

  ​ ​ ​

​

  ​

  ​ ​ ​

​

  ​

Warrants (Note 14)

​

$

—

​

$

—

​

$

5,624

​

$

5,624

Contingent consideration (Note 5)

​

 

—

​

 

—

​

 

1,811

​

 

1,811

Total Liabilities

​

$

—

​

$

—

​

$

7,435

​

$

7,435

​

Changes in Level 3 derivative liabilities, including conversion features embedded in convertible debt and warrants, measured at fair value on a recurring basis as of September 30, 2026 and December 31, 2025 are as follows:

​

​

​

​

​

​

​

​

​

​

Warrant and Derivative

​

​

Liability

​

​

September 30,

​

December 31,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Balance

​

$

5,624

​

$

6,657

Purchases, issuances, sales, and settlements:

​

 

  ​

​

 

  ​

Derivative - conversion feature embedded in convertible debt

​

 

—

​

 

(393)

Warrants exercised

​

 

—

​

 

(104)

Unrealized losses (gains) included in earnings related to investments still held as of reporting date

​

 

9,293

​

 

(536)

Balance

​

$

14,917

​

$

5,624

​

Unrealized gains and losses are reported as interest expense in the unaudited condensed consolidated statements of operations.

Both observable and unobservable inputs may be used to determine the fair value of positions classified as a Level 3 liability. As a result, the unrealized gains and losses for this liability presented in the tables above may include changes in fair value that were attributable to both observable and unobservable inputs.

F-64

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

Changes in Level 3 contingent consideration liability, measured at fair value on a recurring basis as of September 30, 2026 and December 31, 2025 are as follows:

​

​

​

​

​

​

​

​

​

​

Contingent Consideration

​

​

Liability

​

​

September 30,

​

December 31,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Balance

​

$

1,811

​

$

1,413

Changes in fair value recognized in earnings

​

 

958

​

 

748

Payments and settlements

​

 

—

​

 

(350)

Balance

​

$

2,769

​

$

1,811

​

Changes in the fair value of the contingent consideration liability are recognized in Interest expense, change in fair value, and amortization of debt discount in the unaudited condensed consolidated statements of operations. There were no transfers into or out of Level 3 during the periods presented.

16.

Fair Value of Financial Instruments

The fair value of a financial instrument is the current amount that would be exchanged between willing parties, other than in a forced liquidation. Fair value is best determined based upon quoted market prices; however, in many instances, there are no quoted market prices for the Company’s various financial instruments. In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. Accordingly, the fair value estimates may not be realized in an immediate settlement of the instrument. Fair value accounting standards exclude certain financial instruments and all non financial instruments from their disclosure requirements. Accordingly, the aggregate fair value amounts presented may not necessarily represent the underlying fair value of the Company.

The Company’s financial instruments consist of cash and cash equivalents, restricted cash, accounts receivable, unbilled accounts receivable, deposits, notes receivables, accounts payable, credit card payable, deferred revenue, debt, warrant liabilities, and, for the prior period, convertible debt and an embedded derivative liability.

The Company’s financial assets include cash and cash equivalents, current and noncurrent restricted cash, accounts receivable, unbilled accounts receivable, notes receivables and noncurrent deposits. The Company’s financial liabilities include accounts payable, credit card payable, deferred revenue, current and noncurrent portions of debt, noncurrent warrant liabilities and, for prior periods, current and noncurrent portions of convertible debt and the associated derivative liability related to the embedded conversion feature.

For all instruments outstanding as of September 30, 2026 and December 31, 2025, the Company concluded that the estimated fair value of its financial assets and financial liabilities approximated their respective carrying amounts.

17.

Income Taxes

Income tax expense during interim periods is based on applying an estimated annual effective income tax rate to year-to-date ordinary income or loss, plus any significant unusual or infrequently occurring items which are recorded in the interim period. The provision for income taxes for the nine months ended September 30, 2026, and September 30, 2025 is zero and differs from the amount that would be provided by applying the statutory U.S. federal income tax rate of 21% to pre-tax loss primarily due to the change in valuation allowance.

The computation of the annual estimated effective tax rate at each interim period requires certain estimates and significant judgment including, but not limited to, the expected operating income for the year, and permanent differences. The accounting estimates used to compute the provision for income taxes may change as new events occur, more experience is obtained, additional information becomes known or as the tax environment changes.

F-65

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

The deferred tax assets are comprised primarily of net operating loss carry forwards. As of September 30, 2026 and September 30, 2025, the deferred tax assets continue to be subject to a full valuation allowance. The company maintains the valuation allowance based on the analysis of its cumulative loss position.

On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (“OBBBA”). The OBBBA makes permanent key elements of the Tax Cuts and Jobs Act, including 100% bonus depreciation, domestic research cost expensing, and the business interest expense limitation. ASC 740, “Income Taxes”, requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which the legislation is enacted. The Company has completed its initial assessment of the OBBBA corporate tax provisions which were enacted on July 4, 2025 and concluded that there would be no impact to its effective tax rate.

​

18.

Earnings (Loss) Per Common Share

Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share adjusts basic earnings per share for the potentially dilutive impact of stock options. As the Company has reported a loss for the nine months ended September 30, 2026 and 2025, potentially dilutive securities are antidilutive and accordingly, basic net loss per share equals diluted net loss per share.

​

The following table sets forth the computation of basic and diluted loss per share for the three and nine months ended September 30, 2026 and 2025:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended

​

Nine months ended

​

​

September 30,

​

September 30,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Numerator:

​

  ​

​

​

  ​

​

​

  ​

​

​

  ​

​

Net Loss

​

$

(11,954)

​

$

(11,747)

​

$

(44,504)

​

$

(33,669)

Denominator:

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

Weighted average common shares outstanding

​

 

1,701,536

​

 

1,546,401

​

 

1,597,987

​

 

1,543,975

Denominator for basic and diluted loss per share

​

 

1,701,536

​

 

1,546,401

​

 

1,597,987

​

 

1,543,975

Basic and diluted loss per share

​

$

(7.03)

​

$

(7.60)

​

$

(27.85)

​

$

(21.81)

​

Basic and diluted earnings per share was the same for each period presented as the inclusion of all potential Common Stock outstanding would have been anti-dilutive.

Per ASC 260, shares issuable for little to no consideration (“Penny Warrants”) should be included in the number of outstanding shares used for Basic EPS. As of September 30, 2026 and 2025, the Company included 65,430 warrants in the denominator of Basic EPS since the exercise price was $0.01 per share thus are considered Penny Warrants.

The following table presents the potential common stock outstanding that was excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Three months ended

​

Nine months ended

​

​

September 30,

​

September 30,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Warrants

​

250,352

​

483,247

​

250,352

​

483,247

Restricted shares

 

1,547

 

7,733

 

1,547

 

7,733

Options

 

536,273

 

458,975

 

544,773

 

458,975

​

 

788,172

 

949,955

 

796,672

 

949,955

​

​

F-66

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

19.

Segment Reporting

The Company’s CODM has been identified as the Chief Executive Officer (“CEO”) and the Chief Financial Officer (“CFO”) who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has identified the Company’s reportable segments as:

●Tool Manufacturing & Related Services - Production of industrial tools and provision of maintenance services.
●Coating Services - Application of specialized coatings for industrial components.
●Battery Manufacturing - Manufacture of advanced batteries for automotive and energy storage applications.

Segment profit or loss is measured as gross profit (loss), which is defined as revenue less cost of sales. This is the primary measure reviewed by the CODM to evaluate segment performance. Segment measures exclude interest, income taxes, and other non-operating or nonrecurring items. Operating expenses, including general and administrative and research and development expenses, are managed on a consolidated basis and are not allocated to segments.

For financial reporting purposes, the Company presents disaggregated financial information for three reportable segments based on the nature of its products and services:

●Tool Manufacturing & Related Services
●Coating Services
●Battery Manufacturing

Revenue by reportable segment is based on the nature of the Company’s products and services. Tool Manufacturing & Related Services revenue primarily relates to the sale of ALD equipment and related maintenance services. Coating Services revenue relates to project-based coating applications. Battery Manufacturing revenue relates to the production and sale of advanced battery products.

Segment Identification

These segments represent components of the business that meet the definition of operating segments under ASC 280-10-50-1, as discrete financial information is available and regularly reviewed by the CODM.

Performance Measure

Segment profit (loss) is measured as gross profit (loss), which is defined as segment revenue less cost of sales. This is the sole measure provided to the CODM to evaluate trends, segment performance and margin characteristics across product and service offerings.

Segment Assets

Although asset information by segment is available, it is not regularly provided to or reviewed by the CODM for purposes of assessing performance or allocating resources.

F-67

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

Significant Segment Expenses

The CODM regularly reviews cost of sales at the segment level, which represents the only significant segment expense disclosed.

No other expense categories (including general and administrative expenses, research and development, or other operating expenses) are provided to or regularly reviewed by the CODM at the segment level.

Segment performance is therefore evaluated based on gross profit (loss), and operating expenses are managed and evaluated on a consolidated basis.

Corporate and other unallocated amounts included in the reconciliation consist primarily of general and administrative expenses, research and development expenses, and other operating expenses that are not allocated to the reportable segments, as well as interest income, interest expense, and income taxes.

Revenues by geographic region consisted of the following for the three and nine months ended September 30, 2026 and 2025:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended

​

Nine months ended

​

​

September 30,

​

September 30,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

US

​

$

1,449

​

$

1,508

​

$

3,149

​

$

4,080

Canada

 

​

182

 

​

2

 

​

498

 

​

21

EMEA

 

​

327

 

​

228

 

​

688

 

​

482

APAC

 

​

8

 

​

267

 

​

1,732

 

​

744

Total

​

$

1,966

​

$

2,005

​

$

6,067

​

$

5,327

​

Revenues by reportable segment consisted of the following for the three and nine months ended September 30, 2026 and 2025:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended

​

Nine months ended

​

​

September 30,

​

September 30,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Tool manufacturing & related services

​

$

1,044

​

$

944

​

$

4,180

​

$

3,107

Coating services

​

 

358

​

 

296

​

 

972

​

 

1,067

Battery manufacturing

​

 

564

​

 

765

​

 

915

​

 

1,153

Total

​

$

1,966

​

$

2,005

​

$

6,067

​

$

5,327

​

Segment revenue, cost of sales, and gross (loss) profit are as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended September 30, 2026

​

Three months ended September 30, 2025

​

​

Tool

​

​

​

​

​

​

​

​

​

​

Tool

​

​

​

​

​

​

​

​

​

​

​

Manufacturing

​

​

​

​

​

​

​

​

​

​

Manufacturing

​

​

​

​

​

​

​

​

​

​

​

& Related

​

Coating

​

Battery

​

​

​

​

& Related

​

Coating

​

Battery

​

​

​

​

  ​ ​ ​

Services

  ​ ​ ​

Services

  ​ ​ ​

Manufacturing

  ​ ​ ​

Total

  ​ ​ ​

Services

  ​ ​ ​

Services

  ​ ​ ​

Manufacturing

  ​ ​ ​

Total

Total revenue

​

$

1,044

​

$

358

​

$

564

​

$

1,966

​

$

944

​

$

296

​

$

765

​

$

2,005

Cost of sales

​

 

(2,294)

​

 

(1,255)

​

 

(355)

​

 

(3,904)

​

 

(1,255)

​

 

(957)

​

 

(879)

​

 

(3,091)

Gross (loss) profit

​

$

(1,250)

​

$

(897)

​

$

209

​

$

(1,938)

​

$

(311)

​

$

(661)

​

$

(114)

​

$

(1,086)

​

F-68

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Nine months ended September 30, 2026

​

Nine months ended September 30, 2025

​

​

Tool

​

​

​

​

​

​

​

​

​

​

Tool

​

​

​

​

​

​

​

​

​

​

​

Manufacturing

​

​

​

​

​

​

​

​

​

​

Manufacturing

​

​

​

​

​

​

​

​

​

​

​

& Related

​

Coating

​

Battery

​

​

​

​

& Related

​

Coating

​

Battery

​

​

​

​

  ​ ​ ​

Services

  ​ ​ ​

Services

  ​ ​ ​

Manufacturing

  ​ ​ ​

Total

  ​ ​ ​

Services

  ​ ​ ​

Services

  ​ ​ ​

Manufacturing

  ​ ​ ​

Total

Total revenue

​

$

4,180

​

$

972

​

$

915

​

$

6,067

​

$

3,107

​

$

1,067

​

$

1,153

​

$

5,327

Cost of sales

​

 

(6,688)

​

 

(3,921)

​

 

(494)

​

 

(11,103)

​

 

(3,699)

​

 

(2,838)

​

 

(1,040)

​

 

(7,577)

Gross (loss) profit

​

$

(2,508)

​

$

(2,949)

​

$

421

​

$

(5,036)

​

$

(592)

​

$

(1,771)

​

$

113

​

$

(2,250)

​

The following table presents a reconciliation of segment results to consolidated results for the three and nine months ended September 30, 2026 and 2025.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended

​

Nine months ended

​

​

September 30,

​

September 30,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Segment gross profit

​

$

(1,938)

​

$

(1,086)

​

$

(5,036)

​

$

(2,250)

General and administrative

​

 

11,028

​

 

12,438

​

 

31,582

​

 

30,409

Operating loss

​

 

(12,966)

​

 

(13,524)

​

 

(36,618)

​

 

(32,659)

Interest income

​

 

181

​

 

198

​

 

401

​

 

548

Grant income

​

 

896

​

 

2,735

​

 

2,715

​

 

6,153

Other income

​

 

138

​

 

695

​

 

208

​

 

703

Interest expense, change in fair value, and amortization of debt discount

​

 

(194)

​

 

(1,973)

​

 

(11,182)

​

 

(8,385)

Other expense

​

 

(9)

​

 

122

​

 

(28)

​

 

(29)

Nonoperating Income (Expense)

​

 

1,012

​

 

1,777

​

 

(7,886)

​

 

(1,010)

Net loss

​

$

(11,954)

​

$

(11,747)

​

$

(44,504)

​

$

(33,669)

​

​

20.Subsequent Events

​

Management concluded that no subsequent events requiring recognition or additional disclosure in the unaudited condensed consolidated financial statements occurred, other than as disclosed below or elsewhere within these notes.

Business Combination

On October 22, 2026, the Company completed the Business Combination (see Note 2). Pubco is the parent of Merger Sub II, the surviving company in the Second Company Merger. Pubco’s common stock and warrants began trading on Nasdaq on October 22, 2026.

In connection with the consummation of the Business Combination, Pubco:

(1)issued an aggregate of 128,655,585 shares of its common stock, par value $0.0001 per share (the “Pubco Common Stock”), consisting of:
●7,370,932 shares of Pubco Common Stock issued to the holders of ATII ordinary shares (after giving effect to the redemptions);
●116,015,828 shares of Pubco Common Stock issued to the former stockholders of the Company;
●5,268,825 shares of Pubco Common Stock issued in connection with the PIPE Financing;
(2)issued 90,000,000 shares of Pubco Common Stock to the escrow agent;
(3)issued 11,919,995 warrants in exchange for ATII warrants;

F-69

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

(Unaudited)

​

(4)issued warrants exercisable for up to 15,000,000 shares of Pubco Common Stock at $10.00 per share and Pre-Funded Warrants exercisable for up to 7,031,175 shares of Pubco Common Stock at $0.0001 per share in the PIPE Financing;
(5)issued or assumed options and warrants of the Company that collectively are exercisable for 15,954,561 shares of Pubco Common Stock; and
(6)granted an aggregate of 8,744,864 Performance Stock Units (“PSUs”) which will vest as follows: (i) one third of the PSUs will vest if the VWAP of the Pubco Common Stock equals or exceeds $15.00 per share over any 30-trading day period or the revenue of Pubco for the preceding twelve months equals or exceeds $400,000,000, (ii) one third of the PSUs will vest if the VWAP of the Pubco Common Stock equals or exceeds $20.00 per share over any 30-trading day period or the revenue of Pubco for the preceding twelve months equals or exceeds $600,000,000 and (iii) one third of the PSUs will vest if the VWAP of the Pubco Common Stock equals or exceeds $25.00 per share over any 30-trading day period or the revenue of Pubco for the preceding twelve months equals or exceeds $800,000,000.

PIPE Financing

In connection with the Business Combination, Pubco entered into subscription agreements with aggregate gross proceeds of $123,000, which were received in October 2026 in connection with the closing of the Business Combination (the “PIPE Financing”).

Repayment of OIC Loan and Exercise of Warrants

On October 20, 2026, the Company repaid the OIC loan in full with a payment of $10,546 (see Note 12). The warrants issued to OIC in connection with the loan are exercisable only during the 30 calendar days following repayment date. As a result of the October 20, 2026 repayment, the exercise period ends on November 21, 2026 (See Note 14).

In connection with the closing of the Business Combination, OIC exercised all of their outstanding warrants of the Company in exchange for shares of common, which were converted into shares of Pubco Common Stock and are included in the 116,015,828 shares of Pubco Common Stock issued to former stockholders of the Company, as described above.

Acquisition of HzO, Inc.

On November 4, 2026, Pubco completed the acquisition of HzO, Inc. (the “HzO Acquisition”). In connection with the HzO Acquisition, Pubco issued 5,772,645 shares of Pubco Common Stock with an additional 1,533,795 shares of Pubco Common Stock to be held back for twelve months to secure post closing adjustment and indemnification obligations (the “Holdback Shares”). Of the shares issued in connection with the HzO Acquisition, 2,168,979 shares were issued in exchange for the shares of Pubco Common Stock held by HzO prior to completion of the HzO Acquisition. Upon completion of the HzO Acquisition assuming the full issuance of the Holdback Shares, HzO stockholders would own 7,306,440 shares of Pubco Common Stock.

​

​

F-70

Table of Contents

​

Report of Independent Registered Public Accounting Firm

To the Shareholders and the Board of Directors
Forge Nano, Inc. and Subsidiary

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Forge Nano, Inc. and Subsidiary (the Company) as of December 31, 2025 and 2024, the related consolidated statements of operations, mezzanine equity and stockholders’ deficit and cash flows for the years then ended, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2025 and 2024, and the consolidated results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

Going Concern Uncertainty

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company has suffered recurring losses from operations and negative operating cash flows that raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ Baker Tilly US, LLP

Denver, Colorado
May 5, 2026

We have served as the Company’s auditor since 2023.

​

F-71

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

As of December 31, 2025 and 2024

(All amounts in thousands, except share, per share and par values)

​

​

​

​

​

​

​

​

​

  ​ ​ ​

December 31,

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Assets

 

​

​

​

​

  ​

Current Assets

 

​

​

​

​

  ​

Cash and cash equivalents

​

$

9,061

​

$

3,850

Restricted cash and cash equivalents

​

​

313

​

​

—

Accounts receivable - net of allowance for credit losses of $40 and $33 as of December 31, 2025 and December 31, 2024, respectively

​

 

1,963

​

 

1,619

Contract assets - unbilled accounts receivable

​

 

6,586

​

 

3,660

Inventory

​

 

3,665

​

 

2,573

Prepaid expenses and other current assets

​

 

1,607

​

 

1,063

Total current assets

​

 

23,195

​

 

12,765

Property and equipment - net

​

 

14,652

​

 

16,592

Goodwill

​

 

3,124

​

 

3,124

Intangible assets - net

​

 

1,589

​

 

1,792

Restricted cash and cash equivalents

​

 

55

​

 

8,388

Right-of-use operating lease assets

​

 

65,087

​

 

2,636

Deposits

​

 

2,922

​

 

5,189

Total other assets

​

 

87,429

​

 

37,721

Total Assets

​

$

110,624

​

$

50,486

Liabilities, Mezzanine Equity, and Stockholders’ Deficit

​

 

  ​

​

 

  ​

Current Liabilities

​

 

  ​

​

 

  ​

Accounts payable

​

$

4,332

​

$

3,952

Current portion of operating lease liabilities

​

 

1,287

​

 

470

Contract liabilities – deferred revenue

​

 

3,126

​

 

3,012

Provision for loss on contract

​

 

504

​

 

—

Accrued and other current liabilities

​

 

3,027

​

 

3,008

Convertible debt – net of discount

​

 

—

​

 

1,627

Due to Sundew Technologies, LLC – current

​

 

1,811

​

 

1,413

Current portion of debt – net of discount

​

 

10,366

​

 

17,071

Total Current Liabilities

​

 

24,453

​

 

30,553

Operating lease liabilities

​

 

63,163

​

 

2,335

Derivative liability - conversion feature embedded in convertible debt

​

 

—

​

 

393

Warrant liabilities

​

 

5,624

​

 

6,264

Total Liabilities

​

 

93,240

​

 

39,545

Commitments and contingencies

​

 

  ​

​

 

  ​

Mezzanine Equity

​

 

  ​

​

 

  ​

Preferred stock - $0.0001 par value; 4,663,753 and 1,931,849 shares authorized and 1,925,348 and 1,676,528 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively.

​

 

—

​

 

—

Additional paid-in capital

​

 

136,538

​

 

88,347

Stockholders’ Deficit

​

 

  ​

​

 

  ​

Common stock - $0.0001 par value; 4,850,000 and 4,550,000 shares authorized and 1,648,841 and 1,643,081 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively.

​

 

—

​

 

—

Additional paid-in capital

​

 

9,934

​

 

8,508

Accumulated deficit

​

 

(129,088)

​

 

(85,914)

Total Stockholders’ Deficit

​

 

(119,154)

​

 

(77,406)

Total Liabilities, Mezzanine Equity, and Stockholders’ Deficit

​

$

110,624

​

$

50,486

​

The accompanying notes are an integral part of these consolidated financial statements.

F-72

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

For the Years Ended December 31, 2025 and 2024

(All amounts in thousands, except share, per share and per share values)

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Years ended December 31,

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Net Sales

​

​

​

​

​

​

Tool manufacturing and related services

​

$

4,625

​

$

6,852

Coating services

​

 

1,429

​

 

1,332

Battery manufacturing

​

 

1,334

​

 

115

Total Net Sales

​

 

7,388

​

 

8,299

Cost of Sales

​

 

  ​

​

 

  ​

Tool manufacturing and related services

​

 

6,239

​

 

5,441

Coating services

​

 

3,921

​

 

2,486

Battery manufacturing

​

 

1,085

​

 

40

Total Cost of Sales

​

 

11,245

​

 

7,967

Gross (Loss) Profit

​

 

(3,857)

​

 

332

Operating Expenses

​

 

  ​

​

 

  ​

General and administrative

​

 

40,788

​

 

27,474

Total Operating Expenses

​

 

40,788

​

 

27,474

Operating Loss

​

 

(44,645)

​

 

(27,142)

Nonoperating Income (Expense)

​

 

  ​

​

 

  ​

Interest income

​

 

637

​

 

1,053

Grant income

​

 

7,062

​

 

2,306

Other income

​

 

865

​

 

263

Interest expense, change in fair value, and amortization of debt discount

​

 

(6,515)

​

 

(3,439)

Other expense

​

 

(578)

​

 

(25)

Total Nonoperating Expense

​

 

1,471

​

 

158

Net Loss

​

$

(43,174)

​

$

(26,984)

Net Loss Per Share, Basic and Diluted

​

$

(27.94)

​

$

(17.70)

Weighted-Average Shares Outstanding, Basic and Diluted

​

 

1,545,163

​

 

1,524,640

​

The accompanying notes are an integral part of these consolidated financial statements.

​

​

F-73

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT

For the Years Ended December 31, 2025 and 2024

(All amounts in thousands, except share and par values)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Years Ended December 31, 2025

​

​

  ​ ​ ​

  ​ ​ ​

Additional

​

​

​

  ​ ​ ​

​

​

  ​ ​ ​

Additional

  ​ ​ ​

​

​

  ​ ​ ​

​

​

​

​

Preferred Stock

​

Paid-In

​

​

Common Stock

​

Paid-In

​

Accumulated

​

​

​

​

​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Capital

  ​

  ​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Capital

  ​ ​ ​

Deficit

  ​ ​ ​

Total

Balance – January 1, 2025

 

1,676,528

​

$

—

​

$

88,347

​

​

1,643,081

​

$

—

​

$

8,508

​

$

(85,914)

​

$

(77,406)

Stock-based compensation expense

 

—

​

 

—

​

 

—

​

​

—

​

 

—

​

 

851

​

 

—

​

 

851

Issuance of common stock – board of directors compensation

 

—

​

 

—

​

 

—

​

​

5,300

​

 

—

​

 

572

​

 

—

​

 

572

Issuance of Series D preferred stock

​

229,006

​

​

—

​

​

45,131

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

Issuance of Series D preferred stock resulting from debt conversion

​

19,814

​

​

—

​

​

3,905

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

Options exercised

 

—

​

 

—

​

 

—

​

​

460

​

 

—

​

 

3

​

 

—

​

 

3

Series D preferred stock issuance costs

​

—

​

​

—

​

​

(845)

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

Net loss

 

—

​

 

—

​

 

—

​

​

—

​

 

—

​

 

—

​

 

(43,174)

​

 

(43,174)

Balance – December 31, 2025

 

1,925,348

​

$

—

​

$

136,538

​

​

1,648,841

​

$

—

​

$

9,934

​

$

(129,088)

​

$

(119,154)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Years Ended December 31, 2024

​

​

  ​ ​ ​

  ​ ​ ​

Additional

​

​

​

  ​ ​ ​

​

​

  ​ ​ ​

Additional

  ​ ​ ​

​

​

  ​ ​ ​

​

​

​

​

Preferred Stock

​

Paid-In

​

​

Common Stock

​

Paid-In

​

Accumulated

​

​

​

​

​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Capital

  ​

  ​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Capital

  ​ ​ ​

Deficit

  ​ ​ ​

Total

Balance – January 1, 2024

 

1,594,215

​

$

—

​

$

82,150

​

​

1,617,673

​

$

—

​

$

7,254

​

$

(58,930)

​

$

(51,676)

Stock-based compensation expense

 

—

​

 

—

​

 

—

​

​

—

​

 

—

​

 

620

​

 

—

​

 

620

Issuance of common stock - board of directors compensation

 

—

​

 

—

​

 

—

​

​

10,600

​

 

—

​

 

400

​

 

—

​

 

400

Issuance of Series C preferred stock

 

82,313

​

 

—

​

 

6,290

​

​

—

​

 

—

​

 

—

​

 

—

​

 

—

Warrants exercised

 

—

​

 

—

​

 

918

​

​

14,808

​

 

—

​

 

234

​

 

—

​

 

234

Series C preferred stock issuance costs

 

—

​

 

—

​

 

(1,011)

​

​

—

​

 

—

​

 

—

​

 

—

​

 

—

Net loss

 

—

​

 

—

​

 

—

​

​

—

​

 

—

​

 

—

​

 

(26,984)

​

 

(26,984)

Balance – December 31, 2024

 

1,676,528

​

$

—

​

$

88,347

​

​

1,643,081

​

$

—

​

$

8,508

​

$

(85,914)

​

$

(77,406)

​

The accompanying notes are an integral part of these consolidated financial statements.

​

F-74

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Years Ended December 31, 2025 and 2024

(All amounts in thousands)

​

​

​

​

​

​

​

​

  ​ ​ ​

Years ended December 31,

​

​

2025

​

2024

Cash Flows from Operating Activities

 

​

​

​

​

  ​

Net loss

​

$

(43,174)

​

$

(26,984)

Adjustments to reconcile net loss to net cash, cash equivalents, and restricted cash used in operating activities:

​

 

​

​

 

  ​

Depreciation and amortization

​

 

2,822

​

 

1,354

Gain/(loss) on reversal of provision for loss on contract

​

 

504

​

 

(2)

Amortization of debt discount

​

 

2,859

​

 

2,963

Loss on extinguishment of debt

​

​

3,841

​

​

—

Change in fair value of contingent consideration for Sundew ALD acquisition

​

 

748

​

 

811

Noncash interest expense

​

 

0

​

 

17

Change in fair value of warrant liabilities

​

 

(640)

​

 

366

Amortization of noncash lease expense

​

 

2,315

​

 

429

Amortization of intangible assets

​

 

203

​

 

253

Stock-based compensation

​

 

851

​

 

620

Board of directors’ stock-based compensation

​

 

572

​

 

400

Changes in operating assets and liabilities (used in) provided by cash, cash equivalents, and restricted cash:

​

 

  ​

​

 

  ​

Accounts receivable

​

 

(344)

​

 

944

Contract assets - unbilled accounts receivable

​

 

(2,926)

​

 

(2,643)

Inventory

​

 

(1,092)

​

 

(150)

Prepaid expenses and other current assets

​

 

(544)

​

 

(157)

Deposits

​

 

(3,420)

​

 

(2,964)

Accounts payable

​

 

380

​

 

1,175

Contract liabilities – deferred revenue

​

 

114

​

 

369

Accrued and other current liabilities

​

 

19

​

 

(209)

Operating lease liabilities

​

 

2,566

​

 

(364)

Net cash, cash equivalents, and restricted cash used in operating activities

​

 

(34,346)

​

 

(23,772)

Cash Flows from Investing Activities

​

 

  ​

​

 

  ​

Purchase of property and equipment

​

 

(882)

​

 

(12,553)

Net cash, cash equivalents, and restricted cash used in investing activities

​

 

(882)

​

 

(12,553)

Cash Flows from Financing Activities

​

 

  ​

​

 

  ​

Cash paid on principal of debt

​

​

(7,512)

​

​

—

Series D funding issuance costs

​

​

(845)

​

​

—

Series C preferred stock issuance costs

​

​

—

​

​

(1,011)

Cash paid for acquisition (Note 8)

​

​

(350)

​

​

(350)

Proceeds from issuance of Series C preferred stock

​

 

—

​

 

6,290

Proceeds from issuance of Series D convertible note

​

 

1,150

​

 

1,924

Proceeds from issuance of Series D preferred stock

​

​

39,973

​

​

​

Proceeds from warrants exercised

​

 

—

​

 

234

Proceeds from options exercised

​

 

3

​

 

—

Net cash, cash equivalents, and restricted cash provided by financing activities

​

 

32,419

​

 

7,087

Net Decrease in Cash, Cash Equivalents, and Restricted Cash

​

 

(2,809)

​

 

(29,238)

Cash, Cash Equivalents, and Restricted Cash - Beginning of the year

​

 

12,238

​

 

41,476

Cash, Cash Equivalents, and Restricted Cash - End of the year

​

$

9,429

​

$

12,238

Supplemental Disclosure of Noncash Investing and Financing Transactions

​

 

  ​

​

 

  ​

Derivative liability recognized in connection with the issuance of convertible note

​

$

—

​

$

393

Non-cash portion of warrant exercise

​

 

104

​

 

918

Lease liabilities arising from obtaining right-of-use assets

​

 

59,079

​

 

—

Non-cash portion of conversion of convertible debt to Series D preferred stock

​

 

2,755

​

 

—

Fair value of Series D preferred stock in exchange for warrant exercise

​

 

3,158

​

 

—

Fair value of Series D preferred stock in exchange for debt forgiveness

​

 

2,000

​

 

—

​

The accompanying notes are an integral part of these consolidated financial statements.

​

​

F-75

Table of Contents

​

FORGE NANO, INC. AND SUBSIDIARY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except share, per share and stated value per share)

1.

Nature of Business

Forge Nano, Inc. and Subsidiary (the “Company”) was formed on September 1, 2011 under the name PneumatiCoat Technologies LLC. In 2018, the Company changed its name to Forge Nano, Inc. The Company offers commercially viable surface engineering and precision nano-coating technology for a wide range of materials, applications, and industries.

This engineering process, formally known as atomic layer deposition (ALD), has been employed in the semi conductor space for more than a decade to enhance materials used to manufacture better-performing products. The technology developed by the Company allows the application to surfaces and powders, as well as to the wafers used by the semiconductor industry, in a fast and consistent process at a commercial scale.

Applying ALD to the components required for lithium-ion battery manufacturing produces substantial performance and safety improvements. The Company has focused on this industry for the past decade and has validated independently the performance benefits of batteries produced with ALD-coated components. The Company anticipates becoming a world leader in the provision of ALD equipment and corresponding services for this sector as electrification of economies advances.

​

2.

Significant Accounting Policies

Basis of Presentation

The consolidated financial statements of the Company have been prepared on the basis of generally accepted accounting principles of the United States of America (GAAP). The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the consolidated financial statements. Actual results could differ from those estimates.

Use of Estimates

The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Management periodically evaluates estimates used in the preparation of the consolidated financial statements for continued reasonableness. Appropriate adjustments, if any, to estimates are made prospectively based upon such periodic evaluations. It is reasonably possible that changes may occur in the near term that would affect management’s estimates with respect to revenue recognition, estimates of cost to complete contracts, allowance for credit losses, share-based payments, accrued expenses, inventory, deferred taxes, property and equipment and valuation of assets acquired in business combinations.

Reclassification of Previously Issued Presentation

Certain amounts from previously issued financial statements have been reclassified to ensure consistency with the current year’s presentation. These reclassifications did not affect the reported results of operations.

Going Concern

The Company’s consolidated financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company demonstrates adverse conditions that raise substantial doubt about the Company’s ability to continue as a going concern for one year following the issuance of these consolidated financial statements. These adverse conditions are negative financial trends, specifically negative cash flow from operations, minimal revenues, and reoccurring net losses.

During the years ended December 31, 2025 and 2024, the Company incurred net losses in the amount of $43,174 and $26,984, respectively, and generated negative cash flows from operations in the amounts of $34,346 and $23,772, respectively. Additionally, as of December 31, 2025, the Company had an accumulated deficit in the amount of $129,088 and cash and cash equivalents of $9.061

F-76

Table of Contents

​

million. Based on current liquidity, historical operating losses, negative operating cash flows, and forecasted expenditures as of December 31, 2025, the Company’s current forecast of operating results and cash flows, combined with the effect of the financing transactions discussed above, management determined that there is substantial doubt about the Company’s ability to continue as a going concern over the twelve months following the date these financial statements are issued. As a result, the Company may require additional liquidity to continue its operations over the next twelve months.

It should be noted that, as described in Subsequent Events, the Company is taking suitable steps to secure that liquidity.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and all of its wholly owned and majority- owned subsidiaries. All material intercompany accounts and transactions have been eliminated in consolidation.

Cash, Cash Equivalents and Restricted Cash

The Company considers all investments with an original maturity of three months or less when purchased to be cash equivalents. The Company continually monitors its positions with, and the credit quality of, the financial institution with which it invests. As of the balance sheet date and periodically throughout the year, the Company maintained balances with a financial institution in excess of the amount insured by the Federal Deposit Insurance Corporation (FDIC). The total amount of bank deposits (checking and savings accounts) that was insured by the FDIC at year end was $250 at each institution.

Restricted cash consists of cash balances that are restricted as to withdrawal or usage and includes cash to collateralize a bank line of credit related primarily to customer deposits for new projects. The Company has two restricted cash accounts with a combined balance of $368 and $8,388 as of December 31, 2025 and 2024, respectively. Cash, cash equivalents, and restricted cash as of December 31, 2025 and 2024 were as follows:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Cash and cash equivalents

​

$

9,061

​

$

3,850

Restricted cash

​

 

368

​

 

8,388

Total

​

$

9,429

​

$

12,238

​

While the Company maintains cash in excess of FDIC coverage, it intends to diversify its holdings to leverage such coverage. The carrying amount reported in the balance sheet for cash and cash equivalents approximates fair value due to the short-term nature of these investments.

Accounts Receivable

Accounts receivable are stated at net invoice amounts. An allowance for credit losses is established for amounts expected to be uncollectible over the contractual life of the receivables. The Company collectively evaluates accounts receivable to determine the allowance for credit losses based on its historical bad debt expense and benchmarking of the allowances of comparable public companies. The Company calculates the allowance as 2 percent of total accounts receivable on a monthly basis, with an additional allowance added as needed based on a case-by-case analysis of accounts receivable. Uncollectible amounts are written of against the allowance for credit losses in the period they are determined to be uncollectible. Recoveries of amounts previously written off are recognized when received.

Three customers accounted for 65 percent and five customers accounted for 60 percent of net accounts receivable as of December 31, 2025 and 2024, respectively.

Unbilled Receivables

The Company recognizes revenue over time. Unbilled receivables balance represent amounts that have been earned but are not yet billed.

F-77

Table of Contents

​

Inventory

Inventory consists of raw materials and work in progress and is stated at the lower of cost or net realizable value, with cost determined using the average cost method.

Property and Equipment

Property and equipment are recorded at cost or at fair value when acquired as part of a business combination. The straight-line method is used for computing depreciation and amortization and recorded within cost of sales. Assets are depreciated over their estimated useful lives. The cost of leasehold improvements is depreciated (amortized) over the lesser of the length of the related leases or the estimated useful lives of the assets. Costs of maintenance and repairs are charged to expense when incurred.

Leases

The Company has operating leases for building and office rentals. The Company determines if an arrangement is a lease, or contains a lease, at the inception of the arrangement. The Company recognizes expense for operating leases on a straight-line basis over the lease term. The Company elected to include both lease and non lease components as a single component for operating leases. The Company elected to account for leases with a lease term of one year or less as short-term leases. Short-term leases are not included in the right-of-use asset and lease liability. The Company has no short term leases as of December 31, 2025 and 2024.

The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The Company uses the implicit interest rate in the lease when readily determinable.

Intangible Assets

Acquired intangible assets subject to amortization are stated at cost and are amortized using the straight line method over the estimated useful lives of the assets. Intangible assets that are subject to amortization are reviewed for potential impairment whenever events or circumstances indicate that carrying amounts may not be recoverable. Assets not subject to amortization are tested for impairment at least annually.

Goodwill

Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations. Goodwill is not amortized but is tested for impairment at least annually, or more frequently if events or changes in circumstances indicate potential impairment.

Goodwill is evaluated for impairment at the reporting unit level. A reporting unit is defined as an operating segment or one level below an operating segment.

The Company has identified three reporting units, which correspond to its operating and reportable segments:

●Tool Manufacturing and Related Services
●Coating Services
●Battery Manufacturing

This determination is based on the Company’s organizational structure, the availability of discrete financial information, and management’s regular review of such information in assessing performance and allocating resources.

The Company performs its annual impairment test during the fourth quarter and may first perform a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. In performing this assessment, the Company considers factors such as macroeconomic conditions, industry and market trends, cost factors, overall financial performance, and company-specific developments.

F-78

Table of Contents

​

If a quantitative assessment is required, the Company estimates the fair value of the reporting unit using valuation techniques consistent with the income and market approaches, which require significant judgment, including assumptions related to projected financial performance, discount rates, and long-term growth.

For the year ended December 31, 2025, the Company performed qualitative assessments for each reporting unit and concluded that it was more likely than not that the fair value of each reporting unit exceeded its carrying amount. Accordingly, no impairment was recognized.

As of December 31, 2025, goodwill totaled $3,124.

Goodwill is allocated to the Company’s reporting units as follows:

​

​

​

​

​

Reporting Unit

  ​ ​ ​

Goodwill

Tool Manufacturing & Related Services

​

$

900

Coating Services

​

 

2,224

Battery Manufacturing

​

 

—

Total

​

$

3,124

​

Derivative Financial Instruments

The Company accounts for derivative financial instruments in accordance with Accounting Standards Codification 815, Derivatives and Hedging (ASC 815), which establishes accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. ASC 815 requires that an entity recognize all derivatives as either assets or liabilities in the balance sheet and measure those instruments at fair value.

Reclassification of prior year amounts

Certain reclassifications have been made to the prior years’ financial statements to conform to the current year presentation. These reclassifications had no effect on previously reported results of operations or stockholders’ equity.

Subsequent Events

Management concluded that no subsequent events requiring recognition or additional disclosure in the consolidated financial statements occurred, other than those disclosed below.

Convertible Notes and Series D

On March 31, 2025, the initial close of the Series D financing was completed, with Rock Creek and Ascent Funds participating as lead investors. A total of approximately $42,000 was raised in this initial close. This amount included $2,000 from our credit partner, OIC Growth Funds, which retired $2,000 of outstanding debt, through the exercise of a portion of its paid-in warrants.

The Series D round remained open, as it had not yet reached its full $100,000 capacity, and Forge Nano continued to seek additional capital to extend its cash runway into 2026. During the fourth quarter of 2025, several smaller investors participated, including the Ed Smith Group with an investment of $2,000. In March 2026, an additional $15,000 investment was received from the HZO Investor Group. As of March 2026, the total capital raised in the Series D financing amounted to $62,846.

Forge Nano de-SPAC

In October 2025, Forge Nano initiated a process to identify an appropriate special purpose acquisition company (SPAC) as a potential merger partner to facilitate becoming a publicly traded entity. The transaction was pursued to secure additional capital to support Forge Nano’s growth across its battery and semiconductor business lines.

Archimedes Tech SPAC Partners II Co was selected in November 2025. The BCA was announced April 20, 2026. Since selection, the SPAC and Forge Nano have been working together to structure a private investment in public equity (PIPE) financing to provide committed capital for the transaction and has secured to date $100 million from a single investor. The PIPE capital raising

F-79

Table of Contents

​

efforts will continue. Although the SPAC holds $240,000 in its trust account, Forge Nano has assumed a 100% redemption rate, resulting in the PIPE serving as the primary source of financing.

Forge Battery Project Finance

Forge Battery received a term sheet from a suitable lender for a note up to $275,000 for the development of its facility and, in a Phase II development proposal, the development of an electrode line for ALD-coated battery components. As of July 17, 2026, the term sheet is under negotiation.

Revenue Recognition

Revenue is recognized upon the transfer of control of promised products and services in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. If the consideration promised in a contract includes a variable amount, the Company includes an estimate of the amount it expects to receive for the total transaction price if it is probable that a significant reversal of cumulative revenue recognized will not occur. The Company determines the amount of revenue to be recognized through the application of the following steps:

●Identification of the contract, or contracts, with a customer
●Identification of the performance obligations in the contract
●Determination of the transaction price
●Allocation of the transaction price to the performance obligations in the contract
●Recognition of revenue when or as the Company satisfies the performance obligations

Revenue is measured based upon input method and measured by the percentage of labor hours incurred to date compared to the estimated total labor hours for each contract. Of the total net revenue, two customers accounted for 25 percent, and two customers accounted for 27 percent as of December 31, 2025 and 2024, respectively.

For the majority of the Company’s contracts with customers, control and risk of loss is transferred throughout the development and manufacturing process of the agreed-upon goods for which the Company has been engaged to produce. As there is no alternative use for the product development the Company is performing and cancellation provisions result in an enforceable right to payment for the performance completed to date, revenue for these products is recognized over time. Revenue is recognized over time.

Contract costs include all direct material and labor costs and those indirect costs related to contract performance, including depreciation expense. Provisions for estimated losses on contracts in progress are made in the period in which such losses are determined. Selling, general, and administrative costs are charged as incurred.

The Company typically invoices its customers as work is engaged (deposit), completed, and accepted, as determined by the customer’s contract. Typical payment terms provide that customers pay within 30 days of invoice. Amounts that have been invoiced are recorded in accounts receivable and in either deferred revenue or revenue, depending on whether the revenue recognition criteria has been met. The Company occasionally experiences changes in the transaction price subsequent to the inception of the contract term. Variable consideration generally is composed of cost overages related to the contracted amount of time and effort to develop the products. The Company has determined to recognize this revenue in the month the change order is determined probable due to the overages being part of a series of distinct services that are satisfied over time.

In most cases, contracts are cancelable but require payment for performance to date. Therefore, at the time revenue is recognized, the Company does not estimate expected refunds for services, nor does it exclude any such amounts from revenue. The Company excludes from revenue all taxes assessed by a governmental authority that are imposed on the sale of its products and collected from customers.

F-80

Table of Contents

​

Included in unbilled receivables is revenue recognized for billings that have not been presented to customers. The Company has an unconditional right to collection of these receivables.

Deferred revenue primarily consists of billings in advance of revenue recognized. For all transactions in which there is a significant outstanding obligation, the associated revenue is recorded as a contract liability and recognized once such obligation is fulfilled. The Company records advance billings on a gross basis in deferred revenue and accounts receivable when an arrangement exists with a customer to bill and collect the receivable, even if services have not yet been performed.

The Company recognizes its services revenue (tolling) on a similar timeline as its equipment revenue. The revenue recognized is measured using the input method, and it is calculated using the percentage of tooling days incurred to date compared to the estimated total labor hours for each contract.

Government Grant

The Company recognizes government grants in accordance with Accounting Standards Codification 832, Government Assistance, analogous to International Accounting Standards 20, Accounting for Government Grants and Disclosure of Government Assistance (IAS 20).

Grant income is recognized when there is reasonable assurance that the Company has complied with the conditions of the grant and that the grant will be received.

Grants are recognized on a gross basis and are presented as other income within the consolidated statements of operations. Related costs associated with the grants are recorded within the applicable operating expense categories as incurred.

During the years ended December 31, 2025 and 2024, the Company received $7,062 and $2,305, respectively, in other grant proceeds for other projects that pertain to developing technology, proving technological concepts, and showcasing scalability.

Shipping and Handling Costs

The Company records shipping and handling costs for the delivery of finished goods as a cost of sales as they are incurred and are included in cost of sales in the consolidated statement of operations. Total shipping and handling costs for the years ended December 31, 2025 and 2024 were $214 and $227, respectively.

Advertising Expense

Advertising expense is charged to expense during the year in which it is incurred and are included in general and administrative expenses in the consolidated statement of operations. Advertising expense for the years ended December 31, 2025 and 2024 was $650 and $597, respectively.

Income Taxes

The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.

The Company recognizes deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that deferred tax assets would be realized in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.

F-81

Table of Contents

​

The Company records uncertain tax positions in accordance with Accounting Standards Codification 740, Income Taxes (ASC 740), on the basis of a two-step process whereby the Company (1) determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.

The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the accompanying consolidated statements of operations.

Research and Development

Research and development expenditures of approximately $11,928 and $3,589 were recognized as incurred and are included in general and administrative expenses during the years ended December 31, 2025 and 2024, respectively.

Product Warranties

The Company provides limited one-year repair or replacement warranties on all of its manufactured products. Warranty expense incurred for the years ended December 31, 2025 and 2024, was $(52) and $74, respectively, and are included in cost of sales. The Company recognizes warranty obligations at the time products are sold based on an estimated rate of 10 percent of revenue recognized on projects completed during the year for warranty claims and estimated current costs of repair or replacement. The accompanying consolidated financial statements include a liability included in accrued and other liabilities of $63 and $152, as of December 31, 2025 and 2024, respectively, for estimated warranty obligations.

Stock Options

The Company has one stock option plan (see Note 13). The Company estimates the fair value of stock based payment awards on the date of the grant using the Black-Scholes option-pricing model to account for employee and non employee stock compensation cost. Compensation costs are recognized on a straight-line basis over the requisite service period, which is generally the vesting period.

Earnings (Loss) Per share

The Company utilizes the guidance per ASC 260, Earnings per Share (ASC 260), and presents basic and diluted loss per common share amounts. Basic loss per common share is calculated by dividing net loss by the weighted average number of common shares outstanding during the applicable period. The denominator for diluted net loss per share is a computation of the weighted-average number of ordinary shares and the potential dilutive ordinary shares outstanding during the period. Potential dilutive shares outstanding include the dilutive effect of in-the-money options, unvested Restricted Stock Agreements (RSAs), and unvested Restricted Stock Units (RSUs) using the treasury stock method. In periods in which the Company reports a net loss, diluted net loss per share is generally the same as basic net loss per share since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive.

Segments

ASC Topic 280, Segment Reporting (ASC 280) establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s Chief Operating Decision Maker (CODM), or group, in deciding how to allocate resources and assess performance.

The Company’s CODM has been identified as the Chief Executive Officer who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has identified the Company’s reportable segments as:

●Tool Manufacturing & Related Services - Production of industrial tools and provision of maintenance services.

F-82

Table of Contents

​

●Coating Services - Application of specialized coatings for industrial components.
●Battery Manufacturing - Manufacture of advanced batteries for automotive and energy storage applications.

Segment profit or loss is measured using internal reporting metrics reviewed by the CODM and excludes interest, income taxes, and certain nonrecurring items. Segment assets include property, plant, equipment, and working capital directly attributable to each segment. Segment profit for all segments is measured as gross margin excluding corporate overhead.

The Company’s CODM does not regularly review discrete asset information by reportable segment for purposes of performance assessment or resource allocation. Accordingly, total assets are not reported by segment in this footnote.

The Company’s products and services by segment are:

●Tool Manufacturing & Related Services - Industrial tools and maintenance services.
●Coating Services - Protective and performance coatings for industrial components.
●Battery Manufacturing - Lithium-ion and advanced batteries.

Revenue is primarily generated in North America, with a growing presence in Europe and Asia. Management does not consider geographic segmentation meaningful due to the nature of the Company’s operations and demand variability.

Customer concentrations may occur in certain periods; however, they fluctuate significantly and are not considered a reliable basis for segment reporting. Battery sales are in early stages, and no single customer has been identified as a major customer on a recurring basis.

Recent Issued Accounting Pronouncements Not Yet Adopted

The following are recent accounting pronouncements not yet adopted with potential for a material impact on the company’s consolidated financial statements or disclosures.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes: Improvements to Income Tax Disclosures (Topic740). Under the ASU, public business entities must annually “(1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income or loss by the applicable statutory income tax rate).” The ASU’s amendments are effective for public business entities for annual periods beginning after December 15, 2024, whereas for non-public (i.e. private) business entities for annual periods beginning after December 15, 2025. Early adoption is permitted. While the Company expects that adoption of ASU 2023-09 will result in expanded disaggregation and additional qualitative and quantitative disclosures, including more detailed effective tax rate reconciliation categories and jurisdictional income tax payment disclosures, the Company does not expect the adoption of ASU 2023-09 to have an impact on its results of operations, financial position, or cash flows.

In November 2024, the FASB issued ASU 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40). The new guidance requires enhanced disclosures about certain costs and expenses. This standard update is effective for the Company’s annual reports beginning in the fiscal year ending December 31, 2028, and interim period reports beginning in the first quarter of the fiscal year ending December 31, 2029. Early adoption is permitted either on a prospective or retrospective basis. The Company is currently evaluating the impact of this ASU on our disclosures.

In December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities (“ASU 2025-10”), to establish guidance on the recognition, measurement, and presentation of government grants received by business entities. ASU 2025-10 is effective for annual and interim reporting periods after December 15, 2028, and can be applied prospectively, modified prospectively, or retrospectively. The Company is currently evaluating the impact of ASU 2025-10 guidance on its consolidated financial statements and related disclosures.

F-83

Table of Contents

​

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements (“ASU 2025-11”), to clarify the interim reporting requirements by improving navigability of Topic 270 and more clearly specifying what disclosures are required in an interim reporting period. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, and can be applied prospectively or retrospectively to any or all prior periods presented in the condensed consolidated financial statements. The Company is currently evaluating the impact of ASU 2025-11 guidance on its consolidated financial statements and related disclosures.

In December 2025, the FASB issued ASU No. 2025-12, Codification Improvements (“ASU 2025-12”), ASU 2025-12 represents changes to the Codification that (1) clarify, (2) correct errors, or (3) make minor improvements. The amendments in ASU 2025-12 are effective for fiscal years beginning after December 15, 2026, and interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of ASU 2025-12 guidance on its consolidated financial statements and related disclosures.

3.

Prepaid and Other Current Assets

The following is the detail of prepaid and other current assets as of December 31:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Prepaid expenses

​

$

763

​

$

931

Suspense – Funding issuance costs

​

​

844

​

 

132

Total

​

$

1,607

​

$

1,063

​

​

4.Accounts Receivable

The following is the detail of accounts receivable as of December 31:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Trade accounts receivable

​

$

2,003

​

$

1,652

Less: allowance for credit losses

​

​

(40)

​

 

(33)

Net accounts receivable

​

$

1,963

​

$

1,619

​

The activity in the allowance for credit losses is as follows:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Balance – January 1

​

$

(33)

​

$

(52)

Additions charged to expense

​

​

(24)

​

 

(4)

Deductions/Write-offs

​

​

17

​

 

23

Balance – December 31

​

$

(40)

​

$

(33)

​

Accounts receivable, net consist of the following:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

December 31,

  ​ ​ ​

December 31,

​

 

2025

​

2024

Balance – January 1

​

$

1,652

​

$

2,614

Invoicing

​

​

8,816

​

​

7,610

Payments

​

​

(8,488)

​

​

(8,401)

Write-offs

​

​

40

​

​

(33)

Credit memos

​

​

(17)

​

​

(138)

​

​

$

2,003

​

$

1,652

​

​

F-84

Table of Contents

​

5.Inventory

Inventory consists of the following as of December 31, 2025 and 2024:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Raw materials

​

$

2,478

​

$

2,118

Work in progress

​

​

1,187

​

 

455

Total

​

$

3,665

​

$

2,573

​

​

6.Property and Equipment

Property and equipment as of December 31, 2025 and 2024 are summarized as follows:

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

Depreciable

​

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

Life – Years

Machinery and equipment

​

$

14,111

​

$

13,496

​

2-10

Construction in progress

​

​

5,509

​

 

5,423

​

—

Leasehold improvements

​

​

3,310

​

 

3,178

​

5-20

Computer equipment and software

​

​

213

​

 

213

​

3-5

Furniture and fixtures

​

​

179

​

 

128

​

3-5

Total cost

​

​

23,322

​

 

22,438

​

  ​

Accumulated depreciation:

​

​

​

​

 

  ​

​

  ​

Machinery and equipment

​

​

(6,541)

​

 

(4,478)

​

  ​

Leasehold improvements

​

​

(1,835)

​

 

(1,112)

​

  ​

Computer equipment and software

​

​

(203)

​

 

(190)

​

  ​

Furniture and fixtures

​

​

(91)

​

 

(66)

​

  ​

Total accumulated depreciation

​

​

(8,670)

​

 

(5,846)

​

  ​

Net property and equipment

​

$

14,652

​

$

16,592

​

  ​

​

Depreciation and amortization expense for the years ended December 31, 2025 and 2024 was $2,822 and $1,607, respectively, of which $2,060 and $941 was recorded into cost of sales.

7.Commitments and Contingencies

On August 9, 2023, the Company completed the acquisition of Sundew ALD assets from Sundew Technologies, LLC for consideration composed of three cash payments comprised of $350 at the time of close, $350 cash payment on the second anniversary, August 2024, and the remaining $350 future cash payment due upon the last anniversary, August 2025. The consideration also included contingent cash consideration to be paid to the sellers based on percentages ranging from 2 to 5 percent of net sales through 2032. The Company estimated the fair value of the contingent consideration using a Monte Carlo simulation model, resulting in an initial liability of $311 recognized as part of the purchase consideration at the acquisition date. As of December 31, 2025, the fair value of the contingent consideration was remeasured to $1,811 due to a new projection for tool sales related to the Intellectual Property (IP), which was revised sharply upward. As of December 31, 2024, the fair value of the contingent consideration was remeasured to $1,413. The acquisition was completed to enable the Company to repurpose several patents and product designs for its own line of semiconductor coating equipment.

F-85

Table of Contents

​

8.Acquired Intangible Assets and Goodwill

Intangible assets of the Company as of December 31, 2025 and 2025 are summarized as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

​

  ​ ​ ​

Gross

​

​

​

​

​

Gross

  ​ ​ ​

​

  ​ ​ ​

​

​

​

Carrying

​

Accumulated

​

​

​

Carrying

​

Accumulated

​

​

​

  ​ ​ ​

Amount

  ​ ​ ​

Amortization

  ​ ​ ​

Net

  ​ ​ ​

Amount

​

Amortization

​

Net

Amortized intangible assets – Acquired patents

​

$

3,212

​

$

(1,623)

​

$

1,589

​

$

3,212

​

$

(1,420)

​

$

1,792

​

​

$

3,212

​

$

(1,623)

​

$

1,589

​

$

3,212

​

$

(1,420)

​

$

1,792

​

The acquired patents are being amortized over an estimated life of 15 years. Amortization expense for intangible assets totaled $203 and $253 for the years ended December 31, 2025 and 2024, respectively and are included in general and administrative expenses.

Estimated amortization expense as of December 31, 2025 is as follows:

​

​

​

​

Years ending

  ​ ​ ​

Amount

2026

​

$

203

2027

​

 

203

2028

​

 

194

2029

​

 

165

2030

​

​

165

Thereafter

​

 

659

Total

​

$

1,589

​

Goodwill as of both December 31, 2025 and 2024 was $3,124. The Company recognized no impairment to goodwill during the years ended December 31, 2025 and 2024.

Goodwill

Goodwill represents the excess of purchase price over the fair value of identifiable net assets acquired in business combinations. Goodwill is not amortized but is tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the carrying amount may not be recoverable.

Reporting Unit

The Company evaluates goodwill for impairment at the reporting unit level in accordance with ASC 350-20. The Company has identified three reporting units, which correspond to its operating and reportable segments: Tool Manufacturing and Related Services, Coating Services, and Battery Manufacturing.

Each reporting unit represents a component of the business for which discrete financial information is available and regularly reviewed by management for purposes of assessing performance and allocating resources.

F-86

Table of Contents

​

Allocation of Goodwill

Goodwill is allocated to reporting units expected to benefit from the synergies of the related business combinations. The Company has allocated goodwill based on the business combinations giving rise to the goodwill and the manner in which the acquired assets contribute to current operations.

​

Reporting Unit

  ​ ​ ​

Goodwill

Tool Manufacturing & Related Services

​

$

900

Coating Services

​

​

2,224

Battery Manufacturing

​

​

—

Total

​

$

3,124

​

The goodwill associated with the ALD NanoSolutions acquisition is allocated to the Coating Services reporting unit, as the acquired reactor assets and related intellectual property are utilized in coating operations and generate revenue within this reporting unit.

The goodwill associated with the Sundew acquisition is allocated to the Tool Manufacturing & Related Services reporting unit, as the acquired intellectual property supports the Company’s equipment platform. No goodwill is allocated to the Battery Manufacturing reporting unit.

Impairment Testing Process

The Company performs its annual goodwill impairment test during the fourth quarter of each fiscal year. The Company may first perform a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount.

In performing the qualitative assessment, the Company considers relevant events and circumstances, including, but not limited to:

●Macroeconomic conditions, including inflation and general economic trends
●Industry and market considerations, including demand for the Company’s semiconductor and battery technologies
●Cost factors, including changes in labor and material costs
●Overall financial performance, including revenue trends, operating losses, and cash flows
●Company-specific events, including changes in strategy, customers, or operations
●Changes in the carrying value of net assets or expectations of future performance

If, based on the qualitative assessment, the Company determines that it is more likely than not that the fair value of the reporting unit exceeds its carrying amount, no further testing is required. If otherwise, the Company would perform a quantitative impairment test by comparing the fair value of the reporting unit to its carrying amount.

Valuation Methodology and Key Assumptions.

If a quantitative assessment is required, the Company estimates the fair value of the reporting unit using valuation techniques consistent with the income approach and/or market approach. These valuation methods involve the use of significant estimates and assumptions, including projected future revenues and margins, discount rates, and long-term growth rates. These assumptions are inherently uncertain and require management judgment.

F-87

Table of Contents

​

Impairment Assessment Results

For the years ended December 31, 2025 and 2024, the Company performed qualitative assessments for each reporting unit and concluded that it was more likely than not that the fair value of each reporting unit exceeded its carrying value. Accordingly, no goodwill impairment was recognized for either period.

​

9.Leases

The Company is obligated under operating leases only for building and office rentals. The leases require the Company to pay taxes, insurance, utilities, and maintenance costs. Total rent expense under these leases was $7,358 and $762 during the years ended December 31, 2025 and 2024, respectively, and are included in cost of sales and general and administrative expenses.

​

Future minimum annual commitments under these operating leases as of December 31, 2025 are as follows:

​

​

​

​

​

  ​ ​ ​

Amount

2026

​

$

7,917

2027

​

 

8,153

2028

​

 

8,398

2029

​

 

8,305

2030

​

​

8,070

Thereafter

​

​

87,098

Total

​

 

127,941

Less: amount representing interest

​

 

(63,491)

Present value of net minimum lease payments

​

 

64,450

Less: current obligations

​

 

(1,287)

Long-term obligations under leases

​

$

63,163

​

Expenses recognized under these leases for the years ended December 31, 2025 and 2024 consist of the following:

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

Lease cost – Operating lease cost

​

$

7,358

​

$

726

​

Other information:

​

​

​

​

 

  ​

​

Cash paid for amounts included in the measurement of lease liabilities – Operating cash flows from operating leases

​

$

2,477

​

$

660

​

Right-of-use assets obtained in exchange for new operating lease liabilities

​

​

64,766

​

 

—

​

Weighted-average remaining lease term (years) – Operating leases

​

​

13.86

​

 

4.58

​

Weighted-average discount rate – Operating leases

​

​

10.49

%  

 

10.00

%

​

​

10.Retirement Plans

The Company sponsors a 401(k) plan for all employees over the age of 21. The plan provides for the Company to make a required matching contribution. Contributions to the plan totaled $423 and $385 for December 31, 2025 and 2024, respectively.

11.Accrued and Other Current Liabilities

The following is the detail of accrued and other current liabilities as of December 31:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Accrued finder’s fees and commissions

​

$

—

​

$

80

Other accrued liabilities

​

​

1,216

​

 

658

Payroll liabilities

​

​

1,748

​

 

2,118

Warranty reserve liability

​

​

63

​

 

152

Total

​

$

3,027

​

$

3,008

​

​

F-88

Table of Contents

​

12.Capital Stock

As of December 31, 2025 and 2024, common stock consists of 4,850,000 and 4,550,000 authorized shares, respectively, of common stock and 4,663,753 and 1,931,849 authorized shares, respectively, of preferred stock, each with a par value of $0.0001. As of December 31, 2025 and 2024, 1,648,841 and 1,643,081 shares, respectively, of common stock and 1,925,348 and 1,676,528 shares, respectively, of preferred stock were issued and outstanding.

​

Mezzanine Equity

The preferred shares are recorded as mezzanine equity in accordance with Accounting Standards Codification 480, Distinguishing Liabilities from Equity (ASC 480). The Series A, Series B, Series C and Series D shares are recorded as mezzanine equity in accordance with ASC 480, as the shares are contingently redeemable upon the occurrence of events outside of the Company’s control.

Liquidation Rights

In the event of a liquidation, which includes a change in control, the holders of the preferred stock will be entitled, before any payment to holders of common stock, to the greater of the original issue price plus any declared but unpaid dividends or the amount payable on an if-converted-to-common-stock basis immediately prior to the liquidating event. Any remaining assets will be distributed to the holders of the common stock on a pro rata basis.

Voting Rights

On any matter presented to the stockholders of the Company, holders of preferred stock will be entitled to the number of votes equal to the number of shares of common stock into which the shares of preferred stock held are convertible. Holders of common stock will be granted one vote for each share of stock held at the meeting of stockholders. The holders of common stock and preferred stock vote together as a single class. In addition, the holders of preferred stock have certain protective rights.

Conversion Rights

Each share of preferred stock shall be convertible, at the option of the holder, at any time, into fully paid and non assignable shares of common stock. The number of shares of common stock to which a holder of preferred stock can convert is obtained by dividing the preferred stock conversion price that is in effect at the time of conversion by the preferred stock issue price, multiplied by the number of shares of preferred stock being converted. The preferred stock conversion price as of December 31, 2025 and 2024 is equal to the preferred stock issue price. Provisions exist to reduce the conversion price for preferred stock for certain dilutive events.

Upon the closing of the sale of common stock to the public at a price of at least three times the preferred stock original issue price in a firmly underwritten public offering resulting in proceeds of at least $30,000, the preferred shares will automatically convert into common stock at the then-effective conversion rate.

Dividends

The holders of preferred stock shall be entitled to receive annual noncumulative dividends of 7 percent of the original issue price if and when declared by the board of directors. There were no dividends declared as of December 31, 2025 and 2024.

F-89

Table of Contents

​

Capital stock as of December 31 is as follows:

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

​

2024

​

​

Number of

​

APIC

​

Number of

​

APIC

​

  ​ ​ ​

shares

  ​ ​ ​

Amount

  ​ ​ ​

shares

  ​ ​ ​

Amount

Forge Nano, Inc. - Preferred stock:

 

​

​

​

​

​

  ​

​

​

  ​

Series A – $0.0001 par value (voting) – Authorized - 858,410 shares

 

858,410

​

$

31,235

​

858,410

​

$

31,235

Series B – $0.0001 par value (voting) – Authorized – 130,939 shares

 

130,939

​

 

7,070

​

130,939

​

 

7,070

Series C – $0.0001 par value (voting) – Authorized – 942,500 shares

 

687,179

​

 

50,042

​

687,179

​

 

50,042

Series D – $0.0001 par value (voting) – Authorized – 527,688 shares

​

248,820

​

​

48,191

​

—

​

​

—

Total

 

1,925,348

​

$

136,538

​

1,676,528

​

$

88,347

​

Issuance of Series C Preferred Stock

In the first close of the Series C capital raise noted above, investors Hanwha Corporation and Hanwha Aerospace invested a combined $15,000 and Orion Infrastructure Capital (OIC) invested $5 at a price of $76.42 per share. In February 2024, the Company received $1,300 from investor Ascent Funds International Management at a price of $76.42 per share. In September 2024, the Company issued 65,430 shares of Series C preferred stock and received $5 from the investors at a price of $76.42 per share.

Conversion of Series D Convertible Note to Preferred Stock

In March 2025, the first close of the Series D capital raise was completed, which mandated the conversion of the Company’s $3,905 convertible note to preferred stock. The convertible note and related bifurcated derivative liability converted into 19,814 shares of Series D preferred stock with a par value of $0.0001 at a conversion price of $157.66 per share, representing a 20% discount to the Series D fair market value of $197.07. The conversion was accounted for as an extinguishment of the convertible debt liability and subsequently recorded as preferred stock under equity. The impact of the conversion of the convertible loan debt balance to Series D preferred stock was to reduce both the outstanding convertible debt balance of $3,905 to $0.

Series D Preferred Stock

The Series D round held its initial close on March 31, 2025, having raised $41,849. The round remained open for the remainder of 2025, securing an additional $4,072 before December 31, 2025. The round remained open in 2026 and raised a total of $63,596 up to March 31, 2026.

13.Stock-Based Compensation

As of December 31, 2025 and 2024, the Company has one share-based compensation plan the 2017 Equity Incentive Plan (the “Plan”), which is stockholder approved and permits the grant of stock options to its employees for up to 551,686 shares of common stock. The Company believes that such awards better align the interests of its employees with those of its stockholders. Option awards are generally granted with an exercise price equal to the market price of the Company’s stock at the date of grant. Those option awards generally vest over four years, with the first 25 percent vesting after 12 months of continuous service, and options granted have four-year contractual terms. Certain option awards provide for accelerated vesting if there is a change in control (as defined in the Plan).

The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model that uses the weighted-average assumptions noted in the following table. Expected volatilities are based on historical volatility of the Company’s stock price and historical volatility of comparable public companies. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

The compensation cost that has been charged against income for the plan was $1,422 and $620 for the years ended December 31, 2025 and 2024, respectively, and are included in general and administrative expenses.

F-90

Table of Contents

​

When calculating the amount of annual compensation expense, the Company has elected not to estimate forfeitures and instead accounts for forfeitures as they occur.

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

Average expected life (in years)

 

​

3.97

 

​

5.79

 

Risk-free interest rate

 

​

3.74

%  

​

4.23

%

Expected dividend yield

 

​

0

%  

​

0

%

Volatility

 

​

39.06

%  

​

42.25

%

Estimated fair value of options granted

​

$

20.78

​

$

15.42

​

​

A summary of option activity under the Plan as of December 31, 2025 and 2024 is presented below:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted-average

​

Weighted

​

​

​

​

Number of

​

Weighted-average

​

Grant-date

​

Remaining

​

Aggregate

Options

  ​ ​ ​

Options

  ​ ​ ​

Exercise Price

  ​ ​ ​

Fair Value

  ​ ​ ​

Contractual

  ​ ​ ​

Intrinsic Value

​

​

​

​

(Dollars)

​

(Dollars)

​

Term (in Years)

​

(Dollars)

Outstanding at January 1, 2024

​

322,495

​

15.81

​

​

​

4.18

​

3,515

Granted

​

150,161

​

31.56

​

13.18

​

​

​

​

Exercised

​

(14,808)

​

15.81

​

​

​

​

​

325

Forfeited

​

(5,754)

​

22.55

​

10.39

​

​

​

​

Expired

​

(61,806)

​

13.11

​

​

​

​

​

​

Outstanding at December 31, 2024

​

390,288

​

38.57

​

​

​

5.60

​

4,586

Outstanding at January 1, 2025

​

390,288

​

38.57

​

​

​

5.60

​

4,586

Granted

​

102,974

​

165.43

​

20.78

​

​

​

​

Exercised

​

(460)

​

6.86

​

​

​

​

​

35

Forfeited

​

(12,963)

​

38.97

​

16.10

​

​

​

​

Expired

​

(24,288)

​

16.43

​

​

​

​

​

​

Outstanding at December 31, 2025

​

455,551

​

68.45

​

​

​

5.13

​

16,456

Vested or expected to vest at December 31, 2024

​

390,288

​

38.57

​

​

​

5.60

​

4,586

Vested or expected to vest at December 31, 2025

​

455,551

​

68.45

​

​

​

5.13

​

16,456

Exercisable at December 31, 2024

​

238,041

​

43.59

​

​

​

3.97

​

3,493

Exercisable at December 31, 2025

​

323,323

​

75.23

​

​

​

4.03

​

12,245

​

As of December 31, 2025 and 2024 there was $2,676 and $1,896 respectively, of total unrecognized compensation cost related to unvested share-based compensation arrangements granted under the Plan. That cost is expected to be recognized over a weighted-average period of 2.54 years and 3.00 years as of December 31, 2025 and 2024, respectively.

A summary of unvested shares under the Plan for as of December 31, 2025 and 2024 is presented below:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted-average

​

Weighted

​

​

​

​

Number of

​

Weighted-average

​

Grant-date

​

Remaining

​

Aggregate

Unvested Options

  ​ ​ ​

Options

  ​ ​ ​

Exercise Price

  ​ ​ ​

Fair Value

  ​ ​ ​

Contractual

  ​ ​ ​

Intrinsic Value

​

​

​

​

(Dollars)

​

(Dollars)

​

Term (in Years)

​

(Dollars)

Unvested at January 1, 2024

 

59,259

 

20.09

 

8.68

 

​

 

​

Granted

 

150,161

 

31.56

 

13.18

 

​

 

​

Vested

​

(51,419)

​

21.77

​

8.91

​

7.13

​

823

Forfeited

 

(5,754)

 

22.55

 

10.39

 

​

 

​

Unvested at December 31, 2024

 

152,247

 

30.72

 

12.97

 

​

 

​

Unvested at January 1, 2025

 

152,247

 

30.72

 

12.97

 

​

 

​

Granted

 

102,974

 

165.43

 

20.78

 

​

 

​

Vested

​

(110,030)

​

130.41

​

7.90

​

7.90

​

3,274

Forfeited

​

(12,963)

​

38.97

​

16.10

​

​

​

​

Unvested at December 31, 2025

 

132,228

 

51.87

 

22.97

 

​

 

​

​

F-91

Table of Contents

​

Restricted Stock

During the year ended December 31, 2024, the Company granted an additional 24,308 restricted shares. A total of 3,994 shares were vested during the year, with a weighted-average grant-date fair value of $25.43 per share, and 13,708 shares were forfeited. As of January 1, 2025, the Company had 7,731 shares of restricted common stock outstanding, with a weighted-average grant-date fair value of $29.18 per share. During the year ended December 31, 2025, the Company granted an additional 5,300 restricted shares. A total of 7,505 shares were vested during the year ended, with a weighted-average grant-date fair value of $33.71 per share, and 0 shares were forfeited. As of December 31, 2025, 5,526 restricted shares remained outstanding, with a weighted-average grant-date fair value of $31.23 per share. As of December 31, 2025 and 2024, the Company had $112 and $216 of unrecognized compensation expense related to unvested restricted stock awards.

Non plan Stock Options

On August 8, 2022, the Company issued 82,512 common stock options to Ascent Funds International Management as compensation in exchange for consulting services related to the preparation for a potential initial public offering. The options fully vest six weeks after the grant date with an exercise price of $96.95 based on a fixed pre-money valuation of $300,000 and 3,094,378 fully diluted shares at grant date. The options were amended to expire on December 31, 2028 with an option to expire December 31, 2029 with an increase in strike price to $121.19,and may be fully or partially exercised so long as they are fully exercised prior to an initial public offering.

14.Revenue Recognition

Contract Liabilities

The following table provides information on the changes in the balance of contract liabilities for the years ended December 31:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Balance - Beginning of period

 

$

3,012

​

$

2,643

Cash received

​

​

7,007

​

​

6,134

Less revenue recognized from continuing operations (net of returns, allowances, etc.) from satisfaction of performance obligations in the current period

​

​

(6,893)

​

​

(5,765)

Balance - End of period

 

$

3,126

​

$

3,012

​

Total contract liabilities increased by $114 during 2025. The increase was primarily due to the Company’s effort to push sales, and increasing sales deposits during the year

Contract Assets

The following table provides information on the changes in the balance of contract assets for the years ended December 31:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Balance - Beginning of period

 

$

3,660

​

$

1,017

Revenue recognized from continuing operations (net of returns, allowances, etc.) from satisfaction of performance obligations in the current period

​

​

10,706

​

​

4,136

Less contract assets reclassified to receivables

​

​

(7,780)

​

​

(1,493)

Balance - End of period

 

$

6,586

​

$

3,660

​

Total contract assets increased by $2,926 during 2025, primarily driven by unbilled revenue related to equipment orders for which revenue was recognized, but the equipment had not yet been shipped to customers as of year-end.

The Company recognized losses on trade receivables and contract assets of $24 and $4 as of December 31, 2025 and 2024, respectively.

F-92

Table of Contents

​

Performance Obligations

As of December 31, 2025, the Company had remaining performance obligations primarily related to equipment orders. Revenue from these performance obligations is recognized as control of the equipment transfers to customers, which may occur over periods extending beyond twelve months depending on delivery schedules and customer acceptance.

​

15.Debt

Debt as of December 31 is as follows:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Senior secured term loan issued in May 2023 by OIC, LLC, including a weighted-average interest at 10 percent per annum at December 31, 2025 and December 31, 2024. The note is collateralized by the Company’s assets and intellectual property and is due in full on May 5, 2026

​

$

10,488

​

$

20,000

Less: unamortized debt issuance costs and discounts

​

 

(122)

​

 

(2,929)

Total debt, less unamortized debt issuance costs and discounts

 

$

10,366

​

$

17,071

​

The balance of the above debt, as modified in November 2025, matures on May 5, 2026 with the unamortized debt discount of $122 and $2,929 at December 31, 2025 and December 31, 2024, respectively. Interest expense attributable to the debt for year ended December 31, 2025 and 2024 was $1,792 and $2,034, respectively.

16.Convertible Debts

The Company’s convertible notes payable as of December 31, are summarized as follows:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Convertible note – Series D

​

$

—

​

$

1,924

Accrued interest

​

 

—

​

 

17

Debt discount

 

​

—

​

​

(314)

Total

​

$

—

​

$

1,627

​

Series D Convertible Note

In 2024, the Company offered a 6 percent unsecured convertible note (the “Series D Note” or the “Note”) to certain investors as a precursor to its Series D round. A series of notes were issued to investors with identical terms for a maximum principal amount not exceeding $40,000, in aggregate. The Series D Note matured December 31, 2025. Principal and unpaid interest were due at maturity. The Note was not issued at a discount or premium. The outstanding principal was $0 and $1,924 at December 31, 2025 and 2024, respectively and the interest attributable to the Note was $0 and $17 for the year ended December 31, 2025 and 2024, respectively. The Company determined that the conversion features embedded within the Series D Note met the definition of a derivative under ASC 815 and required bifurcation from the host instrument. Accordingly, the embedded derivative was separately recognized at its fair value of $393 (see Note 17). Prior to the maturity date, the note could be converted as follows:

·

Series D Qualified Financing: A Series D Qualified Financing means the sale by the Company of Series D Preferred Stock in the amount of at least $40,000, at any time after the issuance date of the Note and prior to the maturity date. Upon closing of a Series D Qualified Financing, the Note’s outstanding balance is automatically converted, in whole and not in part and without any further action, into Series D Preferred Stock. The conversion price is equal to the lower of (i) 80% of the original issue price of the Series D Preferred Stock or (ii) the product given by (x) $750,000 divided by (y) the total number of shares of common stock of the Company immediately prior to the consummation of such Series D Qualified Financing.

·

Deemed Liquidation Event, SPAC Transaction, Qualified Initial Public Offering (collectively referred to as “Liquidation Event”): Prior to both a Series D Qualified Financing or repayment, the Note’s outstanding balance is automatically converted into common stock of the Company at a conversion price equal to the product given by (x) $750,000 divided by (y) the total number of shares of common stock outstanding immediately prior to the consummation of such Liquidation Event.

F-93

Table of Contents

​

·

Maturity: In the event the Notes did not convert prior to the Maturity Date, then the Notes, together with all accrued and unpaid interest, would have automatically converted into common stock of the Company at a price per share equal to the amount obtained by dividing (x) the Series C post-money valuation of the Company ($300,000) by (y) the fully diluted capitalization of the Company as of immediately prior to the effective date of the Alternate Event (including all exercisable options pursuant to the Company’s compensatory equity plans, but excluding the Notes).

17.Derivative Financial Instruments

The Company evaluates its convertible instruments, options, warrants, or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for ASC 815. The result of this accounting treatment is that the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the condensed consolidated statements of operations as interest income (expense), and reported within the adjustments to reconcile net loss from operating activities as change in fair value of derivative liability within the condensed consolidated statements of cash flows. Upon conversion or exercise of the derivative instrument, it is marked to fair value at the conversion date, and the fair value is reclassified to preferred stock. If equity instruments that are initially classified as equity become subject to reclassification as liabilities under ASC 815, they are measured using the fair value of the instrument as of the reclassification date.

Warrants

In 2023, as part of the loan agreement between OIC and the Company (see Note 15), the Company issued warrants to OIC to purchase common stock at a price of $0.01 per share. The shares may be exercised during the period commencing on the repayment date and ending 30 calendar days following the repayment date. The repayment date is the earlier of (i) the date on which the loan is repaid or (ii) the earlier to occur of (a) November 5, 2025 and (b) the date upon which the entire outstanding principal amount of the loans,together with all unpaid interest, fees, charges and costs, shall be accelerated in accordance with the loan agreement. The number of shares available for purchase by each OIC fund is calculated by dividing $5,000 by the common stock price and then multiplying each OIC fund’s respective percentage. The common stock price is the Series C original issue price. The liability is recorded at fair value at inception and recorded as debt discount at the grant date. The Company extended the repayment date to May 2026 and extended the exercise period to align with the revised payment date. The fair value is revalued at each reporting date on a recurring basis. On March 31, 2025 OIC leveraged $2,000 of its outstanding note to exercise 26,172 of its warrants to purchase Series D shares at the Series C exercise price.

In 2023, the Company issued a warrant to purchase shares of Series C preferred stock to General Motors Ventures, LLC (Holder). The warrants were exercisable between December 26, 2023 and September 26, 2024 unless a joint development agreement between the Company and Holder is entered into prior to September 26, 2024. As of September 11, 2024, the joint development agreement was reached and the General Motors Ventures, LLC warrants were exercised. The number of shares purchasable by Holder was calculated by dividing $5,000 by the stock purchase price of $76.41, rounded down to the nearest whole number, or 65,430. The liability was recorded at fair value at inception and recorded as a discount to the Series C preferred stock at the grant date. The fair value was revalued annually on a recurring basis. Holder exercised its warrants on September 30, 2024.

​

​

​

​

​

​

​

​

Warrant Shares

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Beginning balance

 

339,299

​

404,729

Granted

 

—

​

—

Exercised

 

(26,172)

​

(65,430)

Expired

 

—

​

—

Ending balance

 

313,127

​

339,299

​

Derivative liability — conversion feature embedded in convertible debt

In 2024, the Company issued unsecured convertible notes to certain investors as a precursor to its Series D round financing. The Company evaluated the conversion feature embedded in the note agreement under ASC 815, and concluded that it meets the definition of a derivative instrument. As the conversion feature was not clearly and closely related to the host debt agreement, bifurcation was required. Accordingly, the Company separated the embedded conversion feature from the host instrument and recognized it as a

F-94

Table of Contents

​

derivative liability, measured at fair value. The convertible debt and the corresponding derivative liability converted on March 31, 2025.

As of December 31, the fair value of derivatives was as follows:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Derivatives not designated as hedging instruments:

 

​

  ​

​

​

  ​

Conversion feature embedded in convertible debt (Note 16)

​

$

—

​

$

393

Warrants issued in conjunction with the 2023 issuances of Series C preferred stock and long-term debt

​

 

5,624

​

 

6,264

Total derivatives not designated as hedging instruments

​

$

5,624

​

$

6,657

​

The Company values warrants at fair value using a weighted Black-Scholes calculation. The following inputs and assumptions were used to value the warrants during as of December 31, 2025 and 2024:

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Warrants

 

​

  ​ ​ ​

2025

  ​ ​ ​

2024

​

Expected volatility

 

​

50.00

%

​

50.00

%

Risk-free rate

 

​

4.17

%

​

4.58

%

Event date

​

​

June 4, 2026

​

​

December 5, 2024

​

Term (in years)

​

 

0.68

​

 

0.93

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Conversion Feature

 

​

  ​ ​ ​

2025

  ​ ​ ​

2024

​

Expected volatility

 

​

—

​

​

50.00

%

Risk-free rate

 

​

—

​

​

3.80

%

Event date

​

​

—

​

​

July 5, 2024

​

Term (in years)

​

 

—

​

 

2.53

​

​

For the years ended December 31, 2025 and 2024, the amounts of gain or loss recognized in the statement of operations attributable to derivative instruments and their corresponding locations in the statement of operations are as follows:

​

​

​

​

​

​

​

​

​

​

​

​

Amount of Loss Recognized in Earnings

​

Reported in Statement

​

  ​ ​ ​

2025

​

2024

  ​ ​ ​

of Operations

Derivative - conversion feature embedded in convertible debt (Note 16)

​

$

—

​

$

—

​

Interest expense

Change in fair market value

​

 

536

​

 

366

 

Interest expense

​

​

18.Fair Value Measurements

In accordance with ASC 820, Fair Value Measurements and Disclosures (ASC 820), the Company measures and accounts for certain assets and liabilities at fair value on a recurring basis. ASC 820 provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the inputs and valuation techniques used to measure fair value.

Fair values determined by Level 1 inputs use quoted prices in active markets for identical liabilities that the Company has the ability to access. Fair values determined by Level 2 inputs use other inputs that are observable, either directly or indirectly. These Level 2 inputs include quoted prices for similar liabilities in active markets and other inputs, such as interest rates and yield curves, that are observable at commonly quoted intervals.

Level 3 inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related liability. These Level 3 fair value measurements are based primarily on management’s own estimates using pricing models, discounted cash flow methodologies, or similar techniques taking into account the characteristics of the liability.

F-95

Table of Contents

​

There were no Level 1 or 2 assets or liabilities in any period. The Company’s Level 3 liabilities were its warrants and derivative. See Note 17 for details of the method and inputs used to measure fair value of the derivative liabilities as of December 31, 2025 and 2024.

In instances where inputs used to measure fair value fall into different levels in the above fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each liability.

Investments that are measured at fair value using net asset value per share (or its equivalent) as a practical expedient are not classified in the fair value hierarchy below.

The following tables present information about the Company’s liabilities measured at fair value on a recurring basis as of December 31, 2025 and 2024 and the valuation techniques used by the Company to determine those fair values:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Liabilities Measured at Fair Value on a Recurring Basis at 

​

​

December 31, 2025

​

​

Quoted Prices in

​

​

​

​

​

​

​

​

​

​

​

Active Markets

​

Significant Other

​

Significant

​

​

​

​

​

for Identical

​

Observable

​

Unobservable

​

Balance at

​

​

Assets

​

Inputs

​

Inputs

​

December 31,

​

  ​ ​ ​

(Level 1)

  ​ ​ ​

(Level 2)

  ​ ​ ​

(Level 3)

  ​ ​ ​

2025

Liabilities

​

  ​

​

​

  ​

​

​

  ​

​

​

  ​

​

Warrants (Note 17)

​

$

—

​

$

—

​

$

5,624

​

$

5,624

Contingent consideration (Note 7)

​

​

—

​

​

—

​

​

748

​

​

748

Derivative – conversion feature embedded in convertible debt (Note 17)

 

​

—

 

​

—

 

​

—

 

​

—

Total liabilities

​

$

—

​

$

—

​

$

6,372

​

$

6,372

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Liabilities Measured at Fair Value on a Recurring Basis at 

​

​

December 31, 2024

​

​

Quoted Prices in 

​

​

​

​

​

​

​

​

​

​

​

Active Markets 

​

Significant Other

​

Significant

​

​

​

​

​

for Identical

​

Observable 

​

Unobservable 

​

Balance at 

​

​

Assets 

​

Inputs 

​

Inputs 

​

December 31,

​

  ​ ​ ​

(Level 1)

  ​ ​ ​

(Level 2)

  ​ ​ ​

(Level 3)

  ​ ​ ​

2024

Liabilities

​

  ​

​

​

  ​

​

​

  ​

​

​

  ​

​

Warrants (Note 17)

​

$

—

​

$

—

​

$

6,264

​

$

6,264

Contingent consideration (Note 7)

​

​

—

​

​

—

​

​

811

​

​

811

Derivative - conversion feature embedded in convertible debt
(Note 17)

​

​

—

​

​

—

​

​

393

​

​

393

Total Liabilities

​

$

—

​

$

—

​

$

7,468

​

$

7,468

​

Changes in Level 3 derivative liabilities, including conversion feature embedded in convertible debt and warrants, measured at fair value on a recurring basis as of December 31, 2025 and 2024 are as follows:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Warrant and Derivative 

​

​

Liability

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Balance

​

$

6,657

​

$

6,816

Purchases, issuances, sales, and settlements:

 

​

​

​

​

  ​

Derivative – conversion feature embedded in convertible debt (Note 17)

 

​

(393)

​

​

393

Warrants exercised

 

​

(104)

​

​

(918)

Unrealized (gains) losses included in earnings related to investments still held as of reporting date

 

​

(536)

​

​

366

Balance

​

$

5,624

​

$

6,657

​

F-96

Table of Contents

​

Realized gains and losses are reported as interest expense in the consolidated statements of operations. Realized losses (gains) on the derivative liabilities of $(536) and $366 were recognized as of December 31, 2025 and 2024, respectively.

Both observable and unobservable inputs may be used to determine the fair value of positions classified as Level 3 liability. As a result, the unrealized gains and losses for this liability presented in the tables above may include changes in fair value that were attributable to both observable and unobservable inputs.

19.Fair Value of Financial Instruments

The fair value of a financial instrument is the current amount that would be exchanged between willing parties, other than in a forced liquidation. Fair value is best determined based upon quoted market prices; however, in many instances, there are no quoted market prices for the Company’s various financial instruments. In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. Accordingly, the fair value estimates may not be realized in an immediate settlement of the instrument. Fair value accounting standards exclude certain financial instruments and all non-financial instruments from their disclosure requirements. Accordingly, the aggregate fair value amounts presented may not necessarily represent the underlying fair value of the Company.

The Company’s financial instruments consist of cash and cash equivalents, restricted cash, accounts receivable, unbilled accounts receivable, deposits, accounts payable, credit card payable, deferred revenue, debt, warrant liabilities, and, for the prior period, convertible debt and an embedded derivative liability.

The Company’s financial assets include cash and cash equivalents, current and noncurrent restricted cash, accounts receivable, unbilled accounts receivable, and noncurrent deposits. The Company’s financial liabilities include accounts payable, credit card payable, deferred revenue, current and noncurrent portions of debt, noncurrent warrant liabilities and, for prior periods, current and noncurrent portions of convertible debt and the associated derivative liability related to the embedded conversion feature.

For all instruments outstanding as of December 31, 2025 and 2024, the Company concluded that the estimated fair value of its financial assets and financial liabilities approximated their respective carrying amounts.

​

20.Income Taxes

Our income (loss) before provision for income taxes for the years ended December 31, 2025 and 2024 was as follows:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Domestic

​

$

(43,174)

​

$

(26,984)

Foreign

​

 

—

​

 

—

Total

​

$

(43,174)

​

$

(26,984)

​

A reconciliation of the federal statutory income tax rate to the Company’s effective tax rate is as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2025

  ​ ​ ​

2024

 

Federal income tax expense (benefit) attributable to:

​

​

​

​

​

​

​

​

​

​

​

Current operations

​

$

(9,067)

​

$

(5,667)

 

21.00

%  

21.00

%

State tax effect - Net of federal benefit

​

 

(639)

​

 

(230)

 

1.50

%  

0.86

%

Permanent differences

​

 

1,640

​

 

247

 

(3.47)

%  

(0.92)

%

Other adjustments

​

 

6

​

 

17

 

0.00

%  

(0.06)

%

Valuation allowance

​

 

8,060

​

 

5,633

 

(19.02)

%  

(20.88)

%

Net provision for federal income tax

​

$

—

​

$

—

 

0.00

%  

0.00

%

​

F-97

Table of Contents

​

The cumulative tax effect of significant items comprising our net deferred tax amount are as follows for December 31, 2025 and 2024:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Deferred tax asset attributable to:

​

​

​

​

​

​

Net operating loss carryover

​

$

22,716

​

$

15,970

Accrued bonus

​

​

189

​

 

175

Stock compensation expense – NSOs/RSAs

​

​

222

​

 

90

Provision for loss on contracts

​

​

117

​

 

—

Fixed assets

​

​

558

​

​

—

Other reserves

​

​

172

​

 

198

Operating lease liability

​

​

14,610

​

 

666

Section 174 expenditures

​

​

503

​

 

728

Deferred revenue

​

​

516

​

 

15

Sundew acquisition - earnout liability FMV

​

 

361

​

 

192

Total deferred tax assets

​

​

39,964

​

 

18,034

Less: valuation allowance

​

 

(24,960)

​

 

(16,903)

Net deferred tax assets

​

​

15,004

​

​

1,131

Deferred tax liabilities attributable to:

​

​

​

​

 

  ​

Fixed assets

​

​

—

​

 

(235)

Intangibles

​

​

(240)

​

 

(269)

Goodwill

​

​

(10)

​

 

(2)

Operating lease ROU assets

​

​

(14,754)

​

 

(625)

Total deferred tax liabilities

​

​

(15,004)

​

 

(1,131)

Net deferred tax assets (liabilities)

​

$

—

​

$

—

​

As of December 31, 2025, the Company had net operating loss carry-forwards for federal income tax purposes of approximately $104,170 consisting of pre-2018 losses in the amount of approximately$3,941 that expire in 2037 and 2038, and post-2017 losses in the amount of approximately $100,229. These net operating losses are available to offset future taxable income. The Company was formed in 2011 as a S-Corporation and changed to a corporation in 2016. Activity prior to incorporation is not reflected in the Company’s corporate tax returns. In the future, the cumulative net operating loss carry-forward for income tax purposes may differ from the cumulative financial statement loss due to timing differences between book and tax reporting.

As of December 31, 2025, the Company has various state net operating loss carryforwards. The determination of the state net operating loss carryforwards is dependent upon apportionment percentages and state laws that can change from year to year and impact the amount of such carryforwards. If such net operating loss carryforwards are not utilized, they will begin to expire in 2032.

The ultimate realization of deferred tax assets is dependent upon the Company’s ability to generate sufficient taxable income during the periods in which the net operating losses expire and the temporary differences become deductible. The Company has determined that there is significant uncertainty that the results of future operations and the reversals of existing taxable temporary differences will generate sufficient taxable income to realize the deferred tax assets; therefore, a valuation allowance has been recorded. In making this determination, the Company considered historical levels of income as well as projections for future periods. Increase in the valuation allowance of $8,640 is in relation to the net increase in DTA of $8,640.

The tax years 2022 to 2025 remain open for potential audit by the Internal Revenue Service. There are no uncertain tax positions as of December 31, 2025, and none are expected in the next 12 months.

F-98

Table of Contents

​

On July 4, 2025, President Donald Trump signed the One Big Beautiful Bill Act (OBBBA) into law, which is considered the enactment date under U.S. GAAP. This legislation introduces several provisions affecting businesses, including the permanent extension of certain expiring elements of the Tax Cuts and Jobs Act, modifications to the international tax framework, and favorable tax treatment for certain other business provisions. Key corporate tax provisions include existing 21% corporate income tax rate made permanent, the restoration of 100% bonus depreciation, immediate expensing for domestic research and experimental expenditures, changes to Section 163(j) interest limitations, updates to Global Intangible Low Tax Income (GILTI) and Foreign- Derived Intangible Income (FDII) rules, amendments to energy credits, and expanded Section 162(m) aggregation requirements. The OBBBA contains multiple effective dates, with some provisions applicable beginning in 2025. The legislation does not impact the Company’s prior years’ financial statements.

​

21.Earnings (Loss) Per Common Share

Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share adjusts basic earnings per share for the potentially dilutive impact of stock options. As the Company has reported a loss for the years ended December 31, 2025 and 2024, potentially dilutive securities are antidilutive and accordingly, basic net loss per share equals diluted net loss per share.

The following table sets forth the computation of basic and diluted loss per share for the years ended December 31, 2025 and December 31, 2024:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Numerator:

 

​

​

​

​

  ​

Net Loss

​

$

(43,174)

​

$

(26,984)

Denominator:

​

​

​

​

 

  ​

Weighted average common shares outstanding

​

​

1,545,163

​

 

1,524,640

Denominator for basic and diluted loss per share

​

​

1,545,163

​

 

1,524,640

Basic and diluted loss per share

​

$

(27.94)

​

$

(17.70)

​

Basic and diluted earnings per share was the same for each period presented as the inclusion of all potential Common Stock outstanding would have been anti-dilutive.

Per ASC 260, shares issuable for little to no consideration (“Penny Warrants”) should be included in the number of outstanding shares used for Basic EPS. As of December 31, 2025 and 2024, the Company included 65,430 warrants in the denominator of Basic EPS since the exercise price was $0.01 per share thus are considered Penny Warrants.

The following table presents the potential common stock outstanding that was excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Warrants

 

247,697

​

273,869

Restricted shares

 

5,526

​

3,737

Options

 

455,551

​

375,480

​

 

708,774

​

653,086

​

​

F-99

Table of Contents

​

22.Segment Reporting

The Company’s Chief Operating Decision Maker (CODM) evaluates financial performance and allocates resources using both consolidated financial information and disaggregated operating results by reportable segment, including revenue and gross profit (loss).

The CODM regularly reviews discrete financial information by operating segment, including revenue and gross profit (loss), for purposes of assessing performance and allocating resources.

For financial reporting purposes, the Company presents disaggregated financial information for three reportable segments based on the nature of its products and services:

●Tool Manufacturing & Related Services
●Coating Services
●Battery Manufacturing

Revenue by reportable segment is based on the nature of the Company’s products and services. Tool Manufacturing and Related Services revenue primarily relates to the sale of ALD equipment and related maintenance services. Coating Services revenue relates to project-based coating applications. Battery Manufacturing revenue relates to the production and sale of advanced battery products.

Segment Identification

These segments represent components of the business that meet the definition of operating segments under ASC 280-10-50-1, as discrete financial information is available and regularly reviewed by the CODM.

Performance Measure

Segment profit (loss) is measured as gross profit (loss), which is defined as segment revenue less cost of sales.

This is the sole measure provided to the CODM to evaluate trends segment performance and margin characteristics across product and service offerings.

Segment Assets

Although asset information by segment is available, it is not regularly provided to or reviewed by the CODM for purposes of assessing performance or allocating resources.

Significant Segment Expenses

The CODM regularly reviews cost of sales at the segment level, which represents the only significant segment expense disclosed.

No other expense categories (including general and administrative expenses, research and development, or other operating expenses) are provided to or regularly reviewed by the CODM at the segment level.

Segment performance is therefore evaluated based on gross profit (loss), and operating expenses are managed and evaluated on a consolidated basis.

Corporate and other unallocated amounts included in the reconciliation consist primarily of general and administrative expenses, research and development expenses, and other operating expenses that are not allocated to the reportable segments, as well as interest income, interest expense, and income taxes.

F-100

Table of Contents

​

Revenue by reportable segment is as follows:

​

​

​

​

Years ended December 31,

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Tool manufacturing and related services

​

$

4,625

​

$

6,852

Coating services

​

​

1,429

​

​

1,332

Battery manufacturing

​

​

1,334

​

​

115

Total

​

$

7,388

​

$

8,299

​

Segment revenue, cost of sales, and gross profit (loss) are as follows:

​

​

Years ended December 31, 2025

​

​

​

Tool Manufacturing &

​

​

​

Battery

​

​

​

​

​

Related Services

​

Coating Services

​

Manufacturing

​

Total

​

Total revenue

  ​ ​ ​

$

4,625

  ​ ​ ​

$

1,429

  ​ ​ ​

$

1,334

  ​ ​ ​

$

7,388

 

Cost of sales

​

​

(6,239)

​

​

(3,921)

​

​

(1,085)

​

​

(11,245)

​

Gross (loss) profit

​

$

(1,614)

​

$

(2,492)

​

$

249

​

$

(3,857)

​

​

​

​

Years ended December 31, 2024

​

​

​

Tool Manufacturing &

​

​

​

Battery

​

​

​

​

​

Related Services

​

Coating Services

​

Manufacturing

​

Total

​

Total revenue

  ​ ​ ​

$

6,852

  ​ ​ ​

$

1,332

  ​ ​ ​

$

115

  ​ ​ ​

$

8,299

 

Cost of sales

​

​

(5,441)

​

​

(2,486)

​

​

(40)

​

​

(7,967)

​

Gross profit (loss)

​

$

1,411

​

$

(1,154)

​

$

75

​

$

332

​

​

Reconciliation of segment results to consolidated results is as follows:

​

​

Years ended December 31,

​

​

​

2025

​

2024

​

Segment gross (loss) profit

  ​ ​ ​

$

(3,857)

  ​ ​ ​

$

332

 

General and administrative

​

​

40,788

​

​

27,474

​

Operating loss

​

​

(44,645)

​

​

(27,142)

​

​

​

​

​

​

​

​

​

Interest income

​

​

637

​

​

1,053

​

Grant income

​

​

7,062

​

​

2,306

​

Other income

​

​

865

​

​

263

​

​

​

​

​

​

​

​

​

Interest expense, change in fair value, and amortization of debt discount

​

​

(6,515)

​

​

(3,439)

​

Other expense

​

​

(578)

​

​

(25)

​

​

​

​

​

​

​

​

​

Non-operating income

​

​

1,471

​

​

158

​

​

​

​

​

​

​

​

​

Net loss

​

$

(43,174)

​

$

(26,984)

​

​

Revenues by geographic region consisted of the following for the years ended December 31, 2025 and 2024:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

December 31,

​

  ​ ​ ​

2025

  ​ ​ ​

2024

US

​

$

5,295

​

$

6,571

Canada

​

​

798

​

 

20

EMEA

​

​

588

​

 

1,120

APAC

​

​

707

​

 

588

Total

​

$

7,388

​

$

8,299

​

F-101

Table of Contents

​

Reconciliations of segment revenues and profit or loss to the consolidated financial statements for the years ended December 31, 2025 are as follows:

●Revenue — Adjusted for intersegment eliminations.
●Profit/Loss — Adjusted for corporate expenses, interest, and income taxes.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Tool 

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Manufacturing 

​

​

​

​

​

​

​

​

​

​

​

​

​

​

& Related 

​

Coating

​

Battery 

​

​

​

​

​

​

​

  ​ ​ ​

Services

  ​ ​ ​

Services

  ​ ​ ​

Manufacturing

  ​ ​ ​

Corporate

  ​ ​ ​

Total

Revenue

​

$

4,625

​

$

1,429

​

$

1,334

​

$

—

​

$

7,388

Cost of sales

​

 

6,239

​

 

3,921

​

 

1,085

​

 

—

​

 

11,245

Gross profit (loss)

​

 

(1,614)

​

 

(2,492)

​

 

249

​

 

—

​

 

(3,857)

General and administrative

​

 

1,916

​

 

2,123

​

 

780

​

 

35,969

​

 

40,788

Operating profit (loss)

​

 

(3,530)

​

 

(4,615)

​

 

(531)

​

 

(35,969)

​

 

(44,645)

Other income

​

 

—

​

 

—

​

 

—

​

 

1,471

​

 

1,471

Net income (loss)

​

$

(3,530)

​

$

(4,615)

​

$

(531)

​

$

(34,498)

​

$

(43,174)

​

​

​

​

F-102

Table of Contents

​

FORGE NANO HOLDINGS, INC.

CONDENSED BALANCE SHEETS

​

​

​

​

​

​

​

​

​

  ​ ​ ​

SEPTEMBER 30,

  ​ ​ ​

DECEMBER 31,

​

​

2026

​

2025

​

​

(Unaudited)

​

​

​

ASSETS

 

​

  ​

 

​

  ​

Total Current Assets

​

$

—

​

$

—

TOTAL ASSETS

​

$

—

​

$

—

​

​

​

​

​

​

​

LIABILITIES AND STOCKHOLDER’S DEFICIT

​

 

  ​

​

 

  ​

Current Liabilities:

​

 

  ​

​

 

  ​

Accrued expenses

​

$

225

​

$

659

Due to Parent

​

 

140,338

​

 

—

PIPE subscription derivative liability

​

 

100,420,000

​

 

—

TOTAL LIABILITIES

​

 

100,560,563

​

 

659

​

​

​

​

​

​

​

Commitments and Contingencies (Note 4)

​

 

  ​

​

 

  ​

​

​

​

​

​

​

​

STOCKHOLDER’S DEFICIT

​

 

  ​

​

 

  ​

Common stock, $0.0001 par value; 100 shares authorized, issued and outstanding

​

 

—

​

 

—

Additional paid-in capital

​

 

10

​

 

10

Stock subscription receivable

​

 

(10)

​

 

(10)

Accumulated deficit

​

 

(100,560,563)

​

 

(659)

Total Stockholder’s Deficit

​

 

(100,560,563)

​

 

(659)

TOTAL LIABILITIES AND STOCKHOLDER’S DEFICIT

​

$

—

​

$

—

​

The accompanying notes are an integral part of these unaudited condensed financial statements.

​

F-103

Table of Contents

​

FORGE NANO HOLDINGS, INC.

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

​

​

​

​

​

​

​

​

​

For the Three

​

For the Nine

​

​

Months Ended

​

Months Ended

​

​

September 30, 2026

​

September 30, 2026

​

  ​ ​ ​

​

(Unaudited)

  ​ ​ ​

​

(Unaudited)

​

​

​

​

​

​

​

General and administrative expenses

​

$

19,960

​

$

139,904

Loss from operations

​

 

(19,960)

​

 

(139,904)

​

​

​

​

​

​

​

Other income (expense):

​

 

  ​

​

 

  ​

PIPE subscription expense

​

 

—

​

 

(100,000,000)

Gain (loss) on change in fair value of PIPE subscription derivative liability

​

 

37,522,000

​

 

(420,000)

Total other income (expense)

​

 

37,522,000

​

 

(100,420,000)

​

​

​

​

​

​

​

Net Income (Loss)

​

$

37,502,040

​

$

(100,559,904)

​

​

​

​

​

​

​

Weighted average shares of common stock outstanding, basic and diluted

​

 

100

​

 

100

Basic and diluted net income (loss) per share of common stock

​

$

375,020.40

​

$

(1,005,599.04)

​

The accompanying notes are an integral part of these unaudited condensed financial statements.

​

F-104

Table of Contents

​

FORGE NANO HOLDINGS, INC.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDER’S DEFICIT

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026

(UNAUDITED)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

​

​

​

Stock Subscription

​

Additional

​

​

​

​

Total

​

​

Common Stock

​

Receivable from

​

Paid-in

​

Accumulated

​

Stockholder’s

​

  ​ ​ ​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Stockholder

  ​ ​ ​

Capital

  ​ ​ ​

Deficit

  ​ ​ ​

Deficit

Balance – December 31, 2025

 

100

​

$

—

​

$

(10)

​

$

10

​

$

(659)

​

$

(659)

Net income (loss)

 

—

​

 

—

​

 

—

​

 

—

​

 

(37,269)

​

 

(37,269)

Balance – March 31, 2026 (unaudited)

 

100

​

 

—

​

 

(10)

​

 

10

​

 

(37,928)

​

 

(37,928)

Net income (loss)

 

—

​

 

—

​

 

—

​

 

—

​

 

(138,024,675)

​

 

(138,024,675)

Balance – June 30, 2026 (unaudited)

 

100

​

$

—

​

 

(10)

​

 

10

​

 

(138,062,603)

​

 

(138,062,603)

Net income (loss)

 

—

​

 

—

​

 

—

​

 

—

​

 

37,502,040

​

 

37,502,040

Balance – September 30, 2026 (unaudited)

 

100

​

$

—

​

$

(10)

​

$

10

​

$

(100,560,563)

​

$

(100,560,563)

​

The accompanying notes are an integral part of these unaudited condensed financial statements.

​

F-105

Table of Contents

​

FORGE NANO HOLDINGS, INC.

CONDENSED STATEMENT OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026

(UNAUDITED)

​

​

​

​

Cash Flows from Operating Activities:

  ​ ​ ​

​

  ​

Net loss

​

$

(100,559,904)

General and administrative expenses paid by Parent

​

 

139,904

PIPE subscription expense - initial recognition

​

 

100,000,000

Change in fair value of PIPE subscription derivative liability

​

 

420,000

Net cash used in operating activities

​

 

—

​

​

​

​

Net Change in Cash

​

 

—

Cash – Beginning of period

​

 

—

Cash – End of period

​

$

—

​

The accompanying notes are an integral part of these unaudited condensed financial statements.

​

F-106

Table of Contents

​

FORGE NANO HOLDINGS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(UNAUDITED)

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

ATII Holdings Inc. (“Pubco”) was incorporated in Delaware on December 4, 2025. The Company was formed for the purpose of merging with Archimedes Tech SPAC Partners II Co., a Cayman Islands exempted company (“ATII” or “Parent”), to facilitate the consummation of a Business Combination.

The Business Combination was closed on October 22, 2026 (the “Closing Date”). In connection with the Business Combination, Pubco was renamed “Forge Nano Holdings, Inc.” (the “Company”).

The Business Combination

On April 20, 2026, Parent, Pubco, ATII Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub I”), ATII Merger Sub II, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Parent (“Merger Sub II”), and Forge Nano, Inc., a Delaware corporation (“Forge Nano”), entered into a merger agreement (the “Merger Agreement”).

On October 16, 2026, ATII held an extraordinary general meeting (the “Extraordinary General Meeting”) to approve the Business Combination and the transactions contemplated therewith. On the same date, ATII issued a press release announcing the approval of the Business Combination Proposal as well as other proposals related to the Business Combination considered and voted upon at the Extraordinary General Meeting (see Note 8).

On October 21, 2026, ATII consummated the Domestication Merger (as defined below) and, on the Closing Date, the parties to the Merger Agreement consummated the Company Mergers (as defined below) and the other transactions contemplated by the Merger Agreement (the “Closing”).

Domestication Merger

Pursuant to the Merger Agreement, on October 21, 2026, ATII re-domiciled and became a Delaware corporation by merging with and into Pubco (the “Domestication Merger”), following which the separate corporate existence of ATII ceased and Pubco continued as the surviving corporation. At the effective time of the Domestication Merger (the “Domestication Merger Effective Time”), Pubco adopted Delaware organizational documents (the Charter and the Bylaws), which provide, among other things, that the name of Pubco was changed to “Forge Nano Holdings, Inc.”

Immediately prior to the Domestication Merger Effective Time, each then issued and outstanding unit of ATII (an “ATII Unit”) separated and converted automatically into one ordinary share, par value $0.0001 per share, of ATII (an “ATII Ordinary Share”) and one-half of one warrant of ATII, each whole warrant entitling the holder thereof to acquire one ATII Ordinary Share at a purchase price of $11.50 per share (the “ATII Warrants”), and all ATII Units ceased to be outstanding and ceased to exist. At the Domestication Merger Effective Time, each then issued and outstanding ATII Ordinary Share was cancelled in exchange for the right to receive one share of common stock, par value $0.0001 per share, of Pubco (each, a share of “Pubco Common Stock”) and each whole ATII Warrant that was outstanding and unexercised converted automatically into a warrant to acquire one share of Pubco Common Stock at a purchase price of $11.50 per share (each, a “Pubco SPAC Warrant”), pursuant to the terms of the Warrant Agreement, dated as of February 10, 2025 (as assumed by Pubco pursuant to the Assumption of Warrant Agreement dated as of October 21, 2026, the “ATII Warrant Agreement”), by and between ATII and Odyssey Transfer and Trust Company, as warrant agent.

F-107

Table of Contents

​

Company Mergers

On the Closing Date, as contemplated by the Merger Agreement and as described in the section titled “Proposal No. 1 – The Business Combination Proposal” beginning on page 140 of the definitive proxy statement/prospectus dated September 22, 2026, filed with the SEC on September 24, 2026 (the “Proxy Statement/Prospectus”), the parties to the Merger Agreement consummated the Company Mergers, whereby:

●Merger Sub I merged with and into Forge Nano (the “First Company Merger”), with Forge Nano surviving the First Company Merger as a wholly-owned subsidiary of the Company (the “Initial Surviving Corporation”);
●at the effective time of the First Company Merger (the “First Effective Time”), (i) each share of each class of preferred stock, par value $0.0001 per share, of Forge Nano (the “Forge Nano Preferred Stock”) issued and outstanding immediately prior to the First Effective Time was converted into shares of common stock, par value $0.0001 per share, of Forge Nano (the “Forge Nano Common Stock”) pursuant to Forge Nano’s organizational documents, and (ii) each share of Forge Nano Common Stock issued and outstanding immediately prior to the First Effective Time (including shares of Forge Nano Common Stock issued upon conversion of the Forge Nano Preferred Stock, but excluding treasury shares, which were cancelled) was cancelled and automatically converted into the right to receive, without interest, the applicable pro rata portion of the Closing Payment Shares, based on an exchange ratio calculated as of the First Effective Time of approximately 28.5 to 1 (the “Exchange Ratio”);
●in addition, at the First Effective Time, (i) each option to purchase shares of Forge Nano Common Stock (each, a “Forge Nano Option”) outstanding and unexpired immediately prior to the First Effective Time was converted into an option to purchase shares of Pubco Common Stock (each, a “Pubco Option”) on substantially the same terms and conditions, including with respect to vesting and termination-related provisions, except that the number of shares of Pubco Common Stock subject to each Pubco Option equals the product (rounded down to the nearest whole share) of (a) the number of shares of Forge Nano Common Stock subject to such Forge Nano Option immediately prior to the First Effective Time and (b) the quotient of the Applicable Per Share Merger Consideration divided by the Equity Award Conversion Amount (each as defined in the Merger Agreement), and the per-share exercise price of each Pubco Option equals the exercise price per share of such Forge Nano Option divided by the Equity Award Conversion Amount, rounded up to the nearest whole cent; (ii) each warrant of Forge Nano (each, a “Forge Nano Warrant”) outstanding and unexpired immediately prior to the First Effective Time was assumed by the Company and became a corresponding warrant to purchase shares of Pubco Common Stock (each, a “Pubco Forge Nano Warrant”), subject to the same terms and conditions (including vesting and exercisability) as were applicable to the corresponding Forge Nano Warrant immediately prior to the First Effective Time; and (iii) each option to acquire securities of Forge Nano held by Ascent Funds International Management LLC or its affiliates (the “Forge Nano Ascent Options” and, together with the Forge Nano Warrants, the “Forge Nano Convertible Securities”) outstanding and unexpired immediately prior to the First Effective Time was cancelled and converted into a warrant to purchase shares of Pubco Common Stock (each, a “Pubco Ascent Warrant” and, together with the Pubco Forge Nano Warrants, the “Pubco Convertible Securities”) pursuant to the Pubco Ascent Warrant Agreement (as defined in the Proxy Statement/Prospectus);
●the Company issued an aggregate of 90,000,000 shares of Pubco Common Stock (the “Earn-Out Shares”) to Odyssey Transfer and Trust Company, as escrow agent (the “Escrow Agent”), which will be disbursed to the former shareholders of Forge Nano who received Closing Payment Shares (as defined in the Proxy Statement/Prospectus) and the holders of Pubco Convertible Securities, in proportional amounts, upon the achievement of the following milestones during the five-year period following the Closing Date: (a) 30,000,000 Earn-Out Shares if the VWAP (as defined in the Merger Agreement) of the Pubco Common Stock equals or exceeds $15.00 per share over any 30-trading-day period or the revenue publicly reported by the Company for the preceding twelve months equals or exceeds $400,000,000; (b) 30,000,000 Earn-Out Shares if such VWAP equals or exceeds $20.00 per share or such revenue equals or exceeds $600,000,000; and (c) 30,000,000 Earn-Out Shares if such VWAP equals or exceeds $25.00 per share or such revenue equals or exceeds $800,000,000. The milestones operate on a cumulative basis, and Earn-Out Shares attributable to holders of Pubco Convertible Securities will only be disbursed upon the exercise, conversion or settlement of such Pubco Convertible Securities in accordance with their terms; and
●immediately following the First Effective Time, the Initial Surviving Corporation merged with and into Merger Sub II (the “Second Company Merger” and, together with the First Company Merger, the “Company Mergers” and, the Company Mergers together with the Domestication Merger and the other transactions contemplated by the Merger Agreement, the “Business Combination”), with Merger Sub II surviving the Second Company Merger as a wholly-owned subsidiary of the Company.

F-108

Table of Contents

​

PIPE Financing

On April 20, 2026, concurrently with the execution of the Merger Agreement, ATII, Pubco and Forge Nano entered into a subscription agreement (the “PIPE Subscription”, as amended and restated on October 13, 2026) with a certain accredited investor (the “Initial PIPE Investor”), pursuant to which, substantially concurrently with the Closing, the Company issued and sold to the Initial PIPE Investor for an aggregate purchase price of $100,000,000 (the “PIPE Financing”) (a) 2,968,825 shares of Pubco Common Stock (the “PIPE Subscribed Shares”) at a subscription price of $10.00 per share, (b) pre-funded warrants (the “Pre-Funded Warrants”) to purchase an aggregate of 7,031,175 shares of Pubco Common Stock, each with an exercise price of $0.0001 per share, at a subscription price of $10.00 per Pre-Funded Warrant, and (c) warrants (the “PIPE Warrants”) to purchase an aggregate of 15,000,000 shares of Pubco Common Stock, each with an initial exercise price of $10.00 per share (subject to adjustment as described below).

The PIPE Warrants are exercisable at any time after their issuance and expire five years after the date of issuance. The exercise price of the PIPE Warrants is subject to certain adjustments, including a one-time reset on the 21st trading day following the six-month anniversary of the Closing Date to the greater of (i) the VWAP (as defined in the PIPE Warrant Certificate) of the Pubco Common Stock for the twenty trading day period commencing on the date that is six months after the Closing Date and (ii) a floor price of $5.00 per share (the “PIPE Reset Price”). The terms of the PIPE Warrants are described in the section of the Proxy Statement/Prospectus titled “Description of Pubco Securities – Warrants – PIPE Warrants” beginning on page 360, which is incorporated herein by reference.

In the event that on the 21st trading day following the six-month anniversary of the Closing Date, the VWAP (as defined in the PIPE Warrant Certificate) of the Pubco Common Stock is less than the Exercise Price (as defined in the PIPE Warrant Certificate), the Company will issue to the Initial PIPE Investor additional warrants entitling the Initial PIPE Investor to purchase up to 10,000,000 shares of Pubco Common Stock (the “Reset PIPE Warrants”), in an amount equal to (i) the product of (x) 10,000,000, multiplied by (y) the Exercise Price then in effect divided by the PIPE Reset Price minus (ii) 10,000,000. In addition, if, on the 24-month anniversary of the Closing Date, the Initial PIPE Investor certifies in writing that the Initial PIPE Investor beneficially owns 5,000,000 shares of Pubco Common Stock, the Company will issue to the Initial PIPE Investor additional warrants entitling the Initial PIPE Investor to purchase 5,000,000 shares of Pubco Common Stock (the “Additional PIPE Warrants”).

Additionally, subsequent to the execution of the Merger Agreement, ATII, Pubco and Forge Nano entered into subscription agreements (the “Additional PIPE Subscription Agreements”) with certain other accredited investors (collectively, the “Additional PIPE Investors” and together with the Initial PIPE Investor, the “PIPE Investors”), pursuant to which, substantially concurrently with the Closing, the Company issued and sold an aggregate of 2,300,000 shares of Pubco Common Stock (the “Additional PIPE Subscribed Shares”) to the Additional PIPE Investors at a subscription price of $10.00 per share, for an aggregate purchase price of $23,000,000 (the “Additional PIPE Financing”).

Outstanding Securities

In connection with the consummation of the Business Combination and the PIPE Financing, and after giving effect to the redemptions, the Company:

(1)

issued an aggregate of 128,655,585 shares of Pubco Common Stock, consisting of:

●7,370,932 shares of Pubco Common Stock issued to the holders of ATII Ordinary Shares in the Domestication Merger (after giving effect to the redemptions);
●116,015,828 shares of Pubco Common Stock issued to the former stockholders of Forge Nano as Closing Payment Shares in the First Company Merger;
●5,268,825 shares of Pubco Common Stock issued to the PIPE Investors in the PIPE Financing and the Additional PIPE Financing;

(2)

issued 90,000,000 Earn-Out Shares to the Escrow Agent;

(3)

issued 11,919,995 Pubco SPAC Warrants in exchange for ATII Warrants in the Domestication Merger;

(4)

issued PIPE Warrants exercisable for up to 15,000,000 shares of Pubco Common Stock and Pre-Funded Warrants exercisable for up to 7,031,175 shares of Pubco Common Stock in the PIPE Financing;

F-109

Table of Contents

​

(5)

issued or assumed Pubco Options, Pubco Forge Nano Warrants and Pubco Ascent Warrants that collectively are exercisable for 15,954,561 shares of Pubco Common Stock; and

(6)

granted an aggregate of 8,744,864 Performance Stock Units (“PSUs”) which will vest as follows: (i) one third of the PSUs will vest if the VWAP of the Pubco Common Stock equals or exceeds $15.00 per share over any 30-trading day period or the revenue of the Company for the preceding twelve months equals or exceeds $400,000,000, (ii) one third of the PSUs will vest if the VWAP of the Pubco Common Stock equals or exceeds $20.00 per share over any 30-trading day period or the revenue of the Company for the preceding twelve months equals or exceeds $600,000,000 and (iii) one third of the PSUs will vest if the VWAP of the Pubco Common Stock equals or exceeds $25.00 per share over any 30-trading day period or the revenue of the Company for the preceding twelve months equals or exceeds $800,000,000.

In addition, at the Closing, pursuant to the Purchaser Support Agreement, dated as of April 20, 2026 (the “Purchaser Support Agreement”), by and among ATII, Forge Nano and Archimedes Tech SPAC Sponsors II LLC (the “Sponsor”), the Sponsor transferred an aggregate of 3,300,000 shares of Pubco Common Stock (which it received in exchange for Founder Shares in the Domestication Merger) to certain investors at the Closing in connection with the PIPE Financing for no additional cash consideration.

In connection with the Closing, OIC exercised all of their outstanding Forge Nano Warrants in exchange for shares of Forge Nano Common Stock, which were converted into shares of Pubco Common Stock at the First Effective Time and are included in the 116,015,828 shares of Pubco Common Stock issued to former stockholders of Forge Nano, as described above.

Liquidity and Capital Resources

For the three and nine months ended September 30, 2026, the Company reported net income and net loss of $37,502,040 and $100,559,904, respectively. As of September 30, 2026, the Company had no cash and working capital deficit of $100,560,563.

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s (“FASB”) Accounting Standards Codification (“ASC”) 205-40, “Financial Statement Presentation — Going Concern,” on October 22, 2026, the Company consummated its previously announced Business Combination by and among ATII, Pubco, Merger Sub I, Merger Sub II, and Forge Nano. Prior to the consummation of the Business Combination, management concluded that recurring losses from operations, negative operating cash flows and limited liquidity raised substantial doubt regarding the Company’s ability to continue as a going concern. On October 21, 2026, subsequent to the balance sheet date, the Company completed the Business Combination and received net proceeds from the transaction. Management updated its cash flow forecasts to reflect the capital raised and expected operating expenditures of the combined company. Based on this analysis, management concluded that the Company has sufficient liquidity to meet its obligations and fund planned operations for at least twelve months from the issuance date of these condensed consolidated financial statements. Accordingly, management determined that substantial doubt regarding the Company’s ability to continue as a going concern has been alleviated.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The interim results for the three and nine months ended September 30, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.

F-110

Table of Contents

​

Use of Estimates

The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting periods.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity date of three months or less when purchased to be cash equivalents. The Company did not have any cash or cash equivalents as of September 30, 2026 and December 31, 2025.

Net Income (Loss) Per Share

Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares outstanding for the period. For purposes of calculating diluted income (loss) per share, the denominator includes both the weighted average number of shares outstanding during the period and the number of common share equivalents if the inclusion of such common share equivalents is dilutive.

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2026 and December 31, 2025, the Company did not have a deferred tax liability as the deferred tax asset was fully offset by a valuation allowance.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits and underpayment of income tax as income tax expense. As of September 30, 2026 and December 31, 2025, the Company did not incur interest and penalties related to underpayment of income taxes. There were no unrecognized tax benefits as of September 30, 2026 and December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.

F-111

Table of Contents

​

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period in accordance with FASB ASC Topic 480, “Distinguishing Liabilities from Equity”. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The PIPE Subscription is representative of a derivative instrument within the scope of ASC 815.

Recent Accounting Standards

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company has not yet adopted the ASU 2023-09 and is currently evaluating its impact on the Company’s financial statements and related disclosures.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted ASU 2023-07 on December 4, 2025 (inception). The adoption of ASU 2023-07 did not have a material effect on the Company’s financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

NOTE 3. RELATED PARTY TRANSACTIONS

Due to Parent

Amounts due to Parent represent general and administrative expenses paid on behalf of the Company by Parent and is due on demand. As of September 30, 2026 and December 31, 2025, amounts due to Parent amounted to $140,338 and $0, respectively.

NOTE 4. COMMITMENTS AND CONTINGENCIES

Risks and Uncertainties

The Company’s ability to complete an initial business combination may be adversely affected by various factors, many of which are beyond the Company’s control. The Company’s ability to consummate an initial business combination could be impacted by, among other things, changes in laws or regulations, downturns in the financial markets or in economic conditions, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine and the Middle East. The Company cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company’s ability to complete an initial business combination.

F-112

Table of Contents

​

Any of the above-mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from ongoing global conflicts and/or other future global conflicts and subsequent sanctions or related actions, could adversely affect the Company’s search for an initial business combination and any target business with which the Company may ultimately consummate an initial business combination.

​

NOTE 5. STOCKHOLDER’S DEFICIT

Common Stock

The Company is authorized to issue 100 shares of common stock with a par value of $0.0001 per share. On December 29, 2025, the Company issued 100 shares of common stock to ATII for an aggregate purchase price of $10. Accordingly, as of September 30, 2026 and December 31, 2025, the payment due to the Company is recorded as stock subscription receivable in the stockholder’s deficit section of the accompanying balance sheets. As of September 30, 2026 and December 31, 2025, there are 100 shares of common stock issued and outstanding. Each share of common stock entitles the holder to one vote.

NOTE 6. FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

●Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
●Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
●Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

The PIPE Subscription was evaluated under freestanding financial instrument framework and management concluded that the common stock subscribed and the related warrant features together, should be evaluated as a single common stock PIPE freestanding financial instrument.

On April 20, 2026, the PIPE Subscription was initially recognized at fair value of $100,000,000. As of September 30, 2026, the PIPE Subscription has a fair value of $100,420,000. The fair value of the PIPE Subscription was determined using Monte Carlo Simulation Model. The PIPE Subscription has been classified as current liability within the scope of ASC 815 and will require remeasurement at each reporting period. The following table presents the quantitative information regarding market assumptions used in the Level 3 valuation of the PIPE Subscription:

​

​

​

​

​

​

​

​

​

​

​

April 20,

​

​

September 30,

 

​

  ​ ​ ​

2026

  ​ ​ ​

​

2026

 

Expected term to De-SPAC (Years)

 

​

0.4

 

​

0.1

​

Warrant term

 

​

5.0

 

​

5.0

​

Probability of De-SPAC and Market Adjustment

 

​

64.0

%  

​

52.0

%

Forward Risk-Free Rate (Continuous

 

​

3.88

%  

​

5.04

%

Volatility

 

​

19.5

%  

​

40.0

%

Redemption trigger price

​

$

35.00

 

$

35.00

​

Floor price

​

$

7.28

 

$

7.28

​

​

F-113

Table of Contents

​

The following table provides a summary of the changes in the fair value of PIPE Subscription, a Level 3 financial instrument, that was measured at fair value on a recurring basis:

​

​

​

​

​

Fair value at April 20, 2026

  ​ ​ ​

$

100,000,000

Change in fair value of PIPE subscription derivative liability

​

 

37,942,000

Fair value at June 30, 2026

​

 

137,942,000

Change in fair value of PIPE subscription derivative liability

​

 

(37,522,000)

Fair value at September 30, 2026

​

$

100,420,000

​

​

NOTE 7. SEGMENT INFORMATION

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker, or group, in deciding how to allocate resources and assess performance.

The Company’s CODM has been identified as the Chief Executive Officer, who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that there is only one reportable segment.

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the statements of operations as net income or loss. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews the below key metric included in net income or loss:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

For The Three

  ​ ​ ​

For The Nine

​

​

Months Ended

​

Months Ended

​

​

September 30, 2026

​

September 30, 2026

General and administrative expenses

​

$

19,960

​

$

139,904

PIPE subscription (expense)

​

$

—

​

$

(100,000,000)

Gain (loss) on change in fair value of PIPE subscription derivative liability

​

$

37,522,000

​

$

(420,000)

​

General and administrative expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination or similar transaction within the business combination period. The CODM also reviews operating expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. In addition, the CODM monitors the PIPE subscription expense and the related gain or loss on the change in fair value of the PIPE subscription derivative liability as it is directly tied to securing committed financing for the Business Combination and to assess the expected economic cost of the PIPE subscription agreement and its effect on the terms and feasibility of the Business Combination. The CODM uses the above segments items to evaluate performance and allocate resources.

​

NOTE 8. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in these financial statements.

On October 16, 2026, ATII held the Extraordinary General Meeting, at which its shareholders approved the Business Combination and the transactions contemplated therewith. In connection with the shareholders’ vote at such meeting, 22,219,068 ATII shares were tendered for redemption and $238,404,289, or approximately $10.73 redemption price per share, was withdrawn from the trust account to pay the redeeming shareholders.

Domestication Merger

​

Pursuant to the Merger Agreement, on October 21, 2026, ATII re-domiciled and became a Delaware corporation by merging with and into Pubco, following which the separate corporate existence of ATII ceased and Pubco continued as the surviving corporation. At

F-114

Table of Contents

​

the effective time of the Domestication Merger, Pubco adopted Delaware organizational documents, which provide, among other things, that the name of Pubco was changed to “Forge Nano Holdings, Inc.”

Immediately prior to the Domestication Merger Effective Time, each then issued and outstanding unit of ATII separated and converted automatically into one ordinary share, par value $0.0001 per share, of ATII and one-half of one warrant of ATII, each whole warrant entitling the holder thereof to acquire one ATII Ordinary Share at a purchase price of $11.50 per share, and all ATII Units ceased to be outstanding and ceased to exist. At the Domestication Merger Effective Time, each then issued and outstanding ATII Ordinary Share was cancelled in exchange for the right to receive one share of common stock, par value $0.0001 per share, of Pubco and each whole ATII Warrant that was outstanding and unexercised converted automatically into a warrant to acquire one share of Pubco Common Stock at a purchase price of $11.50 per share, pursuant to the terms of the Warrant Agreement, dated as of February 10, 2025 (as assumed by Pubco pursuant to the Assumption of Warrant Agreement dated as of October 21, 2026), by and between ATII and Odyssey Transfer and Trust Company, as warrant agent.

Company Mergers

On the Closing Date, as contemplated by the Merger Agreement, the parties to the Merger Agreement consummated the Company Mergers, whereby:

●Merger Sub I merged with and into Forge Nano (the “First Company Merger”), with Forge Nano surviving the First Company Merger as a wholly-owned subsidiary of the Company;
●at the effective time of the First Company Merger, (i) each share of each class of preferred stock, par value $0.0001 per share, of Forge Nano issued and outstanding immediately prior to the First Effective Time was converted into shares of common stock, par value $0.0001 per share, of Forge Nano pursuant to Forge Nano’s organizational documents, and (ii) each share of Forge Nano Common Stock issued and outstanding immediately prior to the First Effective Time (including shares of Forge Nano Common Stock issued upon conversion of the Forge Nano Preferred Stock, but excluding treasury shares, which were cancelled) was cancelled and automatically converted into the right to receive, without interest, the applicable pro rata portion of the Closing Payment Shares, based on an exchange ratio calculated as of the First Effective Time of approximately 28.5 to 1;
●in addition, at the First Effective Time, (i) each option to purchase shares of Forge Nano Common Stock outstanding and unexpired immediately prior to the First Effective Time was converted into an option to purchase shares of Pubco Common Stock on substantially the same terms and conditions, including with respect to vesting and termination-related provisions, except that the number of shares of Pubco Common Stock subject to each Pubco Option equals the product (rounded down to the nearest whole share) of (a) the number of shares of Forge Nano Common Stock subject to such Forge Nano Option immediately prior to the First Effective Time and (b) the quotient of the Applicable Per Share Merger Consideration divided by the Equity Award Conversion Amount (each as defined in the Merger Agreement), and the per-share exercise price of each Pubco Option equals the exercise price per share of such Forge Nano Option divided by the Equity Award Conversion Amount, rounded up to the nearest whole cent; (ii) each warrant of Forge Nano outstanding and unexpired immediately prior to the First Effective Time was assumed by the Company and became a corresponding warrant to purchase shares of Pubco Common Stock, subject to the same terms and conditions (including vesting and exercisability) as were applicable to the corresponding Forge Nano Warrant immediately prior to the First Effective Time; and (iii) each option to acquire securities of Forge Nano held by Ascent Funds International Management LLC or its affiliates outstanding and unexpired immediately prior to the First Effective Time was cancelled and converted into a warrant to purchase shares of Pubco Common Stock pursuant to the Pubco Ascent Warrant Agreement;
●the Company issued an aggregate of 90,000,000 shares of Pubco Common Stock to Odyssey Transfer and Trust Company, as escrow agent, which will be disbursed to the former shareholders of Forge Nano who received Closing Payment Shares and the holders of Pubco Convertible Securities, in proportional amounts, upon the achievement of the following milestones during the five-year period following the Closing Date: (a) 30,000,000 Earn-Out Shares if the VWAP (as defined in the Merger Agreement) of the Pubco Common Stock equals or exceeds $15.00 per share over any 30-trading-day period or the revenue publicly reported by the Company for the preceding twelve months equals or exceeds $400,000,000; (b) 30,000,000 Earn-Out Shares if such VWAP equals or exceeds $20.00 per share or such revenue equals or exceeds $600,000,000; and (c) 30,000,000 Earn-Out Shares if such VWAP equals or exceeds $25.00 per share or such revenue equals or exceeds $800,000,000. The milestones operate on a cumulative basis, and Earn-Out Shares attributable to holders of Pubco

F-115

Table of Contents

​

Convertible Securities will only be disbursed upon the exercise, conversion or settlement of such Pubco Convertible Securities in accordance with their terms; and
●immediately following the First Effective Time, the Initial Surviving Corporation merged with and into Merger Sub II, with Merger Sub II surviving the Second Company Merger as a wholly-owned subsidiary of the Company.

PIPE Financing

On April 20, 2026, concurrently with the execution of the Merger Agreement, ATII, Pubco and Forge Nano entered into a subscription agreement (as amended and restated on October 13, 2026) with a certain accredited investor, pursuant to which, substantially concurrently with the Closing, the Company issued and sold to the Initial PIPE Investor for an aggregate purchase price of $100,000,000 (a) 2,968,825 shares of Pubco Common Stock at a subscription price of $10.00 per share, (b) pre-funded warrants to purchase an aggregate of 7,031,175 shares of Pubco Common Stock, each with an exercise price of $0.0001 per share, at a subscription price of $10.00 per Pre-Funded Warrant, and (c) warrants (the “PIPE Warrants”) to purchase an aggregate of 15,000,000 shares of Pubco Common Stock, each with an initial exercise price of $10.00 per share (subject to adjustment as described below).

The PIPE Warrants are exercisable at any time after their issuance and expire five years after the date of issuance. The exercise price of the PIPE Warrants is subject to certain adjustments, including a one-time reset on the 21st trading day following the six-month anniversary of the Closing Date to the greater of (i) the VWAP (as defined in the PIPE Warrant Certificate) of the Pubco Common Stock for the twenty trading day period commencing on the date that is six months after the Closing Date and (ii) a floor price of $5.00 per share.

In the event that on the 21st trading day following the six-month anniversary of the Closing Date, the VWAP (as defined in the PIPE Warrant Certificate) of the Pubco Common Stock is less than the Exercise Price (as defined in the PIPE Warrant Certificate), the Company will issue to the Initial PIPE Investor additional warrants entitling the Initial PIPE Investor to purchase up to 10,000,000 shares of Pubco Common Stock, in an amount equal to (i) the product of (x) 10,000,000, multiplied by (y) the Exercise Price then in effect divided by the PIPE Reset Price minus (ii) 10,000,000. In addition, if, on the 24-month anniversary of the Closing Date, the Initial PIPE Investor certifies in writing that the Initial PIPE Investor beneficially owns 5,000,000 shares of Pubco Common Stock, the Company will issue to the Initial PIPE Investor additional warrants entitling the Initial PIPE Investor to purchase 5,000,000 shares of Pubco Common Stock.

Additionally, subsequent to the execution of the Merger Agreement, ATII, Pubco and Forge Nano entered into subscription agreements with certain other accredited investors, pursuant to which, substantially concurrently with the Closing, the Company issued and sold an aggregate of 2,300,000 shares of Pubco Common Stock to the Additional PIPE Investors at a subscription price of $10.00 per share, for an aggregate purchase price of $23,000,000.

Outstanding Securities

In connection with the consummation of the Business Combination and the PIPE Financing, and after giving effect to the redemptions, the Company:

(7)issued an aggregate of 128,655,585 shares of Pubco Common Stock, consisting of:
●7,370,932 shares of Pubco Common Stock issued to the holders of ATII Ordinary Shares in the Domestication Merger (after giving effect to the redemptions);
●116,015,828 shares of Pubco Common Stock issued to the former stockholders of Forge Nano as Closing Payment Shares in the First Company Merger;
●5,268,825 shares of Pubco Common Stock issued to the PIPE Investors in the PIPE Financing and the Additional PIPE Financing;
(8)issued 90,000,000 Earn-Out Shares to the Escrow Agent;
(9)issued 11,919,995 Pubco SPAC Warrants in exchange for ATII Warrants in the Domestication Merger;
(10)issued PIPE Warrants exercisable for up to 15,000,000 shares of Pubco Common Stock and Pre-Funded Warrants exercisable for up to 7,031,175 shares of Pubco Common Stock in the PIPE Financing;

F-116

Table of Contents

​

(11)issued or assumed Pubco Options, Pubco Forge Nano Warrants and Pubco Ascent Warrants that collectively are exercisable for 15,954,561 shares of Pubco Common Stock; and
(12)granted an aggregate of 8,744,864 Performance Stock Units which will vest as follows: (i) one third of the PSUs will vest if the VWAP of the Pubco Common Stock equals or exceeds $15.00 per share over any 30-trading day period or the revenue of the Company for the preceding twelve months equals or exceeds $400,000,000, (ii) one third of the PSUs will vest if the VWAP of the Pubco Common Stock equals or exceeds $20.00 per share over any 30-trading day period or the revenue of the Company for the preceding twelve months equals or exceeds $600,000,000 and (iii) one third of the PSUs will vest if the VWAP of the Pubco Common Stock equals or exceeds $25.00 per share over any 30-trading day period or the revenue of the Company for the preceding twelve months equals or exceeds $800,000,000.

In addition, at the Closing, pursuant to the Purchaser Support Agreement, dated as of April 20, 2026 (the “Purchaser Support Agreement”), by and among ATII, Forge Nano and the Sponsor), the Sponsor transferred an aggregate of 3,300,000 shares of Pubco Common Stock (which it received in exchange for Founder Shares in the Domestication Merger) to certain investors at the Closing in connection with the PIPE Financing for no additional cash consideration.

In connection with the Closing, OIC exercised all of their outstanding Forge Nano Warrants in exchange for shares of Forge Nano Common Stock, which were converted into shares of Pubco Common Stock at the First Effective Time and are included in the 116,015,828 shares of Pubco Common Stock issued to former stockholders of Forge Nano, as described above.

HzO Acquisition

On November 4, 2026, the Company completed the acquisition of HzO, Inc. (“HzO”), a leading provider of protective nanocoatings for electronics headquartered in Morrisville, North Carolina. Under the terms of the agreement, the Company acquired all outstanding equity of HzO in an all-stock transaction for approximately 7.3 million shares of Company common stock, subject to customary post-closing adjustments. Approximately 2.2 million of those shares were issued in exchange for the approximately 2.2 million shares of Company common stock held by HzO prior to closing, resulting in net issuance of approximately 5.1 million shares. Approximately 5.8 million of the total shares are being issued at closing, and approximately 1.5 million shares are being held back for twelve months to secure post-closing adjustment and indemnification obligations. HzO will operate as a wholly owned subsidiary of the Company under the HzO brand, led by Rachael Lerebours, President of HzO, and its employees will join the Company.

​

​

F-117

Table of Contents

​

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholder and the Board of Directors of
ATII Holdings, Inc:

Opinion on the Financial Statements

We have audited the accompanying balance sheet of ATII Holdings Inc. (the “Company”) as of December 31, 2025, the related statements of operations, changes in stockholder’s deficit and cash flows for the period from December 4, 2025 (inception) through December 31, 2025, and the related notes (collectively referred to as the “financial statements”). In our opinion, based on our audit, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025, and the results of its operations and its cash flows for the period from December 4, 2025 (Inception) through December 31, 2025, in conformity with accounting principles generally accepted in the United States of America.

Going Concern

The accompanying financial statement has been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statement, the Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans which raises substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

/s/ WithumSmith+Brown, PC

We have served as the Company’s auditor since 2025.

New York, New York
May 5, 2026
PCAOB ID Number 100

​

F-118

Table of Contents

​

ATII HOLDINGS INC.

​

BALANCE SHEET

DECEMBER 31, 2025

​

​

ASSETS

  ​ ​ ​

​

  ​ ​ ​

Total Current Assets

​

$

—

TOTAL ASSETS

​

$

—

​

​

​

​

LIABILITIES AND STOCKHOLDER’S DEFICIT

​

​

​

Current liabilities – Accrued expenses

​

$

659

TOTAL LIABILITIES

​

​

659

​

​

​

​

Commitments and Contingencies

​

​

​

​

​

​

​

STOCKHOLDER’S DEFICIT

​

​

​

Common stock, $0.0001 par value; 100 shares authorized, issued and outstanding

​

​

—

Additional paid-in capital

​

​

10

Stock subscription receivable

​

​

(10)

Accumulated deficit

​

​

(659)

Total Stockholder’s Deficit

​

​

(659)

TOTAL LIABILITIES AND STOCKHOLDER’S DEFICIT

​

$

—

​

The accompanying notes are an integral part of these financial statements.

​

F-119

Table of Contents

​

ATII HOLDINGS INC.

​

STATEMENT OF OPERATIONS

FOR THE PERIOD FROM DECEMBER 4, 2025 (INCEPTION) THROUGH DECEMBER 31, 2025

​

General and administrative expenses

  ​ ​ ​

$

659

Loss from operations

​

​

(659)

Net loss

​

$

(659)

Weighted average shares of common stock outstanding, basic and diluted

​

​

100

Basic and diluted net loss per share of common stock

​

$

(6.59)

​

The accompanying notes are an integral part of these financial statements.

​

F-120

Table of Contents

​

ATII HOLDINGS INC.

​

STATEMENT OF CHANGES IN STOCKHOLDER’S DEFICIT

FOR THE PERIOD FROM DECEMBER 4, 2025 (INCEPTION) THROUGH DECEMBER 31, 2025

​

​

​

​

​

​

​

​

  ​ ​ ​

​

​

Stock

  ​ ​ ​

​

  ​ ​ ​

​

  ​ ​ ​

​

​

​

​

​

Subscription

​

​

​

​

​

​

​

​

​

​

Receivable

​

Additional

​

​

​

Total

​

​

Common Stock

  ​ ​ ​

from

  ​ ​ ​

Paid-in

  ​ ​ ​

Accumulated

  ​ ​ ​

Stockholders’

​

​

Shares

  ​ ​ ​

Amount

​

Stockholder

​

Capital

​

Deficit

​

Deficit

Balance – December 4, 2025 (inception)

​

—

​

$

—

​

$

—

​

$

—

​

$

—

​

$

—

Issuance of common stock

​

100

​

​

—

​

​

(10)

​

​

10

​

​

—

​

​

—

Net loss

​

—

​

​

—

​

​

—

​

​

—

​

​

(659)

​

​

(659)

Balance – December 31, 2025

​

100

​

$

—

​

$

(10)

​

$

10

​

$

(659)

​

$

(659)

​

The accompanying notes are an integral part of these financial statements.

​

F-121

Table of Contents

​

ATII HOLDINGS INC.

​

STATEMENT OF CASH FLOWS

FOR THE PERIOD FROM DECEMBER 4, 2025 (INCEPTION) THROUGH DECEMBER 31, 2025

​

​

​

Cash Flows from Operating Activities:

  ​ ​ ​

​

​

Net loss

​

$

(659)

Adjustments to reconcile net loss to net cash used in operations:

​

​

​

Changes in operating assets and liabilities:

​

​

​

Accrued expenses

​

​

659

Net cash used in operating activities

​

​

—

​

​

​

​

Net Change in Cash

​

​

—

Cash – Beginning of period

​

​

—

Cash – End of period

​

$

—

​

The accompanying notes are an integral part of these financial statements.

​

​

F-122

Table of Contents

​

ATII HOLDINGS INC.

NOTES TO FINANCIAL STATEMENTS

FOR THE PERIOD FROM DECEMBER 4, 2025 (INCEPTION) THROUGH DECEMBER 31, 2025

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

ATII Holdings Inc. (the “Company” or “Holdings”) was incorporated in Delaware on December 4, 2025. The Company was formed for the purpose of merging with Archimedes Tech SPAC Partners II Co. (“Archimedes II”) to facilitate the consummation of a business combination.

Liquidity and Going Concern

For the period from December 4, 2025 (inception) through December 31, 2025, the Company reported net loss of $659. As of December 31, 2025, the Company had no cash and working capital deficit of $659.

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s (“FASB”) Accounting Standards Codification (“ASC”) 205-40, “Financial Statement Presentation — Going Concern,” the Company’s management has determined that the Company’s liquidity condition raises substantial doubt about the Company’s ability to continue as a going concern through twelve months from the date these financial statements are available to be issued. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”).

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity date of three months or less when purchased to be cash equivalents. The Company did not have any cash or cash equivalents as of December 31, 2025.

Net Loss Per Share

Net loss per share is computed by dividing net loss by the weighted average number of shares outstanding for the period. For purposes of calculating diluted loss per share, the denominator includes both the weighted average number of shares outstanding during the period and the number of common share equivalents if the inclusion of such common share equivalents is dilutive.

F-123

Table of Contents

​

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of December 31, 2025, the Company did not have deferred tax assets or liabilities.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits and underpayment of income tax as income tax expense. As of December 31, 2025, the Company did not incur interest and penalties related to underpayment of income taxes. There were no unrecognized tax benefits as of December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Recent Accounting Standards

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company has not yet adopted the ASU 2023-09 and is currently evaluating its impact on the Company’s financial statements and related disclosures.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted ASU 2023-07 on December 4, 2025 (inception). The adoption of ASU 2023-07 did not have a material effect on the Company’s financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

NOTE 3. STOCKHOLDER’S DEFICIT

Common Stock

The Company is authorized to issue 100 shares of common stock with a par value of $0.0001 per share. On December 29, 2025, the Company issued 100 shares of common stock to Archimedes II for an aggregate purchase price of $10. Accordingly, as of December 31, 2025, the payment due to the Company is recorded as stock subscription receivable in the stockholder’s deficit section

F-124

Table of Contents

​

of the accompanying balance sheet. As of December 31, 2025, there are 100 shares of common stock issued and outstanding. Each share of common stock entitles the holder to one vote.

NOTE 4. SEGMENT INFORMATION

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker, or group, in deciding how to allocate resources and assess performance.

The Company’s CODM has been identified as the Chief Executive Officer, who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that there is only one reportable segment.

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the statement of operations as net income or loss. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews the below key metric included in net income or loss:

​

​

​

  ​ ​ ​

For the period from
December 4, 2025
(inception) through
December 31, 2025

General and administrative expenses

​

$

659

​

General and administrative expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination or similar transaction within the business combination period. The CODM also reviews operating expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative expenses, as reported on the statement of operations, are the significant segment expenses provided to the CODM on a regular basis.

​

NOTE 5. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in these financial statements.

​

​

F-125

Table of Contents

​

HZO, inc. and subsidiaries

Unaudited Condensed Consolidated Financial Statements

For the Nine Months ended September 30, 2026 and 2025

​

Graphic

​

​

F-126

Table of Contents

​

HZO, inc. and subsidiaries

Unaudited Condensed Consolidated Financial Statements

Table of Contents

​

Page(s)

Unaudited Condensed Consolidated Financial Statements:

​

Unaudited Condensed Consolidated Balance Sheets

F-128

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss

F-129

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity

F-130

Unaudited Condensed Consolidated Statements of Cash Flows

F-131

Notes to Unaudited Condensed Consolidated Financial Statements

F-132 – F-148

​

​

​

F-127

Table of Contents

​

​

HZO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

​

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30,

  ​ ​ ​

December 31,

​

​

2026

​

2025

​

​

(Unaudited)

​

(Audited)

Assets

​

​

​

​

​

​

Current assets

 

​

  ​

 

​

  ​

Cash

​

$

1,730,053

​

$

4,572,687

Accounts receivable, net of allowance for credit losses of $0 and $5,447, respectively

​

 

1,661,822

​

 

802,626

Inventories, net

​

 

970,627

​

 

931,317

Prepaid expenses and other current assets

​

 

545,843

​

 

495,414

Total current assets

​

 

4,908,345

​

 

6,802,044

Property and equipment, net

​

 

2,448,756

​

 

3,827,230

Operating right-of-use asset, net

​

 

2,158,859

​

 

2,675,083

Non-marketable equity securities

​

 

15,000,000

​

 

—

Other assets

​

 

—

​

 

423,676

Intangible assets, net

​

 

865,797

​

 

1,177,485

Goodwill

​

 

8,079,456

​

 

8,079,456

Total assets

​

$

33,461,213

​

$

22,984,974

Liabilities and stockholders’ (deficiency) equity

​

 

  ​

​

 

  ​

Current Liabilities

​

 

  ​

​

 

  ​

Accounts payable

​

$

1,549,623

​

$

781,939

Accrued expenses and other current liabilities

​

 

2,197,598

​

 

704,547

Deferred revenue

​

 

—

​

 

21,728

Current portion of operating lease liabilities

​

 

983,249

​

 

982,996

Current portion of notes payable

​

 

22,914

​

 

21,923

Embedded derivative liability

​

 

62,057,000

​

 

3,396,000

Convertible promissory notes, net of discount

​

 

17,687,220

​

 

2,057,348

Warrant liability

​

 

2,783,673

​

 

51,673

Total current liabilities

​

 

87,281,277

​

 

8,018,154

Other liabilities

​

 

72,743

​

 

94,855

Long-term operating lease liabilities, net of current portion

​

 

1,369,308

​

 

1,931,610

Long-term notes payable, net of current portion

​

 

3,009,968

​

 

27,294

Total liabilities

​

 

91,733,296

​

 

10,071,913

Commitments and contingencies

​

 

—

​

 

—

Stockholders’ (deficiency) equity

​

 

  ​

​

 

  ​

Convertible preferred stock, $0.001 par value, 29,531,472,204 and 49,086,791,753 shares authorized; 28,014,564,020 shares issued and outstanding at September 30, 2026 and December 31, 2025

​

 

28,014,564

​

 

28,014,564

Common stock, $0.001 par value, 33,588,600,000 shares authorized; 44,824,953 shares issued and outstanding at September 30, 2026 and December 31, 2025

​

 

44,825

​

 

44,825

Additional paid-in capital

​

 

291,374,625

​

 

291,373,418

Accumulated deficit

​

 

(377,987,333)

​

 

(307,930,194)

Other comprehensive income

​

 

281,236

​

 

1,410,448

Total stockholders’ (deficiency) equity

​

 

(58,272,083)

​

 

12,913,061

Total liabilities and stockholders’ (deficiency) equity

​

$

33,461,213

​

$

22,984,974

​

The accompanying notes are an integral part of these condensed consolidated financial statements

F-128

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

​

​

​

​

​

​

​

​

​

Nine Months Ended

​

  ​ ​ ​

September 30,

  ​ ​ ​

September 30,

​

​

2026

​

2025

Revenue

​

$

6,811,771

​

$

3,696,119

Cost of revenue

​

 

5,992,240

​

 

4,870,503

Gross profit (loss)

​

 

819,531

​

 

(1,174,384)

Operating expenses:

​

 

  ​

​

 

  ​

Sales and marketing

​

 

1,099,184

​

 

1,658,003

Research and development

​

 

627,349

​

 

813,194

General and administrative

​

 

6,460,868

​

 

6,563,555

Total operating expenses

​

 

8,187,401

​

 

9,034,752

Loss from operations

​

 

(7,367,870)

​

 

(10,209,136)

Other income (expense):

​

 

  ​

​

 

  ​

Interest expense

​

 

(7,862,192)

​

 

(279,988)

Foreign currency gain

​

 

1,151,872

​

 

730,254

Change in fair value of embedded derivative and warrant liability

​

 

(55,318,000)

​

 

(135,000)

Other income (expense), net

​

 

(573,773)

​

 

(3,259,123)

Total other income (expense)

​

 

(62,602,093)

​

 

(2,943,857)

Loss before provision (benefit) for income taxes

​

 

(69,969,963)

​

 

(13,152,993)

Provision (benefit) for income taxes

​

 

87,176

​

 

(200,379)

Net loss

​

$

(70,057,139)

​

$

(12,952,614)

Other comprehensive income

​

 

  ​

​

 

  ​

Foreign currency translation adjustment

​

 

(1,129,212)

​

 

(691,373)

Comprehensive loss

​

$

(71,186,351)

​

$

(13,643,987)

​

The accompanying notes are an integral part of these condensed consolidated financial statements

​

​

F-129

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIENCY)

(Unaudited)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Nine Months Ended September 30, 2025

​

​

Convertible

​

​

​

​

​

​

​

​

​

​

​

​

Accumulated

​

​

​

​

​

Preferred Stock

​

Common Stock

​

​

​

​

​

​

​

Other

​

Total

​

​

​

​

​

​

​

​

​

​

​

​

Additional Paid-

​

Accumulated

​

Comprehensive

​

Stockholders’

​

  ​ ​ ​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

in Capital

  ​ ​ ​

Deficit

  ​ ​ ​

Income (Loss)

  ​ ​ ​

Equity

Balance as of December 31, 2024

​

4,119,991,396

​

$

4,119,991

​

56,438,694

​

$

56,439

​

$

297,328,788

​

$

(292,301,988)

​

$

2,727,448

​

$

11,930,678

Issuance of Series 2 preferred stock, net of issuance costs

 

10,932,485,432

​

 

10,932,485

 

—

​

 

—

​

 

(3,508,968)

​

 

—

​

 

—

​

 

7,423,517

Issuance of Series 2-A preferred stock, net of issuance costs

 

3,026,640,546

​

 

3,026,641

 

—

​

 

—

​

 

(1,080,137)

​

 

—

​

 

—

​

 

1,946,504

Issuance of Series 2-B preferred stock upon conversion of subordinated convertible promissory notes

 

6,027,707,347

​

 

6,027,708

 

—

​

 

—

​

 

(2,252,281)

​

 

—

​

 

—

​

 

3,775,427

Issuance of Series 2-C preferred stock upon conversion of subordinated convertible promissory notes

 

4,059,267,542

​

 

4,059,267

 

—

​

 

—

​

 

718,255

​

 

—

​

 

—

​

 

4,777,522

Repurchase of equity securities

​

(151,528,243)

​

​

(151,528)

​

(7,546,163)

​

​

(7,546)

​

​

159,071

​

​

—

​

​

—

​

​

(3)

Stock-based compensation

 

—

​

 

—

 

—

​

 

—

​

 

3,933

​

 

—

​

 

—

​

 

3,933

Foreign currency translation

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

—

​

 

(691,373)

​

 

(691,373)

Net loss

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

(12,952,614)

​

 

—

​

 

(12,952,614)

Balance as of September 30, 2025

 

28,014,564,020

​

$

28,014,564

 

48,892,531

​

$

48,893

​

$

291,368,661

​

$

(305,254,602)

​

$

2,036,075

​

$

16,213,591

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Nine Months Ended September 30, 2026

​

​

Convertible

​

​

​

​

​

​

​

​

​

​

​

​

Accumulated

​

Total

​

​

Preferred Stock

​

Common Stock

​

​

​

​

​

​

​

Other

​

Stockholders’

​

​

​

​

​

​

​

​

​

​

​

​

Additional Paid-

​

Accumulated

​

Comprehensive

​

Equity

​

  ​ ​ ​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

in Capital

  ​ ​ ​

Deficit

  ​ ​ ​

Income (Loss)

  ​ ​ ​

(Deficiency)

Balance as of December 31, 2025

​

28,014,564,020

​

$

28,014,564

​

44,824,953

​

$

44,825

​

$

291,373,418

​

$

(307,930,194)

​

$

1,410,448

​

$

12,913,061

Stock-based compensation

 

—

​

 

—

 

—

​

 

—

​

 

1,207

​

 

—

​

 

—

​

 

1,207

Foreign currency translation

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

—

​

 

(1,129,212)

​

 

(1,129,212)

Net loss

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

(70,057,139)

​

 

—

​

 

(70,057,139)

Balance as of September 30, 2026

 

28,014,564,020

​

$

28,014,564

 

44,824,953

​

$

44,825

​

$

291,374,625

​

$

(377,987,333)

​

$

281,236

​

$

(58,272,083)

​

The accompanying notes are an integral part of these condensed consolidated financial statements

​

​

F-130

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

​

​

​

​

​

​

​

​

  ​ ​ ​

Nine Months Ended

  ​ ​ ​

Nine Months Ended

​

​

September 30, 2026

​

September 30, 2025

Operating activities:

​

​

​

​

​

​

Net loss

​

$

(70,057,139)

​

$

(12,952,614)

Adjustments to reconcile net loss to net cash used in

​

 

  ​

​

 

  ​

operating activities:

​

 

  ​

​

 

  ​

Depreciation and amortization

​

 

1,749,043

​

 

2,350,727

Change in right-of-use assets

​

 

516,224

​

 

562,030

Loss on extinguishment of debt

​

 

—

​

 

3,071,008

Amortization of debt discount

​

 

6,261,997

​

 

216,156

Stock-based compensation

​

 

1,207

​

 

3,933

Loss on disposal of fixed assets

​

 

194,556

​

 

189,573

Revaluation of convertible note derivative liabilities and warrant liability

​

 

55,318,000

​

 

135,000

Changes in operating assets and liabilities:

​

 

  ​

​

 

  ​

Accounts receivable, net

​

 

(859,196)

​

 

(151,674)

Inventories, net

​

 

(39,310)

​

 

(293,030)

Prepaid expenses and other assets

​

 

373,247

​

 

(193,906)

Accounts payable

​

 

741,356

​

 

(492,937)

Accrued expenses and other liabilities

​

 

1,489,352

​

 

(644,025)

Deferred revenue

​

 

(21,728)

​

 

(25,000)

Operating right-of-use liabilities

​

 

(562,049)

​

 

(571,069)

Net cash used in operating activities

​

 

(4,894,440)

​

 

(8,795,828)

Investing activities:

​

 

  ​

​

 

  ​

Purchases of property and equipment

​

 

(279,120)

​

 

(242,375)

Proceeds from sale of property and equipment

​

 

212

​

 

290

Purchase of non-marketable equity securities

​

 

(13,000,000)

​

 

—

Net cash used in investing activities

​

 

(13,278,908)

​

 

(242,085)

Financing activities:

​

 

  ​

​

 

  ​

Payments on finance leases

​

 

(42,124)

​

 

(35,985)

Proceeds from notes payable

​

 

1,000,000

​

 

13,598

Repayments of notes payable

​

 

(16,335)

​

 

(14,666)

Proceeds from convertible promissory notes, net of issuance costs

​

 

15,443,751

​

 

1,000,000

Proceeds from issuance of preferred stock, net of issuance costs

​

 

—

​

 

9,370,021

Repurchases of equity securities

​

​

—

​

​

(3)

Net cash provided by financing activities

​

 

16,385,292

​

 

10,332,965

Effect of exchange rates on changes in cash

​

 

(1,054,578)

​

 

(213,152)

Net increase (decrease) in cash

​

 

(2,842,634)

​

 

1,081,900

Cash at beginning of period

​

 

4,572,687

​

 

478,626

Cash at end of period

​

$

1,730,053

​

$

1,560,526

Supplemental disclosures of cash flow information:

​

 

  ​

​

 

  ​

Cash paid for interest

​

$

77,371

​

$

14,923

Cash paid for taxes

​

$

103,379

​

$

97,292

Noncash investing and financing activities:

​

 

  ​

​

 

  ​

Note payable exchanged for non-marketable equity securities

​

$

2,000,000

​

$

—

Conversion of convertible promissory notes

​

$

—

​

$

4,942,618

Embedded derivative and warrant liability from convertible promissory notes

​

$

6,075,000

​

$

289,000

​

The accompanying notes are an integral part of these condensed consolidated financial statements

​

​

F-131

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1.Description of Organization and Summary of Significant Accounting Policies

​

Organization

HZO, Inc. (the “Company” or “HZO”) was incorporated on September 25, 2009, as a Delaware corporation. The Company is a liquid protection and nanotechnology company. The Company strives to continually enhance its fully commercialized liquid protection solution and is exploring the capabilities of applying its conformal coating technology to devices and electronics in the technical, industrial, medical, and consumer industries around the world.

Sale of HZO to Forge Nano Holdings, Inc.

On February 24, 2026, the Company entered into a term sheet to be acquired by Forge Nano Holdings, Inc. (“Forge Nano”) for a total purchase price of $55,000,000, plus the fair market value of the preferred stock of Forge Nano, Inc. that was held by the Company prior to the merger. The acquisition will consist of Forge Nano acquiring 100% of the Company’s equity, in exchange for consideration of Forge Nano common shares subject to certain adjustments related to cash, debt, and working capital.

On March 13, 2026, the Company made a $15,000,000 initial investment in Forge Nano’s Series D preferred stock financing for which it paid cash of $13,000,000 and entered into a $2,000,000 unsecured term loan facility with Forge Nano, which is recorded as non-marketable equity securities (see Note 3). The term loan, which was increased to $3,000,000 on August 6, 2026 has a maturity date of March 12, 2028 and bears interest at a rate of 6.00% per annum (Note 9). Upon closing of the aforementioned initial investment, the term sheet for the acquisition became binding.

On November 4, 2026 the acquisition closed and the Company became a wholly owned subsidiary of Forge Nano (see Note 19).

Basis of Presentation

The Company’s unaudited interim condensed consolidated financial statements as of September 30, 2026 and for the nine months ended September 30, 2026 and 2025 have been prepared for interim financial reporting. These condensed consolidated financial statements are unaudited and, in the opinion of management, include all adjustments (consisting of normal recurring adjustments and accruals) necessary for a fair statement of the results for the periods presented in accordance with United States generally accepted accounting principles (“U.S. GAAP”). The year-end condensed consolidated balance sheet data was derived from our audited consolidated financial statements but does not include all disclosures including certain notes required by U.S. GAAP on a recurring basis. Operating results for the nine months ended September 30, 2026 are not necessarily indicative of the results that may be expected for any other interim period or the fiscal year ending December 31, 2026. These condensed consolidated financial statements include the accounts of the Company and its subsidiaries and have been prepared using the accrual basis of accounting.

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of HZO, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Key management estimates include allowance for credit losses, inventory valuation, useful lives for property and equipment, embedded derivative liability, common stock for stock-based compensation, preferred stock, warrants, tax valuation allowance, and goodwill valuation.

F-132

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Changes in trade policies and tariffs can impact the Company’s cost projections and market pricing, which are considered in assessing inventory valuations and impairment of assets. The Company will continue to monitor ongoing regulatory developments and adjust future estimates as necessary.

Summary of Significant Accounting Policies

Our significant accounting policies are disclosed in Note 1 Description of Organization and Summary of Significant Accounting Policies of the consolidated financial statements for the years ended December 31, 2025 and 2024.

Concentrations of Credit Risk

The Company maintains its cash in bank deposit accounts which generally exceed federally insured limits. Cash was $1,730,053 and $4,572,687 at September 30, 2026 and December 31, 2025, respectively. To date, the Company has not experienced a loss or lack of access to its cash and cash equivalents; however, no assurance can be provided that access to the Company’s cash will not be impacted by adverse conditions in the financial markets. In the normal course of business, the Company provides credit terms to its customers and generally requires no collateral. A major customer is considered to be one that comprises more than 10% of the Company’s accounts receivable or sales. As of September 30, 2026 and December 31, 2025, three customers totaled approximately 76% and two customers totaled 82% of accounts receivable, respectively. For the nine months ended September 30, 2026 and 2025, four customers totaled approximately 77% of revenue and two customers totaled approximately 61% of revenue, respectively.

Major vendors are defined as those vendors receiving payments which exceed 10% of the Company’s total expenditures. There were no vendors receiving payments that exceeded 10% of the Company’s total expenditures for the nine months ended September 30, 2026 and 2025.

Accounts Receivable

The Company records its accounts receivable at sales value and establishes specific reserves for those customer accounts identified with collection problems due to insolvency or other credit issues. The amounts of the specific reserves are estimated by management based on various assumptions including the customer’s financial position, age of the customer’s receivables, and changes in payment schedules and historical loss data combined with reasonable and supportable forecasts. Account balances are charged off against the allowance for credit losses when the potential for recovery is remote. Recoveries of receivables previously charged off are recorded when payment is received.

Disaggregated Revenue

The following table presents the Company’s revenue by type:

​

​

​

​

​

​

​

​

​

​

Nine months ended

​

​

September 30,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Coating services, recurring

​

$

5,982,082

​

$

3,674,164

Equipment sales

​

 

829,689

​

 

21,955

Total Revenue

​

$

6,811,771

​

$

3,696,119

​

F-133

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Contract Assets and Liabilities

The following table provides information about receivables and contract liabilities from contracts with customers as of September 30, 2026 and December 31, 2025:

​

​

​

​

​

​

​

​

​

​

As of

​

As of

​

​

September 30,

​

December 31,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Receivables, gross

​

$

1,661,822

​

$

808,073

Contract liabilities

​

$

—

​

$

21,728

​

Receivables are included in accounts receivable, net of allowance for credit losses and contract liabilities are included in deferred revenue on the condensed consolidated balance sheets. The total allowance for credit losses was $0 and $5,447 as of September 30, 2026 and December 31, 2025, respectively.

Advertising

Advertising costs are expensed as incurred. Advertising costs were $81,991 and $114,103 for the nine months ended September 30, 2026 and 2025, respectively.

Income Taxes

Income taxes are accounted for using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the carrying amounts of assets and liabilities and their respective tax bases, operating loss carryforwards, and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the extent that utilization is not presently more likely than not.

Reclassification

Certain prior year amounts have been reclassified to conform to the current year presentation. These reclassifications were made to enhance comparability and consistency with the current year presentation and had no impact on previously reported net loss, comprehensive loss, total assets, total liabilities, stockholders’ equity, or net cash flows for the prior year.

Recently Adopted Accounting Standards

In November 2024, the FASB issued ASU 2024-04, Debt-Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments (“ASU 2024-04”), which provides additional guidance to stakeholders about how to determine whether a settlement of convertible debt (particularly, cash convertible instruments) at terms that differ from the original conversion terms should be accounted for under the induced conversion or extinguishment guidance. The Company adopted ASU 2024-04 effective January 1, 2026 and applied the guidance prospectively. The adoption had no impact on the Company’s financial position or results of operations.

In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets (“ASU 2025-05”), which provides a practical expedient for the estimation of expected credit losses for current accounts receivable and current contract assets under ASC 606. The practical expedient election assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset. The Company adopted ASU 2025-05 effective January 1, 2026 and elected the practical expedient. ASU 2025-05 did not have a material impact on the Company’s financial position or results of operations.

F-134

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Recent Accounting Pronouncements Not Yet Adopted

In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software (“ASU 2025-06”), which amends certain aspects of the accounting for and disclosure of software costs under ASC 350-40. The guidance removes all references to project stages throughout ASC 350-40 and clarifies the threshold entities apply to begin capitalizing costs. ASU 2025-06 is effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods, with the option to apply the guidance prospectively, retrospectively, or via a modified prospective transition method. Early adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2025-06 on its condensed consolidated financial statements.

In December 2025, the FASB issued ASU 2025-12, Codification Improvements (“ASU 2025-12”), which addresses suggestions received from stakeholders on the accounting standards and to make other incremental improvements to GAAP. ASU 2025-12 addresses thirty-three issues on a broad range of topics which are intended to be improvements that are not expected to have a significant effect on current accounting practice or result in significant costs to most entities. ASU 2025-12 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within those annual reporting periods, with the option to apply the guidance prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2025-12 on its condensed consolidated financial statements.

​

2.Going Concern Uncertainty

In accordance with ASU 2014-15, Presentation of Financial Statements - Going Concern, the Company’s management evaluated whether there are conditions or events that raise substantial doubt about its ability to continue as a going concern within one year after the date of issuance of these condensed consolidated financial statements. Specifically, management is required to evaluate whether the presence of adverse conditions or events, when considered individually and in the aggregate, raise substantial doubt about an entity’s ability to continue as a going concern. Substantial doubt exists when it is probable that the entity will be unable to meet its obligations as they become due within one year after the date the financial statements are available for issuance. Management has identified the adverse conditions and events that raise substantial doubt about the Company’s ability to continue as a going concern. Although the following matters raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these consolidated financial statements are available for issuance, the Company’s condensed consolidated financial statements have been prepared assuming that it will continue as a going concern.

The Company incurred a net loss of $70,057,139 and used cash in operating activities of $4,894,440 for the nine months ended September 30, 2026. As a result, the Company had an accumulated deficit of $377,987,333, and limited capital resources to fund ongoing operations at September 30, 2026. These capital resources were comprised of cash of $1,730,053 at September 30, 2026 and the generation of cash inflows from certain elements of working capital. The Company does not currently have sufficient capital resources to allow the Company to continue to meet its obligations on a timely basis and continue its operations for the next twelve months from the date of issuance of these condensed consolidated financial statements. The Company cannot provide any assurance that additional capital will be available on acceptable terms or at all. Management has concluded this uncertainty raises substantial doubt about the Company’s ability to continue as a going concern.

The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates continuity of operations, realization of assets and the satisfaction of liabilities in the normal course of business. As such, the accompanying condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets and their carrying amounts, or the amount and classification of liabilities that may result should the Company be unable to continue as a going concern.

​

F-135

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

3.Fair Value Measurements

The following table summarizes the composition and fair value hierarchy of the Company’s financial assets and liabilities as of September 30, 2026:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

September 30, 2026

​

  ​ ​ ​

Level 1

  ​ ​ ​

Level 2

  ​ ​ ​

Level 3

  ​ ​ ​

Total

Assets:

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

Non-marketable equity securities

​

$

—

​

$

—

​

$

15,000,000

​

$

15,000,000

Total

​

$

—

​

$

—

​

$

15,000,000

​

$

15,000,000

Liabilities:

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

Warrant liability

​

$

—

​

$

—

​

$

2,783,673

​

$

2,783,673

Embedded derivative liability

​

$

—

​

$

—

​

$

62,057,000

​

$

62,057,000

Total

​

$

—

​

$

—

​

$

64,840,673

​

$

64,840,673

​

The following table summarizes the composition and fair value hierarchy of the Company’s financial liabilities as of December 31, 2025:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

December 31, 2025

​

  ​ ​ ​

Level 1

  ​ ​ ​

Level 2

  ​ ​ ​

Level 3

  ​ ​ ​

Total

Liabilities:

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

Warrant liability

​

$

—

​

$

—

​

$

51,673

​

$

51,673

Embedded derivative liability

​

$

—

​

$

—

​

$

3,396,000

​

$

3,396,000

Total

​

$

—

​

$

—

​

$

3,447,673

​

$

3,447,673

​

During the nine months ended September 30, 2026 and 2025, there were no transfers between levels.

Non-marketable Equity Securities

Non-marketable equity securities consist of an investment in a privately held company that does not have a readily determinable fair value. This investment is measured at cost minus impairment, if any, and is adjusted for changes resulting from observable price changes in orderly transactions for an identical or similar investment in the same issuer, or the measurement alternative. Fair value is based upon observable inputs in an inactive market and the valuation requires our judgment due to the absence of market prices and inherent lack of liquidity. All gains and losses on this investment, realized and unrealized, are recognized in Other income (expense), net on our Condensed Consolidated Statements of Operations and Comprehensive Loss. There was no gain or loss on this investment for the nine months ended September 30, 2026. We assess whether an impairment loss has occurred on our investment in non-marketable equity securities, accounted for under the measurement alternative based on quantitative and qualitative factors. If any impairment is identified for non-marketable equity securities, we write down the investment to its fair value and record the corresponding charge through Other income (expense), net on our Condensed Consolidated Statements of Operations and Comprehensive Loss. The Company assesses its investment for significant influence to determine the appropriate method of accounting including application of the equity method. The Company had no equity method investments at September 30, 2026 and December 31, 2025.

Valuation of Warrant Liability

The warrant liability is related to freestanding warrants to purchase shares of convertible preferred stock issued in connection with sales of corresponding convertible preferred stock, as well as warrants to purchase shares of convertible preferred stock issued in connection with the Company’s Convertible Promissory Notes (Note 10).

F-136

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The fair value of the warrant liability related to freestanding warrants to purchase shares of convertible preferred stock was determined based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The liability is required to be marked to market at each reporting period. The Company reassesses the fair value of the corresponding liability each reporting period using the Black-Scholes option-pricing model, which incorporates assumptions and estimates, to value the warrant liability. Key estimates and assumptions impacting the fair value measurement include (i) the expected term of the warrants, (ii) the risk-free interest rate, (iii) the expected dividend yield, (iv) expected volatility of the price of the underlying series of preferred stock and (v) the fair value of the series of preferred stock on the valuation date. The Company estimated the fair value per share of the underlying series of preferred stock based on the results of third-party valuations. The risk-free interest rate was determined by reference to the U.S. Treasury yield curve for time periods approximately equal to the remaining contractual term of the warrants. The Company estimated a 0% expected dividend yield based on the fact the Company has never paid or declared dividends and does not intend to do so in the foreseeable future. As the Company is a private company and accordingly, lacks company-specific historical and implied volatility information of its stock, the expected stock volatility was based on the historical volatility of publicly traded peer companies for a term equal to the remaining expected term of the warrants, adjusted for Company-specific factors.

The following weighted-average assumptions were used in valuing the warrant liability:

​

​

​

​

​

​

​

​

​

As of

​

As of

​

​

​

September 30,

​

December 31,

​

​

  ​ ​ ​

2026

  ​ ​ ​

2025

 

Risk-free interest rate

 

3.4

%  

3.4

%

Expected stock price volatility

 

60

%  

60

%

Expected dividend yield

 

0

%  

0

%

Expected term (years)

 

0.3

 

2.0

​

​

The fair value of the warrant liability related to warrants to purchase shares of convertible preferred stock issued in connection with the Company’s Convertible Promissory Notes (Note 10) was determined using the Scenario Based Model (“SBM”), which incorporates assumptions and estimates, to value the warrant liability. The SBM is based on an income differential model using a with and without scenario based on the features embedded in the convertible promissory note. The value of the warrant liability is based on the difference between the value from the with and without analyses discounted to market participants discount rate. The discount rate is based on a CCC rated index bond of 14% which accounts for credit spread compared to a benchmark of the US treasury note.

The combined warrant liability was valued at $2,783,673 and $51,673 at September 30, 2026 and December 31, 2025, respectively, and classified as a current liability on the condensed consolidated balance sheets. The following table presents a roll forward of the warrant liability:

​

​

​

​

​

​

​

Warrant

​

  ​ ​ ​

Liability

Balance at December 31, 2025

​

$

51,673

Warrants granted in connection with issuance of convertible promissory notes

​

 

1,516,000

Change in fair value

​

​

1,216,000

​

​

​

​

Balance at September 30, 2026

​

$

2,783,673

​

Valuation of Embedded Derivative Liability

The embedded derivative liability is related to the variable redemption feature of the Company’s Convertible Promissory Notes (Note 10). The Company reassesses the fair values of the embedded derivative liability each reporting period using the Scenario Based Model (“SBM”), which incorporates assumptions and estimates, to value the embedded derivative liability. The SBM is based on an income differential model using a with and without scenario based on the features embedded in the convertible promissory note. The value of the embedded derivative liability is based on the difference between the value from the with and without analyses

F-137

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

discounted to market participants discount rate. The discount rate is based on a CCC rated index bond of 17% which accounts for credit spread compared to a benchmark of the U.S. treasury note.

The fair value of the embedded derivative liability at September 30, 2026 and December 31, 2025 was $62,057,000 and $3,396,000, respectively. The change in fair value of the embedded derivative liability was $54,102,000 and $135,000 for the nine months ended September 30, 2026 and 2025, respectively. The following table presents a roll forward of the embedded derivative liability:

​

​

​

​

​

​

​

Embedded

​

​

Derivative

​

  ​ ​ ​

Liability

Balance at December 31, 2025

​

$

3,396,000

Embedded derivative liability from convertible promissory notes

​

 

4,559,000

Change in fair value

​

​

54,102,000

​

​

​

​

Balance at September 30, 2026

​

$

62,057,000

​

​

4.Inventories

Inventories consisted of the following:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

As of

  ​ ​ ​

As of

​

​

September 30,

​

December 31,

​

​

2026

​

2025

Raw materials

​

$

1,118,657

​

$

1,090,884

Work in progress

​

 

47,065

​

 

57,308

Finished goods

​

 

55,206

​

 

1,354

​

​

 

1,220,928

​

 

1,149,546

Less reserve for obsolescence

​

 

(250,301)

​

 

(218,229)

Total inventories

​

$

970,627

​

$

931,317

​

​

5.Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following:

​

​

​

​

​

​

​

​

​

​

As of

​

As of

​

​

September 30,

​

December 31,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Prepaid expenses

​

$

240,027

​

$

227,929

Deposits

​

 

212,839

​

 

191,087

Other

​

 

92,977

​

 

76,398

Total prepaid expenses and other current assets

​

$

545,843

​

$

495,414

​

​

F-138

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

6.Property and Equipment

Property and equipment consisted of the following:

​

​

​

​

​

​

​

​

​

​

As of

​

As of

​

​

September 30,

​

December 31,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Machinery and equipment

​

$

5,361,452

​

$

5,814,929

Leasehold improvements

​

 

1,529,786

​

 

1,381,241

Furniture

​

 

1,296,442

​

 

1,261,196

Electronic equipment

​

 

1,258,947

​

 

1,282,907

Other assets

​

 

2,599,411

​

 

2,566,559

Construction in progress

​

 

112,009

​

 

96,865

Total property and equipment, gross

​

 

12,158,047

​

 

12,403,697

Accumulated depreciation

​

 

(9,709,291)

​

 

(8,576,467)

Total property and equipment, net

​

$

2,448,756

​

$

3,827,230

​

Total depreciation expense on property and equipment was $1,437,355 and $2,039,040 for the nine months ended September 30, 2026 and 2025, respectively.

​

7.Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:

​

​

​

​

​

​

​

​

​

​

As of

​

As of

​

​

September 30,

​

December 31,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Interest on convertible promissory notes

​

$

1,548,269

​

$

32,763

Payroll and payroll tax

​

 

276,017

​

 

264,393

Unbilled receipts of inventory

​

 

98,716

​

 

174,560

Other trade payables

​

 

93,059

​

 

139,315

Income and other taxes payable

​

 

126,437

​

 

42,115

Other

​

 

55,100

​

 

51,401

Total accrued expenses and other current liabilities

​

$

2,197,598

​

$

704,547

​

​

8.Right-of-Use Asset and Lease Liabilities

As of September 30, 2026, the Company had leased properties in the U.S. and internationally, with remaining lease terms of 0.6 to 3.4 years, some of which include options to extend the leases for up to 5 years. None of the options to extend the leases are recognized in operating lease ROU assets or lease liabilities. None of the leases include options to terminate the lease.

F-139

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The components of lease expense recorded in the condensed consolidated statements of operations and comprehensive loss were as follows:

​

​

​

​

​

​

​

​

​

​

Nine months ended

​

​

September 30,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Operating lease cost

​

$

685,696

​

$

773,628

Finance lease cost:

​

 

  ​

​

 

  ​

Amortization of assets

​

 

42,880

​

 

40,358

Interest on lease liabilities

​

 

8,907

​

 

11,884

Total lease cost

​

$

737,483

​

$

825,870

​

Supplemental balance sheet information related to leases was as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

As of

​

As of

​

​

​

​

September 30,

​

December 31,

Leases

  ​ ​ ​

Classification

  ​ ​ ​

2026

  ​ ​ ​

2025

Assets:

 

  ​

 

​

  ​

 

​

  ​

Operating lease assets

 

Operating ROU asset, net

​

$

2,158,859

​

$

2,675,083

Finance lease assets

 

Property and equipment, net

​

 

116,790

​

 

135,959

Total leased assets

 

  ​

​

$

2,275,649

​

$

2,811,042

Liabilities:

 

  ​

​

 

  ​

​

 

  ​

Current

 

  ​

​

 

  ​

​

 

  ​

Operating

 

Operating lease liabilities, current

​

$

983,249

​

$

982,996

Finance

 

Accrued expenses and other current liabilities

​

 

55,100

​

 

51,401

Non-current

 

  ​

​

 

  ​

​

 

  ​

Operating

 

Operating lease liabilities, non-current

​

 

1,369,308

​

 

1,931,610

Finance

 

Other liabilities

​

 

72,743

​

 

94,855

Total lease liabilities

 

  ​

​

$

2,480,400

​

$

3,060,862

​

Other supplemental information related to leases was as follows:

​

​

​

​

​

​

​

​

​

​

​

Nine months ended

​

​

​

September 30,

​

​

  ​ ​ ​

2026

  ​ ​ ​

2025

 

Weighted average remaining operating lease term (in years):

​

 

  ​

​

 

  ​

​

Operating leases

​

 

2.9

​

 

3.8

​

Finance leases

​

 

2.1

​

 

2.9

​

Weighted average lease discount rate:

​

 

  ​

​

 

  ​

​

Operating leases

​

 

8.5

%  

 

8.1

%

Finance leases

​

 

8.2

%  

 

8.9

%

​

F-140

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Maturities of operating lease liabilities were as follows as of September 30, 2026:

​

​

​

​

​

​

  ​ ​ ​

Amount

2026 (remaining)

​

$

338,643

2027

​

 

1,121,004

2028

​

 

758,874

2029

​

 

649,382

2030

​

 

50,673

Thereafter

​

 

—

Total lease payments

​

$

2,918,576

Less: imputed interest

​

 

(566,019)

Total lease obligations

​

 

2,352,557

Less: current obligations

​

 

(983,249)

Long-term lease obligations

​

$

1,369,308

​

Maturities of finance lease liabilities were as follows as of September 30, 2026:

​

​

​

​

​

​

  ​ ​ ​

Amount

2026 (remaining)

​

$

16,525

2027

​

 

62,055

2028

​

 

56,655

2029

​

 

3,090

Total lease payments

​

$

138,325

Less: imputed interest

​

 

(10,481)

Total lease obligations

​

 

127,844

Less: current obligations

​

 

(55,101)

Long-term obligations

​

$

72,743

​

​

9.Notes Payable

Notes payable consisted of the following:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

As of

  ​ ​ ​

As of 

​

​

September 30, 

​

December 31,

​

​

 2026

​

2025

Unsecured term loan

​

$

3,000,000

​

$

—

Equipment financing

​

 

32,882

​

 

49,217

Total notes payable

​

 

3,032,882

​

 

49,217

Less current portion

​

 

(22,914)

​

 

(21,923)

Net long-term portion of notes payable

​

$

3,009,968

​

$

27,294

​

Unsecured term loan: Note payable to Forge Nano, a related party, with an interest rate of 6%. Interest payments are payable monthly and the principal is due at the maturity date of March 12, 2028.

Equipment financing: Consists of borrowings to purchase equipment with interest rates ranging from 4.5% to 6.4%. The corresponding equipment is capitalized in Property and equipment, net on our Condensed Consolidated Balance Sheets. Principal and interest payments are payable monthly through maturity dates ranging from January to February 2028.

​

F-141

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

10.Convertible Securities

During the period from August 26, 2024 to January 10, 2025, the Company issued $4,772,907 in convertible promissory notes (the “2024 Notes”) of which $1,000,000 was issued in the nine months ended September 30, 2025. The 2024 Notes accrue interest at 12% per annum, beginning on the date the note proceeds were received by the Company from the note-holder and through the maturity date August 26, 2025. The 2024 Notes were to automatically convert into preferred shares upon an equity offering by the Company that closes before the maturity date. Due to the variable redemption feature, the share settlement provision was bifurcated from the 2024 Notes and recorded as a derivative liability. The day one derivative liability was $289,000 in the nine months ended September 30, 2025 and was recorded as a discount on the 2024 Notes. The Company recorded $135,000 in other expense during the nine months ended September 30, 2025 to represent the debt discount of the derivative liability. The Company paid $116,440 in deferred financing costs related to the 2024 Notes. Deferred financing costs are amortized over the term of the 2024 Notes. Amortization expense related to the deferred financing costs was $16,655 for the nine months ended September 30, 2025.

On February 14, 2025 the 2024 Notes and accrued interest of $169,711 converted into 6,027,707,347 and 4,059,267,542 shares of Series 2-B and Series 2-C preferred stock, respectively at a conversion price of $0.00049 per share. The fair value of the Series 2-B and Series 2-C preferred stock was approximately $8,553,000 at the conversion date resulting in a loss on extinguishment of approximately $3,071,000 and was recorded as a component of other expense on the condensed consolidated statements of operations and comprehensive loss for the nine months ended September 30, 2025.

During the period from November 28, 2025 to December 22, 2025, the Company issued $5,353,018 in convertible promissory notes (the “2025 Notes”). The 2025 Notes accrue interest at 12% per annum, beginning on the date the note proceeds were received by the Company from the note-holder and through the maturity date November 28, 2026. The 2025 Notes were to automatically convert into preferred shares upon an equity offering by the Company that closes before the maturity date. Due to the variable redemption feature, the share settlement provision was bifurcated from the 2025 Notes and recorded as a derivative liability. The day one derivative liability in 2025 was $3,392,000 and was recorded as a discount on the 2025 Notes. The Company recorded $53,251,000 in other expense during the nine months ended September 30, 2026 to represent the change in fair value of the derivative liability. The Company paid $24,502 in deferred financing costs related to the 2025 Notes. Deferred financing costs are amortized over the term of the 2025 Notes. During the nine months ended September 30, 2026 amortization expense related to the deferred financing costs and derivative liability was $2,703,651. As of September 30, 2026, the total unamortized debt discount was $600,812, which is expected to be amortized to interest expense in 2026.

During the period from March 12, 2026 to March 31, 2026, the Company issued $15,500,209 in convertible promissory notes (the “2026 Notes”). The 2026 Notes accrue interest at 12% per annum, beginning on the date the note proceeds were received by the Company from the note-holder and through the maturity date March 12, 2027. The 2026 Notes were to automatically convert into preferred shares upon an equity offering by the Company that closes before the maturity date. Due to the variable redemption feature, the share settlement provision was bifurcated from the 2026 Notes and recorded as a derivative liability. The day one derivative liability in 2026 was $4,559,000 and was recorded as a discount on the 2026 Notes. The Company recorded $851,000 in other expense during the nine months ended September 30, 2026 to represent the change in fair value of the derivative liability. The Company paid $56,458 in deferred financing costs related to the 2026 Notes. Deferred financing costs are amortized over the term of the 2026 Notes. During the nine months ended September 30, 2026 amortization expense related to the deferred financing costs and derivative liability was $2,674,014. As of September 30, 2026, the total unamortized debt discount was $1,932,652, which is expected to be amortized over the term of the 2026 Notes.

In connection with the issuance of the 2026 Notes, the Company issued a warrant to each of the two lead investors to purchase shares of preferred stock. Each warrant is exercisable for 709,845,703 shares of Series 2 Preferred Stock at an exercise price of $0.0001 per share. Each warrant shall have a term of five years. The warrants were bifurcated from the 2026 Notes and recorded as a warrant liability. The day one warrant liability of $1,516,000 was recorded as a discount on the 2026 Notes. During the nine months ended September 30, 2026 the Company recorded $884,333 in interest expense to represent the debt discount of the warrant liability. As of September 30, 2026, the total unamortized debt discount was $631,667, which is expected to be amortized over the term of the 2026 Notes.

F-142

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Interest expense for all convertible promissory notes was $1,508,109 and $63,099 for the nine months ended September 30, 2026 and 2025, respectively.

​

11.CARES Act

The CARES Act provides an employee retention credit (“ERC”), which is a refundable tax credit against certain employment taxes. The Taxpayer Certainty and Disaster Tax Relief Act of 2020 and the American Rescue Plan Act of 2021 extended and expanded the availability of the ERC. As amended, the ERC is available for wages paid through September 30, 2021 and is equal to 70% of qualified wages (which includes employer qualified health plan expenses) paid to employees. The Company evaluated its eligibility for the ERC and determined that it met all the criteria to claim a refundable tax credit against the employer share of Social Security taxes equal to 70% of the qualified wages that the Company paid to employees for the third and fourth quarter of 2020 and the first, second and third quarters of 2021. The Company adopted ASU 2021-10 to which topic 832 gives guidance to account for transactions with a government by analogizing to a grant accounting model, which the Company’s policy is the International Accounting Standard 20 model. The receivable, net of fees, remaining uncollected was $301,596 as of September 30, 2026 and December 31, 2025. Based upon an evaluation of the realizability of the uncollected receivable, the Company recorded a charge to other expense of $301,596 during the nine months ended September 30, 2026 to fully reserve the uncollected receivable.

​

12.Goodwill

The following table presents the changes in goodwill:

​

​

​

​

​

​

  ​ ​ ​

Amount

December 31, 2025

​

$

8,079,456

​

​

 

—

September 30, 2026

​

$

8,079,456

​

There were no goodwill impairment charges recorded for the nine months ended September 30, 2026 and 2025. The Company’s gross amount of goodwill was $18,293,572 as of September 30, 2026 and December 31, 2025, respectively. The total accumulated impairment loss was $10,214,116 as of September 30, 2026 and December 31, 2025, respectively.

​

13.Intangible Assets, Net of Accumulated Amortization

Intangible assets, net of accumulated amortization consists of the following:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

As of September 30, 2026

​

​

​

​

Remaining 

​

​

​

​

​

​

​

​

​

​

​

​

​

Amortization 

​

Gross

​

​

​

​

​

​

​

​

Useful

​

Period in

​

Carrying

​

Accumulated

​

Net Carrying

​

  ​ ​ ​

 Life

  ​ ​ ​

Years

  ​ ​ ​

Amount

  ​ ​ ​

 Amortization

  ​ ​ ​

 Amount

Developed technology asset

​

10 years

​

2.0

​

$

3,875,812

​

$

3,010,015

​

$

865,797

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

As of December 31, 2025

​

​

​

​

Remaining 

​

​

​

​

​

​

​

​

​

​

​

​

​

Amortization 

​

Gross

​

​

​

​

​

​

​

​

Useful

​

Period in

​

Carrying 

​

Accumulated 

​

Net Carrying 

​

  ​ ​ ​

 Life

  ​ ​ ​

Years

  ​ ​ ​

Amount

  ​ ​ ​

Amortization

  ​ ​ ​

Amount

Developed technology asset

 

10 years

 

2.8

​

$

3,875,812

​

$

2,698,327

 

$

1,177,485

​

The amortization expense on the intangible asset was $311,688 for the nine months ended September 30, 2026 and 2025, respectively.

F-143

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The estimated future amortization expense of the intangible asset as of September 30 is as follows:

​

​

​

​

​

  ​ ​ ​

Amount

2026 (remaining)

 

​

103,895

2027

 

​

415,583

2028

 

​

346,319

Total

 

$

865,797

​

​

14.Commitments and Contingencies

Operating Leases

The Company leases office and manufacturing space under operating lease agreements that expire over the next 3.4 years. See Note 8, “Right-of-Use Asset and Lease Liabilities” to the condensed consolidated financial statements for additional details on the Company’s operating lease commitments.

Litigation

The Company is involved in legal proceedings from time to time arising in the normal course of business. Management, after consultation with legal counsel, believes the outcome of these proceedings will not have a material impact on the Company’s consolidated financial position, or liquidity.

Employee Agreements

The Company has entered into employment agreements with certain members of management. These agreements include stipulated base salary, bonus potential, vacation benefits, severance, and non-competition agreements, and other typical benefits afforded management and senior executives.

Tariffs

On February 20, 2026, the U.S. Supreme Court ruled that the International Emergency Economic Powers Act (“IEEPA”) tariffs were not legally authorized. The Company is currently assessing its ability to file a refund claim for the related tariffs paid. Consistent with ASC 450-30 gain contingencies, the Company will only recognize a refund receivable and corresponding income when realization of the claim is probable and reasonably estimable. The Company continues to monitor developments, including a U.S. Court of International Trade (“CIT”) order in March 2026 directing a refund mechanism, which the government may appeal.

​

F-144

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

15.Convertible Preferred Stock

During the period from February 14, 2025 to May 27, 2025, the Company sold 10,932,485,432 and 3,026,640,546 shares of Series 2 Preferred Stock and Series 2-A Preferred Stock, respectively at $0.00069 per share. Total proceeds received from the sale of these shares, net of costs, was approximately $9.4 million. Pursuant to the terms of the convertible securities (Note 10) the 2024 Notes were converted into 6,027,707,347 and 4,059,267,542 shares of Series 2-B Preferred Stock and Series 2-C Preferred Stock, respectively at a conversion price of $0.00049 per share.

Through September 30, 2026, the Company has authorized 29,531,472,204 shares of convertible preferred stock, issued in various individual series. Information by preferred stock series, including the liquidation preference, as of September 30, 2026 is as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

​

  ​ ​ ​

Original

  ​ ​ ​

Liquidation 

  ​ ​ ​

​

​

Preferred

​

Designated 

​

Outstanding 

​

Issue Price

​

Multiple on 

​

Liquidation 

Stock Series

​

Shares

​

Shares

​

(“OIP”)

​

OIP

​

Preference

​

​

​

​

​

​

​

​

​

​

​

​

​

Series 2

​

17,391,304,345

​

10,932,485,432

​

$

0.00069

​

2X

​

$

15,086,830

Series 2-A

 

17,391,304,345

 

3,026,640,546

​

$

0.00069

 

2X

​

$

4,176,764

Series 2-B

 

6,027,707,347

 

6,027,707,347

​

$

0.00049

 

2X

​

$

5,907,153

Series 2-C

 

4,059,267,542

 

4,059,267,542

​

$

0.00049

 

4X

​

$

7,956,164

Series 1

 

820,703,632

 

710,802,353

​

$

0.02168

 

1.5X

​

$

23,115,293

Series 1-A

 

3,396,504,542

 

3,257,660,800

​

$

0.00826

 

1.5X

​

$

40,362,417

​

Dividends

The Preferred stockholders receive dividends on an as-converted basis and have no dividend preferences over common stockholders. Upon conversion, the dividends on the Series 2, 2-A, 2-B, 2-C preferred stock (“Senior Preferred”) and the Series 1 and 1-A preferred stock (“Junior Preferred”) are cumulative and payable if and when declared by the Company’s Board of Directors. There were no declared and unpaid dividends as of September 30, 2026.

Liquidation

The Senior Preferred and Junior Preferred stockholders have liquidation preferences over common stockholders in the amounts disclosed in the previous table, along with any declared but unpaid dividends. If the assets and funds available for distribution among the holders of the Senior Preferred and Junior Preferred are insufficient to permit payment of the full preferential amount, then the entire amount of the assets and funds available for distribution will be distributed with equal priority and pro rata first among the Senior Preferred in proportion to the aggregate liquidation preference of the Senior Preferred and then among the Junior Preferred in proportion to the aggregate liquidation preference of the Junior Preferred. After payment of the full preferred liquidation preferences, all shares of preferred stock are converted to common stock. The remaining assets are then distributed pro rata among common stockholders, including the converted shares.

Conversion

Each share of convertible preferred stock is convertible into common stock, at any time at the option of the preferred stockholder. Each share of preferred stock will automatically convert into common stock at the then-effective conversion rate upon the closing of an initial public offering of the Company’s common stock or upon change of control. As of September 30, 2026 and December 31, 2025, the conversion prices per share for all series of convertible preferred stock were equal to the original issue prices and the rate at which each share would convert into common stock was one-for-one with the exception of the Series 2-C preferred stock for which each share would convert into common stock at a rate of two-for-one.

F-145

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Redemption

The holders of Preferred Stock have no voluntary rights to redeem shares. Any voluntary or involuntary liquidation, dissolution or winding up of the Company, a greater than 50% change in control, or a sale of substantially all of the Company’s assets would constitute a redemption event. Although the Preferred Stock is not mandatorily or currently redeemable, these events would constitute a redemption event outside of the Company’s control. Accordingly, these shares are considered contingently redeemable. As such, if the Company were subject to SEC reporting requirements, the Preferred Stock would be presented as temporary equity in the accompanying condensed consolidated balance sheets.

Preferred Stock Price Adjustment

The Company’s articles of incorporation contain “down-round” protection for the preferred stock. When additional shares of common stock are issued for an effective price less than the then-existing conversion price of the preferred stock, then and in each such case the then-existing conversion price is reduced to a price equal to the price per share received by the Company for the common stock issuance.

​

16.Stock Options and Warrants

The Company’s 2012 Stock Incentive Plan (the “Plan”) provides for the grant of incentive stock options, nonqualified options, and shares of restricted stock. Under the terms of the Plan, there are 237,795,202 common shares available for grant to employees, officers, directors and consultants. The Board of Directors determines the terms of each grant. Generally, the options have a vesting period of 4 years with 25% vesting after the first year of service and monthly thereafter and have a ten-year contractual life. Certain stock options have provisions to accelerate vesting upon the occurrence of certain events. There were 235,612,023 shares available for grant under the Plan as of September 30, 2026. There were no grants in the nine months ended September 30, 2026 and 2025.

The following table shows stock option activity under the 2012 Stock Incentive Plan for the nine months ended September 30, 2026:

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

​

​

  ​ ​ ​

Weighted-

  ​ ​ ​

​

​

​

​

​

​

Weighted-

​

Average 

​

​

​

​

​

Outstanding 

​

Average 

​

Remaining 

​

Aggregate 

​

​

Options

​

Exercise Price

​

Terms (Years)

​

Intrinsic Value

Balance as of December 31, 2025

​

1,225,125

​

$

0.71

​

​

​

$

—

Granted

​

—

​

​

—

​

  ​

​

  ​

​

Exercised

 

—

 

​

—

 

  ​

 

​

  ​

Forfeited

 

—

 

​

—

 

  ​

 

​

  ​

Canceled

 

(38,125)

​

$

0.93

 

  ​

 

​

  ​

Balance as of September 30, 2026

 

1,187,000

​

$

0.70

 

3.8

​

$

—

Vested and exercisable as of September 30, 2026

 

1,186,062

​

$

0.70

 

3.8

​

$

—

Vested and expected to vest as of September 30, 2026

 

1,186,982

​

$

0.70

 

3.8

​

$

—

​

Total stock-based compensation expense was $1,207 and $3,933 during the nine months ended September 30, 2026 and 2025, respectively. As of September 30, 2026, there was approximately $85 of unrecognized stock-based compensation expense that will be recognized over the weighted average period of 0.1 years. The intrinsic value of all options outstanding as of September 30, 2026 and December 31, 2025 was zero.

F-146

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Warrants

In connection with certain preferred stock offerings, debt issuances, and debt restructurings, the Company has issued warrants to purchase preferred stock. The following summarizes information about stock warrants outstanding as of September 30, 2026:

​

​

​

​

​

​

​

​

​

​

​

​

​

Exercise Price

​

Number of

Original Issue Date

  ​ ​ ​

Stock Class

  ​ ​ ​

 Per Share

  ​ ​ ​

 Shares

​

​

​

​

​

​

​

​

September 2017

 

Common

​

$

0.0010

 

47,693

December 2017

 

Common

​

$

3.7057

 

150,000

March 2018

 

Common

​

$

3.7057

 

67,928

March 2018

 

Common

​

$

3.7057

 

25,629

May 2019

 

Common

​

$

9.0820

 

132,129

July 2023

 

Series 1 Preferred

​

$

0.0217

 

93,237,996

November 2023

 

Series 1 Preferred

​

$

0.0217

 

3,978,782

March 2026

 

Series 2 Preferred

​

$

0.0001

 

1,419,691,406

​

The warrants to purchase the Company’s common stock meet the criteria for equity classification. The Company accounts for freestanding warrants to purchase shares of convertible preferred stock as warrant liability on its condensed consolidated balance sheets. The Company records the convertible preferred stock warrants at their estimated fair value because these warrants may contingently obligate the Company to redeem the underlying convertible preferred stock at some point in the future. At the end of each reporting period, changes in the estimated fair value of the warrant liability are recorded as other income or expense in the condensed consolidated statements of operations and comprehensive loss. The estimated value of these warrants is determined using the Black-Scholes valuation model. The warrants are all exercisable as of September 30, 2026.

​

F-147

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

17.Income Taxes

Income taxes have been computed using the asset and liability method in accordance with ASC 740 “Income Taxes”. The Company computes its interim provision for income taxes by applying the estimated annual effective tax rate method. The Company estimates an annual effective tax rate of 0% for the year ending December 31, 2026. The total tax expense or (benefit) during the nine months ended September 30, 2026 and 2025, was approximately $0.1 million and $(0.2) million, respectively. The income tax expense (benefit) differs from the statutory federal rate primarily due to the change in valuation allowance recorded against the deferred tax assets, as well as state income taxes and permanent non-deductible and non-taxable items.

The Company incurred losses for the nine month period ended September 30, 2026 and is forecasting additional losses through the year, resulting in an estimated net loss for both financial statement and tax purposes for the year ending December 31, 2026. Due to the Company’s history of losses, the Company has provided a full valuation allowance against its net deferred tax assets, since realization of these benefits is not more likely than not.

At September 30, 2026, the Company had no unrecognized tax benefits that would affect the Company’s effective tax rate if recognized.

​

18.Employee Retirement Plan

The Company sponsors a defined contribution 401(k) retirement plan (the Retirement Plan). All U.S. employees are eligible to participate in the Retirement Plan after completing thirty days of employment and after electing to participate in the Retirement Plan. As set forth in the Retirement Plan document, the Company matches employee contributions up to 4% of eligible wages. Employer matching contributions are immediately 100% vested. Employer contributions under the Retirement Plan were $93,050 and $111,579 for the nine months ended September 30, 2026 and 2025, respectively.

​

19.Subsequent Events

Management has evaluated events and transactions for potential recognition or disclosure through November 20, 2026, which is the day these condensed consolidated financial statements were available for issuance and has determined that there have been no events that have occurred that would require adjustments to our disclosures in the condensed consolidated financial statements, except as described below.

Completion of Sale of HZO to Forge Nano

On November 4, 2026, the Company entered into an Agreement and Plan of Merger with Forge Nano pursuant to which Forge Nano agreed to acquire 100% of the outstanding stock of the Company for a total purchase price of $55,000,000, plus the fair market value of the preferred stock of Forge Nano, Inc. that was held by the Company prior to the merger, and converted into common stock of Forge Nano, subject to customary post-closing net working capital adjustments. The transaction was approved by shareholders and officially closed on November 4, 2026. In connection with the transaction, the convertible notes, outstanding equity and equity instruments of the Company were converted into shares of common stock of Forge Nano, and the Company became a wholly owned subsidiary of Forge Nano.

​

​

F-148

Table of Contents

​

HZO, inc. and subsidiaries

Consolidated Financial Statements

For the years ended December 31, 2025 and 2024

​

​

F-149

Table of Contents

​

INDEPENDENT AUDITORS’ REPORT

Board of Directors
HZO, Inc. and Subsidiaries
Morrisville, North Carolina

Report on the Audit of the Financial Statements

Opinion

We have audited the accompanying consolidated financial statements of HZO, Inc and Subsidiaries (the “Company”), which comprise the consolidated balance sheets as of December 31, 2025 and 2024, and the related consolidated statements of operations and comprehensive loss, changes in stockholders’ equity, and their cash flows for each of the years then ended, and the related notes to the consolidated financial statements.

In our opinion, the accompanying financial statements present fairly, in all material respects, the consolidated financial position of HZO, Inc. and Subsidiaries as of December 31, 2025 and 2024, and the consolidated results of their operations and their cash flows for each of the years then ended in accordance with accounting principles generally accepted in the United States of America.

Basis for Opinion

We conducted our audits in accordance with auditing standards generally accepted in the United States of America (“GAAS”). Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Substantial Doubt about the Entity’s Ability to Continue as a Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has suffered recurring losses from operations and recurring cash used in operating activities and has stated that substantial doubt exists about the Company’s ability to continue as a going concern. Management’s evaluation of the events and conditions and management’s plans regarding these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our opinion is not modified with respect to this matter.

Responsibilities of Management for the Financial Statements

Management is responsible for the preparation and fair presentation of these financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date that the financial statements are available to be issued.

F-150

Table of Contents

​

Auditors’ Responsibilities for the Audit of the Financial Statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions,

misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

In performing an audit in accordance with GAAS, we:

●Exercise professional judgment and maintain professional skepticism throughout the audit.
●Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
●Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control. Accordingly, no such opinion is expressed.
●Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.
●Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control — related matters that we identified during the audit.

/s/ EISNERAMPER LLP

Raleigh, North Carolina

May 19, 2026

​

​

F-151

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

​

​

​

​

​

​

​

​

  ​ ​ ​

December 31,

  ​ ​ ​

December 31,

​

​

2025 

​

2024 

Assets

​

​

​

​

​

​

Current assets

​

​

​

​

​

​

Cash

​

$

4,572,687

​

$

478,626

Accounts receivable, net of allowance for credit losses of $5,447 and $191,833, respectively

​

 

802,626

​

 

836,382

Inventories, net

​

 

931,317

​

 

602,729

Prepaid expenses and other current assets

​

 

495,414

​

 

422,669

Total current assets

​

 

6,802,044

​

 

2,340,406

Property and equipment, net

​

 

3,827,230

​

 

6,640,655

Operating right-of-use asset, net

​

 

2,675,083

​

 

3,390,744

Other assets

​

 

423,676

​

 

423,676

Intangible assets, net

​

 

1,177,485

​

 

1,593,067

Goodwill

​

 

8,079,456

​

 

8,079,456

Total assets

​

$

22,984,974

​

$

22,468,004

Liabilities and stockholders’ equity

​

​

​

​

​

​

Current Liabilities

​

​

​

​

​

​

Accounts payable

​

$

781,939

​

$

980,154

Accrued expenses and other current liabilities

​

 

704,547

​

 

1,516,387

Deferred revenue

​

 

21,728

​

 

128,704

Current portion of operating lease liabilities

​

 

982,996

​

 

1,015,052

Current portion of notes payable

​

 

21,923

​

 

16,349

Embedded derivative liability

​

 

3,396,000

​

 

1,052,000

Convertible promissory notes, net of discount

​

 

2,057,348

​

 

2,911,018

Total current liabilities

​

 

7,966,481

​

 

7,619,664

Other liabilities

​

 

94,855

​

 

131,009

Long-term operating lease liabilities, net of current portion

​

 

1,931,610

​

 

2,635,658

Long-term notes payable, net of current portion

​

 

27,294

​

 

39,215

Warrant liability

​

 

51,673

​

 

57,984

Deferred tax liability, net

​

 

—

​

 

53,796

Total Liabilities

​

 

10,071,913

​

 

10,537,326

Commitments and contingencies (Note 13)

​

​

​

​

​

​

Stockholders’ equity

​

​

​

​

​

​

Convertible preferred stock, $0.001 par value, 49,086,791,753 and 4,367,599,785 shares authorized; 28,014,564,020 and 4,119,991,396 shares issued and outstanding at December 31, 2025 and 2024

​

 

28,014,564

​

 

4,119,991

Common stock, $0.001 par value, 33,588,600,000 and 4,894,994,847 shares authorized; 44,824,953 and 56,438,694 issued and outstanding at December 31, 2025 and 2024

​

 

44,825

​

 

56,439

Additional paid-in capital

​

 

291,373,418

​

 

297,328,788

Accumulated deficit

​

 

(307,930,194)

​

 

(292,301,988)

Other comprehensive income

​

 

1,410,448

​

 

2,727,448

Total stockholders’ equity

​

 

12,913,061

​

 

11,930,678

Total liabilities and stockholders’ equity

​

$

22,984,974

​

$

22,468,004

​

The accompanying notes are an integral part of these consolidated financial statements

​

F-152

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

​

​

​

​

​

​

​

​

​

Year Ended

​

​

December 31,

​

December 31,

​

​

2025

​

2024

​

​

​

​

​

​

​

Revenue

  ​ ​ ​

$

4,842,186

  ​ ​ ​

$

5,342,826

Cost of revenue

​

 

6,378,786

​

 

5,577,137

Gross loss

​

 

(1,536,600)

​

 

(234,311)

Operating expenses:

​

 

  ​

​

 

  ​

Sales and marketing

​

 

2,023,320

​

 

2,613,246

Research and development

​

 

1,006,578

​

 

1,021,307

General and administrative

​

 

8,705,555

​

 

8,456,703

Goodwill impairment

​

 

—

​

 

10,214,116

Total operating expenses

​

 

11,735,453

​

 

22,305,372

Loss from operations

​

 

(13,272,053)

​

 

(22,539,683)

Other income (expense):

​

 

  ​

​

 

  ​

Interest expense

​

 

(437,970)

​

 

(391,504)

Foreign currency gain (loss)

​

 

1,343,602

​

 

(788,287)

Other income (expense), net

​

 

(3,502,140)

​

 

992,416

Total other expense

​

 

(2,596,508)

​

 

(187,375)

Loss before provision for income taxes

​

 

(15,868,561)

​

 

(22,727,058)

Provision (benefit) for income taxes

​

 

(240,355)

​

 

(635,631)

Net loss

​

$

(15,628,206)

​

$

(22,091,427)

Other comprehensive income

​

 

  ​

​

 

  ​

Foreign currency translation adjustment

​

 

(1,317,000)

​

 

690,540

Comprehensive loss

​

$

(16,945,206)

​

$

(21,400,887)

​

The accompanying notes are an integral part of these consolidated financial statements

​

​

​

F-153

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Convertible

​

​

​

​

​

​

​

​

​

​

​

​

Accumulated

​

​

​

​

​

Preferred Stock

​

Common Stock

​

Additional

​

​

​

​

Other

​

Total

​

​

​

​

​

​

​

​

​

​

​

​

Paid- in

​

Accumulated

​

Comprehensive

​

Stockholders’

​

  ​ ​ ​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Capital

  ​ ​ ​

Deficit

  ​ ​ ​

Income (Loss)

  ​ ​ ​

Equity

Balance as of December 31, 2023

​

4,119,991,396

​

$

4,119,991

​

56,438,694

​

$

56,439

​

$

297,295,560

​

$

(270,210,561)

​

$

2,036,908

​

$

33,298,337

Stock-based compensation

 

—

​

 

—

 

—

​

 

—

​

 

33,228

​

 

—

​

 

—

​

 

33,228

Foreign currency translation

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

—

​

 

690,540

​

 

690,540

Net loss

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

(22,091,427)

​

 

—

​

 

(22,091,427)

Balance as of December 31, 2024

 

4,119,991,396

​

$

4,119,991

 

56,438,694

​

$

56,439

​

$

297,328,788

​

$

(292,301,988)

​

$

2,727,448

​

$

11,930,678

Issuance of Series 2 preferred stock, net of issuance costs

 

10,932,485,432

​

 

10,932,485

 

—

​

 

—

​

 

(3,511,121)

​

 

—

​

 

—

​

 

7,421,364

Issuance of Series 2-A preferred stock, net of issuance costs

 

3,026,640,546

​

 

3,026,641

 

—

​

 

—

​

 

(1,077,984)

​

 

—

​

 

—

​

 

1,948,657

Issuance of Series 2-B preferred stock upon conversion of subordinated convertible promissory notes

 

6,027,707,347

​

 

6,027,708

 

—

​

 

—

​

 

(2,252,281)

​

 

—

​

 

—

​

 

3,775,427

Issuance of Series 2-C preferred stock upon conversion of subordinated convertible promissory notes

 

4,059,267,542

​

 

4,059,267

 

—

​

 

—

​

 

718,255

​

 

—

​

 

—

​

 

4,777,522

Repurchase of equity securities

 

(151,528,243)

​

 

(151,528)

 

(11,613,741)

​

 

(11,614)

​

 

163,136

​

 

—

​

 

—

​

 

(6)

Stock-based compensation

 

—

​

 

—

 

—

​

 

—

​

 

4,625

​

 

—

​

 

—

​

 

4,625

Foreign currency translation

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

—

​

 

(1,317,000)

​

 

(1,317,000)

Net loss

 

—

​

 

—

 

—

​

 

—

​

 

—

​

 

(15,628,206)

​

 

—

​

 

(15,628,206)

Balance as of December 31, 2025

 

28,014,564,020

​

$

28,014,564

 

44,824,953

​

$

44,825

​

$

291,373,418

​

$

(307,930,194)

​

$

1,410,448

​

$

12,913,061

​

The accompanying notes are an integral part of these consolidated financial statements

​

​

​

F-154

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

​

​

​

​

​

​

​

​

​

Year Ended

​

​

December 31,

​

December 31,

​

​

2025

​

2024

Operating activities:

  ​ ​ ​

​

  ​

  ​ ​ ​

​

  ​

Net loss

​

$

(15,628,206)

​

$

(22,091,427)

Adjustments to reconcile net loss to net cash used in operating activities:

​

 

  ​

​

 

  ​

Depreciation and amortization

​

 

3,089,804

​

 

1,130,123

Change in right-of-use assets

​

 

737,316

​

 

879,665

Loss on extinguishment of debt

​

 

3,071,008

​

 

—

Goodwill impairment

​

 

—

​

 

10,214,116

Amortization of debt discount

​

 

336,988

​

 

302,608

Stock-based compensation

​

 

4,625

​

 

33,228

Deferred taxes, net

​

 

(53,796)

​

 

(331,228)

Loss (gain) on disposal of fixed assets

​

 

292,893

​

 

(279,890)

Revaluation of convertible note derivative liabilities

​

 

139,000

​

 

2,000

Change in warrant liability

​

 

(6,311)

​

 

(726,740)

Changes in operating assets and liabilities:

​

 

  ​

​

 

  ​

Accounts receivable, net

​

 

33,756

​

 

1,477,917

Inventories, net

​

 

(328,588)

​

 

19,083

Prepaid expenses and other assets

​

 

(72,745)

​

 

150,280

Accounts payable

​

 

(224,660)

​

 

(1,052,001)

Accrued expenses and other liabilities

​

 

(629,772)

​

 

(514,261)

Deferred revenue

​

 

(106,976)

​

 

20,646

Operating lease right-of-use liabilities

​

 

(757,759)

​

 

(872,460)

Net cash used in operating activities

​

 

(10,103,423)

​

 

(11,638,341)

Investing activities:

​

 

  ​

​

 

  ​

Purchases of property and equipment

​

 

(258,512)

​

 

(624,632)

Proceeds from sale of property and equipment

​

 

68,628

​

 

322,742

Net cash used for investing activities

​

 

(189,884)

​

 

(301,890)

Financing activities:

​

 

  ​

​

 

  ​

Payments on finance leases

​

 

(48,511)

​

 

(35,199)

Repayments of notes payable

​

 

(6,347)

​

 

(15,338)

Proceeds from subordinated convertible promissory notes, net of issuance costs

​

 

6,353,018

​

 

3,704,188

Proceeds from issuance of preferred stock, net of issuance costs

​

 

9,370,020

​

 

—

Repurchases of equity securities

​

 

(6)

​

 

—

Net cash provided by financing activities

​

 

15,668,174

​

 

3,653,651

Effect of exchange rates on changes in cash

​

 

(1,280,806)

​

 

1,070,732

Net increase (decrease) in cash

​

 

4,094,061

​

 

(7,215,848)

Cash at beginning of the year

​

 

478,626

​

 

7,694,474

Cash at end of year

​

$

4,572,687

​

$

478,626

​

​

​

​

​

​

​

Supplemental disclosures of cash flow information:

​

 

  ​

​

 

  ​

Cash paid for interest

​

$

19,353

​

$

18,480

Cash paid for taxes

​

$

122,242

​

$

72,151

Noncash investing and financing activities:

​

 

  ​

​

 

  ​

Conversion of subordinated convertible promissory notes

​

$

4,942,618

​

$

—

Purchases of property and equipment included in accounts payable

​

$

—

​

$

23,844

Embedded derivative liability from subordinated convertible promissory notes

​

$

3,681,000

​

$

1,050,000

Right-of-use asset obtained in exchange for operating lease liability

​

$

21,655

​

$

161,201

​

The accompanying notes are an integral part of these consolidated financial statements

​

​

​

F-155

Table of Contents

​

HZO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2025 and 2024

1.

Description of Organization and Summary of Significant Accounting Policies

Organization

HZO, Inc. (the “Company” or “HZO”) was incorporated on September 25, 2009, as a Delaware corporation. The Company is a liquid protection and nanotechnology company. The Company strives to continually enhance its fully commercialized liquid protection solution and is exploring the capabilities of applying its conformal coating technology to devices and electronics in the technical, industrial, medical, and consumer industries around the world.

Basis of Presentation

The Company’s consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”). These consolidated financial statements include the accounts of the Company and its subsidiaries and have been prepared using the accrual basis of accounting.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of HZO, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Key management estimates include allowance for credit losses, inventory valuation, useful lives for property and equipment, embedded derivative liability, common stock for stock-based compensation, preferred stock, warrants, tax valuation allowance, and goodwill valuation.

Changes in trade policies and tariffs can impact the Company’s cost projections and market pricing, which are considered in assessing inventory valuations and impairment of assets. The February 20, 2026 U.S. Supreme Court decision invalidating certain tariffs occurred after year-end and is treated as a non-recognized subsequent event. The Company will continue to monitor ongoing regulatory developments and adjust future estimates as necessary.

Concentrations of Credit Risk

The Company maintains its cash in bank deposit accounts which generally exceed federally insured limits. Cash was $4,572,687 and $478,626 at December 31, 2025 and 2024, respectively. To date, the Company has not experienced a loss or lack of access to its cash and cash equivalents; however, no assurance can be provided that access to the Company’s cash will not be impacted by adverse conditions in the financial markets. In the normal course of business, the Company provides credit terms to its customers and generally requires no collateral. A major customer is considered to be one that comprises more than 10% of the Company’s accounts receivable or sales. For the year ended December 31, 2025, two customers totaled approximately 82% of accounts receivable and two customers totaled approximately 62% of revenue. For the year ended December 31, 2024, two customers totaled approximately 85% of accounts receivable and four customers totaled approximately 77% of revenue.

Major vendors are defined as those vendors receiving payments which exceed 10% of the Company’s total expenditures. There were no vendors receiving payments that exceeded 10% of the Company’s total expenditures for the years ended December 31, 2025 and 2024.

F-156

Table of Contents

​

Leases

The Company determines if an arrangement is a lease at inception. Right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease expense attributable to lease payments is recognized on a straight-line basis over the lease term and is included in cost of revenue and general and administrative expense on the consolidated statement of operations and comprehensive loss. Finance leases result in the recognition of depreciation expense, which is recognized on a straight-line basis over the expected life of the leased asset, and interest expense, which is recognized following an effective interest rate method. Depreciation expense attributable to finance leases is included in general and administrative expense on the consolidated statements of operations and comprehensive loss. As the Company’s leases do not generally provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company’s lease agreements do not contain any restrictive covenants, variable lease payments or residual value guarantees. All leases with an initial term of 12 months or less are not recorded on the balance sheet and are not material. The Company presents operating leases in long-term assets and current and long-term liabilities in the accompanying consolidated balance sheets. Finance leases are reported in property and equipment, net, accrued expenses and other current liabilities, and other liabilities on the Company’s consolidated balance sheets.

Foreign Operations

Operations outside the United States (“U.S.”) consist of the operations of the Company’s subsidiaries and locations in China, Hungary, Vietnam, and Mexico. Foreign operations are subject to risks inherent in operating under different legal systems and various political and economic environments. Among the risks are changes in existing laws and regulations, possible limitations on foreign investment and income repatriation, government price or foreign exchange controls, and restrictions on currency exchange, among others. The majority of the Company’s total net assets are held by its foreign operations.

Fair Value of Financial Instruments

The Company determines the fair value of an asset or liability based on the assumptions that market participants would use in pricing the asset or liability in an orderly transaction between market participants at the measurement date. The identification of market participant assumptions provides a basis for determining what inputs are to be used for pricing each asset or liability.

The framework for measuring fair value provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements).

The three levels of the fair value hierarchy are described as follows:

Level 1

Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

​

​

Level 2

Inputs to the valuation methodology include:

​

·

quoted prices for similar assets or liabilities in active markets;

​

·

quoted prices for identical or similar assets or liabilities in inactive markets;

​

·

inputs other than quoted prices that are observable for the asset or liability;

​

·

inputs that are derived principally from or corroborated by observable market data by correlation or other means.

​

If the asset or liability has a specified (contractual) term, the level 2 input must be observable for substantially the full term of the asset or liability.

​

​

Level 3

Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

​

The asset or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

F-157

Table of Contents

​

The Company did not have any Level 1 or Level 2 assets and liabilities as of December 31, 2025 and 2024. The Company’s warrant and derivative liabilities are recorded at fair value using Level 3 inputs (Note 3, Note 9, and Note 15).

Accounts Receivable

The Company records its accounts receivable at sales value and establishes specific reserves for those customer accounts identified with collection problems due to insolvency or other credit issues. The amounts of the specific reserves are estimated by management based on various assumptions including the customer’s financial position, age of the customer’s receivables, and changes in payment schedules and historical loss data combined with reasonable and supportable forecasts. Account balances are charged off against the allowance for credit losses when the potential for recovery is remote. Recoveries of receivables previously charged off are recorded when payment is received.

Inventories

Inventories are recorded at the lower of cost or net realizable value, with cost determined by specific identification and the average cost method. Tariffs paid on imported raw materials and finished goods are capitalized as part of inventory cost. The Company periodically reviews inventories for excess supply, obsolescence, and valuation above estimated realizable amounts, and provides a reserve for these items (Note 4). In performing this review management takes into account whether tariff costs can be passed on to customers in pricing. If tariff-related cost increases cannot be recovered through higher selling prices, this may lead to inventory write-downs to net realizable value.

Property and Equipment

Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated economic useful lives of the assets or over the related lease terms (if shorter) as follows:

​

​

​

​

Machinery and equipment

​

4-7 years

Leasehold improvements

​

the lesser of 7 years or remaining lease term

Electronic equipment

​

3-5 years

Furniture

​

3-7 years

​

Expenditures that materially increase values or capacities or extend useful lives of property and equipment are capitalized. Routine maintenance, repairs, and renewal costs are expensed as incurred. Upon sale or disposition of depreciable property, the cost and accumulated depreciation and amortization are removed from the related accounts and any gain or loss is reflected currently in operations.

Intangible Assets

Intangible assets with finite lives consist of patents and trademarks acquired through business combinations. Intangible assets acquired through business combinations are recorded at their respective estimated fair values upon acquisition close. The Company determines the estimated useful lives for acquired intangible assets based on the expected future cash flows associated with the respective asset. The Company’s intangible assets with finite lives are amortized using the straight-line method over their estimated useful life of 10 years. Amortization expense is charged to cost of revenue. The Company evaluates the recoverability of intangible assets with finite lives whenever events or circumstances that may warrant revised estimates of useful lives or that indicate the asset may be impaired.

Impairment of Long-Lived Assets

The Company reviews its property and equipment, and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may be impaired. The events and circumstances that are considered include business climate and market conditions, legal factors, operating performance indicators and competition. If it is determined that the estimated undiscounted future cash flows are not sufficient to recover the carrying value of the asset, an impairment loss is recognized in operations. During the years ended December 31, 2025 and 2024, no long-lived assets were impaired and management did not identify any assets as held for sale.

F-158

Table of Contents

​

Impairment of Goodwill

Goodwill represents the excess purchase price over the fair value of the net assets acquired in a business combination and is not amortized. Goodwill is tested for impairment annually or more frequently if events or circumstances indicate that the fair value may be below its carrying amount. The events and circumstances that are considered include business climate and market conditions, legal factors, operating performance indicators and competition. In completing our impairment test, we perform either a qualitative or a quantitative analysis on a reporting unit basis. The Company has one reporting unit. In performing qualitative assessments, management evaluates the financial health of the business, including such factors as industry performance, market saturation and opportunity, changes in technology and operating cash flows. Changes in forecasts could cause the book value of reporting units to exceed their fair values. If the results of the qualitative assessment indicate it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the Company will perform a quantitative analysis. If the quantitative analysis indicates the carrying amount of the goodwill of the reporting unit exceeds the fair value of that goodwill, an impairment loss would be recognized in an amount equal to the excess of carrying value over fair value.

The results of the goodwill impairment test as of December 31, 2024 indicated that the estimated fair value of the reporting unit was below its respective carrying value. Accordingly, the Company recorded a non-cash impairment charge of $10,214,116 to reflect the impairment of goodwill. As a result of this impairment charge, the reporting unit had $8,079,456 of goodwill as of December 31, 2024.

The Company did not identify any impairment of its goodwill during the year ended December 31, 2025.

Warrant Liability

The Company accounts for freestanding warrants for shares that are either puttable or warrants for shares that are redeemable as liabilities on the consolidated balance sheets at fair value. At the end of each reporting period, changes in fair value during the period are recorded as a component of other income or expense.

Derivative Liability

The Company accounts for derivative instruments in accordance with Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging, which establishes accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the consolidated balance sheet at fair value. The Company’s derivative financial instrument consists of a variable redemption feature in the Company’s convertible debt. At the end of each reporting period, changes in fair value during the period are recorded as a component of other income or expense.

Revenue Recognition

The Company generates revenue primarily from five major sources: (1) coating services, which is comprised of fees charged to provide coating services; (2) royalties from right to use IP license, which is comprised of fees charged to customers who have been granted the right to use the Company’s functional intellectual property (“IP”) license in order to perform coating services themselves; (3) equipment sales, which is comprised of sales of coating equipment directly to customers; (4) professional services, which is comprised of installation, training and ongoing maintenance and support of equipment, and (5) coating material sales. Revenue is recognized in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services when control of these goods or services is transferred to the Company’s customers. Revenues are recognized net of applicable taxes imposed on the related transaction.

The Company determines revenue recognition through the following steps:

●identification of the contract, or contracts, with a customer;
●identification of the performance obligations in the contract;
●determination of the transaction price;
●allocation of the transaction price to the performance obligations in the contract; and
●recognition of revenue when, or as, the Company satisfies a performance obligation.

F-159

Table of Contents

​

The following describes the nature of the Company’s primary types of revenue and the revenue recognition policies as they pertain to the types of transactions the Company enters into with its customers. The Company’s contract payment terms are generally 30-60 days.

Coating services

Coating services revenue, which is disaggregated within coating services, is fees from providing coating services to its customers. In some cases, these services are performed in the Company’s own facility and in some cases these services are performed in a dedicated space within the customer’s facility. All coating services revenue is recognized on a per unit basis when the coating of the product is completed and delivered.

Royalties from IP license

Royalties revenue, which is disaggregated within coating services, is derived from customers who have been given the right to use the Company’s functional IP license in order to perform coating services and must pay a per unit royalty for the use of the IP license. Revenue from royalties is treated as a combined performance obligation with equipment sales and installation services. The Company recognizes the usage-based royalties as earned.

Equipment sales

Equipment sales revenue, which is disaggregated within equipment, is derived from sales of equipment to customers. The customers are then able to perform the coating service or, in some cases, to hire the Company to perform the coating service. The equipment is sold on a fixed fee basis. In cases where the customer performs their own coating service, revenue from equipment sales is treated as a combined performance obligation with royalties from right to use IP and installation services. Revenue allocated to equipment sales is recognized over the period in which it takes the Company to deliver and install the equipment, generally two to three months.

Professional services

Professional services revenue, which is disaggregated within coating services, is derived from installation, training and ongoing maintenance and support of equipment. Training services are billed in advance, on a fixed-fee basis, and revenue is recognized after the training is delivered. Professional services other than installation are treated as separate performance obligations and the revenue for these services is recognized over time as the service is provided. Revenue from installation services is treated as a combined performance obligation with equipment sales and royalties for the right to use IP. Revenue allocated to the installation services is recognized over time as the service is provided, generally two to three months.

Coating materials sales

Coating materials sales revenue, which is disaggregated within coating services, is derived from sales of coating materials to customers. The customers are then able to use the coating materials to perform the coating services. The materials are sold on a fixed fee basis. Revenue from coating material sales is recognized when delivered.

Contracts with Multiple Performance Obligations

Some of the Company’s contracts with customers may contain multiple performance obligations. The Company accounts for individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price (“SSP”) basis. The Company determines the SSPs based on its overall pricing objectives by reviewing its significant pricing practices, including discounting practices, geographical locations, the size and volume of transactions, the customer type, price lists, pricing strategies, and historical standalone sales. SSP is analyzed on a periodic basis to identify if the Company has experienced significant changes in its selling prices.

Contract origination and fulfillment costs

The Company generally does not incur costs related to the origination and fulfillment of contracts. As such, the Company does not capitalize any such costs.

F-160

Table of Contents

​

Deferred Revenue

Deferred revenue consists of billings and payments received in advance of revenue recognition generated by the services described above. Deferred revenue was $21,728 and $128,704 at December 31, 2025 and 2024, respectively, and consists of payments received for equipment sales containing a repurchase option. Revenue is recognized under this agreement over time as the value of the repurchase option decreases.

Disaggregated Revenue

The following table presents the Company’s revenue by type for the years ended December 31:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Coating services, recurring

​

$

4,787,766

​

$

3,934,930

Equipment sales

​

 

54,420

​

 

1,407,896

Total Revenue

​

$

4,842,186

​

$

5,342,826

​

Contract Assets and Liabilities

The following table provides information about receivables and contract liabilities from contracts with customers at December 31:

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

Receivables, gross

​

$

808,073

​

$

1,028,215

​

$

2,512,029

Contract liabilities

​

$

21,728

​

$

128,704

​

$

108,058

​

Receivables are included in accounts receivable, net of allowance for credit losses and contract liabilities are included in deferred revenue on the consolidated balance sheets. The total allowance for credit losses was $5,447, $191,833, and $197,730 for the years ended December 31, 2025, 2024 and 2023, respectively.

Product Warranty

The Company generally offers a one-year limited warranty for product and service performance. To date, the Company has experienced no warranty claims and has not reimbursed any of its customers for any losses related to the limited indemnifications described above. Accordingly, there was no warranty accrual recorded as of December 31, 2025 and 2024.

Shipping and Handling Costs

The Company classifies freight billed to customers as revenue and the related freight costs as cost of revenue.

Cost of Revenue

The primary components of cost of revenue include labor, materials and manufacturing depreciation costs.

Stock-Based Compensation

Stock-based payments made to employees, including grants of employee stock options, are measured using a fair value-based method, net of estimated forfeitures, as of the measurement date (generally the grant date). The related expense is recorded in the consolidated statements of operations and comprehensive loss over the period of service and is recognized using the straight-line method.

Advertising

Advertising costs are expensed as incurred. Advertising costs for the years ended December 31, 2025 and 2024, were $145,490 and $196,398, respectively.

F-161

Table of Contents

​

Income Taxes

Income taxes are recorded in accordance with ASC Topic 740, Income Taxes, (“ASC 740”) which provides for deferred taxes using an asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are provided, if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.

In accordance with ASC 740, Accounting for Income Taxes, the Company reflects in the financial statements the benefit of positions taken in a previously filed tax return or expected to be taken in a future tax return only when it is considered ‘more-likely-than-not’ that the position taken will be sustained by a taxing authority. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant taxing authority. The Company’s policy for recording interest and penalties relating to uncertain income tax positions is to record them as a component of income tax expense. As of December 31, 2025 and 2024, the Company had no accrued interest or penalties related to uncertain tax positions.

Foreign Currency Translation

The functional currency for the Company’s foreign subsidiaries is their respective local currency. The translation of foreign currencies into U.S. dollars is performed for balance sheet accounts using exchange rates in effect at the balance sheet date and for revenue and expense accounts using a weighted average exchange rate during the period. Gains and losses on transactions denominated in foreign currencies other than the local functional currency are recognized in other income (expense) as incurred. Transaction and translation gains and losses arising from intercompany balances are reported as a component of accumulated other comprehensive income (loss) when the underlying transaction stems from a long-term equity investment or from debt designated as not due in the foreseeable future. Otherwise, the Company recognizes transaction gains and losses arising from intercompany transactions as a component of income (loss) in the accompanying consolidated statements of operations and comprehensive loss. Translation gains or losses are reported as accumulated other comprehensive income (loss).

Reclassification

Certain prior year amounts have been reclassified to conform to the current year presentation. These reclassifications were made to enhance comparability and consistency with the current year presentation and had no impact on previously reported net loss, comprehensive loss, total assets, total liabilities, stockholders’ equity, or net cash flows for the prior year.

Recently Adopted Accounting Standards

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). The amendments in this update require that all business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. The amendments also require entities on an annual basis to disclose disaggregated amounts of income taxes paid. The Company adopted ASU 2023-09 effective January 1, 2025, which had no impact on the Company’s financial position or results of operations. See Note 16, “Income Taxes,” to the consolidated financial statements, for the additional applicable disclosures.

Recent Accounting Pronouncements Not Yet Adopted

In November 2024, the FASB issued ASU 2024-04, Debt-Debt with Conversion and Other Options (Subtopic 470-20):  Induced Conversions of Convertible Debt Instruments (“ASU 2024-04”), which provides additional guidance to stakeholders about how to determine whether a settlement of convertible debt (particularly, cash convertible instruments) at terms that differ from the original conversion terms should be accounted for under the induced conversion or extinguishment guidance. ASU 2024-04 is effective for annual reporting periods beginning after December 15, 2025, and interim periods within those annual reporting periods. Early adoption is permitted for all entities that have adopted the amendments in Update 2020-06. The Company, which has adopted ASU 2020-06, is currently evaluating the impact of adopting ASU 2024-04 on its financial statements and expects to adopt the guidance upon its effective date.

F-162

Table of Contents

​

In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets (“ASU 2025-05”), which provides a practical expedient for the estimation of expected credit losses for current accounts receivable and current contract assets under ASC 606. The practical expedient election assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset. ASU 2025-05 is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Entities should apply the guidance prospectively and early adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2025-05 on its consolidated financial statements and will adopt the guidance upon its effective date.

In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software (“ASU 2025-06”), which amends certain aspects of the accounting for and disclosure of software costs under ASC 350-40. The guidance removes all references to project stages throughout ASC 350-40 and clarifies the threshold entities apply to begin capitalizing costs. ASU 2025-06 is effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods, with the option to apply the guidance prospectively, retrospectively, or via a modified prospective transition method. Early adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2025-06 on its consolidated financial statements.

In December 2025, the FASB issued ASU 2025-12, Codification Improvements (“ASU 2025-12”), which addresses suggestions received from stakeholders on the accounting standards and to make other incremental improvements to GAAP. ASU 2025-12 addresses thirty-three issues on a broad range of topics which are intended to be improvements that are not expected to have a significant effect on current accounting practice or result in significant costs to most entities. ASU 2025-12 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within those annual reporting periods, with the option to apply the guidance prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2025-12 on its consolidated financial statements.

2.

Going Concern Uncertainty

In accordance with ASU 2014-15, Presentation of Financial Statements - Going Concern, the Company’s management evaluated whether there are conditions or events that raise substantial doubt about its ability to continue as a going concern within one year after the date of issuance of these consolidated financial statements. Specifically, management is required to evaluate whether the presence of adverse conditions or events, when considered individually and in the aggregate, raise substantial doubt about an entity’s ability to continue as a going concern. Substantial doubt exists when it is probable that the entity will be unable to meet its obligations as they become due within one year after the date the financial statements are available for issuance. Management has identified the adverse conditions and events that raise substantial doubt about the Company’s ability to continue as a going concern. Although the following matters raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these consolidated financial statements are available for issuance, the Company’s consolidated financial statements have been prepared assuming that it will continue as a going concern.

The Company incurred a net loss of $15,628,206 and used cash in operating activities of $10,103,423 for the year ended December 31, 2025. As a result, the Company had an accumulated deficit of $307,930,194, and limited capital resources to fund ongoing operations at December 31, 2025. These capital resources were comprised of cash of $4,572,687 at December 31, 2025 and the generation of cash inflows from working capital. The Company intends to raise additional funds through either the issuance of subordinated convertible promissory notes or the sale of equity securities in calendar year 2026 that would provide sufficient capital resources to allow the Company to continue to meet its obligations and continue its operations for the next twelve months from the date of issuance of these consolidated financial statements. However, the Company cannot provide any assurance that additional capital will be available on acceptable terms or at all. Management has concluded this uncertainty raises substantial doubt about the Company’s ability to continue as a going concern.

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates continuity of operations, realization of assets and the satisfaction of liabilities in the normal course of business for the 12-month period following the date the Company’s calendar year 2025 financial statements are issued. As such, the accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets and their carrying amounts, or the amount and classification of liabilities that may result should the Company be unable to continue as a going concern.

F-163

Table of Contents

​

3.

Liabilities Measured at Fair Value on a Recurring Basis

The following table summarizes the composition and fair value hierarchy of the Company’s financial liabilities at December 31:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

2025

​

  ​ ​ ​

Level 1

  ​ ​ ​

Level 2

  ​ ​ ​

Level 3

  ​ ​ ​

Total

Liabilities:

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

Warrant liability

​

$

—

​

$

—

​

$

51,673

​

$

51,673

Embedded derivative liability

​

$

—

​

$

—

​

$

3,396,000

​

$

3,396,000

Total

​

$

—

​

$

—

​

$

3,447,673

​

$

3,447,673

​

The following table summarizes the composition and fair value hierarchy of the Company’s financial liabilities at December 31:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

2024

​

  ​ ​ ​

Level 1

  ​ ​ ​

Level 2

  ​ ​ ​

Level 3

  ​ ​ ​

Total

Liabilities:

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

Warrant liability

​

$

—

​

$

—

​

$

57,984

​

$

57,984

Embedded derivative liability

​

$

—

​

$

—

​

$

1,052,000

​

$

1,052,000

Total

​

$

—

​

$

—

​

$

1,109,984

​

$

1,109,984

​

During the years ended December 31, 2025 and 2024, there were no transfers between levels.

Valuation of Warrant Liability

The warrant liability is related to freestanding warrants to purchase shares of convertible preferred stock issued in connection with sales of corresponding convertible preferred stock. The fair value of the warrant liability was determined based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The liability is required to be marked to market at each reporting period. The Company reassesses the fair value of the corresponding liability each reporting period using the Black-Scholes option-pricing model, which incorporates assumptions and estimates, to value the warrant liability. Key estimates and assumptions impacting the fair value measurement include (i) the expected term of the warrants, (ii) the risk-free interest rate, (iii) the expected dividend yield, (iv) expected volatility of the price of the underlying series of preferred stock and (v) the fair value of the series of preferred stock on the valuation date. The Company estimated the fair value per share of the underlying series of preferred stock based on the results of third-party valuations. The risk-free interest rate was determined by reference to the U.S. Treasury yield curve for time periods approximately equal to the remaining contractual term of the warrants. The Company estimated a 0% expected dividend yield based on the fact the Company has never paid or declared dividends and does not intend to do so in the foreseeable future. As the Company is a private company and accordingly, lacks company-specific historical and implied volatility information of its stock, the expected stock volatility was based on the historical volatility of publicly traded peer companies for a term equal to the remaining expected term of the warrants, adjusted for Company-specific factors.

The following weighted-average assumptions were used in valuing the warrant liability as of December 31:

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

​

Risk-free interest rate

 

3.4

%  

4.0

%

Expected stock price volatility

 

60

%  

60

%

Expected dividend yield

 

0

%  

0

%

Expected term (years)

 

2.0

 

2.5

​

​

F-164

Table of Contents

​

The warrant liability was valued at $51,673 and $57,984 at December 31, 2025 and 2024, respectively, and classified as a non-current liability on the consolidated balance sheets. The following table presents a roll forward of the warrant liability:

​

​

​

​

​

​

  ​ ​ ​

Warrant

​

​

Liability

Balance at December 31, 2023

​

$

784,724

Change in fair value

​

 

(726,740)

​

​

​

​

Balance at December 31, 2024

​

 

57,984

Change in fair value

​

 

(6,311)

​

​

​

​

Balance at December 31, 2025

​

$

51,673

​

Valuation of Embedded Derivative Liability

The embedded derivative liability is related to the variable redemption feature of the Company’s Subordinated Convertible Promissory Notes (Note 9). The Company reassesses the fair values of the embedded derivative liability each reporting period using the Scenario Based Model (“SBM”), which incorporates assumptions and estimates, to value the embedded derivative liability. The SBM is based on an income differential model using a with and without scenario based on the features embedded in the convertible promissory note. The value of the embedded derivative liability is based on the difference between the value from the with and without analyses discounted to market participants discount rate. The discount rate is based on a CCC rated index bond of 7.5% which accounts for credit spread compared to a benchmark of the U.S. treasury note. The fair value of the embedded derivative liability at December 31, 2025 and 2024 was $3,396,000 and $1,052,000, respectively. The change in fair value of the embedded derivative liability was $139,000 and $2,000 for the years ended December 31, 2025 and 2024, respectively.

4.

Inventories

Inventories consisted of the following as of December 31:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Raw materials

​

$

1,090,884

​

$

830,121

Work in progress

​

 

57,308

​

 

1,838

Finished goods

​

 

1,354

​

 

—

​

​

​

​

​

​

​

​

​

 

1,149,546

​

 

831,959

Less reserve for obsolescence

​

 

(218,229)

​

 

(229,230)

Total inventories

​

$

931,317

​

$

602,729

​

​

​

5.

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following as of December 31:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Prepaid expenses

​

$

227,929

​

$

148,166

Deposits

​

 

191,087

​

 

208,103

Other

​

 

76,398

​

 

86,400

Total prepaid expenses and other current assets

​

$

495,414

​

$

422,669

​

​

F-165

Table of Contents

​

6.

Property and Equipment

Property and equipment consisted of the following as of December 31:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Machinery and equipment

​

$

5,814,929

​

$

15,238,966

Leasehold improvements

​

 

1,381,241

​

 

2,202,945

Furniture

​

 

1,261,196

​

 

1,320,869

Electronic equipment

​

 

1,282,907

​

 

1,766,121

Other assets

​

 

2,566,559

​

 

2,751,644

Construction in progress

​

 

96,865

​

 

69,410

Total property and equipment, gross

​

 

12,403,697

​

 

23,349,955

Accumulated depreciation

​

 

(8,576,467)

​

 

(16,709,300)

Total property and equipment, net

​

$

3,827,230

​

$

6,640,655

​

Total depreciation expense on property and equipment was $2,674,222 and $714,540 for the years ended December 31, 2025 and 2024, respectively.

7.

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following as of December 31:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Payroll and payroll tax

​

$

264,393

​

$

552,385

Unbilled receipts of inventory

​

 

174,560

​

 

118,923

Other trade payables

​

 

139,315

​

 

633,722

Interest on convertible promissory notes

​

 

32,763

​

 

106,612

Income and other taxes payable

​

 

42,115

​

 

40,986

Other

​

 

51,401

​

 

63,759

Total accrued expenses and other current liabilities

​

$

704,547

​

$

1,516,387

​

​

​

8.

Right-of-Use Asset and Lease Liabilities

As of December 31, 2025, the Company had leased properties in the U.S. and internationally, with remaining lease terms of 1.3 to 4.2 years, some of which include options to extend the leases for up to 5 years. None of the options to extend the leases are recognized in operating lease ROU assets or lease liabilities. None of the leases include options to terminate the lease.

The components of lease expense recorded in the consolidated statements of operations and comprehensive loss were as follows for the year ended December 31:

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Operating lease cost

​

$

1,026,354

​

$

1,118,058

Finance lease cost:

​

 

  ​

​

 

  ​

Amortization of assets

​

 

53,811

​

 

42,143

Interest on lease liabilities

​

 

15,247

​

 

14,387

Total lease cost

​

$

1,095,412

​

$

1,174,588

​

F-166

Table of Contents

​

Supplemental balance sheet information related to leases was as follows as of December 31:

​

​

​

​

​

​

​

​

​

Leases

  ​ ​ ​

Classification

  ​ ​ ​

2025

  ​ ​ ​

2024

Assets:

 

  ​

 

​

  ​

 

​

  ​

Operating lease assets

 

Operating ROU asset, net

​

$

2,675,083

​

$

3,390,744

Finance lease assets

 

Property and equipment, net

​

 

135,959

​

 

189,770

Total leased assets

 

  ​

​

$

2,811,042

​

$

3,580,514

​

​

​

​

​

​

​

​

​

Liabilities:

 

  ​

​

 

  ​

​

 

  ​

Current

 

  ​

​

 

  ​

​

 

  ​

Operating

 

Operating lease liabilities, current

​

$

982,996

​

$

1,015,052

Finance

 

Accrued expenses and other current liabilities

​

 

51,401

​

 

63,759

Non-current

 

  ​

​

 

  ​

​

 

  ​

Operating

 

Operating lease liabilities, non-current

​

 

1,931,610

​

 

2,635,658

Finance

 

Other liabilities

​

 

94,855

​

 

131,009

Total lease liabilities

 

  ​

​

$

3,060,862

​

$

3,845,478

​

Supplemental cash flow and other information related to leases was as follows for the year ended December 31:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

​

Cash paid for amounts included in the measurement of lease liabilities:

 

​

  ​

 

​

  ​

​

Operating cash flows from operating leases

​

$

757,759

 

$

872,460

​

Financing cash flows from finance leases

​

$

48,511

 

$

35,199

​

​

​

$

806,270

​

$

907,659

​

​

​

​

​

​

​

​

​

Weighted average remaining operating lease term (in years):

​

 

  ​

 

 

  ​

​

Operating leases

​

 

3.6

 

 

4.4

​

Finance leases

​

 

2.7

 

 

3.6

​

Weighted average operating lease discount rate:

​

 

  ​

 

 

  ​

​

Operating leases

​

 

8.3

%  

 

8.0

%

Finance leases

​

 

8.9

%  

 

8.9

%

​

Maturities of operating lease liabilities were as follows as of December 31, 2025:

​

​

​

​

​

  ​ ​ ​

Amount

2026

​

$

1,323,468

2027

​

 

1,101,590

2028

​

 

753,945

2029

​

 

649,382

2030

​

 

50,673

Thereafter

​

 

—

​

​

​

​

Total lease payments

​

$

3,879,058

Less: imputed interest

​

 

(964,452)

Total lease obligations

​

 

2,914,606

Less: current obligations

​

 

(982,996)

Long-term lease obligations

​

$

1,931,610

​

F-167

Table of Contents

​

Maturities of finance lease liabilities were as follows as of December 31, 2025:

​

​

​

​

​

  ​ ​ ​

Amount

2026

​

$

63,760

2027

​

 

53,656

2028

​

 

48,257

2029

​

 

—

​

​

​

​

Total lease payments

​

$

165,673

Less: imputed interest

​

 

(19,417)

Total lease obligations

​

 

146,256

Less: current obligations

​

 

(51,401)

Long-term obligations

​

$

94,855

​

​

​

9.

Convertible Securities

During the period from August 26, 2024 to January 10, 2025, the Company issued $4,772,907 in convertible promissory notes (the “2024 Notes”) of which $1,000,000 and $3,772,907 were issued in the years ended December 31, 2025 and 2024, respectively. The 2024 Notes accrue interest at 12% per annum, beginning on the date the note proceeds were received by the Company from the note-holder and through the maturity date August 26, 2025. The 2024 Notes were to automatically convert into preferred shares upon an equity offering by the Company that closes before the maturity date. Due to the variable redemption feature, the share settlement provision was bifurcated from the 2024 Notes and recorded as a derivative liability. The day one derivative liability was $289,000 and $1,050,000 in 2025 and 2024, respectively and was recorded as a discount on the 2024 Notes. The Company recorded $135,000 and $2,000 in other expense during the years ended December 31, 2025 and 2024, respectively to represent the debt discount of the derivative liability. The Company paid $116,440 in deferred financing costs related to the 2024 Notes. Deferred financing costs are amortized over the term of the 2024 Notes. Amortization expense related to the deferred financing costs was $16,655 and $27,614 for the years ended December 31, 2025 and 2024, respectively.

On February 14, 2025 the 2024 Notes and accrued interest of $169,711 converted into 6,027,707,347 and 4,059,267,542 shares of Series 2-B and Series 2-C preferred stock, respectively at a conversion price of $0.00049 per share. The fair value of the Series 2-B and Series 2-C preferred stock was approximately $8,553,000 at the conversion date resulting in a loss on extinguishment of approximately $3,071,000 and was recorded as a component of other expense on the consolidated statements of operations and comprehensive loss.

During the period from November 28, 2025 to December 22, 2025, the Company issued $5,353,018 in convertible promissory notes (the “2025 Notes”). The 2025 Notes accrue interest at 12% per annum, beginning on the date the note proceeds were received by the Company from the note-holder and through the maturity date November 28, 2026. The 2025 Notes were to automatically convert into preferred shares upon an equity offering by the Company that closes before the maturity date. Due to the variable redemption feature, the share settlement provision was bifurcated from the 2025 Notes and recorded as a derivative liability. The day one derivative liability in 2025 was $3,392,000 and was recorded as a discount on the 2025 Notes. The Company recorded $4,000 in other expense during the year ended December 31, 2025 to represent the debt discount of the derivative liability. The Company paid $24,502 in deferred financing costs related to the 2025 Notes. Deferred financing costs are amortized over the term of the 2025 Notes. During 2025, amortization expense related to the deferred financing costs and derivative liability was $366,988. As of December 31, 2025, the total unamortized debt discount was $3,295,670, which is expected to be amortized to interest expense in 2026.

10.

CARES Act

The CARES Act provides an employee retention credit (“ERC”), which is a refundable tax credit against certain employment taxes. The Taxpayer Certainty and Disaster Tax Relief Act of 2020 and the American Rescue Plan Act of 2021 extended and expanded the availability of the ERC. As amended, the ERC is available for wages paid through September 30, 2021 and is equal to 70% of qualified wages (which includes employer qualified health plan expenses) paid to employees. The Company evaluated its eligibility for the ERC and determined that it met all the criteria to claim a refundable tax credit against the employer share of Social Security taxes equal to 70% of the qualified wages that the Company paid to employees for the third and fourth quarter of 2020 and the first, second and third quarters of 2021. The Company adopted ASU 2021-10 to which topic 832 gives guidance to account for

F-168

Table of Contents

​

transactions with a government by analogizing to a grant accounting model, which the Company’s policy is the International Accounting Standard 20 model. The receivable, net of fees, remaining uncollected was $362,636 as of December 31, 2025 and 2024.

11.

Goodwill

The following table presents the changes in goodwill:

​

​

​

​

​

​

  ​ ​ ​

Amount

December 31, 2023

​

$

18,293,572

Impairment charge

​

 

(10,214,116)

December 31, 2024

​

$

8,079,456

​

​

​

​

December 31, 2025

​

$

8,079,456

​

As a result of our 2024 annual impairment test, the Company concluded that the carrying amount of the reporting unit exceeded its fair value and recorded a non-cash goodwill impairment charge of $10,214,116, which is included in goodwill impairment on our consolidated statements of operations and comprehensive loss for the year ended December 31, 2024. The goodwill impairment was related to the Company’s revised internal revenue projections, which anticipated lower year-over-year growth based on their then-current outlook. The fair value of the reporting unit was estimated using the market approach.

There were no goodwill impairment charges recorded for the year ended December 31, 2025. The Company’s gross amount of goodwill was $18,293,572 at December 31, 2025 and 2024, respectively. The total accumulated impairment loss was $10,214,116 at December 31, 2025 and 2024, respectively.

12.

Intangible Assets, Net of Accumulated Amortization

Intangible assets, net of accumulated amortization consists of the following as of December 31:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

2025

​

​

​

 

Remaining

​

​

​

​

​

​

​

​

​

​

​

​

 

Amortization

 

Gross

​

​

​

 

Net

​

 

Useful

 

Period in

 

Carrying

 

Accumulated

 

Carrying

​

  ​ ​ ​

Life

  ​ ​ ​

Years

  ​ ​ ​

Amount

  ​ ​ ​

Amortization

  ​ ​ ​

Amount

Developed technology asset

 

10 years

 

2.8

​

$

3,875,812

​

$

2,698,327

​

$

1,177,485

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

2024

​

​

​

 

Remaining

​

​

​

​

​

​

​

​

​

​

​

​

 

Amortization

 

Gross

​

​

​

 

Net

​

 

Useful

 

Period in

 

Carrying

 

Accumulated

 

Carrying

​

  ​ ​ ​

Life

  ​ ​ ​

Years

  ​ ​ ​

Amount

  ​ ​ ​

Amortization

  ​ ​ ​

Amount

Developed technology asset

 

10 years

 

3.8

​

$

3,875,812

​

$

2,282,745

​

$

1,593,067

​

The amortization expense on the intangible asset was $415,583 for the years ended December 31, 2025 and 2024, respectively.

The estimated future amortization expense of the intangible asset as of December 31 is as follows:

​

​

​

​

​

  ​ ​ ​

Amount

2026

 

​

415,583

2027

 

​

415,583

2028

 

​

346,319

Total

​

$

1,177,485

​

​

​

F-169

Table of Contents

​

13.

Commitments and Contingencies

Operating Leases

The Company leases office and manufacturing space under operating lease agreements that expire over the next 4.2 years. See Note 8, “Right-of-Use Asset and Lease Liabilities” to the consolidated financial statements for additional details on the Company’s operating lease commitments.

Litigation

The Company is involved in legal proceedings from time to time arising in the normal course of business. Management, after consultation with legal counsel, believes the outcome of these proceedings will not have a material impact on the Company’s consolidated financial position, or liquidity.

Employee Agreements

The Company has entered into employment agreements with certain members of management. These agreements include stipulated base salary, bonus potential, vacation benefits, severance, and non-competition agreements, and other typical benefits afforded management and senior executives.

Tariffs

On February 20, 2026, the U.S. Supreme Court ruled that the International Emergency Economic Powers Act (“IEEPA”) tariffs were not legally authorized (Note 18). The Company is currently assessing its ability to file a refund claim for the related tariffs paid. Consistent with ASC 450-30 gain contingencies, the Company will only recognize a refund receivable and corresponding income when realization of the claim is probable and reasonably estimable. The Company continues to monitor developments, including a CIT order in March 2026 directing a refund mechanism, which the government may appeal.

14.

Convertible Preferred Stock

During the period from February 14, 2025 to May 27, 2025, the Company sold 10,932,485,432 and 3,026,640,546 shares of Series 2 Preferred Stock and Series 2-A Preferred Stock, respectively at $0.00069 per share. Total proceeds received from the sale of these shares, net of costs, was approximately $9.4 million. Pursuant to the terms of the convertible securities (Note 9) the 2024 Notes were converted into 6,027,707,347 and 4,059,267,542 shares of Series 2-B Preferred Stock and Series 2-C Preferred Stock, respectively at a conversion price of $0.00049 per share.

Through December 31, 2025, the Company has authorized 49,086,791,753 shares of convertible preferred stock, issued in various individual series. Information by preferred stock series, including the liquidation preference, as of December 31, 2025 is as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Original

​

Liquidation

​

​

​

​

​

Designated

​

Outstanding 

​

Issue Price 

​

Multiple on

​

Liquidation 

Preferred Stock Series

  ​ ​ ​

Shares

  ​ ​ ​

Shares

  ​ ​ ​

(“OIP”)

  ​ ​ ​

OIP

  ​ ​ ​

Preference

​

​

​

​

​

​

​

​

​

​

​

​

​

Series 2

 

17,391,304,345

 

10,932,485,432

​

$

0.00069

 

2X

​

$

15,086,830

Series 2-A

 

17,391,304,345

 

3,026,640,546

​

$

0.00069

 

2X

​

$

4,176,764

Series 2-B

 

6,027,707,347

 

6,027,707,347

​

$

0.00049

 

2X

​

$

5,907,153

Series 2-C

 

4,059,267,542

 

4,059,267,542

​

$

0.00049

 

4X

​

$

7,956,164

Series 1

 

820,703,632

 

710,802,353

​

$

0.02168

 

1.5X

​

$

23,115,293

Series 1-A

 

3,396,504,542

 

3,257,660,800

​

$

0.00826

 

1.5X

​

$

40,362,417

​

Dividends

The Preferred stockholders receive dividends on an as-converted basis and have no dividend preferences over common stockholders. Upon conversion, the dividends on the Series 2, 2-A, 2-B, 2-C preferred stock (“Senior Preferred”) and the Series 1 and

F-170

Table of Contents

​

1-A preferred stock (“Junior Preferred”) are cumulative and payable if and when declared by the Company’s Board of Directors. There were no declared and unpaid dividends as of December 31, 2025.

Liquidation

The Senior Preferred and Junior Preferred stockholders have liquidation preferences over common stockholders in the amounts disclosed in the previous table, along with any declared but unpaid dividends. If the assets and funds available for distribution among the holders of the Senior Preferred and Junior Preferred are insufficient to permit payment of the full preferential amount, then the entire amount of the assets and funds available for distribution will be distributed with equal priority and pro rata first among the Senior Preferred in proportion to the aggregate liquidation preference of the Senior Preferred and then among the Junior Preferred in proportion to the aggregate liquidation preference of the Junior Preferred. After payment of the full preferred liquidation preferences, all shares of preferred stock are converted to common stock. The remaining assets are then distributed pro rata among common stockholders, including the converted shares.

Conversion

Each share of convertible preferred stock is convertible into common stock, at any time at the option of the preferred stockholder. Each share of preferred stock will automatically convert into common stock at the then-effective conversion rate upon the closing of an initial public offering of the Company’s common stock or upon change of control. As of December 31, 2025, the conversion prices per share for all series of convertible preferred stock were equal to the original issue prices and the rate at which each share would convert into common stock was one-for-one with the exception of the Series 2-C preferred stock for which each share would convert into common stock at a rate of two-for-one.

Redemption

The holders of Preferred Stock have no voluntary rights to redeem shares. Any voluntary or involuntary liquidation, dissolution or winding up of the Company, a greater than 50% change in control, or a sale of substantially all of the Company’s assets would constitute a redemption event. Although the Preferred Stock is not mandatorily or currently redeemable, these events would constitute a redemption event outside of the Company’s control. Accordingly, these shares are considered contingently redeemable. As such, if the Company were subject to SEC reporting requirements, the Preferred Stock would be presented as temporary equity in the accompanying consolidated balance sheets.

Preferred Stock Price Adjustment

The Company’s articles of incorporation contain “down-round” protection for the preferred stock. When additional shares of common stock are issued for an effective price less than the then-existing conversion price of the preferred stock, then and in each such case the then-existing conversion price is reduced to a price equal to the price per share received by the Company for the common stock issuance.

15.

Stock Options and Warrants

The Company’s 2012 Stock Incentive Plan (the “Plan”) provides for the grant of incentive stock options, nonqualified options, and shares of restricted stock. Under the terms of the Plan, there are 237,795,202 common shares available for grant to employees, officers, directors and consultants. The Board of Directors determines the terms of each grant. Generally, the options have a vesting period of 4 years with 25% vesting after the first year of service and monthly thereafter and have a ten-year contractual life. Certain stock options have provisions to accelerate vesting upon the occurrence of certain events. There were 235,573,898 shares available for grant under the Plan as of December 31, 2025. There were no grants in the years ended December 31, 2025 and 2024.

F-171

Table of Contents

​

The following table shows stock option activity under the 2012 Stock Incentive Plan for the year ended December 31, 2025:

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

​

​

  ​ ​ ​

Weighted-

  ​ ​ ​

​

​

​

 

​

 

Weighted-

 

Average 

 

Aggregate 

​

​

Outstanding 

 

Average 

 

Remaining 

 

Intrinsic 

​

​

Options

​

Exercise Price

 

Terms (Years)

​

Value

Balance as of December 31, 2024

 

1,343,500

​

$

0.71

​

​

 

$

—

Granted

 

—

​

 

—

​

  ​

 

​

  ​

Exercised

 

—

​

 

—

​

  ​

 

​

  ​

Forfeited

 

(1,875)

​

$

0.44

​

  ​

 

​

  ​

Canceled

 

(116,500)

​

$

0.75

​

  ​

 

​

  ​

Balance as of December 31, 2025

 

1,225,125

​

$

0.71

​

4.4

​

$

—

​

​

​

​

​

​

​

​

​

​

​

Vested and exercisable as of December 31, 2025

 

1,219,500

​

$

0.71

​

4.4

​

$

—

​

​

​

​

​

​

​

​

​

​

​

Vested and expected to vest as of December 31, 2025

 

1,224,652

​

$

0.71

​

4.4

​

$

—

​

The total stock-based compensation expense recognized during the years ended December 31, 2025 and 2024 was $4,625 and $33,228, respectively. As of December 31, 2025, there was approximately $1,166 of unrecognized stock-based compensation expense that will be recognized over the weighted average period of 0.7 years. The intrinsic value of all options outstanding at December 31, 2025 and 2024 was zero.

​

F-172

Table of Contents

​

Warrants

In connection with certain preferred stock offerings, debt issuances, and debt restructurings, the Company has issued warrants to purchase preferred stock. The following summarizes information about stock warrants outstanding as of December 31, 2025:

​

​

​

​

​

​

​

​

​

​

​

​

​

Exercise Price 

​

Number of 

Original Issue Date

  ​ ​ ​

Stock Class

  ​ ​ ​

Per Share

  ​ ​ ​

Shares

​

​

​

​

​

​

​

​

September 2017

 

Common

​

$

0.00

 

47,693

December 2017

 

Common

​

$

3.71

 

150,000

March 2018

 

Common

​

$

3.71

 

67,928

March 2018

 

Common

​

$

3.71

 

25,629

May 2019

 

Common

​

$

9.08

 

132,129

July 2023

 

Series 1 Preferred

​

$

0.02

 

93,237,996

November 2023

 

Series 1 Preferred

​

$

0.02

 

3,978,782

​

The warrants to purchase the Company’s common stock meet the criteria for equity classification. The Company accounts for freestanding warrants to purchase shares of convertible preferred stock as warrant liability on its consolidated balance sheets. The Company records the convertible preferred stock warrants at their estimated fair value because these warrants may contingently obligate the Company to redeem the underlying convertible preferred stock at some point in the future. At the end of each reporting period, changes in the estimated fair value of the warrant liability are recorded as other income or expense in the consolidated statements of operations and comprehensive loss. The estimated value of these warrants is determined using the Black-Scholes valuation model.

The fair value of the warrants for Series 1 Preferred was estimated at $51,673 and $57,984 as of December 31, 2025 and 2024, respectively. The Company recorded other income of $6,311 and $726,740 in the consolidated statements of operations and comprehensive loss for the years ended December 31, 2025 and 2024, respectively. The warrants are all exercisable as of December 31, 2025.

16.

Income Taxes

The Company’s loss before income taxes is as follows:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

​

​

​

​

​

​

​

United States

​

$

(9,510,124)

​

$

(16,408,351)

Foreign

​

 

(6,358,437)

​

 

(6,318,707)

Loss before income taxes

​

$

(15,868,561)

​

$

(22,727,058)

​

​

F-173

Table of Contents

​

The Company reported a ($240,355) income tax benefit for the year ended December 31, 2025, compared to income tax benefit of ($635,631) for the year ended December 31, 2024. The components of the income tax provision (benefit) are as follows:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Current

 

​

  ​

 

​

  ​

U.S. Federal

​

$

—

​

$

—

State

​

 

—

​

 

—

Foreign

​

 

(185,545)

​

 

(310,398)

​

​

 

(185,545)

​

 

(310,398)

​

​

​

​

​

​

​

Deferred

​

 

  ​

​

 

  ​

U.S. Federal

​

 

—

​

 

—

State

​

 

—

​

 

—

Foreign

​

 

(54,810)

​

 

(325,233)

​

​

 

(54,810)

​

 

(325,233)

Provision (benefit) for income taxes

​

$

(240,355)

​

$

(635,631)

​

A reconciliation of the provision for income taxes to the amount computed by applying the 21% statutory U.S. federal income tax rate to income before income taxes after the adoption of ASU 2023-09 is as follows:

​

​

​

2025

 

​

  ​ ​ ​

Amount

  ​ ​ ​

Percent

 

Tax at U.S. federal statutory rate

 

(3,332,398)

 

21.0

%

State income tax, net of federal benefit

 

—

 

—

%

Foreign tax effects

​

​

​

​

​

China

​

​

​

​

​

Statutory tax rate difference

 

(109,018)

 

0.7

%

Changes in valuation allowance

 

(970,355)

 

6.1

%

GAAP to statutory adjustments

 

594,878

 

(3.8)

%

Entity dissolution deferred tax adjustment

 

935,285

 

(5.9)

%

Other

 

(214,391)

 

1.4

%

Hong Kong

 

  ​

 

​

​

Statutory tax rate difference

 

180,561

 

(1.1)

%

Other

 

116,834

 

(0.7)

%

Vietnam

 

  ​

 

​

​

Statutory tax rate difference

 

30,531

 

(0.2)

%

Changes in valuation allowance

 

288,743

 

(1.8)

%

Expiration of NOL carryforward

 

244,434

 

(1.5)

%

Other

 

77,434

 

(0.5)

%

Other foreign jurisdictions

 

  ​

 

​

​

Other

 

(80,019)

 

0.5

%

Changes in valuation allowances

 

1,230,130

 

(7.8)

%

Nontaxable and nondeductible items

 

  ​

 

​

​

Amortization of debt discount and deferred financing fees

 

744,869

 

(4.7)

%

Other

 

22,127

 

(0.2)

%

Effective tax rate

 

(240,355)

 

1.5

%

​

For the year ended December 31, 2024 and prior to the adoption of ASU 2023-09, the provision (benefit) for income taxes differs from the amount computed at U.S. federal statutory rates mainly due to increases in valuation allowances in various jurisdictions, nontaxable and nondeductible items, and expiration of foreign NOL carryforwards.

F-174

Table of Contents

​

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred income tax assets (liabilities) are as follows as of December 31:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Deferred Tax Assets

​

​

​

​

​

​

Net operating losses

​

$

38,834,791

​

$

38,769,005

Disallowed interest expense carryforward

​

 

738,848

​

 

—

Intangible assets

​

 

1,067,412

​

 

1,133,201

Other assets

​

 

1,207,085

​

 

1,508,792

Depreciable assets

​

 

812,902

​

 

886,620

Deferred revenue

​

 

—

​

 

28,459

Valuation allowance

​

 

(41,738,026)

​

 

(41,012,328)

​

​

​

​

​

​

​

Net Deferred Tax Assets

​

 

923,012

​

 

1,313,749

​

​

​

​

​

​

​

Deferred Tax Liabilities

​

 

  ​

​

 

  ​

Depreciable assets

​

 

461,639

​

 

795,938

Other liabilities

​

 

461,373

​

 

571,607

​

​

​

​

​

​

​

Net Deferred Tax Liabilities

​

 

923,012

​

 

1,367,545

​

​

​

​

​

​

​

Deferred Tax Liability, net

​

$

—

​

$

(53,796)

​

The Company has net operating loss (“NOL”) carryforwards available in various jurisdictions to offset future taxable income as of December 31, 2025. The Company had cumulative U.S. federal net operating loss carryforwards of approximately $132,900,000 and $126,500,000 as of December 31, 2025 and 2024, respectively. The Company had cumulative state net operating loss carryforwards of approximately $91,400,000 and $91,000,000 as of December 31, 2025 and 2024, respectively. The Company had cumulative foreign net operating loss carryforwards of approximately $31,300,000 and $34,400,000 as of December 31, 2025 and 2024, respectively. The losses will begin to expire in 2026.

The Company’s ability to utilize its NOL carryforwards may be substantially limited due to ownership changes that may have occurred or that could occur in the future, as required by Section 382 of the Internal Revenue Code of 1986, as amended (the Code), as well as similar state provisions. These ownership changes may limit the amount of NOL carryforwards that can be utilized annually to offset future taxable income and tax, respectively. The Company has not completed a study to assess whether one or more ownership changes have occurred since the Company became a loss corporation under the definition of Section 382. If the Company has experienced an ownership change as defined under Section 382, utilization of the NOL or R&D credit carryforwards would be subject to an annual limitation. Any such limitation may result in the expiration of a portion of the NOL carryforwards before utilization. Due to the existence of the valuation allowance, it is not expected that any possible limitation will have an impact on the results of operations of the Company.

Under U.S. GAAP, deductible temporary book to tax differences may generally only be recognized to the extent future taxable income will be generated to realize the deductions. Management does not believe sufficient evidence exists at December 31, 2025 or 2024 to fully recognize the Company’s net deductible temporary book to tax differences. A valuation allowance has been established as follows to reduce the Company’s deductible temporary differences:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

​

​

​

​

​

​

​

Valuation allowance

​

$

(41,738,026)

​

$

(41,012,328)

​

The Company applies the provisions of ASC 740 related to the recognition of uncertain tax positions. The Company had $500,000 of reserves recorded for unrecognized tax positions at December 31, 2025 and 2024. The Company evaluated its material tax positions and determined that they do not have any interest or penalties associated with its positions. The Company’s policy is to recognize interest and penalties accrued on uncertain tax positions as part of income tax expense. There were no uncertain tax

F-175

Table of Contents

​

positions as of December 31, 2025 and 2024 that would impact the effective tax rate if recognized, and as such, no interest or penalties were recorded to income tax expense.

17.

Employee Retirement Plan

The Company sponsors a defined contribution 401(k) retirement plan (the Retirement Plan). All U.S. employees are eligible to participate in the Retirement Plan after completing thirty days of employment and after electing to participate in the Retirement Plan. As set forth in the Retirement Plan document, the Company matches employee contributions up to 4% of eligible wages. Employer matching contributions are immediately 100% vested. Employer contributions under the Retirement Plan were $136,013 and $150,319 for the years ended December 31, 2025 and 2024, respectively.

18.

Subsequent Events

Management has evaluated events and transactions for potential recognition or disclosure through May 19, 2026, which is the day these consolidated financial statements were available for issuance.

Convertible Promissory Notes

During the period from March 12, 2026 to March 31, 2026, the Company issued $15,500,209 in convertible promissory notes under substantially the same terms and conditions as the 2025 Notes described in Note 9.

Term Sheet for Potential Business Combination

On February 24, 2026, the Company entered into a now binding term sheet to be acquired for a total purchase price of $55,000,000 not to include the value of any equity in the buyer held by the Company at the closing. The acquisition will consist of the buyer acquiring 100% of the Company’s equity, with consideration in common shares subject to certain adjustments related to cash, debt, and working capital.

On March 13, 2026, the Company made a $15,000,000 initial investment in the buyer’s Series D preferred stock financing for which it paid cash of $13,000,000 and entered into a $2,000,000 unsecured term loan facility with the buyer. The term loan has a maturity date of March 12, 2028 and bears interest at a rate of 6.00% per annum. Upon closing of the aforementioned initial investment, the term sheet for the acquisition became binding.

The Company or its affiliates have agreed to make a further $5,000,000 follow-up investment in a separate financing by the buyer.

Tariffs

On February 20, 2026, the United States Supreme Court issued a ruling striking down certain tariffs previously imposed under the IEEPA. The ultimate availability, timing, and amount of any potential refunds of such tariffs remain highly uncertain and are subject to further legal, regulatory, and administrative developments. Following the Supreme Court’s decision, the U.S. presidential administration announced its intention to invoke other laws to collect tariffs and announced new tariffs on imports from all countries, in addition to any existing non-IEEPA tariffs. There remains substantial uncertainty regarding the duration of existing and newly announced tariffs, potential changes or pauses of such tariffs, tariff levels, and whether further additional tariffs or other retaliatory actions may be imposed, modified, or suspended, and the impacts of such actions on the Company. The Company continues to monitor and evaluate these developments and assess their potential impact on its business, financial condition, and results of operations.

​

​

​

F-176

Table of Contents

​

​

Primary Offering of

11,499,995 Shares of Common Stock Issuable Upon Exercise of Warrants

​

​

​

Secondary Offering of

43,553,075 Shares of Common Stock

41,435,272 Shares of Common Stock Issuable Upon Exercise of Warrants and
23,525 Warrants

​

​

​

FORGE NANO HOLDINGS, INC.

​

​

PROSPECTUS

​

​

             , 2026.

​

​

​

​

Table of Contents

​

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

Item 13.Other Expenses of Issuance and Distribution

The following table sets forth all expenses to be paid by us in connection with the issuance and distribution of the shares of Common Stock being registered by this registration statement. All amounts shown are estimates except for the SEC registration fee. We will bear all costs, expenses and fees in connection with the registration of the securities. Selling Securityholders, however, will bear all brokers and underwriting commissions and discounts, if any, attributable to their sale of the Securities.

​

​

​

  ​ ​ ​

Amount

​

SEC registration fee

​

$

56,000

​

Accounting fees and expenses

​

​

*

Legal fees and expenses

​

​

100,000

​

Financial printing and miscellaneous expenses

​

​

*

​

​

​

​

​

Total

​

$

*

*

To be filed by amendment.

Item 14.Indemnification of Directors and Officers

Forge Nano Holdings, Inc. (“Forge Nano Holdings”) is a Delaware corporation. Section 145 of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party (or is threatened to be made a party) to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), because he or she is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding, if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. A Delaware corporation may also indemnify directors, officers, employees and other agents of such corporation in an action by or in the right of the corporation under the same conditions, except that no indemnification is permitted without judicial approval if the person to be indemnified has been adjudged to be liable to the corporation. The DGCL provides that Section 145 of the DGCL is not exclusive of other rights to which those seeking indemnification may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise.

Forge Nano Holdings’ amended and restated bylaws (the “Bylaws”) contain provisions that require Forge Nano Holdings to indemnify any person who was or is made or is threatened to be made a party or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such person, or a person for whom such person is the legal representative, is or was a director or officer of Forge Nano Holdings or, while a director or officer of Forge Nano Holdings, is or was serving at the request of Forge Nano Holdings as a director, officer, employee or agent of another corporation or of a partnership, joint venture, limited liability company, trust, enterprise or nonprofit entity, including service with respect to employee benefit plans, against all liability and loss suffered and expenses (including attorneys’ fees) reasonably incurred by such person, to the fullest extent permitted by the DGCL, as it may be amended from time to time.

In addition, Forge Nano Holdings’ amended and restated certificate of incorporation (the “Charter”) provides that Forge Nano Holdings has the power to provide rights to indemnification and advancement of expenses, and the Bylaws require Forge Nano Holdings to advance expenses incurred by covered directors and officers in defending proceedings, subject to receipt of any undertaking required by applicable law.

As permitted by Section 102(b)(7) of the DGCL, the Charter contains provisions eliminating the personal liability of directors and officers to Forge Nano Holdings or its stockholders for monetary damages for breach of fiduciary duty as a director or officer to the fullest extent permitted under the DGCL.

II-1

Table of Contents

​

Forge Nano Holdings maintains standard policies of insurance under which coverage is provided (a) to its directors and officers against losses arising from claims made by reason of breach of duty or other wrongful act by such persons in their respective capacities as officers and directors of Forge Nano Holdings, and (b) to Forge Nano Holdings with respect to payments which may be made by Forge Nano Holdings to such officers and directors pursuant to the above indemnification provision or otherwise as a matter of law.

In connection with the Business Combination, Forge Nano Holdings entered into indemnification agreements with each of its directors and executive officers. These agreements, among other things, require Forge Nano Holdings to indemnify each such director and executive officer, to the fullest extent permitted by Delaware law, the Charter and the Bylaws, against expenses incurred by reason of his or her status as a director or executive officer of Forge Nano Holdings, and to advance expenses incurred in connection with any proceeding involving such status.

Item 15.Recent Sales of Unregistered Securities

Set forth below is information regarding securities sold by Forge Nano Holdings within the past three years which were not registered under the Securities Act of 1933, as amended (the “Securities Act”). Also included is the consideration received for such securities and information relating to the section of the Securities Act, or rule of the Securities and Exchange Commission (the “SEC”), under which exemption from registration was claimed.

PIPE Subscribed Shares and PIPE Warrants

Pursuant to the PIPE Subscription Agreement entered into in connection with the Business Combination, Forge Nano Holdings issued and sold to the Initial PIPE Investor, in a private placement that closed substantially concurrently with the closing of the Business Combination (the “Closing”), an aggregate of 2,968,825 PIPE Subscribed Shares at a subscription price of $10.00 per share and 7,031,175 Pre-Funded Warrants at a price of $10.00 per Pre-Funded Warrant, together with PIPE Warrants to purchase an aggregate of 15,000,000 shares of Common Stock at an exercise price of $10.00 per share (subject to adjustment), for an aggregate purchase price of $100,000,000. The PIPE Subscribed Shares, the Pre-Funded Warrants and the PIPE Warrants were issued in reliance on the exemption from registration contained in Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. The Initial PIPE Investor is an accredited investor within the meaning of Rule 501 of Regulation D.

Additional Subscribed Shares

Pursuant to Additional PIPE Subscription Agreements entered into in connection with the Business Combination, Forge Nano Holdings issued and sold to the Additional PIPE Investors an aggregate of 2,300,000 shares of Common Stock at a purchase price of $10.00 per share, for aggregate gross proceeds of $23,000,000, in a private placement that closed substantially concurrently with the Closing. The Additional Subscribed Shares were issued in reliance on the exemption from registration contained in Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.

Options

At the closing of the Business Combination, Forge Nano Holdings assumed options to purchase shares of Common Stock that were outstanding immediately prior to the First Effective Time and converted them into options to purchase an aggregate of 11,970,464 shares of Common Stock (the “Options”), with the number of shares subject to each option and the exercise price thereof adjusted based on the Equity Award Conversion Amount (as defined in the Merger Agreement). The Options have a weighted average exercise price of $1.69 per share. The Options were issued in reliance on the exemption from registration contained in Section 4(a)(2) of the Securities Act and Rule 701 promulgated under the Securities Act (to the extent originally granted under compensatory benefit plans or contracts).

II-2

Table of Contents

​

Forge Nano Warrants

At the closing of the Business Combination, the warrants to purchase shares of Common Stock that were outstanding immediately prior to the First Effective Time were assumed by Forge Nano Holdings and converted into warrants to purchase an aggregate of 421,792 shares of Common Stock (collectively, the “Forge Nano Warrants”), consisting of: (a) warrants to purchase 75,656 shares of Common Stock issued in exchange for the warrant to purchase shares of Common Stock issued to Silicon Valley Bank on February 10, 2021 (exercise price of $0.33 per share); (b) warrants to purchase 88,279 shares of Common Stock issued in exchange for the warrant to purchase shares of Common Stock issued to Silicon Valley Bank on May 24, 2022 (exercise price of $0.56 per share); and (c) warrants to purchase 257,857 shares of Common Stock issued in exchange for the warrant to purchase shares of Common Stock issued to Saoradh Energy Partners LLC (exercise price of $0.56 per share). The Forge Nano Warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act.

Ascent Warrants

At the closing of the Business Combination, the certain options to purchase shares of Common Stock were cancelled and converted into warrants (the “Ascent Warrants”) to purchase an aggregate of 3,562,305 shares of Common Stock, consisting of (i) Ascent Warrants to purchase 2,351,238 shares at an exercise price of $3.40 per share, expiring December 31, 2028 (subject to extension to December 31, 2029 at the holder’s election, in which case the exercise price applicable to any exercise during 2029 will increase by 25%), and (ii) Ascent Warrants to purchase 1,211,067 shares at an exercise price of $9.83 per share, expiring December 31, 2029. The Ascent Warrants were issued in reliance on the exemption from registration contained in Section 4(a)(2) of the Securities Act as a transaction by an issuer not involving any public offering.

Earn-Out Shares

At the closing of the Business Combination, we issued 90,000,000 Earn-Out Shares to Odyssey Transfer and Trust Company, as Escrow Agent, to be disbursed to certain securityholders of Forge Nano Holdings upon the achievement of the applicable milestones during the Earn-Out Period. The Earn-Out Shares were issued in reliance on the exemption from registration contained in Section 4(a)(2) of the Securities Act.

Performance Stock Units

At the closing of the Business Combination, we granted an aggregate of 8,744,864 performance stock units (the “PSUs”). One third of the PSUs will vest if the VWAP of our Common Stock equals or exceeds $15.00 per share over any 30-trading-day period or our revenue for the preceding twelve months equals or exceeds $400,000,000; one third will vest if such VWAP equals or exceeds $20.00 per share over any 30-trading-day period or such revenue equals or exceeds $600,000,000; and one third will vest if such VWAP equals or exceeds $25.00 per share over any 30-trading-day period or such revenue equals or exceeds $800,000,000. The PSUs were granted in reliance on the exemption from registration contained in Section 4(a)(2) of the Securities Act and Rule 701 promulgated under the Securities Act.

HzO Merger Shares

On November 4, 2026, in connection with the HzO Merger, Forge Nano Holdings issued 5,772,645 shares of Common Stock to the former equityholders of HzO, and 1,533,795 additional shares are issuable to such equityholders following the expiration of a twelve-month holdback period, subject to adjustment, for an aggregate of up to 7,306,440 shares. The shares were issued, and will be issued, in reliance on the exemption from registration contained in Section 4(a)(2) of the Securities Act.

No underwriting discounts or commissions were paid with respect to any of the foregoing issuances.

​

II-3

Table of Contents

​

Item 16.Exhibits and Financial Statement Schedules.

(a)The following exhibits are filed as part of this registration statement:

​

​

Exhibit No.

  ​ ​ ​

Description

​

​

​

2.1

​

Agreement and Plan of Merger, dated as of April 20, 2026, by and among Archimedes Tech SPAC Partners II Co., ATII Holdings Inc., ATII Merger Sub Inc., ATII Merger Sub II, LLC and Forge Nano, Inc. (incorporated by reference to Annex A to the Registration Statement on Form S-4 (File No. 333-295563), filed on May 5, 2026).

2.2

​

Agreement and Plan of Merger, dated as of November 4, 2026, by and among Forge Nano Holdings, Inc., FN Merger Sub, Inc., HzO, Inc. and Fortis Advisors LLC, as the stockholders’ representative (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K, filed on November 9, 2026).

3.1

​

Amended and Restated Certificate of Incorporation of Forge Nano Holdings, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on October 27, 2026).

3.2

​

Amended and Restated Bylaws of Forge Nano Holdings, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K, filed on October 27, 2026).

4.1

​

Warrant Agreement, dated February 10, 2025, by and between Archimedes Tech SPAC Partners II Co. (as predecessor to the Company) and Odyssey Transfer and Trust Company, as warrant agent (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed on October 27, 2026), as assumed pursuant to the Assumption of Warrant Agreement, dated as of October 21, 2026, by and among the Company, Archimedes Tech SPAC Partners II Co. and Odyssey Transfer and Trust Company (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K, filed on October 27, 2026).

4.2

​

Ascent Warrant Agreements, each dated as of October 22, 2026, between Forge Nano Holdings, Inc. and Ascent Funds International Management LLC (incorporated by reference to Exhibits 4.5 and 4.6 to the Company’s Current Report on Form 8-K, filed on October 27, 2026).

4.3

​

Warrant to Purchase Shares of Common Stock, dated January 31, 2020, by and between Forge Nano, Inc. and Saoradh Energy Partners LLC (incorporated by reference to Exhibit 4.4 to the Registration Statement on Form S-4 (File No. 333-295563), filed on July 24, 2026).

4.4

​

Warrant to Purchase Stock, dated May 24, 2022, by and between Forge Nano, Inc. and Silicon Valley Bank (incorporated by reference to Exhibit 4.5 to the Registration Statement on Form S-4 (File No. 333-295563), filed on July 24, 2026).

4.5

​

Form of PIPE Warrant Certificate (incorporated by reference to Exhibit 4.1 to Archimedes Tech SPAC Partners II Co.’s Current Report on Form 8-K, filed on October 13, 2026).

4.6

​

Form of Pre-Funded Warrant Certificate (incorporated by reference to Exhibit 4.2 to Archimedes Tech SPAC Partners II Co.’s Current Report on Form 8-K, filed on October 13, 2026).

4.7

​

Warrant to Purchase Common Stock, dated February 10, 2021, by and between Forge Nano, Inc. and Silicon Valley Bank (incorporated by reference to Exhibit 4.9 to the Registration Statement on Form S-4 (File No. 333-295563), filed on September 2, 2026).

5.1*

​

Opinion of Paul, Weiss, Rifkind, Wharton & Garrison LLP.

10.1

​

Letter Agreement, dated February 10, 2025, by and among Archimedes Tech SPAC Partners II Co., its officers, its directors and Archimedes Tech SPAC Sponsors II LLC (incorporated by reference to Exhibit 10.1 to Archimedes Tech SPAC Partners II Co.’s Current Report on Form 8-K, filed on February 14, 2025).

10.2

​

Form of Lock-Up Agreement (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K, filed on October 27, 2026).

10.3

​

Amended and Restated Registration Rights Agreement, dated as of October 22, 2026, by and among Forge Nano Holdings, Inc., Archimedes Tech SPAC Sponsors II LLC and the other holders party thereto (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K, filed on October 27, 2026).

10.4

​

Lease Agreement, dated March 31, 2025, by and among Forge Battery, Inc., as tenant, and 401 Southport, LLC, as landlord (incorporated by reference to Exhibit 10.9 to the Registration Statement on Form S-4 (File No. 333-295563), filed on July 24, 2026).

10.5

​

First Amendment to Lease Agreement, dated May 8, 2026, by and among Forge Battery, Inc., as tenant, and 401 Southport, LLC, as landlord (incorporated by reference to Exhibit 10.10 to the Registration Statement on Form S-4 (File No. 333-295563), filed on July 24, 2026).

II-4

Table of Contents

​

​

​

Exhibit No.

  ​ ​ ​

Description

​

​

​

10.6

​

Assistance Agreement between Forge Battery, Inc. and the U.S. Department of Energy, dated April 16, 2026 (incorporated by reference to Exhibit 10.11 to the Registration Statement on Form S-4 (File No. 333-295563), filed on July 24, 2026).

10.7+

​

Forge Nano Holdings, Inc. 2026 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form 8-K, filed on October 27, 2026).

10.8

​

Amended and Restated Loan and Security Agreement, dated February 10, 2021, by and among Forge Nano and Silicon Valley Bank (incorporated by reference to Exhibit 10.19 to the Registration Statement on Form S-4 (File No. 333-295563), filed on July 24, 2026).

10.9

​

Form of Additional PIPE Subscription Agreement (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed on October 27, 2026).

10.10

​

Executive Employment Agreement, by and between Paul Lichty and Forge Nano, dated May 14, 2019 (incorporated by reference to Exhibit 10.21 to the Registration Statement on Form S-4 (File No. 333-295563), filed on July 24, 2026).

10.11

​

Executive Employment Agreement, by and between Michael Kleinberg and Forge Nano, dated September 14, 2020 (incorporated by reference to Exhibit 10.22 to the Registration Statement on Form S-4 (File No. 333-295563), filed on July 24, 2026).

10.12

​

Offer Letter, by and between Curtis Zimmermann and Forge Nano, dated June 2, 2021 (incorporated by reference to Exhibit 10.23 to the Registration Statement on Form S-4 (File No. 333-295563), filed on July 24, 2026).

10.13

​

Form of Amended and Restated PIPE Subscription Agreement, by and among ATII Holdings Inc., Archimedes Tech SPAC Partners II Co., Forge Nano, Inc. and the Initial PIPE Investor (incorporated by reference to Exhibit 10.1 to Archimedes Tech SPAC Partners II Co.’s Current Report on Form 8-K, filed on October 13, 2026).

10.14+

​

Form of Indemnification Agreement (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K, filed on October 27, 2026).

10.15+

​

Form of RSU Award Agreement (incorporated by reference to Exhibit 10.14 to the Company’s Current Report on Form 8-K, filed on October 27, 2026).

10.16+

​

Form of Earnout PSU Award Agreement (incorporated by reference to Exhibit 10.15 to the Company’s Current Report on Form 8-K, filed on October 27, 2026).

10.17

​

Earnout Escrow Agreement, dated as of October 21, 2026, by and between Forge Nano Holdings, Inc. and Odyssey Transfer and Trust Company (incorporated by reference to Exhibit 10.16 to the Company’s Current Report on Form 8-K, filed on October 27, 2026).

10.18*

​

Forge Nano, Inc. 2017 Equity Incentive Plan.

10.19*

​

Form of Stock Option Grant Notice (2017 Equity Incentive Plan).

10.20*

​

Form of Stock Option Agreement (2017 Equity Incentive Plan).

21.1

​

List of Subsidiaries of the Registrant (incorporated by reference to Exhibit 21.1 to the Company’s Current Report on Form 8-K, filed on October 27, 2026).

23.1*

​

Consent of WithumSmith+Brown, PC.

23.2*

​

Consent of Baker Tilly US, LLP.

23.3*

​

Consent of WithumSmith+Brown, PC.

23.4*

​

Consent of EisnerAmper LLP.

23.5*

​

Consent of Paul, Weiss, Rifkind, Wharton & Garrison LLP (included as part of Exhibit 5.1 hereto).

24.1*

​

Power of Attorney (included on the signature page hereto).

104

​

Cover Page Interactive Data File (embedded within the Inline XBRL document)

107*

​

Filing Fee Table

*

Filed herewith.

+

Indicates a management or compensatory plan.

†

Certain schedules and similar attachments to this Exhibit have been omitted or redacted in accordance with Items 601(a)(5), 601(b)(2)(ii) or 601(b)(10)(iv) of Regulation S-K. The Registrant agrees to furnish supplementally a copy of any omitted exhibit or schedule to the SEC upon its request.

II-5

Table of Contents

​

(b)Financial Statement Schedules

All financial statement schedules are omitted because the information called for is not required or is shown either in the consolidated financial statements or in the accompanying notes. The financial statements filed as part of this registration statement are listed in the index to the financial statements immediately preceding such financial statements, which index to the financial statements is incorporated herein by reference.

Item 17.Undertakings

Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

The undersigned registrant hereby undertakes:

1)  To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

a.To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended;
b.To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” in the effective registration statement; and
c.To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.

2)  That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

3)  To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

4)  That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

II-6

Table of Contents

​

5)  That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

a.Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;
b.Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;
c.The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and
d.Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

​

II-7

Table of Contents

​

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Thornton, State of Colorado, on November 20, 2026.

​

FORGE NANO HOLDINGS, INC.

​

​

​

By:

/s/ Paul Lichty

​

​

Name:

Paul Lichty

​

​

Title:

Chief Executive Officer

​

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of Paul Lichty and Michael Kleinberg as his or her true and lawful attorney-in-fact, with full power of substitution and resubstitution for such person in his or her name, place and stead, in any and all capacities, to sign this Registration Statement on Form S-1 (including all pre-effective and post-effective amendments and registration statements filed pursuant to Rule 462 under the Securities Act of 1933, as amended), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the U.S. Securities and Exchange Commission, granting unto said attorney-in-fact, acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that such attorney-in-fact, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

Signature

  ​ ​ ​

Title

  ​ ​ ​

Date

​

​

​

​

​

/s/ Paul Lichty

​

Chief Executive Officer and Director

​

November 20, 2026

Paul Lichty

​

(principal executive officer)

​

​

​

​

​

​

​

/s/ Michael Kleinberg

​

Chief Financial Officer

​

November 20, 2026

Michael Kleinberg

​

(principal financial and accounting officer)

​

​

​

​

​

​

​

/s/ Millicent Pitts-DiCicco

​

Director

​

November 20, 2026

Millicent Pitts-DiCicco

​

​

​

​

​

​

​

​

​

/s/ David Goggins

​

Director

​

November 20, 2026

David Goggins

​

​

​

​

​

​

​

​

​

/s/ Michael Danner

​

Director

​

November 20, 2026

Michael Danner

​

​

​

​

​

​

​

​

​

/s/ Jimmy Smith

​

Director

​

November 20, 2026

Jimmy Smith

​

​

​

​

​

​

​

​

​

/s/ Kamal Bherwani

​

Director

​

November 20, 2026

Kamal Bherwani

​

​

​

​

​

​

​

​

​

/s/ Ben Landen

​

Director

​

November 20, 2026

Ben Landen

​

​

​

​

​

II-8

Keep reading